Primary Purpose
| primary_purpose | Study_Count |
|---|---|
| Treatment | 1749 |
| Prevention | 559 |
| Supportive Care | 154 |
| Diagnostic | 151 |
| Other | 147 |
| Health Services Research | 82 |
| Basic Science | 44 |
| Screening | 35 |
| Device Feasibility | 5 |
Craig Mayer, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD
_See the full regCOVID repository with detailed results at https://github.com/lhncbc/r-snippets-bmi/tree/master/regCOVID
_See the regCOVIDpublications repository for publications from COVID-19 clinical studies: User friendly landing page
## Data as of 2021-11-01| overall_status | Study_Count |
|---|---|
| Recruiting | 2764 |
| Completed | 1690 |
| Not yet recruiting | 929 |
| Active, not recruiting | 658 |
| Enrolling by invitation | 189 |
| Withdrawn | 186 |
| Terminated | 158 |
| Suspended | 27 |
| No longer available | 16 |
| Available | 12 |
| Temporarily not available | 3 |
| Approved for marketing | 2 |
| Type | Study_count |
|---|---|
| Total_Studies | 5459 |
| interventional | 2926 |
| Observational | 2188 |
| Registry | 345 |
| intervention_type | Study_Count |
|---|---|
| Drug | 600 |
| Drug|placebo | 492 |
| Other | 328 |
| Biological | 307 |
| Behavioral | 231 |
| Biological|placebo | 179 |
| Device | 156 |
| Diagnostic Test | 114 |
| Drug|Other | 91 |
| Procedure | 47 |
| Biological|Other | 42 |
| Dietary Supplement | 41 |
| Dietary Supplement|placebo | 39 |
| Biological|Drug | 34 |
| Dietary Supplement|Drug | 19 |
| Behavioral|Other | 17 |
| Device|Other | 17 |
| Drug|Other|placebo | 13 |
| Radiation | 13 |
| Biological|Drug|placebo | 11 |
| Combination Product | 11 |
| Combination Product|Drug | 9 |
| Diagnostic Test|Other | 8 |
| Other|placebo | 7 |
| Dietary Supplement|Other | 6 |
| Behavioral|placebo | 5 |
| Device|Drug | 5 |
| Device|Drug|placebo | 5 |
| Drug|Procedure | 5 |
| Behavioral|Biological | 4 |
| Combination Product|placebo | 4 |
| Device|placebo | 4 |
| Other|Procedure | 4 |
| Device|Drug|Procedure | 3 |
| Device|Procedure | 3 |
| Dietary Supplement|Drug|placebo | 3 |
| Behavioral|Device | 2 |
| Behavioral|Drug | 2 |
| Biological|Device|Other | 2 |
| Biological|Other|placebo | 2 |
| Combination Product|Dietary Supplement | 2 |
| Combination Product|Procedure | 2 |
| Device|Drug|Radiation | 2 |
| Dietary Supplement|Drug|Other | 2 |
| Drug|placebo|Procedure | 2 |
| Genetic | 2 |
| placebo|Radiation | 2 |
| Behavioral|Combination Product | 1 |
| Behavioral|Diagnostic Test | 1 |
| Biological|Combination Product | 1 |
| Biological|Combination Product|Drug|placebo | 1 |
| Biological|Device | 1 |
| Biological|Device|Diagnostic Test | 1 |
| Biological|Device|Diagnostic Test|Other | 1 |
| Biological|Diagnostic Test | 1 |
| Biological|Dietary Supplement|placebo | 1 |
| Biological|Drug|Other | 1 |
| Biological|Drug|Other|placebo | 1 |
| Biological|Drug|Procedure | 1 |
| Biological|Genetic|Other | 1 |
| Combination Product|Device | 1 |
| Device|Drug|Other | 1 |
| Diagnostic Test|Dietary Supplement | 1 |
| Diagnostic Test|Drug | 1 |
| Diagnostic Test|Drug|Other|placebo | 1 |
| Diagnostic Test|Drug|Other|placebo|Procedure | 1 |
| Diagnostic Test|Genetic|Other | 1 |
| Dietary Supplement|Drug|Other|placebo | 1 |
| Dietary Supplement|Other|placebo | 1 |
| Drug|placebo|Radiation | 1 |
| Drug|Radiation | 1 |
| Other|Radiation | 1 |
| placebo | 1 |
| placebo|Procedure | 1 |
Weekly studies for each intervention
| Country | Study_Count |
|---|---|
| United States | 761 |
| France | 205 |
| China | 125 |
| Canada | 116 |
| Brazil | 115 |
| Spain | 112 |
| United Kingdom | 97 |
| Turkey | 85 |
| Egypt | 82 |
| Italy | 80 |
| Mexico | 69 |
| Germany | 54 |
| Belgium | 51 |
| Russian Federation | 50 |
| Pakistan | 44 |
| India | 38 |
| Israel | 32 |
| Argentina | 31 |
| Korea, Republic of | 30 |
| Sweden | 28 |
| Denmark | 27 |
| Indonesia | 25 |
| Netherlands | 24 |
| Hong Kong | 21 |
| Iran, Islamic Republic of | 21 |
| Switzerland | 21 |
| Australia | 20 |
| Bangladesh | 18 |
| Greece | 17 |
| Japan | 17 |
| Saudi Arabia | 16 |
| Taiwan | 16 |
| Colombia | 15 |
| South Africa | 13 |
| Austria | 12 |
| Chile | 12 |
| Poland | 11 |
| Singapore | 11 |
| Vietnam | 10 |
| Norway | 9 |
| Hungary | 8 |
| Thailand | 8 |
| Iraq | 7 |
| Malaysia | 7 |
| Qatar | 7 |
| United States|Canada | 7 |
| Philippines | 6 |
| Tunisia | 6 |
| United States|Puerto Rico | 6 |
| Kazakhstan | 5 |
| Peru | 5 |
| Ukraine | 5 |
| United States|Brazil | 5 |
| Bahrain | 4 |
| Czechia | 4 |
| Finland | 4 |
| Jordan | 4 |
| New Zealand | 4 |
| Romania | 4 |
| France|Monaco | 3 |
| French Guiana | 3 |
| Ireland | 3 |
| Paraguay | 3 |
| Uganda | 3 |
| United Arab Emirates | 3 |
| United States|Spain | 3 |
| Belarus | 2 |
| Belgium|France | 2 |
| Brazil|Canada | 2 |
| Brazil|Italy | 2 |
| Costa Rica | 2 |
| Georgia | 2 |
| Guinea | 2 |
| Guinea-Bissau | 2 |
| Honduras | 2 |
| Kenya | 2 |
| Kuwait | 2 |
| Lebanon | 2 |
| Nigeria | 2 |
| North Macedonia | 2 |
| Puerto Rico | 2 |
| Rwanda | 2 |
| United States|Argentina|Brazil | 2 |
| United States|Argentina|Brazil|Mexico|Peru | 2 |
| United States|China|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Netherlands|Singapore|Spain|Sweden|Switzerland|Taiwan|United Kingdom | 2 |
| United States|Italy | 2 |
| United States|Japan|Korea, Republic of|Mexico|Singapore | 2 |
| United States|Russian Federation | 2 |
| United States|Singapore | 2 |
| United States|United Kingdom | 2 |
| Argentina|Belgium|Brazil|Bulgaria|Chile|Colombia|Costa Rica|Croatia|Denmark|France|Germany|Greece|Hungary|India|Italy|Japan|Mexico|Peru|Poland|Portugal|Romania|Russian Federation|Serbia|South Africa|Spain|Switzerland|Turkey|Ukraine|United Kingdom | 1 |
| Argentina|Belgium|Colombia|Dominican Republic|Germany|Mexico|Netherlands|Panama|Peru|Spain | 1 |
| Argentina|Brazil|Bulgaria|Germany|Greece|Hungary|Poland|South Africa|Ukraine | 1 |
| Argentina|Brazil|Canada|Chile|France|Germany|Israel|Italy|Japan|Russian Federation|Spain | 1 |
| Argentina|Brazil|Chile|Mexico|Russian Federation | 1 |
| Argentina|Brazil|Denmark|Germany|Hungary|India|Mexico|Netherlands|Peru|Russian Federation|South Africa|Spain | 1 |
| Argentina|Brazil|Spain|Bulgaria|Colombia|France|Greece|Mexico|Peru|Portugal|Romania|South Africa|Turkey | 1 |
| Argentina|Chile|Mexico|Pakistan|Russian Federation | 1 |
| Argentina|Egypt | 1 |
| Argentina|Spain | 1 |
| Australia|Belgium|South Africa | 1 |
| Australia|Brazil|Netherlands|Spain|United Kingdom | 1 |
| Australia|India | 1 |
| Austria|Denmark|Germany|Russian Federation|United Kingdom | 1 |
| Austria|Germany | 1 |
| Azerbaijan | 1 |
| Bahrain|Egypt|Jordan|United Arab Emirates | 1 |
| Bangladesh|Benin|Ethiopia|Indonesia|Italy|Kenya|Lao People’s Democratic Republic|Mali|Nepal|Niger|Pakistan|Thailand|United Kingdom|Zambia | 1 |
| Bangladesh|China|India|Indonesia|Spain | 1 |
| Belarus|Russian Federation | 1 |
| Belgium|Brazil|France|Germany|Italy|Mexico|Spain|United Kingdom | 1 |
| Belgium|Brazil|France|Germany|Mexico|Netherlands|Peru|Russian Federation|South Africa | 1 |
| Belgium|France|Monaco | 1 |
| Belgium|Germany | 1 |
| Belgium|Hungary|Poland|Russian Federation | 1 |
| Belgium|Italy | 1 |
| Belgium|Italy|Spain|Switzerland | 1 |
| Bosnia and Herzegovina | 1 |
| Brazil|Argentina|Chile|France|Germany|India|Italy|Japan|Mexico|Peru|Poland|Russian Federation|South Africa|Turkey | 1 |
| Brazil|Canada|Colombia|Ecuador|Egypt|India|Pakistan|Philippines|Russian Federation|Saudi Arabia|United Arab Emirates | 1 |
| Brazil|Canada|Hungary|Mexico|Serbia | 1 |
| Brazil|Canada|Mexico | 1 |
| Brazil|Chile|Colombia | 1 |
| Brazil|France|Russian Federation|Spain | 1 |
| Brazil|Malaysia | 1 |
| Brazil|Mexico|Switzerland | 1 |
| Brazil|Mexico|United Kingdom | 1 |
| Brazil|Poland|South Africa|United Kingdom | 1 |
| Brazil|Switzerland | 1 |
| Brazil|United States|Argentina|Bulgaria|Colombia|Czechia|Hungary|India|Japan|Korea, Republic of|Malaysia|Mexico|Poland|Puerto Rico|Russian Federation|South Africa|Spain|Taiwan|Thailand|Turkey|Ukraine | 1 |
| Brazil|United States|Philippines | 1 |
| Bulgaria | 1 |
| Bulgaria|Canada|Greece|Ireland|Latvia|Lithuania|Poland|Spain|United Kingdom | 1 |
| Bulgaria|Germany | 1 |
| Bulgaria|Greece|Romania|Spain|Turkey | 1 |
| Bulgaria|Israel|Romania | 1 |
| Burkina Faso|Guinea | 1 |
| Burkina Faso|Kenya | 1 |
| Côte D’Ivoire | 1 |
| Cameroon | 1 |
| Canada|India|Thailand | 1 |
| Canada|Israel | 1 |
| Canada|Mexico | 1 |
| Canada|Mongolia | 1 |
| Cape Verde|Guinea-Bissau|Mozambique | 1 |
| China|Ecuador|Indonesia|Pakistan|Uzbekistan | 1 |
| China|Italy | 1 |
| Croatia | 1 |
| Cyprus | 1 |
| Czechia|Romania|United Kingdom | 1 |
| Denmark|India|Sweden|Switzerland | 1 |
| Denmark|Portugal|United States|Spain|United Kingdom | 1 |
| Denmark|Sweden | 1 |
| Dominican Republic | 1 |
| Ecuador | 1 |
| Estonia | 1 |
| France|Austria|Belgium|Brazil|Denmark|Germany|Italy|Netherlands|Portugal|Russian Federation|Spain | 1 |
| France|Austria|Belgium|Luxembourg|Norway|Portugal | 1 |
| France|French Guiana | 1 |
| France|Martinique|Réunion | 1 |
| France|Morocco|Serbia | 1 |
| France|United States|Belgium|Spain|United Kingdom | 1 |
| French Guiana|Guadeloupe|New Caledonia | 1 |
| Gambia | 1 |
| Germany|India|Netherlands|Poland|Romania|South Africa|Spain | 1 |
| Germany|Israel | 1 |
| Germany|Netherlands|Spain|United Kingdom | 1 |
| Germany|Spain | 1 |
| Germany|Sweden | 1 |
| Germany|Switzerland | 1 |
| Germany|United States|Argentina|Brazil|Bulgaria|Czechia|Hungary|Italy|Japan|Mexico|Peru|Poland|Russian Federation|Spain|Ukraine|United Kingdom | 1 |
| Ghana | 1 |
| Ghana|India|Indonesia|Nepal|South Africa|Sri Lanka|United Kingdom|Vietnam | 1 |
| Greece|Italy | 1 |
| Greece|Italy|Poland|Portugal|Spain|Turkey | 1 |
| Greece|Mexico | 1 |
| Iceland | 1 |
| India|Israel | 1 |
| India|South Africa | 1 |
| India|United Kingdom | 1 |
| Indonesia|Kenya|Mexico|Philippines | 1 |
| Italy|Russian Federation | 1 |
| Jamaica | 1 |
| Jordan|Kenya|Lebanon | 1 |
| Korea, Republic of|New Zealand|Philippines|Thailand|Ukraine|Vietnam | 1 |
| Kuwait|Qatar | 1 |
| Kyrgyzstan | 1 |
| Mali | 1 |
| Moldova, Republic of | 1 |
| Monaco | 1 |
| 1 | |
| Nepal | 1 |
| Oman | 1 |
| Panama | 1 |
| Panama|Peru | 1 |
| Poland|United States|Argentina|Belgium|Brazil|Canada|Chile|Colombia|France|India|Italy|Japan|Mexico|Netherlands|Peru|Russian Federation|South Africa|Spain|United Kingdom | 1 |
| Portugal | 1 |
| Romania|Spain | 1 |
| Russian Federation|Slovakia | 1 |
| Russian Federation|Spain | 1 |
| Senegal | 1 |
| Slovakia | 1 |
| Slovenia | 1 |
| South Africa|United Kingdom | 1 |
| Spain|United Kingdom|United States|Denmark|Greece|Japan|Nigeria | 1 |
| Taiwan|Vietnam | 1 |
| United States|Argentina|Belgium|Brazil|Colombia|France|Germany|India|Israel|Italy|Mexico|Netherlands|Portugal|Romania|Serbia|Spain|United Kingdom | 1 |
| United States|Argentina|Brazil|Bulgaria|Colombia|Mexico | 1 |
| United States|Argentina|Brazil|Canada|Chile|Colombia|Egypt|France|Germany|Guatemala|Israel|Italy|Japan|Mexico|Philippines|Poland|Russian Federation|South Africa|Spain|Sweden|Taiwan|Ukraine|United Kingdom | 1 |
| United States|Argentina|Brazil|Canada|Chile|Colombia|Germany|Italy|Mexico|Peru|Spain|Ukraine | 1 |
| United States|Argentina|Brazil|Canada|India|Mexico|United Kingdom | 1 |
| United States|Argentina|Brazil|Canada|Mexico|Philippines|Puerto Rico|South Africa | 1 |
| United States|Argentina|Brazil|Canada|Mexico|United Kingdom | 1 |
| United States|Argentina|Brazil|Chile|Colombia|Mexico|Peru | 1 |
| United States|Argentina|Brazil|Chile|Colombia|Mexico|Peru|South Africa | 1 |
| United States|Argentina|Brazil|Chile|Mexico|Russian Federation|South Africa|Ukraine | 1 |
| United States|Argentina|Brazil|Colombia|Czechia|Peru|Philippines|Ukraine | 1 |
| United States|Argentina|Brazil|Colombia|France|Germany|Mexico|Peru|Russian Federation|Spain|Turkey|United Kingdom | 1 |
| United States|Argentina|Brazil|Colombia|France|Guatemala|Hungary|Japan|Mexico|Romania|Russian Federation|Spain|Turkey|Ukraine | 1 |
| United States|Argentina|Brazil|Colombia|Hungary|Japan|Korea, Republic of|Malaysia|Puerto Rico|Spain|Taiwan|Thailand|Turkey | 1 |
| United States|Argentina|Brazil|Colombia|India|Mexico|Peru|Philippines|Ukraine | 1 |
| United States|Argentina|Brazil|Germany|India|Italy|Japan|Korea, Republic of|Mexico|Puerto Rico|Russian Federation|Spain|United Kingdom | 1 |
| United States|Argentina|Brazil|Germany|South Africa|Turkey | 1 |
| United States|Argentina|Chile|Colombia|Peru | 1 |
| United States|Argentina|Denmark|Georgia|Greece|India|Mozambique|Nigeria|Poland|Singapore|Spain|Switzerland|Uganda|United Kingdom | 1 |
| United States|Argentina|Peru | 1 |
| United States|Argentina|Puerto Rico | 1 |
| United States|Australia | 1 |
| United States|Australia|Belgium|Brazil|Colombia|France|Mexico|Poland|Portugal|South Africa|Spain | 1 |
| United States|Australia|Brazil|Honduras | 1 |
| United States|Australia|Brazil|Mexico|South Africa | 1 |
| United States|Australia|Honduras | 1 |
| United States|Australia|Philippines|Romania | 1 |
| United States|Austria|Belgium | 1 |
| United States|Austria|Brazil|Canada|Peru|Spain|United Kingdom | 1 |
| United States|Austria|France|Israel|Spain|United Kingdom | 1 |
| United States|Belgium | 1 |
| United States|Belgium|Brazil|Colombia|France|Germany|Philippines|South Africa|Spain|United Kingdom | 1 |
| United States|Belgium|Brazil|France|Puerto Rico | 1 |
| United States|Belgium|Brazil|Moldova, Republic of|Romania|South Africa|Ukraine | 1 |
| United States|Belgium|Brazil|Spain | 1 |
| United States|Belgium|Canada|France|Japan|Spain | 1 |
| United States|Belgium|France|Netherlands | 1 |
| United States|Brazil|Canada | 1 |
| United States|Brazil|Canada|Chile|Colombia|France|Israel|Italy|Korea, Republic of|Mexico|Philippines|Poland|Russian Federation|South Africa|Spain|Ukraine|United Kingdom | 1 |
| United States|Brazil|Canada|Greece|South Africa|Spain | 1 |
| United States|Brazil|Canada|Mexico | 1 |
| United States|Brazil|Canada|South Africa | 1 |
| United States|Brazil|Chile|Colombia | 1 |
| United States|Brazil|Chile|Mexico|Moldova, Republic of|Romania | 1 |
| United States|Brazil|Chile|Mexico|Puerto Rico|Spain | 1 |
| United States|Brazil|Chile|Peru|South Africa | 1 |
| United States|Brazil|Colombia|India|Mexico | 1 |
| United States|Brazil|Colombia|Israel|Italy|Mexico|Peru|Poland|Russian Federation|United Kingdom | 1 |
| United States|Brazil|Colombia|Mexico|Philippines | 1 |
| United States|Brazil|Finland|Moldova, Republic of|Romania|Ukraine|United Kingdom | 1 |
| United States|Brazil|Germany|Poland|South Africa | 1 |
| United States|Brazil|Hungary|Japan|Korea, Republic of|Malaysia|Mexico|Poland|Puerto Rico|Taiwan|Thailand|Turkey | 1 |
| United States|Brazil|Kenya|Mexico|Peru|South Africa | 1 |
| United States|Brazil|Mexico | 1 |
| United States|Brazil|Mexico|Peru | 1 |
| United States|Brazil|Mexico|Spain | 1 |
| United States|Brazil|Russian Federation|Spain | 1 |
| United States|Brazil|South Africa | 1 |
| United States|Brazil|South Africa|Spain|United Kingdom | 1 |
| United States|Canada|Colombia | 1 |
| United States|Canada|Denmark|France|Germany|Italy|Netherlands|Spain|United Kingdom | 1 |
| United States|Canada|Italy|Korea, Republic of|Spain | 1 |
| United States|Canada|Kuwait|Saudi Arabia | 1 |
| United States|Canada|Turkey | 1 |
| United States|Chile|Mexico|Romania | 1 |
| United States|Colombia | 1 |
| United States|Colombia|Ghana|Honduras|India|Japan|Kenya|Nepal | 1 |
| United States|Czechia|Georgia|Moldova, Republic of|Poland|Romania|Ukraine | 1 |
| United States|Denmark|Germany|Greece|Japan|Korea, Republic of|Mexico|Singapore|Spain|United Kingdom | 1 |
| United States|Denmark|Japan|Korea, Republic of|Mexico|Singapore|Spain|United Kingdom | 1 |
| United States|Finland|Poland|Spain | 1 |
| United States|France|Italy|Russian Federation|Spain|United Kingdom | 1 |
| United States|France|Japan|Spain|United Kingdom | 1 |
| United States|France|Ukraine | 1 |
| United States|Ghana|South Africa|United Kingdom|Zambia | 1 |
| United States|Hungary|India|Netherlands|Poland|South Africa | 1 |
| United States|Hungary|Israel|Netherlands|Puerto Rico | 1 |
| United States|India|Ukraine | 1 |
| United States|Israel | 1 |
| United States|Italy|Spain|United Kingdom | 1 |
| United States|Italy|United Kingdom | 1 |
| United States|Korea, Republic of | 1 |
| United States|Mexico|Puerto Rico | 1 |
| United States|Moldova, Republic of|Philippines|Romania|Ukraine|United Kingdom | 1 |
| United States|Moldova, Republic of|Romania | 1 |
| United States|Netherlands|Switzerland | 1 |
| United States|New Zealand | 1 |
| United States|North Macedonia|Puerto Rico | 1 |
| United States|Portugal|Spain|United Kingdom | 1 |
| United States|Russian Federation|Ukraine | 1 |
| United States|South Africa | 1 |
| United States|Spain|Uganda | 1 |
| United States|Sweden | 1 |
| United States|Uganda | 1 |
| Site_count | Study_Count |
|---|---|
| 1 | 1900 |
| 2 | 247 |
| 3 | 115 |
| 4 | 103 |
| 5 | 55 |
| 6 | 46 |
| 7 | 40 |
| 8 | 42 |
| 9 | 26 |
| 10 | 22 |
| 11 | 28 |
| 12 | 26 |
| 13 | 14 |
| 14 | 16 |
| 15 | 5 |
| 16 | 9 |
| 17 | 12 |
| 18 | 14 |
| 19 | 7 |
| 20 | 6 |
| 21 | 14 |
| 22 | 7 |
| 23 | 5 |
| 24 | 7 |
| 25 | 9 |
| 26 | 6 |
| 27 | 4 |
| 28 | 4 |
| 29 | 6 |
| 30 | 5 |
| 31 | 9 |
| 32 | 1 |
| 33 | 2 |
| 34 | 3 |
| 35 | 1 |
| 36 | 4 |
| 37 | 1 |
| 38 | 1 |
| 39 | 5 |
| 40 | 5 |
| 41 | 5 |
| 42 | 4 |
| 43 | 2 |
| 45 | 1 |
| 47 | 2 |
| 48 | 1 |
| 50 | 2 |
| 51 | 1 |
| 53 | 3 |
| 55 | 4 |
| 56 | 1 |
| 57 | 4 |
| 58 | 1 |
| 59 | 2 |
| 60 | 4 |
| 61 | 2 |
| 62 | 3 |
| 63 | 2 |
| 64 | 1 |
| 65 | 2 |
| 69 | 1 |
| 71 | 2 |
| 72 | 1 |
| 73 | 1 |
| 74 | 1 |
| 79 | 1 |
| 80 | 1 |
| 81 | 1 |
| 86 | 1 |
| 89 | 1 |
| 91 | 4 |
| 92 | 1 |
| 94 | 1 |
| 95 | 1 |
| 96 | 1 |
| 100 | 1 |
| 105 | 3 |
| 106 | 1 |
| 107 | 1 |
| 115 | 1 |
| 116 | 1 |
| 120 | 1 |
| 121 | 1 |
| 123 | 1 |
| 125 | 2 |
| 134 | 1 |
| 139 | 1 |
| 141 | 1 |
| 146 | 1 |
| 148 | 1 |
| 164 | 1 |
| 166 | 1 |
| 173 | 1 |
| 175 | 1 |
| 183 | 1 |
| 184 | 1 |
| 218 | 1 |
| 225 | 1 |
| 245 | 1 |
| 359 | 1 |
| Phase | Study_Count |
|---|---|
| N/A | 1132 |
| Phase 2 | 634 |
| Phase 3 | 403 |
| Phase 1 | 200 |
| Phase 2/Phase 3 | 184 |
| Phase 1/Phase 2 | 172 |
| Phase 4 | 165 |
| Early Phase 1 | 36 |
| Number_of_Arms | Count_of_Studies |
|---|---|
| 1 | 489 |
| 2 | 1749 |
| 3 | 308 |
| 4 | 175 |
| 5 | 38 |
| 6 | 51 |
| 7 | 13 |
| 8 | 24 |
| 9 | 15 |
| 10 | 8 |
| 11 | 1 |
| 12 | 11 |
| 14 | 3 |
| 15 | 7 |
| 16 | 4 |
| 17 | 2 |
| 18 | 2 |
| 19 | 2 |
| 20 | 1 |
| 21 | 1 |
| 22 | 1 |
| 29 | 1 |
| 32 | 1 |
| 19 |
| Count of Versions | Count of Studies |
|---|---|
| 1 | 516 |
| 2 | 626 |
| 3 | 529 |
| 4 | 419 |
| 5 | 239 |
| 6 | 158 |
| 7 | 114 |
| 8 | 73 |
| 9 | 48 |
| 10 | 39 |
| 11 | 16 |
| 12 | 14 |
| 13 | 20 |
| 14 | 13 |
| 15 | 12 |
| 16 | 11 |
| 17 | 10 |
| 18 | 7 |
| 19 | 9 |
| 20 | 9 |
| 21 | 8 |
| 22 | 7 |
| 23 | 3 |
| 24 | 1 |
| 25 | 1 |
| 26 | 4 |
| 27 | 2 |
| 30 | 2 |
| 31 | 1 |
| 32 | 1 |
| 33 | 1 |
| 34 | 2 |
| 35 | 1 |
| 36 | 1 |
| 47 | 2 |
| 48 | 2 |
| 54 | 1 |
| 55 | 1 |
| 73 | 1 |
| 88 | 1 |
| 357 | 1 |
| Change Type | Count_of_Changes | Count_of_Studies | ratio |
|---|---|---|---|
| Study Status | 9901 | 2410 | 4.108299 |
| Contacts/Locations | 5518 | 2000 | 2.759000 |
| None (earliest Version on record) | 2926 | 2926 | 1.000000 |
| Recruitment Status | 2886 | 1908 | 1.512579 |
| Study Design | 1852 | 1334 | 1.388306 |
| Outcome Measures | 1671 | 1130 | 1.478761 |
| Eligibility | 1415 | 898 | 1.575724 |
| Study Description | 1238 | 869 | 1.424626 |
| Study Identification | 1051 | 806 | 1.303970 |
| Arms | 1019 | 696 | 1.464080 |
| Interventions | 1019 | 696 | 1.464080 |
| Oversight | 849 | 798 | 1.063910 |
| Sponsor/Collaborators | 464 | 367 | 1.264305 |
| Conditions | 323 | 272 | 1.187500 |
| Document Section | 211 | 168 | 1.255952 |
| References | 183 | 137 | 1.335766 |
| IPDSharing | 151 | 137 | 1.102190 |
| Results | 58 | 58 | 1.000000 |
| 2021 Outcome Measures | 46 | 33 | 1.393939 |
| Adverse Events | 38 | 29 | 1.310345 |
| Results Submission Events | 36 | 36 | 1.000000 |
| Baseline Characteristics | 28 | 21 | 1.333333 |
| Participant Flow | 21 | 19 | 1.105263 |
| 2021Recruitment Status | 17 | 17 | 1.000000 |
| 2021 Study Status | 13 | 12 | 1.083333 |
| More Information | 6 | 6 | 1.000000 |
| 2021 Document Section | 5 | 3 | 1.666667 |
| 2020Recruitment Status | 4 | 3 | 1.333333 |
| 2021 Baseline Characteristics | 4 | 4 | 1.000000 |
| Quality Control Review has not concludedReturned: March 8 | 3 | 3 | 1.000000 |
| Quality Control Review has not concludedReturned: May 11 | 3 | 3 | 1.000000 |
| Quality Control Review has not concludedReturned: October 4 | 3 | 3 | 1.000000 |
| 2021 Adverse Events | 2 | 2 | 1.000000 |
| 2021 IPDSharing | 2 | 2 | 1.000000 |
| Quality Control Review has not concludedReturned: April 12 | 2 | 2 | 1.000000 |
| Quality Control Review has not concludedReturned: April 13 | 2 | 2 | 1.000000 |
| Quality Control Review has not concludedReturned: April 20 | 2 | 2 | 1.000000 |
| Quality Control Review has not concludedReturned: April 27 | 2 | 2 | 1.000000 |
| Quality Control Review has not concludedReturned: April 30 | 2 | 2 | 1.000000 |
| Quality Control Review has not concludedReturned: August 12 | 2 | 2 | 1.000000 |
| Quality Control Review has not concludedReturned: August 18 | 2 | 2 | 1.000000 |
| Quality Control Review has not concludedReturned: August 24 | 2 | 2 | 1.000000 |
| Quality Control Review has not concludedReturned: August 25 | 2 | 2 | 1.000000 |
| Quality Control Review has not concludedReturned: August 4 | 2 | 2 | 1.000000 |
| Quality Control Review has not concludedReturned: June 24 | 2 | 2 | 1.000000 |
| Quality Control Review has not concludedReturned: June 7 | 2 | 2 | 1.000000 |
| Quality Control Review has not concludedReturned: May 5 | 2 | 2 | 1.000000 |
| Quality Control Review has not concludedReturned: October 14 | 2 | 2 | 1.000000 |
| Quality Control Review has not concludedReturned: September 10 | 2 | 2 | 1.000000 |
| Quality Control Review has not concludedReturned: September 24 | 2 | 2 | 1.000000 |
| 2020 Adverse Events | 1 | 1 | 1.000000 |
| 2020 IPDSharing | 1 | 1 | 1.000000 |
| 2020 Outcome Measures | 1 | 1 | 1.000000 |
| 2021 Contacts/Locations | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: April 1 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: April 2 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: April 28 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: April 29 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: April 6 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: April 8 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: August 10 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: August 11 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: August 13 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: August 23 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: August 26 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: August 5 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: August 6 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: August 9 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: December 30 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: December 8 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: February 19 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: July 16 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: July 21 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: July 22 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: July 27 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: July 29 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: July 7 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: June 11 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: June 14 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: June 16 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: June 29 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: June 3 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: June 4 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: June 8 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: March 17 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: March 18 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: March 22 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: March 24 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: May 18 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: May 19 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: May 21 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: May 24 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: May 26 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: May 27 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: May 3 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: November 17 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: November 24 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: October 12 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: October 19 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: October 20 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: October 22 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: October 25 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: October 5 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: October 6 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: October 7 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: October 8 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: September 1 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: September 13 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: September 27 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: September 3 | 1 | 1 | 1.000000 |
| Measure | Early.Phase.1 | N.A | Phase.1 | Phase.1.Phase.2 | Phase.2 | Phase.2.Phase.3 | Phase.3 | Phase.4 |
|---|---|---|---|---|---|---|---|---|
| Min. | 3.00000 | 1.00 | 1.0 | 1.0000 | 1.0000 | 3.000 | 1.000 | 1.000 |
| 1st Qu. | 20.00000 | 49.75 | 22.5 | 39.5000 | 48.0000 | 120.000 | 146.000 | 60.000 |
| Median | 33.00000 | 108.00 | 40.0 | 89.0000 | 100.0000 | 315.000 | 432.000 | 170.000 |
| Mean | 97.88889 | 24284.09 | 65.0 | 268.3314 | 234.1719 | 1761.598 | 3820.489 | 1945.915 |
| 3rd Qu. | 100.00000 | 342.50 | 68.5 | 227.2500 | 200.0000 | 714.500 | 1200.000 | 576.000 |
| Max. | 1000.00000 | 20000000.00 | 974.0 | 5394.0000 | 10000.0000 | 45000.000 | 500000.000 | 121000.000 |
| group_type | Group_Count |
|---|---|
| Experimental | 3992 |
| Active Comparator | 1144 |
| Placebo Comparator | 1088 |
| No Intervention | 569 |
| Other | 359 |
| Sham Comparator | 39 |
| 19 |
| intervention_model | Study_Count |
|---|---|
| Parallel Assignment | 2122 |
| Single Group Assignment | 548 |
| Sequential Assignment | 145 |
| Crossover Assignment | 67 |
| Factorial Assignment | 44 |
| primary_purpose | Study_Count |
|---|---|
| Treatment | 1749 |
| Prevention | 559 |
| Supportive Care | 154 |
| Diagnostic | 151 |
| Other | 147 |
| Health Services Research | 82 |
| Basic Science | 44 |
| Screening | 35 |
| Device Feasibility | 5 |
| nct_id | brief_title | link |
|---|---|---|
| NCT04380688 | Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. | https://ClinicalTrials.gov/show/NCT04380688 |
| NCT04365153 | Canakinumab in Covid-19 Cardiac Injury (The Three C Study) | https://ClinicalTrials.gov/show/NCT04365153 |
| NCT04372186 | A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04372186 |
| NCT04371419 | COVID-19 Health Messaging to Underserved Communities | https://ClinicalTrials.gov/show/NCT04371419 |
| NCT04370834 | Tocilizumab for Patients With Cancer and COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04370834 |
| NCT04365699 | Cardiovascular Effects of COVID-19 | https://ClinicalTrials.gov/show/NCT04365699 |
| NCT04363736 | A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04363736 |
| NCT04362813 | Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia | https://ClinicalTrials.gov/show/NCT04362813 |
| NCT04362137 | Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm | https://ClinicalTrials.gov/show/NCT04362137 |
| NCT04358081 | Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04358081 |
| NCT04356937 | Efficacy of Tocilizumab on Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04356937 |
| NCT04354870 | COVID-19 PrEP HCW HCQ Study | https://ClinicalTrials.gov/show/NCT04354870 |
| NCT04345653 | Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers | https://ClinicalTrials.gov/show/NCT04345653 |
| NCT04343092 | Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management | https://ClinicalTrials.gov/show/NCT04343092 |
| NCT04342897 | A Study of LY3127804 in Participants With COVID-19 | https://ClinicalTrials.gov/show/NCT04342897 |
| NCT04340557 | Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04340557 |
| NCT04338074 | TXA and Corona Virus 2019 (COVID19) in Outpatients | https://ClinicalTrials.gov/show/NCT04338074 |
| NCT04346199 | Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. | https://ClinicalTrials.gov/show/NCT04346199 |
| NCT04343261 | Convalescent Plasma in the Treatment of COVID 19 | https://ClinicalTrials.gov/show/NCT04343261 |
| NCT04342663 | A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04342663 |
| NCT04338009 | Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019 | https://ClinicalTrials.gov/show/NCT04338009 |
| NCT04335136 | Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04335136 |
| NCT04335552 | Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04335552 |
| NCT04334876 | Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers | https://ClinicalTrials.gov/show/NCT04334876 |
| NCT04333225 | Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers | https://ClinicalTrials.gov/show/NCT04333225 |
| NCT04332991 | Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease | https://ClinicalTrials.gov/show/NCT04332991 |
| NCT04331899 | Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19 | https://ClinicalTrials.gov/show/NCT04331899 |
| NCT04332107 | Azithromycin for COVID-19 Treatment in Outpatients Nationwide | https://ClinicalTrials.gov/show/NCT04332107 |
| NCT04332081 | Hyperbaric Oxygen for COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04332081 |
| NCT04331366 | Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19 | https://ClinicalTrials.gov/show/NCT04331366 |
| NCT04329923 | The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine) | https://ClinicalTrials.gov/show/NCT04329923 |
| NCT04328467 | Pre-exposure Prophylaxis for SARS-Coronavirus-2 | https://ClinicalTrials.gov/show/NCT04328467 |
| NCT04327388 | Sarilumab COVID-19 | https://ClinicalTrials.gov/show/NCT04327388 |
| NCT04322682 | Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) | https://ClinicalTrials.gov/show/NCT04322682 |
| NCT04322396 | Proactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04322396 |
| NCT04320615 | A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04320615 |
| NCT04317040 | CD24Fc (MK-7110) as a Non-antiviral Immunomodulator in COVID-19 Treatment (MK-7110-007) | https://ClinicalTrials.gov/show/NCT04317040 |
| NCT04315298 | Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04315298 |
| NCT04308668 | Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2 | https://ClinicalTrials.gov/show/NCT04308668 |
| NCT04292899 | Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Severe Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04292899 |
| NCT04292730 | Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment | https://ClinicalTrials.gov/show/NCT04292730 |
| NCT04280705 | Adaptive COVID-19 Treatment Trial (ACTT) | https://ClinicalTrials.gov/show/NCT04280705 |
| NCT04355767 | Convalescent Plasma in Outpatients With COVID-19 | https://ClinicalTrials.gov/show/NCT04355767 |
| NCT04353037 | PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine | https://ClinicalTrials.gov/show/NCT04353037 |
| NCT04347954 | PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19) | https://ClinicalTrials.gov/show/NCT04347954 |
| NCT04504032 | A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19) | https://ClinicalTrials.gov/show/NCT04504032 |
| NCT04558125 | Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism | https://ClinicalTrials.gov/show/NCT04558125 |
| NCT04381988 | A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy | https://ClinicalTrials.gov/show/NCT04381988 |
| NCT04418947 | Project Resurgence Communication Trial | https://ClinicalTrials.gov/show/NCT04418947 |
| NCT04484207 | Addressing COVID-19 Mental Health Problems Among US Veterans | https://ClinicalTrials.gov/show/NCT04484207 |
| NCT04358068 | Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19 | https://ClinicalTrials.gov/show/NCT04358068 |
| NCT04871815 | Effects of Sodium Pyruvate Nasal Spray in COVID-19 Long Haulers. | https://ClinicalTrials.gov/show/NCT04871815 |
| NCT04732819 | Improving COVID-19 Vaccine Uptake in Nursing Homes | https://ClinicalTrials.gov/show/NCT04732819 |
| NCT04728594 | Emails Promoting COVID-19 Vaccination Among Healthcare Workers | https://ClinicalTrials.gov/show/NCT04728594 |
| NCT04728802 | Proxalutamide Treatment for Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04728802 |
| NCT04724538 | Inhalation Low Dose Radionuclide Therapy in Treatment COVID-19 | https://ClinicalTrials.gov/show/NCT04724538 |
| NCT04716426 | APTâ„¢ T3X on the COVID-19 Contamination Rate | https://ClinicalTrials.gov/show/NCT04716426 |
| NCT04698993 | Dräger COVID-19 Antigen Test Clinical Performance Study | https://ClinicalTrials.gov/show/NCT04698993 |
| NCT04674644 | Analysing the Psychosocial Effects of COVID-19 Pandemic on Dental Professionals Using the Turkish Version of the Fear of COVID-19 and Coronavirus Anxiety Scales | https://ClinicalTrials.gov/show/NCT04674644 |
| NCT04673214 | Evaluation of Prognostic Modification in COVID-19 Patients in Early Intervention Treatment | https://ClinicalTrials.gov/show/NCT04673214 |
| NCT04646109 | Ivermectin for Severe COVID-19 Management | https://ClinicalTrials.gov/show/NCT04646109 |
| NCT04634903 | Testing Scalable, Single-Session Interventions for Adolescent Depression in the Context of COVID-19 | https://ClinicalTrials.gov/show/NCT04634903 |
| NCT04610489 | Diagnostic Performance of an Antigen Test for SARS-CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04610489 |
| NCT04599959 | COVID-19 Tests: Nasopharyngeal Swab vs Saliva Collected With Salivette® Cortisol for Viral RNA Sampling for RT-qPCR | https://ClinicalTrials.gov/show/NCT04599959 |
| NCT04596085 | Study to Evaluate Efficacy and Safety of “VIRACIDE” IN THE MANAGEMENT OF CORONA VIRUS DISEASE 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04596085 |
| NCT04542694 | Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04542694 |
| NCT04523831 | Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04523831 |
| NCT04507867 | Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III | https://ClinicalTrials.gov/show/NCT04507867 |
| NCT04502056 | Covid-19 Messaging to Underserved Communities - 2nd Experiment | https://ClinicalTrials.gov/show/NCT04502056 |
| NCT04491994 | Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression | https://ClinicalTrials.gov/show/NCT04491994 |
| NCT04491240 | Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia. | https://ClinicalTrials.gov/show/NCT04491240 |
| NCT04475588 | Efficacy and Safety of Itolizumab in COVID-19 Complications | https://ClinicalTrials.gov/show/NCT04475588 |
| NCT04463004 | Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation | https://ClinicalTrials.gov/show/NCT04463004 |
| NCT04452435 | Safety and Efficacy of C21 in Subjects With COVID-19 | https://ClinicalTrials.gov/show/NCT04452435 |
| NCT04446429 | Anti-Androgen Treatment for COVID-19 | https://ClinicalTrials.gov/show/NCT04446429 |
| NCT04435808 | Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19 | https://ClinicalTrials.gov/show/NCT04435808 |
| NCT04422561 | Prophylactic Ivermectin in COVID-19 Contacts | https://ClinicalTrials.gov/show/NCT04422561 |
| NCT04421404 | Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04421404 |
| NCT04411667 | Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04411667 |
| NCT04409886 | Hyperbaric Oxygen Therapy in Non-ventilated COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04409886 |
| NCT04410159 | Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04410159 |
| NCT04407507 | Efficacy, Safety and Tolerability of Ivermectin in Subjects Infected With SARS-CoV-2 With or Without Symptoms | https://ClinicalTrials.gov/show/NCT04407507 |
| NCT04402970 | Dornase Alfa for ARDS in Patients With Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) | https://ClinicalTrials.gov/show/NCT04402970 |
| NCT04401579 | Adaptive COVID-19 Treatment Trial 2 (ACTT-2) | https://ClinicalTrials.gov/show/NCT04401579 |
| NCT04401202 | Nigella Sativa in COVID-19 | https://ClinicalTrials.gov/show/NCT04401202 |
| NCT04399980 | Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation | https://ClinicalTrials.gov/show/NCT04399980 |
| NCT04392219 | COVID-19 First In Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of EIDD-2801 in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT04392219 |
| NCT04392141 | Colchicine Plus Phenolic Monoterpenes to Treat COVID-19 | https://ClinicalTrials.gov/show/NCT04392141 |
| NCT04390022 | Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial | https://ClinicalTrials.gov/show/NCT04390022 |
| NCT04382066 | Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04382066 |
| nct_id | brief_title | link |
|---|---|---|
| NCT04380701 | A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy and Immunocompromised Adults | https://ClinicalTrials.gov/show/NCT04380701 |
| NCT04380532 | Tableted COVID-19 Therapeutic Vaccine | https://ClinicalTrials.gov/show/NCT04380532 |
| NCT04379336 | BCG Vaccination for Healthcare Workers in COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04379336 |
| NCT04373291 | Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04373291 |
| NCT04368988 | Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant | https://ClinicalTrials.gov/show/NCT04368988 |
| NCT04372589 | Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC) | https://ClinicalTrials.gov/show/NCT04372589 |
| NCT04369794 | COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement | https://ClinicalTrials.gov/show/NCT04369794 |
| NCT04352608 | Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04352608 |
| NCT04348370 | BCG Vaccine for Health Care Workers as Defense Against COVID 19 | https://ClinicalTrials.gov/show/NCT04348370 |
| NCT04341389 | A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector) | https://ClinicalTrials.gov/show/NCT04341389 |
| NCT04336410 | Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT04336410 |
| NCT04334980 | Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19 | https://ClinicalTrials.gov/show/NCT04334980 |
| NCT04328441 | Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine | https://ClinicalTrials.gov/show/NCT04328441 |
| NCT04327206 | BCG Vaccination to Protect Healthcare Workers Against COVID-19 | https://ClinicalTrials.gov/show/NCT04327206 |
| NCT04324606 | A Study of a Candidate COVID-19 Vaccine (COV001) | https://ClinicalTrials.gov/show/NCT04324606 |
| NCT04313127 | Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults | https://ClinicalTrials.gov/show/NCT04313127 |
| NCT04299724 | Safety and Immunity of Covid-19 aAPC Vaccine | https://ClinicalTrials.gov/show/NCT04299724 |
| NCT04283461 | Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04283461 |
| NCT04276896 | Immunity and Safety of Covid-19 Synthetic Minigene Vaccine | https://ClinicalTrials.gov/show/NCT04276896 |
| NCT05028361 | Simultaneous mRNA COVID-19 and IIV4 Vaccination Study | https://ClinicalTrials.gov/show/NCT05028361 |
| NCT05012943 | The ARCT-154 Self-Amplifying RNA Vaccine Efficacy Study (ARCT-154-01) | https://ClinicalTrials.gov/show/NCT05012943 |
| NCT04838795 | Sisonke (Together): OPEN LABEL TRIAL COVID-19 | https://ClinicalTrials.gov/show/NCT04838795 |
| NCT04522089 | A Study to Evaluate the Safety and Immunogenicity of COVID-19 (AdimrSC-2f) Vaccine | https://ClinicalTrials.gov/show/NCT04522089 |
| NCT04951336 | RCT of Mushroom Based Natural Product to Enhance Immune Response to COVID-19 Vaccination | https://ClinicalTrials.gov/show/NCT04951336 |
| NCT04942405 | Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) Versus the CoronaVac Vaccine | https://ClinicalTrials.gov/show/NCT04942405 |
| NCT04852861 | COVID-19: Safety and Immunogenicity of a Reduced Dose of the BioNTech/Pfizer BNT162b2 Vaccine | https://ClinicalTrials.gov/show/NCT04852861 |
| NCT05085145 | Immunogenicity and Safety of COVID-19 Vaccine in People Living With HIV | https://ClinicalTrials.gov/show/NCT05085145 |
| NCT05028257 | Allergy and COVID-19 Vaccines | https://ClinicalTrials.gov/show/NCT05028257 |
| NCT05047770 | A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine | https://ClinicalTrials.gov/show/NCT05047770 |
| NCT04790851 | Evaluation of Immunogenicity and Safety of Combined Immunization of COVID-19 Vaccine (Produced in Beijing) and PPV23 / IIV4 | https://ClinicalTrials.gov/show/NCT04790851 |
| NCT04400838 | Investigating a Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04400838 |
| NCT05087173 | Effectiveness of Using Interactive Consulting System to Enhance Decision Aids of COVID-19 Vaccination | https://ClinicalTrials.gov/show/NCT05087173 |
| NCT04904471 | A Global Phase III Clinical Trial of Recombinant COVID- 19 Vaccine (Sf9 Cells) | https://ClinicalTrials.gov/show/NCT04904471 |
| NCT04952376 | Equitable Access to COVID-19 Vaccines | https://ClinicalTrials.gov/show/NCT04952376 |
| NCT05089045 | Immunogenicity and Safety Evaluation of Recombinant Novel Coronavirus Vaccine (CHO Cells) in Enhancing Immunity | https://ClinicalTrials.gov/show/NCT05089045 |
| NCT05077267 | ABNCoV2 Vaccine in SARS-CoV-2 (COVID-19) Seronegative and Seropositive Adult Subjects | https://ClinicalTrials.gov/show/NCT05077267 |
| NCT05075083 | Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Elderly People With Chronic Bronchitis and COPD | https://ClinicalTrials.gov/show/NCT05075083 |
| NCT05075070 | Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People With HIV Infected | https://ClinicalTrials.gov/show/NCT05075070 |
| NCT05075057 | Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Patients Aged ≥60 Years With Chronic Bronchitis and COPD | https://ClinicalTrials.gov/show/NCT05075057 |
| NCT05075044 | Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People Aged ≥18 Years With HIV Infected | https://ClinicalTrials.gov/show/NCT05075044 |
| NCT04979949 | Booster Vaccination Against SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04979949 |
| NCT05007951 | Immunogenicity and Safety Study of SK SARS-CoV-2 Recombinant Nanoparticle Vaccine (GBP510) Adjuvanted With AS03 (COVID-19) | https://ClinicalTrials.gov/show/NCT05007951 |
| NCT04889209 | Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA Vaccines | https://ClinicalTrials.gov/show/NCT04889209 |
| NCT05091411 | Clinical Trials of the Consistency and Non-inferiority Bridging Between Batches of Recombinant New Coronavirus Vaccine (CHO Cells) | https://ClinicalTrials.gov/show/NCT05091411 |
| NCT05069129 | Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells,NVSI-06-08) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above | https://ClinicalTrials.gov/show/NCT05069129 |
| NCT04860297 | A Study to Evaluate Safety and Immunogenicity of mRNA-1273 Vaccine to Prevent COVID-19 in Adult Organ Transplant Recipients and in Healthy Adult Participants | https://ClinicalTrials.gov/show/NCT04860297 |
| NCT04852978 | COVID-19 Study to Assess Immunogenicity, Safety, and Tolerability of Moderna mRNA-1273 Vaccine Administered With Casirivimab+Imdevimab in Healthy Adult Volunteers | https://ClinicalTrials.gov/show/NCT04852978 |
| NCT05054621 | Immunogenicity of COVID-19 Vaccine on Heterologous Schedule | https://ClinicalTrials.gov/show/NCT05054621 |
| NCT05037201 | Text Message Nudges for COVID-19 Vaccination | https://ClinicalTrials.gov/show/NCT05037201 |
| NCT04969250 | Vaccination for Recovered Inpatients With COVID-19 (VATICO) | https://ClinicalTrials.gov/show/NCT04969250 |
| NCT04642638 | Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure | https://ClinicalTrials.gov/show/NCT04642638 |
| NCT05096845 | Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Phase III | https://ClinicalTrials.gov/show/NCT05096845 |
| NCT05096026 | Effect of Electronic and Mail Outreach From Primary Care Physicians for COVID-19 Vaccination Among Elderly Patients | https://ClinicalTrials.gov/show/NCT05096026 |
| NCT04960228 | Exploring Changes in COVID-19 Vaccination Intentions by Prompting Altruistic Motives Using a Video Intervention | https://ClinicalTrials.gov/show/NCT04960228 |
| NCT04952402 | SARS-CoV-2 Immune Responses After COVID-19 Therapy and Subsequent Vaccine | https://ClinicalTrials.gov/show/NCT04952402 |
| NCT04839042 | A Phase 1, First-In-Human Study of the Investigational COVID-19 Vaccine SC-Ad6-1 in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT04839042 |
| NCT04535453 | A Study to Evaluate a Range of Dose Levels and Vaccination Intervals of Ad26.COV2.S in Healthy Adults and Adolescents | https://ClinicalTrials.gov/show/NCT04535453 |
| NCT04449276 | A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults | https://ClinicalTrials.gov/show/NCT04449276 |
| NCT04368728 | Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals | https://ClinicalTrials.gov/show/NCT04368728 |
| NCT05077176 | Phase 3 Booster Vaccination Against SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT05077176 |
| NCT04999111 | A Study of Ad26.COV2.S Administered as Booster Vaccination in Adults Who Have Previously Received Primary Vaccination With Ad26.COV2.S or BNT162b2 | https://ClinicalTrials.gov/show/NCT04999111 |
| NCT05069623 | A Phase 1/2 Study to Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) and VB10.2210 (T Cell Candidate) Previously Vaccinated in Healthy Adult Volunteers | https://ClinicalTrials.gov/show/NCT05069623 |
| NCT04956224 | Immunogenicity of VLA2101 Compared to VLA2001. | https://ClinicalTrials.gov/show/NCT04956224 |
| NCT04955626 | Study to Evaluate the Safety and Efficacy of a Booster Dose of BNT162b2 Against COVID-19 in Participants ≥16 Years of Age. | https://ClinicalTrials.gov/show/NCT04955626 |
| NCT04773067 | A Study to Evaluate UB-612 COVID-19 Vaccine in Adolescent, Younger and Elderly Adult Volunteers | https://ClinicalTrials.gov/show/NCT04773067 |
| NCT04756271 | Safety and Immunogenicity of Oxford AstraZeneca Vaccine Against COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04756271 |
| NCT04754594 | Study to Evaluate the Safety, Tolerability, and Immunogenicity of SARS CoV-2 RNA Vaccine Candidate (BNT162b2) Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older | https://ClinicalTrials.gov/show/NCT04754594 |
| NCT05079152 | Evaluation of Immunogenicity and Safety of Combined Immunization of COVAX (Produced in Wuhan) and PPV23 / IIV4 | https://ClinicalTrials.gov/show/NCT05079152 |
| NCT05075499 | Immune Response to COVID-19 Vaccine in Multiple Sclerosis Patients Treated With Teriflunomide and Alemtuzumab | https://ClinicalTrials.gov/show/NCT05075499 |
| NCT05074368 | Efficacy and Safety of Heterologous and Homologous COVID-19 Vaccination | https://ClinicalTrials.gov/show/NCT05074368 |
| NCT05069649 | Efficacy and Safety of Ergoferon for COVID-19 Prevention During Vaccination Against SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT05069649 |
| NCT05069454 | Study on COVID-19 Vaccine Effectiveness Among Health Workers in Azerbaijan | https://ClinicalTrials.gov/show/NCT05069454 |
| NCT05067933 | A Ph 2 Trial With an Oral Tableted COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT05067933 |
| NCT05060939 | SARS-CoV-2 Infection in COVID-19 Vaccinated Patients | https://ClinicalTrials.gov/show/NCT05060939 |
| NCT05060991 | Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients | https://ClinicalTrials.gov/show/NCT05060991 |
| NCT05059106 | EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF THE HALF DOSE OF THE VACCINE ChadOx1 nCoV-19 (AZD1222) for COVID-19 | https://ClinicalTrials.gov/show/NCT05059106 |
| NCT05057923 | The Development of a COVID19 Oral Vaccine Consisting of Bacillus Subtilis Spores | https://ClinicalTrials.gov/show/NCT05057923 |
| NCT05057182 | Third Dose of mRNA Vaccination to Boost COVID-19 Immunity | https://ClinicalTrials.gov/show/NCT05057182 |
| NCT05050474 | Booster Immunization Study of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) | https://ClinicalTrials.gov/show/NCT05050474 |
| NCT05048849 | A Study to Evaluate the Safety, Tolerability, and Immunogenicity of COVID-19 Vaccine, CT-COV-21 Extension Study | https://ClinicalTrials.gov/show/NCT05048849 |
| NCT05047692 | Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT05047692 |
| NCT05047445 | A First Time in Human Phase 1 Open-Label Study of the COVIDITY Vaccine Administered by Needle-free Injection | https://ClinicalTrials.gov/show/NCT05047445 |
| NCT05046548 | This is a Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19 | https://ClinicalTrials.gov/show/NCT05046548 |
| NCT05043259 | Heterologous Prime-boost Immunization With an Aerosolised Adenovirus Type-5 Vector-based COVID-19 Vaccine (Ad5-nCoV) After Priming With an Inactivated SARS-CoV-2 Vaccine | https://ClinicalTrials.gov/show/NCT05043259 |
| NCT05037266 | Cohort Assessing the Immunogenicity and the Safety of the COVID-19 Vaccine Janssen in Healthy Volunteers Based on 2 Age Groups: 65 Years or Older - 55 to 65 Years. Covicompare-Janssen | https://ClinicalTrials.gov/show/NCT05037266 |
| NCT05038618 | A Study o Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901, CT-COV-21 Sub-study | https://ClinicalTrials.gov/show/NCT05038618 |
| NCT05037097 | A Trial Evaluating the Safety and Immunogenicity of 3 COVID-19 SARS-CoV-2 RNA Vaccines in Healthy Adults | https://ClinicalTrials.gov/show/NCT05037097 |
| NCT05037188 | Clinical Study of the Safety and Immunogenicity of a Recombinant Viral Vector AAV5 (Adeno-Associated Virus Type 5 )-RBD (Receptor Binding Domain)-S Vaccine for the Prevention of Coronavirus Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT05037188 |
| NCT05033860 | The Influence of Education During Waiting Time of Vaccination on the Knowledge Towards COVID-19 Among Chinese Residents | https://ClinicalTrials.gov/show/NCT05033860 |
| NCT05033158 | The Immune Reaction Upon COVID-19 Vaccination in the Belgian Cancer Population. | https://ClinicalTrials.gov/show/NCT05033158 |
| NCT05033847 | Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above | https://ClinicalTrials.gov/show/NCT05033847 |
| NCT05028374 | COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies | https://ClinicalTrials.gov/show/NCT05028374 |
| NCT05027672 | Strategies for Combining the First Component of Sputnik V With Other Adenoviral or mRNA-based Vaccines. | https://ClinicalTrials.gov/show/NCT05027672 |
| NCT05021016 | Study of the EpiVacCorona Vaccine With the Involvement of Volunteers Aged 60 Years and Above | https://ClinicalTrials.gov/show/NCT05021016 |
| NCT05022329 | COVID-19 Vaccine Boosters in Patients With CKD | https://ClinicalTrials.gov/show/NCT05022329 |
| NCT05022472 | Project 2VIDA! COVID-19 Vaccine Intervention Delivery for Adults in Southern California | https://ClinicalTrials.gov/show/NCT05022472 |
| NCT05018078 | Safety and Immunogenicity of COVID-19 Vaccination in Patients With Cancer | https://ClinicalTrials.gov/show/NCT05018078 |
| NCT05017792 | Evaluation of Clinical and Antibody Response to Covid-19 Vaccination Strategy in TBRI, Egypt | https://ClinicalTrials.gov/show/NCT05017792 |
| NCT05017805 | COVID-19 Vaccines in Patients With Chronic Liver Disease | https://ClinicalTrials.gov/show/NCT05017805 |
| NCT05012800 | Safety and Immunogenicity of COVID-19 Vaccine Administered in Older Adults | https://ClinicalTrials.gov/show/NCT05012800 |
| NCT05007509 | Safety and Immunogenicity Study of Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Adult Healthy Volunteers (COVID-19) | https://ClinicalTrials.gov/show/NCT05007509 |
| NCT05007496 | Preventive Dendritic Cell Vaccine, AV-COVID-19, in Subjects Not Actively Infected With COVID-19 | https://ClinicalTrials.gov/show/NCT05007496 |
| NCT05005156 | Phase IIb Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (Ad5-nCoV) in Adults 18 Years of Age and Older. | https://ClinicalTrials.gov/show/NCT05005156 |
| NCT05005559 | Phase III Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen) | https://ClinicalTrials.gov/show/NCT05005559 |
| NCT05000216 | COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders | https://ClinicalTrials.gov/show/NCT05000216 |
| NCT04996238 | Local and General Immune Response After Coronavirus Disease (COVID-19) Vaccination in Volunteers | https://ClinicalTrials.gov/show/NCT04996238 |
| NCT04993586 | Phase I/II Study of COVID-19 DNA Vaccine (AG0302-COVID19 High-dose) | https://ClinicalTrials.gov/show/NCT04993586 |
| NCT04993209 | Clinical Trial of the COVID-19 Vaccine (Recombinant, Inactivated) in Brazil | https://ClinicalTrials.gov/show/NCT04993209 |
| NCT04992260 | Efficacy, Immunogenicity and Safety of COVID-19 Vaccine , Inactivated in Children and Adolescents | https://ClinicalTrials.gov/show/NCT04992260 |
| NCT04992182 | Reactogenicity, Safety, and Immunogenicity of Covid-19 Vaccine Booster | https://ClinicalTrials.gov/show/NCT04992182 |
| NCT04990544 | Phase II Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) | https://ClinicalTrials.gov/show/NCT04990544 |
| NCT04988048 | Collaborative Study to Evaluate Heterologous Vaccination Against Covid-19 in Argentina | https://ClinicalTrials.gov/show/NCT04988048 |
| NCT04983537 | Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes in an Elderly Population | https://ClinicalTrials.gov/show/NCT04983537 |
| NCT04982068 | Phase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) | https://ClinicalTrials.gov/show/NCT04982068 |
| NCT04973449 | Phase II/III Study of AZD2816, for the Prevention of COVID-19 in Adults | https://ClinicalTrials.gov/show/NCT04973449 |
| NCT04977479 | The Safety of Administering a Second Dose of a COVID-19 mRNA Vaccine in Individuals Who Experienced a Systemic Allergic Reaction to an Initial Dose | https://ClinicalTrials.gov/show/NCT04977479 |
| NCT04977024 | SARS-CoV-2 Vaccine (COH04S1) Versus Emergency Use Authorization SARS-COV-2 Vaccine for the Treatment of COVID-19 in Patients With Blood Cancer | https://ClinicalTrials.gov/show/NCT04977024 |
| NCT04967742 | A Extension Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04967742 |
| NCT04969276 | Study of a Quadrivalent High-Dose Influenza Vaccine and a Moderna COVID-19 Vaccine Administered Either Concomitantly or Singly in Participants 65 Years of Age and Older Previously Vaccinated With a 2-dose Schedule of Moderna COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04969276 |
| NCT04969263 | COVID-19 Protection After Transplant Pilot Study | https://ClinicalTrials.gov/show/NCT04969263 |
| NCT04967807 | Myocardial Injury and Outcomes Following COVID-19 Vaccination (MYOVAX Study) | https://ClinicalTrials.gov/show/NCT04967807 |
| NCT04964154 | Building Resiliency and Vital Equity (BRAVE) Project: Understanding Native Americans’ Perceptions/Beliefs About COVID-19 Testing and Vaccination Study | https://ClinicalTrials.gov/show/NCT04964154 |
| NCT04962906 | Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes | https://ClinicalTrials.gov/show/NCT04962906 |
| NCT04962893 | Study of a Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine | https://ClinicalTrials.gov/show/NCT04962893 |
| NCT04961541 | Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine | https://ClinicalTrials.gov/show/NCT04961541 |
| NCT04961502 | Humoral and Cellular Responses to Vaccination Against Coronavirus Disease 2019 (COVID-19) in the Very Elderly Living in Geriatric Institutions | https://ClinicalTrials.gov/show/NCT04961502 |
| NCT04962308 | Clinical Trial of Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04962308 |
| NCT04961359 | Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2（COVID-19） Phase I Clinical Trial (3~17 Years Old) | https://ClinicalTrials.gov/show/NCT04961359 |
| NCT04954469 | B-pVAC-SARS-CoV-2: Study to Prevent COVID-19 Infection in Adults With Bcell/ Antibody Deficiency | https://ClinicalTrials.gov/show/NCT04954469 |
| NCT04954287 | Phase 1 Study of Intranasal PIV5-vectored COVID-19 Vaccine Expressing SARS-CoV-2 Spike Protein in Healthy Adults | https://ClinicalTrials.gov/show/NCT04954287 |
| NCT04954092 | Study of Gam-COVID-Vac in Adolescents | https://ClinicalTrials.gov/show/NCT04954092 |
| NCT04953325 | Immunogenicity and Safety of an Inactivated COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04953325 |
| NCT04952766 | Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults | https://ClinicalTrials.gov/show/NCT04952766 |
| NCT04952727 | Study on Sequential Immunization of Inactivated COVID-19 Vaccine and Recombinant COVID-19 Vaccine (Ad5 Vector) in Elderly Adults | https://ClinicalTrials.gov/show/NCT04952727 |
| NCT04951388 | A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adolescents | https://ClinicalTrials.gov/show/NCT04951388 |
| NCT04951323 | Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo) | https://ClinicalTrials.gov/show/NCT04951323 |
| NCT04951310 | COVID-19 Vaccinations With a Sweepstakes | https://ClinicalTrials.gov/show/NCT04951310 |
| NCT04944368 | Phase II Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen) | https://ClinicalTrials.gov/show/NCT04944368 |
| NCT04939519 | SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Vaccination Rates Among Utah Community Health Centers | https://ClinicalTrials.gov/show/NCT04939519 |
| NCT04939402 | SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the UZ Brussel Following COVID-19 Vaccination Using an Adenoviral Vector | https://ClinicalTrials.gov/show/NCT04939402 |
| NCT04936997 | Immune Response to the COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04936997 |
| NCT04935528 | Mechanisms of Anti COVID-19 Humoral and Cellular Immune Response After Vaccination in a Sample of Patients and Salaried Staff From a French Anti-cancer Center | https://ClinicalTrials.gov/show/NCT04935528 |
| NCT04932824 | Long-term Follow-up to the Phase 1 Study of Adjuvanted SARS-CoV-2 (SCB 2019) Vaccine for COVID-19. | https://ClinicalTrials.gov/show/NCT04932824 |
| NCT04930965 | Impact of LA-CEAL HALT COVID-19 Ambassador Program on Likelihood to Vaccinate | https://ClinicalTrials.gov/show/NCT04930965 |
| NCT04930003 | Reactogenicity, Safety and Immunogenicity of QazCoVac-P COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04930003 |
| NCT04928456 | Augmentation of Immune Response to COVID-19 mRNA Vaccination Through OMT With Lymphatic Pumps | https://ClinicalTrials.gov/show/NCT04928456 |
| NCT04927065 | A Study to Evaluate the Immunogenicity and Safety of mRNA-1273.211 Vaccine for COVID-19 Variants | https://ClinicalTrials.gov/show/NCT04927065 |
| NCT04922788 | Study to Evaluate the Safety, Immunogenicity, and Efficacy of Nanocovax Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04922788 |
| NCT04918940 | Efficacy of COVID-19 Vaccination in Patientstreated With Anti-CD20 for Follicular Lymphoma or Mantle Cell Lymphoma | https://ClinicalTrials.gov/show/NCT04918940 |
| NCT04918797 | COVAXIN in a Pediatric Cohort | https://ClinicalTrials.gov/show/NCT04918797 |
| NCT04916886 | A Clinical Trial of Immunobridging and Lot-to-lot Consistency of COVID-19 Vaccine (Ad5-nCoV) in Different Age Groups. | https://ClinicalTrials.gov/show/NCT04916886 |
| NCT04915820 | Iron and COVID-19 Vaccine Response | https://ClinicalTrials.gov/show/NCT04915820 |
| NCT04915989 | Safety and Immunogenicity of GX-19N, a COVID-19 Preventive DNA Vaccine in Elderly Individuals | https://ClinicalTrials.gov/show/NCT04915989 |
| NCT04911790 | Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Adults | https://ClinicalTrials.gov/show/NCT04911790 |
| NCT04907331 | Heterologous SARS-CoV-2 Vaccination With ChAdOx-1 and BNT162b2 | https://ClinicalTrials.gov/show/NCT04907331 |
| NCT04904744 | Effect of Varied Outreach Methods on Appointment Scheduling, Appointment Completion, and Receipt of COVID-19 Vaccination | https://ClinicalTrials.gov/show/NCT04904744 |
| NCT04904549 | Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older | https://ClinicalTrials.gov/show/NCT04904549 |
| NCT04900467 | Compare Immunological Efficacy of a Vaccine Regimen Combining Two Covid19 mRNA Vaccines (Pfizer-BioNTech and Moderna) With That of a Homologous Vaccination of Each Covid19 mRNA Vaccine | https://ClinicalTrials.gov/show/NCT04900467 |
| NCT04896788 | Monitoring of the Post-vaccination Immune Response to COVID-19 Among Hospital Staff | https://ClinicalTrials.gov/show/NCT04896788 |
| NCT04895449 | Safety, Tolerability and Immunogenicity of the Candidate Vaccine MVA-SARS-2-ST Against COVID-19 | https://ClinicalTrials.gov/show/NCT04895449 |
| NCT04894435 | Mix and Match of the Second COVID-19 Vaccine Dose for Safety and Immunogenicity | https://ClinicalTrials.gov/show/NCT04894435 |
| NCT04894227 | Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04894227 |
| NCT04892459 | Study on Sequential Immunization of Inactivated SARS-CoV-2 Vaccine and Recombinant SARS-CoV-2 Vaccine (Ad5 Vector) | https://ClinicalTrials.gov/show/NCT04892459 |
| NCT04889274 | Investigation of the Effects of Dietary Nitrate and Sex on COVID-19 Vaccine Induced Vascular Dysfunction in Healthy Men and Women (DiNOVasc-COVID-19) | https://ClinicalTrials.gov/show/NCT04889274 |
| NCT04885907 | Third Dose of Moderna COVID-19 Vaccine in Transplant Recipients | https://ClinicalTrials.gov/show/NCT04885907 |
| NCT04885764 | Profiling Antibody Status and Vaccine Effectiveness in Post Vaccination With SARS CoV2 in Ain Shams University | https://ClinicalTrials.gov/show/NCT04885764 |
| NCT04885361 | To Evaluate the Safety, and Immunogenicity of Vaccine Candidate Against COVID-19, in Healthy Adults | https://ClinicalTrials.gov/show/NCT04885361 |
| NCT04884685 | Safety of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Children and Adolescents | https://ClinicalTrials.gov/show/NCT04884685 |
| NCT04881227 | The Impact of a Chatbot on COVID-19 Vaccine Perceptions and Intentions in ESPERES Cohort (ESPERES-COVID-19-CHATBOT) | https://ClinicalTrials.gov/show/NCT04881227 |
| NCT04880174 | SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel Following mRNA COVID-19 Vaccination | https://ClinicalTrials.gov/show/NCT04880174 |
| NCT04878211 | A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab | https://ClinicalTrials.gov/show/NCT04878211 |
| NCT04873128 | Comparative Genetic and Immune Response Analysis of Different COVID-19 Vaccine Candidates Using Multi-OMICS Approach | https://ClinicalTrials.gov/show/NCT04873128 |
| NCT04871737 | Study of a Live rNDV Based Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04871737 |
| NCT04870593 | What Works to Get the Elderly Vaccinated Against COVID-19? Experimental Evidence From India | https://ClinicalTrials.gov/show/NCT04870593 |
| NCT04869358 | Exploring the Immune Response to SARS-CoV-2 COVID-19 Vaccines in Patients With Relapsing Multiple Sclerosis (RMS) Treated With Ofatumumab | https://ClinicalTrials.gov/show/NCT04869358 |
| NCT04869592 | A Clinical Trial to Evaluate the Recombinant SARS-CoV-2 Vaccine (CHO Cell) for COVID-19 | https://ClinicalTrials.gov/show/NCT04869592 |
| NCT04867174 | COVID-19 Vaccination Take-Up | https://ClinicalTrials.gov/show/NCT04867174 |
| NCT04863131 | Safety and Immunogenicity of EXG-5003 | https://ClinicalTrials.gov/show/NCT04863131 |
| NCT04866069 | Study of a Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Adjuvanted Inactivated Vaccine in Healthy Adults | https://ClinicalTrials.gov/show/NCT04866069 |
| NCT04864561 | Study To Compare The Immunogenicity Against COVID-19, Of VLA2001 Vaccine To AZD1222 Vaccine | https://ClinicalTrials.gov/show/NCT04864561 |
| NCT04863638 | A Immuno-bridging and Immunization Schedules Study of COVID-19 Vaccine (Vero Cell), Inactivated | https://ClinicalTrials.gov/show/NCT04863638 |
| NCT04860739 | Vaccination With COMIRNATY in Subjects With a VAXZEVRIA First Dose | https://ClinicalTrials.gov/show/NCT04860739 |
| NCT04860258 | A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities for COVID-19 | https://ClinicalTrials.gov/show/NCT04860258 |
| NCT04847050 | A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy | https://ClinicalTrials.gov/show/NCT04847050 |
| NCT04844346 | Plant Stanol Esters and COVID-19 Vaccination Response | https://ClinicalTrials.gov/show/NCT04844346 |
| NCT04844489 | Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People | https://ClinicalTrials.gov/show/NCT04844489 |
| NCT04839315 | COVID-19 Vaccination in Rheumatic Disease Patients | https://ClinicalTrials.gov/show/NCT04839315 |
| NCT04842708 | Evaluation of Anti-COVID 19 Pfizer Vaccination Effect on COVID 19 Detection Using Breath Analysis | https://ClinicalTrials.gov/show/NCT04842708 |
| NCT04840992 | Phase I/II Clinical Trial of Recombinant Novel Coronavirus (COVID-19) Vaccine (Adenovirus Type 5 Vector) for Inhalation | https://ClinicalTrials.gov/show/NCT04840992 |
| NCT04839146 | Safety and Tolerability of COVID-19 Vaccine (ABNCoV2) | https://ClinicalTrials.gov/show/NCT04839146 |
| NCT04838080 | Safety and Immunogenicity of the Inactivated Koçak-19 Inaktif Adjuvanlı COVID-19 Vaccine Compared to Placebo | https://ClinicalTrials.gov/show/NCT04838080 |
| NCT04834726 | COVID-19 Vaccine Text Outreach | https://ClinicalTrials.gov/show/NCT04834726 |
| NCT04833101 | Study on Heterologous Prime-boost of Recombinant COVID-19 Vaccine (Ad5 Vector) and RBD-based Protein Subunit Vaccine | https://ClinicalTrials.gov/show/NCT04833101 |
| NCT04830800 | A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC | https://ClinicalTrials.gov/show/NCT04830800 |
| NCT04824638 | BNT162b2 Vaccination With Two Doses in COVID-19 Negative Adult Volunteers and With a Single Dose in COVID-19 Positive Adult Volunteers | https://ClinicalTrials.gov/show/NCT04824638 |
| NCT04822025 | A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Elderly Adults | https://ClinicalTrials.gov/show/NCT04822025 |
| NCT04824391 | Efficacy, Immunogenicity and Safety of Inactivated ERUCOV-VAC Compared With Placebo in COVID-19 | https://ClinicalTrials.gov/show/NCT04824391 |
| NCT04821674 | Study of DS-5670a (COVID-19 Vaccine) in Japanese Healthy Adults and Elderly Subjects | https://ClinicalTrials.gov/show/NCT04821674 |
| NCT04818801 | Safety, Reactogenicity and Immunogenicity Study of ReCOV | https://ClinicalTrials.gov/show/NCT04818801 |
| NCT04818281 | Study of a Severe Acute Respiratory Syndrome CoV-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine in Healthy Adults | https://ClinicalTrials.gov/show/NCT04818281 |
| NCT04816669 | Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04816669 |
| NCT04816643 | A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children and Young Adults | https://ClinicalTrials.gov/show/NCT04816643 |
| NCT04816019 | A Study of Intranasal ChAdOx1 nCOV-19 | https://ClinicalTrials.gov/show/NCT04816019 |
| NCT04813796 | A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1283 and mRNA-1273 Vaccines in Healthy Adults Between 18 Years and 55 Years of Age to Prevent COVID-19 | https://ClinicalTrials.gov/show/NCT04813796 |
| NCT04813770 | The Impact of Theory-based Messaging on Covid-19 Vaccination Intentions | https://ClinicalTrials.gov/show/NCT04813770 |
| NCT04813562 | Immunogenicity and Safety of Recombinant COVID-19 Vaccine (CHO Cells) | https://ClinicalTrials.gov/show/NCT04813562 |
| NCT04811664 | A Study of SARS CoV-2 Infection and Potential Transmission in Individuals Immunized With Moderna COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04811664 |
| NCT04805931 | VEText Message Framing and Covid-19 Vaccine Uptake Among at Risk Veterans | https://ClinicalTrials.gov/show/NCT04805931 |
| NCT04806113 | COVID-19 Vaccine in Immunosuppressed Adults With Autoimmune Diseases | https://ClinicalTrials.gov/show/NCT04806113 |
| NCT04805125 | Immunocompromised Swiss Cohorts Based Trial Platform | https://ClinicalTrials.gov/show/NCT04805125 |
| NCT04801888 | Study on Combined Vaccination With SARS-CoV-2 Inactivated Vaccine and Quadrivalent Influenza Vaccine | https://ClinicalTrials.gov/show/NCT04801888 |
| NCT04801524 | Text-based Reminders to Promote COVID-19 Vaccinations | https://ClinicalTrials.gov/show/NCT04801524 |
| NCT04800965 | Text-based Interventions to Promote COVID-19 Vaccinations | https://ClinicalTrials.gov/show/NCT04800965 |
| NCT04800133 | Covid-19 Vaccination in Adolescents | https://ClinicalTrials.gov/show/NCT04800133 |
| NCT04798677 | Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 Vaccine | https://ClinicalTrials.gov/show/NCT04798677 |
| NCT04798027 | Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older | https://ClinicalTrials.gov/show/NCT04798027 |
| NCT04798001 | Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults | https://ClinicalTrials.gov/show/NCT04798001 |
| NCT04796896 | A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age | https://ClinicalTrials.gov/show/NCT04796896 |
| NCT04794946 | Safety and Efficacy of a Non-replicating ChAdOx1 Vector Vaccine AZD1222 (COVISHIELD), for Prevention of COVID-19 in Patients With Liver Cirrhosis | https://ClinicalTrials.gov/show/NCT04794946 |
| NCT04792567 | Exploring the Immune Response to SARS-CoV-2 modRNA Vaccines in Patients With Secondary Progressive Multiple Sclerosis (AMA-VACC) | https://ClinicalTrials.gov/show/NCT04792567 |
| NCT04791423 | Study of GRAd-COV2 for the Prevention of COVID-19 in Adults | https://ClinicalTrials.gov/show/NCT04791423 |
| NCT04789356 | Effectiveness of the Adsorbed Vaccine COVID-19 (Coronavac) Among Education and Public Safety Workers With Risk Factors for Severity | https://ClinicalTrials.gov/show/NCT04789356 |
| NCT04788459 | Safety and Immunogenicity of COVID-eVax, a Candidate Plasmid DNA Vaccine for COVID-19, in Healthy Adult Volunteers | https://ClinicalTrials.gov/show/NCT04788459 |
| NCT04785144 | Safety and Immunogenicity Study of a SARS-CoV-2 (COVID-19) Variant Vaccine (mRNA-1273.351) in Naïve and Previously Vaccinated Adults | https://ClinicalTrials.gov/show/NCT04785144 |
| NCT04784767 | SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04784767 |
| NCT04783311 | Safety, Tolerance and Immunogenicity of EuCorVac-19 for the Prevention of COVID-19 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04783311 |
| NCT04780659 | COVID-19 Vaccination of Immunodeficient Persons (COVAXID) | https://ClinicalTrials.gov/show/NCT04780659 |
| NCT04780035 | Study of the Tolerability, Safety, Immunogenicity and Preventive Efficacy of the EpiVacCorona Vaccine for the Prevention of COVID-19 | https://ClinicalTrials.gov/show/NCT04780035 |
| NCT04779827 | Improving Health Equity for COVID-19 Vaccination for At-risk Populations Using Online Social Networks | https://ClinicalTrials.gov/show/NCT04779827 |
| NCT04776317 | Chimpanzee Adenovirus and Self-Amplifying mRNA Prime-Boost Prophylactic Vaccines Against SARS-CoV-2 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04776317 |
| NCT04775069 | Antibody Response to COVID-19 Vaccines in Liver Disease Patients | https://ClinicalTrials.gov/show/NCT04775069 |
| NCT04773665 | Safety, Tolerability, and Immunogenicity of the COVID-19 Vaccine Candidates VBI-2902a and VBI-2905a | https://ClinicalTrials.gov/show/NCT04773665 |
| NCT04771559 | Evaluation of the Effect and Side Effect Profile of Covid-19 Vaccine in Cancer Patients | https://ClinicalTrials.gov/show/NCT04771559 |
| NCT04765839 | Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With COVID-19 Vaccine Messages to Minority Populations | https://ClinicalTrials.gov/show/NCT04765839 |
| NCT04765436 | PTX-COVID19-B, an mRNA Humoral Vaccine, is Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Evaluate Safety, Tolerability, and Immunogenicity of PTX-COVID19-B Vaccine in Healthy Seronegative Adults Aged 18-64 | https://ClinicalTrials.gov/show/NCT04765436 |
| NCT04762680 | Study of Recombinant Protein Vaccines With Adjuvant as a Primary Series and as a Booster Dose Against COVID-19 in Adults 18 Years of Age and Older | https://ClinicalTrials.gov/show/NCT04762680 |
| NCT04761822 | COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations | https://ClinicalTrials.gov/show/NCT04761822 |
| NCT04760743 | Safety and Immunogenicity of a SARS-CoV-2 Vaccine (NBP2001) in Healthy Adults (COVID-19) | https://ClinicalTrials.gov/show/NCT04760743 |
| NCT04760132 | National Cohort Study of Effectiveness and Safety of SARS-CoV-2/COVID-19 Vaccines (ENFORCE) | https://ClinicalTrials.gov/show/NCT04760132 |
| NCT04758962 | A Study of the Safety of and Immune Response to Varying Doses of a Vaccine Against COVID-19 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04758962 |
| NCT04758273 | A Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19) | https://ClinicalTrials.gov/show/NCT04758273 |
| NCT04756830 | A Study to Assess the Safety and Immunogenicity of the Coronavac Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04756830 |
| NCT04756323 | A Study to Evaluate Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19) | https://ClinicalTrials.gov/show/NCT04756323 |
| NCT04751682 | Safety and Immunogenicity of an Intranasal SARS-CoV-2 Vaccine (BBV154) for COVID-19 | https://ClinicalTrials.gov/show/NCT04751682 |
| NCT04750343 | Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With or Without AS03 (COVID-19) | https://ClinicalTrials.gov/show/NCT04750343 |
| NCT04747821 | An Effectiveness Study of the Sinovac’s Adsorbed COVID-19 (Inactivated) Vaccine | https://ClinicalTrials.gov/show/NCT04747821 |
| NCT04742738 | Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With Aluminum Hydroxide (COVID-19) | https://ClinicalTrials.gov/show/NCT04742738 |
| NCT04732819 | Improving COVID-19 Vaccine Uptake in Nursing Homes | https://ClinicalTrials.gov/show/NCT04732819 |
| NCT04732468 | COVID-19 Oral and Subcutaneous Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenovirus Platform in Healthy Volunteers in USA | https://ClinicalTrials.gov/show/NCT04732468 |
| NCT04728594 | Emails Promoting COVID-19 Vaccination Among Healthcare Workers | https://ClinicalTrials.gov/show/NCT04728594 |
| NCT04715997 | Safety and Immunogenicity Study of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Adults | https://ClinicalTrials.gov/show/NCT04715997 |
| NCT04715438 | Vaccination Against COVID-19 in Cancer | https://ClinicalTrials.gov/show/NCT04715438 |
| NCT04713553 | A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants | https://ClinicalTrials.gov/show/NCT04713553 |
| NCT04713488 | An Open Study on the Safety, Tolerability, and Immunogenicity of “Sputnik Light” Vaccine | https://ClinicalTrials.gov/show/NCT04713488 |
| NCT04710303 | COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral Platform in Healthy South African Adults | https://ClinicalTrials.gov/show/NCT04710303 |
| NCT04706403 | Views on COVID-19 and Vaccination | https://ClinicalTrials.gov/show/NCT04706403 |
| NCT04695652 | A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult | https://ClinicalTrials.gov/show/NCT04695652 |
| NCT04691947 | Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VAC | https://ClinicalTrials.gov/show/NCT04691947 |
| NCT04691908 | Immunogenicity, Efficacy and Safety of QazCovid-in® COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04691908 |
| NCT04690387 | Dendritic Cell Vaccine, AV-COVID-19, to Prevent COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04690387 |
| NCT04685603 | Dendritic Cell Vaccine to Prevent COVID-19 | https://ClinicalTrials.gov/show/NCT04685603 |
| NCT04681092 | Anti-COVID19 AKS-452 - ACT Study | https://ClinicalTrials.gov/show/NCT04681092 |
| NCT04679909 | Safety and Immunogenicity of AdCOVID in Healthy Adults (COVID-19 Vaccine Study) | https://ClinicalTrials.gov/show/NCT04679909 |
| NCT04674189 | A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19 | https://ClinicalTrials.gov/show/NCT04674189 |
| NCT04673149 | GLS-5310 Vaccine for the Prevention of SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04673149 |
| NCT04672291 | Nasal Poly-ICLC (Hiltonol®) in Healthy COVID-19 Vaccinated Adults | https://ClinicalTrials.gov/show/NCT04672291 |
| NCT04671017 | Dose Finding Study to Evaluate Safety, Tolerability and Immunogenicity of an Inactiviated Adjuvanted Sars-Cov-2 Virus Vaccine Candidate Against Covid-19 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04671017 |
| NCT04668339 | A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04668339 |
| NCT04666012 | Safety and Immunogenicity Study of AdCLD-CoV19: A COVID-19 Preventive Vaccine in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT04666012 |
| NCT04659941 | Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers | https://ClinicalTrials.gov/show/NCT04659941 |
| NCT04659239 | The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 | https://ClinicalTrials.gov/show/NCT04659239 |
| NCT04655625 | Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19) | https://ClinicalTrials.gov/show/NCT04655625 |
| NCT04651790 | Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adults | https://ClinicalTrials.gov/show/NCT04651790 |
| NCT04652102 | A Study to Determine the Safety and Efficacy of SARS-CoV-2 mRNA Vaccine CVnCoV in Adults for COVID-19 | https://ClinicalTrials.gov/show/NCT04652102 |
| NCT04649021 | Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy Population | https://ClinicalTrials.gov/show/NCT04649021 |
| NCT04649151 | A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19 | https://ClinicalTrials.gov/show/NCT04649151 |
| NCT04648800 | Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in Poland | https://ClinicalTrials.gov/show/NCT04648800 |
| NCT04646590 | A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19 | https://ClinicalTrials.gov/show/NCT04646590 |
| NCT04641858 | BCG to Reduce Absenteeism Among Health Care Workers During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04641858 |
| NCT04641481 | An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers | https://ClinicalTrials.gov/show/NCT04641481 |
| NCT04640233 | Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Сov-2) Infection | https://ClinicalTrials.gov/show/NCT04640233 |
| NCT04640402 | A Phase â…¡ Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells) | https://ClinicalTrials.gov/show/NCT04640402 |
| NCT04639375 | Polio Vaccine (IPV) for SARS-CoV-2 and Prevention of Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04639375 |
| NCT04639466 | A Synthetic MVA-based SARS-CoV-2 Vaccine, COH04S1, for the Prevention of COVID-19 | https://ClinicalTrials.gov/show/NCT04639466 |
| NCT04636333 | Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell) | https://ClinicalTrials.gov/show/NCT04636333 |
| NCT04636697 | Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults | https://ClinicalTrials.gov/show/NCT04636697 |
| NCT04627675 | CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2) | https://ClinicalTrials.gov/show/NCT04627675 |
| NCT04619628 | Safety and Immunogenicity of COVI-VAC, a Live Attenuated Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04619628 |
| NCT04617483 | Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in Adults | https://ClinicalTrials.gov/show/NCT04617483 |
| NCT04612972 | Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru | https://ClinicalTrials.gov/show/NCT04612972 |
| NCT04611802 | A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years) at Risk for SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04611802 |
| NCT04608305 | Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine | https://ClinicalTrials.gov/show/NCT04608305 |
| NCT04604743 | Clinic-based HPV and COVID-19 Vaccine Promoting Intervention for AfAm Adolescents in Alabama | https://ClinicalTrials.gov/show/NCT04604743 |
| NCT04591717 | COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral-COVID-19 in Normal Healthy Volunteers | https://ClinicalTrials.gov/show/NCT04591717 |
| NCT04591184 | A Clinical Trial of a Prophylactic Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults | https://ClinicalTrials.gov/show/NCT04591184 |
| NCT04588480 | Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults | https://ClinicalTrials.gov/show/NCT04588480 |
| NCT04587219 | The Study of “Gam-COVID-Vac” Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older | https://ClinicalTrials.gov/show/NCT04587219 |
| NCT04583995 | A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom | https://ClinicalTrials.gov/show/NCT04583995 |
| NCT04582344 | Clinical Trial For SARS-CoV-2 Vaccine (COVID-19) | https://ClinicalTrials.gov/show/NCT04582344 |
| NCT04569383 | Safety and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S and a Booster Vaccination With a Licensed Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04569383 |
| NCT04569786 | Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001) | https://ClinicalTrials.gov/show/NCT04569786 |
| NCT04568811 | The Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04568811 |
| NCT04568031 | Study of AZD1222 for the Prevention of COVID-19 in Japan | https://ClinicalTrials.gov/show/NCT04568031 |
| NCT04566770 | A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) | https://ClinicalTrials.gov/show/NCT04566770 |
| NCT04563702 | Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04563702 |
| NCT04564716 | Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus | https://ClinicalTrials.gov/show/NCT04564716 |
| NCT04560881 | Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19) | https://ClinicalTrials.gov/show/NCT04560881 |
| NCT04551547 | Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19 | https://ClinicalTrials.gov/show/NCT04551547 |
| NCT04552366 | A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults | https://ClinicalTrials.gov/show/NCT04552366 |
| NCT04550351 | Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old) | https://ClinicalTrials.gov/show/NCT04550351 |
| NCT04546841 | Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults | https://ClinicalTrials.gov/show/NCT04546841 |
| NCT04545749 | A Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04545749 |
| NCT04542395 | COVID-2019 Testing and Vaccination Among African American and Latinx Public Housing Residents | https://ClinicalTrials.gov/show/NCT04542395 |
| NCT04542330 | Using BCG to Protect Senior Citizens During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04542330 |
| NCT04540419 | Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Against COVID-19 | https://ClinicalTrials.gov/show/NCT04540419 |
| NCT04540185 | A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 | https://ClinicalTrials.gov/show/NCT04540185 |
| NCT04537663 | Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults | https://ClinicalTrials.gov/show/NCT04537663 |
| NCT04537949 | A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04537949 |
| NCT04537208 | Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older | https://ClinicalTrials.gov/show/NCT04537208 |
| NCT04536051 | A Study of a Candidate COVID-19 Vaccine (COV003) | https://ClinicalTrials.gov/show/NCT04536051 |
| NCT04533399 | A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults | https://ClinicalTrials.gov/show/NCT04533399 |
| NCT04530656 | Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell) | https://ClinicalTrials.gov/show/NCT04530656 |
| NCT04530396 | Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04530396 |
| NCT04530357 | Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04530357 |
| NCT04528641 | GRAd-COV2 Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04528641 |
| NCT04527575 | Study of the Safety, Reactogenicity and Immunogenicity of “EpiVacCorona” Vaccine for the Prevention of COVID-19 | https://ClinicalTrials.gov/show/NCT04527575 |
| NCT04527081 | Study of COVID-19 DNA Vaccine (AG0302-COVID19) | https://ClinicalTrials.gov/show/NCT04527081 |
| NCT04526990 | Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above | https://ClinicalTrials.gov/show/NCT04526990 |
| NCT04523571 | Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects | https://ClinicalTrials.gov/show/NCT04523571 |
| NCT04523246 | Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents | https://ClinicalTrials.gov/show/NCT04523246 |
| NCT04516746 | Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults | https://ClinicalTrials.gov/show/NCT04516746 |
| NCT04515147 | A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19 | https://ClinicalTrials.gov/show/NCT04515147 |
| NCT04510207 | A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above | https://ClinicalTrials.gov/show/NCT04510207 |
| NCT04508075 | Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine | https://ClinicalTrials.gov/show/NCT04508075 |
| NCT04498247 | A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001) | https://ClinicalTrials.gov/show/NCT04498247 |
| NCT04495933 | A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults | https://ClinicalTrials.gov/show/NCT04495933 |
| NCT04497298 | Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04497298 |
| NCT04480957 | Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects | https://ClinicalTrials.gov/show/NCT04480957 |
| NCT04475302 | BCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 Hotspots | https://ClinicalTrials.gov/show/NCT04475302 |
| NCT04473690 | KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT04473690 |
| NCT04471519 | Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT04471519 |
| NCT04470609 | Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ⩾60 Years | https://ClinicalTrials.gov/show/NCT04470609 |
| NCT04470427 | A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19 | https://ClinicalTrials.gov/show/NCT04470427 |
| NCT04466085 | Clinical Study of Recombinant Novel Coronavirus Vaccine | https://ClinicalTrials.gov/show/NCT04466085 |
| NCT04463472 | Study of COVID-19 DNA Vaccine (AG0301-COVID19) | https://ClinicalTrials.gov/show/NCT04463472 |
| NCT04461379 | Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare Workers | https://ClinicalTrials.gov/show/NCT04461379 |
| NCT04460703 | COVID-19 Vaccine Messaging, Part 1 | https://ClinicalTrials.gov/show/NCT04460703 |
| NCT04456595 | Clinical Trial of Efficacy and Safety of Sinovac’s Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals | https://ClinicalTrials.gov/show/NCT04456595 |
| NCT04453852 | Monovalent Recombinant COVID19 Vaccine | https://ClinicalTrials.gov/show/NCT04453852 |
| NCT04450004 | Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years. | https://ClinicalTrials.gov/show/NCT04450004 |
| NCT04447781 | Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19 | https://ClinicalTrials.gov/show/NCT04447781 |
| NCT04445428 | OPV as Potential Protection Against COVID-19 | https://ClinicalTrials.gov/show/NCT04445428 |
| NCT04445389 | Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults | https://ClinicalTrials.gov/show/NCT04445389 |
| NCT04445194 | Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine | https://ClinicalTrials.gov/show/NCT04445194 |
| NCT04444674 | COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection | https://ClinicalTrials.gov/show/NCT04444674 |
| NCT04437875 | An Open Study of the Safety, Tolerability and Immunogenicity of “Gam-COVID-Vac Lyo” Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04437875 |
| NCT04436471 | An Open Study of the Safety, Tolerability and Immunogenicity of the Drug “Gam-COVID-Vac” Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04436471 |
| NCT04417335 | Reducing COVID-19 Related Hospital Admission in Elderly by BCG Vaccination | https://ClinicalTrials.gov/show/NCT04417335 |
| NCT04414267 | Bacillus Calmette-guérin Vaccination to Prevent COVID-19 | https://ClinicalTrials.gov/show/NCT04414267 |
| NCT04412538 | Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 | https://ClinicalTrials.gov/show/NCT04412538 |
| NCT04405908 | SCB-2019 as COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04405908 |
| NCT04405076 | Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older | https://ClinicalTrials.gov/show/NCT04405076 |
| NCT04384549 | Efficacy of BCG Vaccination in the Prevention of COVID19 Via the Strengthening of Innate Immunity in Health Care Workers | https://ClinicalTrials.gov/show/NCT04384549 |
| NCT04383574 | Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19) | https://ClinicalTrials.gov/show/NCT04383574 |
| phase | Study_Count |
|---|---|
| Early Phase 1 | 4 |
| N/A | 57 |
| Phase 1 | 65 |
| Phase 1/Phase 2 | 59 |
| Phase 2 | 51 |
| Phase 2/Phase 3 | 20 |
| Phase 3 | 64 |
| Phase 4 | 44 |
| country | Study_Count |
|---|---|
| Argentina | 11 |
| Australia | 11 |
| Austria | 2 |
| Azerbaijan | 1 |
| Bahrain | 1 |
| Belarus | 1 |
| Belgium | 12 |
| Brazil | 19 |
| Canada | 16 |
| Cape Verde | 1 |
| Chile | 5 |
| China | 58 |
| Colombia | 4 |
| Denmark | 3 |
| Dominican Republic | 1 |
| Ecuador | 1 |
| Egypt | 4 |
| Finland | 1 |
| France | 14 |
| Germany | 15 |
| Ghana | 1 |
| Greece | 1 |
| Guinea-Bissau | 2 |
| Honduras | 3 |
| Hong Kong | 3 |
| India | 9 |
| Indonesia | 6 |
| Iran, Islamic Republic of | 2 |
| Israel | 3 |
| Italy | 3 |
| Japan | 9 |
| Jordan | 1 |
| Kazakhstan | 3 |
| Kenya | 3 |
| Korea, Republic of | 12 |
| Malaysia | 1 |
| Mexico | 10 |
| Mongolia | 1 |
| Mozambique | 1 |
| Nepal | 1 |
| Netherlands | 10 |
| New Zealand | 4 |
| Norway | 1 |
| Pakistan | 2 |
| Panama | 2 |
| Peru | 4 |
| Philippines | 4 |
| Poland | 3 |
| Puerto Rico | 2 |
| Russian Federation | 14 |
| Singapore | 3 |
| South Africa | 10 |
| Spain | 9 |
| Sweden | 1 |
| Switzerland | 1 |
| Taiwan | 11 |
| Thailand | 1 |
| Turkey | 12 |
| Uganda | 1 |
| Ukraine | 1 |
| United Arab Emirates | 3 |
| United Kingdom | 14 |
| United States | 91 |
| Uzbekistan | 1 |
| Vietnam | 5 |
| Site_count | Study_Count |
|---|---|
| 1 | 206 |
| 2 | 30 |
| 3 | 13 |
| 4 | 14 |
| 5 | 12 |
| 6 | 9 |
| 7 | 4 |
| 8 | 9 |
| 9 | 3 |
| 10 | 5 |
| 11 | 4 |
| 12 | 6 |
| 14 | 4 |
| 15 | 2 |
| 16 | 1 |
| 17 | 1 |
| 18 | 3 |
| 19 | 1 |
| 20 | 3 |
| 21 | 2 |
| 22 | 1 |
| 23 | 3 |
| 25 | 2 |
| 26 | 3 |
| 29 | 2 |
| 30 | 1 |
| 31 | 1 |
| 33 | 1 |
| 34 | 1 |
| 36 | 1 |
| 40 | 1 |
| 41 | 1 |
| 53 | 1 |
| 55 | 2 |
| 60 | 1 |
| 74 | 1 |
| 79 | 1 |
| 91 | 1 |
| 92 | 1 |
| 94 | 1 |
| 100 | 1 |
| 105 | 1 |
| 146 | 1 |
| 148 | 1 |
| 166 | 1 |
| number_of_arms | Study_Count |
|---|---|
| 1 | 50 |
| 2 | 124 |
| 3 | 55 |
| 4 | 41 |
| 5 | 9 |
| 6 | 19 |
| 7 | 6 |
| 8 | 13 |
| 9 | 11 |
| 10 | 6 |
| 12 | 8 |
| 14 | 1 |
| 15 | 6 |
| 16 | 2 |
| 17 | 1 |
| 18 | 2 |
| 19 | 2 |
| 20 | 1 |
| 21 | 1 |
| 22 | 1 |
| 29 | 1 |
| 32 | 1 |
| 3 |
| Measure | Vaccine |
|---|---|
| Min | 4.00 |
| 1st Qu | 120.00 |
| Median | 400.00 |
| Mean | 17522.98 |
| 3rd Qu | 1762.00 |
| Max | 3827656.00 |
| intervention_model | Study_Count |
|---|---|
| Crossover Assignment | 5 |
| Factorial Assignment | 4 |
| Parallel Assignment | 249 |
| Sequential Assignment | 48 |
| Single Group Assignment | 58 |
| group_type | Group_Count |
|---|---|
| Experimental | 1091 |
| Placebo Comparator | 231 |
| Active Comparator | 155 |
| Other | 34 |
| No Intervention | 26 |
| 3 | |
| Sham Comparator | 1 |
| Count of Versions | Count of Studies |
|---|---|
| 1 | 60 |
| 2 | 82 |
| 3 | 63 |
| 4 | 59 |
| 5 | 26 |
| 6 | 18 |
| 7 | 12 |
| 8 | 9 |
| 9 | 5 |
| 10 | 6 |
| 11 | 3 |
| 12 | 3 |
| 13 | 3 |
| 14 | 1 |
| 15 | 2 |
| 16 | 1 |
| 17 | 3 |
| 19 | 1 |
| 20 | 2 |
| 21 | 2 |
| 34 | 2 |
| 35 | 1 |
| Change Type | Count_of_Changes | Count_of_Studies | ratio |
|---|---|---|---|
| Study Status | 1205 | 304 | 3.963816 |
| Contacts/Locations | 688 | 260 | 2.646154 |
| None (earliest Version on record) | 364 | 364 | 1.000000 |
| Recruitment Status | 359 | 243 | 1.477366 |
| Study Design | 244 | 156 | 1.564103 |
| Outcome Measures | 205 | 127 | 1.614173 |
| Study Description | 185 | 115 | 1.608696 |
| Eligibility | 180 | 110 | 1.636364 |
| Arms | 160 | 103 | 1.553398 |
| Interventions | 160 | 103 | 1.553398 |
| Study Identification | 159 | 121 | 1.314050 |
| Oversight | 84 | 80 | 1.050000 |
| Sponsor/Collaborators | 44 | 36 | 1.222222 |
| Conditions | 39 | 35 | 1.114286 |
| References | 25 | 15 | 1.666667 |
| Document Section | 16 | 12 | 1.333333 |
| IPDSharing | 11 | 11 | 1.000000 |
| Results | 2 | 2 | 1.000000 |
| Results Submission Events | 2 | 2 | 1.000000 |
| Country | Study_Count |
|---|---|
| France | 430 |
| United States | 312 |
| Turkey | 167 |
| Italy | 154 |
| United Kingdom | 135 |
| Egypt | 115 |
| Spain | 67 |
| China | 65 |
| Germany | 64 |
| Canada | 52 |
| Belgium | 42 |
| Switzerland | 41 |
| Denmark | 23 |
| Austria | 22 |
| India | 22 |
| Mexico | 22 |
| Israel | 21 |
| Norway | 21 |
| Russian Federation | 21 |
| Brazil | 20 |
| Sweden | 20 |
| Argentina | 19 |
| Hong Kong | 17 |
| Pakistan | 17 |
| Poland | 17 |
| Greece | 15 |
| Netherlands | 15 |
| Czechia | 14 |
| Saudi Arabia | 11 |
| Malaysia | 10 |
| Chile | 9 |
| Singapore | 9 |
| Jordan | 7 |
| 6 | |
| Portugal | 6 |
| Colombia | 5 |
| Hungary | 5 |
| Japan | 5 |
| Korea, Republic of | 5 |
| Qatar | 5 |
| United Arab Emirates | 5 |
| Australia | 4 |
| Indonesia | 4 |
| Kazakhstan | 4 |
| Slovenia | 4 |
| Taiwan | 4 |
| Croatia | 3 |
| Finland | 3 |
| Iran, Islamic Republic of | 3 |
| Ireland | 3 |
| Lithuania | 3 |
| Monaco | 3 |
| Peru | 3 |
| Thailand | 3 |
| Tunisia | 3 |
| Bangladesh | 2 |
| Congo, The Democratic Republic of the | 2 |
| Dominican Republic | 2 |
| France|French Guiana | 2 |
| Iraq | 2 |
| Luxembourg | 2 |
| Morocco | 2 |
| Mozambique | 2 |
| Nepal | 2 |
| Romania | 2 |
| United States|Canada | 2 |
| United States|Puerto Rico | 2 |
| Albania | 1 |
| Albania|Bosnia and Herzegovina|Croatia|Montenegro|Serbia | 1 |
| Albania|Brazil|Bulgaria|Chile|Cyprus|France|Greece|Israel|Malta|Portugal|Spain|Turkey|United Kingdom | 1 |
| Algeria | 1 |
| Argentina|Belgium|Brazil|Chile|Colombia|Costa Rica|Croatia|Denmark|France|Germany|Greece|Hungary|India|Italy|Japan|Mexico|Peru|Poland|Portugal|Romania|Russian Federation|Serbia|South Africa|Spain|Switzerland|Turkey|Ukraine | 1 |
| Argentina|Bosnia and Herzegovina|Ghana|India|Iran, Islamic Republic of|Sudan | 1 |
| Argentina|Brazil|Cameroon|India|Malaysia|Nigeria|South Africa|Thailand|Uganda|Zimbabwe | 1 |
| Argentina|Chile|Colombia|Ecuador|Spain | 1 |
| Australia|Belgium|Brazil|Denmark|France|Georgia|Germany|Ireland|Italy|Netherlands|Poland|Romania|Sweden|Ukraine|United Kingdom | 1 |
| Australia|Canada|China|France|Gambia|Germany|Israel|Italy|Malaysia|Poland|Portugal|Romania|Singapore|Switzerland | 1 |
| Austria|Belgium|Canada|Finland|France|Germany|Greece|Iran, Islamic Republic of|Ireland|Italy|Norway|Poland|Portugal|Spain|Switzerland|United Kingdom | 1 |
| Austria|Belgium|Czechia|Denmark|France|Germany|Greece|Hungary|Israel|Italy|Lithuania|Netherlands|Poland|Portugal|Russian Federation|Spain|Sweden|Switzerland|United Kingdom | 1 |
| Austria|Belgium|Czechia|Germany|Greece|Italy|Netherlands|United Kingdom | 1 |
| Austria|France|Germany | 1 |
| Austria|France|Italy | 1 |
| Austria|Germany | 1 |
| Bahrain | 1 |
| Belarus | 1 |
| Belarus|Russian Federation | 1 |
| Belgium|France|Italy | 1 |
| Belgium|Greece|Italy | 1 |
| Belgium|Italy|United Kingdom | 1 |
| Bolivia | 1 |
| Brazil|Chile|Uruguay | 1 |
| Brazil|Denmark|Germany|Ireland|Italy|Mexico|Spain|Turkey | 1 |
| Brazil|Mexico|Spain | 1 |
| Burkina Faso | 1 |
| Burkina Faso|Guinea | 1 |
| Burkina Faso|Guinea|Mali|Senegal|Sierra Leone | 1 |
| Chile|Colombia|Ecuador|Spain | 1 |
| China|Pakistan | 1 |
| Congo, The Democratic Republic of the|Guinea|Indonesia|Liberia|Mali|Mexico | 1 |
| Congo, The Democratic Republic of the|India|Senegal | 1 |
| Congo, The Democratic Republic of the|South Sudan | 1 |
| Croatia|Finland|France|Greece|Italy | 1 |
| Czechia|Germany|Slovakia | 1 |
| Denmark|France|Germany|Norway | 1 |
| Ecuador | 1 |
| Ethiopia | 1 |
| Finland|France|Germany|Italy|Sweden|United Kingdom | 1 |
| France|Guadeloupe|Martinique | 1 |
| France|Israel|Netherlands|Spain|United Kingdom | 1 |
| France|Martinique | 1 |
| France|Martinique|Mayotte|Réunion | 1 |
| France|United Kingdom | 1 |
| Gabon | 1 |
| Georgia | 1 |
| Germany|Portugal|Spain|United Kingdom | 1 |
| Germany|Romania | 1 |
| Greece|Italy|Singapore | 1 |
| Italy|Romania|United Kingdom | 1 |
| Italy|San Marino | 1 |
| Kenya | 1 |
| Kuwait | 1 |
| Martinique | 1 |
| Philippines | 1 |
| Puerto Rico | 1 |
| Serbia | 1 |
| Slovakia | 1 |
| Ukraine | 1 |
| United States|Albania|Australia|Czechia|France|Germany|Hong Kong|Israel|Italy|Lebanon|Norway|Poland|Spain|Sweden|Taiwan | 1 |
| United States|Argentina|Armenia|Australia|Bolivia|Chile|Costa Rica|Czechia|Germany|Guatemala|Italy|Lebanon|Mexico|Netherlands|Nigeria|Puerto Rico|Saudi Arabia|Spain|Tunisia|Turkey|Venezuela | 1 |
| United States|Argentina|Botswana|Brazil|Malawi|Mexico|Peru|South Africa|Tanzania|Zambia|Zimbabwe | 1 |
| United States|Argentina|Denmark|United Kingdom | 1 |
| United States|Bolivia|Canada|Chile|India|United Kingdom | 1 |
| United States|Brazil|Denmark|Japan|Philippines | 1 |
| United States|Canada|Croatia|Czechia|Estonia|Ethiopia|Germany|Ghana|Mexico|Poland|Portugal|Russian Federation|Serbia|Slovenia | 1 |
| United States|Canada|Puerto Rico | 1 |
| United States|Egypt|Germany|Peru|Singapore | 1 |
| United States|Egypt|Iran, Islamic Republic of | 1 |
| United States|France|Germany|Italy|Poland|Spain|United Kingdom | 1 |
| United States|France|Germany|Spain|Switzerland | 1 |
| United States|India | 1 |
| United States|India|Spain|United Kingdom | 1 |
| United States|Kenya|United Kingdom | 1 |
| United States|Malawi|Peru|South Africa|Zambia|Zimbabwe | 1 |
| United States|Spain | 1 |
| United States|United Kingdom | 1 |
| Zimbabwe | 1 |
| Site_count | Study_Count |
|---|---|
| 1 | 1787 |
| 2 | 133 |
| 3 | 66 |
| 4 | 38 |
| 5 | 25 |
| 6 | 16 |
| 7 | 16 |
| 8 | 11 |
| 9 | 8 |
| 10 | 9 |
| 11 | 7 |
| 12 | 11 |
| 13 | 2 |
| 14 | 9 |
| 15 | 7 |
| 17 | 6 |
| 18 | 2 |
| 19 | 1 |
| 20 | 4 |
| 22 | 4 |
| 23 | 2 |
| 27 | 3 |
| 31 | 2 |
| 32 | 1 |
| 33 | 1 |
| 34 | 1 |
| 37 | 1 |
| 40 | 1 |
| 44 | 2 |
| 45 | 1 |
| 51 | 1 |
| 52 | 1 |
| 53 | 1 |
| 68 | 2 |
| 81 | 1 |
| 97 | 1 |
| 98 | 1 |
| 128 | 1 |
| 191 | 1 |
| 931 | 1 |
| Count of Versions | Count of Studies |
|---|---|
| 1 | 705 |
| 2 | 683 |
| 3 | 407 |
| 4 | 197 |
| 5 | 87 |
| 6 | 36 |
| 7 | 18 |
| 8 | 4 |
| 9 | 6 |
| 10 | 4 |
| 11 | 4 |
| 12 | 2 |
| 13 | 2 |
| 16 | 1 |
| 18 | 1 |
| 19 | 1 |
| 20 | 3 |
| 21 | 1 |
| 25 | 1 |
| 26 | 1 |
| 29 | 1 |
| 38 | 1 |
| 41 | 1 |
| 42 | 2 |
| 44 | 1 |
| 46 | 1 |
| 94 | 1 |
| 105 | 1 |
| 117 | 1 |
| 133 | 1 |
| 144 | 1 |
| 186 | 1 |
| 195 | 1 |
| 208 | 1 |
| 210 | 1 |
| 212 | 1 |
| 213 | 2 |
| 221 | 1 |
| 229 | 1 |
| 240 | 1 |
| 248 | 1 |
| 272 | 1 |
| Change Type | Count_of_Changes | Count_of_Studies | ratio |
|---|---|---|---|
| Study Status | 6582 | 1483 | 4.438301 |
| None (earliest Version on record) | 2188 | 2188 | 1.000000 |
| Contacts/Locations | 1612 | 949 | 1.698630 |
| Recruitment Status | 1129 | 895 | 1.261453 |
| Study Design | 692 | 603 | 1.147595 |
| Study Description | 577 | 436 | 1.323395 |
| Outcome Measures | 571 | 489 | 1.167689 |
| Study Identification | 486 | 427 | 1.138173 |
| Eligibility | 359 | 289 | 1.242214 |
| Oversight | 266 | 259 | 1.027027 |
| Groups | 217 | 184 | 1.179348 |
| Interventions | 217 | 184 | 1.179348 |
| Sponsor/Collaborators | 193 | 174 | 1.109195 |
| Conditions | 143 | 138 | 1.036232 |
| References | 85 | 77 | 1.103896 |
| IPDSharing | 28 | 27 | 1.037037 |
| Document Section | 20 | 18 | 1.111111 |
| Results Submission Events | 14 | 14 | 1.000000 |
| Results | 10 | 10 | 1.000000 |
| Baseline Characteristics | 2 | 1 | 2.000000 |
| Measure | Observational |
|---|---|
| Min | 3.00 |
| 1st Qu | 100.00 |
| Median | 300.00 |
| Mean | 37909.82 |
| 3rd Qu | 1000.00 |
| Max | 25428392.00 |
| observational_model | Study_Count |
|---|---|
| Cohort | 1367 |
| Case-Only | 242 |
| Case-Control | 241 |
| Other | 232 |
| Ecologic or Community | 76 |
| Case-Crossover | 22 |
| Family-Based | 7 |
| 1 |
| time_perspective | Study_Count |
|---|---|
| Prospective | 1233 |
| Retrospective | 548 |
| Cross-Sectional | 280 |
| Other | 126 |
| 1 |
| nct_id | brief_title | link |
|---|---|---|
| NCT04347408 | Seroprevalence of SARS-Cov-2 Antibodies in Children | https://ClinicalTrials.gov/show/NCT04347408 |
| NCT05043142 | Epidemiological Study of the COVID-2019 in Participating Organizations. | https://ClinicalTrials.gov/show/NCT05043142 |
| NCT04912700 | The Impact of Vaccination on Severity of Illness in COVID-19 | https://ClinicalTrials.gov/show/NCT04912700 |
| NCT04709068 | Risk Stratification and Early Alerting Regarding COVID-19 Hospitalization | https://ClinicalTrials.gov/show/NCT04709068 |
| NCT04542226 | Observational Open Study of Polyoxidonium in Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04542226 |
| NCT04474496 | Impact of COVID-19 on Marshallese Communities in the U.S. | https://ClinicalTrials.gov/show/NCT04474496 |
| NCT04431908 | Validation of a Rapid Quantitative Test for Loss of Smell in COVID-19 Subjects | https://ClinicalTrials.gov/show/NCT04431908 |
| NCT04425863 | Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19 | https://ClinicalTrials.gov/show/NCT04425863 |
| NCT04425850 | USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19 | https://ClinicalTrials.gov/show/NCT04425850 |
| NCT04385238 | Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04385238 |
| Country | Study_Count |
|---|---|
| United States | 45 |
| France | 40 |
| Spain | 30 |
| Turkey | 29 |
| Italy | 22 |
| Egypt | 19 |
| Germany | 13 |
| Switzerland | 10 |
| Argentina | 9 |
| Belgium | 8 |
| Brazil | 7 |
| China | 7 |
| Sweden | 7 |
| Canada | 6 |
| Pakistan | 6 |
| Poland | 6 |
| United Kingdom | 6 |
| Mexico | 5 |
| Netherlands | 5 |
| Denmark | 4 |
| Israel | 4 |
| Russian Federation | 4 |
| Chile | 3 |
| Colombia | 3 |
| Norway | 3 |
| Austria | 2 |
| Bangladesh | 2 |
| France|Martinique | 2 |
| Greece | 2 |
| India | 2 |
| Kuwait | 2 |
| Qatar | 2 |
| Tunisia | 2 |
| Australia | 1 |
| Belgium|Congo|France|Italy|Netherlands|Spain | 1 |
| Belgium|France | 1 |
| Brazil|India | 1 |
| Brazil|Mexico|Spain | 1 |
| Cape Verde | 1 |
| China|Hong Kong|Spain | 1 |
| China|India|Indonesia|Japan|Malaysia|Pakistan|Singapore | 1 |
| Congo, The Democratic Republic of the | 1 |
| Czechia|France|Germany|Italy|Lithuania | 1 |
| Hungary | 1 |
| Iceland | 1 |
| Ireland | 1 |
| Korea, Republic of | 1 |
| Lebanon | 1 |
| 1 | |
| Netherlands|Ukraine | 1 |
| Nigeria|South Africa | 1 |
| Saudi Arabia | 1 |
| Singapore | 1 |
| South Africa | 1 |
| Ukraine | 1 |
| United States|Brazil|Colombia|Egypt|France|Mexico|Spain | 1 |
| United States|Canada|Israel|Japan|Serbia|Spain|United Kingdom | 1 |
| United States|India|Sweden | 1 |
| United States|Poland | 1 |
| United States|United Kingdom | 1 |
| Uruguay | 1 |
| Site_count | Study_Count |
|---|---|
| 1 | 270 |
| 2 | 24 |
| 3 | 6 |
| 4 | 6 |
| 5 | 3 |
| 6 | 3 |
| 7 | 3 |
| 8 | 2 |
| 9 | 1 |
| 10 | 1 |
| 11 | 3 |
| 13 | 2 |
| 14 | 2 |
| 15 | 2 |
| 17 | 2 |
| 18 | 1 |
| 22 | 1 |
| 27 | 2 |
| 31 | 1 |
| 36 | 1 |
| 39 | 1 |
| 47 | 1 |
| 50 | 1 |
| 53 | 1 |
| 63 | 1 |
| 75 | 1 |
| 76 | 1 |
| 109 | 1 |
| 148 | 1 |
| Count of Versions | Count of Studies |
|---|---|
| 1 | 109 |
| 2 | 106 |
| 3 | 70 |
| 4 | 25 |
| 5 | 17 |
| 6 | 7 |
| 7 | 6 |
| 8 | 1 |
| 9 | 1 |
| 11 | 2 |
| 14 | 1 |
| Change Type | Count_of_Changes | Count_of_Studies | ratio |
|---|---|---|---|
| Study Status | 503 | 236 | 2.131356 |
| None (earliest Version on record) | 345 | 345 | 1.000000 |
| Contacts/Locations | 233 | 144 | 1.618056 |
| Recruitment Status | 162 | 134 | 1.208955 |
| Study Design | 120 | 99 | 1.212121 |
| Study Description | 91 | 77 | 1.181818 |
| Outcome Measures | 88 | 74 | 1.189189 |
| Study Identification | 70 | 64 | 1.093750 |
| Eligibility | 49 | 45 | 1.088889 |
| Sponsor/Collaborators | 37 | 37 | 1.000000 |
| Oversight | 33 | 33 | 1.000000 |
| Groups | 30 | 29 | 1.034483 |
| Interventions | 30 | 29 | 1.034483 |
| Conditions | 18 | 18 | 1.000000 |
| References | 15 | 13 | 1.153846 |
| Document Section | 8 | 6 | 1.333333 |
| IPDSharing | 8 | 8 | 1.000000 |
| Results Submission Events | 5 | 5 | 1.000000 |
| Results | 2 | 2 | 1.000000 |
| Measure | Registries |
|---|---|
| Min | 1.00 |
| 1st Qu | 100.00 |
| Median | 350.00 |
| Mean | 41133.91 |
| 3rd Qu | 1200.00 |
| Max | 12000000.00 |
| observational_model | Study_Count |
|---|---|
| Cohort | 232 |
| Case-Control | 41 |
| Other | 34 |
| Case-Only | 31 |
| Ecologic or Community | 6 |
| Case-Crossover | 1 |
| time_perspective | Study_Count |
|---|---|
| Prospective | 250 |
| Other | 51 |
| Cross-Sectional | 44 |
| target_duration | Study_Count |
|---|---|
| 1 Year | 41 |
| 6 Months | 35 |
| 12 Months | 34 |
| 1 Month | 31 |
| 1 Day | 22 |
| 3 Months | 18 |
| 2 Months | 17 |
| 2 Years | 16 |
| 30 Days | 12 |
| 4 Weeks | 11 |
| 18 Months | 10 |
| 28 Days | 7 |
| 14 Days | 6 |
| 5 Years | 6 |
| 9 Months | 5 |
| 1 Week | 4 |
| 2 Weeks | 4 |
| 24 Months | 4 |
| 10 Days | 3 |
| 10 Months | 3 |
| 3 Weeks | 3 |
| 3 Years | 3 |
| 36 Months | 3 |
| 4 Months | 3 |
| 4 Years | 3 |
| 5 Months | 3 |
| 6 Weeks | 3 |
| 60 Days | 3 |
| 7 Days | 3 |
| 90 Days | 3 |
| 12 Weeks | 2 |
| 2 Days | 2 |
| 20 Years | 2 |
| 21 Days | 2 |
| 21 Months | 2 |
| 5 Days | 2 |
| 7 Months | 2 |
| 10 Years | 1 |
| 100 Years | 1 |
| 12 Years | 1 |
| 14 Weeks | 1 |
| 16 Months | 1 |
| 16 Weeks | 1 |
| 20 Days | 1 |
| 20 Months | 1 |
| 3 Days | 1 |
| 8 Months | 1 |
| 8 Weeks | 1 |
| 9 Weeks | 1 |
| nct_id | brief_title | link |
|---|---|---|
| NCT04323592 | Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome | https://ClinicalTrials.gov/show/NCT04323592 |
| NCT04898166 | Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019 (COVID-19). | https://ClinicalTrials.gov/show/NCT04898166 |
| nct_id | brief_title | link |
|---|---|---|
| NCT04381377 | Efficacy and Safety of Polyoxidonium® in Hospitalized Patients With Coronavirus Disease COVID-19 | https://ClinicalTrials.gov/show/NCT04381377 |
| NCT04381364 | Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19) | https://ClinicalTrials.gov/show/NCT04381364 |
| NCT04381052 | Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04381052 |
| NCT04381000 | Quarantine and Telerehabilitation in Chronic Pain Patients During COVID-19 Pandemic. | https://ClinicalTrials.gov/show/NCT04381000 |
| NCT04380961 | A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19 | https://ClinicalTrials.gov/show/NCT04380961 |
| NCT04380935 | Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04380935 |
| NCT04380909 | ROCO - Self-help for People With Psychological Distress Due to the Covid-19 Situation | https://ClinicalTrials.gov/show/NCT04380909 |
| NCT04380818 | Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19 | https://ClinicalTrials.gov/show/NCT04380818 |
| NCT04380701 | A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy and Immunocompromised Adults | https://ClinicalTrials.gov/show/NCT04380701 |
| NCT04380688 | Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. | https://ClinicalTrials.gov/show/NCT04380688 |
| NCT04380532 | Tableted COVID-19 Therapeutic Vaccine | https://ClinicalTrials.gov/show/NCT04380532 |
| NCT04380519 | Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04380519 |
| NCT04380402 | Atorvastatin as Adjunctive Therapy in COVID-19 | https://ClinicalTrials.gov/show/NCT04380402 |
| NCT04380376 | Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia | https://ClinicalTrials.gov/show/NCT04380376 |
| NCT04379661 | SUNLIGHT Study: Online Support Groups for MS to Address COVID-19 | https://ClinicalTrials.gov/show/NCT04379661 |
| NCT04379531 | LDCT in COVID-19 Pneumonia: a Prospective Moscow Study | https://ClinicalTrials.gov/show/NCT04379531 |
| NCT04379518 | Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients | https://ClinicalTrials.gov/show/NCT04379518 |
| NCT04379453 | Robot Assisted Percutaneous Cardiovascular Intervention as a Strategy to Reduce or Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses | https://ClinicalTrials.gov/show/NCT04379453 |
| NCT04379375 | Nudges to Improve Health Behaviors That Limit COVID-19 Spread | https://ClinicalTrials.gov/show/NCT04379375 |
| NCT04379336 | BCG Vaccination for Healthcare Workers in COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04379336 |
| NCT04379271 | A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator’s Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19) | https://ClinicalTrials.gov/show/NCT04379271 |
| NCT04379154 | Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-COV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04379154 |
| NCT04379076 | InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort | https://ClinicalTrials.gov/show/NCT04379076 |
| NCT04379037 | Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04379037 |
| NCT04378920 | A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes | https://ClinicalTrials.gov/show/NCT04378920 |
| NCT04378803 | Mindfulness Training for Seniors | https://ClinicalTrials.gov/show/NCT04378803 |
| NCT04378738 | Social Media and Covid19 Pandemic | https://ClinicalTrials.gov/show/NCT04378738 |
| NCT04378712 | Hydrogen/Oxygen Mixed Gas Inhalation for Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04378712 |
| NCT04377165 | Innovative Tool to Limit Spread of COVID 19 in Residential Aged Care Facilities | https://ClinicalTrials.gov/show/NCT04377165 |
| NCT04377672 | Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04377672 |
| NCT04377659 | Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04377659 |
| NCT04377620 | Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT) | https://ClinicalTrials.gov/show/NCT04377620 |
| NCT04377477 | COVID-19 Pneumonitis Low Dose Lung Radiotherapy (COLOR-19) | https://ClinicalTrials.gov/show/NCT04377477 |
| NCT04377789 | Effect of Quercetin on Prophylaxis and Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04377789 |
| NCT04377750 | The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation | https://ClinicalTrials.gov/show/NCT04377750 |
| NCT04377711 | A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04377711 |
| NCT04377308 | Fluoxetine to Reduce Intubation and Death After COVID19 Infection | https://ClinicalTrials.gov/show/NCT04377308 |
| NCT04376840 | Prevalence of Long-term Respiratory Complications of Severe SARS-CoV-2 Pneumonia - COVID-19 | https://ClinicalTrials.gov/show/NCT04376840 |
| NCT04376814 | Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19 | https://ClinicalTrials.gov/show/NCT04376814 |
| NCT04376788 | Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04376788 |
| NCT04376476 | Host-pathogen Interactions During SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04376476 |
| NCT04376684 | Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease | https://ClinicalTrials.gov/show/NCT04376684 |
| NCT04375774 | Verification of Alternative Do-it-yourself Equipment Respirators for the COVID-19 Personal Protective Equipment (PPE) | https://ClinicalTrials.gov/show/NCT04375774 |
| NCT04376593 | PET/CT Imaging in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04376593 |
| NCT04376034 | Convalescent Plasma Collection and Treatment in Pediatrics and Adults | https://ClinicalTrials.gov/show/NCT04376034 |
| NCT04375397 | Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury | https://ClinicalTrials.gov/show/NCT04375397 |
| NCT04375202 | Colchicine in COVID-19: a Pilot Study | https://ClinicalTrials.gov/show/NCT04375202 |
| NCT04375124 | Treatment of Angiotensin Peptide (1-7) for COVID-19 | https://ClinicalTrials.gov/show/NCT04375124 |
| NCT04375098 | Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04375098 |
| NCT04374942 | Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus? | https://ClinicalTrials.gov/show/NCT04374942 |
| NCT04374539 | Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial | https://ClinicalTrials.gov/show/NCT04374539 |
| NCT04374526 | Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression. | https://ClinicalTrials.gov/show/NCT04374526 |
| NCT04374487 | Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications | https://ClinicalTrials.gov/show/NCT04374487 |
| NCT04374461 | A Study of N-acetylcysteine in Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04374461 |
| NCT04374786 | Effects of Mobile App in House Staff Health and Well-being During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04374786 |
| NCT04374591 | The Role of Sodium Bicarbonate as Adjuvant Treatment of Computed Tomography Identified COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04374591 |
| NCT04374565 | Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia | https://ClinicalTrials.gov/show/NCT04374565 |
| NCT04374084 | Moxibustion Plus Cupping in Convalescent Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04374084 |
| NCT04374032 | Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04374032 |
| NCT04374019 | Novel Agents for Treatment of High-risk COVID-19 Positive Patients | https://ClinicalTrials.gov/show/NCT04374019 |
| NCT04374149 | Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS | https://ClinicalTrials.gov/show/NCT04374149 |
| NCT04373824 | Max Ivermectin- COVID 19 Study Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study | https://ClinicalTrials.gov/show/NCT04373824 |
| NCT04373382 | Peer Champion Support for Hospital Staff During and After the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04373382 |
| NCT04373291 | Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04373291 |
| NCT04373096 | Enhanced Hood PPE to Minimize COVID-19 Transmission to Front-line Health Care Workers | https://ClinicalTrials.gov/show/NCT04373096 |
| NCT04373044 | Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04373044 |
| NCT04372693 | Unplanned Shifting to Online Distance Learning: Nursing Students’ Perception and Achievement | https://ClinicalTrials.gov/show/NCT04372693 |
| NCT04372680 | WeanINg From Mechanical Ventilation for ARDS CovId-19 Patients Guided by Combined Thoracic UltraSound | https://ClinicalTrials.gov/show/NCT04372680 |
| NCT04372017 | Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04372017 |
| NCT04372004 | Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19) | https://ClinicalTrials.gov/show/NCT04372004 |
| NCT04371367 | Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE ) | https://ClinicalTrials.gov/show/NCT04371367 |
| NCT04371029 | Impact of Neck Inspiratory Muscle Activation During Sleep in ICU Patients After a COVID 19 ARDS | https://ClinicalTrials.gov/show/NCT04371029 |
| NCT04370288 | Clinical Application of Methylene Blue for Treatment of Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04370288 |
| NCT04370262 | Multi-site Adaptive Trials for COVID-19 | https://ClinicalTrials.gov/show/NCT04370262 |
| NCT04370236 | INB03 for the Treatment of Pulmonary Complications From COVID-19 | https://ClinicalTrials.gov/show/NCT04370236 |
| NCT04369378 | Effectiveness of Using a Meditation App in Reducing Anxiety and Improving Well-being During the Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04369378 |
| NCT04369365 | A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic | https://ClinicalTrials.gov/show/NCT04369365 |
| NCT04369066 | COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur | https://ClinicalTrials.gov/show/NCT04369066 |
| NCT04368988 | Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant | https://ClinicalTrials.gov/show/NCT04368988 |
| NCT04368923 | Management of Covid-19 Patients During Home Isolation | https://ClinicalTrials.gov/show/NCT04368923 |
| NCT04368676 | Breath Regulation and Yogic Exercise An Online Therapy for Calm and Happiness During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04368676 |
| NCT04367662 | Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19 | https://ClinicalTrials.gov/show/NCT04367662 |
| NCT04367636 | The Effects of Attention Training on Emotion Regulation and Stress Related Complaints During COVID-19 | https://ClinicalTrials.gov/show/NCT04367636 |
| NCT04366960 | Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04366960 |
| NCT04366947 | Intravascular Access in Suspected/Confirmed COVID-19 Patient | https://ClinicalTrials.gov/show/NCT04366947 |
| NCT04366908 | Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome | https://ClinicalTrials.gov/show/NCT04366908 |
| NCT04366882 | Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04366882 |
| NCT04366856 | PROne Positioning in coVID-19 Oxygeno-dependent Patients in Spontaneous Ventilation (PROVID Study) | https://ClinicalTrials.gov/show/NCT04366856 |
| NCT04366323 | Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04366323 |
| NCT04366297 | Intravascular Access of COVID-19 Patient Under Personal Protective Equipment | https://ClinicalTrials.gov/show/NCT04366297 |
| NCT04366245 | Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04366245 |
| NCT04366232 | Efficacy of Intravenous Anakinra and Ruxolitinib During COVID-19 Inflammation | https://ClinicalTrials.gov/show/NCT04366232 |
| NCT04365985 | Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19 | https://ClinicalTrials.gov/show/NCT04365985 |
| NCT04365972 | Attention Bias Modification for Reducing Health Anxiety During the Coronavirus Pandemic | https://ClinicalTrials.gov/show/NCT04365972 |
| NCT04365608 | Prehospital Intubation of COVID-19 Patient With Personal Protective Equipment | https://ClinicalTrials.gov/show/NCT04365608 |
| NCT04365439 | Convalescent Plasma for COVID-19 | https://ClinicalTrials.gov/show/NCT04365439 |
| NCT04365309 | Protective Effect of Aspirin on COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04365309 |
| NCT04365257 | Prazosin to Prevent COVID-19 (PREVENT-COVID Trial) | https://ClinicalTrials.gov/show/NCT04365257 |
| NCT04365153 | Canakinumab in Covid-19 Cardiac Injury (The Three C Study) | https://ClinicalTrials.gov/show/NCT04365153 |
| NCT04365127 | Progesterone for the Treatment of COVID-19 in Hospitalized Men | https://ClinicalTrials.gov/show/NCT04365127 |
| NCT04365101 | Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 | https://ClinicalTrials.gov/show/NCT04365101 |
| NCT04373733 | Early Intervention in COVID-19: Favipiravir Verses Standard Care | https://ClinicalTrials.gov/show/NCT04373733 |
| NCT04373707 | Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19 | https://ClinicalTrials.gov/show/NCT04373707 |
| NCT04373200 | Human Ab Response & immunoMONItoring of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04373200 |
| NCT04373161 | Home Pulse Oximeter Use in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04373161 |
| NCT04373135 | Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19 | https://ClinicalTrials.gov/show/NCT04373135 |
| NCT04372979 | Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients. | https://ClinicalTrials.gov/show/NCT04372979 |
| NCT04372628 | Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19 | https://ClinicalTrials.gov/show/NCT04372628 |
| NCT04372602 | Duvelisib to Combat COVID-19 | https://ClinicalTrials.gov/show/NCT04372602 |
| NCT04372589 | Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC) | https://ClinicalTrials.gov/show/NCT04372589 |
| NCT04372186 | A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04372186 |
| NCT04371978 | Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19 | https://ClinicalTrials.gov/show/NCT04371978 |
| NCT04371965 | Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04371965 |
| NCT04371601 | Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019 | https://ClinicalTrials.gov/show/NCT04371601 |
| NCT04371510 | Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients | https://ClinicalTrials.gov/show/NCT04371510 |
| NCT04371419 | COVID-19 Health Messaging to Underserved Communities | https://ClinicalTrials.gov/show/NCT04371419 |
| NCT04304313 | A Pilot Study of Sildenafil in COVID-19 | https://ClinicalTrials.gov/show/NCT04304313 |
| NCT04371393 | MSCs in COVID-19 ARDS | https://ClinicalTrials.gov/show/NCT04371393 |
| NCT04370886 | Recruit Blood Donors Via SMS During Epidemic of COVID-19 | https://ClinicalTrials.gov/show/NCT04370886 |
| NCT04370834 | Tocilizumab for Patients With Cancer and COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04370834 |
| NCT04370782 | Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting | https://ClinicalTrials.gov/show/NCT04370782 |
| NCT04369820 | C5a Receptor Expression - COVID-19 (C5-COV) | https://ClinicalTrials.gov/show/NCT04369820 |
| NCT04369794 | COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement | https://ClinicalTrials.gov/show/NCT04369794 |
| NCT04369742 | Treating COVID-19 With Hydroxychloroquine (TEACH) | https://ClinicalTrials.gov/show/NCT04369742 |
| NCT04369469 | Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia | https://ClinicalTrials.gov/show/NCT04369469 |
| NCT04369456 | Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients | https://ClinicalTrials.gov/show/NCT04369456 |
| NCT04368845 | Telerehabilitation in Patients With COVID-19 After Hospitalization. The ATHLOS Study | https://ClinicalTrials.gov/show/NCT04368845 |
| NCT04368377 | Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04368377 |
| NCT04368299 | Telemedicine for Follow-up of Systemic Lupus Erythematosus | https://ClinicalTrials.gov/show/NCT04368299 |
| NCT04368260 | Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04368260 |
| NCT04368156 | Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms | https://ClinicalTrials.gov/show/NCT04368156 |
| NCT04368000 | Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization | https://ClinicalTrials.gov/show/NCT04368000 |
| NCT04367831 | Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04367831 |
| NCT04367545 | Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04367545 |
| NCT04367168 | Colchicine Twice Daily During 10 Days as an Option for the Treatment of Symptoms Induced by Inflammation in Patients With Mild and Severe Coronavirus Disease | https://ClinicalTrials.gov/show/NCT04367168 |
| NCT04367077 | MultiStem Administration for COVID-19 Induced ARDS (MACoVIA) | https://ClinicalTrials.gov/show/NCT04367077 |
| NCT04366817 | Psychological Impact of the Lockdown on Patients Giving Birth During the COVID-19 Epidemic Short Title : Isolement and Childbirth: Psychological Impact | https://ClinicalTrials.gov/show/NCT04366817 |
| NCT04366180 | Evaluation of the Probiotic Lactobacillus Coryniformis K8 on COVID-19 Prevention in Healthcare Workers | https://ClinicalTrials.gov/show/NCT04366180 |
| NCT04366141 | COVID-19 (Coronavirus Disease 2019) Intubation Barrier Box | https://ClinicalTrials.gov/show/NCT04366141 |
| NCT04366089 | Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora | https://ClinicalTrials.gov/show/NCT04366089 |
| NCT04366063 | Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04366063 |
| NCT04366050 | Ramipril for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04366050 |
| NCT04365738 | Pulmonary Rehabilitation in Post-Acute Period of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04365738 |
| NCT04365699 | Cardiovascular Effects of COVID-19 | https://ClinicalTrials.gov/show/NCT04365699 |
| NCT04364893 | Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19 | https://ClinicalTrials.gov/show/NCT04364893 |
| NCT04364828 | NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease Progression | https://ClinicalTrials.gov/show/NCT04364828 |
| NCT04364802 | COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients | https://ClinicalTrials.gov/show/NCT04364802 |
| NCT04364763 | A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study) | https://ClinicalTrials.gov/show/NCT04364763 |
| NCT04364737 | CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04364737 |
| NCT04364594 | COVID-19 Search in Conjunctival Cells | https://ClinicalTrials.gov/show/NCT04364594 |
| NCT04373460 | Convalescent Plasma to Limit SARS-CoV-2 Associated Complications | https://ClinicalTrials.gov/show/NCT04373460 |
| NCT04363853 | Tocilizumab Treatment in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04363853 |
| NCT04363827 | Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04363827 |
| NCT04363814 | Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04363814 |
| NCT04364022 | Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland | https://ClinicalTrials.gov/show/NCT04364022 |
| NCT04364009 | Anakinra for COVID-19 Respiratory Symptoms | https://ClinicalTrials.gov/show/NCT04364009 |
| NCT04363528 | Incidence of Deep Vein Thrombosis at Doppler Echo in Covid-19 Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU | https://ClinicalTrials.gov/show/NCT04363528 |
| NCT04363502 | Use of the Interleukin-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04363502 |
| NCT04363749 | COVID-19 Infection: Exploration of Respiratory Control Center Abnormalities | https://ClinicalTrials.gov/show/NCT04363749 |
| NCT04363736 | A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04363736 |
| NCT04363463 | Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory Distress | https://ClinicalTrials.gov/show/NCT04363463 |
| NCT04363450 | Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP) | https://ClinicalTrials.gov/show/NCT04363450 |
| NCT04363437 | COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19 | https://ClinicalTrials.gov/show/NCT04363437 |
| NCT04363385 | Collection of Biological Samples With Clinical Characterization of Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04363385 |
| NCT04363606 | Chronic Fatigue Etiology and Recovery in Covid-19 Patients: the Role of Fatigability | https://ClinicalTrials.gov/show/NCT04363606 |
| NCT04363346 | Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia | https://ClinicalTrials.gov/show/NCT04363346 |
| NCT04363593 | Serology COVID-19 From the Cornwall Hospital Union | https://ClinicalTrials.gov/show/NCT04363593 |
| NCT04363541 | Local Thermotherapy for Patients With Mild-to-moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04363541 |
| NCT04362059 | A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04362059 |
| NCT04362189 | Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04362189 |
| NCT04362176 | Passive Immunity Trial for Our Nation to Treat COVID-19 in Hospitalized Adults | https://ClinicalTrials.gov/show/NCT04362176 |
| NCT04362813 | Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia | https://ClinicalTrials.gov/show/NCT04362813 |
| NCT04362358 | Online Cognitive Behavioral Therapy (CBT) for Stress Disorders in Health Workers Involved in the Care of Patients During the Covid-19 Epidemic | https://ClinicalTrials.gov/show/NCT04362358 |
| NCT04362332 | Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04362332 |
| NCT04362137 | Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm | https://ClinicalTrials.gov/show/NCT04362137 |
| NCT04362111 | Early Treatment of Cytokine Storm Syndrome in Covid-19 | https://ClinicalTrials.gov/show/NCT04362111 |
| NCT04361838 | The COVID-19 ICU PRAYER Study | https://ClinicalTrials.gov/show/NCT04361838 |
| NCT04361942 | Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV) | https://ClinicalTrials.gov/show/NCT04361942 |
| NCT04361916 | Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino) | https://ClinicalTrials.gov/show/NCT04361916 |
| NCT04361214 | Leflunomide in Mild COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04361214 |
| NCT04361526 | Pilot Study on Cytokine Filtration in COVID-19 ARDS | https://ClinicalTrials.gov/show/NCT04361526 |
| NCT04361474 | Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity | https://ClinicalTrials.gov/show/NCT04361474 |
| NCT04361448 | Performance of 3 Sampling Methods for the Detection of SARS-CoV-2 (COVID-19) With Real-time Reverse Transcriptase PCR | https://ClinicalTrials.gov/show/NCT04361448 |
| NCT04361396 | Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04361396 |
| NCT04360980 | The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04360980 |
| NCT04361344 | Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04361344 |
| NCT04361253 | Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy | https://ClinicalTrials.gov/show/NCT04361253 |
| NCT04360837 | PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) Patients | https://ClinicalTrials.gov/show/NCT04360837 |
| NCT04360824 | Covid-19 Associated Coagulopathy | https://ClinicalTrials.gov/show/NCT04360824 |
| NCT04360811 | Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04360811 |
| NCT04360551 | Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04360551 |
| NCT04359251 | Different PEEP Settings of COVID-19 Induced ARDS | https://ClinicalTrials.gov/show/NCT04359251 |
| NCT04359953 | Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04359953 |
| NCT04359901 | Sarilumab for Patients With Moderate COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04359901 |
| NCT04359875 | A Phone-call With a Student/General Practitioner Team to Impact Morbidity of Chronic Patients During COVID-19 Containment | https://ClinicalTrials.gov/show/NCT04359875 |
| NCT04359862 | Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection | https://ClinicalTrials.gov/show/NCT04359862 |
| NCT04359810 | Plasma Therapy of COVID-19 in Severely Ill Patients | https://ClinicalTrials.gov/show/NCT04359810 |
| NCT04359797 | COVID-19 Patient Positioning Pragmatic Trial | https://ClinicalTrials.gov/show/NCT04359797 |
| NCT04359680 | Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04359680 |
| NCT04359095 | Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia | https://ClinicalTrials.gov/show/NCT04359095 |
| NCT04358809 | Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill | https://ClinicalTrials.gov/show/NCT04358809 |
| NCT04358783 | Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia | https://ClinicalTrials.gov/show/NCT04358783 |
| NCT04358406 | Rhu-pGSN for Severe Covid-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04358406 |
| NCT04358081 | Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04358081 |
| NCT04357366 | suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE) | https://ClinicalTrials.gov/show/NCT04357366 |
| NCT04357340 | The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04357340 |
| NCT04357327 | Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04357327 |
| NCT04356937 | Efficacy of Tocilizumab on Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04356937 |
| NCT04356833 | Nebulised Rt-PA for ARDS Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04356833 |
| NCT04355962 | Sevoflurane in COVID-19 ARDS (SevCov) | https://ClinicalTrials.gov/show/NCT04355962 |
| NCT04355936 | Telmisartan for Treatment of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04355936 |
| NCT04355897 | CoVID-19 Plasma in Treatment of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04355897 |
| NCT04355728 | Use of UC-MSCs for COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04355728 |
| NCT04355364 | Efficacy and Safety of aerosolizedDornase Alfa Administration in Patients With COVID19 Induced ARDS (COVIDORNASE) | https://ClinicalTrials.gov/show/NCT04355364 |
| NCT04355351 | Study of Immune Response During SARS-CoV-2 Infection - (COVID-19) | https://ClinicalTrials.gov/show/NCT04355351 |
| NCT04355143 | Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19) | https://ClinicalTrials.gov/show/NCT04355143 |
| NCT04354428 | Treatment for COVID-19 in High-Risk Adult Outpatients | https://ClinicalTrials.gov/show/NCT04354428 |
| NCT04353128 | Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers. | https://ClinicalTrials.gov/show/NCT04353128 |
| NCT04352751 | Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020 | https://ClinicalTrials.gov/show/NCT04352751 |
| NCT04352400 | Efficacy of Nafamostat in Covid-19 Patients (RACONA Study) | https://ClinicalTrials.gov/show/NCT04352400 |
| NCT04352348 | Cohort of Patients Infected With SARS-CoV2 (COVID-19) or Suspected of Being | https://ClinicalTrials.gov/show/NCT04352348 |
| NCT04351620 | High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19 | https://ClinicalTrials.gov/show/NCT04351620 |
| NCT04351581 | Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With and Without COVID-19 | https://ClinicalTrials.gov/show/NCT04351581 |
| NCT04351542 | Ayurveda for Flu Like Illness During Covid-19 Outbreak | https://ClinicalTrials.gov/show/NCT04351542 |
| NCT04351347 | The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment | https://ClinicalTrials.gov/show/NCT04351347 |
| NCT04351152 | Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04351152 |
| NCT04360096 | Inhaled ZYESAMIâ„¢ (Aviptadil Acetate) for the Treatment of Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04360096 |
| NCT04359654 | Nebulised Dornase Alfa for Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04359654 |
| NCT04359537 | Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19 | https://ClinicalTrials.gov/show/NCT04359537 |
| NCT04359329 | Estrogen Patch for COVID-19 Symptoms | https://ClinicalTrials.gov/show/NCT04359329 |
| NCT04359290 | Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS | https://ClinicalTrials.gov/show/NCT04359290 |
| NCT04359264 | Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a Randomized Controlled Trial | https://ClinicalTrials.gov/show/NCT04359264 |
| NCT04358939 | Prone Position in Patients on High-flow Nasal Oxygen Therapy for COVID-19 (HIGH-PRONE-COVID-19) | https://ClinicalTrials.gov/show/NCT04358939 |
| NCT04358926 | Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19) | https://ClinicalTrials.gov/show/NCT04358926 |
| NCT04358614 | Baricitinib Therapy in COVID-19 | https://ClinicalTrials.gov/show/NCT04358614 |
| NCT04358549 | Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19 | https://ClinicalTrials.gov/show/NCT04358549 |
| NCT04358003 | Plasma Adsorption in Patients With Confirmed COVID-19 | https://ClinicalTrials.gov/show/NCT04358003 |
| NCT04357990 | Viruxal Oral and Nasal Spray for Treating the Symptoms of COVID-19 | https://ClinicalTrials.gov/show/NCT04357990 |
| NCT04357860 | Clinical Trial of Sarilumab in Adults With COVID-19 | https://ClinicalTrials.gov/show/NCT04357860 |
| NCT04357808 | Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID) | https://ClinicalTrials.gov/show/NCT04357808 |
| NCT04357782 | Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation | https://ClinicalTrials.gov/show/NCT04357782 |
| NCT04357730 | Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04357730 |
| NCT04357444 | Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19 | https://ClinicalTrials.gov/show/NCT04357444 |
| NCT04357106 | COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma | https://ClinicalTrials.gov/show/NCT04357106 |
| NCT04356690 | Etoposide in Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04356690 |
| NCT04356495 | Trial of COVID-19 Outpatient Treatment in Individuals With Risk Factors for Aggravation | https://ClinicalTrials.gov/show/NCT04356495 |
| NCT04356482 | CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19 | https://ClinicalTrials.gov/show/NCT04356482 |
| NCT04355637 | Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia | https://ClinicalTrials.gov/show/NCT04355637 |
| NCT04355533 | Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19 | https://ClinicalTrials.gov/show/NCT04355533 |
| NCT04355247 | Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm | https://ClinicalTrials.gov/show/NCT04355247 |
| NCT04355234 | Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns | https://ClinicalTrials.gov/show/NCT04355234 |
| NCT04355026 | Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04355026 |
| NCT04354870 | COVID-19 PrEP HCW HCQ Study | https://ClinicalTrials.gov/show/NCT04354870 |
| NCT04354831 | A Study Evaluating the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04354831 |
| NCT04354610 | Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04354610 |
| NCT04354259 | Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19 | https://ClinicalTrials.gov/show/NCT04354259 |
| NCT04354155 | COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial | https://ClinicalTrials.gov/show/NCT04354155 |
| NCT04353674 | Modulation of Hyperinflammation in COVID-19 | https://ClinicalTrials.gov/show/NCT04353674 |
| NCT04353596 | Stopping ACE-inhibitors in COVID-19 | https://ClinicalTrials.gov/show/NCT04353596 |
| NCT04353518 | Clinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19 | https://ClinicalTrials.gov/show/NCT04353518 |
| NCT04353336 | Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment | https://ClinicalTrials.gov/show/NCT04353336 |
| NCT04353284 | Camostat Mesylate in COVID-19 Outpatients | https://ClinicalTrials.gov/show/NCT04353284 |
| NCT04353271 | Trial of Hydroxychloroquine In Covid-19 Kinetics | https://ClinicalTrials.gov/show/NCT04353271 |
| NCT04353206 | Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure | https://ClinicalTrials.gov/show/NCT04353206 |
| NCT04352959 | COVID-19: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses | https://ClinicalTrials.gov/show/NCT04352959 |
| NCT04352933 | PROLIFIC ChemoprophylaxisTrial (COVID-19) | https://ClinicalTrials.gov/show/NCT04352933 |
| NCT04352608 | Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04352608 |
| NCT04351906 | Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04351906 |
| NCT04351789 | Impact of a Minimal Psychoeducational Intervention on Anxiety Among Hospitalized COVID-19 Patients in Denmark | https://ClinicalTrials.gov/show/NCT04351789 |
| NCT04351763 | Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms | https://ClinicalTrials.gov/show/NCT04351763 |
| NCT04351724 | Austrian CoronaVirus Adaptive Clinical Trial (COVID-19) | https://ClinicalTrials.gov/show/NCT04351724 |
| NCT04351295 | Efficacy of Faviprevir in COVID-19 Treatment | https://ClinicalTrials.gov/show/NCT04351295 |
| NCT04351243 | A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE) | https://ClinicalTrials.gov/show/NCT04351243 |
| NCT04351191 | PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds | https://ClinicalTrials.gov/show/NCT04351191 |
| NCT04350723 | Awake Prone Position in Hypoxemic Patients With Coronavirus Disease 19 COVID-19 (COVI-PRONE) | https://ClinicalTrials.gov/show/NCT04350723 |
| NCT04350684 | Umifenovir in Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04350684 |
| NCT04350671 | Interferon Beta 1a in Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04350671 |
| NCT04350593 | Dapagliflozin in Respiratory Failure in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04350593 |
| NCT04350580 | Polyvalent Immunoglobulin in COVID-19 Related ARds | https://ClinicalTrials.gov/show/NCT04350580 |
| NCT04350736 | First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19 | https://ClinicalTrials.gov/show/NCT04350736 |
| NCT04350320 | Trial to Study the Benefit of Colchicine in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04350320 |
| NCT04350281 | Double Therapy With IFN-beta 1b and Hydroxychloroquine | https://ClinicalTrials.gov/show/NCT04350281 |
| NCT04349592 | Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19 | https://ClinicalTrials.gov/show/NCT04349592 |
| NCT04349631 | A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19 | https://ClinicalTrials.gov/show/NCT04349631 |
| NCT04349618 | Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 Pneumonia | https://ClinicalTrials.gov/show/NCT04349618 |
| NCT04349410 | The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol | https://ClinicalTrials.gov/show/NCT04349410 |
| NCT04349371 | Saved From COVID-19 | https://ClinicalTrials.gov/show/NCT04349371 |
| NCT04349098 | Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04349098 |
| NCT04349241 | Efficacy and Safety of Favipiravir in Management of COVID-19 | https://ClinicalTrials.gov/show/NCT04349241 |
| NCT04348929 | Birth Experience During COVID-19 Confinement | https://ClinicalTrials.gov/show/NCT04348929 |
| NCT04348383 | Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19. | https://ClinicalTrials.gov/show/NCT04348383 |
| NCT04348695 | Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19. | https://ClinicalTrials.gov/show/NCT04348695 |
| NCT04348513 | Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04348513 |
| NCT04348500 | Clazakizumab (Anti-IL- 6 Monoclonal) Compared to Placebo for COVID19 Disease | https://ClinicalTrials.gov/show/NCT04348500 |
| NCT04348435 | A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19 | https://ClinicalTrials.gov/show/NCT04348435 |
| NCT04348409 | Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04348409 |
| NCT04348656 | CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1) | https://ClinicalTrials.gov/show/NCT04348656 |
| NCT04348370 | BCG Vaccine for Health Care Workers as Defense Against COVID 19 | https://ClinicalTrials.gov/show/NCT04348370 |
| NCT04348305 | Hydrocortisone for COVID-19 and Severe Hypoxia | https://ClinicalTrials.gov/show/NCT04348305 |
| NCT04347980 | Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19 | https://ClinicalTrials.gov/show/NCT04347980 |
| NCT04347941 | Awake Prone Positioning to Reduce Invasive VEntilation in COVID-19 Induced Acute Respiratory failurE | https://ClinicalTrials.gov/show/NCT04347941 |
| NCT04347915 | The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04347915 |
| NCT04347681 | Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04347681 |
| NCT04347239 | Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04347239 |
| NCT04347382 | Honey & Nigella Sativa Trial Against COVID-19 | https://ClinicalTrials.gov/show/NCT04347382 |
| NCT04347226 | Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04347226 |
| NCT04347031 | A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19 | https://ClinicalTrials.gov/show/NCT04347031 |
| NCT04346927 | Telerehabilitation for Patients Diagnosed With Coronavirus | https://ClinicalTrials.gov/show/NCT04346927 |
| NCT04346693 | An Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug in Patients With Severe and Critical Manifestations of SARS-COVID-19 | https://ClinicalTrials.gov/show/NCT04346693 |
| NCT04346667 | Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds | https://ClinicalTrials.gov/show/NCT04346667 |
| NCT04346628 | Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19 | https://ClinicalTrials.gov/show/NCT04346628 |
| NCT04346420 | Impact of the Double-Trunk Mask on Oxygenation Titration in COVID-19 | https://ClinicalTrials.gov/show/NCT04346420 |
| NCT04346355 | Efficacy of Early Administration of Tocilizumab in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04346355 |
| NCT04346017 | Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome | https://ClinicalTrials.gov/show/NCT04346017 |
| NCT04345692 | A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04345692 |
| NCT04345679 | Anti COVID-19 Convalescent Plasma Therapy | https://ClinicalTrials.gov/show/NCT04345679 |
| NCT04345653 | Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers | https://ClinicalTrials.gov/show/NCT04345653 |
| NCT04345419 | Remdesivir Efficacy in Coronavirus Disease | https://ClinicalTrials.gov/show/NCT04345419 |
| NCT04344600 | Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection | https://ClinicalTrials.gov/show/NCT04344600 |
| NCT04344587 | Awake Prone Position for Early Hypoxemia in COVID-19 | https://ClinicalTrials.gov/show/NCT04344587 |
| NCT04344561 | Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation | https://ClinicalTrials.gov/show/NCT04344561 |
| NCT04344535 | Convalescent Plasma vs. Standard Plasma for COVID-19 | https://ClinicalTrials.gov/show/NCT04344535 |
| NCT04344457 | Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19 | https://ClinicalTrials.gov/show/NCT04344457 |
| NCT04344444 | Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease | https://ClinicalTrials.gov/show/NCT04344444 |
| NCT04344431 | Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04344431 |
| NCT04344379 | Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus | https://ClinicalTrials.gov/show/NCT04344379 |
| NCT04344210 | Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus | https://ClinicalTrials.gov/show/NCT04344210 |
| NCT04344184 | SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI) | https://ClinicalTrials.gov/show/NCT04344184 |
| NCT04344106 | Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study | https://ClinicalTrials.gov/show/NCT04344106 |
| NCT04343976 | Pegylated Interferon Lambda Treatment for COVID-19 | https://ClinicalTrials.gov/show/NCT04343976 |
| NCT04343963 | Pyridostigmine in Severe SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04343963 |
| NCT04343092 | Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management | https://ClinicalTrials.gov/show/NCT04343092 |
| NCT04343053 | Pro-thrombotic Status in Patients With SARS-Cov-2 Infection | https://ClinicalTrials.gov/show/NCT04343053 |
| NCT04342897 | A Study of LY3127804 in Participants With COVID-19 | https://ClinicalTrials.gov/show/NCT04342897 |
| NCT04342221 | Hydroxychloroquine for COVID-19 | https://ClinicalTrials.gov/show/NCT04342221 |
| NCT04342182 | Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study) | https://ClinicalTrials.gov/show/NCT04342182 |
| NCT04342169 | University of Utah COVID-19 Hydrochloroquine Trial | https://ClinicalTrials.gov/show/NCT04342169 |
| NCT04341493 | Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04341493 |
| NCT04341441 | Will Hydroxychloroquine Impede or Prevent COVID-19 | https://ClinicalTrials.gov/show/NCT04341441 |
| NCT04341415 | Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome | https://ClinicalTrials.gov/show/NCT04341415 |
| NCT04341207 | Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients | https://ClinicalTrials.gov/show/NCT04341207 |
| NCT04340557 | Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04340557 |
| NCT04340544 | Hydroxychloroquine for the Treatment of Mild COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04340544 |
| NCT04340349 | Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals | https://ClinicalTrials.gov/show/NCT04340349 |
| NCT04338841 | HOME-CoV: Hospitalization or Outpatient ManagEment of Patients With a SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04338841 |
| NCT04338828 | Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED | https://ClinicalTrials.gov/show/NCT04338828 |
| NCT04338074 | TXA and Corona Virus 2019 (COVID19) in Outpatients | https://ClinicalTrials.gov/show/NCT04338074 |
| NCT04330586 | A Trial of Ciclesonide in Adults With Mild-to-moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04330586 |
| NCT04337541 | Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System | https://ClinicalTrials.gov/show/NCT04337541 |
| NCT04337008 | Renin Angiotensin System - CoronaVirus | https://ClinicalTrials.gov/show/NCT04337008 |
| NCT04346797 | CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort | https://ClinicalTrials.gov/show/NCT04346797 |
| NCT04346615 | Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen | https://ClinicalTrials.gov/show/NCT04346615 |
| NCT04346589 | Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients | https://ClinicalTrials.gov/show/NCT04346589 |
| NCT04346446 | Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04346446 |
| NCT04346199 | Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. | https://ClinicalTrials.gov/show/NCT04346199 |
| NCT04346147 | Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19 | https://ClinicalTrials.gov/show/NCT04346147 |
| NCT04345861 | Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial) | https://ClinicalTrials.gov/show/NCT04345861 |
| NCT04345848 | Preventing COVID-19 Complications With Low- and High-dose Anticoagulation | https://ClinicalTrials.gov/show/NCT04345848 |
| NCT04345614 | A Study of Auxora in Patients With Severe COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04345614 |
| NCT04345601 | Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease) | https://ClinicalTrials.gov/show/NCT04345601 |
| NCT04345549 | Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak | https://ClinicalTrials.gov/show/NCT04345549 |
| NCT04345523 | Convalescent Plasma Therapy vs. SOC for the Treatment of COVID-19 in Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04345523 |
| NCT04345289 | Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04345289 |
| NCT04345276 | Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04345276 |
| NCT04344951 | Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial | https://ClinicalTrials.gov/show/NCT04344951 |
| NCT04344730 | Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04344730 |
| NCT04344288 | Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection | https://ClinicalTrials.gov/show/NCT04344288 |
| NCT04344080 | Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04344080 |
| NCT04344041 | COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial) | https://ClinicalTrials.gov/show/NCT04344041 |
| NCT04344015 | COVID-19 Plasma Collection | https://ClinicalTrials.gov/show/NCT04344015 |
| NCT04343989 | A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04343989 |
| NCT04343794 | Using Biovitals® Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19 | https://ClinicalTrials.gov/show/NCT04343794 |
| NCT04343768 | An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial | https://ClinicalTrials.gov/show/NCT04343768 |
| NCT04343755 | Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04343755 |
| NCT04343729 | Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19 | https://ClinicalTrials.gov/show/NCT04343729 |
| NCT04343651 | Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04343651 |
| NCT04343261 | Convalescent Plasma in the Treatment of COVID 19 | https://ClinicalTrials.gov/show/NCT04343261 |
| NCT04343248 | Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF) | https://ClinicalTrials.gov/show/NCT04343248 |
| NCT04342728 | Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation | https://ClinicalTrials.gov/show/NCT04342728 |
| NCT04342689 | The Role of Resistant Starch in COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04342689 |
| NCT04342663 | A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04342663 |
| NCT04342650 | Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04342650 |
| NCT04341922 | A Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04341922 |
| NCT04341727 | Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04341727 |
| NCT04341675 | Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04341675 |
| NCT04341584 | CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04341584 |
| NCT04341389 | A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector) | https://ClinicalTrials.gov/show/NCT04341389 |
| NCT04341142 | Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER | https://ClinicalTrials.gov/show/NCT04341142 |
| NCT04341116 | Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04341116 |
| NCT04341038 | Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury | https://ClinicalTrials.gov/show/NCT04341038 |
| NCT04340050 | COVID-19 Convalescent Plasma | https://ClinicalTrials.gov/show/NCT04340050 |
| NCT04339816 | Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial | https://ClinicalTrials.gov/show/NCT04339816 |
| NCT04339712 | Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction | https://ClinicalTrials.gov/show/NCT04339712 |
| NCT04339660 | Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04339660 |
| NCT04339426 | Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04339426 |
| NCT04338958 | Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation | https://ClinicalTrials.gov/show/NCT04338958 |
| NCT04338698 | Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT | https://ClinicalTrials.gov/show/NCT04338698 |
| NCT04338568 | Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study | https://ClinicalTrials.gov/show/NCT04338568 |
| NCT04338009 | Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019 | https://ClinicalTrials.gov/show/NCT04338009 |
| NCT04337996 | Dynamic Evaluation of COVID-19 Diagnostic Tests | https://ClinicalTrials.gov/show/NCT04337996 |
| NCT04337918 | Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04337918 |
| NCT04336904 | Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19 | https://ClinicalTrials.gov/show/NCT04336904 |
| NCT04347174 | A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients | https://ClinicalTrials.gov/show/NCT04347174 |
| NCT04336410 | Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT04336410 |
| NCT04336332 | Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19 | https://ClinicalTrials.gov/show/NCT04336332 |
| NCT04335851 | Video-Based Exercises and Well-Being During Social Isolation | https://ClinicalTrials.gov/show/NCT04335851 |
| NCT04336254 | Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04336254 |
| NCT04336462 | Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19 | https://ClinicalTrials.gov/show/NCT04336462 |
| NCT04335786 | Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease | https://ClinicalTrials.gov/show/NCT04335786 |
| NCT04335305 | Checkpoint Blockade in COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04335305 |
| NCT04335279 | Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program | https://ClinicalTrials.gov/show/NCT04335279 |
| NCT04335201 | Defibrotide in COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04335201 |
| NCT04335136 | Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04335136 |
| NCT04335123 | Study of Open Label Losartan in COVID-19 | https://ClinicalTrials.gov/show/NCT04335123 |
| NCT04334928 | Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel | https://ClinicalTrials.gov/show/NCT04334928 |
| NCT04335552 | Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04335552 |
| NCT04335097 | Sensor Based Vital Signs Monitoring of Covid 19 Patients During Home Isolation | https://ClinicalTrials.gov/show/NCT04335097 |
| NCT04335071 | Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04335071 |
| NCT04334876 | Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers | https://ClinicalTrials.gov/show/NCT04334876 |
| NCT04334629 | LIBERATE Trial in COVID-19 | https://ClinicalTrials.gov/show/NCT04334629 |
| NCT04334850 | Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04334850 |
| NCT04334460 | Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects | https://ClinicalTrials.gov/show/NCT04334460 |
| NCT04334434 | Telerehabilitation in Individuals Over 65 Years of Age Having Social Isolation Due to Coronavirus (Covid-19) | https://ClinicalTrials.gov/show/NCT04334434 |
| NCT04334382 | Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19 | https://ClinicalTrials.gov/show/NCT04334382 |
| NCT04334980 | Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19 | https://ClinicalTrials.gov/show/NCT04334980 |
| NCT04334512 | A Study of Quintuple Therapy to Treat COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04334512 |
| NCT04334044 | Treatment of SARS Caused by COVID-19 With Ruxolitinib | https://ClinicalTrials.gov/show/NCT04334044 |
| NCT04334265 | Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019 | https://ClinicalTrials.gov/show/NCT04334265 |
| NCT04333914 | Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04333914 |
| NCT04333732 | CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION | https://ClinicalTrials.gov/show/NCT04333732 |
| NCT04333654 | Hydroxychloroquine in Outpatient Adults With COVID-19 | https://ClinicalTrials.gov/show/NCT04333654 |
| NCT04333628 | Chloroquine for Mild Symptomatic and Asymptomatic COVID-19 | https://ClinicalTrials.gov/show/NCT04333628 |
| NCT04333550 | Application of Desferal to Treat COVID-19 | https://ClinicalTrials.gov/show/NCT04333550 |
| NCT04333472 | Piclidenoson for Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04333472 |
| NCT04333225 | Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers | https://ClinicalTrials.gov/show/NCT04333225 |
| NCT04333589 | Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive | https://ClinicalTrials.gov/show/NCT04333589 |
| NCT04333368 | Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS | https://ClinicalTrials.gov/show/NCT04333368 |
| NCT04333355 | Safety in Convalescent Plasma Transfusion to COVID-19 | https://ClinicalTrials.gov/show/NCT04333355 |
| NCT04333420 | Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04333420 |
| NCT04333407 | Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial. | https://ClinicalTrials.gov/show/NCT04333407 |
| NCT04332835 | Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study | https://ClinicalTrials.gov/show/NCT04332835 |
| NCT04332991 | Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease | https://ClinicalTrials.gov/show/NCT04332991 |
| NCT04332380 | Convalescent Plasma for Patients With COVID-19: A Pilot Study | https://ClinicalTrials.gov/show/NCT04332380 |
| NCT04331899 | Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19 | https://ClinicalTrials.gov/show/NCT04331899 |
| NCT04331054 | Protective Role of Inhaled Steroids for Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04331054 |
| NCT04332107 | Azithromycin for COVID-19 Treatment in Outpatients Nationwide | https://ClinicalTrials.gov/show/NCT04332107 |
| NCT04332094 | Clinical Trial of the Use of Tocilizumab for Treatment of SARS-CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04332094 |
| NCT04332081 | Hyperbaric Oxygen for COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04332081 |
| NCT04331834 | Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04331834 |
| NCT04331665 | Study of the Efficacy and Safety of Ruxolitinib to Treat COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04331665 |
| NCT04331808 | CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI) | https://ClinicalTrials.gov/show/NCT04331808 |
| NCT04331795 | Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis | https://ClinicalTrials.gov/show/NCT04331795 |
| NCT04331613 | Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS | https://ClinicalTrials.gov/show/NCT04331613 |
| NCT04331600 | Chloroquine as Antiviral Treatment in Coronavirus Infection 2020 | https://ClinicalTrials.gov/show/NCT04331600 |
| NCT04331366 | Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19 | https://ClinicalTrials.gov/show/NCT04331366 |
| NCT04331470 | Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04331470 |
| NCT04330690 | Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial | https://ClinicalTrials.gov/show/NCT04330690 |
| NCT04330638 | Treatment of COVID-19 Patients With Anti-interleukin Drugs | https://ClinicalTrials.gov/show/NCT04330638 |
| NCT04329650 | Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04329650 |
| NCT04329611 | ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease | https://ClinicalTrials.gov/show/NCT04329611 |
| NCT04329923 | The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine) | https://ClinicalTrials.gov/show/NCT04329923 |
| NCT04329832 | Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19 | https://ClinicalTrials.gov/show/NCT04329832 |
| NCT04326452 | Treating COVID-19 With a Bidirectional Oxygenation Valve | https://ClinicalTrials.gov/show/NCT04326452 |
| NCT04329533 | Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04329533 |
| NCT04329195 | ACE Inhibitors or ARBs Discontinuation in Context of COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04329195 |
| NCT04328129 | Household Transmission Investigation Study for COVID-19 in Tropical Regions | https://ClinicalTrials.gov/show/NCT04328129 |
| NCT04328285 | Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers | https://ClinicalTrials.gov/show/NCT04328285 |
| NCT04328961 | Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP) | https://ClinicalTrials.gov/show/NCT04328961 |
| NCT04328493 | The Vietnam Chloroquine Treatment on COVID-19 | https://ClinicalTrials.gov/show/NCT04328493 |
| NCT04328480 | The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients. | https://ClinicalTrials.gov/show/NCT04328480 |
| NCT04328467 | Pre-exposure Prophylaxis for SARS-Coronavirus-2 | https://ClinicalTrials.gov/show/NCT04328467 |
| NCT04328441 | Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine | https://ClinicalTrials.gov/show/NCT04328441 |
| NCT04328012 | COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19 | https://ClinicalTrials.gov/show/NCT04328012 |
| NCT04327505 | Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04327505 |
| NCT04326426 | ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04326426 |
| NCT04327401 | COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III | https://ClinicalTrials.gov/show/NCT04327401 |
| NCT04327388 | Sarilumab COVID-19 | https://ClinicalTrials.gov/show/NCT04327388 |
| NCT04327349 | Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial | https://ClinicalTrials.gov/show/NCT04327349 |
| NCT04326920 | Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC) | https://ClinicalTrials.gov/show/NCT04326920 |
| NCT04326790 | The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention | https://ClinicalTrials.gov/show/NCT04326790 |
| NCT04327206 | BCG Vaccination to Protect Healthcare Workers Against COVID-19 | https://ClinicalTrials.gov/show/NCT04327206 |
| NCT04325906 | Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS | https://ClinicalTrials.gov/show/NCT04325906 |
| NCT04325893 | Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease | https://ClinicalTrials.gov/show/NCT04325893 |
| NCT04325867 | Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19 | https://ClinicalTrials.gov/show/NCT04325867 |
| NCT04326075 | Early CPAP in COVID-19 Patients With Respiratory Failure. | https://ClinicalTrials.gov/show/NCT04326075 |
| NCT04326036 | Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04326036 |
| NCT04325633 | Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04325633 |
| NCT04325061 | Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19 | https://ClinicalTrials.gov/show/NCT04325061 |
| NCT04324996 | A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19 | https://ClinicalTrials.gov/show/NCT04324996 |
| NCT04324606 | A Study of a Candidate COVID-19 Vaccine (COV001) | https://ClinicalTrials.gov/show/NCT04324606 |
| NCT04324528 | Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation | https://ClinicalTrials.gov/show/NCT04324528 |
| NCT04324489 | DAS181 for Severe COVID-19: Compassionate Use | https://ClinicalTrials.gov/show/NCT04324489 |
| NCT04324463 | Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial | https://ClinicalTrials.gov/show/NCT04324463 |
| NCT04324190 | DIgital Online SuPport for COVID-19 StrEss | https://ClinicalTrials.gov/show/NCT04324190 |
| NCT04324073 | Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI | https://ClinicalTrials.gov/show/NCT04324073 |
| NCT04324021 | Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection. | https://ClinicalTrials.gov/show/NCT04324021 |
| NCT04323800 | Convalescent Plasma to Stem Coronavirus (CSSC-001) | https://ClinicalTrials.gov/show/NCT04323800 |
| NCT04323527 | Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 | https://ClinicalTrials.gov/show/NCT04323527 |
| NCT04323514 | Use of Ascorbic Acid in Patients With COVID 19 | https://ClinicalTrials.gov/show/NCT04323514 |
| NCT04323228 | Anti-inflammatory/Antioxidant Oral Nutrition Supplementation in COVID-19 | https://ClinicalTrials.gov/show/NCT04323228 |
| NCT04322773 | Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure | https://ClinicalTrials.gov/show/NCT04322773 |
| NCT04322682 | Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) | https://ClinicalTrials.gov/show/NCT04322682 |
| NCT04323345 | Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus | https://ClinicalTrials.gov/show/NCT04323345 |
| NCT04322396 | Proactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04322396 |
| NCT04322344 | Escin in Patients With Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04322344 |
| NCT04322123 | Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19) | https://ClinicalTrials.gov/show/NCT04322123 |
| NCT04322565 | Colchicine Counteracting Inflammation in COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04322565 |
| NCT04321928 | Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary | https://ClinicalTrials.gov/show/NCT04321928 |
| NCT04321993 | Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04321993 |
| NCT04321421 | Hyperimmune Plasma for Critical Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04321421 |
| NCT04321278 | Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II) | https://ClinicalTrials.gov/show/NCT04321278 |
| NCT04321174 | COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir | https://ClinicalTrials.gov/show/NCT04321174 |
| NCT04321616 | The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients | https://ClinicalTrials.gov/show/NCT04321616 |
| NCT04320953 | Non-contact Endoscopy at Covid-19 Outbreak | https://ClinicalTrials.gov/show/NCT04320953 |
| NCT04321096 | The Impact of Camostat Mesilate on COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04321096 |
| NCT04320615 | A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04320615 |
| NCT04320238 | Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff | https://ClinicalTrials.gov/show/NCT04320238 |
| NCT04319731 | A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure | https://ClinicalTrials.gov/show/NCT04319731 |
| NCT04319900 | Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia | https://ClinicalTrials.gov/show/NCT04319900 |
| NCT04320056 | Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19) | https://ClinicalTrials.gov/show/NCT04320056 |
| NCT04318015 | Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial) | https://ClinicalTrials.gov/show/NCT04318015 |
| NCT04318444 | Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04318444 |
| NCT04318431 | Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children | https://ClinicalTrials.gov/show/NCT04318431 |
| NCT04317092 | Tocilizumab in COVID-19 Pneumonia (TOCIVID-19) | https://ClinicalTrials.gov/show/NCT04317092 |
| NCT04317040 | CD24Fc (MK-7110) as a Non-antiviral Immunomodulator in COVID-19 Treatment (MK-7110-007) | https://ClinicalTrials.gov/show/NCT04317040 |
| NCT04315298 | Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04315298 |
| NCT04316377 | Norwegian Coronavirus Disease 2019 Study | https://ClinicalTrials.gov/show/NCT04316377 |
| NCT04315948 | Trial of Treatments for COVID-19 in Hospitalized Adults | https://ClinicalTrials.gov/show/NCT04315948 |
| NCT04315896 | Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial) | https://ClinicalTrials.gov/show/NCT04315896 |
| NCT04315480 | Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis | https://ClinicalTrials.gov/show/NCT04315480 |
| NCT04313322 | Treatment of COVID-19 Patients Using Wharton’s Jelly-Mesenchymal Stem Cells | https://ClinicalTrials.gov/show/NCT04313322 |
| NCT04313023 | The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04313023 |
| NCT04312997 | The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04312997 |
| NCT04312009 | Losartan for Patients With COVID-19 Requiring Hospitalization | https://ClinicalTrials.gov/show/NCT04312009 |
| NCT04312243 | NO Prevention of COVID-19 for Healthcare Providers | https://ClinicalTrials.gov/show/NCT04312243 |
| NCT04313127 | Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults | https://ClinicalTrials.gov/show/NCT04313127 |
| NCT04311177 | Losartan for Patients With COVID-19 Not Requiring Hospitalization | https://ClinicalTrials.gov/show/NCT04311177 |
| NCT04311697 | Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure | https://ClinicalTrials.gov/show/NCT04311697 |
| NCT04310228 | Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019 | https://ClinicalTrials.gov/show/NCT04310228 |
| NCT04308668 | Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2 | https://ClinicalTrials.gov/show/NCT04308668 |
| NCT04308317 | Tetrandrine Tablets Used in the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04308317 |
| NCT04307693 | Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04307693 |
| NCT04305457 | Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04305457 |
| NCT04306393 | Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19 | https://ClinicalTrials.gov/show/NCT04306393 |
| NCT04306055 | Blood Donor Recruitment During Epidemic of COVID-19 | https://ClinicalTrials.gov/show/NCT04306055 |
| NCT04303507 | Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting | https://ClinicalTrials.gov/show/NCT04303507 |
| NCT04305106 | Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT | https://ClinicalTrials.gov/show/NCT04305106 |
| NCT04304690 | COVID-19 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic | https://ClinicalTrials.gov/show/NCT04304690 |
| NCT04303299 | Fight COVID-19 Trial | https://ClinicalTrials.gov/show/NCT04303299 |
| NCT04304053 | Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention | https://ClinicalTrials.gov/show/NCT04304053 |
| NCT04299724 | Safety and Immunity of Covid-19 aAPC Vaccine | https://ClinicalTrials.gov/show/NCT04299724 |
| NCT04296643 | Medical Masks vs N95 Respirators for COVID-19 | https://ClinicalTrials.gov/show/NCT04296643 |
| NCT04292899 | Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Severe Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04292899 |
| NCT04292730 | Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment | https://ClinicalTrials.gov/show/NCT04292730 |
| NCT04291729 | Evaluation of Ganovo （Danoprevir ） Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04291729 |
| NCT04288102 | Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04288102 |
| NCT04283461 | Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04283461 |
| NCT04282902 | A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection | https://ClinicalTrials.gov/show/NCT04282902 |
| NCT04280705 | Adaptive COVID-19 Treatment Trial (ACTT) | https://ClinicalTrials.gov/show/NCT04280705 |
| NCT04280224 | NK Cells Treatment for COVID-19 | https://ClinicalTrials.gov/show/NCT04280224 |
| NCT04279197 | Treatment of Pulmonary Fibrosis Due to COVID-19 With Fuzheng Huayu | https://ClinicalTrials.gov/show/NCT04279197 |
| NCT04276688 | Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment | https://ClinicalTrials.gov/show/NCT04276688 |
| NCT04276987 | A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia | https://ClinicalTrials.gov/show/NCT04276987 |
| NCT04275245 | Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia | https://ClinicalTrials.gov/show/NCT04275245 |
| NCT04276896 | Immunity and Safety of Covid-19 Synthetic Minigene Vaccine | https://ClinicalTrials.gov/show/NCT04276896 |
| NCT04275414 | Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04275414 |
| NCT04273321 | Efficacy and Safety of Corticosteroids in COVID-19 | https://ClinicalTrials.gov/show/NCT04273321 |
| NCT04273763 | Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19) | https://ClinicalTrials.gov/show/NCT04273763 |
| NCT04269525 | Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia | https://ClinicalTrials.gov/show/NCT04269525 |
| NCT04264533 | Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia | https://ClinicalTrials.gov/show/NCT04264533 |
| NCT04263402 | The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia | https://ClinicalTrials.gov/show/NCT04263402 |
| NCT04260594 | Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus | https://ClinicalTrials.gov/show/NCT04260594 |
| NCT04261270 | A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia | https://ClinicalTrials.gov/show/NCT04261270 |
| NCT04261517 | Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04261517 |
| NCT04257656 | A Trial of Remdesivir in Adults With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04257656 |
| NCT04255017 | A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia | https://ClinicalTrials.gov/show/NCT04255017 |
| NCT04254874 | A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia | https://ClinicalTrials.gov/show/NCT04254874 |
| NCT04252118 | Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19 | https://ClinicalTrials.gov/show/NCT04252118 |
| NCT04252274 | Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04252274 |
| NCT04252885 | The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection | https://ClinicalTrials.gov/show/NCT04252885 |
| NCT04244591 | Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure | https://ClinicalTrials.gov/show/NCT04244591 |
| NCT04251871 | Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04251871 |
| NCT05080920 | Rosmalip® for Cancer Infections Prevention | https://ClinicalTrials.gov/show/NCT05080920 |
| NCT05074888 | Сlinical Trial of Efficacy and Safety of Prospekta in the Treatment of Post-COVID-19 Asthenia. | https://ClinicalTrials.gov/show/NCT05074888 |
| NCT05028361 | Simultaneous mRNA COVID-19 and IIV4 Vaccination Study | https://ClinicalTrials.gov/show/NCT05028361 |
| NCT05012943 | The ARCT-154 Self-Amplifying RNA Vaccine Efficacy Study (ARCT-154-01) | https://ClinicalTrials.gov/show/NCT05012943 |
| NCT04992273 | COVID-19 Administration of Single-Dose Subcutaneous or Intramuscular Anti- Spike(s) SARS-CoV-2 Monoclonal Antibodies Casirivimab and Imdevimab in High-Risk Pediatric Participants Under 12 Years of Age | https://ClinicalTrials.gov/show/NCT04992273 |
| NCT04838795 | Sisonke (Together): OPEN LABEL TRIAL COVID-19 | https://ClinicalTrials.gov/show/NCT04838795 |
| NCT04522089 | A Study to Evaluate the Safety and Immunogenicity of COVID-19 (AdimrSC-2f) Vaccine | https://ClinicalTrials.gov/show/NCT04522089 |
| NCT04508023 | A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection | https://ClinicalTrials.gov/show/NCT04508023 |
| NCT04565249 | Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04565249 |
| NCT04516564 | A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects | https://ClinicalTrials.gov/show/NCT04516564 |
| NCT04388826 | COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111 | https://ClinicalTrials.gov/show/NCT04388826 |
| NCT04357457 | Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia | https://ClinicalTrials.gov/show/NCT04357457 |
| NCT04345991 | Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort | https://ClinicalTrials.gov/show/NCT04345991 |
| NCT05083000 | Reducing Hypoxia in Patients With COVID-19 Using Topotecan With Standard of Care | https://ClinicalTrials.gov/show/NCT05083000 |
| NCT05082714 | Tocilizumab Versus Baricitinib in Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT05082714 |
| NCT05032950 | Drug-Drug Interaction Study to Estimate the Effect of PF-07321332/Ritonavir and Ritonavir on Midazolam in Healthy Participants | https://ClinicalTrials.gov/show/NCT05032950 |
| NCT05027815 | Tregs for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Associated With COVID-19 (regARDS) | https://ClinicalTrials.gov/show/NCT05027815 |
| NCT05082727 | Safety and Efficacy of KOVIR (TD0068) in the Combination Regimen With Background Treatment in COVID-19 Patients (KOVIR) | https://ClinicalTrials.gov/show/NCT05082727 |
| NCT05081362 | Cardiovascular Assessment in Patient Recovered From COVID-19 and Recovery of Autonomic Nervous System in Association With the Severity of the Disease | https://ClinicalTrials.gov/show/NCT05081362 |
| NCT05042141 | Safety and Efficacy of KOVIR in the Combination Regimen With Background Treatment in COVID-19 Patients (KOVIR) | https://ClinicalTrials.gov/show/NCT05042141 |
| NCT04951336 | RCT of Mushroom Based Natural Product to Enhance Immune Response to COVID-19 Vaccination | https://ClinicalTrials.gov/show/NCT04951336 |
| NCT04942405 | Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) Versus the CoronaVac Vaccine | https://ClinicalTrials.gov/show/NCT04942405 |
| NCT04918927 | Favipiravir +/- Nitazoxanide: Early Antivirals Combination Therapy in COVID-19 | https://ClinicalTrials.gov/show/NCT04918927 |
| NCT04869228 | A Phase 3 Randomized, Double-Blind Placebo Controlled, Multi-regional Trial to Evaluate the Efficacy and Safety of GT0918 for the Treatment of Mild to Moderate COVID-19 Male Patients | https://ClinicalTrials.gov/show/NCT04869228 |
| NCT04842747 | VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study | https://ClinicalTrials.gov/show/NCT04842747 |
| NCT04852861 | COVID-19: Safety and Immunogenicity of a Reduced Dose of the BioNTech/Pfizer BNT162b2 Vaccine | https://ClinicalTrials.gov/show/NCT04852861 |
| NCT04588428 | Safety, Tolerability and Immunogenicity of INO-4700 for MERS-CoV in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT04588428 |
| NCT04806074 | FOODLIT-Trial: Digital Behaviour Change Intervention to Improve Food Literacy Amidst the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04806074 |
| NCT04749173 | To Assess the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Which is the Treatment of COVID-19 in Healthy Volunteers. | https://ClinicalTrials.gov/show/NCT04749173 |
| NCT04527614 | Influence of Prior Infection With COVID-19 on Occurrence of Influenza-like Illness or Acute Respiratory Infection | https://ClinicalTrials.gov/show/NCT04527614 |
| NCT04439071 | A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19) | https://ClinicalTrials.gov/show/NCT04439071 |
| NCT04431453 | Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734â„¢) in Participants From Birth to < 18 Years of Age With Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04431453 |
| NCT04355767 | Convalescent Plasma in Outpatients With COVID-19 | https://ClinicalTrials.gov/show/NCT04355767 |
| NCT04353037 | PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine | https://ClinicalTrials.gov/show/NCT04353037 |
| NCT05085145 | Immunogenicity and Safety of COVID-19 Vaccine in People Living With HIV | https://ClinicalTrials.gov/show/NCT05085145 |
| NCT05084898 | Far-UVC Light Devices in Long-term Care Facilities to Reduce Infections | https://ClinicalTrials.gov/show/NCT05084898 |
| NCT04927182 | Impact of Moderate Exercise Training on Vitals and Peak VO2 in Different Age Categories of Adult in COVID-19. | https://ClinicalTrials.gov/show/NCT04927182 |
| NCT05074771 | At Home REhabilitation and Monitoring of People in poST-covid Condition Through ARc-inTellicare Platform (RESTART/RICOMINCIARE) | https://ClinicalTrials.gov/show/NCT05074771 |
| NCT05028257 | Allergy and COVID-19 Vaccines | https://ClinicalTrials.gov/show/NCT05028257 |
| NCT04962204 | Virtual Visitation in Intensive Care Unit Study | https://ClinicalTrials.gov/show/NCT04962204 |
| NCT05047770 | A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine | https://ClinicalTrials.gov/show/NCT05047770 |
| NCT04790851 | Evaluation of Immunogenicity and Safety of Combined Immunization of COVID-19 Vaccine (Produced in Beijing) and PPV23 / IIV4 | https://ClinicalTrials.gov/show/NCT04790851 |
| NCT04640194 | A Study to Test Whether Different Doses of Alteplase Help People With Severe Breathing Problems Because of COVID-19 | https://ClinicalTrials.gov/show/NCT04640194 |
| NCT04745351 | Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04745351 |
| NCT04726098 | Low or High Dose of Dexamethasone in Patients With Respiratory Failure by COVID-19 | https://ClinicalTrials.gov/show/NCT04726098 |
| NCT04400838 | Investigating a Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04400838 |
| NCT04595773 | COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE) | https://ClinicalTrials.gov/show/NCT04595773 |
| NCT04470622 | Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1) | https://ClinicalTrials.gov/show/NCT04470622 |
| NCT04381936 | Randomised Evaluation of COVID-19 Therapy | https://ClinicalTrials.gov/show/NCT04381936 |
| NCT05087381 | Randomized-controlled Trial of the Effectiveness of COVID-19 Early Treatment in Community | https://ClinicalTrials.gov/show/NCT05087381 |
| NCT05087329 | Mindfulness Practice in Pregnancy as an Intervention to Decrease Prenatal Stress During the COVID19 Pandemic | https://ClinicalTrials.gov/show/NCT05087329 |
| NCT05087173 | Effectiveness of Using Interactive Consulting System to Enhance Decision Aids of COVID-19 Vaccination | https://ClinicalTrials.gov/show/NCT05087173 |
| NCT04581200 | Lift Mobile Mindfulness for COVID-19 Distress Symptoms | https://ClinicalTrials.gov/show/NCT04581200 |
| NCT04939428 | Study of MK-4482 for Prevention of Coronavirus Disease 2019 (COVID-19) in Adults (MK-4482-013) | https://ClinicalTrials.gov/show/NCT04939428 |
| NCT04931238 | Efficacy and Safety of JS016 in Patients With SARS-CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04931238 |
| NCT04904471 | A Global Phase III Clinical Trial of Recombinant COVID- 19 Vaccine (Sf9 Cells) | https://ClinicalTrials.gov/show/NCT04904471 |
| NCT04701502 | Efficacy and Safety of Viusid and Asbrip in Hospitalized Patients With Mild and Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04701502 |
| NCT04980534 | Evaluation of the Effectiveness of Therapy for Patients With Covid-19 Using Food Supplements Viusid + Asbrip | https://ClinicalTrials.gov/show/NCT04980534 |
| NCT04953052 | A Randomized Study to Investigate the Effect of Intravenous Imatinib on the Amount of Oxygen in the Lungs and Blood of Adults With COVID-19 Needing Mechanical Ventilation and Supportive Care. | https://ClinicalTrials.gov/show/NCT04953052 |
| NCT04952376 | Equitable Access to COVID-19 Vaccines | https://ClinicalTrials.gov/show/NCT04952376 |
| NCT04896866 | Efficacy and Safety of Antimicrobial Stewardship Intervention in Hospitalized COVID-19 Patients (COVASP) | https://ClinicalTrials.gov/show/NCT04896866 |
| NCT04590547 | GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04590547 |
| NCT04528771 | S-Nitrosylation Therapy of COVID-19 | https://ClinicalTrials.gov/show/NCT04528771 |
| NCT04400305 | “Increasing Physical Activity in Canadian Adults Affected by COVID-19 Social Distancing Restrictions: A Feasibility Trial of an Online Intervention” | https://ClinicalTrials.gov/show/NCT04400305 |
| NCT04394117 | Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease | https://ClinicalTrials.gov/show/NCT04394117 |
| NCT05089045 | Immunogenicity and Safety Evaluation of Recombinant Novel Coronavirus Vaccine (CHO Cells) in Enhancing Immunity | https://ClinicalTrials.gov/show/NCT05089045 |
| NCT04348864 | COVID-19 Diagnostic Self-testing Using Virtual Point-of-care | https://ClinicalTrials.gov/show/NCT04348864 |
| NCT04347954 | PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19) | https://ClinicalTrials.gov/show/NCT04347954 |
| NCT04335084 | A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04335084 |
| NCT05077267 | ABNCoV2 Vaccine in SARS-CoV-2 (COVID-19) Seronegative and Seropositive Adult Subjects | https://ClinicalTrials.gov/show/NCT05077267 |
| NCT05084911 | The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients (Phase3) | https://ClinicalTrials.gov/show/NCT05084911 |
| NCT05075083 | Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Elderly People With Chronic Bronchitis and COPD | https://ClinicalTrials.gov/show/NCT05075083 |
| NCT05075070 | Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People With HIV Infected | https://ClinicalTrials.gov/show/NCT05075070 |
| NCT05075057 | Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Patients Aged ≥60 Years With Chronic Bronchitis and COPD | https://ClinicalTrials.gov/show/NCT05075057 |
| NCT05075044 | Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People Aged ≥18 Years With HIV Infected | https://ClinicalTrials.gov/show/NCT05075044 |
| NCT05047601 | A Post-Exposure Prophylaxis Study of PF-07321332/Ritonavir in Adult Household Contacts of an Individual With Symptomatic COVID-19 | https://ClinicalTrials.gov/show/NCT05047601 |
| NCT04979949 | Booster Vaccination Against SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04979949 |
| NCT05007951 | Immunogenicity and Safety Study of SK SARS-CoV-2 Recombinant Nanoparticle Vaccine (GBP510) Adjuvanted With AS03 (COVID-19) | https://ClinicalTrials.gov/show/NCT05007951 |
| NCT04889209 | Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA Vaccines | https://ClinicalTrials.gov/show/NCT04889209 |
| NCT04952389 | Acupuncture Therapy for COVID-Related Olfactory Loss | https://ClinicalTrials.gov/show/NCT04952389 |
| NCT04932915 | Safety and Efficacy of Intranasal Administration of Niclosamide (UNI91103) in Adults With Asymptomatic or Mild COVID-19 | https://ClinicalTrials.gov/show/NCT04932915 |
| NCT04518410 | ACTIV-2: A Study for Outpatients With COVID-19 | https://ClinicalTrials.gov/show/NCT04518410 |
| NCT04568564 | Telerehabilitation in Lung Surgery Patients | https://ClinicalTrials.gov/show/NCT04568564 |
| NCT04707664 | Sargramostim Use in COVID-19 to Recover Patient Health | https://ClinicalTrials.gov/show/NCT04707664 |
| NCT04504032 | A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19) | https://ClinicalTrials.gov/show/NCT04504032 |
| NCT04484025 | SPI-1005 Treatment in Moderate COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04484025 |
| NCT04483973 | SPI-1005 Treatment in Severe COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04483973 |
| NCT05092607 | Evaluation of the Detection Performance of the N Antigenemia of SARS-CoV-2 in the General Population for the Diagnosis and Screening of COVID-19 | https://ClinicalTrials.gov/show/NCT05092607 |
| NCT05092698 | The Efficacy of Vitamin D Supplementation in Patients With Severe and Extremely Severe COVID-19 | https://ClinicalTrials.gov/show/NCT05092698 |
| NCT05092542 | Multilevel Community-Based Mental Health Intervention to Address Structural Inequities and Adverse Disparate Consequences of COVID-19 Pandemic on Latinx Immigrant and African Refugees | https://ClinicalTrials.gov/show/NCT05092542 |
| NCT05091411 | Clinical Trials of the Consistency and Non-inferiority Bridging Between Batches of Recombinant New Coronavirus Vaccine (CHO Cells) | https://ClinicalTrials.gov/show/NCT05091411 |
| NCT05072210 | Mobile Interventions for the Prevention and Detection of Distress | https://ClinicalTrials.gov/show/NCT05072210 |
| NCT05069129 | Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells,NVSI-06-08) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above | https://ClinicalTrials.gov/show/NCT05069129 |
| NCT04952350 | Atorvastatin for Reduction of 28-day Mortality in COVID-19: RCT | https://ClinicalTrials.gov/show/NCT04952350 |
| NCT04716985 | Evaluation of the Daily Intake of 0.5 L of Water Saturated With Molecular Hydrogen for 21 Days in COVID-19 Patients Treated in Ambulatory Care | https://ClinicalTrials.gov/show/NCT04716985 |
| NCT04874766 | The Effects of Wearing a Face Mask During Exercise in Youth Hockey Players During COVID-19 | https://ClinicalTrials.gov/show/NCT04874766 |
| NCT04860297 | A Study to Evaluate Safety and Immunogenicity of mRNA-1273 Vaccine to Prevent COVID-19 in Adult Organ Transplant Recipients and in Healthy Adult Participants | https://ClinicalTrials.gov/show/NCT04860297 |
| NCT04852978 | COVID-19 Study to Assess Immunogenicity, Safety, and Tolerability of Moderna mRNA-1273 Vaccine Administered With Casirivimab+Imdevimab in Healthy Adult Volunteers | https://ClinicalTrials.gov/show/NCT04852978 |
| NCT04805671 | Evaluation of ADG20 for the Treatment of Mild or Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04805671 |
| NCT04710199 | Trial to Evaluate the Safety and Efficacy of Maraviroc in Patients Hospitalized for Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04710199 |
| NCT04583956 | ACTIV-5 / Big Effect Trial (BET-A) for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04583956 |
| NCT04399889 | hCT-MSCs for COVID19 ARDS | https://ClinicalTrials.gov/show/NCT04399889 |
| NCT04415151 | Tofacitinib for Treatment of Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04415151 |
| NCT05094726 | Effect of PBM on Functional Capacity and Fatigability in Post Covid-19 Elderly | https://ClinicalTrials.gov/show/NCT05094726 |
| NCT05094674 | Clinical Validation of Breath Analyser Tests for Diagnosis of COVID-19. | https://ClinicalTrials.gov/show/NCT05094674 |
| NCT05094661 | Predictors of Non-invasive Respiratory Support Failure in COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT05094661 |
| NCT05093530 | Safety and Tolerability of Single and Multiple Doses of Neumifil | https://ClinicalTrials.gov/show/NCT05093530 |
| NCT05082935 | COVID-19: Healthy Oregon (Oregon Saludable): Together We Can (Juntos Podemos) Phase II | https://ClinicalTrials.gov/show/NCT05082935 |
| NCT05079308 | Clinical Trial on the Efficacy of Different Masks With and Without a Peripheral Sealing Device, Against Covid-19 | https://ClinicalTrials.gov/show/NCT05079308 |
| NCT05054621 | Immunogenicity of COVID-19 Vaccine on Heterologous Schedule | https://ClinicalTrials.gov/show/NCT05054621 |
| NCT05037201 | Text Message Nudges for COVID-19 Vaccination | https://ClinicalTrials.gov/show/NCT05037201 |
| NCT04988035 | ACTIV-5 / Big Effect Trial (BET-C) for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04988035 |
| NCT04880109 | A Phase 2 Study of APX-115 in Hospitalized Patients With Confirmed Mild to Moderate COVID-19. | https://ClinicalTrials.gov/show/NCT04880109 |
| NCT04859699 | Reopening Schools Safely and Educating Youth (ROSSEY) COVID-19 Health Disparities Research Study | https://ClinicalTrials.gov/show/NCT04859699 |
| NCT04859517 | Evaluation of ADG20 for the Prevention of COVID-19 | https://ClinicalTrials.gov/show/NCT04859517 |
| NCT04858425 | Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection | https://ClinicalTrials.gov/show/NCT04858425 |
| NCT04969250 | Vaccination for Recovered Inpatients With COVID-19 (VATICO) | https://ClinicalTrials.gov/show/NCT04969250 |
| NCT04966013 | Evaluation of the RD-X19 Treatment Device in Individuals With Mild to Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04966013 |
| NCT04913675 | Intramuscular VIR-7831 (Sotrovimab) for Mild/Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04913675 |
| NCT04853836 | Olfactory Disfunction and Co-ultraPEALut | https://ClinicalTrials.gov/show/NCT04853836 |
| NCT04642638 | Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure | https://ClinicalTrials.gov/show/NCT04642638 |
| NCT04843761 | ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19 | https://ClinicalTrials.gov/show/NCT04843761 |
| NCT04657809 | Clinical Assessment of Insulin Fast Dissolving Film in Treatment of Post Infection Anosmia | https://ClinicalTrials.gov/show/NCT04657809 |
| NCT04655638 | HFNT vs. COT in COVID-19 | https://ClinicalTrials.gov/show/NCT04655638 |
| NCT04619680 | The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19 | https://ClinicalTrials.gov/show/NCT04619680 |
| NCT04575610 | IRAK4 Inhibition in Treatment of COVID-19 With ARDS (I-RAMIC) | https://ClinicalTrials.gov/show/NCT04575610 |
| NCT04565665 | Cord Blood-Derived Mesenchymal Stem Cells for the Treatment of COVID-19 Related Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04565665 |
| NCT04504240 | Role of Famotidine in the Clinical Improvement of COVID-19 Patients. | https://ClinicalTrials.gov/show/NCT04504240 |
| NCT04501978 | ACTIV-3: Therapeutics for Inpatients With COVID-19 | https://ClinicalTrials.gov/show/NCT04501978 |
| NCT04444700 | A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04444700 |
| NCT04435379 | Study to Assess VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04435379 |
| NCT04429854 | Donated Antibodies Working Against nCoV | https://ClinicalTrials.gov/show/NCT04429854 |
| NCT04387760 | Favipiravir vs Hydroxychloroquine vs Control in COVID -19 | https://ClinicalTrials.gov/show/NCT04387760 |
| NCT04362085 | Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care | https://ClinicalTrials.gov/show/NCT04362085 |
| NCT04356534 | Convalescent Plasma Trial in COVID -19 Patients | https://ClinicalTrials.gov/show/NCT04356534 |
| NCT04704544 | Effectiveness of Tele-rheumatology for Delivering High Quality Rheumatology Care During the COVID-19 Crisis (EVOLVE) | https://ClinicalTrials.gov/show/NCT04704544 |
| NCT04703205 | Study in COvid-19 Patients With iveRmectin (CORVETTE-01) | https://ClinicalTrials.gov/show/NCT04703205 |
| NCT04583969 | ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04583969 |
| NCT04558125 | Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism | https://ClinicalTrials.gov/show/NCT04558125 |
| NCT04542850 | Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC in Subjects With COVID-19 | https://ClinicalTrials.gov/show/NCT04542850 |
| NCT04469179 | Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19 | https://ClinicalTrials.gov/show/NCT04469179 |
| NCT05096845 | Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Phase III | https://ClinicalTrials.gov/show/NCT05096845 |
| NCT04631705 | SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Inhalation | https://ClinicalTrials.gov/show/NCT04631705 |
| NCT05096026 | Effect of Electronic and Mail Outreach From Primary Care Physicians for COVID-19 Vaccination Among Elderly Patients | https://ClinicalTrials.gov/show/NCT05096026 |
| NCT05074745 | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Buccal Screening Evaluation Using an RT-PCR Assay and a Rapid ELISA Test Among Symptomatic and Asymptomatic Patients | https://ClinicalTrials.gov/show/NCT05074745 |
| NCT04894305 | A Study of Ad26.COV2.S in Healthy Adults (COVID-19) | https://ClinicalTrials.gov/show/NCT04894305 |
| NCT04960228 | Exploring Changes in COVID-19 Vaccination Intentions by Prompting Altruistic Motives Using a Video Intervention | https://ClinicalTrials.gov/show/NCT04960228 |
| NCT04952402 | SARS-CoV-2 Immune Responses After COVID-19 Therapy and Subsequent Vaccine | https://ClinicalTrials.gov/show/NCT04952402 |
| NCT04908722 | A Study to Evaluate Dose Levels of Ad26.COV2.S Administered as a Two-dose Schedule in Healthy Adults | https://ClinicalTrials.gov/show/NCT04908722 |
| NCT04828161 | A Dose Finding, Efficacy and Safety Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19 | https://ClinicalTrials.gov/show/NCT04828161 |
| NCT04880642 | A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects | https://ClinicalTrials.gov/show/NCT04880642 |
| NCT04839042 | A Phase 1, First-In-Human Study of the Investigational COVID-19 Vaccine SC-Ad6-1 in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT04839042 |
| NCT04765384 | A Study of Ad26.COV2.S in Healthy Pregnant Participants (COVID-19) | https://ClinicalTrials.gov/show/NCT04765384 |
| NCT04632381 | Intravenous Zotatifin in Adults With Mild or Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04632381 |
| NCT04514302 | Safety and Efficacy of Anti-SARS-CoV-2 Equine Antibody F(ab’)2 Fragments (INOSARS) for Adult Patients With Mild COVID-19 | https://ClinicalTrials.gov/show/NCT04514302 |
| NCT04646044 | A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19 | https://ClinicalTrials.gov/show/NCT04646044 |
| NCT04509947 | A Study of Ad26.COV2.S in Adults (COVID-19) | https://ClinicalTrials.gov/show/NCT04509947 |
| NCT04507256 | AZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04507256 |
| NCT04535453 | A Study to Evaluate a Range of Dose Levels and Vaccination Intervals of Ad26.COV2.S in Healthy Adults and Adolescents | https://ClinicalTrials.gov/show/NCT04535453 |
| NCT04478071 | Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04478071 |
| NCT04505722 | A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants | https://ClinicalTrials.gov/show/NCT04505722 |
| NCT04492891 | Cyclosporine For The Treatment Of COVID-19(+) | https://ClinicalTrials.gov/show/NCT04492891 |
| NCT04482686 | Trial of Combination Therapy to Treat COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04482686 |
| NCT04415086 | Treatment of Patients With COVID-19 With Convalescent Plasma | https://ClinicalTrials.gov/show/NCT04415086 |
| NCT04449276 | A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults | https://ClinicalTrials.gov/show/NCT04449276 |
| NCT04400058 | Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression | https://ClinicalTrials.gov/show/NCT04400058 |
| NCT04410549 | Pulmonary Optical Coherence Tomography in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04410549 |
| NCT04368728 | Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals | https://ClinicalTrials.gov/show/NCT04368728 |
| NCT05089305 | Ozone Plasma on Lung Function and Inflammatory Parameters in Pulmonary Sequelae Associated With Coronavirus 19 Infection | https://ClinicalTrials.gov/show/NCT05089305 |
| NCT04381988 | A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy | https://ClinicalTrials.gov/show/NCT04381988 |
| NCT05087524 | BinaxNOW for Evaluating Children for Infection With SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT05087524 |
| NCT05077176 | Phase 3 Booster Vaccination Against SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT05077176 |
| NCT04999111 | A Study of Ad26.COV2.S Administered as Booster Vaccination in Adults Who Have Previously Received Primary Vaccination With Ad26.COV2.S or BNT162b2 | https://ClinicalTrials.gov/show/NCT04999111 |
| NCT05069623 | A Phase 1/2 Study to Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) and VB10.2210 (T Cell Candidate) Previously Vaccinated in Healthy Adult Volunteers | https://ClinicalTrials.gov/show/NCT05069623 |
| NCT05062473 | Utilizing Telemedicine for Hypertension Treatment Lifestyle Modification in Central Harlem | https://ClinicalTrials.gov/show/NCT05062473 |
| NCT05012267 | Duration of Prone Position in the Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19). | https://ClinicalTrials.gov/show/NCT05012267 |
| NCT04956224 | Immunogenicity of VLA2101 Compared to VLA2001. | https://ClinicalTrials.gov/show/NCT04956224 |
| NCT04955626 | Study to Evaluate the Safety and Efficacy of a Booster Dose of BNT162b2 Against COVID-19 in Participants ≥16 Years of Age. | https://ClinicalTrials.gov/show/NCT04955626 |
| NCT04960202 | A Study of PF-07321332/Ritonavir in Nonhospitalized High Risk Adult Participants With COVID-19 | https://ClinicalTrials.gov/show/NCT04960202 |
| NCT04919031 | Inspiratory Muscle Trainer and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) COVID-19 Persistent Symptoms | https://ClinicalTrials.gov/show/NCT04919031 |
| NCT04901689 | Leronlimab in Patients With Coronavirus Disease 2019 (COVID-19) With Need for Mechanical Ventilation or Extracorporeal Membrane Oxygenation | https://ClinicalTrials.gov/show/NCT04901689 |
| NCT04784559 | Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04784559 |
| NCT04773067 | A Study to Evaluate UB-612 COVID-19 Vaccine in Adolescent, Younger and Elderly Adult Volunteers | https://ClinicalTrials.gov/show/NCT04773067 |
| NCT04756271 | Safety and Immunogenicity of Oxford AstraZeneca Vaccine Against COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04756271 |
| NCT04754594 | Study to Evaluate the Safety, Tolerability, and Immunogenicity of SARS CoV-2 RNA Vaccine Candidate (BNT162b2) Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older | https://ClinicalTrials.gov/show/NCT04754594 |
| NCT04418947 | Project Resurgence Communication Trial | https://ClinicalTrials.gov/show/NCT04418947 |
| NCT04593940 | Immune Modulators for Treating COVID-19 | https://ClinicalTrials.gov/show/NCT04593940 |
| NCT04615949 | Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors | https://ClinicalTrials.gov/show/NCT04615949 |
| NCT04497324 | PERUCONPLASMA: Evaluating the Use of Convalescent Plasma as Management of COVID-19 | https://ClinicalTrials.gov/show/NCT04497324 |
| NCT04484207 | Addressing COVID-19 Mental Health Problems Among US Veterans | https://ClinicalTrials.gov/show/NCT04484207 |
| NCT04414241 | Hydroxychloroquine to Prevent SARS-CoV-2 Infection/COVID-19 | https://ClinicalTrials.gov/show/NCT04414241 |
| NCT04399356 | Niclosamide for Mild to Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04399356 |
| NCT04377100 | Impact on Anxiety and Motivation of COVID-19 and Predictors of Individual Responses | https://ClinicalTrials.gov/show/NCT04377100 |
| NCT04358068 | Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19 | https://ClinicalTrials.gov/show/NCT04358068 |
| NCT04347538 | Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04347538 |
| NCT05080179 | Impact of Nudges on Downloads of COVID-19 Exposure Notification Smartphone Apps: A Randomized Trial | https://ClinicalTrials.gov/show/NCT05080179 |
| NCT05079152 | Evaluation of Immunogenicity and Safety of Combined Immunization of COVAX (Produced in Wuhan) and PPV23 / IIV4 | https://ClinicalTrials.gov/show/NCT05079152 |
| NCT05077943 | The Effect of Home-based Exercise on Functional Capacity of Covid-19 Survivor With Cardiovascular Comorbidity | https://ClinicalTrials.gov/show/NCT05077943 |
| NCT05077930 | Convalescent Plasma Therapy for Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT05077930 |
| NCT05077306 | Receptive Music Therapy on Anxiety and Vital Parameters in Hospitalized Covid-19 Patients. | https://ClinicalTrials.gov/show/NCT05077306 |
| NCT05077241 | Efficacy of Home Inspiratory Muscle Training in Post-covid-19 Patients: a Randomized Clinical Trial | https://ClinicalTrials.gov/show/NCT05077241 |
| NCT05076253 | Efficacy of Ivermectin in COVID-19 | https://ClinicalTrials.gov/show/NCT05076253 |
| NCT05075499 | Immune Response to COVID-19 Vaccine in Multiple Sclerosis Patients Treated With Teriflunomide and Alemtuzumab | https://ClinicalTrials.gov/show/NCT05075499 |
| NCT05075304 | A Safety and Tolerability Study of BDB-001 in Mild, Moderate COVID-19 Patients | https://ClinicalTrials.gov/show/NCT05075304 |
| NCT05074979 | Telerehabilitation in COVID-19 Survivors | https://ClinicalTrials.gov/show/NCT05074979 |
| NCT05074368 | Efficacy and Safety of Heterologous and Homologous COVID-19 Vaccination | https://ClinicalTrials.gov/show/NCT05074368 |
| NCT05069649 | Efficacy and Safety of Ergoferon for COVID-19 Prevention During Vaccination Against SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT05069649 |
| NCT05069454 | Study on COVID-19 Vaccine Effectiveness Among Health Workers in Azerbaijan | https://ClinicalTrials.gov/show/NCT05069454 |
| NCT05069103 | ImplementatioN of Remote Surgical wOund Assessment During the coviD-19 pandEmic | https://ClinicalTrials.gov/show/NCT05069103 |
| NCT05067933 | A Ph 2 Trial With an Oral Tableted COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT05067933 |
| NCT05065619 | Safety Immunogenicity Study of MT-2766 in Japanese Adults（COVID-19） | https://ClinicalTrials.gov/show/NCT05065619 |
| NCT05063825 | Understanding Reactions to Emotional Material in the Media During COVID-19 - Study 2 | https://ClinicalTrials.gov/show/NCT05063825 |
| NCT05062681 | RCT on the Efficacy of Dexamethasone Versus Methyl Prednisolone in Covid-19 Infected Patients With High Oxygen Flow | https://ClinicalTrials.gov/show/NCT05062681 |
| NCT05060939 | SARS-CoV-2 Infection in COVID-19 Vaccinated Patients | https://ClinicalTrials.gov/show/NCT05060939 |
| NCT05060991 | Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients | https://ClinicalTrials.gov/show/NCT05060991 |
| NCT05060510 | The School SPIT Study - COVID-19 Testing in Secondary Schools | https://ClinicalTrials.gov/show/NCT05060510 |
| NCT05058742 | Non-invasive Nervus Vagus Stimulation in Patients With COVID-19 and ARDS | https://ClinicalTrials.gov/show/NCT05058742 |
| NCT05059106 | EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF THE HALF DOSE OF THE VACCINE ChadOx1 nCoV-19 (AZD1222) for COVID-19 | https://ClinicalTrials.gov/show/NCT05059106 |
| NCT05057923 | The Development of a COVID19 Oral Vaccine Consisting of Bacillus Subtilis Spores | https://ClinicalTrials.gov/show/NCT05057923 |
| NCT05057182 | Third Dose of mRNA Vaccination to Boost COVID-19 Immunity | https://ClinicalTrials.gov/show/NCT05057182 |
| NCT05055505 | The School SPIT Study - Elementary Schools in Low COVID-19 Incidence Regions | https://ClinicalTrials.gov/show/NCT05055505 |
| NCT05055427 | Efficacy Evaluation of Shen Cao Gan Jiang Tang on Mild and Moderate COVID-19 Patients | https://ClinicalTrials.gov/show/NCT05055427 |
| NCT05055492 | The School SPIT Study - Elementary Schools in High COVID-19 Incidence Regions | https://ClinicalTrials.gov/show/NCT05055492 |
| NCT05054322 | FLuticasone in cOvid Treatment (FLOT) | https://ClinicalTrials.gov/show/NCT05054322 |
| NCT05054114 | Study of the Use of Nasal IFN-γ in Patients for the Prevention of Acute Respiratory Viral Infections, Icluding COVID-19 | https://ClinicalTrials.gov/show/NCT05054114 |
| NCT05050474 | Booster Immunization Study of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) | https://ClinicalTrials.gov/show/NCT05050474 |
| NCT05050201 | Implementation of Digital CBT for Insomnia in First Episode Psychosis | https://ClinicalTrials.gov/show/NCT05050201 |
| NCT05049213 | Effect of Local Treatment(Carrageenan Nasal Spray and PVP-I Mouthwash) in Reducing Viral Load in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT05049213 |
| NCT05048849 | A Study to Evaluate the Safety, Tolerability, and Immunogenicity of COVID-19 Vaccine, CT-COV-21 Extension Study | https://ClinicalTrials.gov/show/NCT05048849 |
| NCT05047952 | Vortioxetine for Post-Covid-19 Syndrome | https://ClinicalTrials.gov/show/NCT05047952 |
| NCT05047692 | Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT05047692 |
| NCT05043220 | Covid-19 Predictors: Safety of Gynecological Oncology Patients Undergoing Chemotherapy | https://ClinicalTrials.gov/show/NCT05043220 |
| NCT05041907 | Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV) | https://ClinicalTrials.gov/show/NCT05041907 |
| NCT05047445 | A First Time in Human Phase 1 Open-Label Study of the COVIDITY Vaccine Administered by Needle-free Injection | https://ClinicalTrials.gov/show/NCT05047445 |
| NCT05046548 | This is a Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19 | https://ClinicalTrials.gov/show/NCT05046548 |
| NCT05045989 | Process Evaluation of a Residence-Based SARS-CoV-2 Testing Participation Pilot | https://ClinicalTrials.gov/show/NCT05045989 |
| NCT05043376 | Study to Investigate the Treatment Benefits of Probiotic Streptococcus Salivarius K12 for Mild-to-moderate COVID-19 | https://ClinicalTrials.gov/show/NCT05043376 |
| NCT05043324 | Prevention and Treatment of Patient Before, During, and After Covid-19 Infection | https://ClinicalTrials.gov/show/NCT05043324 |
| NCT05043259 | Heterologous Prime-boost Immunization With an Aerosolised Adenovirus Type-5 Vector-based COVID-19 Vaccine (Ad5-nCoV) After Priming With an Inactivated SARS-CoV-2 Vaccine | https://ClinicalTrials.gov/show/NCT05043259 |
| NCT05040737 | PMMA vs Polysulfone in SARS-CoV-2 Infection Hemodialysis Patients | https://ClinicalTrials.gov/show/NCT05040737 |
| NCT05040724 | Evaluation of the Impact of the Administration of Single Dose of Ivermectin in the Early Phase of COVID-19 | https://ClinicalTrials.gov/show/NCT05040724 |
| NCT05037266 | Cohort Assessing the Immunogenicity and the Safety of the COVID-19 Vaccine Janssen in Healthy Volunteers Based on 2 Age Groups: 65 Years or Older - 55 to 65 Years. Covicompare-Janssen | https://ClinicalTrials.gov/show/NCT05037266 |
| NCT05038618 | A Study o Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901, CT-COV-21 Sub-study | https://ClinicalTrials.gov/show/NCT05038618 |
| NCT05038514 | The Effect of Music Therapy in COVID-19 Patients Given Prone Position | https://ClinicalTrials.gov/show/NCT05038514 |
| NCT05037110 | Physical Activity and Smell Trainings to Help Individuals With Coronavirus Disease (COVID-19) Recover From Persistent Smell and Taste Impairments - A Pilot Study | https://ClinicalTrials.gov/show/NCT05037110 |
| NCT05037097 | A Trial Evaluating the Safety and Immunogenicity of 3 COVID-19 SARS-CoV-2 RNA Vaccines in Healthy Adults | https://ClinicalTrials.gov/show/NCT05037097 |
| NCT05037448 | Exploring Telehealth to Deliver Me & My Wishes During Coronavirus-19 | https://ClinicalTrials.gov/show/NCT05037448 |
| NCT05037253 | COVID-19 Morbidity in Healthcare Workers and Vitamin D Supplementation | https://ClinicalTrials.gov/show/NCT05037253 |
| NCT05037240 | Quercetin in the Prevention of Covid-19 Infection | https://ClinicalTrials.gov/show/NCT05037240 |
| NCT05037188 | Clinical Study of the Safety and Immunogenicity of a Recombinant Viral Vector AAV5 (Adeno-Associated Virus Type 5 )-RBD (Receptor Binding Domain)-S Vaccine for the Prevention of Coronavirus Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT05037188 |
| NCT05035628 | Cardiopulmonary Rehabilitation in Long COVID-19 Patients With Persistent Breathlessness and Fatigue | https://ClinicalTrials.gov/show/NCT05035628 |
| NCT05035524 | A Randomized Controlled Trial to Investigate The Role of Adjuvant Inhalable Sodium Bicarbonate Solution 8.4% in Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT05035524 |
| NCT05035576 | A Study to Evaluate Change in Viral Load After OPN-019 in Adults With COVID-19 | https://ClinicalTrials.gov/show/NCT05035576 |
| NCT05035563 | Impact of a Communication Strategy in the Prevention of Depressive Symptoms in Patients With Covid-19 | https://ClinicalTrials.gov/show/NCT05035563 |
| NCT05035550 | Effects of Open-label Placebos on COVID-related Psychological Health | https://ClinicalTrials.gov/show/NCT05035550 |
| NCT05033860 | The Influence of Education During Waiting Time of Vaccination on the Knowledge Towards COVID-19 Among Chinese Residents | https://ClinicalTrials.gov/show/NCT05033860 |
| NCT05035186 | Efficacy of Clarithromycin and Flouroquinolones Based Regimens in H.Pylori Eradication in Covid-19 Era | https://ClinicalTrials.gov/show/NCT05035186 |
| NCT05033158 | The Immune Reaction Upon COVID-19 Vaccination in the Belgian Cancer Population. | https://ClinicalTrials.gov/show/NCT05033158 |
| NCT05033847 | Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above | https://ClinicalTrials.gov/show/NCT05033847 |
| NCT05028374 | COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies | https://ClinicalTrials.gov/show/NCT05028374 |
| NCT05032885 | Early Physiotherapy in Covid Patients | https://ClinicalTrials.gov/show/NCT05032885 |
| NCT05028244 | Evaluation of Serial Ultrasound Screening in ICU COVID-19 Patients | https://ClinicalTrials.gov/show/NCT05028244 |
| NCT05021588 | Steroid and Anticoagulant Therapy in covid19 | https://ClinicalTrials.gov/show/NCT05021588 |
| NCT05027672 | Strategies for Combining the First Component of Sputnik V With Other Adenoviral or mRNA-based Vaccines. | https://ClinicalTrials.gov/show/NCT05027672 |
| NCT05024500 | Clinical and Functional Outcomes of Critically Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT05024500 |
| NCT05024474 | Effects of Inspiratory Muscle Training After Covid-19 (ReCOV) | https://ClinicalTrials.gov/show/NCT05024474 |
| NCT05024461 | Comparison of Detection of SARS-CoV2 (COVID-19) Between Nasopharyngeal Swab Specimens and Those Obtained by Salivary Sputum | https://ClinicalTrials.gov/show/NCT05024461 |
| NCT05024006 | Public Health Emergency: SOLIDARITY TRIAL Philippines | https://ClinicalTrials.gov/show/NCT05024006 |
| NCT05021016 | Study of the EpiVacCorona Vaccine With the Involvement of Volunteers Aged 60 Years and Above | https://ClinicalTrials.gov/show/NCT05021016 |
| NCT05022329 | COVID-19 Vaccine Boosters in Patients With CKD | https://ClinicalTrials.gov/show/NCT05022329 |
| NCT05022303 | AT1001 for the Treatment of COVID-19 Related MIS-C | https://ClinicalTrials.gov/show/NCT05022303 |
| NCT05022472 | Project 2VIDA! COVID-19 Vaccine Intervention Delivery for Adults in Southern California | https://ClinicalTrials.gov/show/NCT05022472 |
| NCT05019326 | Andrographis Paniculata vs Boesenbergia Rotunda vs Control in Asymptomatic COVID-19 | https://ClinicalTrials.gov/show/NCT05019326 |
| NCT05018065 | Sexual Functions and Covid-19 | https://ClinicalTrials.gov/show/NCT05018065 |
| NCT05019287 | Menstrual Blood Stem Cells in Severe Covid-19 | https://ClinicalTrials.gov/show/NCT05019287 |
| NCT05019456 | Exercise and COVID-19 Viral T-cell Immunity | https://ClinicalTrials.gov/show/NCT05019456 |
| NCT05018078 | Safety and Immunogenicity of COVID-19 Vaccination in Patients With Cancer | https://ClinicalTrials.gov/show/NCT05018078 |
| NCT05017792 | Evaluation of Clinical and Antibody Response to Covid-19 Vaccination Strategy in TBRI, Egypt | https://ClinicalTrials.gov/show/NCT05017792 |
| NCT05017805 | COVID-19 Vaccines in Patients With Chronic Liver Disease | https://ClinicalTrials.gov/show/NCT05017805 |
| NCT05017493 | Treatment of Covid-19 With a Herbal Compound, Xagrotin | https://ClinicalTrials.gov/show/NCT05017493 |
| NCT05014373 | Philippine Trial to Determine Efficacy and Safety of Favipiravir for COVID-19 | https://ClinicalTrials.gov/show/NCT05014373 |
| NCT05012826 | Osteopathy and Physiotherapy Compared to Physiotherapy Alone on Fatigue and Functional Status in Long COVID | https://ClinicalTrials.gov/show/NCT05012826 |
| NCT05012800 | Safety and Immunogenicity of COVID-19 Vaccine Administered in Older Adults | https://ClinicalTrials.gov/show/NCT05012800 |
| NCT05012319 | Phase 3 Clinical Study Evaluating Nitric Oxide Nasal Spray (NONS) Efficacy To Treat and Prevent the Exacerbation of Infection in Individuals With Documented Asymptomatic or Mild COVID-19 | https://ClinicalTrials.gov/show/NCT05012319 |
| NCT05011344 | Evolution of Protective Immunization Against COVID-19 Among Hospital Workers in Health Care Facilities | https://ClinicalTrials.gov/show/NCT05011344 |
| NCT05011513 | A Study of PF-07321332/Ritonavir in Non-hospitalized Low-Risk Adult Participants With COVID-19 | https://ClinicalTrials.gov/show/NCT05011513 |
| NCT05010876 | Evaluation of the Effects of Bradykinin Antagonists on Pulmonary Manifestations of COVID-19 Infections (AntagoBrad-Cov Study). | https://ClinicalTrials.gov/show/NCT05010876 |
| NCT05007600 | Online Interactive Courses on Loneliness and Quality of Life of Older Adults | https://ClinicalTrials.gov/show/NCT05007600 |
| NCT05009563 | COvid iMaging With POSitron Emission Tomography | https://ClinicalTrials.gov/show/NCT05009563 |
| NCT05009186 | Changing of Prostate Specific Antigen Value in Patients With Covid-19 | https://ClinicalTrials.gov/show/NCT05009186 |
| NCT05008003 | Dietary Supplements Vit D, Quercetin and Curcumin Combination for Early Symptoms of COVID-19 | https://ClinicalTrials.gov/show/NCT05008003 |
| NCT05008393 | Efficacy of PJS-539 for Adult Patients With COVID-19. | https://ClinicalTrials.gov/show/NCT05008393 |
| NCT05008380 | Efficacy of the Early Prone-positioning in Hospitalized Patients With Mild Covid-19 Pneumonia | https://ClinicalTrials.gov/show/NCT05008380 |
| NCT05007678 | Targeting de Novo Pyrimidine Biosynthesis by Leflunomide for the Treatment of COVID-19 Virus Disease | https://ClinicalTrials.gov/show/NCT05007678 |
| NCT05007457 | The Effectiveness of Respiratory Tele-rehabilitation After COVID-19 Pneumonia Related: a Randomized Controlled Trial | https://ClinicalTrials.gov/show/NCT05007457 |
| NCT05007509 | Safety and Immunogenicity Study of Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Adult Healthy Volunteers (COVID-19) | https://ClinicalTrials.gov/show/NCT05007509 |
| NCT05007496 | Preventive Dendritic Cell Vaccine, AV-COVID-19, in Subjects Not Actively Infected With COVID-19 | https://ClinicalTrials.gov/show/NCT05007496 |
| NCT05007236 | Study to Evaluate the Efficacy and Safety of Oral RP7214, a DHODH Inhibitor, in Patients With Symptomatic Mild COVID-19 Infection. | https://ClinicalTrials.gov/show/NCT05007236 |
| NCT05004805 | COVID-19 Methylene Blue Antiviral Treatment | https://ClinicalTrials.gov/show/NCT05004805 |
| NCT05005156 | Phase IIb Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (Ad5-nCoV) in Adults 18 Years of Age and Older. | https://ClinicalTrials.gov/show/NCT05005156 |
| NCT05005559 | Phase III Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen) | https://ClinicalTrials.gov/show/NCT05005559 |
| NCT05004753 | A Study to Evaluate the Safety and Efficacy of Artemisinin- a Herbal Supplement on COVID-19 Subjects | https://ClinicalTrials.gov/show/NCT05004753 |
| NCT05002348 | Laser Acupuncture Improves Constipation in Patients Hospitalized for Stroke During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT05002348 |
| NCT05002517 | Randomized, Unicentric, Open, Controlled Clinical Trial, in Phase Iii, to Demonstrate the Effectiveness of Tocilizumab | https://ClinicalTrials.gov/show/NCT05002517 |
| NCT05001542 | Digital Interventions for Detection and Reduction of Moral Distress | https://ClinicalTrials.gov/show/NCT05001542 |
| NCT05000307 | Co-Sér: Serological Analysis and Viral Neutralization in People With a Documented COVID-19 Infection | https://ClinicalTrials.gov/show/NCT05000307 |
| NCT05000255 | Coping With Covid-19: Loneliness, Self-Efficacy, Social Support, Depression & Anxiety in Patients in Medical Rehab. | https://ClinicalTrials.gov/show/NCT05000255 |
| NCT05000216 | COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders | https://ClinicalTrials.gov/show/NCT05000216 |
| NCT05000008 | Aerobic Versus Anaerobic Exercise on Immune Functions and Disease Severity in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT05000008 |
| NCT04998708 | Relaxation Exercise in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04998708 |
| NCT04998253 | Effects in Oxygenation and Hypoxic Pulmonary Vasoconstriction in ARDS Secondary to SARS-CoV2 | https://ClinicalTrials.gov/show/NCT04998253 |
| NCT04997551 | Double Blind Randomized Clinical Trial of Use of Colchicine Added to Standard Treatment in Hospitalized With Covid-19 | https://ClinicalTrials.gov/show/NCT04997551 |
| NCT04996238 | Local and General Immune Response After Coronavirus Disease (COVID-19) Vaccination in Volunteers | https://ClinicalTrials.gov/show/NCT04996238 |
| NCT04993586 | Phase I/II Study of COVID-19 DNA Vaccine (AG0302-COVID19 High-dose) | https://ClinicalTrials.gov/show/NCT04993586 |
| NCT04993547 | Cluster-RCT Collective Nasopharyngeal COVID-19 Testing Amongst Pupils | https://ClinicalTrials.gov/show/NCT04993547 |
| NCT04993209 | Clinical Trial of the COVID-19 Vaccine (Recombinant, Inactivated) in Brazil | https://ClinicalTrials.gov/show/NCT04993209 |
| NCT04992000 | Self-Care of Hypertension Among Older Adults During COVID-19 | https://ClinicalTrials.gov/show/NCT04992000 |
| NCT04992260 | Efficacy, Immunogenicity and Safety of COVID-19 Vaccine , Inactivated in Children and Adolescents | https://ClinicalTrials.gov/show/NCT04992260 |
| NCT04992182 | Reactogenicity, Safety, and Immunogenicity of Covid-19 Vaccine Booster | https://ClinicalTrials.gov/show/NCT04992182 |
| NCT04992390 | A Brief GAmeplay Intervention for NHS ICU Staff Affected by COVID-19 Trauma (GAINS Study) | https://ClinicalTrials.gov/show/NCT04992390 |
| NCT04988282 | Systemic Corticosteroids in Treatment of Post-COVID-19 Interstitial Lung Disease | https://ClinicalTrials.gov/show/NCT04988282 |
| NCT04990544 | Phase II Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) | https://ClinicalTrials.gov/show/NCT04990544 |
| NCT04990531 | Low-field Magnetic Resonance Imaging of Pediatric COVID-19 | https://ClinicalTrials.gov/show/NCT04990531 |
| NCT04990830 | Effects of Low Molecular Weight Heparin Therapy With Soft-Mist Inhaler for COVID-19 Induced Hypoxemia | https://ClinicalTrials.gov/show/NCT04990830 |
| NCT04988217 | Inhaled Interferon α2b for the Treatment of Coronavirus Disease 19 (COVID-19) | https://ClinicalTrials.gov/show/NCT04988217 |
| NCT04988048 | Collaborative Study to Evaluate Heterologous Vaccination Against Covid-19 in Argentina | https://ClinicalTrials.gov/show/NCT04988048 |
| NCT04987554 | Glycophosphopeptical AM3 A Potential Adjuvant in the Treatment of SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04987554 |
| NCT04729491 | EAT-DUTA AndroCoV Trial | https://ClinicalTrials.gov/show/NCT04729491 |
| NCT04983394 | The Effect of Virtual Reality Exercises on Patients With Post-SARS-CoV-2 Syndrome | https://ClinicalTrials.gov/show/NCT04983394 |
| NCT04983537 | Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes in an Elderly Population | https://ClinicalTrials.gov/show/NCT04983537 |
| NCT04982887 | Tele-Rehabilitation in Parkinson’s Disease | https://ClinicalTrials.gov/show/NCT04982887 |
| NCT04982757 | Accelerated TMS for Depression and OCD | https://ClinicalTrials.gov/show/NCT04982757 |
| NCT04982068 | Phase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) | https://ClinicalTrials.gov/show/NCT04982068 |
| NCT04982042 | Post COVID-19 Pulmonary Rehabilitation Program | https://ClinicalTrials.gov/show/NCT04982042 |
| NCT04981743 | The Efficacy of Nigella Sativa Versus VitaminD3 as Supplement Therapy in Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04981743 |
| NCT04981314 | Echinacea Drug for Covid-19 | https://ClinicalTrials.gov/show/NCT04981314 |
| NCT04981379 | Clinical Trial For Early SARS-CoV-2 (COVID-19) Treatment | https://ClinicalTrials.gov/show/NCT04981379 |
| NCT04979923 | Efficacy of Nebulized Lidocaine, Salbutamol, and Beclomethasone Plus Salbutamol in the Covid-19 Patients With ARDS on Non-invasive Ventilation; Randomized Control Trial | https://ClinicalTrials.gov/show/NCT04979923 |
| NCT04979858 | Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask | https://ClinicalTrials.gov/show/NCT04979858 |
| NCT04980508 | Effects of COVID-19 on Cavernous Smooth Muscle | https://ClinicalTrials.gov/show/NCT04980508 |
| NCT04979221 | Effect of Cyproheptadine on Ventilatory Support-free Days in Critically Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04979221 |
| NCT04972864 | Effects of Respiratory Muscle Training in Patients With Post COVID-19 | https://ClinicalTrials.gov/show/NCT04972864 |
| NCT04978259 | SOLIDARITY Finland Long COVID-19 | https://ClinicalTrials.gov/show/NCT04978259 |
| NCT04978207 | A Faithful Response to COVID-19 Project | https://ClinicalTrials.gov/show/NCT04978207 |
| NCT04977921 | Lab Skills Nursing Education Into Effective Clinical Practice During COVID-19: Elsevier Clinical Skill Platform | https://ClinicalTrials.gov/show/NCT04977921 |
| NCT04974203 | Saliva-based COVID-19 DNA Aptamer Test | https://ClinicalTrials.gov/show/NCT04974203 |
| NCT04973488 | Therapeutic Plasma Exchange Followed by Convalescent Plasma Transfusion in Severe and Critically Ill COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04973488 |
| NCT04973462 | Evaluation of The Efficacy of Triazavirin Versus Oseltamivir in Egyptian Patients Infected With COVID-19 | https://ClinicalTrials.gov/show/NCT04973462 |
| NCT04973449 | Phase II/III Study of AZD2816, for the Prevention of COVID-19 in Adults | https://ClinicalTrials.gov/show/NCT04973449 |
| NCT04978051 | Investigating the Efficacy and Safety ICATIBANT For The Treatment of Patients With SARS-CoV-2 (COVID-19) Infection | https://ClinicalTrials.gov/show/NCT04978051 |
| NCT04978025 | Colloidal Silver, Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04978025 |
| NCT04977479 | The Safety of Administering a Second Dose of a COVID-19 mRNA Vaccine in Individuals Who Experienced a Systemic Allergic Reaction to an Initial Dose | https://ClinicalTrials.gov/show/NCT04977479 |
| NCT04977024 | SARS-CoV-2 Vaccine (COH04S1) Versus Emergency Use Authorization SARS-COV-2 Vaccine for the Treatment of COVID-19 in Patients With Blood Cancer | https://ClinicalTrials.gov/show/NCT04977024 |
| NCT04970563 | Detection of Asymptomatic SARS-Cov2 Infected Patients by Detection Dogs: “Proof of Concept” Study (CoviDetectionDog)-Covid-19 | https://ClinicalTrials.gov/show/NCT04970563 |
| NCT04970719 | Baricitinib in Hospitalized Covid-19 Patients With Diabetes Mellitus | https://ClinicalTrials.gov/show/NCT04970719 |
| NCT04967755 | Jing-Si-Herbal-Tea Accelerates SARS-Cov-2 Load Reduction Among COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04967755 |
| NCT04969991 | Study of Varespladib in Patients Hospitalized With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04969991 |
| NCT04967430 | TOGETHER - Toronto: Trial to Evaluate the Effect of Peginterferon Lambda for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04967430 |
| NCT04969172 | A Phase II Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Exosomes Overexpressing CD24 to Prevent Clinical Deterioration in Patients With Moderate or Severe COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04969172 |
| NCT04967742 | A Extension Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04967742 |
| NCT04967729 | COVID-19 and Lung Ultrasound Utility | https://ClinicalTrials.gov/show/NCT04967729 |
| NCT04969276 | Study of a Quadrivalent High-Dose Influenza Vaccine and a Moderna COVID-19 Vaccine Administered Either Concomitantly or Singly in Participants 65 Years of Age and Older Previously Vaccinated With a 2-dose Schedule of Moderna COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04969276 |
| NCT04969263 | COVID-19 Protection After Transplant Pilot Study | https://ClinicalTrials.gov/show/NCT04969263 |
| NCT04967807 | Myocardial Injury and Outcomes Following COVID-19 Vaccination (MYOVAX Study) | https://ClinicalTrials.gov/show/NCT04967807 |
| NCT04967794 | Effectiveness of Teleorientation in Oral Hygiene During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04967794 |
| NCT04966910 | Stay Connected: Testing an Intervention to Combat COVID-19 Related Social Isolation Among Seattle-area Older Adults | https://ClinicalTrials.gov/show/NCT04966910 |
| NCT04964414 | Treatment of Pediatric Patients That Lost Sense of Smell Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04964414 |
| NCT04964583 | Hidroxicloroquina With Azitromicina Versus Hidroxicloroquina and Placebo Int Patients With Mild COVID-19 | https://ClinicalTrials.gov/show/NCT04964583 |
| NCT04964570 | Digital Mental Health Care for COVID-19 High-Risk Populations | https://ClinicalTrials.gov/show/NCT04964570 |
| NCT04964154 | Building Resiliency and Vital Equity (BRAVE) Project: Understanding Native Americans’ Perceptions/Beliefs About COVID-19 Testing and Vaccination Study | https://ClinicalTrials.gov/show/NCT04964154 |
| NCT04962906 | Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes | https://ClinicalTrials.gov/show/NCT04962906 |
| NCT04962893 | Study of a Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine | https://ClinicalTrials.gov/show/NCT04962893 |
| NCT04962022 | Drug-Drug Interaction Study Assessing Effect of Itraconazole on PF-07321332/Ritonavir in Healthy Participants | https://ClinicalTrials.gov/show/NCT04962022 |
| NCT04961541 | Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine | https://ClinicalTrials.gov/show/NCT04961541 |
| NCT04961502 | Humoral and Cellular Responses to Vaccination Against Coronavirus Disease 2019 (COVID-19) in the Very Elderly Living in Geriatric Institutions | https://ClinicalTrials.gov/show/NCT04961502 |
| NCT04962308 | Clinical Trial of Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04962308 |
| NCT04961359 | Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2（COVID-19） Phase I Clinical Trial (3~17 Years Old) | https://ClinicalTrials.gov/show/NCT04961359 |
| NCT04961333 | Internet-based Multidisciplinary Rehabilitation for Longterm COVID-19 Syndrome | https://ClinicalTrials.gov/show/NCT04961333 |
| NCT04960215 | Coenzyme Q10 as Treatment for Long Term COVID-19 | https://ClinicalTrials.gov/show/NCT04960215 |
| NCT04959786 | MANS-NRIZ Trial for COVID-19 Treatment : Extension Study | https://ClinicalTrials.gov/show/NCT04959786 |
| NCT04959760 | BinaxNow COVID-19 IgG Rapid Test Device and Antibody Self Test | https://ClinicalTrials.gov/show/NCT04959760 |
| NCT04958863 | Impact of Facemasks on Running During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04958863 |
| NCT04957940 | Lipid Emulsion Infusion and COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04957940 |
| NCT04957017 | Effect of Hand-Washing Training in Covid-19 | https://ClinicalTrials.gov/show/NCT04957017 |
| NCT04954469 | B-pVAC-SARS-CoV-2: Study to Prevent COVID-19 Infection in Adults With Bcell/ Antibody Deficiency | https://ClinicalTrials.gov/show/NCT04954469 |
| NCT04954118 | A Different Use of The Aerosol Box in COVID-19 Patients; Internal Jugular Vein Cannulation | https://ClinicalTrials.gov/show/NCT04954118 |
| NCT04954287 | Phase 1 Study of Intranasal PIV5-vectored COVID-19 Vaccine Expressing SARS-CoV-2 Spike Protein in Healthy Adults | https://ClinicalTrials.gov/show/NCT04954287 |
| NCT04954092 | Study of Gam-COVID-Vac in Adolescents | https://ClinicalTrials.gov/show/NCT04954092 |
| NCT04954040 | Prevention and Treatment With Hydroxychloroquine + Azithromycin of Acute Respiratory Syndrome Induced by COVID-19 | https://ClinicalTrials.gov/show/NCT04954040 |
| NCT04954157 | Studies to Determine Whether Oxygen Sensing is Impaired in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Patients | https://ClinicalTrials.gov/show/NCT04954157 |
| NCT04954014 | Pilot Study of Single Dose Bevacizumab as Treatment for Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04954014 |
| NCT04953234 | Effect of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Best Standard of Care for the Treatment of Hospitalized COVID-19 Patients and Continued Treatment Following Discharge | https://ClinicalTrials.gov/show/NCT04953234 |
| NCT04953325 | Immunogenicity and Safety of an Inactivated COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04953325 |
| NCT04952519 | Efficacy of Amantadine Treatment in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04952519 |
| NCT04952857 | Short Term, High Dose Vitamin D Supplementation in Moderate to Severe COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04952857 |
| NCT04952805 | Study to Select the Dose and Evaluate Safety and Efficacy of Monoclonal Antibody in Adult With Recently Diagnosed Asymptomatic to Moderately Severe COVID-19. | https://ClinicalTrials.gov/show/NCT04952805 |
| NCT04952766 | Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults | https://ClinicalTrials.gov/show/NCT04952766 |
| NCT04952727 | Study on Sequential Immunization of Inactivated COVID-19 Vaccine and Recombinant COVID-19 Vaccine (Ad5 Vector) in Elderly Adults | https://ClinicalTrials.gov/show/NCT04952727 |
| NCT04950803 | A Randomised-controlled Trial of an Oral Microbiome Immunity Formula in Recovered COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04950803 |
| NCT04951388 | A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adolescents | https://ClinicalTrials.gov/show/NCT04951388 |
| NCT04951362 | Role of Ivermectin Nanosuspension as Nasal Spray in Treatment of Persistant Post covid19 Anosmia | https://ClinicalTrials.gov/show/NCT04951362 |
| NCT04951349 | Safety and Efficacy of Intranasal Application of GX-03 as a Treatment and Prevention for COVID-19. | https://ClinicalTrials.gov/show/NCT04951349 |
| NCT04951323 | Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo) | https://ClinicalTrials.gov/show/NCT04951323 |
| NCT04951310 | COVID-19 Vaccinations With a Sweepstakes | https://ClinicalTrials.gov/show/NCT04951310 |
| NCT04950725 | Covid-19 Virtual Recovery Study | https://ClinicalTrials.gov/show/NCT04950725 |
| NCT04948203 | Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis | https://ClinicalTrials.gov/show/NCT04948203 |
| NCT04947488 | Evaluation of the Effects of Treatment With Bioarginin C in Adult Subjects Belonging to the Post-Covid Day Hospital | https://ClinicalTrials.gov/show/NCT04947488 |
| NCT04945811 | Role of Interleukin-6 and Procalcitonin as Novel Inflammatory Biomarkers in Evaluating COVID 19 Disease Severity - an Experience at CMH Quetta | https://ClinicalTrials.gov/show/NCT04945811 |
| NCT04945356 | Telerehabilitation During Pandemic Containment Measures of COVID19 | https://ClinicalTrials.gov/show/NCT04945356 |
| NCT04945564 | Covid-19 Patients Management During Home Isolation | https://ClinicalTrials.gov/show/NCT04945564 |
| NCT04942990 | The Effectiveness of Calistenic Exercise Training in Adolescents | https://ClinicalTrials.gov/show/NCT04942990 |
| NCT04942392 | Digital Dance for People With Parkinson’s Disease During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04942392 |
| NCT04941703 | “CHANGE COVID-19 Severity” | https://ClinicalTrials.gov/show/NCT04941703 |
| NCT04941105 | Impact of PCSK9 Inhibition on Clinical Outcome in Patients During the Inflammatory Stage of the COVID-19 | https://ClinicalTrials.gov/show/NCT04941105 |
| NCT04944368 | Phase II Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen) | https://ClinicalTrials.gov/show/NCT04944368 |
| NCT04944121 | Phase 2 Study of RSLV-132 in Subjects With Long COVID | https://ClinicalTrials.gov/show/NCT04944121 |
| NCT04941183 | Phase 1 Study to Assess Safety, Tolerability, PD, PK, Immunogenicity of IV NTR-441 Solution in Healthy Volunteers and COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04941183 |
| NCT04940182 | A Study to Assess the Efficacy and Safety of XC221 in Patients With Mild COVID-19 | https://ClinicalTrials.gov/show/NCT04940182 |
| NCT04939532 | SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Testing Among Utah Community Health Centers | https://ClinicalTrials.gov/show/NCT04939532 |
| NCT04939714 | Caregiving During Crisis | https://ClinicalTrials.gov/show/NCT04939714 |
| NCT04939519 | SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Vaccination Rates Among Utah Community Health Centers | https://ClinicalTrials.gov/show/NCT04939519 |
| NCT04939415 | Chinese Herbal Formula for COVID-19 | https://ClinicalTrials.gov/show/NCT04939415 |
| NCT04939402 | SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the UZ Brussel Following COVID-19 Vaccination Using an Adenoviral Vector | https://ClinicalTrials.gov/show/NCT04939402 |
| NCT04936997 | Immune Response to the COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04936997 |
| NCT04936893 | Effects of Mindfulness Practice on Healthcare Workers | https://ClinicalTrials.gov/show/NCT04936893 |
| NCT04936503 | Support for the Resumption of Training of High-level Athletes Post-epidemic COVID-19 | https://ClinicalTrials.gov/show/NCT04936503 |
| NCT04935437 | Implementing a Rehabilitation Program in Patients Recovering From Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04935437 |
| NCT04935528 | Mechanisms of Anti COVID-19 Humoral and Cellular Immune Response After Vaccination in a Sample of Patients and Salaried Staff From a French Anti-cancer Center | https://ClinicalTrials.gov/show/NCT04935528 |
| NCT04935515 | C Reactive Protein in Home Quarantined Coronavirus Disease 2019 (COVID -19) Patients. | https://ClinicalTrials.gov/show/NCT04935515 |
| NCT04935502 | Home Based Exercises With and Without Posture and Ergonomics Training Among Students During COVID-19 | https://ClinicalTrials.gov/show/NCT04935502 |
| NCT04933929 | Personalized Dietary Advice 3 Months After Discharge From Hospitalization in Geriatrics: Effect on Nutritional Status According to Coronavirus Disease 2019 (COVID-19) Status (Positive or Negative) During Hospitalization | https://ClinicalTrials.gov/show/NCT04933929 |
| NCT04933864 | COVID-19 Treatment Using Methylene Blue and Photodynamic Therapy | https://ClinicalTrials.gov/show/NCT04933864 |
| NCT04933799 | IRAK 4 Inhibitor (PF-06650833) in Hospitalized Patients With COVID-19 Pneumonia and Exuberant Inflammation. | https://ClinicalTrials.gov/show/NCT04933799 |
| NCT04932850 | Study to Evaluate the Safety and Concentrations of Monoclonal Antibody Against Virus That Causes COVID-19 Disease. | https://ClinicalTrials.gov/show/NCT04932850 |
| NCT04932824 | Long-term Follow-up to the Phase 1 Study of Adjuvanted SARS-CoV-2 (SCB 2019) Vaccine for COVID-19. | https://ClinicalTrials.gov/show/NCT04932824 |
| NCT04932369 | The Effect of Emotion Regulation Training on Anxiety, in College Students in Egypt | https://ClinicalTrials.gov/show/NCT04932369 |
| NCT04931888 | Implementing and Evaluating a Social-Emotional Learning Program for Refugee Children During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04931888 |
| NCT04930874 | Cerebral Autoregulation and COVID-19 | https://ClinicalTrials.gov/show/NCT04930874 |
| NCT04930965 | Impact of LA-CEAL HALT COVID-19 Ambassador Program on Likelihood to Vaccinate | https://ClinicalTrials.gov/show/NCT04930965 |
| NCT04930861 | Study of Codivir in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04930861 |
| NCT04930003 | Reactogenicity, Safety and Immunogenicity of QazCoVac-P COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04930003 |
| NCT04929691 | The CircumVent Project: A CPAP/O2 Helmet Solution for Non-Invasive Ventilation Among Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04929691 |
| NCT04928456 | Augmentation of Immune Response to COVID-19 mRNA Vaccination Through OMT With Lymphatic Pumps | https://ClinicalTrials.gov/show/NCT04928456 |
| NCT04928430 | Efficacy and Safety of XAV-19 for the Treatment of Moderate-to-severe COVID-19 | https://ClinicalTrials.gov/show/NCT04928430 |
| NCT04926779 | Open Label, Single-Center Study Utilizing BIOZEK COVID-19 Antigen Rapid Test | https://ClinicalTrials.gov/show/NCT04926779 |
| NCT04927845 | StriveWeekly Trial Post-pandemic | https://ClinicalTrials.gov/show/NCT04927845 |
| NCT04927169 | InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection (Brazil Cohort) | https://ClinicalTrials.gov/show/NCT04927169 |
| NCT04927065 | A Study to Evaluate the Immunogenicity and Safety of mRNA-1273.211 Vaccine for COVID-19 Variants | https://ClinicalTrials.gov/show/NCT04927065 |
| NCT04926428 | In Situ Thrombolysis With tPA and Inflow Perfusion Analysis in Patient With Severe Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04926428 |
| NCT04924660 | Novel Experimental COVID-19 Therapies Affecting Host Response | https://ClinicalTrials.gov/show/NCT04924660 |
| NCT04922957 | A Phase 2b Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study, Evaluating Efficacy and Safety of Allocetra-OTS in Patients With Severe or Critical COVID-19 With Associated Acute Respiratory Distress Syndrome (ARDS) | https://ClinicalTrials.gov/show/NCT04922957 |
| NCT04922827 | Infliximab in the Treatment of Patients With Severe COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04922827 |
| NCT04922788 | Study to Evaluate the Safety, Immunogenicity, and Efficacy of Nanocovax Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04922788 |
| NCT04923061 | The Effect of Acupressure on the Sleep Quality and Fatigue | https://ClinicalTrials.gov/show/NCT04923061 |
| NCT04922918 | Ligilactobacillus Salivarius MP101 for Elderly in a Nursing Home | https://ClinicalTrials.gov/show/NCT04922918 |
| NCT04922905 | Nervous System Symptoms Associated With COVID 19 | https://ClinicalTrials.gov/show/NCT04922905 |
| NCT04920942 | Ivermectin Treatment Efficacy in Covid-19 High Risk Patients | https://ClinicalTrials.gov/show/NCT04920942 |
| NCT04920773 | Community-based Post-exposure Prophylaxis for COVID-19 | https://ClinicalTrials.gov/show/NCT04920773 |
| NCT04920916 | Safety and Efficacy of Dupilumab for Treatment of Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04920916 |
| NCT04920890 | Radiofrequency Intervention in Post COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04920890 |
| NCT04920838 | Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04920838 |
| NCT04918940 | Efficacy of COVID-19 Vaccination in Patientstreated With Anti-CD20 for Follicular Lymphoma or Mantle Cell Lymphoma | https://ClinicalTrials.gov/show/NCT04918940 |
| NCT04918914 | Critical Care Results of SARS-CoV-2 ARDS by Dapsone and Standard COVID-19 Treatment | https://ClinicalTrials.gov/show/NCT04918914 |
| NCT04918797 | COVAXIN in a Pediatric Cohort | https://ClinicalTrials.gov/show/NCT04918797 |
| NCT04916886 | A Clinical Trial of Immunobridging and Lot-to-lot Consistency of COVID-19 Vaccine (Ad5-nCoV) in Different Age Groups. | https://ClinicalTrials.gov/show/NCT04916886 |
| NCT04916821 | Investigation of Clinical Effectiveness of Propolis Extracts as Food Supplements in Patients With SARS-CoV-2(COVID-19) | https://ClinicalTrials.gov/show/NCT04916821 |
| NCT04916574 | Clinical Trial of BioBlock COVID-19 Nasal Spray Containing Anti-SARS-CoV-2 Antibodies Derived From Bovine Colostrum | https://ClinicalTrials.gov/show/NCT04916574 |
| NCT04915820 | Iron and COVID-19 Vaccine Response | https://ClinicalTrials.gov/show/NCT04915820 |
| NCT04915989 | Safety and Immunogenicity of GX-19N, a COVID-19 Preventive DNA Vaccine in Elderly Individuals | https://ClinicalTrials.gov/show/NCT04915989 |
| NCT04914767 | Nigella 5 in the Treatment of SARS COV2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04914767 |
| NCT04914377 | To Evaluate the Safety and Efficacy of TQ Formula in Covid-19 Participants | https://ClinicalTrials.gov/show/NCT04914377 |
| NCT04913779 | Safety and Effectiveness of an Immunobiological Drug in CoViD-19 | https://ClinicalTrials.gov/show/NCT04913779 |
| NCT04913740 | Nursing Study of Skin Lesions Related to Health Care Protection in Novel Nursing Study of Skin Lesions Related to Health Care Protection in Novel Coronavirus Epidemic | https://ClinicalTrials.gov/show/NCT04913740 |
| NCT04912921 | Effect of Palmitoylethanolamide on Proinflammatory Markers in Adults Recently Diagnosed With COVID-19 | https://ClinicalTrials.gov/show/NCT04912921 |
| NCT04912895 | Detection of SARS-CoV-2 RNA in Coughed Droplets From Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04912895 |
| NCT04911790 | Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Adults | https://ClinicalTrials.gov/show/NCT04911790 |
| NCT04911777 | Proof of Principle Study to Evaluate the Safety, PK, Viral Shedding and Efficacy of Pentarlandirâ„¢ UPPTA for Patients With Early COVID-19 | https://ClinicalTrials.gov/show/NCT04911777 |
| NCT04912011 | Mineralocorticoid Receptor Antagonist and Pulmonary Fibrosis in COVID-19. | https://ClinicalTrials.gov/show/NCT04912011 |
| NCT04910932 | Effects of Breathing Exercises on Fear of COVID-19, Anxiety, Sleep and Quality of Life During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04910932 |
| NCT04910542 | Epidemiologic Intelligence Network (EpI-Net) to Promote COVID-19 Testing | https://ClinicalTrials.gov/show/NCT04910542 |
| NCT04910516 | Emotional Freedom Technique (EFT) Effect on Nurses | https://ClinicalTrials.gov/show/NCT04910516 |
| NCT04910269 | Outpatient Treatment With Anti-Coronavirus Immunoglobulin | https://ClinicalTrials.gov/show/NCT04910269 |
| NCT04909905 | Glutamine Supplementation and Short-term Mortality in Covid-19 | https://ClinicalTrials.gov/show/NCT04909905 |
| NCT04910230 | Nicotinamide-based Supportive Therapy in Lymphopenia for Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04910230 |
| NCT04910191 | Collecting Respiratory Sound Samples From Corona Patients to Extend the Diagnostic Capability of VOQX Electronic Stethoscope to Diagnose COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04910191 |
| NCT04909996 | Study on the Performance and Safety of Sentinox in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04909996 |
| NCT04909918 | Impact of Steroids on Inflammatory Response in Covid-19 | https://ClinicalTrials.gov/show/NCT04909918 |
| NCT04907331 | Heterologous SARS-CoV-2 Vaccination With ChAdOx-1 and BNT162b2 | https://ClinicalTrials.gov/show/NCT04907331 |
| NCT04559035 | Nasal Irrigation to Reduce COVID-19 Morbidity | https://ClinicalTrials.gov/show/NCT04559035 |
| NCT04904783 | Low-Dose Radiation Therapy to Lungs in Moderate COVID-19 Pneumonitis: A Case-Control Pilot Study | https://ClinicalTrials.gov/show/NCT04904783 |
| NCT04904744 | Effect of Varied Outreach Methods on Appointment Scheduling, Appointment Completion, and Receipt of COVID-19 Vaccination | https://ClinicalTrials.gov/show/NCT04904744 |
| NCT04904510 | Evaluation of the INDICAIDâ„¢ COVID-19 Rapid Antigen Test | https://ClinicalTrials.gov/show/NCT04904510 |
| NCT04904497 | Early Occupational Therapy in Mechanical Ventilated Patients With Covid-19 | https://ClinicalTrials.gov/show/NCT04904497 |
| NCT04900961 | CISCO-21 Prevent and Treat Long COVID-19. | https://ClinicalTrials.gov/show/NCT04900961 |
| NCT04904549 | Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older | https://ClinicalTrials.gov/show/NCT04904549 |
| NCT04903184 | Exploratory Study to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers | https://ClinicalTrials.gov/show/NCT04903184 |
| NCT04902183 | Safety and Efficacy of Exosomes Overexpressing CD24 in Two Doses for Patients With Moderate or Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04902183 |
| NCT04902976 | Evaluation of SARS-COV-2 Viral Load of Covid-19 Patients After Rinsing With Oral Antimicrobial Mouthwashes | https://ClinicalTrials.gov/show/NCT04902976 |
| NCT04902911 | Point of Care Evaluation of Novir 2019-nCoV Immunoglobulin G/ Immunoglobulin M (IgG/IgM) Antibody Test (Collodial Gold) | https://ClinicalTrials.gov/show/NCT04902911 |
| NCT04901676 | Leronlimab in Moderately Ill Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04901676 |
| NCT04901624 | Use of Behavioral Economics in Repeat SARS-CoV-2 (COVID-19) Antibody Testing in Disadvantaged Communities | https://ClinicalTrials.gov/show/NCT04901624 |
| NCT04900454 | Allogeneic Natural Killer (NK) Cell Therapy in Subjects Hospitalized for COVID-19 | https://ClinicalTrials.gov/show/NCT04900454 |
| NCT04900428 | Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPSâ„¢) in Outpatient Adults With COVID-19 (UK) | https://ClinicalTrials.gov/show/NCT04900428 |
| NCT04900415 | Olfactory and Neurosensory Rehabilitation in COVID-19-related Olfactory Dysfunction | https://ClinicalTrials.gov/show/NCT04900415 |
| NCT04900337 | Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) Compared to Placebo and Best Available Care (BAT), for the Treatment of Moderate to Severe COVID-19 Patients. | https://ClinicalTrials.gov/show/NCT04900337 |
| NCT04900129 | Inhalation of Vapor With Medication (Diclofenac Sodium, Menthol, Methyl Salicylate and N-Acetyl Cysteine) Reduces Oxygen Need and Hospital Stay in COVID-19 Patients - A Case Control Study | https://ClinicalTrials.gov/show/NCT04900129 |
| NCT04900155 | Evaluation of the Effect of Long-term Lipid-lowering Therapy in STEMI Patients With Coronavirus Infection COVID-19 | https://ClinicalTrials.gov/show/NCT04900155 |
| NCT04899245 | ReSET Aim 1b: Restarting Safe Education and Testing for Children With Medical Complexity - COVID-19 Testing in School With Children and Staff | https://ClinicalTrials.gov/show/NCT04899245 |
| NCT04899232 | Antithrombin III in Infectious Disease Caused by COVID-19 | https://ClinicalTrials.gov/show/NCT04899232 |
| NCT04900467 | Compare Immunological Efficacy of a Vaccine Regimen Combining Two Covid19 mRNA Vaccines (Pfizer-BioNTech and Moderna) With That of a Homologous Vaccination of Each Covid19 mRNA Vaccine | https://ClinicalTrials.gov/show/NCT04900467 |
| NCT04898088 | A Proof of Concept Study for the DNA Repair Driven by the Mesenchymal Stem Cells in Critical COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04898088 |
| NCT04898205 | Cardiopulmonary Rehabilitation in COVID-19 Longhaulers | https://ClinicalTrials.gov/show/NCT04898205 |
| NCT04898062 | CRP-Apheresis for Attenuation of Pulmonary, MYocardial and/or Kidney Injury in COvid-19 | https://ClinicalTrials.gov/show/NCT04898062 |
| NCT04896853 | Treatment of Respiratory Complications Associated With COVID-19 Infection Using ProTrans® | https://ClinicalTrials.gov/show/NCT04896853 |
| NCT04896840 | Tele-rehabilitation in Children With Cerebral Palsy in the Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04896840 |
| NCT04896710 | COVID-19 Rapid Testing for Self-Administration Among an Asymptomatic Sample | https://ClinicalTrials.gov/show/NCT04896710 |
| NCT04896788 | Monitoring of the Post-vaccination Immune Response to COVID-19 Among Hospital Staff | https://ClinicalTrials.gov/show/NCT04896788 |
| NCT04895267 | Low-field Thoracic Magnetic Stimulation Increases Peripheral Oxygen Saturation Levels in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04895267 |
| NCT04894721 | Prophylaxis for COVID-19: Ivermectin in Close Contacts of COVID-19 Cases (IVERNEX-TUC) | https://ClinicalTrials.gov/show/NCT04894721 |
| NCT04895449 | Safety, Tolerability and Immunogenicity of the Candidate Vaccine MVA-SARS-2-ST Against COVID-19 | https://ClinicalTrials.gov/show/NCT04895449 |
| NCT04895085 | ReSET Aim 1a: Restarting Safe Education and Testing for Children With Medical Complexity - Feasibility of In-home Cohort COVID-19 Testing Strategies, and Associations With CMC Parent Perceptions About In-person School Attendance | https://ClinicalTrials.gov/show/NCT04895085 |
| NCT04894617 | Amantadine for COVID-19 | https://ClinicalTrials.gov/show/NCT04894617 |
| NCT04894435 | Mix and Match of the Second COVID-19 Vaccine Dose for Safety and Immunogenicity | https://ClinicalTrials.gov/show/NCT04894435 |
| NCT04894409 | Evaluation of Silver Nanoparticles for the Prevention of COVID-19 | https://ClinicalTrials.gov/show/NCT04894409 |
| NCT04894227 | Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04894227 |
| NCT04893512 | First-In-Human Study Of Orally Administered CoV2-OGEN1 In Healthy Subjects | https://ClinicalTrials.gov/show/NCT04893512 |
| NCT04892979 | 3R Rehabilitation Management of COVID-19 Survivors | https://ClinicalTrials.gov/show/NCT04892979 |
| NCT04891302 | The Proof of Concept Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Mild and Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04891302 |
| NCT04892459 | Study on Sequential Immunization of Inactivated SARS-CoV-2 Vaccine and Recombinant SARS-CoV-2 Vaccine (Ad5 Vector) | https://ClinicalTrials.gov/show/NCT04892459 |
| NCT04891172 | Anti COVID 19 Hyperimmune Intravenous Immunoglobulin (C-IVIG) Therapy for Severe COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04891172 |
| NCT04890483 | tDCS in Post-Acute COVID-19 Patients With SARDs | https://ClinicalTrials.gov/show/NCT04890483 |
| NCT04890665 | Online Multi-component Psychological Intervention for Healthcare Workers During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04890665 |
| NCT04890626 | Clinical Trial to Evaluate the Efficacy of Different Treatments in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04890626 |
| NCT04890509 | A Study of Bemcentinib for the Treatment of COVID-19 in Hospitalised Patients | https://ClinicalTrials.gov/show/NCT04890509 |
| NCT04889040 | Study to Evaluate the Effects of RO7496998 (AT-527) in Non-Hospitalized Adult and Adolescent Participants With Mild or Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04889040 |
| NCT04889274 | Investigation of the Effects of Dietary Nitrate and Sex on COVID-19 Vaccine Induced Vascular Dysfunction in Healthy Men and Women (DiNOVasc-COVID-19) | https://ClinicalTrials.gov/show/NCT04889274 |
| NCT04888949 | A Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04888949 |
| NCT04887350 | SSIPP vs. PST vs. WLC | https://ClinicalTrials.gov/show/NCT04887350 |
| NCT04887129 | Testing for COVID-19 in High Risk Children With Intellectual and Developmental Disabilities (COV-IDD) | https://ClinicalTrials.gov/show/NCT04887129 |
| NCT04885907 | Third Dose of Moderna COVID-19 Vaccine in Transplant Recipients | https://ClinicalTrials.gov/show/NCT04885907 |
| NCT04885517 | Breathing Effort in Covid-19 Pneumonia: Effects of Positive Pressure, Inspired Oxygen Fraction and Decubitus | https://ClinicalTrials.gov/show/NCT04885517 |
| NCT04885491 | A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in Covid-19 Patients With aPH | https://ClinicalTrials.gov/show/NCT04885491 |
| NCT04885764 | Profiling Antibody Status and Vaccine Effectiveness in Post Vaccination With SARS CoV2 in Ain Shams University | https://ClinicalTrials.gov/show/NCT04885764 |
| NCT04885361 | To Evaluate the Safety, and Immunogenicity of Vaccine Candidate Against COVID-19, in Healthy Adults | https://ClinicalTrials.gov/show/NCT04885361 |
| NCT04885530 | ACTIV-6: COVID-19 Study of Repurposed Medications | https://ClinicalTrials.gov/show/NCT04885530 |
| NCT04884685 | Safety of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Children and Adolescents | https://ClinicalTrials.gov/show/NCT04884685 |
| NCT04884776 | Modulation of Gut Microbiota to Enhance Health and Immunity | https://ClinicalTrials.gov/show/NCT04884776 |
| NCT04884529 | Virtual Chair Yoga for Older Adults and Caregivers: Randomized Controlled Trial | https://ClinicalTrials.gov/show/NCT04884529 |
| NCT04883528 | Protecting With ARNI Against Cardiac Consequences of Coronavirus Disease 2019 | https://ClinicalTrials.gov/show/NCT04883528 |
| NCT04884295 | Dose-Finding, Safety, and Efficacy Study of XVR011 Added to Standard of Care in Patients Hospitalised for COVID-19 | https://ClinicalTrials.gov/show/NCT04884295 |
| NCT04883203 | The Effect of Vitamin D Supplementation on COVID-19 Recovery | https://ClinicalTrials.gov/show/NCT04883203 |
| NCT04883138 | Recombinant Hyperimmune Polyclonal Antibody (GIGA-2050) in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04883138 |
| NCT04881227 | The Impact of a Chatbot on COVID-19 Vaccine Perceptions and Intentions in ESPERES Cohort (ESPERES-COVID-19-CHATBOT) | https://ClinicalTrials.gov/show/NCT04881227 |
| NCT04881214 | COVID-19 Pneumonia: Pulmonary Physiology, Health-related Quality of Life and Benefit of a Rehabilitation Program | https://ClinicalTrials.gov/show/NCT04881214 |
| NCT04880694 | A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019（COVID-19）Pneumonia | https://ClinicalTrials.gov/show/NCT04880694 |
| NCT04880174 | SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel Following mRNA COVID-19 Vaccination | https://ClinicalTrials.gov/show/NCT04880174 |
| NCT04880161 | A Study to Evaluate Ampion in Patients With Prolonged Respiratory Symptoms Due to COVID-19 (Long COVID) | https://ClinicalTrials.gov/show/NCT04880161 |
| NCT04880135 | Supervised Versus Home Based Exercises Neck and Low Back Pain Among Students Due to Quarantine During COVID-19 | https://ClinicalTrials.gov/show/NCT04880135 |
| NCT04880122 | Dried Blood Spots for SARS-CoV-2 Serology (COVID-19). | https://ClinicalTrials.gov/show/NCT04880122 |
| NCT04878809 | Rapid Screening Circuit of COVID 19 in Schools, Pilot Study | https://ClinicalTrials.gov/show/NCT04878809 |
| NCT04878328 | Leveraging CHWs to Improve COVID-19 Testing and Mitigation Among CJIs Accessing a Corrections-focused CBO | https://ClinicalTrials.gov/show/NCT04878328 |
| NCT04878211 | A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab | https://ClinicalTrials.gov/show/NCT04878211 |
| NCT04878055 | Study on Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients With Severe COVID-19 Pneumonia. | https://ClinicalTrials.gov/show/NCT04878055 |
| NCT04878042 | COVID-19 Infection Control Using H2O2 Mouth Wash and Nasal Spray | https://ClinicalTrials.gov/show/NCT04878042 |
| NCT04877769 | Bronchopulmonary PK of AT-527 (R07496998) | https://ClinicalTrials.gov/show/NCT04877769 |
| NCT04876417 | tDCS for Post COVID-19 Fatigue | https://ClinicalTrials.gov/show/NCT04876417 |
| NCT04876560 | Implementation of a CDSS in Oncology Patients During COVID-19 | https://ClinicalTrials.gov/show/NCT04876560 |
| NCT04873414 | Convalescent Plasma as Adjunct Therapy for COVID-19 | https://ClinicalTrials.gov/show/NCT04873414 |
| NCT04873401 | Leveraging Social Networks to Increase COVID-19 Testing Uptake | https://ClinicalTrials.gov/show/NCT04873401 |
| NCT04873128 | Comparative Genetic and Immune Response Analysis of Different COVID-19 Vaccine Candidates Using Multi-OMICS Approach | https://ClinicalTrials.gov/show/NCT04873128 |
| NCT04872075 | Study on Prevention of SARS-CoV-2 Transmission During a Large Indoor Gathering Event | https://ClinicalTrials.gov/show/NCT04872075 |
| NCT04872712 | Comparing Press and Filiform Needle Acupuncture Effectiveness for Improving Insomnia in COVID-19 Healthcare Workers | https://ClinicalTrials.gov/show/NCT04872712 |
| NCT04872686 | Virucidal Effect of PVP-I on COVID-19 and as Well as Safety of Its Application on Nasopharynx & Oropharynx | https://ClinicalTrials.gov/show/NCT04872686 |
| NCT04871958 | Individualized, Technological Interventions for Diabetes Care in the COVID-19 Ward | https://ClinicalTrials.gov/show/NCT04871958 |
| NCT04871854 | Evaluating Tocilizumab for Sever COVID-19 Infection in Breast Cancer vs. Non Cancer Pateints | https://ClinicalTrials.gov/show/NCT04871854 |
| NCT04871828 | The Efficacy of Leukotriene Inhibitor in Adult Patients With Moderate SARS-COV-2 Symptoms (COVID19) | https://ClinicalTrials.gov/show/NCT04871828 |
| NCT04871815 | Effects of Sodium Pyruvate Nasal Spray in COVID-19 Long Haulers. | https://ClinicalTrials.gov/show/NCT04871815 |
| NCT04871737 | Study of a Live rNDV Based Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04871737 |
| NCT04871646 | Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of CKD-314 | https://ClinicalTrials.gov/show/NCT04871646 |
| NCT04871633 | Effectiveness of Remedesvir in COVID-19 Patients Presenting at Mayo Hospital Lahore | https://ClinicalTrials.gov/show/NCT04871633 |
| NCT04870723 | #SafeHandsSafeHearts: An eHealth Intervention for COVID-19 Prevention and Support | https://ClinicalTrials.gov/show/NCT04870723 |
| NCT04870606 | Proxalutamide (GT0918) Treatment for Outpatients With Mild or Moderate COVID-19 Illness | https://ClinicalTrials.gov/show/NCT04870606 |
| NCT04870593 | What Works to Get the Elderly Vaccinated Against COVID-19? Experimental Evidence From India | https://ClinicalTrials.gov/show/NCT04870593 |
| NCT04870385 | An Islamic Psychospiritual-Acceptance and Commitment-based Prevention Program for At-risk Young Adults in the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04870385 |
| NCT04870333 | PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V | https://ClinicalTrials.gov/show/NCT04870333 |
| NCT04870164 | Safety, Tolerability and PK of Ensovibep (MP0420 - a New Candidate With Potential for Treatment of COVID-19) | https://ClinicalTrials.gov/show/NCT04870164 |
| NCT04869397 | Treatment of Respiratory Complications Associated With COVID-19 Using Umbilical Cord Mesenchymal Stromal Cells | https://ClinicalTrials.gov/show/NCT04869397 |
| NCT04869358 | Exploring the Immune Response to SARS-CoV-2 COVID-19 Vaccines in Patients With Relapsing Multiple Sclerosis (RMS) Treated With Ofatumumab | https://ClinicalTrials.gov/show/NCT04869358 |
| NCT04869592 | A Clinical Trial to Evaluate the Recombinant SARS-CoV-2 Vaccine (CHO Cell) for COVID-19 | https://ClinicalTrials.gov/show/NCT04869592 |
| NCT04869072 | Convalescent Plasma Therapy - Zurich Protocol | https://ClinicalTrials.gov/show/NCT04869072 |
| NCT04867174 | COVID-19 Vaccination Take-Up | https://ClinicalTrials.gov/show/NCT04867174 |
| NCT04868903 | Low vs. Moderate to High Dose Vitamin D for Prevention of COVID-19 | https://ClinicalTrials.gov/show/NCT04868903 |
| NCT04868890 | A Study of Inhaled Ampion in Adults With Respiratory Distress Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04868890 |
| NCT04863131 | Safety and Immunogenicity of EXG-5003 | https://ClinicalTrials.gov/show/NCT04863131 |
| NCT04867265 | Mouth-to-mouth Ventilation Efficiency Through Breathable Self-sterilizing Respirator During BLS in COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04867265 |
| NCT04867226 | Effectiveness of Colchicine Among Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04867226 |
| NCT04866303 | Protecting Our Community: COVID-19 Testing | https://ClinicalTrials.gov/show/NCT04866303 |
| NCT04866069 | Study of a Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Adjuvanted Inactivated Vaccine in Healthy Adults | https://ClinicalTrials.gov/show/NCT04866069 |
| NCT04865029 | Estradiol and Progesterone in Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04865029 |
| NCT04865237 | SARS-CoV-2 Human Challenge Characterisation Study | https://ClinicalTrials.gov/show/NCT04865237 |
| NCT04864899 | Clinical Significance of Subclinical Myocardial Involvement in Recovered COVID-19 Patients Using Cardiovascular Magnetic Resonance (R-COVID-CMR) | https://ClinicalTrials.gov/show/NCT04864899 |
| NCT04864561 | Study To Compare The Immunogenicity Against COVID-19, Of VLA2001 Vaccine To AZD1222 Vaccine | https://ClinicalTrials.gov/show/NCT04864561 |
| NCT04865107 | Cellular Immuno-Therapy for COVID-19 ARDS Randomized Clinical Trial | https://ClinicalTrials.gov/show/NCT04865107 |
| NCT04864548 | COV-CHIM01: SARS-CoV-2 (COVID-19) Dose Finding Infection Study | https://ClinicalTrials.gov/show/NCT04864548 |
| NCT04863638 | A Immuno-bridging and Immunization Schedules Study of COVID-19 Vaccine (Vero Cell), Inactivated | https://ClinicalTrials.gov/show/NCT04863638 |
| NCT04864015 | COVID-19 Aerosol in EGD Using a Droplet Reduction Mouthpiece | https://ClinicalTrials.gov/show/NCT04864015 |
| NCT04861298 | Study to Investigate the Clinical Benefits of Dietary Supplement Quercetin for Managing Early COVID-19 Symptoms at Home | https://ClinicalTrials.gov/show/NCT04861298 |
| NCT04860895 | Detection of SARS-CoV-2 in Nasopharyngeal Swabs by Using Multi-Spectral Screening System | https://ClinicalTrials.gov/show/NCT04860895 |
| NCT04860739 | Vaccination With COMIRNATY in Subjects With a VAXZEVRIA First Dose | https://ClinicalTrials.gov/show/NCT04860739 |
| NCT04860284 | Hydroxychloroquine for Treatment of Non-Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04860284 |
| NCT04860518 | Human Intravenous Interferon Beta-Ia Safety and Preliminary Efficacy in Hospitalized Subjects With CoronavirUS | https://ClinicalTrials.gov/show/NCT04860518 |
| NCT04860271 | Manual Acupuncture Using Acupuncture Needle vs Press Needle for COVID-19 Healthcare Anxiety | https://ClinicalTrials.gov/show/NCT04860271 |
| NCT04860258 | A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities for COVID-19 | https://ClinicalTrials.gov/show/NCT04860258 |
| NCT04860219 | Lactoferrin Use in (SARS-CoV-2) Management | https://ClinicalTrials.gov/show/NCT04860219 |
| NCT04859244 | First-in-Human Study of Orally Administered GS-441524 for COVID-19 | https://ClinicalTrials.gov/show/NCT04859244 |
| NCT04858633 | Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19 | https://ClinicalTrials.gov/show/NCT04858633 |
| NCT04859023 | Comparison of Strategies Based on RT-PCR or Antigenic Test for the Screening of SARS-CoV-2 Infection (COVID-19). | https://ClinicalTrials.gov/show/NCT04859023 |
| NCT04858789 | The Effectiveness of a CA-CBI on Psychological Distress of University Students During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04858789 |
| NCT04854772 | Mind Body Intervention for COVID-19 Long Haul Syndrome | https://ClinicalTrials.gov/show/NCT04854772 |
| NCT04858542 | Evaluating the Impact of Vocal Health Education on Mask-wearing Workers During COVID-19 | https://ClinicalTrials.gov/show/NCT04858542 |
| NCT04858451 | COmmunity Patients at Risk of Viral Infections Including SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04858451 |
| NCT04857060 | Palliative Care Educator | https://ClinicalTrials.gov/show/NCT04857060 |
| NCT04856111 | Pirfenidone vs. Nintedanib for Fibrotic Lung Disease After Coronavirus Disease-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04856111 |
| NCT04854941 | Efficacy of Probiotics in the Treatment of Hospitalised Patients With Novel Coronavirus Infection | https://ClinicalTrials.gov/show/NCT04854941 |
| NCT04854928 | Study to Evaluate a Single Dose of LTX-109 in Subjects With COVID-19 (Coronavirus Disease 2019) Infection. | https://ClinicalTrials.gov/show/NCT04854928 |
| NCT04854798 | UNITE Study (UMN-SW) for COVID-19 | https://ClinicalTrials.gov/show/NCT04854798 |
| NCT04858412 | Study of HMB-enriched Amino Acid Supplementation in Patients With Alcoholic Liver Disease and COVID-19 | https://ClinicalTrials.gov/show/NCT04858412 |
| NCT04854759 | The Use of Amantadine in the Prevention of Progression and Treatment of COVID-19 Symptoms | https://ClinicalTrials.gov/show/NCT04854759 |
| NCT04853134 | Proxalutamide Treatment for COVID-19 Female Outpatients | https://ClinicalTrials.gov/show/NCT04853134 |
| NCT04854382 | Tailored Information About the Coronavirus in Chronic Kidney Disease Patients | https://ClinicalTrials.gov/show/NCT04854382 |
| NCT04853979 | Awake Prone Positioning in COVID-19 Suspects With Hypoxemic Respiratory Failure | https://ClinicalTrials.gov/show/NCT04853979 |
| NCT04853966 | The Effects of Physical Activity Counseling on Physical Activity and Quality of Life in Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04853966 |
| NCT04853927 | Proxalutamide Treatment for COVID-19 Patients in Intensive Care Unit | https://ClinicalTrials.gov/show/NCT04853927 |
| NCT04853901 | Remdesivir Efficacy In Management Of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04853901 |
| NCT04853199 | Quercetin In The Treatment Of SARS-COV 2 | https://ClinicalTrials.gov/show/NCT04853199 |
| NCT04852770 | Efficacy of TBCT, MBHP and PPT for PTSD During the Covid-19 Pandemics | https://ClinicalTrials.gov/show/NCT04852770 |
| NCT04851821 | The Effectiveness of Phytotherapy in SARS-COV2(COVID-19) | https://ClinicalTrials.gov/show/NCT04851821 |
| NCT04849793 | The Effect of Acupressure on the Anxiety Level | https://ClinicalTrials.gov/show/NCT04849793 |
| NCT04849637 | Virgin Coconut Oil as Adjunctive Therapy for Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04849637 |
| NCT04849598 | Automatic Oxygen Titration in Patients After SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04849598 |
| NCT04847362 | The Effect of Tele-Health Education Provided in the Postpartum Period in the Covid 19 Pandemic | https://ClinicalTrials.gov/show/NCT04847362 |
| NCT04847661 | Efficacy of Mefloquine as Prophylaxis Against COVID-19: A Placebo-control, Randomized Clinical Trial | https://ClinicalTrials.gov/show/NCT04847661 |
| NCT04847583 | A Phase 2 Study to Evaluate Biomarker Change, Efficacy, Pharmacokinetics, Safety and Tolerability of Telacebec (Q203) in Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04847583 |
| NCT04847544 | A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacodynamics for the Treatment of COVID-19. | https://ClinicalTrials.gov/show/NCT04847544 |
| NCT04847518 | Assessment of Efficacy of KAN-JANG® in Mild COVID-19 | https://ClinicalTrials.gov/show/NCT04847518 |
| NCT04847791 | Lactoferrin in Covid-19 Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04847791 |
| NCT04841707 | Total-Body Parametric 18F-FDG PET of COVID-19 | https://ClinicalTrials.gov/show/NCT04841707 |
| NCT04847479 | COVID-19 Close Contact Self-Testing Study | https://ClinicalTrials.gov/show/NCT04847479 |
| NCT04847349 | Live Microbials to Boost Anti-Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Immunity Clinical Trial | https://ClinicalTrials.gov/show/NCT04847349 |
| NCT04847141 | A Study to Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory Outpatients | https://ClinicalTrials.gov/show/NCT04847141 |
| NCT04847050 | A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy | https://ClinicalTrials.gov/show/NCT04847050 |
| NCT04846790 | The Effect of a Combined Nature-based and Virtual Mindfulness Intervention on Perceived Stress in Healthcare Workers | https://ClinicalTrials.gov/show/NCT04846790 |
| NCT04846010 | Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04846010 |
| NCT04845971 | Efficacy and Safety of Oral Immunotherapy With GcMAF in Hospitalized Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04845971 |
| NCT04845880 | SARS Cov_2 Incidence of Healthy Health Workers | https://ClinicalTrials.gov/show/NCT04845880 |
| NCT04844710 | The Effects of Acupuncture in Overcoming Inflammatory Response to COVID-19 Mild-moderate Symptoms | https://ClinicalTrials.gov/show/NCT04844710 |
| NCT04844658 | Covid-19, Hospitalized, PatIents, Nasafytol | https://ClinicalTrials.gov/show/NCT04844658 |
| NCT04844580 | A Clinical Study Evaluating Inhaled Aviptadil on COVID-19 | https://ClinicalTrials.gov/show/NCT04844580 |
| NCT04844567 | Virtual Reality Intervention to Alleviate Breathlessness (COVID-19) | https://ClinicalTrials.gov/show/NCT04844567 |
| NCT04844554 | Protocol of Assistance to Patients With Covid-19 Submitted to Treatment With HD-tDCS | https://ClinicalTrials.gov/show/NCT04844554 |
| NCT04844346 | Plant Stanol Esters and COVID-19 Vaccination Response | https://ClinicalTrials.gov/show/NCT04844346 |
| NCT04844489 | Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People | https://ClinicalTrials.gov/show/NCT04844489 |
| NCT04839315 | COVID-19 Vaccination in Rheumatic Disease Patients | https://ClinicalTrials.gov/show/NCT04839315 |
| NCT04843930 | Improving Cognitive Health in COVID-19 Survivors | https://ClinicalTrials.gov/show/NCT04843930 |
| NCT04842448 | Safety and Efficacy of Hyperbaric Oxygen Therapy for Long COVID Syndrome | https://ClinicalTrials.gov/show/NCT04842448 |
| NCT04842435 | Clinical Study in the Treatment of Patients With Moderate Course of COVID-19 | https://ClinicalTrials.gov/show/NCT04842435 |
| NCT04842331 | PREvent Viral Exposure aNd Transmission Study: a SARS-CoV-2 PEP Study (PREVENT) | https://ClinicalTrials.gov/show/NCT04842331 |
| NCT04839965 | Study of Intravenous Ampion in Adult COVID-19 Patients Requiring Supplemental Oxygen | https://ClinicalTrials.gov/show/NCT04839965 |
| NCT04844138 | Evaluating Overcoming Anxiety in Pregnancy and Postpartum as an Online Self-Directed Program | https://ClinicalTrials.gov/show/NCT04844138 |
| NCT04842734 | Comparison of the Effect of Online Physical Exercise and Computerized Cognitive Stimulation in Patients With Alzheimer’s Disease During the Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04842734 |
| NCT04842708 | Evaluation of Anti-COVID 19 Pfizer Vaccination Effect on COVID 19 Detection Using Breath Analysis | https://ClinicalTrials.gov/show/NCT04842708 |
| NCT04842292 | Nebulized Heparin for COVID19-associated Acute Respiratory Failure | https://ClinicalTrials.gov/show/NCT04842292 |
| NCT04841759 | The Effects of a Multi-factorial Rehabilitation Program for Healthcare Workers Suffering From Post-COVID-19 Fatigue Syndrome | https://ClinicalTrials.gov/show/NCT04841759 |
| NCT04841746 | Efficacy of FES Cycling After a Severe Form of COVID-19 | https://ClinicalTrials.gov/show/NCT04841746 |
| NCT04841681 | Video-based Psychotherapy for COVID-19 Patients in Isolation Ward in Jakarta | https://ClinicalTrials.gov/show/NCT04841681 |
| NCT04840992 | Phase I/II Clinical Trial of Recombinant Novel Coronavirus (COVID-19) Vaccine (Adenovirus Type 5 Vector) for Inhalation | https://ClinicalTrials.gov/show/NCT04840992 |
| NCT04840459 | Use of Monoclonal Antibodies for the Treatment of Mild to Moderate COVID-19 in Non-Hospitalized Setting | https://ClinicalTrials.gov/show/NCT04840459 |
| NCT04839146 | Safety and Tolerability of COVID-19 Vaccine (ABNCoV2) | https://ClinicalTrials.gov/show/NCT04839146 |
| NCT04838821 | Efficacy and Safety of Three Different Doses of an Anti SARS-CoV-2 Hyperimmune Equine Serum in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04838821 |
| NCT04838080 | Safety and Immunogenicity of the Inactivated Koçak-19 Inaktif Adjuvanlı COVID-19 Vaccine Compared to Placebo | https://ClinicalTrials.gov/show/NCT04838080 |
| NCT04836780 | DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04836780 |
| NCT04836351 | Rehabilitation for Patients With Persistent Symptoms Post COVID-19 | https://ClinicalTrials.gov/show/NCT04836351 |
| NCT04836260 | Preemptive Use of Convalescent Plasma for High-risk Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04836260 |
| NCT04836052 | Omega-3 Oil Use in COVID-19 Patients in Qatar | https://ClinicalTrials.gov/show/NCT04836052 |
| NCT04834856 | Viral Clearance, PK and Tolerability of Ensovibep in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04834856 |
| NCT04834908 | Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection | https://ClinicalTrials.gov/show/NCT04834908 |
| NCT04834739 | Comparison of Functional Capacities of Healthcare Workers With and Without Covid-19 | https://ClinicalTrials.gov/show/NCT04834739 |
| NCT04834726 | COVID-19 Vaccine Text Outreach | https://ClinicalTrials.gov/show/NCT04834726 |
| NCT04834115 | Efficacy of Ivermectin in Outpatients With Non-severe COVID-19 | https://ClinicalTrials.gov/show/NCT04834115 |
| NCT04833101 | Study on Heterologous Prime-boost of Recombinant COVID-19 Vaccine (Ad5 Vector) and RBD-based Protein Subunit Vaccine | https://ClinicalTrials.gov/show/NCT04833101 |
| NCT04832919 | A Nurse-Community Health Worker-Family Partnership Model: Addressing Uptake of COVID-19 Testing and Control Measures | https://ClinicalTrials.gov/show/NCT04832919 |
| NCT04830943 | Cerebrolycin for Treatment of Covid-related Anosmia and Ageusia | https://ClinicalTrials.gov/show/NCT04830943 |
| NCT04830800 | A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC | https://ClinicalTrials.gov/show/NCT04830800 |
| NCT04830761 | Behavior Change in Context to Contain the Spread of COVID-19 | https://ClinicalTrials.gov/show/NCT04830761 |
| NCT04830033 | ENO Breathe vs Usual Care in COVID-19 Recovery | https://ClinicalTrials.gov/show/NCT04830033 |
| NCT04830020 | Use of Inhaled High-molecular Weight Hyaluronan in Patients With Severe COVID19: Feasibility and Outcomes | https://ClinicalTrials.gov/show/NCT04830020 |
| NCT04828668 | Study to Evaluate Benefits & Safety of Endourage Formula Câ„¢ Oral Drops in People With Post-Acute COVID-19 Syndrome. | https://ClinicalTrials.gov/show/NCT04828668 |
| NCT04828538 | Vitamin D, Omega-3, and Combination Vitamins B, C and Zinc Supplementation for the Treatment and Prevention of COVID-19 | https://ClinicalTrials.gov/show/NCT04828538 |
| NCT04828434 | Virtual Individual Cognitive Stimulation Therapy: a Proof of Concept Study | https://ClinicalTrials.gov/show/NCT04828434 |
| NCT04828135 | Dual MRI for Cardiopulmonary COVID-19 Long Haulers | https://ClinicalTrials.gov/show/NCT04828135 |
| NCT04826822 | Spironolactone and Dexamethasone in Patients Hospitalized With COVID-19 | https://ClinicalTrials.gov/show/NCT04826822 |
| NCT04826367 | Relaxation Training by Tele-Rehabilitation in Patients With Breast Cancer | https://ClinicalTrials.gov/show/NCT04826367 |
| NCT04826588 | Randomised Evaluation of COVID-19 Therapy (RECOVERY) in Children With PIMS-TS in Switzerland (SWISSPED-RECOVERY) | https://ClinicalTrials.gov/show/NCT04826588 |
| NCT04824638 | BNT162b2 Vaccination With Two Doses in COVID-19 Negative Adult Volunteers and With a Single Dose in COVID-19 Positive Adult Volunteers | https://ClinicalTrials.gov/show/NCT04824638 |
| NCT04822025 | A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Elderly Adults | https://ClinicalTrials.gov/show/NCT04822025 |
| NCT04824443 | Exercise Therapy in Cancer Patients Who Are Recovering From COVID-19 | https://ClinicalTrials.gov/show/NCT04824443 |
| NCT04824391 | Efficacy, Immunogenicity and Safety of Inactivated ERUCOV-VAC Compared With Placebo in COVID-19 | https://ClinicalTrials.gov/show/NCT04824391 |
| NCT04824365 | Sodium Pyruvate Nasal Spray Treatment of COVID-19 and Influenza Infections | https://ClinicalTrials.gov/show/NCT04824365 |
| NCT04821674 | Study of DS-5670a (COVID-19 Vaccine) in Japanese Healthy Adults and Elderly Subjects | https://ClinicalTrials.gov/show/NCT04821674 |
| NCT04822701 | A Study to Test BI 767551 in People With Mild to Moderate Symptoms of COVID-19 | https://ClinicalTrials.gov/show/NCT04822701 |
| NCT04822285 | Effect Psychological Triaging Intervention on Students’ Psychological Distress and Resilience Capacity | https://ClinicalTrials.gov/show/NCT04822285 |
| NCT04821934 | Tele-rehabilitation Program After Hospitalization for COVID-19 | https://ClinicalTrials.gov/show/NCT04821934 |
| NCT04821999 | Diode Laser 940 nm in Management of Loss of Taste Sensation | https://ClinicalTrials.gov/show/NCT04821999 |
| NCT04821973 | Respiratory Tele Monitoring COVID 19 (TMR COVID-19) | https://ClinicalTrials.gov/show/NCT04821973 |
| NCT04820803 | Assessment of the Impact of Oral Intervention With Cetylpyridinium Chloride to Decrease SARS-CoV-2 Viral Load in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04820803 |
| NCT04821037 | Nurse Health Pilot: Feasibility and Acceptability of a Virtual ACT-intervention in Nurses During COVID-19 | https://ClinicalTrials.gov/show/NCT04821037 |
| NCT04818970 | Photo-Protection Trial (NB-UVB vs. Placebo) in High-risk Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04818970 |
| NCT04818801 | Safety, Reactogenicity and Immunogenicity Study of ReCOV | https://ClinicalTrials.gov/show/NCT04818801 |
| NCT04818489 | Colchicine and Post-COVID-19 Pulmonary Fibrosis | https://ClinicalTrials.gov/show/NCT04818489 |
| NCT04818320 | Favipiravir in High-risk COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04818320 |
| NCT04818281 | Study of a Severe Acute Respiratory Syndrome CoV-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine in Healthy Adults | https://ClinicalTrials.gov/show/NCT04818281 |
| NCT04818216 | Nicotinamide Riboside in SARS-CoV-2 (COVID-19) Patients for Renal Protection | https://ClinicalTrials.gov/show/NCT04818216 |
| NCT04816942 | Clinical Efficacy of Early Administration of Convalescent Plasma Among COVID-19 Cases in Egypt | https://ClinicalTrials.gov/show/NCT04816942 |
| NCT04816682 | Silymarin in COVID-19 Patients Admitted to Hospital With Elevated Liver Enzymes | https://ClinicalTrials.gov/show/NCT04816682 |
| NCT04816669 | Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04816669 |
| NCT04816656 | An Integrated Digital PROM-platform for Cancer Patients During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04816656 |
| NCT04816643 | A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children and Young Adults | https://ClinicalTrials.gov/show/NCT04816643 |
| NCT04817371 | Analysis of Volatile Organic Compounds in Exhaled Air and Sweat: Interest in Rapid Screening for COVID-19 Infection. | https://ClinicalTrials.gov/show/NCT04817371 |
| NCT04817332 | STOP-COVID19: Superiority Trial Of Protease Inhibition in COVID-19 | https://ClinicalTrials.gov/show/NCT04817332 |
| NCT04816084 | SERUR: COVID-19 Serological Survey of Staff From the University Reims-Champagne Ardennes | https://ClinicalTrials.gov/show/NCT04816084 |
| NCT04815096 | Imaging Immune Activation in COVID-19 | https://ClinicalTrials.gov/show/NCT04815096 |
| NCT04816019 | A Study of Intranasal ChAdOx1 nCOV-19 | https://ClinicalTrials.gov/show/NCT04816019 |
| NCT04815057 | The Effects of Wellness Training Given to Fifth Grade Students During the Covid-19 Epidemic Period | https://ClinicalTrials.gov/show/NCT04815057 |
| NCT04813575 | COVID-19 Pathophysiology of Long Term Implications | https://ClinicalTrials.gov/show/NCT04813575 |
| NCT04813497 | Monitoring of COVID-19 Seroprevalence Among GHdC Staff Members | https://ClinicalTrials.gov/show/NCT04813497 |
| NCT04813471 | Managing Endothelial Dysfunction in Critically Ill COVID-19 Patients at LAUMCRH | https://ClinicalTrials.gov/show/NCT04813471 |
| NCT04813796 | A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1283 and mRNA-1273 Vaccines in Healthy Adults Between 18 Years and 55 Years of Age to Prevent COVID-19 | https://ClinicalTrials.gov/show/NCT04813796 |
| NCT04813770 | The Impact of Theory-based Messaging on Covid-19 Vaccination Intentions | https://ClinicalTrials.gov/show/NCT04813770 |
| NCT04813718 | Post COVID-19 Syndrome and the Gut-lung Axis | https://ClinicalTrials.gov/show/NCT04813718 |
| NCT04813562 | Immunogenicity and Safety of Recombinant COVID-19 Vaccine (CHO Cells) | https://ClinicalTrials.gov/show/NCT04813562 |
| NCT04811859 | The Effect of Inspiratory Muscle Training in Post COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04811859 |
| NCT04811664 | A Study of SARS CoV-2 Infection and Potential Transmission in Individuals Immunized With Moderna COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04811664 |
| NCT04811339 | Studies of COVID-19 Patients Treated With Oral Bismuth Subsalicylate (Pepto-Bismol) | https://ClinicalTrials.gov/show/NCT04811339 |
| NCT04810949 | Vitamine D3 Supplementation in Patients With Serum Values +/- 20ng/ml | https://ClinicalTrials.gov/show/NCT04810949 |
| NCT04810728 | Efficacy of Psidii Guava’s Extract For COVID-19 | https://ClinicalTrials.gov/show/NCT04810728 |
| NCT04810689 | Pilot Trial of XFBD, a TCM, in Persons With COVID-19 | https://ClinicalTrials.gov/show/NCT04810689 |
| NCT04810637 | A Study to Evaluate the Safety and Efficacy of GX-I7 in Elderly Patients With Asymptomatic or Mild Symptoms of COVID-19 | https://ClinicalTrials.gov/show/NCT04810637 |
| NCT04809974 | Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19 Illness (Long-COVID) | https://ClinicalTrials.gov/show/NCT04809974 |
| NCT04810065 | SingStrong: Strong Lungs Through Song - Long COVID-19 Study | https://ClinicalTrials.gov/show/NCT04810065 |
| NCT04809389 | A Study to Evaluate Safety and Immunogenicity of DelNS1-nCoV-RBD LAIV for COVID-19 | https://ClinicalTrials.gov/show/NCT04809389 |
| NCT04809272 | ePLH Pilot Study: Online Support Parent Groups - ParentChat | https://ClinicalTrials.gov/show/NCT04809272 |
| NCT04808284 | Neuromodulation in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04808284 |
| NCT04808921 | Performance Evaluation of SARS-COV-2 (Covid-19) Antigen Rapid Test | https://ClinicalTrials.gov/show/NCT04808921 |
| NCT04808882 | ANTIcoagulation in Severe COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04808882 |
| NCT04805931 | VEText Message Framing and Covid-19 Vaccine Uptake Among at Risk Veterans | https://ClinicalTrials.gov/show/NCT04805931 |
| NCT04806113 | COVID-19 Vaccine in Immunosuppressed Adults With Autoimmune Diseases | https://ClinicalTrials.gov/show/NCT04806113 |
| NCT04805892 | Open Label, Single-Center Study Utilizing BIOZEK COVID-19 Antigen Rapid Test. | https://ClinicalTrials.gov/show/NCT04805892 |
| NCT04805125 | Immunocompromised Swiss Cohorts Based Trial Platform | https://ClinicalTrials.gov/show/NCT04805125 |
| NCT04805086 | The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19 | https://ClinicalTrials.gov/show/NCT04805086 |
| NCT04805684 | Different Lung Ultrasound Imaging Protocols in COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04805684 |
| NCT04805203 | Analysis of the Immune Parameters of COVID-19 Infection in Patients With Multiple Myeloma | https://ClinicalTrials.gov/show/NCT04805203 |
| NCT04803227 | Safety and Tolerability of Emricasan in Symptomatic Outpatients Diagnosed With Mild-COVID-19 | https://ClinicalTrials.gov/show/NCT04803227 |
| NCT04803812 | Supporting the Wellness of Ontario Physicians During COVID-19 | https://ClinicalTrials.gov/show/NCT04803812 |
| NCT04803409 | UNITE Study (UCSD-SW) for COVID-19 | https://ClinicalTrials.gov/show/NCT04803409 |
| NCT04803370 | Efficacy of Reinforcing Standard Therapy in COVID-19 Patients With Repeated Transfusion of Convalescent Plasma | https://ClinicalTrials.gov/show/NCT04803370 |
| NCT04802187 | Implementation of COVID-19 Testing Strategies in Community Health Centers | https://ClinicalTrials.gov/show/NCT04802187 |
| NCT04801888 | Study on Combined Vaccination With SARS-CoV-2 Inactivated Vaccine and Quadrivalent Influenza Vaccine | https://ClinicalTrials.gov/show/NCT04801888 |
| NCT04802382 | Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19 | https://ClinicalTrials.gov/show/NCT04802382 |
| NCT04802018 | Clinical Decision Support System Based on Non-invasive Tele-monitoring of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04802018 |
| NCT04801940 | HElping Alleviate the Longer-term Consequences of COVID-19 (HEAL-COVID) | https://ClinicalTrials.gov/show/NCT04801940 |
| NCT04801524 | Text-based Reminders to Promote COVID-19 Vaccinations | https://ClinicalTrials.gov/show/NCT04801524 |
| NCT04801836 | Estetrol (E4) for the Treatment of Patients With Confirmed SARS-COV-2 Infection | https://ClinicalTrials.gov/show/NCT04801836 |
| NCT04800965 | Text-based Interventions to Promote COVID-19 Vaccinations | https://ClinicalTrials.gov/show/NCT04800965 |
| NCT04800939 | The Effect of Acupressure on the Sleep Quality and Daytime Sleepiness | https://ClinicalTrials.gov/show/NCT04800939 |
| NCT04800133 | Covid-19 Vaccination in Adolescents | https://ClinicalTrials.gov/show/NCT04800133 |
| NCT04800120 | Use of Hyperbaric Oxygen Therapy to Treat COVID-19 Patients With Respiratory Distress | https://ClinicalTrials.gov/show/NCT04800120 |
| NCT04800224 | Brazilian Green Propolis Extract (EPP-AF) as an Adjunct Treatment for Hospitalized COVID-19 Patients (BeeCovid2) | https://ClinicalTrials.gov/show/NCT04800224 |
| NCT04799743 | The Anti-fibrotic Therapeutic Effects of Resveratrol for Discharged COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04799743 |
| NCT04799561 | Teleprehabilitation for Surgical Cancer Patients | https://ClinicalTrials.gov/show/NCT04799561 |
| NCT04798599 | Information and Communication Technologies (ICTS) in Dentistry for SUS | https://ClinicalTrials.gov/show/NCT04798599 |
| NCT04799392 | NOWDx Test for the Detection of Antibodies to COVID-19 in Lay Persons | https://ClinicalTrials.gov/show/NCT04799392 |
| NCT04798677 | Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 Vaccine | https://ClinicalTrials.gov/show/NCT04798677 |
| NCT04798053 | Impact of COVID-19 Pandemic and Social Distancing on Mental Health of Chronic Inflammatory Rheumatism Affected Patients | https://ClinicalTrials.gov/show/NCT04798053 |
| NCT04798027 | Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older | https://ClinicalTrials.gov/show/NCT04798027 |
| NCT04798001 | Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults | https://ClinicalTrials.gov/show/NCT04798001 |
| NCT04797936 | BNO 1030 Extract (Imupret) in the Treatment of Mild Forms of COVID-19 | https://ClinicalTrials.gov/show/NCT04797936 |
| NCT04797871 | Resistance Training and Clinical Status in Patients With Post Discharge Symptoms After Covid-19 | https://ClinicalTrials.gov/show/NCT04797871 |
| NCT04797858 | COVID-19 Self-Testing Through Rapid Network Distribution | https://ClinicalTrials.gov/show/NCT04797858 |
| NCT04796896 | A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age | https://ClinicalTrials.gov/show/NCT04796896 |
| NCT04796402 | A Study to Assess if a Medicine Called Bamlanivimab is Safe and Effective in Reducing Hospitalization Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04796402 |
| NCT04796064 | Low Versus High-Intensity Aerobic Training in Community-dwelling Older Men With Post-COVID 19 (SARS-CoV-2) Sarcopenia | https://ClinicalTrials.gov/show/NCT04796064 |
| NCT04795557 | Efficacy of Adaptogens in Patients With Long COVID-19 | https://ClinicalTrials.gov/show/NCT04795557 |
| NCT04793464 | COVID-19: Healthy Oregon (Oregon Saludable): Together We Can (Juntos Podemos) | https://ClinicalTrials.gov/show/NCT04793464 |
| NCT04794803 | Reparixin in COVID-19 Pneumonia - Efficacy and Safety | https://ClinicalTrials.gov/show/NCT04794803 |
| NCT04794400 | The Application of a Mask in Patients With Severe Covid-19 Already Treated With High-flow Nasal Cannula. | https://ClinicalTrials.gov/show/NCT04794400 |
| NCT04794374 | Effects of Telerehabilitation After Discharge in COVID-19 Survivors | https://ClinicalTrials.gov/show/NCT04794374 |
| NCT04794946 | Safety and Efficacy of a Non-replicating ChAdOx1 Vector Vaccine AZD1222 (COVISHIELD), for Prevention of COVID-19 in Patients With Liver Cirrhosis | https://ClinicalTrials.gov/show/NCT04794946 |
| NCT04794088 | Intravenous Imatinib in Mechanically Ventilated COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04794088 |
| NCT04794036 | Efficacy of an Asynchronous Telerehabilitation Programme in Post-COVID-19 Patient | https://ClinicalTrials.gov/show/NCT04794036 |
| NCT04793984 | Efficacy and Safety Evaluation of Inhaleen Inhalation in Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04793984 |
| NCT04793243 | Vitamin D3 Levels in COVID-19 Outpatients From Western Mexico | https://ClinicalTrials.gov/show/NCT04793243 |
| NCT04792567 | Exploring the Immune Response to SARS-CoV-2 modRNA Vaccines in Patients With Secondary Progressive Multiple Sclerosis (AMA-VACC) | https://ClinicalTrials.gov/show/NCT04792567 |
| NCT04792021 | Effect of N-acetylcysteine on Oxidative Stress in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04792021 |
| NCT04791241 | A Check-list Including Lung Ultrasound for ED Patients With ARF | https://ClinicalTrials.gov/show/NCT04791241 |
| NCT04791423 | Study of GRAd-COV2 for the Prevention of COVID-19 in Adults | https://ClinicalTrials.gov/show/NCT04791423 |
| NCT04790786 | UPMC OPTIMISE-C19 Trial, a COVID-19 Study | https://ClinicalTrials.gov/show/NCT04790786 |
| NCT04790240 | Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID) | https://ClinicalTrials.gov/show/NCT04790240 |
| NCT04789603 | Effects of Using Mask During the 6-minute Walking Test in Times of COVID-19 | https://ClinicalTrials.gov/show/NCT04789603 |
| NCT04789525 | Physical Training and Diet for Childhood Obesity | https://ClinicalTrials.gov/show/NCT04789525 |
| NCT04789499 | Smell in Covid-19 and Efficacy of Nasal Theophylline | https://ClinicalTrials.gov/show/NCT04789499 |
| NCT04789356 | Effectiveness of the Adsorbed Vaccine COVID-19 (Coronavac) Among Education and Public Safety Workers With Risk Factors for Severity | https://ClinicalTrials.gov/show/NCT04789356 |
| NCT04788355 | Prevention of Complications (SARS-CoV-2): Clinical Study | https://ClinicalTrials.gov/show/NCT04788355 |
| NCT04788459 | Safety and Immunogenicity of COVID-eVax, a Candidate Plasmid DNA Vaccine for COVID-19, in Healthy Adult Volunteers | https://ClinicalTrials.gov/show/NCT04788459 |
| NCT04788407 | Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19 in Household Contacts | https://ClinicalTrials.gov/show/NCT04788407 |
| NCT04787211 | A Study of Human Monoclonal Antibodies, BRII-196 and BRII-198 | https://ClinicalTrials.gov/show/NCT04787211 |
| NCT04786483 | The Effect of Laughter Therapy on Students in the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04786483 |
| NCT04786080 | Supporting Parents & Kids Through Lockdown Experiences (SPARKLE). | https://ClinicalTrials.gov/show/NCT04786080 |
| NCT04784897 | A Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19 | https://ClinicalTrials.gov/show/NCT04784897 |
| NCT04785144 | Safety and Immunogenicity Study of a SARS-CoV-2 (COVID-19) Variant Vaccine (mRNA-1273.351) in Naïve and Previously Vaccinated Adults | https://ClinicalTrials.gov/show/NCT04785144 |
| NCT04784767 | SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04784767 |
| NCT04784754 | Dose-Ranging Study to Assess the Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19 | https://ClinicalTrials.gov/show/NCT04784754 |
| NCT04785898 | Diagnostic Performance of the ID Nowâ„¢ COVID-19 Screening Test Versus Simplexaâ„¢ COVID-19 Direct Assay | https://ClinicalTrials.gov/show/NCT04785898 |
| NCT04784481 | Ivermectin Reproposing for Mild Stage COVID-19 Outpatients | https://ClinicalTrials.gov/show/NCT04784481 |
| NCT04782700 | P-Co-Li (Pulmonary Covid-19 Study) | https://ClinicalTrials.gov/show/NCT04782700 |
| NCT04780698 | DCI COVID-19 Surveillance Project | https://ClinicalTrials.gov/show/NCT04780698 |
| NCT04783025 | A Blended Gaming COVID-19 Training System (BGCTS) With WHO Guidelines for Staff in Residential Care Homes | https://ClinicalTrials.gov/show/NCT04783025 |
| NCT04783311 | Safety, Tolerance and Immunogenicity of EuCorVac-19 for the Prevention of COVID-19 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04783311 |
| NCT04780685 | A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04780685 |
| NCT04782336 | Sample Collection Study to Aid Evaluation of an Influenza A/B, Respiratory Syncytial Virus & COVID-19 Virus POC Test | https://ClinicalTrials.gov/show/NCT04782336 |
| NCT04780581 | Glucocorticoid Therapy in Coronavirus Disease COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04780581 |
| NCT04780672 | Clinical Study in the Treatment of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04780672 |
| NCT04780659 | COVID-19 Vaccination of Immunodeficient Persons (COVAXID) | https://ClinicalTrials.gov/show/NCT04780659 |
| NCT04780425 | Structured Diabetes Self-Management Education and Care Outcomes in Adults liVIng With Type 2 Diabetes in Accra, Ghana | https://ClinicalTrials.gov/show/NCT04780425 |
| NCT04780321 | JS016 (Anti-SARS-CoV-2 Monoclonal Antibody)With Mild and Moderate COVID-19 or SARS-CoV-2 Asymptomatic Infection Subects | https://ClinicalTrials.gov/show/NCT04780321 |
| NCT04780152 | TDCS in Pediatric and Teenage Patients With Major Depressive Disorder During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04780152 |
| NCT04780061 | Dietary Supplements for COVID-19 | https://ClinicalTrials.gov/show/NCT04780061 |
| NCT04780035 | Study of the Tolerability, Safety, Immunogenicity and Preventive Efficacy of the EpiVacCorona Vaccine for the Prevention of COVID-19 | https://ClinicalTrials.gov/show/NCT04780035 |
| NCT04779879 | Safety, Tolerability and Pharmacokinetics of Second Generation VIR-7831 Material in Non-hospitalized Participants With Mild to Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04779879 |
| NCT04779450 | Effect of Telemonitoring on Functionality, Quality of Life and Risk of Lymphedema in Breast Cancer Survivors | https://ClinicalTrials.gov/show/NCT04779450 |
| NCT04779827 | Improving Health Equity for COVID-19 Vaccination for At-risk Populations Using Online Social Networks | https://ClinicalTrials.gov/show/NCT04779827 |
| NCT04779047 | Comparative Therapeutic Efficacy and Safety of Different Antiviral and Anti Inflammatory Drugs in COVID-19 Patients. | https://ClinicalTrials.gov/show/NCT04779047 |
| NCT04778059 | Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04778059 |
| NCT04776941 | Expressive Writing for the Management of Stress in Cancer Survivors | https://ClinicalTrials.gov/show/NCT04776941 |
| NCT04776044 | Clinical Trial to Evaluate the Safety and Efficacy of ATR-002 in Adult Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04776044 |
| NCT04776317 | Chimpanzee Adenovirus and Self-Amplifying mRNA Prime-Boost Prophylactic Vaccines Against SARS-CoV-2 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04776317 |
| NCT04775069 | Antibody Response to COVID-19 Vaccines in Liver Disease Patients | https://ClinicalTrials.gov/show/NCT04775069 |
| NCT04773665 | Safety, Tolerability, and Immunogenicity of the COVID-19 Vaccine Candidates VBI-2902a and VBI-2905a | https://ClinicalTrials.gov/show/NCT04773665 |
| NCT04771611 | COVFIS-HOME: COVID-19 Pilot Study of Fisetin to Alleviate Dysfunction and Decrease Complications | https://ClinicalTrials.gov/show/NCT04771611 |
| NCT04771585 | Quantification of Exhaled Particles to Identify Airborne Transmission Risks of COVID-19 | https://ClinicalTrials.gov/show/NCT04771585 |
| NCT04771559 | Evaluation of the Effect and Side Effect Profile of Covid-19 Vaccine in Cancer Patients | https://ClinicalTrials.gov/show/NCT04771559 |
| NCT04771351 | Study to Evaluate a Single Dose of STI-2020 (COVI-AMGâ„¢) in Hospitalized Adults With COVID-19 | https://ClinicalTrials.gov/show/NCT04771351 |
| NCT04772859 | Evaluation of an Online Lifestyle Intervention in Mexican School Children During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04772859 |
| NCT04771013 | Safety and Efficacy of Thymic Peptides in the Treatment of Hospitalized COVID-19 Patients in Honduras | https://ClinicalTrials.gov/show/NCT04771013 |
| NCT04771000 | A Study of Micro Dose Ambrisentan in Hospitalized Patients With Respiratory Insufficiency Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04771000 |
| NCT04769999 | Computer Assisted Lessening of Intrusive Memories in the Emergency Department | https://ClinicalTrials.gov/show/NCT04769999 |
| NCT04770740 | Randomized Controlled Clinical Trial to Investigate Effects of Vitamin K2 in COVID-19 | https://ClinicalTrials.gov/show/NCT04770740 |
| NCT04769297 | Micro-Dose, Macro-Impact: Leveraging Psychedelics in Frontline Healthcare Workers During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04769297 |
| NCT04767958 | The RAPID COVID Study - Application of Point-of-Care COVID-19 Testing | https://ClinicalTrials.gov/show/NCT04767958 |
| NCT04767477 | Telerehabilitation and Face-to-face Rehabilitation on COVID-19 Survivors | https://ClinicalTrials.gov/show/NCT04767477 |
| NCT04767087 | Honey and Nigella Sativa in COVID-19 Prophylaxis | https://ClinicalTrials.gov/show/NCT04767087 |
| NCT04766931 | The Safety and Efficacy of FB2001 in Healthy Subjects and Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04766931 |
| NCT04765475 | Protecting Native Families From COVID-19 | https://ClinicalTrials.gov/show/NCT04765475 |
| NCT04765839 | Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With COVID-19 Vaccine Messages to Minority Populations | https://ClinicalTrials.gov/show/NCT04765839 |
| NCT04765449 | Transfer of Infection Fighting Immune Cells Generated in the Laboratory to High Risk Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04765449 |
| NCT04765371 | Comparison Between Prednisolone and Dexamethasone on Mortality in Patients on Oxygen Therapy, With CoViD-19 | https://ClinicalTrials.gov/show/NCT04765371 |
| NCT04765436 | PTX-COVID19-B, an mRNA Humoral Vaccine, is Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Evaluate Safety, Tolerability, and Immunogenicity of PTX-COVID19-B Vaccine in Healthy Seronegative Adults Aged 18-64 | https://ClinicalTrials.gov/show/NCT04765436 |
| NCT04764981 | Olfactory Training for Olfactory Dysfunction After Coronavirus Disease - 19 (COVID-19) | https://ClinicalTrials.gov/show/NCT04764981 |
| NCT04763681 | Couple HOPES (Helping Overcome PTSD and Enhance Satisfaction) | https://ClinicalTrials.gov/show/NCT04763681 |
| NCT04762628 | Trial Efficacy of Saisei Pharma Dietary Supplements MAF Capsules, 148 mg and M Capsules, 148 mg in Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04762628 |
| NCT04762680 | Study of Recombinant Protein Vaccines With Adjuvant as a Primary Series and as a Booster Dose Against COVID-19 in Adults 18 Years of Age and Older | https://ClinicalTrials.gov/show/NCT04762680 |
| NCT04762173 | Self-Help for Stress Related to COVID-19 | https://ClinicalTrials.gov/show/NCT04762173 |
| NCT04761874 | Telestroke at Comprehensive Stroke Center During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04761874 |
| NCT04761822 | COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations | https://ClinicalTrials.gov/show/NCT04761822 |
| NCT04760821 | Prevention of Acute Myocardial Injury by Trimetazidine in Patients Hospitalized for COVID-19 | https://ClinicalTrials.gov/show/NCT04760821 |
| NCT04760743 | Safety and Immunogenicity of a SARS-CoV-2 Vaccine (NBP2001) in Healthy Adults (COVID-19) | https://ClinicalTrials.gov/show/NCT04760743 |
| NCT04760132 | National Cohort Study of Effectiveness and Safety of SARS-CoV-2/COVID-19 Vaccines (ENFORCE) | https://ClinicalTrials.gov/show/NCT04760132 |
| NCT04760418 | Trauma and Trauma-Focused Therapy in the University of Kentucky SMART Clinic | https://ClinicalTrials.gov/show/NCT04760418 |
| NCT04758962 | A Study of the Safety of and Immune Response to Varying Doses of a Vaccine Against COVID-19 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04758962 |
| NCT04757857 | COVID-19 Antithrombotic Rivaroxaban Evaluation | https://ClinicalTrials.gov/show/NCT04757857 |
| NCT04758299 | Understanding Communications Included With COVID-19 (Corona Virus Disease of 2019) Home Testing Kits | https://ClinicalTrials.gov/show/NCT04758299 |
| NCT04758286 | Anesthetic & Surgical Protocol for Emergency Surgeries During the Era of COVID-19 | https://ClinicalTrials.gov/show/NCT04758286 |
| NCT04758273 | A Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19) | https://ClinicalTrials.gov/show/NCT04758273 |
| NCT04757818 | Double-blind, Randomized, Parallel, Placebo-controlled Clinical Study to Evaluate the Viral Load of SARS-CoV-2 (COVID-19) in the Oral Cavity of SARS-CoV-2 Positive Subjects After the Use of a Mouthwash Containing Cetylpyridinium Chloride 0,07%. | https://ClinicalTrials.gov/show/NCT04757818 |
| NCT04757298 | COVID-19 Treatment Cascade Optimization Study | https://ClinicalTrials.gov/show/NCT04757298 |
| NCT04756856 | Muscle-targeted Nutritional Therapy for the Recovery From COVID-19 | https://ClinicalTrials.gov/show/NCT04756856 |
| NCT04756830 | A Study to Assess the Safety and Immunogenicity of the Coronavac Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04756830 |
| NCT04756141 | CGM Use in COVID19 Patients (Infection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)) | https://ClinicalTrials.gov/show/NCT04756141 |
| NCT04756128 | Impact of Colchicine and Low-dose Naltrexone on COVID-19 | https://ClinicalTrials.gov/show/NCT04756128 |
| NCT04756323 | A Study to Evaluate Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19) | https://ClinicalTrials.gov/show/NCT04756323 |
| NCT04756466 | Effect of the Consumption of a Lactobacillus Strain on the Incidence of Covid-19 in the Elderly | https://ClinicalTrials.gov/show/NCT04756466 |
| NCT04755972 | Mucolytics in Patients on Invasive Mechanical Ventilation Due to Severe Acute Respiratory Syndrome Coronavirus 2 | https://ClinicalTrials.gov/show/NCT04755972 |
| NCT04753645 | BRAC Institute of Governance and Development-Hygiene Behavioural Change and Coalition | https://ClinicalTrials.gov/show/NCT04753645 |
| NCT04753619 | Effectiveness of Niclosamide as Add-on Therapy to the Standard of Care Measures in COVID-19 Management | https://ClinicalTrials.gov/show/NCT04753619 |
| NCT04754698 | COVID-19 CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDS | https://ClinicalTrials.gov/show/NCT04754698 |
| NCT04754113 | Effect of Prone Position onV/Q Matching in Non-intubated Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04754113 |
| NCT04753476 | Treatment of Severe COVID-19 Patients Using Secretome of Hypoxia-Mesenchymal Stem Cells in Indonesia | https://ClinicalTrials.gov/show/NCT04753476 |
| NCT04751474 | The Effect of Motivational Messages on Optimism, Hopelessness and Life Satisfaction | https://ClinicalTrials.gov/show/NCT04751474 |
| NCT04751682 | Safety and Immunogenicity of an Intranasal SARS-CoV-2 Vaccine (BBV154) for COVID-19 | https://ClinicalTrials.gov/show/NCT04751682 |
| NCT04751643 | Therapeutic Plasma Exchange to Alleviate Hyperinflammatory Condition During Severe Covid-19 Infections | https://ClinicalTrials.gov/show/NCT04751643 |
| NCT04751630 | Effects of COVID-19 Hospitalization on Physical Performance | https://ClinicalTrials.gov/show/NCT04751630 |
| NCT04751617 | Pulmonary Rehabilitation of Patients With a History of COVID-19 | https://ClinicalTrials.gov/show/NCT04751617 |
| NCT04751604 | Improvement of the Nutritional Status Regarding Nicotinamide (Vitamin B3) and the Disease Course of COVID-19 | https://ClinicalTrials.gov/show/NCT04751604 |
| NCT04750720 | Study of the Kinetics of COVID-19 Antibodies for 24 Months in Patients With Confirmed SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04750720 |
| NCT04750317 | Efficacy and Safety of Tofacitinib in Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04750317 |
| NCT04750278 | A Phase 2/3, Randomized, Double Blind, Placebo Controlled, Multicenter Study to Evaluate the Efficacy and Safety of FP-025 in Patients With Severe to Critical COVID 19 With Associated Acute Respiratory Distress Syndrome (ARDS) | https://ClinicalTrials.gov/show/NCT04750278 |
| NCT04750265 | Robotic Assisted Early Mobilization in Ventilated ICU Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04750265 |
| NCT04750343 | Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With or Without AS03 (COVID-19) | https://ClinicalTrials.gov/show/NCT04750343 |
| NCT04748783 | Antiviral Efficacy and Acceptability of Mouth Rinses for Inactivation of COVID-19 | https://ClinicalTrials.gov/show/NCT04748783 |
| NCT04749121 | Ultraviolet Germicidal Irradiation on the New Silicone Half-Piece Elastometric Respirators | https://ClinicalTrials.gov/show/NCT04749121 |
| NCT04748757 | Annexin A5 in Patients With Severe COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04748757 |
| NCT04747821 | An Effectiveness Study of the Sinovac’s Adsorbed COVID-19 (Inactivated) Vaccine | https://ClinicalTrials.gov/show/NCT04747821 |
| NCT04748588 | Treatment of Nosocomial COVID-19 | https://ClinicalTrials.gov/show/NCT04748588 |
| NCT04748120 | Operative vs Non-Operative Management of Acute Appendicitis and Acute Cholecystitis in COVID-19 Positive Patients | https://ClinicalTrials.gov/show/NCT04748120 |
| NCT04748536 | Safety and PK of Repeated Doses of IRL201104 in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT04748536 |
| NCT04747756 | Creating a Virtual Village for People Aging With HIV During COVID-19 | https://ClinicalTrials.gov/show/NCT04747756 |
| NCT04747574 | Evaluation of the Safety of CD24-Exosomes in Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04747574 |
| NCT04747249 | Psychological Care of Oncology Patients With Post-traumatic Stress in the Context of a COVID-19 | https://ClinicalTrials.gov/show/NCT04747249 |
| NCT04747158 | COVID-19 Convalescent Plasma Therapy | https://ClinicalTrials.gov/show/NCT04747158 |
| NCT04747132 | Effectiveness of a Telegeriatric Intervention in Older Adults During the Covid-19 Contingency | https://ClinicalTrials.gov/show/NCT04747132 |
| NCT04746183 | AGILE (Early Phase Platform Trial for COVID-19) | https://ClinicalTrials.gov/show/NCT04746183 |
| NCT04746430 | COVID-19 Primary Care Platform for Early Treatment and Recovery (COPPER) Study | https://ClinicalTrials.gov/show/NCT04746430 |
| NCT04746365 | Ivermectin Role in Covid-19 Clinical Trial | https://ClinicalTrials.gov/show/NCT04746365 |
| NCT04746339 | Apixaban for PrOphyLaxis of thromboemboLic Outcomes in COVID-19 | https://ClinicalTrials.gov/show/NCT04746339 |
| NCT04745442 | Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04745442 |
| NCT04743401 | Feasibility of a Tele-game-based Exercise (Tele-exergame) Program to Prevent Deconditioning in Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04743401 |
| NCT04743349 | Steam Inhalations in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04743349 |
| NCT04743232 | COVID-19 Resuscitation Plans and Decisions on Escalation and Limitation of Treatment | https://ClinicalTrials.gov/show/NCT04743232 |
| NCT04742738 | Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With Aluminum Hydroxide (COVID-19) | https://ClinicalTrials.gov/show/NCT04742738 |
| NCT04743011 | Enriched Heparin Anti COVID-19 Trial | https://ClinicalTrials.gov/show/NCT04743011 |
| NCT04742725 | A Study to Evaluate the Efficacy and Safety of Prothioneâ„¢ Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04742725 |
| NCT04742595 | Viral Specific T Cell Therapy for COVID-19 Related Pneumonia | https://ClinicalTrials.gov/show/NCT04742595 |
| NCT04739020 | Respiratory Aerosols in Patients With COVID-19 and Healthy Controls | https://ClinicalTrials.gov/show/NCT04739020 |
| NCT04739462 | SMS Maama Project COVID-19 | https://ClinicalTrials.gov/show/NCT04739462 |
| NCT04739410 | Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04739410 |
| NCT04738045 | Comparison of Remdesivir Versus Lopinavir/ Ritonavir and Remdesivir Combination in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04738045 |
| NCT04734561 | Effects of Respiratory Muscle Training in People Who Have Had COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04734561 |
| NCT04734912 | Evaluation of Transnasal Endoscopy During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04734912 |
| NCT04734886 | The Effect of Probiotic Supplementation on SARS-CoV-2 Antibody Response After COVID-19 | https://ClinicalTrials.gov/show/NCT04734886 |
| NCT04734873 | CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04734873 |
| NCT04734860 | Study to Evaluate a Single Dose of STI-2020 (COVI-AMGâ„¢) in Adults With Mild COVID-19 Symptoms | https://ClinicalTrials.gov/show/NCT04734860 |
| NCT04734717 | Coordination and Locomotor Problems in Patients With Covid-19 Virus | https://ClinicalTrials.gov/show/NCT04734717 |
| NCT04734171 | Social Activity, Loneliness and Stigma During COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04734171 |
| NCT04733833 | A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04733833 |
| NCT04733625 | The Effect of Vitamin D Therapy on Morbidity and Moratlity in Patients With SARS-CoV 2 Infection | https://ClinicalTrials.gov/show/NCT04733625 |
| NCT04732949 | Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19 | https://ClinicalTrials.gov/show/NCT04732949 |
| NCT04732819 | Improving COVID-19 Vaccine Uptake in Nursing Homes | https://ClinicalTrials.gov/show/NCT04732819 |
| NCT04732468 | COVID-19 Oral and Subcutaneous Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenovirus Platform in Healthy Volunteers in USA | https://ClinicalTrials.gov/show/NCT04732468 |
| NCT04730661 | Efficacy of the Sit to Stand Test in the Decision to Hospitalize a Patient Consulting the Emergency Dept for COVID 19 | https://ClinicalTrials.gov/show/NCT04730661 |
| NCT04731116 | Cannabidiol Treatment for Severe and Critical Coronavirus (COVID-19) Pulmonary Infection | https://ClinicalTrials.gov/show/NCT04731116 |
| NCT04730856 | Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID) | https://ClinicalTrials.gov/show/NCT04730856 |
| NCT04729595 | Study to Evaluate the Effects of Tempol (MBM-02) in COVID-19 Patients. | https://ClinicalTrials.gov/show/NCT04729595 |
| NCT04730427 | Safety and Preliminary Efficacy Study of GX-I7 in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04730427 |
| NCT04730401 | Convalescent Plasma in the Treatment of Covid-19 | https://ClinicalTrials.gov/show/NCT04730401 |
| NCT04730323 | TOCILIZUMAB - An Option for Patients With COVID-19 Associated Cytokine Release Syndrome; A Single Center Experience | https://ClinicalTrials.gov/show/NCT04730323 |
| NCT04730284 | Evaluation of a Synbiotic Formula in Patient With COVID-19 | https://ClinicalTrials.gov/show/NCT04730284 |
| NCT04730206 | The DAWN Camostat Trial for Ambulatory COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04730206 |
| NCT04729140 | An Outpatient Clinical Trial Using Ivermectin and Doxycycline in COVID-19 Positive Patients at High Risk to Prevent COVID-19 Related Hospitalization | https://ClinicalTrials.gov/show/NCT04729140 |
| NCT04724720 | Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19 | https://ClinicalTrials.gov/show/NCT04724720 |
| NCT04728594 | Emails Promoting COVID-19 Vaccination Among Healthcare Workers | https://ClinicalTrials.gov/show/NCT04728594 |
| NCT04726163 | Tele-expertise in Patients With Diabetes Hospitalized for Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04726163 |
| NCT04726111 | COVID-19 and Pregnancy: Placental and Immunological Impacts | https://ClinicalTrials.gov/show/NCT04726111 |
| NCT04728802 | Proxalutamide Treatment for Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04728802 |
| NCT04727424 | Repurposed Approved and Under Development Therapies for Patients With Early-Onset COVID-19 and Mild Symptoms | https://ClinicalTrials.gov/show/NCT04727424 |
| NCT04726371 | Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings | https://ClinicalTrials.gov/show/NCT04726371 |
| NCT04724616 | CARTOON: CoronAviRus (COVID-19) educaTional prOgram fOr childreN | https://ClinicalTrials.gov/show/NCT04724616 |
| NCT04724681 | Continuous Wireless Monitoring of Vital Signs and Automated Alerts of Patient Deterioration in Patients Admitted With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04724681 |
| NCT04724538 | Inhalation Low Dose Radionuclide Therapy in Treatment COVID-19 | https://ClinicalTrials.gov/show/NCT04724538 |
| NCT04724629 | Survival TRial Using CytoKines in COVID-19 (STRUCK Trial) | https://ClinicalTrials.gov/show/NCT04724629 |
| NCT04723576 | Mental and Physical Well-Being of Frontline Health Care Workers During Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04723576 |
| NCT04723446 | Efficacy of Mouthwashes in Reducing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Saliva | https://ClinicalTrials.gov/show/NCT04723446 |
| NCT04723394 | Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults | https://ClinicalTrials.gov/show/NCT04723394 |
| NCT04723563 | Nebulized Heparin for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04723563 |
| NCT04723550 | COVID-19 Lockdown Related Telemedicine for Type 2 Diabetes | https://ClinicalTrials.gov/show/NCT04723550 |
| NCT04723537 | Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04723537 |
| NCT04723524 | Jinhua Qinggan Granules in the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04723524 |
| NCT04723459 | Efficacy of Nano-Ivermectin Impregnated Masks in Prevention of Covid-19 Among Healthy Contacts and Medical Staff | https://ClinicalTrials.gov/show/NCT04723459 |
| NCT04723290 | COVID-19 Seroconversion Study Among GHdC Staff Members - Summer 2020 | https://ClinicalTrials.gov/show/NCT04723290 |
| NCT04721236 | Early Use of Hyperimmune Plasma in COVID-19 | https://ClinicalTrials.gov/show/NCT04721236 |
| NCT04720404 | Mindful Prevention of Psychopathology in Healthcare Workers During the COVID-19 Crisis (COVID-19 MindPreP) | https://ClinicalTrials.gov/show/NCT04720404 |
| NCT04720378 | Safety and Tolerability Study of IV ST266 in COVID-19 Subjects | https://ClinicalTrials.gov/show/NCT04720378 |
| NCT04720235 | A Follow On Community Testing Study To Evaluate The Performance of the Lucira COVID-19 All-In-One Test Kit | https://ClinicalTrials.gov/show/NCT04720235 |
| NCT04719234 | Lung Ultrasonography in COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04719234 |
| NCT04719208 | [COVID-19] Reduction of Sars-CoV-2 Oral Viral Load With Prophylactic Mouth Rinse | https://ClinicalTrials.gov/show/NCT04719208 |
| NCT04718506 | Rehabilitation for Post-COVID-19 Syndrome Through a Supervised Exercise Intervention | https://ClinicalTrials.gov/show/NCT04718506 |
| NCT04718480 | Fluvoxamine Administration in Moderate SARS-CoV-2 (COVID-19) Infected Patients | https://ClinicalTrials.gov/show/NCT04718480 |
| NCT04718220 | Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19 | https://ClinicalTrials.gov/show/NCT04718220 |
| NCT04715997 | Safety and Immunogenicity Study of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Adults | https://ClinicalTrials.gov/show/NCT04715997 |
| NCT04715932 | Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN) | https://ClinicalTrials.gov/show/NCT04715932 |
| NCT04715438 | Vaccination Against COVID-19 in Cancer | https://ClinicalTrials.gov/show/NCT04715438 |
| NCT04715360 | Management of Cytokine Storms in Severe COVID-19 Patients With Autologous Activated Platelet-rich Plasma Therapy | https://ClinicalTrials.gov/show/NCT04715360 |
| NCT04721457 | The Efficacy of Pre-procedural Mouth Rinses on COVID-19 Saliva Viral Load | https://ClinicalTrials.gov/show/NCT04721457 |
| NCT04720794 | A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit vs Hologic Panther Fusion | https://ClinicalTrials.gov/show/NCT04720794 |
| NCT04716998 | Safety and the Efficacy of MesenCure for the Treatment of Pulmonary Manifestations of COVID-19 | https://ClinicalTrials.gov/show/NCT04716998 |
| NCT04716647 | Feasibility of Ayurveda in Patients With Mild-to-Moderate COVID-19: A Community-Based Participatory Research | https://ClinicalTrials.gov/show/NCT04716647 |
| NCT04716569 | Evaluation of Ivermectin Mucoadhesive Nanosuspension as Nasal Spray in Management of Early Covid-19 | https://ClinicalTrials.gov/show/NCT04716569 |
| NCT04716556 | TranSfUsion of coNvalescent plAsma for the Early Treatment of pneuMonIa in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04716556 |
| NCT04716426 | APTâ„¢ T3X on the COVID-19 Contamination Rate | https://ClinicalTrials.gov/show/NCT04716426 |
| NCT04716179 | Prospective Two-arm Study of Fertility in Men With COVID-19 | https://ClinicalTrials.gov/show/NCT04716179 |
| NCT04715607 | COVID-19: SARS-CoV-2 Detection in Saliva, Oropharyngeal and Nasopharyngeal Specimens | https://ClinicalTrials.gov/show/NCT04715607 |
| NCT04715295 | Safety and Efficacy of Doxycycline and Rivaroxaban in COVID-19 | https://ClinicalTrials.gov/show/NCT04715295 |
| NCT04715763 | INvestigating TELmisartin Study | https://ClinicalTrials.gov/show/NCT04715763 |
| NCT04715243 | Comparison of High Flow Nasal Cannula (HFNC), Face-mask Non-Invasive Ventilation (NIV) & Helmet NIV in COVID-19 ARDS Patients | https://ClinicalTrials.gov/show/NCT04715243 |
| NCT04713878 | Mesenchymal Stem Cells Therapy in Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04713878 |
| NCT04713111 | Stress and Recovery in Frontline COVID-19 Workers | https://ClinicalTrials.gov/show/NCT04713111 |
| NCT04713553 | A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants | https://ClinicalTrials.gov/show/NCT04713553 |
| NCT04713488 | An Open Study on the Safety, Tolerability, and Immunogenicity of “Sputnik Light” Vaccine | https://ClinicalTrials.gov/show/NCT04713488 |
| NCT04713176 | Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04713176 |
| NCT04712357 | Clinical Experimentation With Tenofovir Disoproxyl Fumarate and Emtricitabine for COVID-19 | https://ClinicalTrials.gov/show/NCT04712357 |
| NCT04712110 | A Study of TAK-019 in Healthy Japanese Adults (COVID-19) | https://ClinicalTrials.gov/show/NCT04712110 |
| NCT04712045 | Rational Use of Personal Protective Equipment During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04712045 |
| NCT04712344 | Assessment of Efficacy and Safety of Therapy With COVID-19 Convalescent Plasma in Subjects With Severe COVID-19 (IPCO) | https://ClinicalTrials.gov/show/NCT04712344 |
| NCT04710394 | Visual-OLfactory Training in Participants With COVID-19 Resultant Loss of Smell | https://ClinicalTrials.gov/show/NCT04710394 |
| NCT04710381 | IMUNOR® Preparation in the Prevention of COVID-19 | https://ClinicalTrials.gov/show/NCT04710381 |
| NCT04710316 | Study of COVID-19 Outbreak in Hospital Departments of Bamako, Mali | https://ClinicalTrials.gov/show/NCT04710316 |
| NCT04710303 | COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral Platform in Healthy South African Adults | https://ClinicalTrials.gov/show/NCT04710303 |
| NCT04709835 | Study to Evaluate the Effects of AT-527 in Non-Hospitalized Adult Patients With Mild or Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04709835 |
| NCT04709172 | Pilot Study of Cefditoren Pivoxil in COVID-19 Patients With Mild to Moderate Pneumonia | https://ClinicalTrials.gov/show/NCT04709172 |
| NCT04708340 | Tolerability and Efficacy of RJX in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04708340 |
| NCT04707742 | Antiseptic Mouth Rinses to Reduce Salivary Viral Load in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04707742 |
| NCT04707833 | Evaluation of Serological Techniques for Screening for COVID-19 Infection at the University Hospital of Rouen | https://ClinicalTrials.gov/show/NCT04707833 |
| NCT04707820 | Antiviral T Lymphocyte Immunity During Acute COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04707820 |
| NCT04707703 | Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis | https://ClinicalTrials.gov/show/NCT04707703 |
| NCT04707534 | Dexamethasone for COVID-19 | https://ClinicalTrials.gov/show/NCT04707534 |
| NCT04706039 | Rapid Diagnosis of COVID-19 by Chemical Analysis of Exhaled Air | https://ClinicalTrials.gov/show/NCT04706039 |
| NCT04706416 | N-Acetyl Glucosamine as Therapeutic Intervention for Coronavirus Disease-19 (COVID-19) | https://ClinicalTrials.gov/show/NCT04706416 |
| NCT04706403 | Views on COVID-19 and Vaccination | https://ClinicalTrials.gov/show/NCT04706403 |
| NCT04705753 | Assessment of the Clinical Effectiveness of a Herbal Extract (Cretan IAMA) in Patients With Viral Respiratory Infections, Including COVID-19, in Primary Healthcare Settings, and Co-assessment of Its Prophylactic Effect in People Cohabiting With These Patients | https://ClinicalTrials.gov/show/NCT04705753 |
| NCT04705831 | Study to Evaluate the Benefit of RUCONEST in Improving Neurological Symptoms in Post COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04705831 |
| NCT04705597 | Study to Evaluate the Safety, Tolerability, and Efficacy of BGE-175 in Hospitalized Adults With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure | https://ClinicalTrials.gov/show/NCT04705597 |
| NCT04703907 | Auricular Stimulation for Relief of Stress and Anxiety | https://ClinicalTrials.gov/show/NCT04703907 |
| NCT04704063 | Efficacy and Safety of Tocovid Suprabio 200mg in Non-alcoholic Fatty Liver (NAFL) | https://ClinicalTrials.gov/show/NCT04704063 |
| NCT04703608 | Prevention and Treatment for COVID -19 (Severe Acute Respiratory Syndrome Coronavirus 2 SARS-CoV-2) Associated Severe Pneumonia in the Gambia | https://ClinicalTrials.gov/show/NCT04703608 |
| NCT04703140 | COVIDISC: Rapid Diagnostic Tests on Nasopharyngeal Swabs for the Detection of COVID-19 | https://ClinicalTrials.gov/show/NCT04703140 |
| NCT04703114 | Study of the Immunological and Virological Response of Patients With COVID-19 and Presenting an Asymptomatic or Pauci-symptomatic Form (AMBUCOV) | https://ClinicalTrials.gov/show/NCT04703114 |
| NCT04701710 | Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan | https://ClinicalTrials.gov/show/NCT04701710 |
| NCT04703036 | Glutathione, Oxidative Stress and Mitochondrial Function in COVID-19 | https://ClinicalTrials.gov/show/NCT04703036 |
| NCT04701606 | The Safety and Efficacy of Pyronaridine-artesunate (Pyramax® or Artecom®)in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04701606 |
| NCT04701658 | A Real World Study of Bamlanivimab in Participants With Mild-to-moderate Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04701658 |
| NCT04701528 | Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant Recipients | https://ClinicalTrials.gov/show/NCT04701528 |
| NCT04701489 | UNITE Study (UMN-GE) for COVID-19 | https://ClinicalTrials.gov/show/NCT04701489 |
| NCT04700137 | Mental Health Among Patients, Providers, and Staff During the COVID-19 Era | https://ClinicalTrials.gov/show/NCT04700137 |
| NCT04700462 | COVID-19 Preventive Behavior in African Americans | https://ClinicalTrials.gov/show/NCT04700462 |
| NCT04699916 | EEG-based Sedation Protocol for Patients on Mechanical Ventilation Due to SARS-CoV-2 Pneumonia | https://ClinicalTrials.gov/show/NCT04699916 |
| NCT04700163 | RU Anti-SARS-CoV-2 (COVID-19) mAbs in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT04700163 |
| NCT04699851 | Optimization of the Management of COVID-19 Through Tailored Recommendations to the Citizens | https://ClinicalTrials.gov/show/NCT04699851 |
| NCT04699227 | Can RIC Prevent Deterioration to Critical Care in Covid19 | https://ClinicalTrials.gov/show/NCT04699227 |
| NCT04698993 | Dräger COVID-19 Antigen Test Clinical Performance Study | https://ClinicalTrials.gov/show/NCT04698993 |
| NCT04698798 | Skeletal Muscle Wasting in SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04698798 |
| NCT04695743 | Group CST Using Zoom: A Proof of Concept Study | https://ClinicalTrials.gov/show/NCT04695743 |
| NCT04695652 | A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult | https://ClinicalTrials.gov/show/NCT04695652 |
| NCT04695301 | Functional Outcomes in COVID-19 Survivors and Use of a Digital Platform for Rehabilitation | https://ClinicalTrials.gov/show/NCT04695301 |
| NCT04695197 | Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso | https://ClinicalTrials.gov/show/NCT04695197 |
| NCT04694638 | Use of Combined Prone Positioning and High-Flow Nasal Cannula, and Non-invasive Positive Pressure Ventilation to Prevent Intubation in COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04694638 |
| NCT04694612 | Efficacy of Favipiravir in Treatment of Mild & Moderate COVID-19 Infection in Nepal | https://ClinicalTrials.gov/show/NCT04694612 |
| NCT04693026 | Efficacy of Ramdicivir and Baricitinib for the Treatment of Severe COVID 19 Patients | https://ClinicalTrials.gov/show/NCT04693026 |
| NCT04691947 | Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VAC | https://ClinicalTrials.gov/show/NCT04691947 |
| NCT04691908 | Immunogenicity, Efficacy and Safety of QazCovid-in® COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04691908 |
| NCT04690920 | Theranostic Implication of Complementary Medicines Against Interleukin Receptors and Gp-130 Proteins | https://ClinicalTrials.gov/show/NCT04690920 |
| NCT04690413 | NOWDx Test for the Detection of Antibodies to COVID-19 | https://ClinicalTrials.gov/show/NCT04690413 |
| NCT04690387 | Dendritic Cell Vaccine, AV-COVID-19, to Prevent COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04690387 |
| NCT04689542 | Surgical Face Mask Effects in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04689542 |
| NCT04689399 | Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Test Compared to RT-PCR Test | https://ClinicalTrials.gov/show/NCT04689399 |
| NCT04687488 | Aerosol and Droplet Dispersion During Gastrointestinal Motility Investigations | https://ClinicalTrials.gov/show/NCT04687488 |
| NCT04686760 | Efficacy of Inhaled Nitroglycerin in Moderate to Critically Ill COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04686760 |
| NCT04685681 | The Get Outside Study | https://ClinicalTrials.gov/show/NCT04685681 |
| NCT04686539 | Synthetic CBD as a Therapy for COVID-19 | https://ClinicalTrials.gov/show/NCT04686539 |
| NCT04685655 | RescuE pLAsma eXchange in Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04685655 |
| NCT04685603 | Dendritic Cell Vaccine to Prevent COVID-19 | https://ClinicalTrials.gov/show/NCT04685603 |
| NCT04685213 | Electrical Stimulation for Critically Ill Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04685213 |
| NCT04685512 | Effect of Tenofovir/Emtricitabine in Patients Recently Infected With SARS-COV2 (Covid-19) Discharged Home | https://ClinicalTrials.gov/show/NCT04685512 |
| NCT04685447 | Effects of Different Dialysis Strategies on Inflammation in COVID-19 Maintenance Hemodialysis Patients | https://ClinicalTrials.gov/show/NCT04685447 |
| NCT04682574 | Role of Mega Dose of Vitamin C in Critical COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04682574 |
| NCT04684446 | Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime-Boost Regimen for the Prevention of COVID-19 | https://ClinicalTrials.gov/show/NCT04684446 |
| NCT04682873 | A Clinical Study to Assess the Efficacy and Safety of Amizon® Max in the Treatment of Moderate Covid-19 | https://ClinicalTrials.gov/show/NCT04682873 |
| NCT04682041 | Evaluating the Impact of EnteraGam In People With COVID-19 | https://ClinicalTrials.gov/show/NCT04682041 |
| NCT04680858 | Impact of Digital Communication Assist Tools in Endoscopic Team Communication During COVID-19 | https://ClinicalTrials.gov/show/NCT04680858 |
| NCT04681430 | Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals | https://ClinicalTrials.gov/show/NCT04681430 |
| NCT04681859 | Evaluation of a Low-cost CPAP Device on Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04681859 |
| NCT04681092 | Anti-COVID19 AKS-452 - ACT Study | https://ClinicalTrials.gov/show/NCT04681092 |
| NCT04681001 | Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers | https://ClinicalTrials.gov/show/NCT04681001 |
| NCT04681053 | Inhaled Ivermectin and COVID-19 | https://ClinicalTrials.gov/show/NCT04681053 |
| NCT04680949 | suPAR-Guided Anakinra Treatment for Management of Severe Respiratory Failure by COVID-19 | https://ClinicalTrials.gov/show/NCT04680949 |
| NCT04679909 | Safety and Immunogenicity of AdCOVID in Healthy Adults (COVID-19 Vaccine Study) | https://ClinicalTrials.gov/show/NCT04679909 |
| NCT04679493 | Study to Assess Safety, Tolerability and Pharmacokinetics of XC7 (Which is Planned Use in the Treatment of COVID-19) in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT04679493 |
| NCT04679415 | Efficacy and Safety of hzVSF-v13 in Moderate to Severe Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04679415 |
| NCT04678739 | Efficacy and Safety of Remdesivir and Tociluzumab for the Management of Severe COVID-19: A Randomized Controlled Trial | https://ClinicalTrials.gov/show/NCT04678739 |
| NCT04679350 | Efficacy and Safety of hzVSFv13 in Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04679350 |
| NCT04678700 | Implementation of a Respiratory Physiotherapy Program in Post COVID-19 Patients Through Tele-assistance | https://ClinicalTrials.gov/show/NCT04678700 |
| NCT04678843 | Adapting and Adopting Highly Specialized Pediatric Eating Disorder Treatment to Virtual Care: Implementation Research for the COVID-19 Context and Beyond | https://ClinicalTrials.gov/show/NCT04678843 |
| NCT04678830 | COVID-19 Long-Haulers Study | https://ClinicalTrials.gov/show/NCT04678830 |
| NCT04678687 | COVID-19 and Tissue Damage in Vital Organs | https://ClinicalTrials.gov/show/NCT04678687 |
| NCT04678778 | Virtual Reality Study - COVID-19 Protocol | https://ClinicalTrials.gov/show/NCT04678778 |
| NCT04677660 | A Study of TAK-919 in Healthy Japanese Adults (COVID-19) | https://ClinicalTrials.gov/show/NCT04677660 |
| NCT04677270 | Evaluation of Two Versions of a Digital Problem Solving Tool for the General Public Specific for the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04677270 |
| NCT04676867 | Effect of Dalcetrapib in Patients With Confirmed Mild to Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04676867 |
| NCT04676971 | Efficacy and Safety of hzVSF-v13 in Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04676971 |
| NCT04674644 | Analysing the Psychosocial Effects of COVID-19 Pandemic on Dental Professionals Using the Turkish Version of the Fear of COVID-19 and Coronavirus Anxiety Scales | https://ClinicalTrials.gov/show/NCT04674644 |
| NCT04674566 | Evaluation of Safety and Tolerability of COR-101 in Hospitalized Patients With Moderate to Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04674566 |
| NCT04674189 | A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19 | https://ClinicalTrials.gov/show/NCT04674189 |
| NCT04673318 | Physical Rehabilitation of COVID-19 Survivors by Heat Therapy | https://ClinicalTrials.gov/show/NCT04673318 |
| NCT04673292 | Community Collaboration to Combat COVID-19 (C-FORWARD) | https://ClinicalTrials.gov/show/NCT04673292 |
| NCT04673214 | Evaluation of Prognostic Modification in COVID-19 Patients in Early Intervention Treatment | https://ClinicalTrials.gov/show/NCT04673214 |
| NCT04673149 | GLS-5310 Vaccine for the Prevention of SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04673149 |
| NCT04672291 | Nasal Poly-ICLC (Hiltonol®) in Healthy COVID-19 Vaccinated Adults | https://ClinicalTrials.gov/show/NCT04672291 |
| NCT04672564 | Study to Evaluate Safety and Efficacy of Carrimycin for Treatment of Severe Coronavirus Disease 2019 (COVID-19) in Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04672564 |
| NCT04671017 | Dose Finding Study to Evaluate Safety, Tolerability and Immunogenicity of an Inactiviated Adjuvanted Sars-Cov-2 Virus Vaccine Candidate Against Covid-19 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04671017 |
| NCT04669015 | Phase 3 Inhaled Novaferon Study in Hospitalized Patients With Moderate to Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04669015 |
| NCT04668950 | Fluvoxamine for Early Treatment of Covid-19 (Stop Covid 2) | https://ClinicalTrials.gov/show/NCT04668950 |
| NCT04668625 | Risk of Infection of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), COVID-19, in a Massive Musical Show With Transmission Prevention Measures | https://ClinicalTrials.gov/show/NCT04668625 |
| NCT04668339 | A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04668339 |
| NCT04668235 | Study on Safety and Clinical Efficacy of AZVUDINE in COVID-19 Patients (SARS-CoV-2 Infected) | https://ClinicalTrials.gov/show/NCT04668235 |
| NCT04668209 | Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04668209 |
| NCT04668469 | Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04668469 |
| NCT04667286 | Awake Pronation for Covid-19 Treatment | https://ClinicalTrials.gov/show/NCT04667286 |
| NCT04667780 | Study to Investigate the Treatment Effect of Colchicine in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04667780 |
| NCT04667247 | Mushroom-based Product for COVID-19 | https://ClinicalTrials.gov/show/NCT04667247 |
| NCT04666558 | Heal-Me Personalized Online Nutrition and Exercise Routines | https://ClinicalTrials.gov/show/NCT04666558 |
| NCT04666441 | COVID-19 Study Assessing the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Adult Outpatients With SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04666441 |
| NCT04666493 | Adapting Anxiety Intervention for Youth With Autism for Rapid Response to COVID-19 | https://ClinicalTrials.gov/show/NCT04666493 |
| NCT04666233 | Personal Protective Equipment for the Prevention of SARS-Cov-2 During Neonatal Resuscitation | https://ClinicalTrials.gov/show/NCT04666233 |
| NCT04666116 | Changes in Viral Load in COVID-19 After Probiotics | https://ClinicalTrials.gov/show/NCT04666116 |
| NCT04666012 | Safety and Immunogenicity Study of AdCLD-CoV19: A COVID-19 Preventive Vaccine in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT04666012 |
| NCT04665193 | An Approach to Screening for COVID-19 at Vancouver Airport | https://ClinicalTrials.gov/show/NCT04665193 |
| NCT04663737 | Evaluating Safety, Pharmacokinetics and Clinical Benefit of Silmitasertib (CX-4945) in Subjects With Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04663737 |
| NCT04663594 | Online Culture for Mental Health in People Aged 16-24 | https://ClinicalTrials.gov/show/NCT04663594 |
| NCT04664010 | Efficacy and Safety of High-dose Vitamin C Combined With Chinese Medicine Against Coronavirus Pneumonia (COVID-19) | https://ClinicalTrials.gov/show/NCT04664010 |
| NCT04663945 | Predictors of Recovery and the App-Facilitated Tele-Rehabilitation (AFTER) Program for COVID-19 Survivors | https://ClinicalTrials.gov/show/NCT04663945 |
| NCT04663555 | Effect of Two Different Doses of Dexamethasone in Patients With ARDS and COVID-19 | https://ClinicalTrials.gov/show/NCT04663555 |
| NCT04662684 | Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trial | https://ClinicalTrials.gov/show/NCT04662684 |
| NCT04662671 | Phase I/II Randomized, Dose Escalation Study to Evaluate the Safety and Antiviral Activity of the RD-X19 Device in SARS-CoV-2 Infected Individuals With Uncomplicated COVID-19 | https://ClinicalTrials.gov/show/NCT04662671 |
| NCT04661813 | Assess and Adapt to the Impact of COVID-19 on CVD Self-Management and Prevention Care in Adults Living With HIV | https://ClinicalTrials.gov/show/NCT04661813 |
| NCT04662060 | COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Acebilustat Sub-Protocol | https://ClinicalTrials.gov/show/NCT04662060 |
| NCT04662021 | Aerobic Training Versus Cognitive Behavioral Therapy in Management of Anxiety | https://ClinicalTrials.gov/show/NCT04662021 |
| NCT04661930 | Fenofibrate for Patients With COVID-19 Requiring Hospitalization | https://ClinicalTrials.gov/show/NCT04661930 |
| NCT04661839 | A COVID-19 Study to Evaluate Safety and Pharmacokinetics of COVID-HIGIV Administered in Healthy Adults | https://ClinicalTrials.gov/show/NCT04661839 |
| NCT04661410 | Reward Re-Training: A New Treatment to Address Reward Imbalance During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04661410 |
| NCT04662086 | COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol | https://ClinicalTrials.gov/show/NCT04662086 |
| NCT04662073 | COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Camostat Sub-Protocol | https://ClinicalTrials.gov/show/NCT04662073 |
| NCT04661540 | A Study of Auxora in Patients With Critical COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04661540 |
| NCT04661527 | Sarilumab Treatment In cytoKinE Storm Caused by Infection With COVID-19 | https://ClinicalTrials.gov/show/NCT04661527 |
| NCT04659941 | Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers | https://ClinicalTrials.gov/show/NCT04659941 |
| NCT04659772 | A Study to Evaluate Clazakizumab in Patients With Life-threatening COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04659772 |
| NCT04659707 | Hyperpolarized 129Xe MRI of Survivors of COVID-19 | https://ClinicalTrials.gov/show/NCT04659707 |
| NCT04659746 | MejoraCare-Paraguay: mHealth Solution for Chronic Patients During the COVID-19 Outbreak in Paraguay | https://ClinicalTrials.gov/show/NCT04659746 |
| NCT04659109 | Glenzocimab in SARS-Cov-2 Acute Respiratory DistrEss syNdrome Related to COVID-19 | https://ClinicalTrials.gov/show/NCT04659109 |
| NCT04659486 | Adolescents With COVID-19/MIS-C at HCFMUSP | https://ClinicalTrials.gov/show/NCT04659486 |
| NCT04659239 | The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 | https://ClinicalTrials.gov/show/NCT04659239 |
| NCT04659122 | A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04659122 |
| NCT04658433 | The Effect of Omega -3 Supplements on the Serum Levels of ACE/ACE2 Ratio as a Potential Key in Cardiovascular Disease and COVID-19; A Randomized Clinical Trial in the Covid-19 Uninfected Jordanian People | https://ClinicalTrials.gov/show/NCT04658433 |
| NCT04658979 | Pulmonary TELE-REHABilitation Program : Feasibility and Safety Study | https://ClinicalTrials.gov/show/NCT04658979 |
| NCT04656626 | Brief Mindfulness Based Intervention to Improve Psychological Wellbeing | https://ClinicalTrials.gov/show/NCT04656626 |
| NCT04657497 | A Study of FOY-305 in Patients With SARS-Cov-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04657497 |
| NCT04657484 | Comparison of Two Corticosteroid Regimens for Post COVID-19 Diffuse Lung Disease | https://ClinicalTrials.gov/show/NCT04657484 |
| NCT04657471 | Hospitalization or Outpatient ManagEment of Patients With SRAS-CoV-2 Infection - Revised HOME-CoV Score Study | https://ClinicalTrials.gov/show/NCT04657471 |
| NCT04655716 | Urine Alkalinisation to Prevent AKI in COVID-19 | https://ClinicalTrials.gov/show/NCT04655716 |
| NCT04656691 | At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04656691 |
| NCT04655625 | Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19) | https://ClinicalTrials.gov/show/NCT04655625 |
| NCT04655586 | Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19 | https://ClinicalTrials.gov/show/NCT04655586 |
| NCT04654481 | Study of AffloVest in At-Risk Respiratory Patients During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04654481 |
| NCT04653831 | Treatment With Pirfenidone for COVID-19 Related Severe ARDS | https://ClinicalTrials.gov/show/NCT04653831 |
| NCT04652765 | Camostat With Bicalutamide for COVID-19 | https://ClinicalTrials.gov/show/NCT04652765 |
| NCT04652674 | Impact of Postoperative Telemedicine Visit vs In-person Visit on Patient Satisfaction During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04652674 |
| NCT04652518 | LYT-100 in Post-acute COVID-19 Respiratory Disease | https://ClinicalTrials.gov/show/NCT04652518 |
| NCT04652648 | Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts | https://ClinicalTrials.gov/show/NCT04652648 |
| NCT04651790 | Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adults | https://ClinicalTrials.gov/show/NCT04651790 |
| NCT04652596 | Reducing Food Insecurity During COVID-19 | https://ClinicalTrials.gov/show/NCT04652596 |
| NCT04652115 | Defibrotide for the Treatment of Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04652115 |
| NCT04652102 | A Study to Determine the Safety and Efficacy of SARS-CoV-2 mRNA Vaccine CVnCoV in Adults for COVID-19 | https://ClinicalTrials.gov/show/NCT04652102 |
| NCT04650087 | COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis | https://ClinicalTrials.gov/show/NCT04650087 |
| NCT04649736 | Home-based Respiratory Physiotherapy and Telephone-Based Psychological Support in Severe COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04649736 |
| NCT04649775 | AirFLO2 Treatment for Hypoxia and/or Tachypnea in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04649775 |
| NCT04649515 | Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans | https://ClinicalTrials.gov/show/NCT04649515 |
| NCT04649424 | COVID-19 Nasal Swab Trial | https://ClinicalTrials.gov/show/NCT04649424 |
| NCT04649021 | Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy Population | https://ClinicalTrials.gov/show/NCT04649021 |
| NCT04649151 | A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19 | https://ClinicalTrials.gov/show/NCT04649151 |
| NCT04649086 | Muscular Rehabilitation by Eccentric Exercise After Severe COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04649086 |
| NCT04647695 | IFN-beta 1b and Remdesivir for COVID19 | https://ClinicalTrials.gov/show/NCT04647695 |
| NCT04648800 | Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in Poland | https://ClinicalTrials.gov/show/NCT04648800 |
| NCT04647604 | Resolving Inflammatory Storm in COVID-19 Patients by Omega-3 Polyunsaturated Fatty Acids - | https://ClinicalTrials.gov/show/NCT04647604 |
| NCT04647305 | Effectiveness and Adherence to Closed Face Shields to Prevent COVID-19 Transmission | https://ClinicalTrials.gov/show/NCT04647305 |
| NCT04647747 | Silent Hypoxia and Awake Proning in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04647747 |
| NCT04646655 | Enoxaparin at Prophylactic or Therapeutic Doses in COVID-19 | https://ClinicalTrials.gov/show/NCT04646655 |
| NCT04646616 | CRISOL Contigo: a Multi-level Intervention to Reduce the Disproportionate Toll of COVID-19 Among Latino Communities in Philadelphia. | https://ClinicalTrials.gov/show/NCT04646616 |
| NCT04646603 | MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04646603 |
| NCT04646590 | A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19 | https://ClinicalTrials.gov/show/NCT04646590 |
| NCT04646109 | Ivermectin for Severe COVID-19 Management | https://ClinicalTrials.gov/show/NCT04646109 |
| NCT04645407 | Effects of Fuzheng Huayu Tablets on COVID-19 | https://ClinicalTrials.gov/show/NCT04645407 |
| NCT04644198 | Convalescent Plasma Transfusion in Severe COVID-19 Patients in Jamaica | https://ClinicalTrials.gov/show/NCT04644198 |
| NCT04644120 | Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04644120 |
| NCT04644705 | Safety and Pharmacokinetics of a Novel Niclosamide Solution in Combination With Camostat | https://ClinicalTrials.gov/show/NCT04644705 |
| NCT04644328 | The Doctors for Coronavirus Prevention Project Thanksgiving / Christmas Messaging Campaign | https://ClinicalTrials.gov/show/NCT04644328 |
| NCT04644185 | The Efficacy and Safety of SCTA01 in Hospitalized Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04644185 |
| NCT04644172 | Improving Thinking in Everyday Life After Covid-19 | https://ClinicalTrials.gov/show/NCT04644172 |
| NCT04643691 | Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS | https://ClinicalTrials.gov/show/NCT04643691 |
| NCT04643561 | Using Travelan to Boost Immune Response in Vitro to COVID-19 | https://ClinicalTrials.gov/show/NCT04643561 |
| NCT04643964 | Brief Video Interventions for Depression | https://ClinicalTrials.gov/show/NCT04643964 |
| NCT04643678 | Anakinra in the Management of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04643678 |
| NCT04632368 | Targeting the Health Care Provider (HCP) Burnout Crisis During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04632368 |
| NCT04642950 | A Phase II/III Study of Sargramostim | https://ClinicalTrials.gov/show/NCT04642950 |
| NCT04642326 | Study Investigating the Effects of UVC Beam and Laser Beam Therapy According to Standard Therapy in Patients With Covid-19 Diagnosis | https://ClinicalTrials.gov/show/NCT04642326 |
| NCT04641195 | Vitamin D and Zinc Supplementation for Improving Treatment Outcomes Among COVID-19 Patients in India | https://ClinicalTrials.gov/show/NCT04641195 |
| NCT04641858 | BCG to Reduce Absenteeism Among Health Care Workers During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04641858 |
| NCT04641481 | An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers | https://ClinicalTrials.gov/show/NCT04641481 |
| NCT04642040 | Effectiveness of Pulmonary Rehabilitation Program in Patients With SARS-CoV-2 Pneumonia | https://ClinicalTrials.gov/show/NCT04642040 |
| NCT04640233 | Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Сov-2) Infection | https://ClinicalTrials.gov/show/NCT04640233 |
| NCT04640402 | A Phase â…¡ Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells) | https://ClinicalTrials.gov/show/NCT04640402 |
| NCT04640181 | Factor Xa Inhibitor Versus Standard of Care Heparin in Hospitalized Patients With COVID-19 (XACT) | https://ClinicalTrials.gov/show/NCT04640181 |
| NCT04640168 | Adaptive COVID-19 Treatment Trial 4 (ACTT-4) | https://ClinicalTrials.gov/show/NCT04640168 |
| NCT04638673 | NeuroCovid Rehab and Recovery Related to COVID-19 Diagnosis | https://ClinicalTrials.gov/show/NCT04638673 |
| NCT04639349 | Effect of Home Exercise Activity on Cortisol and Depression in COPD During the Pandemic COVID | https://ClinicalTrials.gov/show/NCT04639349 |
| NCT04639375 | Polio Vaccine (IPV) for SARS-CoV-2 and Prevention of Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04639375 |
| NCT04638842 | Online Multi-component Psychological Intervention for Prevention of Grief Disorder Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04638842 |
| NCT04640038 | Contrast Enhanced Ultrasound in COVID-19 | https://ClinicalTrials.gov/show/NCT04640038 |
| NCT04639466 | A Synthetic MVA-based SARS-CoV-2 Vaccine, COH04S1, for the Prevention of COVID-19 | https://ClinicalTrials.gov/show/NCT04639466 |
| NCT04638634 | Pharmacokinetics, Safety, and Tolerability of CSL760, an Intravenous Anti-SARS-CoV-2 Hyperimmune Globulin, in Healthy Adult Subjects | https://ClinicalTrials.gov/show/NCT04638634 |
| NCT04637906 | Short and Long-term Effects of Adding Oral L-arginine to Standard Therapy in Patients With COVID-19 (SARS-CoV-2) | https://ClinicalTrials.gov/show/NCT04637906 |
| NCT04637867 | COVID-19 - Multicentre Study on Nosocomial Transmission of SARS-CoV-2 Virus: an Ancillary Study (NOSO-COR IMMUNO) | https://ClinicalTrials.gov/show/NCT04637867 |
| NCT04637828 | A Study to Compare the Efficacy of GNS561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection | https://ClinicalTrials.gov/show/NCT04637828 |
| NCT04637477 | Virtual Enhanced Lifestyle for Metabolic Syndrome (ELM) Proof-of-Concept Study | https://ClinicalTrials.gov/show/NCT04637477 |
| NCT04636333 | Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell) | https://ClinicalTrials.gov/show/NCT04636333 |
| NCT04636697 | Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults | https://ClinicalTrials.gov/show/NCT04636697 |
| NCT04636671 | Methylprednisolone vs. Dexamethasone in COVID-19 Pneumonia (MEDEAS RCT) | https://ClinicalTrials.gov/show/NCT04636671 |
| NCT04636320 | Prevalence of Myocardial Scars on CMR After COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04636320 |
| NCT04636034 | The Effect of Ganglion Sphenopalatine Block Versus Placebo on Persistent Headache Following COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04636034 |
| NCT04635241 | Inhaled Heparin for Hospitalised COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04635241 |
| NCT04635943 | Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19 | https://ClinicalTrials.gov/show/NCT04635943 |
| NCT04635618 | Psychotherapy Strategies for the Treatment of Professionals and Students From Essential Services With High Levels of Emotional Distress in the Context of COVID-19 | https://ClinicalTrials.gov/show/NCT04635618 |
| NCT04635605 | Methylene Blue Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04635605 |
| NCT04636086 | Effect of Vitamin D on Hospitalized Adults With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04636086 |
| NCT04634903 | Testing Scalable, Single-Session Interventions for Adolescent Depression in the Context of COVID-19 | https://ClinicalTrials.gov/show/NCT04634903 |
| NCT04634799 | Study To antagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04634799 |
| NCT04632706 | Exploratory Ph I Trial of the Active IMP in Healthy Volunteers in Relation to COVID-19 | https://ClinicalTrials.gov/show/NCT04632706 |
| NCT04634318 | Organization of Pulmonary Rehabilitation of Post-COVID-19 Patient With Sequelae (REHABCOVID) | https://ClinicalTrials.gov/show/NCT04634318 |
| NCT04633772 | Use of Angiotensin-(1-7) in COVID-19 | https://ClinicalTrials.gov/show/NCT04633772 |
| NCT04634422 | Plasma Exchange (PLEX) and Convalescent Plasma (CCP) in COVID-19 Patients With Multiorgan Failure | https://ClinicalTrials.gov/show/NCT04634422 |
| NCT04634409 | A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness | https://ClinicalTrials.gov/show/NCT04634409 |
| NCT04632719 | The MentalPlus® for Assessment and Rehabilitation of Cognitive Function After Remission of the Symptoms of COVID-19 | https://ClinicalTrials.gov/show/NCT04632719 |
| NCT04632602 | Awake Prone Position to Reduce Ventilation Inhomogeneity in COVID-19 Acute Respiratory Failure | https://ClinicalTrials.gov/show/NCT04632602 |
| NCT04632043 | Early Versus Delayed Intubation of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04632043 |
| NCT04632082 | Telepsychoeducation for the Prevention of Emotional Distress in Professionals and Students From Essential Services in the Context of COVID-19 | https://ClinicalTrials.gov/show/NCT04632082 |
| NCT04631666 | SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Infusion | https://ClinicalTrials.gov/show/NCT04631666 |
| NCT04631536 | Managing Endothelial Dysfunction in COVID-19 : A Randomized Controlled Trial at LAUMC | https://ClinicalTrials.gov/show/NCT04631536 |
| NCT04631380 | Prayer in Commbate to Corona Virus - Covid -19 | https://ClinicalTrials.gov/show/NCT04631380 |
| NCT04631367 | mHealth Intervention for Increasing COVID-19 Prevention Practices With Urban Refugee and Displaced Youth in Uganda | https://ClinicalTrials.gov/show/NCT04631367 |
| NCT04630054 | Face Masks to Reduce COVID-19 in Bangladesh | https://ClinicalTrials.gov/show/NCT04630054 |
| NCT04629989 | Comparison of the Surgical Facemask With the Double-trunk Mask on Oxygenation in COVID-19 | https://ClinicalTrials.gov/show/NCT04629989 |
| NCT04629157 | The LAVA (Lateral Flow Antigen Validation and Applicability) Study for COVID-19 | https://ClinicalTrials.gov/show/NCT04629157 |
| NCT04629105 | Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER) | https://ClinicalTrials.gov/show/NCT04629105 |
| NCT04629703 | Double-Blind, Randomized, Placebo-Controlled, Adaptive Design, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects | https://ClinicalTrials.gov/show/NCT04629703 |
| NCT04628143 | A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04628143 |
| NCT04628039 | Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs | https://ClinicalTrials.gov/show/NCT04628039 |
| NCT04627584 | A Phase 2 Clinical Trial of MW33 Injection in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04627584 |
| NCT04627519 | Effectiveness and Safety of Rhea Health Tone® as add-on Therapy for COVID-19 in Hospitalized Adults in Indonesia | https://ClinicalTrials.gov/show/NCT04627519 |
| NCT04627675 | CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2) | https://ClinicalTrials.gov/show/NCT04627675 |
| NCT04627467 | Prevention With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19) (TS-COVID) | https://ClinicalTrials.gov/show/NCT04627467 |
| NCT04625985 | Metformin Glycinate, Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2. | https://ClinicalTrials.gov/show/NCT04625985 |
| NCT04625972 | Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults | https://ClinicalTrials.gov/show/NCT04625972 |
| NCT04625725 | Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult. | https://ClinicalTrials.gov/show/NCT04625725 |
| NCT04625114 | The Potential of Oral Camostat in Early COVID-19 Disease in an Ambulatory Setting to Reduce Viral Load and Disease Burden | https://ClinicalTrials.gov/show/NCT04625114 |
| NCT04623671 | Intravenous Infusion of CAP-1002 in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04623671 |
| NCT04623255 | Randomised Study of Plasma Exchange in Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04623255 |
| NCT04622891 | Clarithromycin Versus Azithromycin in Treatment of Mild COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04622891 |
| NCT04623021 | A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04623021 |
| NCT04622865 | Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04622865 |
| NCT04622826 | plasmApuane CoV-2 : Efficacy and Safety of Immune Covid-19 Plasma in Covid-19 Pneumonia in Non ITU Patients | https://ClinicalTrials.gov/show/NCT04622826 |
| NCT04622332 | A Pilot Study to Assess Safety and Efficacy of SIR1-365 in Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04622332 |
| NCT04621903 | A Pilot Study on Efficacy and Safety of Ayurveda Combination in Patients With Mild-to-Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04621903 |
| NCT04621461 | Placebo Controlled Trial to Evaluate Zinc for the Treatment of COVID-19 in the Outpatient Setting | https://ClinicalTrials.gov/show/NCT04621461 |
| NCT04621071 | Efficacy of Probiotics in Reducing Duration and Symptoms of COVID-19 | https://ClinicalTrials.gov/show/NCT04621071 |
| NCT04621058 | Efficacy of Vitamin D Treatment in Mortality Reduction Due to COVID-19. | https://ClinicalTrials.gov/show/NCT04621058 |
| NCT04621149 | An Outpatient Study Investigating Non-prescription Treatments for COVID-19 | https://ClinicalTrials.gov/show/NCT04621149 |
| NCT04621123 | Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04621123 |
| NCT04620798 | Longitudinal COVID-19 Antibody Testing in Indiana University Undergraduate Students | https://ClinicalTrials.gov/show/NCT04620798 |
| NCT04619628 | Safety and Immunogenicity of COVI-VAC, a Live Attenuated Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04619628 |
| NCT04619719 | Hyperbaric Oxygen for COVID-19 Patients With Moderate to Severe Hypoxemia | https://ClinicalTrials.gov/show/NCT04619719 |
| NCT04619706 | Ultramicronized Palmitoylethanolamide (PEA) Treatment in Hospitalized Participants With COVID-19 | https://ClinicalTrials.gov/show/NCT04619706 |
| NCT04615936 | Nasal Photodisinfection COVID Proof of Concept Study | https://ClinicalTrials.gov/show/NCT04615936 |
| NCT04619290 | Outpatient Treatment With CoVid-19 With Prexablu | https://ClinicalTrials.gov/show/NCT04619290 |
| NCT04618042 | FX06 to Rescue Acute Respiratory Distress Syndrome During Covid-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04618042 |
| NCT04617483 | Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in Adults | https://ClinicalTrials.gov/show/NCT04617483 |
| NCT04616846 | Thromboembolic Risk Screening in Patients With Cancer and COVID-19 | https://ClinicalTrials.gov/show/NCT04616846 |
| NCT04617262 | Pilot Feasibility Study of Remote Problem Management Plus for Adults Affected by COVID-19 | https://ClinicalTrials.gov/show/NCT04617262 |
| NCT04615975 | Ketogenic Diet as Protective Factor During COVID-19 | https://ClinicalTrials.gov/show/NCT04615975 |
| NCT04616989 | Mental Health in Communities Affected by COVID-19 in Uganda | https://ClinicalTrials.gov/show/NCT04616989 |
| NCT04615741 | Finding Wellness in the Pandemic | https://ClinicalTrials.gov/show/NCT04615741 |
| NCT04615416 | Emotion Regulation Training Via Telehealth During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04615416 |
| NCT04615429 | Clinical Trial to Assess the Efficacy of MSC in Patients With ARDS Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04615429 |
| NCT04614844 | COVID-19 Responsive Intervention: Systems Improvement Simulations (CRI:SIS) | https://ClinicalTrials.gov/show/NCT04614844 |
| NCT04614948 | A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults | https://ClinicalTrials.gov/show/NCT04614948 |
| NCT04614883 | Analysis of Volatile Organic Compounds in Exhaled Air and in Sweat in the Context of Suspicion of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04614883 |
| NCT04615052 | Home-based Exercise in COVID-19 Survivors | https://ClinicalTrials.gov/show/NCT04615052 |
| NCT04614025 | Open-label Multicenter Study to Evaluate the Efficacy of PLX-PAD for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04614025 |
| NCT04614012 | Hyperimmune Plasma for Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04614012 |
| NCT04613739 | Asthma in Families Facing Out-of-pocket Requirements Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04613739 |
| NCT04613310 | PCR and Rapid Diagnostic Test on Saliva and Nasopharyngeal Swabs for the Detection of SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04613310 |
| NCT04613297 | HLA-G Immuno-Inhibitor Checkpoint Study in Patients With COVID-19 Infection: Molecular and Cellular Assessment | https://ClinicalTrials.gov/show/NCT04613297 |
| NCT04613271 | Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia | https://ClinicalTrials.gov/show/NCT04613271 |
| NCT04613050 | Effect of Respiratory Versus Aerobic Training on Respiratory and Immunity Efficiency in Recovered COVID- 19 Patients | https://ClinicalTrials.gov/show/NCT04613050 |
| NCT04610567 | Treatment of Patients With Mild Coronavirus-19 (COVID-19) Disease With Methotrexate Associated to LDL Like Nanoparticles (Nano-COVID19) | https://ClinicalTrials.gov/show/NCT04610567 |
| NCT04612972 | Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru | https://ClinicalTrials.gov/show/NCT04612972 |
| NCT04611256 | Mesenchymal Stem Cells in Patients Diagnosed With COVID-19 | https://ClinicalTrials.gov/show/NCT04611256 |
| NCT04611802 | A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years) at Risk for SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04611802 |
| NCT04611425 | REmimazolam Infusion in the Context of Hypnotic Shortage in the Critical Care Unit During the Pandemic of COVID-19, the REHSCU Study | https://ClinicalTrials.gov/show/NCT04611425 |
| NCT04611399 | MIND-VR: Virtual Reality for COVID-19 Operators’ Psychological Support | https://ClinicalTrials.gov/show/NCT04611399 |
| NCT04610541 | REMdesivir-HU Clinical Study and Severe Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04610541 |
| NCT04610502 | Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04610502 |
| NCT04610489 | Diagnostic Performance of an Antigen Test for SARS-CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04610489 |
| NCT04609969 | Diagnostic Performance Evaluation of a Novel SARS-CoV-2 (COVID-19) Antigen Detection Test | https://ClinicalTrials.gov/show/NCT04609969 |
| NCT04609865 | Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 Pandemia | https://ClinicalTrials.gov/show/NCT04609865 |
| NCT04609462 | High-Flow Nasal Cannula in Severe COVID-19 With Acute Hypoxemic Respiratory Failure. | https://ClinicalTrials.gov/show/NCT04609462 |
| NCT04609423 | Cod Liver Oil for Covid-19 Prevention Study | https://ClinicalTrials.gov/show/NCT04609423 |
| NCT04609371 | PanDirect: Self-care Tools and Telephone Coaching for Depression and Anxiety During Pandemics | https://ClinicalTrials.gov/show/NCT04609371 |
| NCT04609722 | Effect of Solution-Focused Support Program on Anxiety Levels of Parents During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04609722 |
| NCT04608305 | Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine | https://ClinicalTrials.gov/show/NCT04608305 |
| NCT04608266 | CAMOVID : Evaluation of Efficacy and Safety of Camostat Mesylate for the Treatment of SARS-CoV-2 Infection - COVID-19 in Ambulatory Adult Patients | https://ClinicalTrials.gov/show/NCT04608266 |
| NCT04608201 | Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04608201 |
| NCT04608097 | Understanding Reactions to Emotional Material in the Media During COVID-19 | https://ClinicalTrials.gov/show/NCT04608097 |
| NCT04607928 | Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis COVID-19 | https://ClinicalTrials.gov/show/NCT04607928 |
| NCT04607915 | Technology-enabled Collaborative Care for Diabetes Management During COVID-19 | https://ClinicalTrials.gov/show/NCT04607915 |
| NCT04606563 | Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan on Outcomes of Coronavirus Infection? | https://ClinicalTrials.gov/show/NCT04606563 |
| NCT04606784 | Study of Nebulized Ampion for the Treatment of Adult COVID-19 Patients With Respiratory Distress | https://ClinicalTrials.gov/show/NCT04606784 |
| NCT04606069 | Treat COVID-19 Patients With Regadenoson | https://ClinicalTrials.gov/show/NCT04606069 |
| NCT04605887 | Angiotensin 1-7 as a Therapy in the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04605887 |
| NCT04605588 | A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19 | https://ClinicalTrials.gov/show/NCT04605588 |
| NCT04604977 | Feasibility and Effectiveness of Home-behavioral Program for Adolescents With Migraine | https://ClinicalTrials.gov/show/NCT04604977 |
| NCT04604704 | Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome | https://ClinicalTrials.gov/show/NCT04604704 |
| NCT04604184 | ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19 | https://ClinicalTrials.gov/show/NCT04604184 |
| NCT04604743 | Clinic-based HPV and COVID-19 Vaccine Promoting Intervention for AfAm Adolescents in Alabama | https://ClinicalTrials.gov/show/NCT04604743 |
| NCT04604327 | Comparison of Two Different Doses of Bemiparin in COVID-19 | https://ClinicalTrials.gov/show/NCT04604327 |
| NCT04604145 | Self-Collected Saliva Samples Without Viral Transport Media for COVID-19 Testing Via RT-PCR | https://ClinicalTrials.gov/show/NCT04604145 |
| NCT04604223 | Effect of Pioglitazone on T2DM Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04604223 |
| NCT04603963 | Inspiratory Muscle Training in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04603963 |
| NCT04603924 | Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) Patients | https://ClinicalTrials.gov/show/NCT04603924 |
| NCT04603729 | Comparison of Efficacy of Dexamethasone and Methylprednisolone in Moderate to Severe Covid 19 Disease | https://ClinicalTrials.gov/show/NCT04603729 |
| NCT04603794 | Efficacy of Mouthwash in Reducing Salivary Carriage of COVID-19 | https://ClinicalTrials.gov/show/NCT04603794 |
| NCT04603781 | CBD Oil for Reducing Emotional Impact of COVID-19 | https://ClinicalTrials.gov/show/NCT04603781 |
| NCT04602871 | Early Detection of COVID-19 Using Breath Analysis - Feasibility Study | https://ClinicalTrials.gov/show/NCT04602871 |
| NCT04602832 | Enduring Happiness and Continued Self-Enhancement (ENHANCE) for COVID-19 | https://ClinicalTrials.gov/show/NCT04602832 |
| NCT04602949 | Detection of COVID-19 Using Breath Analysis - Validation Study | https://ClinicalTrials.gov/show/NCT04602949 |
| NCT04602507 | Ivermectin in Adults With Severe COVID-19. | https://ClinicalTrials.gov/show/NCT04602507 |
| NCT04602442 | Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Pneumonia | https://ClinicalTrials.gov/show/NCT04602442 |
| NCT04602312 | How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Healthy Sample) | https://ClinicalTrials.gov/show/NCT04602312 |
| NCT04602286 | How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Pain Sample) | https://ClinicalTrials.gov/show/NCT04602286 |
| NCT04602000 | To Evaluate the Safety and Efficacy of CT-P59 in Patients With Mild to Moderate Syptoms of Severe Acute Respiratory Syndrome COVID-19 | https://ClinicalTrials.gov/show/NCT04602000 |
| NCT04601077 | The Evaluation of Nitric Oxide Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patient of African American and Hispanic Origin | https://ClinicalTrials.gov/show/NCT04601077 |
| NCT04600999 | Clinical Trial of Favipiravir Treatment of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04600999 |
| NCT04600895 | The Prevent Severe COVID-19 (PRESECO) Study | https://ClinicalTrials.gov/show/NCT04600895 |
| NCT04600440 | Convalescent Plasma in the Treatment of Covid-19 | https://ClinicalTrials.gov/show/NCT04600440 |
| NCT04599959 | COVID-19 Tests: Nasopharyngeal Swab vs Saliva Collected With Salivette® Cortisol for Viral RNA Sampling for RT-qPCR | https://ClinicalTrials.gov/show/NCT04599959 |
| NCT04600141 | Clinical Efficacy of Heparin and Tocilizumab in Patients With Severe COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04600141 |
| NCT04596839 | Antiviral Activity and Safety of Remdesivir in Bangladeshi Patients With Severe Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04596839 |
| NCT04598594 | Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Intensive Care Unit Patients | https://ClinicalTrials.gov/show/NCT04598594 |
| NCT04598581 | Low Dose Radiation Therapy for Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2), COVID-19 | https://ClinicalTrials.gov/show/NCT04598581 |
| NCT04597047 | Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test | https://ClinicalTrials.gov/show/NCT04597047 |
| NCT04597034 | Efficacy and Safety of a Highly Selective Semipermeable Membrane (AN-69 Oxiris) vs (Standard AN-69) in COVID-19 | https://ClinicalTrials.gov/show/NCT04597034 |
| NCT04596085 | Study to Evaluate Efficacy and Safety of “VIRACIDE” IN THE MANAGEMENT OF CORONA VIRUS DISEASE 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04596085 |
| NCT04595136 | Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient | https://ClinicalTrials.gov/show/NCT04595136 |
| NCT04595097 | Inspiratory Muscle Training in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04595097 |
| NCT04595084 | Remotely Delivered Programs Targeting COVID-19 Stress-Related Depression and Substance Use | https://ClinicalTrials.gov/show/NCT04595084 |
| NCT04594668 | Senicapoc in COVID-19 Patients With Severe Respiratory Insufficiency | https://ClinicalTrials.gov/show/NCT04594668 |
| NCT04593641 | This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04593641 |
| NCT04594343 | Clinical Study to Evaluate the Effects of Disulfiram in Patients With Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04594343 |
| NCT04594330 | Virgin Coconut Oil (VCO) as a Potential Adjuvant Therapy in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04594330 |
| NCT04593069 | The COGCOV Study in ICU Patients | https://ClinicalTrials.gov/show/NCT04593069 |
| NCT04593433 | A 3-month Cycle of Virtual Guided Tours to Promote Health in Older Community Members in a Context of COVID-19 Induced Social Isolation: a Pilot Study | https://ClinicalTrials.gov/show/NCT04593433 |
| NCT04592354 | Anhydrous Enol-Oxaloacetate (AEO) on Improving Fatigue in Post-COVID-19 Survivors | https://ClinicalTrials.gov/show/NCT04592354 |
| NCT04592549 | Study of Monoclonal Antibody Cocktail Being Tested for the Prevention of COVID-19 | https://ClinicalTrials.gov/show/NCT04592549 |
| NCT04591015 | Dulce Digital-COVID Aware (DD-CA) Discharge Texting Platform for US/Mexico Border Hispanics With Diabetes + COVID-19 | https://ClinicalTrials.gov/show/NCT04591015 |
| NCT04591717 | COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral-COVID-19 in Normal Healthy Volunteers | https://ClinicalTrials.gov/show/NCT04591717 |
| NCT04591613 | Late Clinical Events Associated With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04591613 |
| NCT04591210 | The COVID-RASi Trial (COVID-19) | https://ClinicalTrials.gov/show/NCT04591210 |
| NCT04591184 | A Clinical Trial of a Prophylactic Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults | https://ClinicalTrials.gov/show/NCT04591184 |
| NCT04591158 | COVID-19 and Lung Ultrasound Utility | https://ClinicalTrials.gov/show/NCT04591158 |
| NCT04591600 | Effectiveness of Ivermectin and Doxycycline on COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04591600 |
| NCT04590469 | Improving Wellbeing and Health for Care Home Residents During COVID-19 | https://ClinicalTrials.gov/show/NCT04590469 |
| NCT04590430 | Study to Assess the Safety, Tolerability, and Pharmacokinetics of HFB30132A Against COVID-19 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04590430 |
| NCT04590586 | Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04590586 |
| NCT04590365 | Carrageenan Nasal Spray for COVID-19 Prophylaxis | https://ClinicalTrials.gov/show/NCT04590365 |
| NCT04589936 | Prone Position to Improve Oxygenation in COVID-19 Patients Outside Critical Care | https://ClinicalTrials.gov/show/NCT04589936 |
| NCT04590053 | Allocetra-OTS in COVID-19, Phase II | https://ClinicalTrials.gov/show/NCT04590053 |
| NCT04589949 | Early Convalescent Plasma Therapy for High-risk Patients With COVID-19 in Primary Care (the CoV-Early Study) | https://ClinicalTrials.gov/show/NCT04589949 |
| NCT04588480 | Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults | https://ClinicalTrials.gov/show/NCT04588480 |
| NCT04589117 | Expressive Writing for COVID-19 Resilience for Parents | https://ClinicalTrials.gov/show/NCT04589117 |
| NCT04589104 | Expressive Writing for COVID-19 Resilience | https://ClinicalTrials.gov/show/NCT04589104 |
| NCT04588792 | Furosemide as Supportive Therapy for COVID-19 Respiratory Failure | https://ClinicalTrials.gov/show/NCT04588792 |
| NCT04588415 | Supporting Family Members With Severe Grief Reaction During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04588415 |
| NCT04587414 | eHealth Intervention on Physical Activity for Type 2 Diabetics - Frustrated by COVID-19 | https://ClinicalTrials.gov/show/NCT04587414 |
| NCT04587921 | Feasibility and Impact of Remote Oximetry in Patients Hospitalized With Covid-19 | https://ClinicalTrials.gov/show/NCT04587921 |
| NCT04587219 | The Study of “Gam-COVID-Vac” Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older | https://ClinicalTrials.gov/show/NCT04587219 |
| NCT04584710 | A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults | https://ClinicalTrials.gov/show/NCT04584710 |
| NCT04586153 | Study to Assess the Effect of Meplazumab on COVID-19 | https://ClinicalTrials.gov/show/NCT04586153 |
| NCT04584684 | Mouth Rinses for Inactivation of COVID-19 | https://ClinicalTrials.gov/show/NCT04584684 |
| NCT04584593 | Pilot Study to Detect SARS-CoV-2 Virus in Sperm | https://ClinicalTrials.gov/show/NCT04584593 |
| NCT04584580 | D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04584580 |
| NCT04584567 | OD-doxy-PNV-COVID-19 Old Drug " DOXY " for Prevention of New Virus " COVID-19 " | https://ClinicalTrials.gov/show/NCT04584567 |
| NCT04584541 | SarS-Cov-2 Viral Infection (COVID-19) in Patients With Chronic Inflammatory Rheumatism | https://ClinicalTrials.gov/show/NCT04584541 |
| NCT04583410 | Efficacy of Nicotine in Preventing COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04583410 |
| NCT04583995 | A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom | https://ClinicalTrials.gov/show/NCT04583995 |
| NCT04583592 | Camostat Efficacy vs. Placebo for Outpatient Treatment of COVID-19 (CAMELOT) | https://ClinicalTrials.gov/show/NCT04583592 |
| NCT04583449 | Mental Imagery to Increase Face Covering Use in UK-based Public Places During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04583449 |
| NCT04582344 | Clinical Trial For SARS-CoV-2 Vaccine (COVID-19) | https://ClinicalTrials.gov/show/NCT04582344 |
| NCT04583189 | Evaluation of the Performance of the Covid-19 Ag BSS Rapid Antigenic Test in Symptomatic Children in a Pediatric Emergency Department | https://ClinicalTrials.gov/show/NCT04583189 |
| NCT04582318 | A Phase 1/2 Study to Assess the Safety, Tolerability and Pharmacokinetics of NGM621 in Healthy Subjects, and to Assess the Safety, PK and Efficacy in Subjects With Moderate to Severe ARDS Caused by COVID-19 | https://ClinicalTrials.gov/show/NCT04582318 |
| NCT04582214 | Oscillation and Lung Expansion Therapy in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04582214 |
| NCT04582201 | An Experiment to Evaluate the Safety of agenT-797 in COVID-19 Patients With Severe Difficulty Breathing. | https://ClinicalTrials.gov/show/NCT04582201 |
| NCT04581811 | Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome (ARDS) | https://ClinicalTrials.gov/show/NCT04581811 |
| NCT04581746 | Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2) | https://ClinicalTrials.gov/show/NCT04581746 |
| NCT04581954 | Inflammatory Signal Inhibitors for COVID-19 (MATIS) | https://ClinicalTrials.gov/show/NCT04581954 |
| NCT04581915 | PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04581915 |
| NCT04581291 | The Effect of Aerobic Exercise on Immune Biomarkers and Symptoms Severity and Progression in Patients With COVID-19: A Pilot Randomized Control Trial | https://ClinicalTrials.gov/show/NCT04581291 |
| NCT04581863 | COVID-19 Watch + COVID-19 Pulse | https://ClinicalTrials.gov/show/NCT04581863 |
| NCT04581031 | COntinuous Signs Monitoring In Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04581031 |
| NCT04581018 | An Evaluation of a Synbiotic Formula for Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04581018 |
| NCT04581161 | Proportional Open Ventilation (POV) Device and Its Efficacy in Managing Acute Respiratory Failure in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04581161 |
| NCT04579640 | Trial of Vitamin D to Reduce Risk and Severity of COVID-19 and Other Acute Respiratory Infections | https://ClinicalTrials.gov/show/NCT04579640 |
| NCT04579549 | Repeat Testing for SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04579549 |
| NCT04578158 | Trial to Study the Adjuvant Benefits of Quercetin Phytosome in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04578158 |
| NCT04579393 | Fostamatinib for Hospitalized Adults With COVID-19 | https://ClinicalTrials.gov/show/NCT04579393 |
| NCT04577534 | COVID-19: Salvage TOcilizumab as a Rescue Measure | https://ClinicalTrials.gov/show/NCT04577534 |
| NCT04578210 | Safety Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in COVID-19 pnEumonia or Lymphopenia | https://ClinicalTrials.gov/show/NCT04578210 |
| NCT04577235 | Correlation Between Thoracic Ultrasound and Thorax Computed Tomography Scores. | https://ClinicalTrials.gov/show/NCT04577235 |
| NCT04576728 | Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04576728 |
| NCT04576312 | Safety of Ascending Doses of Niclosamide (UNI911 INHALATION) in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT04576312 |
| NCT04575064 | An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY | https://ClinicalTrials.gov/show/NCT04575064 |
| NCT04575038 | CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19 | https://ClinicalTrials.gov/show/NCT04575038 |
| NCT04575597 | Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002) | https://ClinicalTrials.gov/show/NCT04575597 |
| NCT04575584 | Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001) | https://ClinicalTrials.gov/show/NCT04575584 |
| NCT04574219 | Virtual Parental Presence on Induction | https://ClinicalTrials.gov/show/NCT04574219 |
| NCT04573764 | Acute Effects of Oral Ketone Ester on Cardiac Function in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04573764 |
| NCT04573153 | Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04573153 |
| NCT04573361 | Access to Chiropractic Care During the COVID-19 Healthcare Emergency in Spain | https://ClinicalTrials.gov/show/NCT04573361 |
| NCT04573322 | Safety and Efficacy of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 (COVID-19) Infected Subjects | https://ClinicalTrials.gov/show/NCT04573322 |
| NCT04573270 | Mesenchymal Stem Cells for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04573270 |
| NCT04572412 | Low Dose Lung Radiotherapy to Treat COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04572412 |
| NCT04572399 | UVA Light Device to Treat COVID-19 | https://ClinicalTrials.gov/show/NCT04572399 |
| NCT04572360 | Cardiorespiratory Exercise & Chinese Medicine for Rehabilitation of Discharged Coronavirus Disease (COVID-19) Patients | https://ClinicalTrials.gov/show/NCT04572360 |
| NCT04570397 | Ravulizumab and COVID-19 | https://ClinicalTrials.gov/show/NCT04570397 |
| NCT04570254 | Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04570254 |
| NCT04570384 | Intravenous L-Citrulline to Delay and Potentially Prevent the Need for Invasive Mechanical Ventilation for Acute Hypoxemic Respiratory Failure in Patients With COVID-19 (SARS-CoV-2) Illness | https://ClinicalTrials.gov/show/NCT04570384 |
| NCT04570488 | Predicting Favorable Outcomes in Hospitalized Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04570488 |
| NCT04569188 | Convalescent Plasma in COVID-19 Elderly Patients | https://ClinicalTrials.gov/show/NCT04569188 |
| NCT04569877 | GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04569877 |
| NCT04569383 | Safety and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S and a Booster Vaccination With a Licensed Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04569383 |
| NCT04570202 | Health cAre woRkers exposeD to COVID-19 | https://ClinicalTrials.gov/show/NCT04570202 |
| NCT04569825 | Effect of Nasal Steroid in the Treatment of Anosmia Due to COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04569825 |
| NCT04569786 | Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001) | https://ClinicalTrials.gov/show/NCT04569786 |
| NCT04569266 | Effectiveness of an Exercise Re-training Program on Dyspnea in Patients After Acute Respiratory Distress Syndrome Secondary to Severe COVID-19 Pneumonia in Post-ICU | https://ClinicalTrials.gov/show/NCT04569266 |
| NCT04569227 | Prevention of COVID-19 Infection to Severe Pneumonia or ARDS | https://ClinicalTrials.gov/show/NCT04569227 |
| NCT04567173 | Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04567173 |
| NCT04568811 | The Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04568811 |
| NCT04568707 | Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES) | https://ClinicalTrials.gov/show/NCT04568707 |
| NCT04568356 | A Clinical Evaluation of COVID-19 Rapid Point of Care Antigen Tests | https://ClinicalTrials.gov/show/NCT04568356 |
| NCT04568031 | Study of AZD1222 for the Prevention of COVID-19 in Japan | https://ClinicalTrials.gov/show/NCT04568031 |
| NCT04567953 | COVID-19 Tests With Saliva Specimens | https://ClinicalTrials.gov/show/NCT04567953 |
| NCT04568889 | Minnesota COVID-19 Testing Project | https://ClinicalTrials.gov/show/NCT04568889 |
| NCT04568876 | Micronized and Ultramicronized Palmitoylethanolamide in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04568876 |
| NCT04568863 | Efficacy of Intravenous Melatonin on Mortality in Adult Patients Admitted to the Intensive Care Unit With COVID-19 | https://ClinicalTrials.gov/show/NCT04568863 |
| NCT04568525 | Passive Microwave Radiometry (MWR) and AI for COVID-19 Complications Early Diagnostics of Lungs | https://ClinicalTrials.gov/show/NCT04568525 |
| NCT04568122 | Rapid Turnaround, Home-based Saliva Testing for COVID-19 | https://ClinicalTrials.gov/show/NCT04568122 |
| NCT04567810 | Safety, Tolerability, and Pharmacokinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Chicken Egg Antibody (IgY) (COVID-19) | https://ClinicalTrials.gov/show/NCT04567810 |
| NCT04566770 | A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) | https://ClinicalTrials.gov/show/NCT04566770 |
| NCT04565509 | Supporting the Health and Well-being of Children With Intellectual and Developmental Disability During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04565509 |
| NCT04565197 | Convalescent Plasma Therapy for COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04565197 |
| NCT04565379 | Clinical Trial to Investigate the Efficacy and Safety of NuSepin® in COVID-19 Pneumonia Patients | https://ClinicalTrials.gov/show/NCT04565379 |
| NCT04563702 | Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04563702 |
| NCT04564716 | Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus | https://ClinicalTrials.gov/show/NCT04564716 |
| NCT04563676 | Physiopathology and Sequelae of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04563676 |
| NCT04563689 | Pilot Study to Evaluate Effect of CHX0.12/CPC 0.05 of SARS-CoV-2 Viral Load in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04563689 |
| NCT04563650 | COVID-19 Serology and Immunosenescence | https://ClinicalTrials.gov/show/NCT04563650 |
| NCT04563208 | Study of Oral Administration of Ribavirin and Nitazoxamide Versus Placebo in COVID-19 | https://ClinicalTrials.gov/show/NCT04563208 |
| NCT04563065 | Active Pregnancy Against COVID-19 | https://ClinicalTrials.gov/show/NCT04563065 |
| NCT04561219 | Nitazoxanide Therapy for Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04561219 |
| NCT04561063 | COVID-19 Prophylaxis South Africa (COVER HCW) | https://ClinicalTrials.gov/show/NCT04561063 |
| NCT04561154 | Identifying Functional and Psycho-social Complaints After Hospitalization for SARS-CoV-2 Infection( COVID 19)- REPERCOV | https://ClinicalTrials.gov/show/NCT04561154 |
| NCT04560881 | Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19) | https://ClinicalTrials.gov/show/NCT04560881 |
| NCT04560257 | High Flow Nasal Cannula HFNC In Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04560257 |
| NCT04560231 | Remdesivir in COVID-19 Lahore General Hospital | https://ClinicalTrials.gov/show/NCT04560231 |
| NCT04560205 | Tocilizumab in COVID-19 Lahore General Hospital | https://ClinicalTrials.gov/show/NCT04560205 |
| NCT04559113 | Methylprednisolone in COVID-19 Patients (Methyl19LGH) | https://ClinicalTrials.gov/show/NCT04559113 |
| NCT04559074 | Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension- Pilot Study for Remote Medical Management of Hypertension During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04559074 |
| NCT04557605 | Effects of a Face Mask on Oxygenation During Exercise | https://ClinicalTrials.gov/show/NCT04557605 |
| NCT04558476 | Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical Ventilation | https://ClinicalTrials.gov/show/NCT04558476 |
| NCT04558463 | The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19 | https://ClinicalTrials.gov/show/NCT04558463 |
| NCT04558411 | Brief, Scaleable Intervention for Coronavirus (COVID-19) Mental Health Sequelae in College Students | https://ClinicalTrials.gov/show/NCT04558411 |
| NCT04558372 | Genosvid Diagnostic Test for Early Detection of COVID-19 | https://ClinicalTrials.gov/show/NCT04558372 |
| NCT04558021 | A Study To Evaluate The Efficacy And Safety Of a Novel Niclosamide Suspension Formulation For COVID-19 | https://ClinicalTrials.gov/show/NCT04558021 |
| NCT04557046 | Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test | https://ClinicalTrials.gov/show/NCT04557046 |
| NCT04557241 | Brief Informational Intervention for COVID-19 Misinformation Prophylaxis | https://ClinicalTrials.gov/show/NCT04557241 |
| NCT04555148 | COVIDIG (COVID-19 Hyper-ImmunoGlobulin) | https://ClinicalTrials.gov/show/NCT04555148 |
| NCT04555096 | A Trial of GC4419 in Patients With Critical Illness Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04555096 |
| NCT04555005 | Mindfulness-based Crisis Intervention for COVID-19 Frontline Healthcare Workers During COVID-19 | https://ClinicalTrials.gov/show/NCT04555005 |
| NCT04555213 | A Dose Escalation and Dose Expansion Study of NOX66 in the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04555213 |
| NCT04554992 | Convalescent Plasma for the Treatment of COVID-19 (Coronavirus Disease 2019) | https://ClinicalTrials.gov/show/NCT04554992 |
| NCT04554264 | Complicated Grief in ICU in the Aftermath of COVID-19 | https://ClinicalTrials.gov/show/NCT04554264 |
| NCT04551547 | Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19 | https://ClinicalTrials.gov/show/NCT04551547 |
| NCT04553705 | Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19) | https://ClinicalTrials.gov/show/NCT04553705 |
| NCT04552379 | The Containing Coronavirus Disease 19 (COVID-19) Trial | https://ClinicalTrials.gov/show/NCT04552379 |
| NCT04552366 | A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults | https://ClinicalTrials.gov/show/NCT04552366 |
| NCT04551781 | Short Term Low Dose Corticosteroids for Management of Post covid19 Pulmonary Fibrosis | https://ClinicalTrials.gov/show/NCT04551781 |
| NCT04551768 | Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04551768 |
| NCT04551339 | Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19 | https://ClinicalTrials.gov/show/NCT04551339 |
| NCT04552951 | Effect of Vitamin D on Morbidity and Mortality of the COVID-19 | https://ClinicalTrials.gov/show/NCT04552951 |
| NCT04552483 | Effects of Early Use of Nitazoxanide in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04552483 |
| NCT04551911 | Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04551911 |
| NCT04551898 | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04551898 |
| NCT04550351 | Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old) | https://ClinicalTrials.gov/show/NCT04550351 |
| NCT04550325 | Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19 | https://ClinicalTrials.gov/show/NCT04550325 |
| NCT04549922 | Antisense Therapy to Block the Kallikrein-kinin Pathway in COVID-19 | https://ClinicalTrials.gov/show/NCT04549922 |
| NCT04548934 | Effect of Wearing Personal Protective Equipment (PPE) on CPR Quality in Times of the COVID-19-pandemic | https://ClinicalTrials.gov/show/NCT04548934 |
| NCT04549337 | Feasibility and Safety of High-intensity Exercise Training in Patients Surviving COVID-19 | https://ClinicalTrials.gov/show/NCT04549337 |
| NCT04549376 | Virucidal Effect of Povidone Iodine on COVID-19 In-Vivo | https://ClinicalTrials.gov/show/NCT04549376 |
| NCT04548531 | Engaging Patients in Colon Cancer Screening Decisions During COVID-19 | https://ClinicalTrials.gov/show/NCT04548531 |
| NCT04547660 | Convalescent Plasma for Severe COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04547660 |
| NCT04548544 | A Randomized Controlled Feasibility Study of Emotional Well-being of Adolescents Undergoing a Mindfulness Training During COVID-19 | https://ClinicalTrials.gov/show/NCT04548544 |
| NCT04547634 | Telerehabilitation in Oncology Patients | https://ClinicalTrials.gov/show/NCT04547634 |
| NCT04547140 | Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04547140 |
| NCT04547283 | Awake-Prone Positioning Strategy for Hypoxic Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04547283 |
| NCT04547257 | Safety & Effectiveness Evaluation of Seraph 100 in Treatment of Pts With COVID-19 | https://ClinicalTrials.gov/show/NCT04547257 |
| NCT04546841 | Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults | https://ClinicalTrials.gov/show/NCT04546841 |
| NCT04547127 | A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04547127 |
| NCT04545541 | Nebulised Heparin in Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04545541 |
| NCT04546737 | Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04546737 |
| NCT04546581 | Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC) | https://ClinicalTrials.gov/show/NCT04546581 |
| NCT04545749 | A Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04545749 |
| NCT04545060 | VIR-7831 for the Early Treatment of COVID-19 in Outpatients | https://ClinicalTrials.gov/show/NCT04545060 |
| NCT04545008 | Trial of Famotidine & N-Acetyl Cysteine for Outpatients With COVID-19 | https://ClinicalTrials.gov/show/NCT04545008 |
| NCT04543760 | Effect of Prone Positioning Combined With High Flow Oxygen Therapy on Oxygenation During Acute Respiratory Failure Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04543760 |
| NCT04542967 | Study on the Safety and Efficacy of Convalescent Plasma in Patients With Severe COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04542967 |
| NCT04542941 | Assessment of Safety and Efficacy of CCP | https://ClinicalTrials.gov/show/NCT04542941 |
| NCT04542876 | Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04542876 |
| NCT04542993 | Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy | https://ClinicalTrials.gov/show/NCT04542993 |
| NCT04542447 | To Evaluate Safety and Efficacy of Nuvastatic as an Immunomodulator Adjuvant Therapy in COVID-19 Patients. | https://ClinicalTrials.gov/show/NCT04542447 |
| NCT04542421 | Lung Ultrasound Implementation in the Management of Patients Hospitalized With COVID-19 | https://ClinicalTrials.gov/show/NCT04542421 |
| NCT04542408 | Hamburg Edoxaban for Anticoagulation in COVID-19 Study | https://ClinicalTrials.gov/show/NCT04542408 |
| NCT04542395 | COVID-2019 Testing and Vaccination Among African American and Latinx Public Housing Residents | https://ClinicalTrials.gov/show/NCT04542395 |
| NCT04542343 | COVID-19 Risk Reduction Among African American Parishioners | https://ClinicalTrials.gov/show/NCT04542343 |
| NCT04542694 | Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04542694 |
| NCT04542330 | Using BCG to Protect Senior Citizens During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04542330 |
| NCT04541979 | Aerosoliserat DNase for Treatment of Respiratory Failure in Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04541979 |
| NCT04542213 | Dipeptidyl Peptidase-4 Inhibitor (DPP4i) for the Control of Hyperglycemia in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04542213 |
| NCT04542031 | COVID-19 in a Single Large UK Rheumatology Centre and Impact on QOL | https://ClinicalTrials.gov/show/NCT04542031 |
| NCT04541485 | To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines) | https://ClinicalTrials.gov/show/NCT04541485 |
| NCT04541680 | Nintedanib for the Treatment of SARS-Cov-2 Induced Pulmonary Fibrosis | https://ClinicalTrials.gov/show/NCT04541680 |
| NCT04540939 | Neural Mechanisms of Mindfulness-based Cognitive Therapy (MBCT) for Posttraumatic Stress Disorder (PTSD) - COVID Related Substudy | https://ClinicalTrials.gov/show/NCT04540939 |
| NCT04540419 | Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Against COVID-19 | https://ClinicalTrials.gov/show/NCT04540419 |
| NCT04540406 | NBT-NM108 as an Early Treatment for Suspected or Confirmed Symptomatic COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04540406 |
| NCT04540185 | A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 | https://ClinicalTrials.gov/show/NCT04540185 |
| NCT04539821 | Virtual Pain Care Management (COVID-19) | https://ClinicalTrials.gov/show/NCT04539821 |
| NCT04536376 | First Responder Resiliency Program During COVID-19 | https://ClinicalTrials.gov/show/NCT04536376 |
| NCT04539795 | COVID-19 Study of Safety and Tolerability of Alvelestat | https://ClinicalTrials.gov/show/NCT04539795 |
| NCT04540120 | Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome | https://ClinicalTrials.gov/show/NCT04540120 |
| NCT04539626 | Estrogen Therapy in Non-severe COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04539626 |
| NCT04539275 | COVID-19 (VA CURES-1) | https://ClinicalTrials.gov/show/NCT04539275 |
| NCT04539262 | Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation | https://ClinicalTrials.gov/show/NCT04539262 |
| NCT04537663 | Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults | https://ClinicalTrials.gov/show/NCT04537663 |
| NCT04537962 | Salivary SARS-CoV-2 Load of Covid-19 Patients After Oral Antimicrobial Solutions and Dentifrices | https://ClinicalTrials.gov/show/NCT04537962 |
| NCT04537949 | A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04537949 |
| NCT04537858 | Virtual Reality Therapy Influence on Heart Rate Variability of Inpatients With COVID-19 | https://ClinicalTrials.gov/show/NCT04537858 |
| NCT04537806 | A Study of Brexanolone for Acute Respiratory Distress Syndrome Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04537806 |
| NCT04537208 | Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older | https://ClinicalTrials.gov/show/NCT04537208 |
| NCT04537351 | The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying Cause | https://ClinicalTrials.gov/show/NCT04537351 |
| NCT04537299 | COVID-FIS: Pilot in COVID-19 (SARS-CoV-2) of Fisetin in Older Adults in Nursing Homes | https://ClinicalTrials.gov/show/NCT04537299 |
| NCT04536350 | Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS | https://ClinicalTrials.gov/show/NCT04536350 |
| NCT04536298 | Vitamin D and COVID-19 Trial | https://ClinicalTrials.gov/show/NCT04536298 |
| NCT04535869 | Efficacy and Safety of Direct Anti HCV Drugs in the Treatment of SARS-COV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04535869 |
| NCT04535856 | Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04535856 |
| NCT04535791 | Efficacy of Vitamin D Supplementation to Prevent the Risk of Acquiring COVID-19 in Healthcare Workers | https://ClinicalTrials.gov/show/NCT04535791 |
| NCT04535778 | COMPASS Study: an Online Cognitive-behavioural Therapy (CBT) Program Treating Anxiety and Low Mood in Long-term Conditions During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04535778 |
| NCT04536935 | Mobile Mental Health Apps for Suicide Prevention | https://ClinicalTrials.gov/show/NCT04536935 |
| NCT04536441 | Ultra-brief Online Mindfulness-based Intervention During COVID-19 Movement Control Order | https://ClinicalTrials.gov/show/NCT04536441 |
| NCT04536051 | A Study of a Candidate COVID-19 Vaccine (COV003) | https://ClinicalTrials.gov/show/NCT04536051 |
| NCT04535700 | Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19 | https://ClinicalTrials.gov/show/NCT04535700 |
| NCT04535674 | Asunercept in Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04535674 |
| NCT04535167 | First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19. | https://ClinicalTrials.gov/show/NCT04535167 |
| NCT04535063 | Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04535063 |
| NCT04534725 | COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial; | https://ClinicalTrials.gov/show/NCT04534725 |
| NCT04534673 | Pegylated Interferon Lambda for Treatment of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04534673 |
| NCT04534790 | Anti-inflammatory Effect of Low-Dose Whole-Lung Radiation for COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04534790 |
| NCT04532372 | Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy | https://ClinicalTrials.gov/show/NCT04532372 |
| NCT04533399 | A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults | https://ClinicalTrials.gov/show/NCT04533399 |
| NCT04533347 | Tafenoquine in Patients With Mild to Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04533347 |
| NCT04532931 | COVID-19 Treatment in South Africa | https://ClinicalTrials.gov/show/NCT04532931 |
| NCT04532294 | Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants | https://ClinicalTrials.gov/show/NCT04532294 |
| NCT04531774 | RECHARGE: A Brief Psychological Intervention to Build Resilience in Healthcare Workers During COVID-19 | https://ClinicalTrials.gov/show/NCT04531774 |
| NCT04531618 | Mother-infant Bonding During COVID-19 | https://ClinicalTrials.gov/show/NCT04531618 |
| NCT04530656 | Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell) | https://ClinicalTrials.gov/show/NCT04530656 |
| NCT04530617 | Camostat and Artemisia Annua vs Placebo in COVID-19 Outpatients | https://ClinicalTrials.gov/show/NCT04530617 |
| NCT04530539 | The Effect of Melatonin and Vitamin C on COVID-19 | https://ClinicalTrials.gov/show/NCT04530539 |
| NCT04530604 | Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS) | https://ClinicalTrials.gov/show/NCT04530604 |
| NCT04530578 | Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19 | https://ClinicalTrials.gov/show/NCT04530578 |
| NCT04530448 | Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization | https://ClinicalTrials.gov/show/NCT04530448 |
| NCT04530435 | PEP Flute-selfcare in COVID-19 | https://ClinicalTrials.gov/show/NCT04530435 |
| NCT04530422 | Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment | https://ClinicalTrials.gov/show/NCT04530422 |
| NCT04530409 | Timing of Corticosteroids in COVID-19 | https://ClinicalTrials.gov/show/NCT04530409 |
| NCT04530396 | Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04530396 |
| NCT04530370 | Efficacy and Safety of Recovered Covid 19 Plasma Transfusion to Covid 19 Severly Ill Patients | https://ClinicalTrials.gov/show/NCT04530370 |
| NCT04530357 | Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04530357 |
| NCT04530136 | Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04530136 |
| NCT04529525 | Ivermectin to Prevent Hospitalizations in COVID-19 | https://ClinicalTrials.gov/show/NCT04529525 |
| NCT04529499 | Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04529499 |
| NCT04528888 | Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04528888 |
| NCT04528667 | Study of the Safety and Efficacy of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04528667 |
| NCT04528641 | GRAd-COV2 Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04528641 |
| NCT04527575 | Study of the Safety, Reactogenicity and Immunogenicity of “EpiVacCorona” Vaccine for the Prevention of COVID-19 | https://ClinicalTrials.gov/show/NCT04527575 |
| NCT04527562 | Colchicine in Moderate Symptomatic COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04527562 |
| NCT04527471 | Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04527471 |
| NCT04528368 | Convalescent Plasma for Treating Patients With COVID-19 Pneumonia Without Indication of Ventilatory Support | https://ClinicalTrials.gov/show/NCT04528368 |
| NCT04528329 | Anosmia and / or Ageusia and Early Corticosteroid Use | https://ClinicalTrials.gov/show/NCT04528329 |
| NCT04527432 | COVID-19 Health Professional Impact Study | https://ClinicalTrials.gov/show/NCT04527432 |
| NCT04527354 | Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04527354 |
| NCT04527081 | Study of COVID-19 DNA Vaccine (AG0302-COVID19) | https://ClinicalTrials.gov/show/NCT04527081 |
| NCT04527133 | An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19 | https://ClinicalTrials.gov/show/NCT04527133 |
| NCT04526990 | Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above | https://ClinicalTrials.gov/show/NCT04526990 |
| NCT04526912 | Treatment and Prevention of Acute Lung Injury (ALI) in Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04526912 |
| NCT04526145 | OUR Stress/ Emotion Management for Black/African American Women With Hypertension | https://ClinicalTrials.gov/show/NCT04526145 |
| NCT04525742 | COVID-19 Pandemic and Parents of Disabled Children | https://ClinicalTrials.gov/show/NCT04525742 |
| NCT04525820 | High Dose Vitamin-D Substitution in Patients With COVID-19: a Randomized Controlled, Multi Center Study | https://ClinicalTrials.gov/show/NCT04525820 |
| NCT04526054 | Morphological Abnormalities of the Olfactory Bulb on MRI and Olfactometry in Anosmic Versus Normosmic COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04526054 |
| NCT04525417 | Rapid Screening Test for Covid-19 Antibodies in Healthcare Workers | https://ClinicalTrials.gov/show/NCT04525417 |
| NCT04525378 | MSC-based Therapy in COVID-19-associated Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04525378 |
| NCT04524507 | COVID-19 Antibody Plasma Research Study in Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04524507 |
| NCT04524663 | Oral Camostat Compared With Standard Supportive Care in Mild-Moderate COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04524663 |
| NCT04524598 | A CBT-based Mobile Intervention as First Line Treatment for Adolescent Depression During COVID-19 | https://ClinicalTrials.gov/show/NCT04524598 |
| NCT04523831 | Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04523831 |
| NCT04523571 | Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects | https://ClinicalTrials.gov/show/NCT04523571 |
| NCT04523246 | Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents | https://ClinicalTrials.gov/show/NCT04523246 |
| NCT04523181 | Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04523181 |
| NCT04523090 | Catalysing the Containment of COVID-19 | https://ClinicalTrials.gov/show/NCT04523090 |
| NCT04522986 | An Exploratory Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04522986 |
| NCT04522128 | Does Quality of Life Decline During the COVID-19 Pandemic and Can we Change Behaviour to Improve Poor Quality of Life? | https://ClinicalTrials.gov/show/NCT04522128 |
| NCT04522830 | A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19 | https://ClinicalTrials.gov/show/NCT04522830 |
| NCT04522492 | Impact of COVID-19 on Mental Health of Patients With Skin Picking | https://ClinicalTrials.gov/show/NCT04522492 |
| NCT04522466 | Evaluation of the Pharmacokinetics and Pharmacodynamics of Hydroxychloroquine in COVID-19 Intensive Care Unit Patients | https://ClinicalTrials.gov/show/NCT04522466 |
| NCT04521322 | Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04521322 |
| NCT04521296 | Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo | https://ClinicalTrials.gov/show/NCT04521296 |
| NCT04521309 | SARS-CoV-2 Antibodies Based IVIG Therapy for COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04521309 |
| NCT04519437 | Study Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19 | https://ClinicalTrials.gov/show/NCT04519437 |
| NCT04519411 | Transpulmonary Pressure Measurements in Intubated Children With Covid-19 Respiratory Failure | https://ClinicalTrials.gov/show/NCT04519411 |
| NCT04519385 | Toclizumam Versus Dexamethasone in Severe Covid-19 Cases | https://ClinicalTrials.gov/show/NCT04519385 |
| NCT04519320 | Medium and Long Term Follow-up of COVID-19 Infected Patients: Research and Characterization of Pulmonary Sequelae | https://ClinicalTrials.gov/show/NCT04519320 |
| NCT04518969 | Determination of the Hemoadsorption Impact as Adjunctive Treatment Upon the Support Therapy of COVID-19 | https://ClinicalTrials.gov/show/NCT04518969 |
| NCT04519216 | Breastfeeding Education in the Time of COVID-19 | https://ClinicalTrials.gov/show/NCT04519216 |
| NCT04518514 | Telemedical Risk Assessment and Preoperative Evaluation (TAPE) | https://ClinicalTrials.gov/show/NCT04518514 |
| NCT04517162 | Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04517162 |
| NCT04517422 | Efficacy of L. Plantarum and P. Acidilactici in Adults With SARS-CoV-2 and COVID-19 | https://ClinicalTrials.gov/show/NCT04517422 |
| NCT04517123 | Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The “PRONE” Study | https://ClinicalTrials.gov/show/NCT04517123 |
| NCT04517396 | FEnofibRate as a Metabolic INtervention for COVID-19 | https://ClinicalTrials.gov/show/NCT04517396 |
| NCT04517006 | Prosocial Behavior Can Safeguard Mental Health and Foster Emotional Well-being During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04517006 |
| NCT04516746 | Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults | https://ClinicalTrials.gov/show/NCT04516746 |
| NCT04516954 | Convalescent Plasma for COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04516954 |
| NCT04516941 | CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19 | https://ClinicalTrials.gov/show/NCT04516941 |
| NCT04516915 | IMU-838 and Oseltamivir in the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04516915 |
| NCT04516837 | Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19) | https://ClinicalTrials.gov/show/NCT04516837 |
| NCT04516811 | Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04516811 |
| NCT04516759 | AZD1656 in Diabetic Patients Hospitalised With Suspected or Confirmed COVID-19 | https://ClinicalTrials.gov/show/NCT04516759 |
| NCT04515147 | A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19 | https://ClinicalTrials.gov/show/NCT04515147 |
| NCT04514900 | Exploring Optimal Treatment Components for Contactless Online Group-based Behavioral Weight Loss Program | https://ClinicalTrials.gov/show/NCT04514900 |
| NCT04514705 | Characteristics in Post Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04514705 |
| NCT04514627 | Neuromodulation With Percutaneous Electrical Nerve Field Stimulation for Adults With COVID-19 | https://ClinicalTrials.gov/show/NCT04514627 |
| NCT04513990 | Novel Point-of-Care Diagnostic Test for SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04513990 |
| NCT04513470 | Allocetra-OTS in COVID-19 | https://ClinicalTrials.gov/show/NCT04513470 |
| NCT04513184 | Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04513184 |
| NCT04513158 | Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection | https://ClinicalTrials.gov/show/NCT04513158 |
| NCT04512079 | FREEDOM COVID-19 Anticoagulation Strategy | https://ClinicalTrials.gov/show/NCT04512079 |
| NCT04512027 | Prolectin-M in COVID-19 Patients Having Mild to Moderate Symptoms Not Requiring Oxygen Support. | https://ClinicalTrials.gov/show/NCT04512027 |
| NCT04511819 | Losmapimod Safety and Efficacy in COVID-19 | https://ClinicalTrials.gov/show/NCT04511819 |
| NCT04511949 | COVID-19: Epidemiological Study of the Spread of SARS-CoV-2 in the Household of a Person Who Has Had a COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04511949 |
| NCT04511923 | Nebulised Heparin to Reduce COVID-19 Induced Acute Lung Injury | https://ClinicalTrials.gov/show/NCT04511923 |
| NCT04511650 | A Study to Evaluate the Safety and Efficacy of Razuprotafib, a Novel Tie 2 Activator, in Hospitalized Subjects With Moderate to Severe Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04511650 |
| NCT04510662 | Telmisartan in Respiratory Failure Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04510662 |
| NCT04510493 | Canakinumab in Patients With COVID-19 and Type 2 Diabetes | https://ClinicalTrials.gov/show/NCT04510493 |
| NCT04510207 | A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above | https://ClinicalTrials.gov/show/NCT04510207 |
| NCT04510194 | COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04510194 |
| NCT04510454 | Evaluation of a ddPCR Technology for the SARS-CoV-2 Detection in Symptomatic Patients With Suspicion of COVID-19 | https://ClinicalTrials.gov/show/NCT04510454 |
| NCT04509973 | Higher vs. Lower Doses of Dexamethasone for COVID-19 and Severe Hypoxia | https://ClinicalTrials.gov/show/NCT04509973 |
| NCT04508868 | Treatment of Depressive Symptoms in Older Individuals in Isolation During Covid-19 | https://ClinicalTrials.gov/show/NCT04508868 |
| NCT04508439 | Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04508439 |
| NCT04508075 | Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine | https://ClinicalTrials.gov/show/NCT04508075 |
| NCT04507867 | Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III | https://ClinicalTrials.gov/show/NCT04507867 |
| NCT04506268 | COVID-19 SAFE Enrollment | https://ClinicalTrials.gov/show/NCT04506268 |
| NCT04505774 | Anti-thrombotics for Adults Hospitalized With COVID-19 (ACTIV-4) | https://ClinicalTrials.gov/show/NCT04505774 |
| NCT04505761 | The Usability, Feasibility, and Tolerability of Virtual Reality for Rehabilitation From COVID-19 | https://ClinicalTrials.gov/show/NCT04505761 |
| NCT04505592 | Tenecteplase in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04505592 |
| NCT04502667 | Efficacy of Vitamin D Treatment in Pediatric Patients Hospitalized by COVID-19 | https://ClinicalTrials.gov/show/NCT04502667 |
| NCT04504877 | Burnout and Distress preventiOn With caNnabidiol in Front-line Health Care workerS deAling wIth COVID-19 | https://ClinicalTrials.gov/show/NCT04504877 |
| NCT04504734 | Bucillamine in Treatment of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04504734 |
| NCT04502342 | Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug vs Hydroxychloroquine in Uncomplicated COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04502342 |
| NCT04502472 | Open-label Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma | https://ClinicalTrials.gov/show/NCT04502472 |
| NCT04502433 | Poractant Alfa - Curosurf and SARS-COV-19 ARDS (Covid-19) | https://ClinicalTrials.gov/show/NCT04502433 |
| NCT04502056 | Covid-19 Messaging to Underserved Communities - 2nd Experiment | https://ClinicalTrials.gov/show/NCT04502056 |
| NCT04501965 | Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04501965 |
| NCT04501952 | Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734â„¢) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting | https://ClinicalTrials.gov/show/NCT04501952 |
| NCT04501796 | A Trial of NT-I7 in COVID-19 (SPESELPIS) | https://ClinicalTrials.gov/show/NCT04501796 |
| NCT04501783 | Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04501783 |
| NCT04501458 | Western Kenya Integrated COVID-19 Response | https://ClinicalTrials.gov/show/NCT04501458 |
| NCT04501445 | Psychological Symptoms and Families of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04501445 |
| NCT04500626 | Hyperbaric Versus Normobaric Oxygen Therapy for COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04500626 |
| NCT04499677 | FLARE: Favipiravir +/- Lopinavir: A RCT of Early Antivirals | https://ClinicalTrials.gov/show/NCT04499677 |
| NCT04500418 | Charité Trial of Cenicriviroc (CVC) Treatment for COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04500418 |
| NCT04500366 | GERAS Frailty Rehabilitation at Home During COVID-19 | https://ClinicalTrials.gov/show/NCT04500366 |
| NCT04500132 | To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia | https://ClinicalTrials.gov/show/NCT04500132 |
| NCT04500067 | Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment | https://ClinicalTrials.gov/show/NCT04500067 |
| NCT04499391 | COVID-19 Project ECHO in Nursing Homes | https://ClinicalTrials.gov/show/NCT04499391 |
| NCT04499313 | Dexamethasone Vs Methylprednisolone for the Treatment of Patients With ARDS Caused by COVID-19 | https://ClinicalTrials.gov/show/NCT04499313 |
| NCT04498936 | Sofosbuvir/Ledipasvir and Nitazoxanide for Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04498936 |
| NCT04498273 | COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 | https://ClinicalTrials.gov/show/NCT04498273 |
| NCT04498247 | A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001) | https://ClinicalTrials.gov/show/NCT04498247 |
| NCT04497948 | Acalabrutinib Study With Best Supportive Care in Participants Hospitalized With COVID-19 | https://ClinicalTrials.gov/show/NCT04497948 |
| NCT04498442 | A Study on Prevalence, Protection and Recovery From COVID-19 in Seasoned Yoga Practitioners in Comparison to Age and Gender Matched Controls | https://ClinicalTrials.gov/show/NCT04498442 |
| NCT04498377 | Study of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04498377 |
| NCT04497987 | A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff | https://ClinicalTrials.gov/show/NCT04497987 |
| NCT04497649 | Sofosbuvir Containing Regimens in Treatment of COVID 19 Patients | https://ClinicalTrials.gov/show/NCT04497649 |
| NCT04497454 | Mechanical Ventilation Strategy for Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04497454 |
| NCT04497415 | The COVID-19 and Healthcare Workers: An Active Intervention | https://ClinicalTrials.gov/show/NCT04497415 |
| NCT04497389 | Safety and Feasibility of Amniotic Fluid as a Treatment for COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04497389 |
| NCT04497623 | Clinical Evaluation of Ventilador Innovation Product in Colombia in the SARS COVID 19 Pandemic, Unisabana Herons. | https://ClinicalTrials.gov/show/NCT04497623 |
| NCT04495933 | A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults | https://ClinicalTrials.gov/show/NCT04495933 |
| NCT04497298 | Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04497298 |
| NCT04497272 | Assesment of the Metabolomic Signature in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04497272 |
| NCT04496245 | Reducing Acute Severe Respiratory Events in Health Care Workers During the Covid-19 Pandemic With OM85 | https://ClinicalTrials.gov/show/NCT04496245 |
| NCT04495543 | Mitigating Suicide Risk With Single Session ‘Brief Skills for Safer Living’ | https://ClinicalTrials.gov/show/NCT04495543 |
| NCT04495842 | The Effect of Aromatherapy on COVID-19-induced Anxiety | https://ClinicalTrials.gov/show/NCT04495842 |
| NCT04495816 | COVID-19 Anosmia Study | https://ClinicalTrials.gov/show/NCT04495816 |
| NCT04495803 | Augmented CBGT for Perinatal Anxiety During a Global Pandemic (COVID-19) | https://ClinicalTrials.gov/show/NCT04495803 |
| NCT04494867 | Core Warming in COVID-19 Patients Undergoing Mechanical Ventilation | https://ClinicalTrials.gov/show/NCT04494867 |
| NCT04494984 | A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19. | https://ClinicalTrials.gov/show/NCT04494984 |
| NCT04495101 | Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19 | https://ClinicalTrials.gov/show/NCT04495101 |
| NCT04494724 | Clazakizumab vs. Placebo - COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04494724 |
| NCT04494399 | IFN Beta-1b and Ribavirin for Covid-19 | https://ClinicalTrials.gov/show/NCT04494399 |
| NCT04494646 | BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04494646 |
| NCT04494386 | Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS | https://ClinicalTrials.gov/show/NCT04494386 |
| NCT04492527 | Student-delivered Telehealth Program for COVID-19 Education and Health Promotion | https://ClinicalTrials.gov/show/NCT04492527 |
| NCT04494204 | Effect of a Combination of Treatment of Reginmune Capsule and Immunofree Tablets in the Treatment of Mild to Moderate COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04494204 |
| NCT04493242 | Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS | https://ClinicalTrials.gov/show/NCT04493242 |
| NCT04492358 | Treatment for Moderate/Severe COVID-19 in a Fragile and Vulnerable Population, Admitted to a Geriatric Hospital Unit or in a Transicional Care Center | https://ClinicalTrials.gov/show/NCT04492358 |
| NCT04493359 | Switch of Renin-Angiotensin System Inhibitors in Patients With Covid-19 | https://ClinicalTrials.gov/show/NCT04493359 |
| NCT04492514 | Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflation | https://ClinicalTrials.gov/show/NCT04492514 |
| NCT04492501 | Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan | https://ClinicalTrials.gov/show/NCT04492501 |
| NCT04492475 | Adaptive COVID-19 Treatment Trial 3 (ACTT-3) | https://ClinicalTrials.gov/show/NCT04492475 |
| NCT04492254 | Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients | https://ClinicalTrials.gov/show/NCT04492254 |
| NCT04492228 | Eucaloric Ketogenic Diet in COVID-19 Cytokine Storm Syndrome | https://ClinicalTrials.gov/show/NCT04492228 |
| NCT04492410 | COVID-19 Infection Screening in Cancer Patients (NEOSCREENCOVID) | https://ClinicalTrials.gov/show/NCT04492410 |
| NCT04491994 | Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression | https://ClinicalTrials.gov/show/NCT04491994 |
| NCT04491240 | Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia. | https://ClinicalTrials.gov/show/NCT04491240 |
| NCT04490850 | COVID-19 Seroprevalence Study in French Guiana | https://ClinicalTrials.gov/show/NCT04490850 |
| NCT04490824 | Inhalation of KELEA Excellerated Water in Covid-19 Infected Individuals | https://ClinicalTrials.gov/show/NCT04490824 |
| NCT04490278 | CoV-PICS: A Virtual Post-ICU Clinic | https://ClinicalTrials.gov/show/NCT04490278 |
| NCT04490473 | Turkish of the SARS-CoV-2 Anxiety Scale | https://ClinicalTrials.gov/show/NCT04490473 |
| NCT04490200 | Effectiveness of a Novel Respirator With Chitosan Nanoparticles | https://ClinicalTrials.gov/show/NCT04490200 |
| NCT04489446 | Sildenafil in COVID-19 | https://ClinicalTrials.gov/show/NCT04489446 |
| NCT04489628 | Tele-health Enabled Clinical Trial for COVID-19 | https://ClinicalTrials.gov/show/NCT04489628 |
| NCT04488796 | STAND UP to SARS-CoV-2 (COVID-19): Using Behavioural Economics to Reduce Sedentary Behaviour in At-home Office Workers | https://ClinicalTrials.gov/show/NCT04488796 |
| NCT04488575 | Safety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04488575 |
| NCT04488484 | Medical and Serological Follow-up of the Staff of the Paris Saint-Joseph Hospital Group Infected With Severe Acute Respiratory Syndrome Coronavirus 2. | https://ClinicalTrials.gov/show/NCT04488484 |
| NCT04488081 | I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients | https://ClinicalTrials.gov/show/NCT04488081 |
| NCT04487990 | CoV-Hep Study: Regional Anticoagulation Modalities in Continuous Venous Venous Hemodialysis in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04487990 |
| NCT04487964 | Complementary Intervention for COVID-19 | https://ClinicalTrials.gov/show/NCT04487964 |
| NCT04487886 | Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04487886 |
| NCT04487639 | Presence of SARS-CoV-2 in Semen: Impact on Fertility Preservation in Male Oncological Patients ? | https://ClinicalTrials.gov/show/NCT04487639 |
| NCT04487574 | A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04487574 |
| NCT04487691 | Nebulized PL for Post-COVID-19 Syndrome | https://ClinicalTrials.gov/show/NCT04487691 |
| NCT04487444 | Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04487444 |
| NCT04487171 | Screening for Postpartum Depression and Associated Risk Factors Among Women Who Deliver in Four Hospital in France During the COVID-19 Epidemic | https://ClinicalTrials.gov/show/NCT04487171 |
| NCT04487210 | A Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 Against COVID-19 | https://ClinicalTrials.gov/show/NCT04487210 |
| NCT04485130 | DISulfiram for COvid-19 (DISCO) Trial | https://ClinicalTrials.gov/show/NCT04485130 |
| NCT04486482 | A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function | https://ClinicalTrials.gov/show/NCT04486482 |
| NCT04486313 | Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04486313 |
| NCT04486508 | Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04486508 |
| NCT04486001 | Study of Intravenous Administration of Allogeneic Adipose Stem Cells for COVID-19 | https://ClinicalTrials.gov/show/NCT04486001 |
| NCT04484493 | Corticosteroid Nasal Spray in COVID-19 Anosmia | https://ClinicalTrials.gov/show/NCT04484493 |
| NCT04485169 | Therapeutic Plasma Exchange for Coronavirus Disease-2019 Triggered Cytokine Release Storm; | https://ClinicalTrials.gov/show/NCT04485169 |
| NCT04483960 | Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial | https://ClinicalTrials.gov/show/NCT04483960 |
| NCT04483375 | Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects | https://ClinicalTrials.gov/show/NCT04483375 |
| NCT04483830 | Suloexide in the Treatment of Early Stages of COVID-19 | https://ClinicalTrials.gov/show/NCT04483830 |
| NCT04483752 | Predicting the Progression to Chronic Fibrosis of Lung Lesions Related to Covid-19 Infection From Chest CT Images | https://ClinicalTrials.gov/show/NCT04483752 |
| NCT04483635 | PRevention of COVID-19 With Oral Vitamin D Supplemental Therapy in Essential healthCare Teams | https://ClinicalTrials.gov/show/NCT04483635 |
| NCT04482387 | DigiVis: Self-testing Vision App for Telephone Consultations | https://ClinicalTrials.gov/show/NCT04482387 |
| NCT04482647 | Breathing Techniques and Meditation for Health Care Workers During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04482647 |
| NCT04482634 | Tele-rehabilitation Versus Home Exercise Program in COVID-19 | https://ClinicalTrials.gov/show/NCT04482634 |
| NCT04482595 | BIO 300 Oral Suspension in Discharged COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04482595 |
| NCT04483271 | The Effect of Omega-3 on Selected Cytokines Involved in Cytokine Storm | https://ClinicalTrials.gov/show/NCT04483271 |
| NCT04482621 | Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial | https://ClinicalTrials.gov/show/NCT04482621 |
| NCT04482699 | RAPA-501-Allo Therapy of COVID-19-ARDS | https://ClinicalTrials.gov/show/NCT04482699 |
| NCT04482673 | Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04482673 |
| NCT04481685 | A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04481685 |
| NCT04481633 | Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04481633 |
| NCT04480424 | Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04480424 |
| NCT04480957 | Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects | https://ClinicalTrials.gov/show/NCT04480957 |
| NCT04480593 | The Use of Brazilian Green Propolis Extract (EPP-AF) in Patients Affected by COVID-19. | https://ClinicalTrials.gov/show/NCT04480593 |
| NCT04479358 | Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04479358 |
| NCT04480112 | Impact of Covid-19 on Frequent Social Interaction Through Communication Technologies in the Cognitive Status of Socially-isolated Older Adults | https://ClinicalTrials.gov/show/NCT04480112 |
| NCT04480138 | Pegylated Interferon - α2b With SARSCoV- 2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04480138 |
| NCT04479540 | Assessment of the Risk of Pulmonary Embolism and Coagulation Profile in Patients With COVID-19 Lung Disease | https://ClinicalTrials.gov/show/NCT04479540 |
| NCT04479202 | The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19 | https://ClinicalTrials.gov/show/NCT04479202 |
| NCT04479163 | Prevention of Severe Covid-19 in Infected Elderly by Early Administration of Convalescent Plasma With High-titers of Antibody Against SARS-CoV2 | https://ClinicalTrials.gov/show/NCT04479163 |
| NCT04477954 | Hyperbaric Oxygen as an Adjuvant Treatment for Patients With Covid-19 Severe Hypoxemia | https://ClinicalTrials.gov/show/NCT04477954 |
| NCT04478539 | Extracorporeal Blood Purification as a Treatment Modality for COVID-19 | https://ClinicalTrials.gov/show/NCT04478539 |
| NCT04477083 | Development and Validation of “Ready-to-Use” Inhalable Forms of Hydroxychloroquine for Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04477083 |
| NCT04478019 | SHIELD Study: Using Naso-oropharyngeal Antiseptic Decolonization to Reduce COVID-19 Viral Shedding | https://ClinicalTrials.gov/show/NCT04478019 |
| NCT04477993 | Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04477993 |
| NCT04477668 | Helmet Non-Invasive Ventilation for COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04477668 |
| NCT04477655 | Prone Positioning in Non-intubated Patients With COVID-19 Associated Acute Respiratory Failure | https://ClinicalTrials.gov/show/NCT04477655 |
| NCT04476992 | Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement | https://ClinicalTrials.gov/show/NCT04476992 |
| NCT04476953 | COVID-FISETIN: Pilot in SARS-CoV-2 of Fisetin to Alleviate Dysfunction and Inflammation | https://ClinicalTrials.gov/show/NCT04476953 |
| NCT04476888 | Convalescent Plasma Treatment in COVID-19 | https://ClinicalTrials.gov/show/NCT04476888 |
| NCT04476745 | The Effect of D3 on Selected Cytokines Involved in Cytokine Storm in the Covid-19 Uninfected Jordanian People | https://ClinicalTrials.gov/show/NCT04476745 |
| NCT04476680 | Influence of Military Preventive Policy for reCruit Training on COVID-19 Seroconversion | https://ClinicalTrials.gov/show/NCT04476680 |
| NCT04476667 | Online Delivery of Psychotherapy, Tailored to Patients’ Suffering From Mental Health Problems Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04476667 |
| NCT04476979 | Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19 | https://ClinicalTrials.gov/show/NCT04476979 |
| NCT04475120 | Efficacy and Safety of Liposomal Lactoferrin in COVID-19 Patients With Mild-to-Moderate Disease and in COVID-19 Asymptomatic Patients | https://ClinicalTrials.gov/show/NCT04475120 |
| NCT04475991 | Safety and Efficacy of Maraviroc and/or Favipiravir With Standard Therapy in Severe COVID-19 Adults | https://ClinicalTrials.gov/show/NCT04475991 |
| NCT04475601 | Enzalutamide Treatment in COVID-19 | https://ClinicalTrials.gov/show/NCT04475601 |
| NCT04475588 | Efficacy and Safety of Itolizumab in COVID-19 Complications | https://ClinicalTrials.gov/show/NCT04475588 |
| NCT04475575 | Can the Electronic Nose Smell COVID-19 Antibodies? | https://ClinicalTrials.gov/show/NCT04475575 |
| NCT04475562 | Can the Electronic Nose Smell COVID-19? | https://ClinicalTrials.gov/show/NCT04475562 |
| NCT04475302 | BCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 Hotspots | https://ClinicalTrials.gov/show/NCT04475302 |
| NCT04475185 | Safety and Effectiveness Assessment of the MakAir Artificial Ventilator | https://ClinicalTrials.gov/show/NCT04475185 |
| NCT04475913 | Digital vs Analog Impression in Cases of All-on-4 - Prosthesis | https://ClinicalTrials.gov/show/NCT04475913 |
| NCT04475107 | The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04475107 |
| NCT04474340 | COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients | https://ClinicalTrials.gov/show/NCT04474340 |
| NCT04474483 | Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19 | https://ClinicalTrials.gov/show/NCT04474483 |
| NCT04473690 | KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT04473690 |
| NCT04473898 | Telerehabilitation After Coronavirus | https://ClinicalTrials.gov/show/NCT04473898 |
| NCT04473170 | Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19 | https://ClinicalTrials.gov/show/NCT04473170 |
| NCT04473274 | GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot Study | https://ClinicalTrials.gov/show/NCT04473274 |
| NCT04473261 | Efficacy of Iodine Complex Against COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04473261 |
| NCT04473248 | Spartan COVID-19 System: Evaluation of Clinical Sample Collection | https://ClinicalTrials.gov/show/NCT04473248 |
| NCT04473053 | DEFINE - Evaluating Therapies for COVID-19 | https://ClinicalTrials.gov/show/NCT04473053 |
| NCT04472728 | Testing the Efficacy and Safety of BIO101 for the Prevention of Respiratory Deterioration in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04472728 |
| NCT04472611 | Colchicine/Statins for the Prevention of COVID-19 Complications (COLSTAT) Trial | https://ClinicalTrials.gov/show/NCT04472611 |
| NCT04472585 | Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04472585 |
| NCT04472559 | Acupressure for COVID-19 Related Quality of Life and Stress | https://ClinicalTrials.gov/show/NCT04472559 |
| NCT04472494 | Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise | https://ClinicalTrials.gov/show/NCT04472494 |
| NCT04471766 | Locally Produced Cloth Face Mask and COVID-19 Like Illness Prevention | https://ClinicalTrials.gov/show/NCT04471766 |
| NCT04471636 | Telemedicine in Outpatient Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04471636 |
| NCT04470739 | Is Thymus Size of Infants Who Born to COVID-19 Positive Mothers Associated With Neonatal Morbidities? | https://ClinicalTrials.gov/show/NCT04470739 |
| NCT04470869 | Impact on the OLAF Intervention to Prevent Post Traumatic Disorders During the Confinement. | https://ClinicalTrials.gov/show/NCT04470869 |
| NCT04471519 | Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT04471519 |
| NCT04470999 | Changes in Cellular Immune Profile During COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04470999 |
| NCT04470609 | Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ⩾60 Years | https://ClinicalTrials.gov/show/NCT04470609 |
| NCT04470544 | Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04470544 |
| NCT04470531 | Role of Co-trimoxazole in Severe COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04470531 |
| NCT04470427 | A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19 | https://ClinicalTrials.gov/show/NCT04470427 |
| NCT04470258 | Elmo Respiratory Support Project - COVID-19 | https://ClinicalTrials.gov/show/NCT04470258 |
| NCT04469491 | Treatment of COVID-19 by Nebulization of Inteferon Beta 1b Efficiency and Safety Study | https://ClinicalTrials.gov/show/NCT04469491 |
| NCT04469634 | Are SARS-CoV-2 Specific Antibodies a Correlate for Protection? | https://ClinicalTrials.gov/show/NCT04469634 |
| NCT04469621 | A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04469621 |
| NCT04468971 | REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia | https://ClinicalTrials.gov/show/NCT04468971 |
| NCT04468893 | Online Positive Psychology Intervention for Depression and Anxiety Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04468893 |
| NCT04469114 | Tofacitinib in Hospitalized Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04469114 |
| NCT04468646 | To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04468646 |
| NCT04468009 | Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma | https://ClinicalTrials.gov/show/NCT04468009 |
| NCT04468139 | The Study of Quadruple Therapy Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected With COVID-19 | https://ClinicalTrials.gov/show/NCT04468139 |
| NCT04467918 | CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms | https://ClinicalTrials.gov/show/NCT04467918 |
| NCT04467840 | Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04467840 |
| NCT04468087 | Antiviral Agents Against COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04468087 |
| NCT04466540 | Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04466540 |
| NCT04466800 | Functional and Respiratory Rehabilitation and Nutritional Care of COVID-19 Patients (RECOVER-19) | https://ClinicalTrials.gov/show/NCT04466800 |
| NCT04466683 | Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia | https://ClinicalTrials.gov/show/NCT04466683 |
| NCT04466670 | Hemostasis in COVID-19: an Adaptive Clinical Trial | https://ClinicalTrials.gov/show/NCT04466670 |
| NCT04466098 | Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19) | https://ClinicalTrials.gov/show/NCT04466098 |
| NCT04466085 | Clinical Study of Recombinant Novel Coronavirus Vaccine | https://ClinicalTrials.gov/show/NCT04466085 |
| NCT04466605 | Effect of Tele-Yoga Therapy on Patients With Chronic Musculoskeletal Pain During Covid-19 Lockdown | https://ClinicalTrials.gov/show/NCT04466605 |
| NCT04466280 | Efficacy and Safety of Mucoadhesive Sustained Release, Mucodentol, in Comparison With Hydroxychloroquine to Prevent COVID-19 | https://ClinicalTrials.gov/show/NCT04466280 |
| NCT04466241 | Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial | https://ClinicalTrials.gov/show/NCT04466241 |
| NCT04465604 | Hypertonic Saline for COVID-19 Symptoms | https://ClinicalTrials.gov/show/NCT04465604 |
| NCT04465695 | Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19 | https://ClinicalTrials.gov/show/NCT04465695 |
| NCT04465513 | Investigation of the Efficacy of CARDIO Softgels PLUS Best-standard-of-care in the Recovery of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04465513 |
| NCT04463849 | Effects of COVID-19 Infection on Beta-cell Function in Euglycemic Patients | https://ClinicalTrials.gov/show/NCT04463849 |
| NCT04464486 | Remote COVID-19 Symptom Tracking for Cancer Patients at Home During the Pandemic | https://ClinicalTrials.gov/show/NCT04464486 |
| NCT04464408 | Favipiravir Therapy in Adults With Mild COVID-19 | https://ClinicalTrials.gov/show/NCT04464408 |
| NCT04464395 | Study of CPI-006 as Immunotherapy for Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04464395 |
| NCT04463472 | Study of COVID-19 DNA Vaccine (AG0301-COVID19) | https://ClinicalTrials.gov/show/NCT04463472 |
| NCT04463433 | Psychological Intervention for Parent-child Relationship and Couple Relationship Under COVID-19 in China | https://ClinicalTrials.gov/show/NCT04463433 |
| NCT04463420 | Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04463420 |
| NCT04463602 | Desidustat in the Management of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04463602 |
| NCT04463004 | Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation | https://ClinicalTrials.gov/show/NCT04463004 |
| NCT04463264 | Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04463264 |
| NCT04461340 | Efficacy and Safety of Sirolimus in COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04461340 |
| NCT04461925 | Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs | https://ClinicalTrials.gov/show/NCT04461925 |
| NCT04461379 | Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare Workers | https://ClinicalTrials.gov/show/NCT04461379 |
| NCT04462757 | SCIL-1Ra in COVID-19 Feasibility & PK/PD | https://ClinicalTrials.gov/show/NCT04462757 |
| NCT04462627 | Reduction of COVID 19 Transmission to Health Care Professionals | https://ClinicalTrials.gov/show/NCT04462627 |
| NCT04460534 | Detection of COVID-19 (SARS-CoV-2) in the Semen of COVID+ Patients (Positive RT-PCR on a Nasopharyngeal Swab) | https://ClinicalTrials.gov/show/NCT04460534 |
| NCT04460027 | W-SUDs for COVID-19 | https://ClinicalTrials.gov/show/NCT04460027 |
| NCT04460014 | Simple Cognitive Task Intervention After Trauma During COVID-19 In Hospital Staff EKUT-P RCT | https://ClinicalTrials.gov/show/NCT04460014 |
| NCT04459962 | Covid-19 Breath Test | https://ClinicalTrials.gov/show/NCT04459962 |
| NCT04460703 | COVID-19 Vaccine Messaging, Part 1 | https://ClinicalTrials.gov/show/NCT04460703 |
| NCT04460690 | Rapid, Onsite COVID-19 Detection | https://ClinicalTrials.gov/show/NCT04460690 |
| NCT04460677 | ASD (Autism Spectrum Disorder) Telehealth for Distress Related to COVID-19 | https://ClinicalTrials.gov/show/NCT04460677 |
| NCT04460651 | PREPARE-IT. Prevention and Treatment of COVID19 With EPA in Subjects at Risk - Intervention Trial | https://ClinicalTrials.gov/show/NCT04460651 |
| NCT04460443 | Sofosbuvir in Treatment of COVID 19 | https://ClinicalTrials.gov/show/NCT04460443 |
| NCT04460183 | A Study to Assess Efficacy and Safety of RESP301 Plus Standard of Care (SOC) Compared to SOC Alone in Hospitalized Participants With COVID-19 | https://ClinicalTrials.gov/show/NCT04460183 |
| NCT04459676 | Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04459676 |
| NCT04458363 | Convalescent Plasma in Pediatric COVID-19 | https://ClinicalTrials.gov/show/NCT04458363 |
| NCT04459520 | Effect of Availability of COVID-19 Testing on Choice to Isolate and Socially Distance | https://ClinicalTrials.gov/show/NCT04459520 |
| NCT04459455 | Project H-COVID: Evaluating Hyper-Brief, Online Materials During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04459455 |
| NCT04459286 | The Nitazoxanide Plus Atazanavir for COVID-19 Study | https://ClinicalTrials.gov/show/NCT04459286 |
| NCT04458948 | Open Label Non-comparative Trial of the Combination of Hydroxychloroquine and Azithromycin in the Treatment of Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04458948 |
| NCT04459325 | Tigerase® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04459325 |
| NCT04459247 | Short Term, High Dose Vitamin D Supplementation for COVID-19 | https://ClinicalTrials.gov/show/NCT04459247 |
| NCT04458519 | Efficacy of Intranasal Probiotic Treatment to Reduce Severity of Symptoms in COVID19 Infection | https://ClinicalTrials.gov/show/NCT04458519 |
| NCT04458246 | Home-based Aerobic Training Among Adolescents With Chronic Diseases During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04458246 |
| NCT04458298 | A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients | https://ClinicalTrials.gov/show/NCT04458298 |
| NCT04456595 | Clinical Trial of Efficacy and Safety of Sinovac’s Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals | https://ClinicalTrials.gov/show/NCT04456595 |
| NCT04457817 | Compensatory Reserve Index (CRI) for Management of COVID-19 | https://ClinicalTrials.gov/show/NCT04457817 |
| NCT04456361 | Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19 | https://ClinicalTrials.gov/show/NCT04456361 |
| NCT04457726 | Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04457726 |
| NCT04457388 | Tele-Yoga Therapy for Chronic Pain | https://ClinicalTrials.gov/show/NCT04457388 |
| NCT04456452 | Study of Ampion for the Treatment of Adult COVID-19 Patients Requiring Oxygen Supplementation | https://ClinicalTrials.gov/show/NCT04456452 |
| NCT04456413 | Convalescent Plasma as Treatment for Subjects With Early COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04456413 |
| NCT04457609 | Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04457609 |
| NCT04457349 | Therapeutic Plasma Exchange in Resistant Cytokine Storm of COVID 19 | https://ClinicalTrials.gov/show/NCT04457349 |
| NCT04456153 | Atovaquone for Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04456153 |
| NCT04456062 | Using Caring Contacts to Reduce Psychiatric Morbidity Following Hospitalization During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04456062 |
| NCT04455815 | A Trial Looking at the Use of Camostat to Reduce Progression of Symptoms of Coronavirus (COVID-19) in People Who Have Tested Positive. | https://ClinicalTrials.gov/show/NCT04455815 |
| NCT04455360 | Early EMDR Following Covid-19 Critical Illness: A Feasibility Trial | https://ClinicalTrials.gov/show/NCT04455360 |
| NCT04455308 | COVID-19 and Chilblains | https://ClinicalTrials.gov/show/NCT04455308 |
| NCT04454606 | The New Silicone N99 Half-Piece Respirator | https://ClinicalTrials.gov/show/NCT04454606 |
| NCT04453657 | Tele-Wellness Supported App for Family Child Care Home Providers and Families to Promote Health, Family Engagement, and School Readiness Amid COVID-19 | https://ClinicalTrials.gov/show/NCT04453657 |
| NCT04453852 | Monovalent Recombinant COVID19 Vaccine | https://ClinicalTrials.gov/show/NCT04453852 |
| NCT04453475 | Feasibility and Benefits of Digital Services During the COVID19 Pandemic | https://ClinicalTrials.gov/show/NCT04453475 |
| NCT04453384 | Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia | https://ClinicalTrials.gov/show/NCT04453384 |
| NCT04453774 | At Home Monitoring for Patients With Covid19 | https://ClinicalTrials.gov/show/NCT04453774 |
| NCT04453514 | Feasibility of a Brief Trauma-informed Yoga Intervention for Anxiety During the Coronavirus Disease (COVID-19) Pandemic | https://ClinicalTrials.gov/show/NCT04453514 |
| NCT04452773 | Clinical Trial to Evaluate the Efficacy of Food Supplement Manremyc® Against SARS- COV-2 Infection (COVID-19) in Healthcare Workers | https://ClinicalTrials.gov/show/NCT04452773 |
| NCT04452669 | VentaProst in Subjects With COVID-19 Requiring Mechanical Ventilation | https://ClinicalTrials.gov/show/NCT04452669 |
| NCT04452565 | NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04452565 |
| NCT04452435 | Safety and Efficacy of C21 in Subjects With COVID-19 | https://ClinicalTrials.gov/show/NCT04452435 |
| NCT04452318 | COVID-19 Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay | https://ClinicalTrials.gov/show/NCT04452318 |
| NCT04451889 | Probe-based Confocal Laser Endomicroscopy in Critically Ill COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04451889 |
| NCT04451291 | Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure | https://ClinicalTrials.gov/show/NCT04451291 |
| NCT04451174 | Early Use of Corticosteroids in Non-critical Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04451174 |
| NCT04450004 | Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years. | https://ClinicalTrials.gov/show/NCT04450004 |
| NCT04449718 | Vitamin D Supplementation in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04449718 |
| NCT04449588 | Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS | https://ClinicalTrials.gov/show/NCT04449588 |
| NCT04448119 | Control of COVID-19 Outbreaks in Long Term Care | https://ClinicalTrials.gov/show/NCT04448119 |
| NCT04448769 | Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19) | https://ClinicalTrials.gov/show/NCT04448769 |
| NCT04448756 | Study of M5049 in Participants With COVID-19 Pneumonia (ANEMONE) | https://ClinicalTrials.gov/show/NCT04448756 |
| NCT04449380 | Clinical Study for the Treatment With Interferon-ß-1a (IFNß-1a) of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04449380 |
| NCT04447781 | Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19 | https://ClinicalTrials.gov/show/NCT04447781 |
| NCT04447469 | Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation | https://ClinicalTrials.gov/show/NCT04447469 |
| NCT04447534 | Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04447534 |
| NCT04447404 | DUR-928 in Subjects With SARS-CoV-2 With Acute Lung, Liver or Kidney Injury | https://ClinicalTrials.gov/show/NCT04447404 |
| NCT04447235 | Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04447235 |
| NCT04446429 | Anti-Androgen Treatment for COVID-19 | https://ClinicalTrials.gov/show/NCT04446429 |
| NCT04446377 | A Study of LAM-002A for the Prevention of Progression of COVID-19 | https://ClinicalTrials.gov/show/NCT04446377 |
| NCT04445935 | Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial | https://ClinicalTrials.gov/show/NCT04445935 |
| NCT04446104 | A Preventive Treatment for Migrant Workers at High-risk of COVID-19 | https://ClinicalTrials.gov/show/NCT04446104 |
| NCT04445467 | An Adaptive Clinical Trial of Antivirals for COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04445467 |
| NCT04445454 | Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04445454 |
| NCT04445597 | ANalyzing Olfactory Dysfunction Mechanisms In COVID-19 | https://ClinicalTrials.gov/show/NCT04445597 |
| NCT04445428 | OPV as Potential Protection Against COVID-19 | https://ClinicalTrials.gov/show/NCT04445428 |
| NCT04445324 | Effects of Online and Recovery-oriented Peer Support Groups Facilitated by Peer Support Workers in Times of COVID-19 | https://ClinicalTrials.gov/show/NCT04445324 |
| NCT04445311 | Ivermectin in Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04445311 |
| NCT04445285 | Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure | https://ClinicalTrials.gov/show/NCT04445285 |
| NCT04445272 | Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04445272 |
| NCT04445246 | Inhaled Iloprost for Suspected COVID-19 Respiratory Failure | https://ClinicalTrials.gov/show/NCT04445246 |
| NCT04445389 | Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults | https://ClinicalTrials.gov/show/NCT04445389 |
| NCT04445376 | Effect of Physical Therapy Exercises on Cardiorespiratory Fitness Level in COVID19 Patients After Recovery. | https://ClinicalTrials.gov/show/NCT04445376 |
| NCT04445220 | A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy | https://ClinicalTrials.gov/show/NCT04445220 |
| NCT04445194 | Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine | https://ClinicalTrials.gov/show/NCT04445194 |
| NCT04444674 | COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection | https://ClinicalTrials.gov/show/NCT04444674 |
| NCT04444596 | Conjunctival Swab vs Nasopharyngeal Swab in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04444596 |
| NCT04444271 | Mesenchymal Stem Cell Infusion for COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04444271 |
| NCT04443881 | Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS) | https://ClinicalTrials.gov/show/NCT04443881 |
| NCT04443673 | Glycine Supplement for Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04443673 |
| NCT04442958 | Effectiveness of Convalescent Immune Plasma Therapy | https://ClinicalTrials.gov/show/NCT04442958 |
| NCT04442191 | Convalescent Plasma as a Possible Treatment for COVID-19 | https://ClinicalTrials.gov/show/NCT04442191 |
| NCT04442230 | NasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04442230 |
| NCT04442178 | InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I ) | https://ClinicalTrials.gov/show/NCT04442178 |
| NCT04442152 | Impact of COVID-19 on Family Dynamics on Bandebereho Study Participants | https://ClinicalTrials.gov/show/NCT04442152 |
| NCT04442087 | Study of Seroprevalence of Anti-SARS-CoV2 Among Children of Hospital Workers in AP-HP | https://ClinicalTrials.gov/show/NCT04442087 |
| NCT04442048 | Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure | https://ClinicalTrials.gov/show/NCT04442048 |
| NCT04441918 | Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects | https://ClinicalTrials.gov/show/NCT04441918 |
| NCT04441632 | Effect of Positive Attitudes on Behavior and Wellness | https://ClinicalTrials.gov/show/NCT04441632 |
| NCT04441996 | Therapeutic Plasma Exchange for COVID-19-associated Hyperviscosity | https://ClinicalTrials.gov/show/NCT04441996 |
| NCT04441424 | Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients | https://ClinicalTrials.gov/show/NCT04441424 |
| NCT04441385 | Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19). | https://ClinicalTrials.gov/show/NCT04441385 |
| NCT04441684 | Seroprevalence of SARS-CoV-2 in Strasbourg University Hospital, Strasbourg, France (COVID-19) | https://ClinicalTrials.gov/show/NCT04441684 |
| NCT04440007 | Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized With COVID-19 | https://ClinicalTrials.gov/show/NCT04440007 |
| NCT04439006 | Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization | https://ClinicalTrials.gov/show/NCT04439006 |
| NCT04439825 | Impact of Botox Treatment Into the Upper One Third of the Face an Area on Mood and Self -Appearance Satisfaction | https://ClinicalTrials.gov/show/NCT04439825 |
| NCT04438980 | Glucocorticoids in COVID-19 (CORTIVID) | https://ClinicalTrials.gov/show/NCT04438980 |
| NCT04319445 | Mindfulness During COVID-19 | https://ClinicalTrials.gov/show/NCT04319445 |
| NCT04438850 | COVidIVERmectin: Ivermectin for Treatment of Covid-19 | https://ClinicalTrials.gov/show/NCT04438850 |
| NCT04439045 | Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and Severity | https://ClinicalTrials.gov/show/NCT04439045 |
| NCT04438694 | Assessment of the Effect of Convalescent Plasma Therapy in Patients With Life-threatening COVID19 Infection | https://ClinicalTrials.gov/show/NCT04438694 |
| NCT04437875 | An Open Study of the Safety, Tolerability and Immunogenicity of “Gam-COVID-Vac Lyo” Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04437875 |
| NCT04437823 | Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04437823 |
| NCT04438070 | COVID Screening Strategies in Homeless Shelters | https://ClinicalTrials.gov/show/NCT04438070 |
| NCT04438057 | Evaluating the Efficacy of Convalescent Plasma in Symptomatic Outpatients Infected With COVID-19 | https://ClinicalTrials.gov/show/NCT04438057 |
| NCT04437719 | Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group for a Period of 6 Months During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04437719 |
| NCT04436471 | An Open Study of the Safety, Tolerability and Immunogenicity of the Drug “Gam-COVID-Vac” Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04436471 |
| NCT04436276 | A Study of Ad26.COV2.S in Adults (COVID-19) | https://ClinicalTrials.gov/show/NCT04436276 |
| NCT04435808 | Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19 | https://ClinicalTrials.gov/show/NCT04435808 |
| NCT04435795 | Inhaled Ciclesonide for Outpatients With COVID19 | https://ClinicalTrials.gov/show/NCT04435795 |
| NCT04435717 | Efficacy of Tocilizumab in Modifying the Inflammatory Parameters of Patients With COVID-19 (COVITOZ-01) | https://ClinicalTrials.gov/show/NCT04435717 |
| NCT04435353 | Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19 | https://ClinicalTrials.gov/show/NCT04435353 |
| NCT04435275 | Virtual Assistant for COVID-19 PPE | https://ClinicalTrials.gov/show/NCT04435275 |
| NCT04435184 | Crizanlizumab for Treating COVID-19 Vasculopathy | https://ClinicalTrials.gov/show/NCT04435184 |
| NCT04435587 | Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04435587 |
| NCT04435522 | Maraviroc in Patients With Moderate and Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04435522 |
| NCT04434248 | An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04434248 |
| NCT04434131 | Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19 | https://ClinicalTrials.gov/show/NCT04434131 |
| NCT04433949 | Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04433949 |
| NCT04433910 | A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04433910 |
| NCT04433546 | Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS). | https://ClinicalTrials.gov/show/NCT04433546 |
| NCT04432805 | Descriptive and Evaluation Study of the Use of Pulmonary Ultrasound in the Initial Management of Pregnant Women in the Context of COVID-19 | https://ClinicalTrials.gov/show/NCT04432805 |
| NCT04432324 | Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04432324 |
| NCT04432298 | Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Participants With Acute COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04432298 |
| NCT04432103 | Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma | https://ClinicalTrials.gov/show/NCT04432103 |
| NCT04432051 | The Use of Lung Ultrasonography in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04432051 |
| NCT04432987 | Dornase Alpha for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04432987 |
| NCT04432272 | ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS) | https://ClinicalTrials.gov/show/NCT04432272 |
| NCT04431856 | CO-PARENT: COVID-19 - Parent Action in Response to Emotions and Needs for Treatment | https://ClinicalTrials.gov/show/NCT04431856 |
| NCT04431466 | A Study to Compare the Efficacy and Safety of Different Doses of Ivermectin for COVID-19 | https://ClinicalTrials.gov/show/NCT04431466 |
| NCT04390477 | Study to Evaluate the Effect of a Probiotic in COVID-19 | https://ClinicalTrials.gov/show/NCT04390477 |
| NCT04431180 | Recruit Blood Donors Via SMS During Epidemic of COVID-19 #Second Repeat Trial# | https://ClinicalTrials.gov/show/NCT04431180 |
| NCT04430608 | Remote Continues Glucose Monitoring During the COVID-19 Pandemic in Quarantined Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04430608 |
| NCT04431297 | Virtual Mindfulness Rounds in the Time of COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04431297 |
| NCT04429867 | Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease | https://ClinicalTrials.gov/show/NCT04429867 |
| NCT04429828 | COVID-19 Psychological Wellbeing for Healthcare Students | https://ClinicalTrials.gov/show/NCT04429828 |
| NCT04429724 | Health Professional Exposure Assessment to Covid-19 | https://ClinicalTrials.gov/show/NCT04429724 |
| NCT04429711 | Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04429711 |
| NCT04429529 | Safety of TY027, a Treatment for COVID-19, in Humans | https://ClinicalTrials.gov/show/NCT04429529 |
| NCT04429334 | Efficacy and Safety Study of Nangibotide in Patients With COVID-19 Receiving Ventilatory Support and Features of Systemic Inflammation. | https://ClinicalTrials.gov/show/NCT04429334 |
| NCT04429594 | Study of the Incidence of SARS-CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04429594 |
| NCT04429555 | Efficacy, Safety, Tolerability, and Biomarkers of MN-166 (Ibudilast) in Patients Hospitalized With COVID-19 and at Risk for ARDS | https://ClinicalTrials.gov/show/NCT04429555 |
| NCT04428099 | Healthy Lifestyle Promotion as Adjunctive Teletherapy for Treatment-resistant Major Depression | https://ClinicalTrials.gov/show/NCT04428099 |
| NCT04428021 | Standard or Convalescent Plasma in Patients With Recent Onset of COVID-19 Respiratory Failure | https://ClinicalTrials.gov/show/NCT04428021 |
| NCT04428008 | Thymosin Alpha 1 to Prevent COVID-19 Infection in Renal Dialysis Patients | https://ClinicalTrials.gov/show/NCT04428008 |
| NCT04427098 | Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04427098 |
| NCT04427566 | Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise | https://ClinicalTrials.gov/show/NCT04427566 |
| NCT04427501 | A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness | https://ClinicalTrials.gov/show/NCT04427501 |
| NCT04427254 | Study of the Sars-Cov2 Neuroinvasiveness - COVID19 | https://ClinicalTrials.gov/show/NCT04427254 |
| NCT04427137 | Accelerated LFR for Bipolar Patients During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04427137 |
| NCT04426695 | Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04426695 |
| NCT04426318 | COVID-19 and the Healthy Minds Program for Educators | https://ClinicalTrials.gov/show/NCT04426318 |
| NCT04426201 | InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O ) | https://ClinicalTrials.gov/show/NCT04426201 |
| NCT04426305 | Community Health Workers Against COVID19 | https://ClinicalTrials.gov/show/NCT04426305 |
| NCT04426292 | SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel During the 2020 COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04426292 |
| NCT04426006 | Serological Response to SARS-Cov-2 Virus in Personnel of the Institut Bergonié in the Context of the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04426006 |
| NCT04425915 | Efficacy of Convalescent Plasma Therapy in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04425915 |
| NCT04425707 | Ivermectin In Treatment of COVID 19 Patients | https://ClinicalTrials.gov/show/NCT04425707 |
| NCT04425538 | A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19). | https://ClinicalTrials.gov/show/NCT04425538 |
| NCT04425629 | Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04425629 |
| NCT04425616 | SafeFit Trial: Virtual Clinics to Deliver Universal Interventions in People With Cancer | https://ClinicalTrials.gov/show/NCT04425616 |
| NCT04425317 | Detection of SARS-CoV-2 in Follicular Fluid and Cumulus-oocyte-complexes in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04425317 |
| NCT04425252 | Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04425252 |
| NCT04425031 | Handling Oxygenation Targets in COVID-19 | https://ClinicalTrials.gov/show/NCT04425031 |
| NCT04425005 | Home-based Exercise Training During Covid-19 Pandemic in Post-bariatric | https://ClinicalTrials.gov/show/NCT04425005 |
| NCT04424953 | To Compare Videolaryngoscope Against Direct Laryngoscope for Intubation When Powered Air Purifying Respirator is Worn | https://ClinicalTrials.gov/show/NCT04424953 |
| NCT04424212 | ICBT for Mental Health Problems Related to the Coronavirus Pandemic | https://ClinicalTrials.gov/show/NCT04424212 |
| NCT04424082 | External Dead Space in Ventilated COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04424082 |
| NCT04423289 | Telematic Monitoring Through a Mobile Application of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04423289 |
| NCT04422613 | Characterization of Persistent Pulmonary Abnormalities Following COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04422613 |
| NCT04422561 | Prophylactic Ivermectin in COVID-19 Contacts | https://ClinicalTrials.gov/show/NCT04422561 |
| NCT04422509 | Lanadelumab for Treatment of COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04422509 |
| NCT04421664 | Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada) | https://ClinicalTrials.gov/show/NCT04421664 |
| NCT04421625 | Patients and Health Staff of Cancer Centres During the Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04421625 |
| NCT04421612 | COVID-19 - No Health Without Mental Health | https://ClinicalTrials.gov/show/NCT04421612 |
| NCT04421508 | A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04421508 |
| NCT04421027 | A Study of Baricitinib (LY3009104) in Participants With COVID-19 | https://ClinicalTrials.gov/show/NCT04421027 |
| NCT04420676 | Synbiotic Therapy of Gastrointestinal Symptoms During Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04420676 |
| NCT04420338 | SeroCOVIDial Study: Assessment of COVID-19 Seroconversion in Patients on Chronic Hemodialysis and in Their Caregivers, a Cohort Study | https://ClinicalTrials.gov/show/NCT04420338 |
| NCT04420299 | Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19 | https://ClinicalTrials.gov/show/NCT04420299 |
| NCT04420273 | Targeted Melanoma Detection With Skin Self-Examination During COVID-19 Restricted Physician Access | https://ClinicalTrials.gov/show/NCT04420273 |
| NCT04420260 | Primary Prevention of Infection by COVID-19 in Workers | https://ClinicalTrials.gov/show/NCT04420260 |
| NCT04420247 | Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19 | https://ClinicalTrials.gov/show/NCT04420247 |
| NCT04419623 | A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer | https://ClinicalTrials.gov/show/NCT04419623 |
| NCT04419610 | RAS and Coagulopathy in COVID19 | https://ClinicalTrials.gov/show/NCT04419610 |
| NCT04424901 | Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04424901 |
| NCT04424797 | Prone Positioning on Admission for Hospitalized COVID-19 Pneumonia Protocol | https://ClinicalTrials.gov/show/NCT04424797 |
| NCT04423991 | Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning | https://ClinicalTrials.gov/show/NCT04423991 |
| NCT04422353 | Video Dance Class and Unsupervised Physical Activity During Covid-19 Pandemic in People With Parkinson’s Disease | https://ClinicalTrials.gov/show/NCT04422353 |
| NCT04421404 | Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04421404 |
| NCT04421391 | QuadraMune(TM) for Prevention of COVID-19 | https://ClinicalTrials.gov/show/NCT04421391 |
| NCT04420806 | Effects of COVID-19 Lockdown in Exercising Early Postmenopausal Women | https://ClinicalTrials.gov/show/NCT04420806 |
| NCT04420741 | Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure | https://ClinicalTrials.gov/show/NCT04420741 |
| NCT04420390 | Low Dose Radiotherapy for COVID-19 Pneumonitis | https://ClinicalTrials.gov/show/NCT04420390 |
| NCT04420182 | COVID-19 Virtual Care at Home | https://ClinicalTrials.gov/show/NCT04420182 |
| NCT04419025 | Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease | https://ClinicalTrials.gov/show/NCT04419025 |
| NCT04418505 | Vielight RX Plus for the Treatment of COVID-19 Respiratory Symptoms | https://ClinicalTrials.gov/show/NCT04418505 |
| NCT04418206 | Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19 | https://ClinicalTrials.gov/show/NCT04418206 |
| NCT04416139 | Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19 | https://ClinicalTrials.gov/show/NCT04416139 |
| NCT04417335 | Reducing COVID-19 Related Hospital Admission in Elderly by BCG Vaccination | https://ClinicalTrials.gov/show/NCT04417335 |
| NCT04417270 | Reliability of the Freestyle Libre CGM in the Inpatient Setting During the COVID-19 Surge | https://ClinicalTrials.gov/show/NCT04417270 |
| NCT04417257 | Study of LAU-7b for the Treatment of COVID-19 Disease in Adults | https://ClinicalTrials.gov/show/NCT04417257 |
| NCT04416399 | STerOids in COVID-19 Study | https://ClinicalTrials.gov/show/NCT04416399 |
| NCT04416360 | Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak | https://ClinicalTrials.gov/show/NCT04416360 |
| NCT04416334 | PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 60 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS | https://ClinicalTrials.gov/show/NCT04416334 |
| NCT04416308 | COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne (AntiCoV-HB) | https://ClinicalTrials.gov/show/NCT04416308 |
| NCT04416919 | Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment | https://ClinicalTrials.gov/show/NCT04416919 |
| NCT04416113 | Photodynamic Therapy for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04416113 |
| NCT04416048 | Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19 | https://ClinicalTrials.gov/show/NCT04416048 |
| NCT04415060 | SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival | https://ClinicalTrials.gov/show/NCT04415060 |
| NCT04414631 | Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04414631 |
| NCT04414618 | A Study of Opaganib in Coronavirus Disease 2019 Pneumonia | https://ClinicalTrials.gov/show/NCT04414618 |
| NCT04414124 | A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04414124 |
| NCT04414371 | Tools for Wellbeing COVID-19 National Study of Undergraduate Students | https://ClinicalTrials.gov/show/NCT04414371 |
| NCT04414293 | Low Dose Pulmonary Irradiation in Patients With COVID-19 Infection of Bad Prognosis | https://ClinicalTrials.gov/show/NCT04414293 |
| NCT04414267 | Bacillus Calmette-guérin Vaccination to Prevent COVID-19 | https://ClinicalTrials.gov/show/NCT04414267 |
| NCT04413864 | Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19 | https://ClinicalTrials.gov/show/NCT04413864 |
| NCT04413006 | Self-compassion for Chronic Pain Virtual Group Treatment Program | https://ClinicalTrials.gov/show/NCT04413006 |
| NCT04413968 | COVID-19 Infection and Transmission in Exposed, Confined and Community-based Infants | https://ClinicalTrials.gov/show/NCT04413968 |
| NCT04412668 | Study to Evaluate the Safety and Efficacy of ATYR1923 In Patients With Severe Pneumonia Related to COVID-19 | https://ClinicalTrials.gov/show/NCT04412668 |
| NCT04412785 | Cyclosporine in Patients With Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04412785 |
| NCT04412772 | Trial of Tocilizumab for Treatment of Severe COVID-19: ARCHITECTS | https://ClinicalTrials.gov/show/NCT04412772 |
| NCT04412538 | Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 | https://ClinicalTrials.gov/show/NCT04412538 |
| NCT04412343 | The Seniors COvid-19 Pandemic and Exercise Study | https://ClinicalTrials.gov/show/NCT04412343 |
| NCT04412330 | Optimizing Outcomes With Physical Therapy Treatment for IndividuALs Surviving an ICU Admission for Covid-19 | https://ClinicalTrials.gov/show/NCT04412330 |
| NCT04412291 | A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study | https://ClinicalTrials.gov/show/NCT04412291 |
| NCT04412239 | To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04412239 |
| NCT04412486 | COVID-19 Convalescent Plasma (CCP) Transfusion | https://ClinicalTrials.gov/show/NCT04412486 |
| NCT04412356 | Timing of Tracheotomy in Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04412356 |
| NCT04412018 | An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19 | https://ClinicalTrials.gov/show/NCT04412018 |
| NCT04412057 | Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury | https://ClinicalTrials.gov/show/NCT04412057 |
| NCT04411680 | Study of Sargramostim in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04411680 |
| NCT04411667 | Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04411667 |
| NCT04411433 | Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04411433 |
| NCT04411628 | A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19 | https://ClinicalTrials.gov/show/NCT04411628 |
| NCT04411446 | Cholecalciferol to Improve the Outcomes of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04411446 |
| NCT04410692 | Can the Prediction Market Improve Predictions of COVID-19? | https://ClinicalTrials.gov/show/NCT04410692 |
| NCT04410536 | Home Detox in Medication Overuse Headache (MOH) During Covid-19 Emergency | https://ClinicalTrials.gov/show/NCT04410536 |
| NCT04410510 | P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19 | https://ClinicalTrials.gov/show/NCT04410510 |
| NCT04410354 | Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19 | https://ClinicalTrials.gov/show/NCT04410354 |
| NCT04410562 | Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy and Postpartum | https://ClinicalTrials.gov/show/NCT04410562 |
| NCT04410328 | Aggrenox To Treat Acute Covid-19 | https://ClinicalTrials.gov/show/NCT04410328 |
| NCT04410458 | Recruit Blood Donors Via SMS During Epidemic of COVID-19 （Repeat Trial） | https://ClinicalTrials.gov/show/NCT04410458 |
| NCT04410016 | Evaluation of Staff COVID-19 Wellbeing Centres in a Healthcare Workplace: COVID-WELL Study | https://ClinicalTrials.gov/show/NCT04410016 |
| NCT04409886 | Hyperbaric Oxygen Therapy in Non-ventilated COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04409886 |
| NCT04409873 | Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19) | https://ClinicalTrials.gov/show/NCT04409873 |
| NCT04409834 | Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial | https://ClinicalTrials.gov/show/NCT04409834 |
| NCT04409821 | Tele-based Psychological Emotional Support for Informal CARegivers of COVID-19 Patients in Intensive Care | https://ClinicalTrials.gov/show/NCT04409821 |
| NCT04410159 | Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04410159 |
| NCT04409743 | Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04409743 |
| NCT04409522 | Evaluation of Therapeutic Effects of Melatonin by Inhibition of NLRP3 Inflammasome in COVID19 Patients | https://ClinicalTrials.gov/show/NCT04409522 |
| NCT04409509 | Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04409509 |
| NCT04409496 | Chat-based Support for Preventing Smoking Relapse | https://ClinicalTrials.gov/show/NCT04409496 |
| NCT04409925 | DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1) | https://ClinicalTrials.gov/show/NCT04409925 |
| NCT04409327 | Phase 2 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes | https://ClinicalTrials.gov/show/NCT04409327 |
| NCT04409262 | A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04409262 |
| NCT04408287 | Improving Activity Engagement Among Persons With SCI During COVID-19 | https://ClinicalTrials.gov/show/NCT04408287 |
| NCT04408456 | Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19 | https://ClinicalTrials.gov/show/NCT04408456 |
| NCT04408157 | A Research Study to Evaluate the Benefits of a Self-management Booklet to Promote Wellbeing During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04408157 |
| NCT04408131 | Morbi-mortality by COVID-19 Among Homeless People in Marseille: a Cohort Study | https://ClinicalTrials.gov/show/NCT04408131 |
| NCT04408209 | Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04408209 |
| NCT04408066 | COVID-19: A POC Test Under Research & Evaluation | https://ClinicalTrials.gov/show/NCT04408066 |
| NCT04408183 | GLS-1200 Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04408183 |
| NCT04408040 | Use of Convalescent Plasma for COVID-19 | https://ClinicalTrials.gov/show/NCT04408040 |
| NCT04408027 | Mental Health Support for SickKids Children and Families During COVID-19 Using Established eHealth Interventions | https://ClinicalTrials.gov/show/NCT04408027 |
| NCT04407689 | InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort | https://ClinicalTrials.gov/show/NCT04407689 |
| NCT04407507 | Efficacy, Safety and Tolerability of Ivermectin in Subjects Infected With SARS-CoV-2 With or Without Symptoms | https://ClinicalTrials.gov/show/NCT04407507 |
| NCT04407390 | Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly | https://ClinicalTrials.gov/show/NCT04407390 |
| NCT04407182 | Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19 | https://ClinicalTrials.gov/show/NCT04407182 |
| NCT04407130 | Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection. | https://ClinicalTrials.gov/show/NCT04407130 |
| NCT04407286 | Vitamin D Testing and Treatment for COVID 19 | https://ClinicalTrials.gov/show/NCT04407286 |
| NCT04407208 | Convalescent Plasma Therapy in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04407208 |
| NCT04406493 | Monitoring COVID-19 Patients’ Lung Fluid Using Impedance Technique | https://ClinicalTrials.gov/show/NCT04406493 |
| NCT04406389 | Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial) | https://ClinicalTrials.gov/show/NCT04406389 |
| NCT04406246 | Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide | https://ClinicalTrials.gov/show/NCT04406246 |
| NCT04406181 | Psychological Well-being of Patients Awaiting for Cardiac Surgery During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04406181 |
| NCT04405999 | Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease | https://ClinicalTrials.gov/show/NCT04405999 |
| NCT04405986 | Exploring Brain Damages After COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04405986 |
| NCT04405908 | SCB-2019 as COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04405908 |
| NCT04405843 | Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19 (EPIC Trial) | https://ClinicalTrials.gov/show/NCT04405843 |
| NCT04405739 | The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID) | https://ClinicalTrials.gov/show/NCT04405739 |
| NCT04405310 | Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial | https://ClinicalTrials.gov/show/NCT04405310 |
| NCT04405570 | A Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19 | https://ClinicalTrials.gov/show/NCT04405570 |
| NCT04405544 | Determination of Acute Encephalopathy Predictors in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04405544 |
| NCT04404361 | PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer | https://ClinicalTrials.gov/show/NCT04404361 |
| NCT04405102 | COVID-19 Ozanimod Intervention Study | https://ClinicalTrials.gov/show/NCT04405102 |
| NCT04405076 | Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older | https://ClinicalTrials.gov/show/NCT04405076 |
| NCT04404426 | CACOLAC : Citrulline Administration in the Hospital Patient in Intensive Care for COVID-19 Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04404426 |
| NCT04404218 | The Açaà Berry COVID-19 Anti-Inflammation Trial | https://ClinicalTrials.gov/show/NCT04404218 |
| NCT04403555 | Ivermectin as a Novel Therapy in COVID-19 Treatment | https://ClinicalTrials.gov/show/NCT04403555 |
| NCT04403685 | Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers | https://ClinicalTrials.gov/show/NCT04403685 |
| NCT04403646 | Tannin Specific Natural Extract for COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04403646 |
| NCT04403100 | Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: “The Hope Coalition - 1” | https://ClinicalTrials.gov/show/NCT04403100 |
| NCT04403477 | Convalescent Plasma Therapy in Severe COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04403477 |
| NCT04403269 | NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER, COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE | https://ClinicalTrials.gov/show/NCT04403269 |
| NCT04402970 | Dornase Alfa for ARDS in Patients With Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) | https://ClinicalTrials.gov/show/NCT04402970 |
| NCT04402957 | LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04402957 |
| NCT04402944 | Pulmozyme to Improve COVID-19 ARDS Outcomes | https://ClinicalTrials.gov/show/NCT04402944 |
| NCT04402983 | The Effectiveness of Telerehabilitation-Based Physiotherapy in COVID 19 Patients | https://ClinicalTrials.gov/show/NCT04402983 |
| NCT04402918 | Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy | https://ClinicalTrials.gov/show/NCT04402918 |
| NCT04402879 | CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals | https://ClinicalTrials.gov/show/NCT04402879 |
| NCT04402866 | TD-0903 for ALI Associated With COVID-19 | https://ClinicalTrials.gov/show/NCT04402866 |
| NCT04402840 | Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS) | https://ClinicalTrials.gov/show/NCT04402840 |
| NCT04402203 | Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh | https://ClinicalTrials.gov/show/NCT04402203 |
| NCT04401579 | Adaptive COVID-19 Treatment Trial 2 (ACTT-2) | https://ClinicalTrials.gov/show/NCT04401579 |
| NCT04401475 | A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04401475 |
| NCT04402060 | A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04402060 |
| NCT04401423 | TXA127 for the Treatment of Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04401423 |
| NCT04401202 | Nigella Sativa in COVID-19 | https://ClinicalTrials.gov/show/NCT04401202 |
| NCT04401410 | Anti-SARS Cov-2 T Cell Infusions for COVID 19 | https://ClinicalTrials.gov/show/NCT04401410 |
| NCT04401046 | COVID-19 and Reorganisation of Cancer Patient Care: Self- Evaluation of Potential Post-traumatic Stress Disorder | https://ClinicalTrials.gov/show/NCT04401046 |
| NCT04400799 | Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04400799 |
| NCT04401150 | Lessening Organ Dysfunction With VITamin C - COVID-19 | https://ClinicalTrials.gov/show/NCT04401150 |
| NCT04401293 | Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04401293 |
| NCT04400929 | Using GM-CSF as a Host Directed Therapeutic Against COVID-19 | https://ClinicalTrials.gov/show/NCT04400929 |
| NCT04399967 | COVID-19 Brief Advice and Chat-based Support for Smoking Cessation Via “Quit to Win” Contest 2020 | https://ClinicalTrials.gov/show/NCT04399967 |
| NCT04400890 | Randomized Proof-of-Concept Trial to Evaluate the Safety and Explore the Effectiveness of Resveratrol, a Plant Polyphenol, for COVID-19 | https://ClinicalTrials.gov/show/NCT04400890 |
| NCT04400279 | The COVID-19 Pandemic and Exercise Study | https://ClinicalTrials.gov/show/NCT04400279 |
| NCT04399746 | Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19 | https://ClinicalTrials.gov/show/NCT04399746 |
| NCT04399681 | The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19 | https://ClinicalTrials.gov/show/NCT04399681 |
| NCT04400032 | Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04400032 |
| NCT04399980 | Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation | https://ClinicalTrials.gov/show/NCT04399980 |
| NCT04399109 | Evaluation of a Remote Monitoring Smartphone Application and Care Model of COVID-19 Patients in the Community (ReCOVER) | https://ClinicalTrials.gov/show/NCT04399109 |
| NCT04399317 | Flow Controlled Ventilation in ARDS Associated With COVID-19 | https://ClinicalTrials.gov/show/NCT04399317 |
| NCT04399252 | Effect of Lactobacillus on the Microbiome of Household Contacts Exposed to COVID-19 | https://ClinicalTrials.gov/show/NCT04399252 |
| NCT04399005 | The Efficacy Comparing Daily and After-each-case Room Disinfection. | https://ClinicalTrials.gov/show/NCT04399005 |
| NCT04398277 | A Daily Coping Toolkit for Medical Personnel and First-Responders During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04398277 |
| NCT04398004 | Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early | https://ClinicalTrials.gov/show/NCT04398004 |
| NCT04397796 | Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation | https://ClinicalTrials.gov/show/NCT04397796 |
| NCT04397757 | COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2. | https://ClinicalTrials.gov/show/NCT04397757 |
| NCT04397718 | Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization | https://ClinicalTrials.gov/show/NCT04397718 |
| NCT04397705 | Remote Monitoring of Cancer Patients With Suspected Covid-19 | https://ClinicalTrials.gov/show/NCT04397705 |
| NCT04397692 | Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial) | https://ClinicalTrials.gov/show/NCT04397692 |
| NCT04397666 | RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19 | https://ClinicalTrials.gov/show/NCT04397666 |
| NCT04397523 | Efficacy and Safety of COVID-19 Convalescent Plasma | https://ClinicalTrials.gov/show/NCT04397523 |
| NCT04397510 | Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury | https://ClinicalTrials.gov/show/NCT04397510 |
| NCT04397614 | Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer Patients | https://ClinicalTrials.gov/show/NCT04397614 |
| NCT04397562 | A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04397562 |
| NCT04396106 | Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04396106 |
| NCT04395807 | Helmet CPAP Versus HFNC in COVID-19 | https://ClinicalTrials.gov/show/NCT04395807 |
| NCT04395768 | International ALLIANCE Study of Therapies to Prevent Progression of COVID-19 | https://ClinicalTrials.gov/show/NCT04395768 |
| NCT04395911 | Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections | https://ClinicalTrials.gov/show/NCT04395911 |
| NCT04395430 | A Novel School-clinic-community Online Model of Child Obesity Treatment in Singapore During COVID-19 | https://ClinicalTrials.gov/show/NCT04395430 |
| NCT04395105 | Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial | https://ClinicalTrials.gov/show/NCT04395105 |
| NCT04395144 | COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss | https://ClinicalTrials.gov/show/NCT04395144 |
| NCT04394793 | Low Dose Radiation Therapy for Covid-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04394793 |
| NCT04394455 | Brief Cognitive Behavioral Therapy Versus Crisis Intervention Therapy Through Telepsychiatry on Psychiatric Symptoms | https://ClinicalTrials.gov/show/NCT04394455 |
| NCT04394442 | Hydroxychloroquine in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04394442 |
| NCT04394416 | Trial of Imatinib for Hospitalized Adults With COVID-19 | https://ClinicalTrials.gov/show/NCT04394416 |
| NCT04394403 | Pilot Internet-based Self-Help Program for Managing Corona (COVID-19) Stress | https://ClinicalTrials.gov/show/NCT04394403 |
| NCT04394377 | Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial | https://ClinicalTrials.gov/show/NCT04394377 |
| NCT04394208 | Silymarin in COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04394208 |
| NCT04394039 | Post-Pandemic Perception of Public Space in Singapore | https://ClinicalTrials.gov/show/NCT04394039 |
| NCT04394013 | A Web-Based Gentle Body Stretching to Alleviate Loneliness and Improve Mental Fitness During COVID-19 Isolation Period | https://ClinicalTrials.gov/show/NCT04394013 |
| NCT04393961 | At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study | https://ClinicalTrials.gov/show/NCT04393961 |
| NCT04393948 | Lung Irradiation for COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04393948 |
| NCT04394182 | Ultra Low Doses of Therapy With Radiation Applicated to COVID-19 | https://ClinicalTrials.gov/show/NCT04394182 |
| NCT04394169 | Early Care Program for the Management of Post-ICU Syndrome and Chronic Pain After COVID-19 Infection. | https://ClinicalTrials.gov/show/NCT04394169 |
| NCT04393818 | Mobile Phone Based Intervention to Protect Mental Health in Healthcare Workers at Frontline Against COVID19 | https://ClinicalTrials.gov/show/NCT04393818 |
| NCT04393792 | SINUS WASH Pilot Study in Adults Testing Positive for COVID-19 | https://ClinicalTrials.gov/show/NCT04393792 |
| NCT04393727 | Transfusion of Convalescent Plasma for the Early Treatment of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04393727 |
| NCT04393415 | Using PRP and Cord Blood in Treatment of Covid -19 | https://ClinicalTrials.gov/show/NCT04393415 |
| NCT04393636 | Digital Cardiac Counseling Trial: DCC Trial | https://ClinicalTrials.gov/show/NCT04393636 |
| NCT04392778 | Clinical Use of Stem Cells for the Treatment of Covid-19 | https://ClinicalTrials.gov/show/NCT04392778 |
| NCT04393246 | mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms | https://ClinicalTrials.gov/show/NCT04393246 |
| NCT04392713 | Efficacy of Ivermectin in COVID-19 | https://ClinicalTrials.gov/show/NCT04392713 |
| NCT04393077 | Emotional Freedom Technique (EFT) Effect on Nurses | https://ClinicalTrials.gov/show/NCT04393077 |
| NCT04393038 | ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04393038 |
| NCT04392973 | FAvipiravir and HydroxyChloroquine Combination Therapy | https://ClinicalTrials.gov/show/NCT04392973 |
| NCT04392531 | Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19 | https://ClinicalTrials.gov/show/NCT04392531 |
| NCT04392453 | Upper Limb Robotic Rehabilitation During COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04392453 |
| NCT04392414 | Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04392414 |
| NCT04392323 | Incidence of COVID-19 Test Conversion in Post-surgical Patients | https://ClinicalTrials.gov/show/NCT04392323 |
| NCT04392232 | A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection | https://ClinicalTrials.gov/show/NCT04392232 |
| NCT04392219 | COVID-19 First In Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of EIDD-2801 in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT04392219 |
| NCT04392141 | Colchicine Plus Phenolic Monoterpenes to Treat COVID-19 | https://ClinicalTrials.gov/show/NCT04392141 |
| NCT04391829 | Detection of SARS-CoV-2 in Semen of COVID-19 Positive Males | https://ClinicalTrials.gov/show/NCT04391829 |
| NCT04390594 | Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal | https://ClinicalTrials.gov/show/NCT04390594 |
| NCT04391712 | Photobiomodulation Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease | https://ClinicalTrials.gov/show/NCT04391712 |
| NCT04391309 | COVID-19 and Anti-CD14 Treatment Trial | https://ClinicalTrials.gov/show/NCT04391309 |
| NCT04391179 | Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19 | https://ClinicalTrials.gov/show/NCT04391179 |
| NCT04391140 | Prone Positioning and High-flow Nasal Cannula in COVID-19 Induced ARDS | https://ClinicalTrials.gov/show/NCT04391140 |
| NCT04391127 | Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04391127 |
| NCT04390412 | Low Dose Radiotherapy in COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04390412 |
| NCT04390516 | Respiratory Decompensation and Model for the Triage of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04390516 |
| NCT04390191 | Early CPAP in COVID-19 Confirmed or Suspected Patients | https://ClinicalTrials.gov/show/NCT04390191 |
| NCT04390178 | Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04390178 |
| NCT04390152 | Safety and Efficacy of Intravenous Wharton’s Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19 | https://ClinicalTrials.gov/show/NCT04390152 |
| NCT04390139 | Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04390139 |
| NCT04390503 | Convalescent Plasma for Early Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04390503 |
| NCT04390464 | mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R) | https://ClinicalTrials.gov/show/NCT04390464 |
| NCT04389710 | Convalescent Plasma for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04389710 |
| NCT04390022 | Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial | https://ClinicalTrials.gov/show/NCT04390022 |
| NCT04389944 | Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04389944 |
| NCT04389840 | Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure | https://ClinicalTrials.gov/show/NCT04389840 |
| NCT04389671 | The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04389671 |
| NCT04389450 | Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04389450 |
| NCT04389385 | COVID-19 Specific T Cell Derived Exosomes (CSTC-Exo) | https://ClinicalTrials.gov/show/NCT04389385 |
| NCT04389372 | Effectiveness and Acceptability of MINDFULNESS by Smartphone, for Patients With Chronic Migraine and Medication Overuse | https://ClinicalTrials.gov/show/NCT04389372 |
| NCT04389333 | Feasibility of Non-contact Magnetically-controlled Capsule Endoscopy During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04389333 |
| NCT04389294 | HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists | https://ClinicalTrials.gov/show/NCT04389294 |
| NCT04388527 | COVID-19 Convalescent Plasma for Mechanically Ventilated Population | https://ClinicalTrials.gov/show/NCT04388527 |
| NCT04388514 | Blood Ozonization in Patients With SARS-CoV-2 Respiratory Failure | https://ClinicalTrials.gov/show/NCT04388514 |
| NCT04388410 | Safety and Efficacy of Convalescent Plasma Transfusion for Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04388410 |
| NCT04388683 | Inhaled Nitric Oxide for Preventing Progression in COVID-19 | https://ClinicalTrials.gov/show/NCT04388683 |
| NCT04387409 | Study to Assess VPM1002 in Reducing Healthcare Professionals’ Absenteeism in COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04387409 |
| NCT04387955 | Analysis of Chilblains pROfile During coVID-19 Epidemic (ACROVID) | https://ClinicalTrials.gov/show/NCT04387955 |
| NCT04387292 | Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic | https://ClinicalTrials.gov/show/NCT04387292 |
| NCT04387253 | Study of Late Fetal Loss in Poitou-Charentes. GYNE-COVID | https://ClinicalTrials.gov/show/NCT04387253 |
| NCT04386850 | Oral 25-hydroxyvitamin D3 and COVID-19 | https://ClinicalTrials.gov/show/NCT04386850 |
| NCT04386798 | Stress and Anxiety Levels of Mothers Lying in the Baby Newborn Intensive Care Unit | https://ClinicalTrials.gov/show/NCT04386798 |
| NCT04386694 | Photobiomodulation Therapy Combined With Static Magnetic Field in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04386694 |
| NCT04386668 | Let It Out (LIO) and COVID19: Testing an Online Emotional Disclosure-based Intervention During the COVID19 Pandemic | https://ClinicalTrials.gov/show/NCT04386668 |
| NCT04386616 | A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04386616 |
| NCT04386291 | Meditation and Kundalini Yoga for Heightened Anxiety Related to COVID-19 | https://ClinicalTrials.gov/show/NCT04386291 |
| NCT04386239 | Study on the Use of Sarilumab in Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04386239 |
| NCT04384965 | Accelerated iTBS for Depressed Patients During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04384965 |
| NCT04385810 | Description of Ophthalmologic Injuries in Intensive Care During the SARS-CoV2 Epidemic - COVID19 | https://ClinicalTrials.gov/show/NCT04385810 |
| NCT04385940 | Vitamin D and COVID-19 Management | https://ClinicalTrials.gov/show/NCT04385940 |
| NCT04385901 | Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth | https://ClinicalTrials.gov/show/NCT04385901 |
| NCT04385849 | Study of the Safety of Therapeutic Treatment With an Immunomodulatory Agent (N-803) in Adults With COVID-19 | https://ClinicalTrials.gov/show/NCT04385849 |
| NCT04385836 | Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | https://ClinicalTrials.gov/show/NCT04385836 |
| NCT04385108 | Predictive Immune Biomarkers for COVID-19 Pathogenesis | https://ClinicalTrials.gov/show/NCT04385108 |
| NCT04385095 | Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection | https://ClinicalTrials.gov/show/NCT04385095 |
| NCT04385043 | Hyperimmune Plasma in Patients With COVID-19 Severe Infection | https://ClinicalTrials.gov/show/NCT04385043 |
| NCT04385017 | Role of Inflammasomes in COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04385017 |
| NCT04385199 | Convalescent Plasma for Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04385199 |
| NCT04384588 | COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID) | https://ClinicalTrials.gov/show/NCT04384588 |
| NCT04384731 | Curosurf® in Adult Acute Respiratory Distress Syndrome Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04384731 |
| NCT04384549 | Efficacy of BCG Vaccination in the Prevention of COVID19 Via the Strengthening of Innate Immunity in Health Care Workers | https://ClinicalTrials.gov/show/NCT04384549 |
| NCT04384497 | Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study | https://ClinicalTrials.gov/show/NCT04384497 |
| NCT04384458 | Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis | https://ClinicalTrials.gov/show/NCT04384458 |
| NCT04384445 | Zofin (Organicell Flow) for Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04384445 |
| NCT04384380 | Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04384380 |
| NCT04383574 | Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19) | https://ClinicalTrials.gov/show/NCT04383574 |
| NCT04383535 | Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia | https://ClinicalTrials.gov/show/NCT04383535 |
| NCT04383613 | Prone Positioning for Patients on General Medical Wards With COVID19 | https://ClinicalTrials.gov/show/NCT04383613 |
| NCT04382846 | Novel Regimens in COVID-19 Treatment | https://ClinicalTrials.gov/show/NCT04382846 |
| NCT04382768 | Inhaled Ibuprofen to Treat COVID-19 | https://ClinicalTrials.gov/show/NCT04382768 |
| NCT04382755 | Zilucoplan® in Improving Oxygenation and Short- and Long-term Outcome of COVID-19 Patients With Acute Hypoxic Respiratory Failure | https://ClinicalTrials.gov/show/NCT04382755 |
| NCT04382729 | Neuromuscular Electrical Stimulation in Patients With COVID19 Associated Pneumonia | https://ClinicalTrials.gov/show/NCT04382729 |
| NCT04383002 | High Dose Inhaled Nitric Oxide for COVID-19 (ICU Patients) | https://ClinicalTrials.gov/show/NCT04383002 |
| NCT04382924 | Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Hospitalized Patient With Confirmed COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04382924 |
| NCT04382651 | Study of Efficacy and Safety of MAS825 in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04382651 |
| NCT04382586 | Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants | https://ClinicalTrials.gov/show/NCT04382586 |
| NCT04382560 | Coping Strategies and Responsiveness to a Brief Online Intervention During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04382560 |
| NCT04382547 | Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells | https://ClinicalTrials.gov/show/NCT04382547 |
| NCT04382131 | Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19) | https://ClinicalTrials.gov/show/NCT04382131 |
| NCT04382391 | Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms | https://ClinicalTrials.gov/show/NCT04382391 |
| NCT04382092 | Co-infection Management in COVID-19 Critically Ill | https://ClinicalTrials.gov/show/NCT04382092 |
| NCT04382378 | Effects of NMES in Critically Ill Patients | https://ClinicalTrials.gov/show/NCT04382378 |
| NCT04382066 | Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04382066 |
| NCT04382053 | Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04382053 |
| NCT04382040 | A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19 | https://ClinicalTrials.gov/show/NCT04382040 |
| NCT04381962 | A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2) | https://ClinicalTrials.gov/show/NCT04381962 |
| NCT04381884 | Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04381884 |
| NCT04381858 | Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04381858 |
## Warning: 1 parsing failure.
## row col expected actual file
## 1725 baseline_population 1/0/T/F/TRUE/FALSE 120 eligible individuals completed at least 10 survey items and were included in the final analytical sample 'regCovid_obs_a.csv'| nct_id | brief_title | link |
|---|---|---|
| NCT04381819 | Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of COVID-19 | https://ClinicalTrials.gov/show/NCT04381819 |
| NCT04381351 | Noncoding RNAs in COVID-19 and COVID-19 Related Kidney Dysfunction | https://ClinicalTrials.gov/show/NCT04381351 |
| NCT04381312 | Direct and Indirect Impact of COVID-19 In Older Populations | https://ClinicalTrials.gov/show/NCT04381312 |
| NCT04381286 | Transpulmonary Driving Pressure in ARDS COVID19 Patients | https://ClinicalTrials.gov/show/NCT04381286 |
| NCT04380987 | Luxembourg Cohort of Positive Patients for COVID-19: a Stratification Study to Predict Patient Prognosis | https://ClinicalTrials.gov/show/NCT04380987 |
| NCT04380896 | COVID-19 Staff Testing of Antibody Responses Study (Co-Stars) | https://ClinicalTrials.gov/show/NCT04380896 |
| NCT04380870 | Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19 | https://ClinicalTrials.gov/show/NCT04380870 |
| NCT04380792 | Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital | https://ClinicalTrials.gov/show/NCT04380792 |
| NCT04380779 | Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses | https://ClinicalTrials.gov/show/NCT04380779 |
| NCT04380714 | Changes in the Consumption of Psychoactive Substances During Containment Linked to COVID-19 | https://ClinicalTrials.gov/show/NCT04380714 |
| NCT04379466 | Effector and Regulatory T Cell Receptor Repertoire Analyses in Patients Affected by COVID-19 | https://ClinicalTrials.gov/show/NCT04379466 |
| NCT04379310 | Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019) | https://ClinicalTrials.gov/show/NCT04379310 |
| NCT04379297 | COvid-19 National Survey for Assessing VIral Spread by Nonaffected CarriErs (CON-VINCE) | https://ClinicalTrials.gov/show/NCT04379297 |
| NCT04379245 | COVID-19 Infection in Patients Infected With HIV and/or on PrEP | https://ClinicalTrials.gov/show/NCT04379245 |
| NCT04379232 | Surgical Activity During the Covid-19 Pandemic: Results for 112 Patients in a French Tertiary Care Center | https://ClinicalTrials.gov/show/NCT04379232 |
| NCT04361877 | Cardiovascular Prevention During COVID-19 Pandemic Lockdown in Young Adults (COLA Trial) | https://ClinicalTrials.gov/show/NCT04361877 |
| NCT04379089 | Neurologic Manifestations of COVID 19 in Children | https://ClinicalTrials.gov/show/NCT04379089 |
| NCT04379063 | COVID-19 Pandemic Short Interval National Survey Gauging Psychological Distress | https://ClinicalTrials.gov/show/NCT04379063 |
| NCT04378881 | Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations | https://ClinicalTrials.gov/show/NCT04378881 |
| NCT04378842 | COVID-19 and ICU-acquired MDR Bacteria | https://ClinicalTrials.gov/show/NCT04378842 |
| NCT04378829 | Platelet Count, Platelet, Mean Platelet Volume and Platelet Distribution Width in COVID-19 | https://ClinicalTrials.gov/show/NCT04378829 |
| NCT04378777 | Immunophenotyping Assessment in a COVID-19 Cohort | https://ClinicalTrials.gov/show/NCT04378777 |
| NCT04378686 | Serological Testing for COVID-19 (SARS-CoV-2) in ESKD | https://ClinicalTrials.gov/show/NCT04378686 |
| NCT04378595 | Assessing Pediatric Food Insecurity During the COVID-19 Pandemic in Austin | https://ClinicalTrials.gov/show/NCT04378595 |
| NCT04378582 | Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU | https://ClinicalTrials.gov/show/NCT04378582 |
| NCT04377685 | Prediction of Clinical Course in COVID19 Patients | https://ClinicalTrials.gov/show/NCT04377685 |
| NCT04377607 | Haemoglobin Concentration on COVID-19 | https://ClinicalTrials.gov/show/NCT04377607 |
| NCT04377581 | COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior | https://ClinicalTrials.gov/show/NCT04377581 |
| NCT04377490 | Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy | https://ClinicalTrials.gov/show/NCT04377490 |
| NCT04377035 | The Role of Ultrasound in COVID-19 | https://ClinicalTrials.gov/show/NCT04377035 |
| NCT04376996 | Slovenian National COVID-19 Prevalence Study | https://ClinicalTrials.gov/show/NCT04376996 |
| NCT04377815 | Finding Out if COVID-19 Infection Can be pREdicted by ChAnges in Smell and/or Taste | https://ClinicalTrials.gov/show/NCT04377815 |
| NCT04377776 | Observational Study Concerning COVID-19 Infection in Transplanted Kidney, Pancreas or Pancreatic Islet Patients | https://ClinicalTrials.gov/show/NCT04377776 |
| NCT04377763 | Developement and Evaluation of Serological Assays for COVID-19 | https://ClinicalTrials.gov/show/NCT04377763 |
| NCT04377724 | Spread and Course of COVID-19 Infections | https://ClinicalTrials.gov/show/NCT04377724 |
| NCT04377412 | Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04377412 |
| NCT04376905 | Extra Vascular Lung Water and Pulmonary Permeability in Critically Ill Patients With SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04376905 |
| NCT04376879 | Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19) | https://ClinicalTrials.gov/show/NCT04376879 |
| NCT04376853 | CoronaWatch - Early Detection of Cardiovascular Risks in COVID-19 Via SmartWatch | https://ClinicalTrials.gov/show/NCT04376853 |
| NCT04376775 | Assessment of the Impact of COVID-19 on Transplant Patients and on Patients Awaiting Transplantation | https://ClinicalTrials.gov/show/NCT04376775 |
| NCT04376710 | Surgical Telemedicine in the COVID-19 Pandemic Era | https://ClinicalTrials.gov/show/NCT04376710 |
| NCT04376944 | Barrier Measures to Limit Covid-19.Nosocomial Transmission: a Cross-sectional Evaluation | https://ClinicalTrials.gov/show/NCT04376944 |
| NCT04377074 | Parental Stress During the COVID-19 Pandemic and Its Association With Depression and Anxiety | https://ClinicalTrials.gov/show/NCT04377074 |
| NCT04376658 | Quality of Life and Long-term Outcomes After Hospitalization for COVID-19 | https://ClinicalTrials.gov/show/NCT04376658 |
| NCT04376580 | Use of the Nasal Cannula During COVID-19 | https://ClinicalTrials.gov/show/NCT04376580 |
| NCT04375501 | A Study of Outcomes in Patients With Fractured Neck of Femur During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04375501 |
| NCT04375709 | Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19); | https://ClinicalTrials.gov/show/NCT04375709 |
| NCT04375670 | COVID19-FOIE National Observatory | https://ClinicalTrials.gov/show/NCT04375670 |
| NCT04375644 | Impact of the COVID-19 Pandemic on the Quality of Psychological Life (COVID-PRO-IMPACT) | https://ClinicalTrials.gov/show/NCT04375644 |
| NCT04375761 | COVID-19: Human Epidemiology and Response to SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04375761 |
| NCT04375748 | Hospital Registry of Acute Myocarditis: Evolution of the Proportion of Positive SARS-COV-2 (COVID19) Cases | https://ClinicalTrials.gov/show/NCT04375748 |
| NCT04375176 | Monocytes and NK Cells Activity in Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04375176 |
| NCT04375137 | Correlation Between Oxidative Stress Status and COVID-19 Severity | https://ClinicalTrials.gov/show/NCT04375137 |
| NCT04374838 | Effect of COVID-19 Pandemic on Pediatric Cancer Care | https://ClinicalTrials.gov/show/NCT04374838 |
| NCT04375410 | Consequences of Intensified Handwash and Hand Disinfection Among Children During the COVID19 Pandemic | https://ClinicalTrials.gov/show/NCT04375410 |
| NCT04374656 | Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04374656 |
| NCT04374513 | Community Pharmacists Behaviour During Covid-19 | https://ClinicalTrials.gov/show/NCT04374513 |
| NCT04374422 | COVID-19 Pandemic and Female Sexual Behavior | https://ClinicalTrials.gov/show/NCT04374422 |
| NCT04374617 | Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04374617 |
| NCT04374097 | Level and Predictors of Trauma-symptoms Among Health Workers and Public Service Providers During the COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04374097 |
| NCT04374071 | Early Short Course Corticosteroids in COVID-19 | https://ClinicalTrials.gov/show/NCT04374071 |
| NCT04374058 | Less Frequency Hemodialysis and COVID-19 | https://ClinicalTrials.gov/show/NCT04374058 |
| NCT04373486 | Incidence of Acute Pulmonary Embolism in Covid-19 Patients on CT Angiography and Relationship to D-dimer Levels | https://ClinicalTrials.gov/show/NCT04373486 |
| NCT04374123 | COVID-19 Serology Screening and Strict Protocol in the Endoscopy Unit | https://ClinicalTrials.gov/show/NCT04374123 |
| NCT04373889 | COVID-19 Among Healthcare Workers in Belgian Hospitals | https://ClinicalTrials.gov/show/NCT04373889 |
| NCT04373811 | One-Year Quality of Life and Functional Prognosis of COVID-19 Patients in Post-ICU Setting | https://ClinicalTrials.gov/show/NCT04373811 |
| NCT04373798 | C-reactive Protein Levels Among Individuals With COVID-19 | https://ClinicalTrials.gov/show/NCT04373798 |
| NCT04373109 | Stroke Rehabilitation Outcome During COVID-19 Lockdown | https://ClinicalTrials.gov/show/NCT04373109 |
| NCT04373005 | Screening of Cancer Patients to Assess Impact of COVID-19 | https://ClinicalTrials.gov/show/NCT04373005 |
| NCT04372056 | The COVID-ICU Healthcare Professional Study | https://ClinicalTrials.gov/show/NCT04372056 |
| NCT04371679 | Changes in Cardiac and Pulmonary Hemodynamics as Predictor of Outcome in Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04371679 |
| NCT04371354 | Outcomes of Covid-19 Protective Measures in Endoscopy | https://ClinicalTrials.gov/show/NCT04371354 |
| NCT04371315 | Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children | https://ClinicalTrials.gov/show/NCT04371315 |
| NCT04371302 | Nursing Perspective on Burnout and Medical Errors in the Intensive Care Unit During Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04371302 |
| NCT04371289 | Predictors of Cardiovascular Risk in Covid-19 Patients During Acute Disease and at Short Term Follow-up | https://ClinicalTrials.gov/show/NCT04371289 |
| NCT04370678 | Changes in Preference for Surgery of Patients Signed up for Arthroscopic Procedures | https://ClinicalTrials.gov/show/NCT04370678 |
| NCT04370275 | Accuracy of Lung Ultrasound in the Diagnosis of covid19 Pneumonia | https://ClinicalTrials.gov/show/NCT04370275 |
| NCT04370249 | Construction of a Composite Clinical-echo Score Predictive of a Risk of Short-term Aggravation of Respiratory Impairment in Patients Suspected of Covid-19 | https://ClinicalTrials.gov/show/NCT04370249 |
| NCT04370210 | Sleep Quality During COVID-19 Containment in Children Whether or Not Usually Followed in Child Psychiatry | https://ClinicalTrials.gov/show/NCT04370210 |
| NCT04370197 | Covid-19 Epidemic on Acute Stroke Management | https://ClinicalTrials.gov/show/NCT04370197 |
| NCT04369989 | Observational Study of COVID-19 Treatment Efficacy | https://ClinicalTrials.gov/show/NCT04369989 |
| NCT04369859 | Obstetric and Perinatal Outcomes of Women With COVID-19 | https://ClinicalTrials.gov/show/NCT04369859 |
| NCT04369690 | The Psychological, Social, and Economic Impacts of COVID-19 | https://ClinicalTrials.gov/show/NCT04369690 |
| NCT04368637 | Acute Cardiovascular Events Triggered by COVID-19-Related Stress | https://ClinicalTrials.gov/show/NCT04368637 |
| NCT04368026 | SARS-CoV-2 (COVID-19) and Surgery | https://ClinicalTrials.gov/show/NCT04368026 |
| NCT04367740 | ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19 | https://ClinicalTrials.gov/show/NCT04367740 |
| NCT04366765 | COVID-19 Survival - The COVIVA Study | https://ClinicalTrials.gov/show/NCT04366765 |
| NCT04367402 | COST (COvid STudio) ACTION: Study for the Evaluation of Specific Antibodies Anti Covid-19 Linked to Covid-19 Infection, Symptoms and Genetic Expression of ACE2 Polymorphisms in Patients (COST ACTION) | https://ClinicalTrials.gov/show/NCT04367402 |
| NCT04367363 | Social Media and COVID-19 | https://ClinicalTrials.gov/show/NCT04367363 |
| NCT04367337 | Health Behavior Change During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04367337 |
| NCT04366934 | Study of the Pathogenesis of Olfactory Disorders in COVID-19 | https://ClinicalTrials.gov/show/NCT04366934 |
| NCT04366921 | European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID-19 Patients in ECMO | https://ClinicalTrials.gov/show/NCT04366921 |
| NCT04365959 | The Prone Position in Covid-19 Affected Patients | https://ClinicalTrials.gov/show/NCT04365959 |
| NCT04365881 | Loneliness During the NPIs for the COVID-19 Pandemic in Norway: Risk Factors and Associations With Psychopathology | https://ClinicalTrials.gov/show/NCT04365881 |
| NCT04365634 | A Single-center Retrospective Study to Find Prediction Factors Related to Mortality of COVID-19 Patients. | https://ClinicalTrials.gov/show/NCT04365634 |
| NCT04365595 | SARS-CoV-2 Associated Respiratory Failure Recovery (COVID-19 CAir) | https://ClinicalTrials.gov/show/NCT04365595 |
| NCT04365530 | Become of Patients Infected or Suspected of Being Infected by Covid-19 and Supported by the GHPSJ and the Establishments of the Paris Plaisance Hospital City | https://ClinicalTrials.gov/show/NCT04365530 |
| NCT04365348 | The Psychological Impact of COVID-19 Outbreak on COVID-19 Survivors and Their Families | https://ClinicalTrials.gov/show/NCT04365348 |
| NCT04365335 | Stress Biomarkers Leading to Professional Burnout Among People Involved in a Mobile Intensive Care Unit During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04365335 |
| NCT04365166 | Study of Clinical and Immune Severity Profiles of Patients Infected With SARS-Cov2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04365166 |
| NCT04373148 | Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19 | https://ClinicalTrials.gov/show/NCT04373148 |
| NCT04372576 | Epidemiology and Outcome of Ventilator-associated Pneumonia Among Critically Ill COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04372576 |
| NCT04372472 | SQuISH-COVID: A Pilot Study | https://ClinicalTrials.gov/show/NCT04372472 |
| NCT04371848 | Impact of the COVID-19 Pandemic on Diet Quality and Food Insecurity: a NutriQuébec Sub-study | https://ClinicalTrials.gov/show/NCT04371848 |
| NCT04371835 | COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings | https://ClinicalTrials.gov/show/NCT04371835 |
| NCT04371562 | Predicting Death and ICU Admission in COVID-19 Patients in ED | https://ClinicalTrials.gov/show/NCT04371562 |
| NCT04371471 | Covid-19 Pandemic Triage Score | https://ClinicalTrials.gov/show/NCT04371471 |
| NCT04371432 | Genetics of COVID-19 Susceptibility and Manifestations | https://ClinicalTrials.gov/show/NCT04371432 |
| NCT04371250 | Study of Resilience and Loneliness in Youth (18 - 25 Years Old) During the COVID-19 Pandemic Lock-down Measures. | https://ClinicalTrials.gov/show/NCT04371250 |
| NCT04370808 | VITACOV: Vitamin D Polymorphisms and Severity of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04370808 |
| NCT04370171 | Management of Diabetic Patients With Telemedicine in the Context of the Covid-19 Epidemic | https://ClinicalTrials.gov/show/NCT04370171 |
| NCT04370119 | Screening for COVID-19 and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers | https://ClinicalTrials.gov/show/NCT04370119 |
| NCT04369807 | Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04369807 |
| NCT04368897 | In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity | https://ClinicalTrials.gov/show/NCT04368897 |
| NCT04368884 | Assess the Seroconversion Status of Health Care Workers Suspected or Confirmed Cases of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04368884 |
| NCT04368871 | Radiographic Findings and Their Temporal Changes in COVID-19 Positive Changes Patients: A Prospective Study | https://ClinicalTrials.gov/show/NCT04368871 |
| NCT04368793 | Clinical Effects of Internet Assisted Pulmonary Rehabilitation of COVID-2019 Pneumonia Patients After Discharge | https://ClinicalTrials.gov/show/NCT04368793 |
| NCT04368390 | Neuroradiolological Analysis of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04368390 |
| NCT04368351 | Bacteriotherapy in the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04368351 |
| NCT04368338 | Lung Ultrasound to Diagnose COVID-19 | https://ClinicalTrials.gov/show/NCT04368338 |
| NCT04368312 | Psychological Impairment Due to Covid-19 | https://ClinicalTrials.gov/show/NCT04368312 |
| NCT04366778 | Thrombosis and Covid-19 | https://ClinicalTrials.gov/show/NCT04366778 |
| NCT04368221 | Characterization of Fungal Infections in COVID-19 Infected and Mechanically Ventilated Patients in ICU | https://ClinicalTrials.gov/show/NCT04368221 |
| NCT04368208 | Impact of Giving Birth During the Covid 19 Pandemia on Postnatal Women’s Depression | https://ClinicalTrials.gov/show/NCT04368208 |
| NCT04367896 | COVID-19 OUTBREAK AND SOLID ORGAN TRANSPLANTATION (SOT) : AN INTERNATIONAL WEB-BASED SURVEY | https://ClinicalTrials.gov/show/NCT04367896 |
| NCT04367883 | Influenza Vaccination, ACEI and ARB in the Evolution of SARS-Covid19 Infection | https://ClinicalTrials.gov/show/NCT04367883 |
| NCT04367870 | COVID-19 Detection Test in Oncology | https://ClinicalTrials.gov/show/NCT04367870 |
| NCT04367805 | COVID-19 Infection in Patients With Hepatocellular Carcinoma | https://ClinicalTrials.gov/show/NCT04367805 |
| NCT04367792 | Cardiac Injury in COVID-19: a Pathology Study | https://ClinicalTrials.gov/show/NCT04367792 |
| NCT04367142 | Rapid Detection of COVID-19 by Portable and Connected Biosensor | https://ClinicalTrials.gov/show/NCT04367142 |
| NCT04367129 | Electrocardiogram Analysis in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04367129 |
| NCT04367064 | To Study the Clinical Characteristics and Treatment Outcome of COVID-19 Patients Admitted in Hospitals of Max Healthcare (SCOPe Study) | https://ClinicalTrials.gov/show/NCT04367064 |
| NCT04366752 | Thrombo Embolic Events in Critical Care Patients With Covid-19 Serious Acute Pneumopathy | https://ClinicalTrials.gov/show/NCT04366752 |
| NCT04366167 | Patient Recovery From Heart Surgery During the Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04366167 |
| NCT04365361 | The Psychological Impact of the COVID-19 on Students. | https://ClinicalTrials.gov/show/NCT04365361 |
| NCT04366154 | Impact of the COVID-19 Infectious Epidemic on the Management of Oncology and Onco-hematology Patients and on the Psychological Consequences for Patients and Caregivers | https://ClinicalTrials.gov/show/NCT04366154 |
| NCT04366024 | A Novel Nomogram to Predict Severity of COVID-19 | https://ClinicalTrials.gov/show/NCT04366024 |
| NCT04365816 | NutriCovid30 : Nutritional Evaluation for Covid-19 Infection at D30 | https://ClinicalTrials.gov/show/NCT04365816 |
| NCT04365764 | Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study | https://ClinicalTrials.gov/show/NCT04365764 |
| NCT04365725 | Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections | https://ClinicalTrials.gov/show/NCT04365725 |
| NCT04364698 | Observational Cohort of COVID-19 Patients at Raymond-Poincare | https://ClinicalTrials.gov/show/NCT04364698 |
| NCT04363788 | Needle Stick Injuries in Emergency Medical Service Practice | https://ClinicalTrials.gov/show/NCT04363788 |
| NCT04363489 | The CEDiD Study (COVID-19 Early Diagnosis in Doctors and Healthcare Workers) | https://ClinicalTrials.gov/show/NCT04363489 |
| NCT04363333 | Obstructive Sleep Apnea & Covid-19 Outcomes | https://ClinicalTrials.gov/show/NCT04363333 |
| NCT04363268 | ACCESS A Master Digital Surveillance Protocol for COVID-19 | https://ClinicalTrials.gov/show/NCT04363268 |
| NCT04363008 | COVID 19 Biomarkers | https://ClinicalTrials.gov/show/NCT04363008 |
| NCT04363099 | Multicentre Observational Study on Management COVID 19 Positive Outpatients in a French Cluster. | https://ClinicalTrials.gov/show/NCT04363099 |
| NCT04363047 | Immune Cells in Inflammatory Arthritis With Coronaviruses, Including COVID-19 | https://ClinicalTrials.gov/show/NCT04363047 |
| NCT04362995 | St. Jude Tracking of Viral and Host Factors Associated With COVID-19 | https://ClinicalTrials.gov/show/NCT04362995 |
| NCT04362956 | Clinical and Immunologic Impact of Perinatal SARS-CoV-2 (COVID-19) Infection | https://ClinicalTrials.gov/show/NCT04362956 |
| NCT04362943 | Clinical-epidemiological Characterization of COVID-19 Disease in Hospitalized Older Adults | https://ClinicalTrials.gov/show/NCT04362943 |
| NCT04362930 | Cohort of Patients With Covid-19 Presenting Neurological or Psychiatric Disorders (CoCo-Neurosciences) | https://ClinicalTrials.gov/show/NCT04362930 |
| NCT04362345 | Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04362345 |
| NCT04362319 | Burnout and Medical Errors in the Anaesthesiology Fraternity During Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04362319 |
| NCT04362267 | Longitudinal Study of Covid-19 Infection Among HCW in a French University Hospital | https://ClinicalTrials.gov/show/NCT04362267 |
| NCT04362150 | Long-term Impact of Infection With Novel Coronavirus (COVID-19) | https://ClinicalTrials.gov/show/NCT04362150 |
| NCT04361786 | Acral Cutaneous Thrombotic Vasculopathy and Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04361786 |
| NCT04361565 | Frequency and Clinical Evolution of Olfactory and Taste Disorders in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04361565 |
| NCT04361019 | Physical Activity in University Students Around COVID-19 Confinement | https://ClinicalTrials.gov/show/NCT04361019 |
| NCT04360954 | Evaluation of Antibody Tests for COVID-19 | https://ClinicalTrials.gov/show/NCT04360954 |
| NCT04361123 | Atrium COVID-19 Syndromic and Serologic Surveillance | https://ClinicalTrials.gov/show/NCT04361123 |
| NCT04360733 | Precision Immunology to Determine the Immune Response in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04360733 |
| NCT04360863 | The Impact of COVID-19 Pandemic on the Smoking Behaviour of Young Smokers and the Youth Quitline Service in Hong Kong | https://ClinicalTrials.gov/show/NCT04360863 |
| NCT04360850 | Use of Telehealth Technology by Mental Health Care Professionals in Times of COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04360850 |
| NCT04359836 | A Study to Explore the Role of Gut Flora in COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04359836 |
| NCT04360538 | Long Term Outcomes of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04360538 |
| NCT04360278 | Plasma Collection From Convalescent and/or Immunized Donors for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04360278 |
| NCT04359914 | Neurocognitive Impairment in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04359914 |
| NCT04359849 | Sequencing and Tracking of Phylogeny in COVID-19 Study | https://ClinicalTrials.gov/show/NCT04359849 |
| NCT04359706 | Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With COVID-19 | https://ClinicalTrials.gov/show/NCT04359706 |
| NCT04359407 | Prone Positioning and Regional Ventilation in Mechanically Ventilated COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04359407 |
| NCT04359121 | COVID-19 and the Developement of Phobic Fears of Disease | https://ClinicalTrials.gov/show/NCT04359121 |
| NCT04358510 | COVID-19 Mortality Prediction Model | https://ClinicalTrials.gov/show/NCT04358510 |
| NCT04358380 | Liver Injury in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04358380 |
| NCT04357574 | Assessing the System for High-Intensity Evaluation During Radiotherapy During Changes in Response to COVID-19 | https://ClinicalTrials.gov/show/NCT04357574 |
| NCT04357314 | Myocardial Infarction Rates Overview During COVID-19 Pandemic In France: MODIF Study | https://ClinicalTrials.gov/show/NCT04357314 |
| NCT04357041 | COVID-19 Survey Study on Dietary Intake, Physical Activity and Overall Well-being | https://ClinicalTrials.gov/show/NCT04357041 |
| NCT04356950 | Analysis of the Coagulopathy Developed by COVID-19 Infected Patients | https://ClinicalTrials.gov/show/NCT04356950 |
| NCT04356885 | COVID-19 and Psychotic Symptoms in France | https://ClinicalTrials.gov/show/NCT04356885 |
| NCT04356365 | The Mental Health Status of the General Population During the COVID-19 Pandemic and Its Association With Adherence to Government-initiated Non-pharmacological Epidemiological Interventions (NPI’s) | https://ClinicalTrials.gov/show/NCT04356365 |
| NCT04355871 | Characteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain | https://ClinicalTrials.gov/show/NCT04355871 |
| NCT04355741 | Gut Microbiota, “Spark and Flame” of COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04355741 |
| NCT04355715 | Combination of Chest Scanography and Nasal Viral Detection Test to Detect COVID-19 Positive Patients Before Surgical Intervention in a University Hospital During Coronavirus Pandemia | https://ClinicalTrials.gov/show/NCT04355715 |
| NCT04355507 | Computed Tomography for COVID-19 Diagnosis | https://ClinicalTrials.gov/show/NCT04355507 |
| NCT04355481 | Dissemination of SARS-COV-2 (COVID-19) in the Environment of Infected Patients Admitted to Intensive Care Unit | https://ClinicalTrials.gov/show/NCT04355481 |
| NCT04355442 | Evolution of Facial Trauma During COVID Containment Measures | https://ClinicalTrials.gov/show/NCT04355442 |
| NCT04355338 | Assessment of Incidence of SARS-CoV-2 Infection and COVID-19 in Brazil (AVISA) | https://ClinicalTrials.gov/show/NCT04355338 |
| NCT04354792 | Asymptomatic COVID-19 Infection Among Healthcare Workers | https://ClinicalTrials.gov/show/NCT04354792 |
| NCT04354779 | Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel. | https://ClinicalTrials.gov/show/NCT04354779 |
| NCT04354766 | COVID-19 : Neutralizing Human Monoclonal Antibodies Against SARS-Cov-2 | https://ClinicalTrials.gov/show/NCT04354766 |
| NCT04354753 | AiM COVID for Covid 19 Tracking and Prediction | https://ClinicalTrials.gov/show/NCT04354753 |
| NCT04353154 | The RAPID COVID-19 TRIAGE Algorithm | https://ClinicalTrials.gov/show/NCT04353154 |
| NCT04353141 | International Lung UltraSound Analysis (ILUSA) Study | https://ClinicalTrials.gov/show/NCT04353141 |
| NCT04353011 | Psychological Impact of Quarantine in Chronic Pain Patient During COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04353011 |
| NCT04352699 | Outcomes of Urological Surgery During Periods of Social COVID-19 Containemnt: is it Reasonable to Limit Access to Surgical Care for All? | https://ClinicalTrials.gov/show/NCT04352699 |
| NCT04351659 | Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04351659 |
| NCT04351633 | Psychological Impact of Quarantine in Osteoporosis Patient During COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04351633 |
| NCT04351568 | Professional and Ethical Challenges of Social Media Usage in Providing Healthcare Services During the Period of 19 Covid Pandemics; | https://ClinicalTrials.gov/show/NCT04351568 |
| NCT04351503 | A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19 | https://ClinicalTrials.gov/show/NCT04351503 |
| NCT04351399 | Psychological Impact of Quarantine in Rheumatoid Arthritis Patient During COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04351399 |
| NCT04351139 | Impact of the COVID-19 Pandemic in Gynecological Oncology | https://ClinicalTrials.gov/show/NCT04351139 |
| NCT04360707 | Solid Organ Transplant Recipients With SARS-CoV-2 French Registry | https://ClinicalTrials.gov/show/NCT04360707 |
| NCT04359693 | Impact of COVID-19 Infection on the Incidence of Ventilator-acquired Infections | https://ClinicalTrials.gov/show/NCT04359693 |
| NCT04359667 | Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19 Pneumonia Treated With Tocilizumab | https://ClinicalTrials.gov/show/NCT04359667 |
| NCT04359212 | Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19 | https://ClinicalTrials.gov/show/NCT04359212 |
| NCT04358952 | Myocardial Involvement of Severe Acute Respiratory Syndrome-Cov-2 (Covid19) Infected Patients | https://ClinicalTrials.gov/show/NCT04358952 |
| NCT04358640 | Anxiety and Work Resilience Among Tertiary University Hospital Workers During the COVID-19 Outbreak: An Online Survey | https://ClinicalTrials.gov/show/NCT04358640 |
| NCT04358536 | Classification of COVID-19 Infection in Posteroanterior Chest X-rays | https://ClinicalTrials.gov/show/NCT04358536 |
| NCT04358029 | Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04358029 |
| NCT04357938 | Risk Stratification With Chest CT to Rule-out Suspected SARS-CoV-2 Infections | https://ClinicalTrials.gov/show/NCT04357938 |
| NCT04357886 | Awareness of COVID-19 in Turkey | https://ClinicalTrials.gov/show/NCT04357886 |
| NCT04357847 | Assessment of Endothelial and Haemostatic Changes During Severe SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04357847 |
| NCT04357834 | WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories | https://ClinicalTrials.gov/show/NCT04357834 |
| NCT04357769 | COVID-19 Pandemic Burden in Severe Mental Disease Patients | https://ClinicalTrials.gov/show/NCT04357769 |
| NCT04357535 | Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives | https://ClinicalTrials.gov/show/NCT04357535 |
| NCT04357431 | COVID-19 Among Egyptian Health Care Providers | https://ClinicalTrials.gov/show/NCT04357431 |
| NCT04357418 | Psychological Outcome of COVID-19 Lockdown on Psychiatric Hospital Staff and Close Relatives | https://ClinicalTrials.gov/show/NCT04357418 |
| NCT04356560 | COVID-19 Surveillance of Patients and Healthcare Workers in a Hospital Department | https://ClinicalTrials.gov/show/NCT04356560 |
| NCT04356443 | Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04356443 |
| NCT04356378 | Long Term Physical Functional Limitations in Daily Living in SARS-CoV2 Infected Patients Hospitalized in the Acute Phase Then Requiring Rehabilitation | https://ClinicalTrials.gov/show/NCT04356378 |
| NCT04355624 | Kidney Involvement in COVID-19 Disease (COVKID) | https://ClinicalTrials.gov/show/NCT04355624 |
| NCT04355611 | Epidemiological Characteristics of COVID-19 in Patients With MS or NMO | https://ClinicalTrials.gov/show/NCT04355611 |
| NCT04354857 | Qualitative and Quantitative Evaluation of Anosmia Over Time in Clinically Symptomatic Patients Tested for COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04354857 |
| NCT04354584 | Compartmental Inflammation in Mechanically Ventilated Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04354584 |
| NCT04354558 | French Single Centre Experience of Critically Ill Patients With Covid 19 | https://ClinicalTrials.gov/show/NCT04354558 |
| NCT04354272 | Evaluation of Dental Emergency Treatments During COVID19 Crisis | https://ClinicalTrials.gov/show/NCT04354272 |
| NCT04353934 | The Ariel University Survey on Dietary Changes and Anxiety During the Coronavirus Pandemic | https://ClinicalTrials.gov/show/NCT04353934 |
| NCT04353609 | Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare Diseases | https://ClinicalTrials.gov/show/NCT04353609 |
| NCT04352842 | Echocardiographic Manifestation in Patient With COVID-19 （EARLY-MYO COVID-19） | https://ClinicalTrials.gov/show/NCT04352842 |
| NCT04352634 | The Covid-19 HEalth caRe wOrkErS (HEROES) Study | https://ClinicalTrials.gov/show/NCT04352634 |
| NCT04352582 | COVID-19 and Vaccination Attitudes | https://ClinicalTrials.gov/show/NCT04352582 |
| NCT04352556 | COVID19-hematological Malignancies: the Italian Hematology Alliance | https://ClinicalTrials.gov/show/NCT04352556 |
| NCT04352517 | Influence Physical Activity Psychological Responses COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04352517 |
| NCT04352491 | An Online Survey to Understand Feelings Related to COVID-19 Among ILBS Patients With Liver Disease | https://ClinicalTrials.gov/show/NCT04352491 |
| NCT04351854 | Registry for Clinical Presentation and Management of Patients With COVID-19 in the Emergency Room | https://ClinicalTrials.gov/show/NCT04351854 |
| NCT04351802 | CORonavirus (COVID-19) Diagnostic Lung UltraSound Study | https://ClinicalTrials.gov/show/NCT04351802 |
| NCT04351711 | Immunological Profiling of Patients With COVID-19 in Respiratory Distress | https://ClinicalTrials.gov/show/NCT04351711 |
| NCT04350710 | Description of Respiratory Mechanics in Patients With SARS-CoV-2 Associated ARDS | https://ClinicalTrials.gov/show/NCT04350710 |
| NCT04350099 | Emotional Burden of Healthcare Professionals and Covid Infection 19 | https://ClinicalTrials.gov/show/NCT04350099 |
| NCT04349540 | Role of Immune and Inflammatory Response in Recipients of Allogeneic Haematopoietic Stem Cell Transplantation (SCT) Affected by Severe COVID19 | https://ClinicalTrials.gov/show/NCT04349540 |
| NCT04349202 | Beaumont Health Large-scale Automated Serologic Testing for COVID-19 | https://ClinicalTrials.gov/show/NCT04349202 |
| NCT04349163 | Resilience Evaluation of Caregivers During the SARS-CoV2 Epidemic Period : Prospective Cohort. | https://ClinicalTrials.gov/show/NCT04349163 |
| NCT04348422 | Evaluating the Immune Response for COVID-19 | https://ClinicalTrials.gov/show/NCT04348422 |
| NCT04348396 | Clinical and Biological Predictors of COVID-19 Disease in Older Patients | https://ClinicalTrials.gov/show/NCT04348396 |
| NCT04348552 | Non-COVID Patient-safety Incidents Reported by Primary Care Professionals in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study | https://ClinicalTrials.gov/show/NCT04348552 |
| NCT04348240 | Transmissibility and Viral Load of SARS-CoV-2 in Oral Secretions | https://ClinicalTrials.gov/show/NCT04348240 |
| NCT04348214 | Screening & Risk Assessment of Healthcare Workers & Infection Control in University & COVID-19 Quarantine Hospitals | https://ClinicalTrials.gov/show/NCT04348214 |
| NCT04347928 | Respiratory and Hemodynamic Changes Induced in Mechanically Ventilated Patients for COVID-19 | https://ClinicalTrials.gov/show/NCT04347928 |
| NCT04347876 | Outcome of COVID-19 Cases Based on Tuberculin Test: Can Previous BCG Alter the Prognosis? | https://ClinicalTrials.gov/show/NCT04347876 |
| NCT04347694 | Study to Determine the Immunization Status Among Nephrological Health Care Personnel Against SARS-CoV-2 in a Single Center Over the Course of 12 Months During the Worldwide COVID-19 Pandemic. | https://ClinicalTrials.gov/show/NCT04347694 |
| NCT04347850 | A Cohort of Patients With Possible or Confirmed SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04347850 |
| NCT04347824 | Predict Adverse Events by Covid-19 Nephritis | https://ClinicalTrials.gov/show/NCT04347824 |
| NCT04347408 | Seroprevalence of SARS-Cov-2 Antibodies in Children | https://ClinicalTrials.gov/show/NCT04347408 |
| NCT04347369 | A Retrospective Study of Neural Network Model to Dynamically Quantificate the Severity in COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04347369 |
| NCT04347460 | Establishing a COVID-19 Prospective Cohort for Identification of Secondary HLH | https://ClinicalTrials.gov/show/NCT04347460 |
| NCT04347070 | Implementation of Physiotherapy on COVID-19 Patients in ICU | https://ClinicalTrials.gov/show/NCT04347070 |
| NCT04346342 | PRactice of VENTilation in COVID-19 Patients (PRoVENT-COVID) | https://ClinicalTrials.gov/show/NCT04346342 |
| NCT04346121 | Non-COVID Patient-safety Incidents Reported by General Practitioners in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study.cRisis | https://ClinicalTrials.gov/show/NCT04346121 |
| NCT04346056 | Retrospective Study on Severe Respiratory Illness to Access the Presence of COVID-19 | https://ClinicalTrials.gov/show/NCT04346056 |
| NCT04345315 | Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent. | https://ClinicalTrials.gov/show/NCT04345315 |
| NCT04344197 | Surgery During Covid-19: The Role of Asymptomatic Patients, a Survey | https://ClinicalTrials.gov/show/NCT04344197 |
| NCT04344171 | CovidDB: The Covid-19 Inpatient Database | https://ClinicalTrials.gov/show/NCT04344171 |
| NCT04344145 | Exhaustion and Needs in Frontline COVID-19 Healthcare Workers: Cross-sectional Study in a Belgian Population | https://ClinicalTrials.gov/show/NCT04344145 |
| NCT04344119 | Assessment of Chilbains Occuring During Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04344119 |
| NCT04343898 | Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04343898 |
| NCT04343404 | Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19 | https://ClinicalTrials.gov/show/NCT04343404 |
| NCT04342884 | COVID-19 Community Research Partnership | https://ClinicalTrials.gov/show/NCT04342884 |
| NCT04342195 | Acquiring Convalescent Specimens for COVID-19 Antibodies | https://ClinicalTrials.gov/show/NCT04342195 |
| NCT04342104 | NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure | https://ClinicalTrials.gov/show/NCT04342104 |
| NCT04341792 | Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient | https://ClinicalTrials.gov/show/NCT04341792 |
| NCT04341519 | Psychological Burden in ICU Survivors of Severe COVID-19 Pneumonia, Their Relatives and Their Healthcare Providers | https://ClinicalTrials.gov/show/NCT04341519 |
| NCT04341506 | Non-contact ECG Sensor System for COVID19 | https://ClinicalTrials.gov/show/NCT04341506 |
| NCT04341480 | The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19 | https://ClinicalTrials.gov/show/NCT04341480 |
| NCT04340921 | The Role of Adaptive Immunity in COVID-19 Associated Myocardial Injury | https://ClinicalTrials.gov/show/NCT04340921 |
| NCT04340219 | Oncology-patient-reported Anxiety, Mood, and QoL During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04340219 |
| NCT04339634 | Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy | https://ClinicalTrials.gov/show/NCT04339634 |
| NCT04339608 | Max COVID19- Study | https://ClinicalTrials.gov/show/NCT04339608 |
| NCT04339491 | Physical Activity During Social Isolation | https://ClinicalTrials.gov/show/NCT04339491 |
| NCT04337762 | Beat COVID-19 - Observational Trial | https://ClinicalTrials.gov/show/NCT04337762 |
| NCT04337502 | Clinical and Radiomic Model of COVID-19 | https://ClinicalTrials.gov/show/NCT04337502 |
| NCT04337424 | Evaluation of Quickly Diagnostic Saliva Tests for SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04337424 |
| NCT04337320 | Maternal And Neonatal Outcome of Pregnant Patients With COVID-19 in Istanbul, Turkey: A Single-Center, Retrospective, Descriptive Study | https://ClinicalTrials.gov/show/NCT04337320 |
| NCT04337190 | Impact of Angiotensin II Receptor Blockers Treatment in Patients With COVID 19 (COVID-ARA2) | https://ClinicalTrials.gov/show/NCT04337190 |
| NCT04337151 | Blood Titanium Analysis of Patients With MAGEC Spine Rods in the COVID-19 Environment | https://ClinicalTrials.gov/show/NCT04337151 |
| NCT04337047 | Distress in Crisis Situations During COVID-19 | https://ClinicalTrials.gov/show/NCT04337047 |
| NCT04346602 | A Study on the Clinical and Psychological Characteristics of Patients With COVID-2019 | https://ClinicalTrials.gov/show/NCT04346602 |
| NCT04346264 | CoVid-19 - Infection and Antibody Formation in the Viennese Population | https://ClinicalTrials.gov/show/NCT04346264 |
| NCT04346212 | Oropharyngeal Dysphagia in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04346212 |
| NCT04346186 | COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff | https://ClinicalTrials.gov/show/NCT04346186 |
| NCT04345640 | The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver. | https://ClinicalTrials.gov/show/NCT04345640 |
| NCT04345510 | Testing for COVID-19 Infection in Asymptomatic Persons | https://ClinicalTrials.gov/show/NCT04345510 |
| NCT04345159 | Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease | https://ClinicalTrials.gov/show/NCT04345159 |
| NCT04344977 | Collection of Anti-SARS-CoV-2 Immune Plasma | https://ClinicalTrials.gov/show/NCT04344977 |
| NCT04344964 | Endoscopy-related Phone Consultation During the COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04344964 |
| NCT04344925 | Non Invasive Positive Pressure Ventilation to Minimize Aerosolization for COVID 19 | https://ClinicalTrials.gov/show/NCT04344925 |
| NCT04344834 | Short and Long-term Psychological Impact of Covid-19 on The Egyptians | https://ClinicalTrials.gov/show/NCT04344834 |
| NCT04344327 | Early Risk Stratification of Patient Hospitalized for SARS-CoV2 Infection: Critical COVID-19 France CCF | https://ClinicalTrials.gov/show/NCT04344327 |
| NCT04343781 | National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19 | https://ClinicalTrials.gov/show/NCT04343781 |
| NCT04343742 | Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19 | https://ClinicalTrials.gov/show/NCT04343742 |
| NCT04343339 | Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment | https://ClinicalTrials.gov/show/NCT04343339 |
| NCT04342637 | COVID-19 Endoscopy Survey | https://ClinicalTrials.gov/show/NCT04342637 |
| NCT04342702 | A Study on the Prospective Cohort Library of COVID-19 in Southeran | https://ClinicalTrials.gov/show/NCT04342702 |
| NCT04341714 | Efficiency and Satisfaction With Telephone Consultation in Neuro-urology: Experience of the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04341714 |
| NCT04341012 | Breath Analysis Based Disease Biomarkers of COVID-19 and Other Diseases | https://ClinicalTrials.gov/show/NCT04341012 |
| NCT04338932 | COVID-19 and Deep Venous Thrombosis | https://ClinicalTrials.gov/show/NCT04338932 |
| NCT04339998 | Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS) | https://ClinicalTrials.gov/show/NCT04339998 |
| NCT04339790 | Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers | https://ClinicalTrials.gov/show/NCT04339790 |
| NCT04339686 | Multicentric Retrospective Observational Study of Thoracic Scanner Performance in COVID Screening. | https://ClinicalTrials.gov/show/NCT04339686 |
| NCT04339387 | COVID-19 Risk Stratification | https://ClinicalTrials.gov/show/NCT04339387 |
| NCT04338945 | Impact of Pandemic COVID-19 on Surgical Specialities Residents in Italy | https://ClinicalTrials.gov/show/NCT04338945 |
| NCT04338672 | The Impact of the Covid-19 Outbreak on Emergency Room Attendances of Surgical Patients | https://ClinicalTrials.gov/show/NCT04338672 |
| NCT04337983 | Hemodynamic Characteristics of Patients With SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04337983 |
| NCT04336787 | Physical Activity Level, Stress Level, Sleep Quality in Pregnant Women During Covid-19 Quarantine | https://ClinicalTrials.gov/show/NCT04336787 |
| NCT04336761 | Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France | https://ClinicalTrials.gov/show/NCT04336761 |
| NCT04336657 | Corona-Like Illness: Did we Got it Before WHO Announcement of the Disease? | https://ClinicalTrials.gov/show/NCT04336657 |
| NCT04336384 | Impact of Covid-19 in Congenital Heart Disease | https://ClinicalTrials.gov/show/NCT04336384 |
| NCT04336215 | Rutgers COVID-19 Cohort Study | https://ClinicalTrials.gov/show/NCT04336215 |
| NCT04335747 | COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases | https://ClinicalTrials.gov/show/NCT04335747 |
| NCT04335630 | Cardiovascular Manifestations of COVID-19 | https://ClinicalTrials.gov/show/NCT04335630 |
| NCT04335188 | COVID-19 Registry Rhineland-Palatinate (Germany) | https://ClinicalTrials.gov/show/NCT04335188 |
| NCT04335162 | Cardiovascular Complications and COVID-19 (CovCardioVasc-Study) | https://ClinicalTrials.gov/show/NCT04335162 |
| NCT04334954 | SARS-COV2 Pandemic Serosurvey and Blood Sampling | https://ClinicalTrials.gov/show/NCT04334954 |
| NCT04334252 | Descriptive Study Regarding Ambulant Screening During COVID-19 Pandemia | https://ClinicalTrials.gov/show/NCT04334252 |
| NCT04333862 | Assessment of Covid-19 Infection Rates in Healthcare Workers Using a Desynchronization Strategy | https://ClinicalTrials.gov/show/NCT04333862 |
| NCT04333849 | Telephony Or Videophony for Isolated elDerly in Maine-Et-Loire 49 During COVID-19 | https://ClinicalTrials.gov/show/NCT04333849 |
| NCT04332913 | Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related Pneumonia | https://ClinicalTrials.gov/show/NCT04332913 |
| NCT04332016 | COVID-19 Biological Samples Collection | https://ClinicalTrials.gov/show/NCT04332016 |
| NCT04331886 | An Observational Study of Patients With Coronavirus Disease 2019 | https://ClinicalTrials.gov/show/NCT04331886 |
| NCT04331509 | COVID-19 Symptom Tracker | https://ClinicalTrials.gov/show/NCT04331509 |
| NCT04331106 | Survey of the Anxiety Associated With the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04331106 |
| NCT04330599 | Longitudinal Population-based Observational Study of COVID-19 in the UK Population | https://ClinicalTrials.gov/show/NCT04330599 |
| NCT04330521 | Impact of the Coronavirus (COVID-19) on Patients With Cancer | https://ClinicalTrials.gov/show/NCT04330521 |
| NCT04330261 | Clinical Characteristics and Outcomes of Pediatric COVID-19 | https://ClinicalTrials.gov/show/NCT04330261 |
| NCT04329546 | Understanding COVID-19 | https://ClinicalTrials.gov/show/NCT04329546 |
| NCT04329507 | Non-invasive Detection of Pneumonia in Context of Covid-19 Using Gas Chromatography - Ion Mobility Spectrometry (GC-IMS) | https://ClinicalTrials.gov/show/NCT04329507 |
| NCT04328454 | Clinical Characteristics and Prognostic Factors of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04328454 |
| NCT04327531 | Evaluation of Covid 19 Knowledge Anxiety and Expectation Levels of Turkish Physicians, Survey Study | https://ClinicalTrials.gov/show/NCT04327531 |
| NCT04327804 | A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research | https://ClinicalTrials.gov/show/NCT04327804 |
| NCT04327180 | PREdiction of DIagnosed Covid-19 infecTion in IUC Patients | https://ClinicalTrials.gov/show/NCT04327180 |
| NCT04326725 | Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia | https://ClinicalTrials.gov/show/NCT04326725 |
| NCT04326387 | Evaluation of Novel Diagnostic Tests for COVID-19 | https://ClinicalTrials.gov/show/NCT04326387 |
| NCT04325919 | Coronavirus Disease 2019 (COVID-19) Study of Hospitalized Patients in Hong Kong | https://ClinicalTrials.gov/show/NCT04325919 |
| NCT04325646 | Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in France | https://ClinicalTrials.gov/show/NCT04325646 |
| NCT04324736 | “COVID-19 and Diabetes Outcomes” | https://ClinicalTrials.gov/show/NCT04324736 |
| NCT04324684 | Prognostic Factors Keeping Track for COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04324684 |
| NCT04324047 | Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04324047 |
| NCT04323878 | Early CPAP in COVID-19 Patients With Respiratory Failure. A Prospective Cohort Study. | https://ClinicalTrials.gov/show/NCT04323878 |
| NCT04323787 | Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry | https://ClinicalTrials.gov/show/NCT04323787 |
| NCT04323644 | Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg) | https://ClinicalTrials.gov/show/NCT04323644 |
| NCT04322487 | Simple, Safe, Same: Lung Ultrasound for COVID-19 | https://ClinicalTrials.gov/show/NCT04322487 |
| NCT04322279 | Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. COVID19. | https://ClinicalTrials.gov/show/NCT04322279 |
| NCT04322188 | An Observational Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications | https://ClinicalTrials.gov/show/NCT04322188 |
| NCT04321369 | Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals | https://ClinicalTrials.gov/show/NCT04321369 |
| NCT04321265 | Outcomes and Prognostic Factors in COVID-19 | https://ClinicalTrials.gov/show/NCT04321265 |
| NCT04320732 | Risk Factors for Community- and Workplace Transmission of COVID-19 | https://ClinicalTrials.gov/show/NCT04320732 |
| NCT04320511 | Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2 | https://ClinicalTrials.gov/show/NCT04320511 |
| NCT04320017 | Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19 | https://ClinicalTrials.gov/show/NCT04320017 |
| NCT04319315 | Social Media Effect on Knowledge Dissemination During COVID-19 Virus Outbreak | https://ClinicalTrials.gov/show/NCT04319315 |
| NCT04318301 | Hypertension in Patients Hospitalized With COVID-19 | https://ClinicalTrials.gov/show/NCT04318301 |
| NCT04316949 | Predictors of Respiratory Failure in SARS-Cov-2 Infection | https://ClinicalTrials.gov/show/NCT04316949 |
| NCT04318366 | COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor | https://ClinicalTrials.gov/show/NCT04318366 |
| NCT04318418 | ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19 | https://ClinicalTrials.gov/show/NCT04318418 |
| NCT04316299 | Acute Kidney Injury in Patients Hospitalized With COVID-19 | https://ClinicalTrials.gov/show/NCT04316299 |
| NCT04314817 | Adverse Events Related to Treatments Used Against Coronavirus Disease 2019 | https://ClinicalTrials.gov/show/NCT04314817 |
| NCT04313946 | Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays | https://ClinicalTrials.gov/show/NCT04313946 |
| NCT04314232 | Mechanisms for Covid-19 Disease Complications | https://ClinicalTrials.gov/show/NCT04314232 |
| NCT04312464 | Myocardial Damage in COVID-19 | https://ClinicalTrials.gov/show/NCT04312464 |
| NCT04312100 | Sequential Oxygen Therapy Strategy for Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04312100 |
| NCT04307459 | Acute Respiratory Failure and COVID-19 in Real Life | https://ClinicalTrials.gov/show/NCT04307459 |
| NCT04306705 | Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19 | https://ClinicalTrials.gov/show/NCT04306705 |
| NCT04306497 | TCM Differentiation and Treatment Protocol of COVID-19 | https://ClinicalTrials.gov/show/NCT04306497 |
| NCT04305574 | Social Media Use During COVID-19 | https://ClinicalTrials.gov/show/NCT04305574 |
| NCT04302688 | Accurate Classification System for Patients With COVID-19 Pneumonitis | https://ClinicalTrials.gov/show/NCT04302688 |
| NCT04292964 | Prognostic Factors of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04292964 |
| NCT04292340 | Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04292340 |
| NCT04292327 | Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus | https://ClinicalTrials.gov/show/NCT04292327 |
| NCT04290780 | COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus | https://ClinicalTrials.gov/show/NCT04290780 |
| NCT04285801 | Critically Ill Patients With COVID-19 in Hong Kong: a Multicentre Observational Cohort Study | https://ClinicalTrials.gov/show/NCT04285801 |
| NCT04284046 | CT Scores Predict Mortality in 2019-nCoV Pneumonia | https://ClinicalTrials.gov/show/NCT04284046 |
| NCT04283396 | Study for Novel Coronavirus Pneumonia (NCP) | https://ClinicalTrials.gov/show/NCT04283396 |
| NCT04282135 | Detection of Influenza or SARS-CoV-2 Infection by IMS of Nasal Air Sampling | https://ClinicalTrials.gov/show/NCT04282135 |
| NCT04279899 | The Investigation of the Neonates With or With Risk of COVID-19 | https://ClinicalTrials.gov/show/NCT04279899 |
| NCT04279795 | Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations | https://ClinicalTrials.gov/show/NCT04279795 |
| NCT04279782 | Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection | https://ClinicalTrials.gov/show/NCT04279782 |
| NCT04275947 | The COVID-19 Mobile Health Study (CMHS) | https://ClinicalTrials.gov/show/NCT04275947 |
| NCT04274322 | Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool | https://ClinicalTrials.gov/show/NCT04274322 |
| NCT04262921 | French COVID Cohort | https://ClinicalTrials.gov/show/NCT04262921 |
| NCT04259892 | Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19. | https://ClinicalTrials.gov/show/NCT04259892 |
| NCT04260308 | A Survey of Psychological Status of Medical Workers and Residents in the Context of 2019 Novel Coronavirus Pneumonia | https://ClinicalTrials.gov/show/NCT04260308 |
| NCT04256395 | Efficacy of a Self-test and Self-alert Mobile Applet in Detecting Susceptible Infection of COVID-19 | https://ClinicalTrials.gov/show/NCT04256395 |
| NCT04255940 | 2019-nCoV Outbreak and Cardiovascular Diseases | https://ClinicalTrials.gov/show/NCT04255940 |
| NCT04245631 | Development of a Simple, Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV | https://ClinicalTrials.gov/show/NCT04245631 |
| NCT05080933 | ECMO for COVID-19 vs Influenza A H1N1 Associated ARDS | https://ClinicalTrials.gov/show/NCT05080933 |
| NCT05026788 | Impact of COVID-19 Pandemic on Orthopaedic Practice | https://ClinicalTrials.gov/show/NCT05026788 |
| NCT05082168 | Capnodynamic Monitoring of Cardiorespiratory Function in Critically Ill Patients | https://ClinicalTrials.gov/show/NCT05082168 |
| NCT04666246 | Inspiratory Effort in COVID-19 | https://ClinicalTrials.gov/show/NCT04666246 |
| NCT05083039 | Observational Program, Double-blind, Placebo-controlled to Study the Preventive Efficacy of the BiVac Polio Vaccine Against the Incidence of Acute Respiratory Infections, Including COVID-19 | https://ClinicalTrials.gov/show/NCT05083039 |
| NCT05083026 | Neutralizing Antibody Level After COVID-19 Vaccination | https://ClinicalTrials.gov/show/NCT05083026 |
| NCT04910243 | The Practice of Providing Palliative Care in the Situation of the COVID-19 (Coronavirus Disease 2019) Pandemic in Czech Republic | https://ClinicalTrials.gov/show/NCT04910243 |
| NCT04880447 | Special Investigation of COMIRNATY in the Population With Underlying Diseases | https://ClinicalTrials.gov/show/NCT04880447 |
| NCT04492384 | Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients | https://ClinicalTrials.gov/show/NCT04492384 |
| NCT05085652 | Spinal Anesthesia Related Hypotension in SARS-CoV-2 (COVID-19) Pregnant Patients | https://ClinicalTrials.gov/show/NCT05085652 |
| NCT04384029 | The Geneva Covid-19 CVD Study | https://ClinicalTrials.gov/show/NCT04384029 |
| NCT05085522 | Study of the Effect of Systematic Screening of Residents and Caregivers by Nasopharyngeal Swab (RT-PCR) | https://ClinicalTrials.gov/show/NCT05085522 |
| NCT05085262 | Cardiovascular Disease and Outcomes Among Patients With SARS-CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT05085262 |
| NCT05084950 | Informing the Population of Their Level of Protection Against COVID-19 in Monaco: a Prospective Study (MonaVacc) | https://ClinicalTrials.gov/show/NCT05084950 |
| NCT05084976 | Parental Perception of COVID 19 Vaccine in Technology Dependent Patients | https://ClinicalTrials.gov/show/NCT05084976 |
| NCT05058339 | Distress Associated With Coronavirus Disease 2019 and Telehealth on Supportive Care Patients With Advanced Cancer | https://ClinicalTrials.gov/show/NCT05058339 |
| NCT05054088 | ImmuneSense COVID-19 Variant Study | https://ClinicalTrials.gov/show/NCT05054088 |
| NCT05074017 | COVAG - Covid-19 Antigen Study - the Diagnostic Efficacy of SARS-CoV-2 Rapid Detection Tests | https://ClinicalTrials.gov/show/NCT05074017 |
| NCT04761913 | Paediatric Inflammatory Multisystem Syndrome During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04761913 |
| NCT04417673 | Living With Sickle Cell Disease in the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04417673 |
| NCT04362865 | Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04362865 |
| NCT05087355 | Health Status Prior and Post Infection With Influenza or COVID 19: a Population Based Retrospective Analysis of 2016-2021 | https://ClinicalTrials.gov/show/NCT05087355 |
| NCT05087277 | Correlation Study of Isotype Switching and Neutralizing Capacity to the COVID-19 Variants Strain | https://ClinicalTrials.gov/show/NCT05087277 |
| NCT05087225 | Suspicion of Hypoglycemic Effect of mRNA Based Covid-19 Vaccines (Polyethylene Glycol) Will Happen , Observational Study on Diabetic Patients at Saudia Arabia | https://ClinicalTrials.gov/show/NCT05087225 |
| NCT05060562 | Post Coronavirus Disease (COVID-19) Syndrome Indonesian Population | https://ClinicalTrials.gov/show/NCT05060562 |
| NCT04766788 | Studying Students at Risk for COVID-19 | https://ClinicalTrials.gov/show/NCT04766788 |
| NCT05067985 | SARS-CoV-2 PANDEMIC AND FAILED SPINAL ANESTHESIA | https://ClinicalTrials.gov/show/NCT05067985 |
| NCT05089968 | Ventilation Associated Pneumonia and Covid-19 | https://ClinicalTrials.gov/show/NCT05089968 |
| NCT05089578 | Integrative Treatment Methods in COVID-19 | https://ClinicalTrials.gov/show/NCT05089578 |
| NCT05088941 | Impact of SARSCoV2 on Allogeneic Stem Cell Transplantation Organization : a French Experience | https://ClinicalTrials.gov/show/NCT05088941 |
| NCT05080231 | COVID-19 Immunity Assessment | https://ClinicalTrials.gov/show/NCT05080231 |
| NCT05065827 | Lung Ultrasound Findings in Patients With COVID-19 in a UK ED | https://ClinicalTrials.gov/show/NCT05065827 |
| NCT05070091 | The Impact of Pituitary-thyroid and Pituitary-adrenal Axes Function on COVID-19 Clinical Course. | https://ClinicalTrials.gov/show/NCT05070091 |
| NCT04962347 | Real World Study of COVID-19 in a Flyover Region | https://ClinicalTrials.gov/show/NCT04962347 |
| NCT04866082 | Corticosteroids in Severe COVID-19 (ASAP-ESICM/ESAIC Study) | https://ClinicalTrials.gov/show/NCT04866082 |
| NCT04852276 | Analysis of the Immune Response to COVID-19 Vaccination and Outcomes in Individuals With and Without Immune Deficiencies and Dysregulations | https://ClinicalTrials.gov/show/NCT04852276 |
| NCT04838106 | Outcomes of Patients Who Survived Treatment on an Intensive Care Unit for COVID-19 in England and Wales | https://ClinicalTrials.gov/show/NCT04838106 |
| NCT04379284 | Risks of COVID19 in the Pregnant Population | https://ClinicalTrials.gov/show/NCT04379284 |
| NCT05092737 | Physiological Response to Prone Position in ARDS COVID-19 | https://ClinicalTrials.gov/show/NCT05092737 |
| NCT05092529 | Psychological Impact of COVID-19 on Intensive Care Survivors | https://ClinicalTrials.gov/show/NCT05092529 |
| NCT05074953 | Post-COVID-19 Monitoring in Routine Health Insurance Data | https://ClinicalTrials.gov/show/NCT05074953 |
| NCT04974164 | Effectiveness of COVID-19 Vaccine for Prevention of COVID-19 in the Dominican Republic | https://ClinicalTrials.gov/show/NCT04974164 |
| NCT04669054 | Hospital Interns Psychological State During the COVID-19 | https://ClinicalTrials.gov/show/NCT04669054 |
| NCT04657263 | Impact of the COVID-19 Pandemic on Vaccination | https://ClinicalTrials.gov/show/NCT04657263 |
| NCT04798625 | Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive Medication | https://ClinicalTrials.gov/show/NCT04798625 |
| NCT04689490 | Prospective Study of Persistent Dyspnea in Recovered COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04689490 |
| NCT04581148 | SARS-CoV2 Antibodies in Pediatric Patients (COVID-19) | https://ClinicalTrials.gov/show/NCT04581148 |
| NCT04596579 | SARS-CoV-2 (COVID-19) Immune Surveillance Among a Population Based Sample of Adults in Florida | https://ClinicalTrials.gov/show/NCT04596579 |
| NCT04590794 | SuPAR in Adult Patients With Covid-19 | https://ClinicalTrials.gov/show/NCT04590794 |
| NCT04322513 | Biomarkers for Identification of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04322513 |
| NCT04316884 | Mechanisms for Organ Dysfunction in Covid-19 | https://ClinicalTrials.gov/show/NCT04316884 |
| NCT04350073 | Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID) | https://ClinicalTrials.gov/show/NCT04350073 |
| NCT05078905 | Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases | https://ClinicalTrials.gov/show/NCT05078905 |
| NCT04993560 | Safety and Efficacy of COVID-19 Prime-boost Vaccine in Bahrain | https://ClinicalTrials.gov/show/NCT04993560 |
| NCT04728919 | Nasal and Pulmonary Nitric Oxide Output in COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04728919 |
| NCT04726176 | COVID-19 and the Brain | https://ClinicalTrials.gov/show/NCT04726176 |
| NCT04319172 | Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant Recipients | https://ClinicalTrials.gov/show/NCT04319172 |
| NCT05096962 | SARS-CoV-2-CZ-PREVAL-II Study | https://ClinicalTrials.gov/show/NCT05096962 |
| NCT04664309 | Understanding Immunity to the COVID-19 Vaccines | https://ClinicalTrials.gov/show/NCT04664309 |
| NCT04526977 | Differences in Immune Response Among HIV-1-infected Individuals With Previous or Current COVID-19 (CoVIHDis). | https://ClinicalTrials.gov/show/NCT04526977 |
| NCT04474249 | Follow-up of Critical COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04474249 |
| NCT04402827 | Different Susceptibility to SARS CoV-2 Infection Among Health Care Workers Highly Exposed to COVID-19. | https://ClinicalTrials.gov/show/NCT04402827 |
| NCT05096858 | Continuous Glucose Monitorization in Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT05096858 |
| NCT05096819 | Evaluation of the Usefulness of Adopting Remote, Mobile-based 6MWT Among Hospital Outpatients (the 6-APPnow), Within the Constraints Imposed by the SARS-COV2 Pandemic | https://ClinicalTrials.gov/show/NCT05096819 |
| NCT05087290 | LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR) | https://ClinicalTrials.gov/show/NCT05087290 |
| NCT05096091 | International Study on COVID-19 Vaccine to Assess Immunogenicity, Reactogenicity and Efficacy (InVITE) | https://ClinicalTrials.gov/show/NCT05096091 |
| NCT05069389 | Registry of Management Strategies for Patients With COVID-19 in Healthcare Establishments | https://ClinicalTrials.gov/show/NCT05069389 |
| NCT05025514 | Retrospective Study of COVID-19 Vaccines in Patients Undergoing Immunotherapy for Cancer. | https://ClinicalTrials.gov/show/NCT05025514 |
| NCT04813328 | The Effect of Helminth Infection Plus COVID-19 Infection on the Immune Response and Intestinal Microorganisms | https://ClinicalTrials.gov/show/NCT04813328 |
| NCT04858568 | Immune Responses to COVID-19 Vaccination in Lymphoma Patients | https://ClinicalTrials.gov/show/NCT04858568 |
| NCT04582266 | PK and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the US | https://ClinicalTrials.gov/show/NCT04582266 |
| NCT04462393 | Characteristics and Outcomes of Patients Admitted to Swedish Intensive Care Units for COVID-19 | https://ClinicalTrials.gov/show/NCT04462393 |
| NCT04387656 | NCI COVID-19 in Cancer Patients, NCCAPS Study | https://ClinicalTrials.gov/show/NCT04387656 |
| NCT05097664 | Ocular Manifestation and Related Risk Factors of Covid-19 Associated Mucormycosis: a Multicenter Study in Iran | https://ClinicalTrials.gov/show/NCT05097664 |
| NCT05069116 | The Impact of Covid 19 Pandemic on the Training of General Surgery Residents | https://ClinicalTrials.gov/show/NCT05069116 |
| NCT04927442 | Natural History Study of COVID-19 Using Digital Wearables | https://ClinicalTrials.gov/show/NCT04927442 |
| NCT04684615 | Mental Health Impact of the COVID-19 Pandemic on Amish and Mennonite Participants in AMBiGen | https://ClinicalTrials.gov/show/NCT04684615 |
| NCT04853004 | Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare With Regard to Vaccinations | https://ClinicalTrials.gov/show/NCT04853004 |
| NCT04852289 | A Clinical Observational Study of SARS-CoV-2 Specific CD8 T-Cell Responses to COVID-19 Vaccines in Humans | https://ClinicalTrials.gov/show/NCT04852289 |
| NCT04818164 | Prone Position Improves End-Expiratory Lung Volumes in COVID-19 Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04818164 |
| NCT04753242 | Psychosocial Care During the COVID-19 Pandemic in Acute Hospitals | https://ClinicalTrials.gov/show/NCT04753242 |
| NCT04609085 | SARS-COV2 Pandemic Serosurvey in a Rare Disease Population | https://ClinicalTrials.gov/show/NCT04609085 |
| NCT05080192 | Cardiovascular, Pulmonary, and Integrative Functional Phenotypes in COVID-19 Survivors - Effect of Fenofibrate | https://ClinicalTrials.gov/show/NCT05080192 |
| NCT05079191 | Impact of the CT Scan in Patients With Suspected Covid-19 | https://ClinicalTrials.gov/show/NCT05079191 |
| NCT05079373 | Study of Neurological Damage From Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT05079373 |
| NCT05079178 | Newborns of COVID-19 Mothers in Level III Services in Alsace | https://ClinicalTrials.gov/show/NCT05079178 |
| NCT05079165 | Covid Vaccination in Liver Transplantation | https://ClinicalTrials.gov/show/NCT05079165 |
| NCT05077228 | Efficiency of the Imaging Strategy for the Management of Suspected Covid-19 | https://ClinicalTrials.gov/show/NCT05077228 |
| NCT05077319 | Characteristics and Outcome of Patients With COVID-19 in ICUs in South Tyrol | https://ClinicalTrials.gov/show/NCT05077319 |
| NCT05077163 | Patients With Acute Renal Failure During Severe COVID-19 | https://ClinicalTrials.gov/show/NCT05077163 |
| NCT05076240 | FilmArray® and Management of Ventilator Associated Pneumonia in COVID-19 ARDS | https://ClinicalTrials.gov/show/NCT05076240 |
| NCT05076227 | SARS-CoV-2 (COVID-19) Vaccine Tolerability and Clinical Outcome Among Hospital Staff | https://ClinicalTrials.gov/show/NCT05076227 |
| NCT05075629 | Mental Health in Undergraduate Health Science Students During the Covid-19 Pandemic. | https://ClinicalTrials.gov/show/NCT05075629 |
| NCT05075928 | Description of a Cohort of COVID Patients With a Circulating Anticoagulant | https://ClinicalTrials.gov/show/NCT05075928 |
| NCT05075915 | Transfusion and COVID-19 | https://ClinicalTrials.gov/show/NCT05075915 |
| NCT05074719 | Index Individuals in SARS-CoV-2 Prevention Research Studies (an Index Individuals Companion Study) | https://ClinicalTrials.gov/show/NCT05074719 |
| NCT05074706 | Evaluation of the Immune Response to Sars-Cov-2 Vaccines in Haematological Patients: Prospective Single Center Study | https://ClinicalTrials.gov/show/NCT05074706 |
| NCT05074875 | COVID-19 Respiratory Outcomes Registry | https://ClinicalTrials.gov/show/NCT05074875 |
| NCT05075018 | Musculoskeletal Problems and Endurance in Healthcare Professionals With and Without COVID-19 | https://ClinicalTrials.gov/show/NCT05075018 |
| NCT05072496 | Study on Antibody Persistence and Immune Memory of Inactivated COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT05072496 |
| NCT05074043 | COVID-19 Associated Mucormycosis: A Multidisciplinary Dilemma in Assiut University Hospital | https://ClinicalTrials.gov/show/NCT05074043 |
| NCT04914364 | Balance in COVID-19 | https://ClinicalTrials.gov/show/NCT04914364 |
| NCT05069662 | Impact of the COVID-19 Pandemic on Drug Use and Monitoring of Cancer Patients | https://ClinicalTrials.gov/show/NCT05069662 |
| NCT05069090 | Effect of COVID-19 Lockdown on Alcohol and Tobacco Use in Two Chilean Universities | https://ClinicalTrials.gov/show/NCT05069090 |
| NCT05065788 | Ophthalmological Emergencies and COVID-19 Pandemia | https://ClinicalTrials.gov/show/NCT05065788 |
| NCT05067959 | Covid-19 Vaccine Responses in Patients With Inflammatory Bowel Diseases | https://ClinicalTrials.gov/show/NCT05067959 |
| NCT05068375 | Unleash the Mystery of COVID-19 Related Unusual Thrombosis | https://ClinicalTrials.gov/show/NCT05068375 |
| NCT05067907 | Efficacy of Respiratory Physiotherapy on Severe ICU-admitted COVID-19 Patients. | https://ClinicalTrials.gov/show/NCT05067907 |
| NCT05067881 | Post-COVID-19 Pneumo-hematocele | https://ClinicalTrials.gov/show/NCT05067881 |
| NCT05067400 | SARS-CoV-2 (COVID-19) Antibody PrevalencE in an Adult London HIV Cohort | https://ClinicalTrials.gov/show/NCT05067400 |
| NCT05065658 | Posaconazole Prophylaxis for CAPA Prevention in Critically-Ill Patients | https://ClinicalTrials.gov/show/NCT05065658 |
| NCT05062603 | Lung Ultrasound Changes in Covid 19 Patients Discharged From Hospital | https://ClinicalTrials.gov/show/NCT05062603 |
| NCT05063812 | Performance of a Remote Monitoring Program for Patients Diagnosed With COVID-19 | https://ClinicalTrials.gov/show/NCT05063812 |
| NCT05062538 | Cancer Patient Perspectives During COVID | https://ClinicalTrials.gov/show/NCT05062538 |
| NCT05062525 | Immune Response to COVID-19 Vaccine in Immunotherapy (IO) and Non-IO Treated Cancer Patients | https://ClinicalTrials.gov/show/NCT05062525 |
| NCT05060926 | Intubation Prediction in COVID-19 Patients Treated With Awake Prone Positioning | https://ClinicalTrials.gov/show/NCT05060926 |
| NCT05060692 | Changes of NLF in Serum of Long COVID Patients | https://ClinicalTrials.gov/show/NCT05060692 |
| NCT05060497 | DYNamic Assessment of Multi Organ Level Dysfunction in Patients Recovering From Covid-19 | https://ClinicalTrials.gov/show/NCT05060497 |
| NCT05060354 | COVID Vaccine Response in MS | https://ClinicalTrials.gov/show/NCT05060354 |
| NCT05059080 | A Six-Month Follow-Up Study of Participants With Coronavirus Disease 2019 (COVID-19) Previously Enrolled in a RO7496998 (AT-527) Study | https://ClinicalTrials.gov/show/NCT05059080 |
| NCT05059184 | Long-term Sequelae of COVID-19 (Myalgic Encephalomyelitis): An International Cross-Sectional Study | https://ClinicalTrials.gov/show/NCT05059184 |
| NCT05057962 | Tocilizumab in Covid-19 Penumonia in Buenos Aires City | https://ClinicalTrials.gov/show/NCT05057962 |
| NCT05058729 | MS PATHS COVID-19 Questionnaire Data Linkage Sub-Study | https://ClinicalTrials.gov/show/NCT05058729 |
| NCT05058716 | Assessment of Clinical Effects of Coenzyme Q10 Levels in COVID-19 Patients in Intensive Care Unit | https://ClinicalTrials.gov/show/NCT05058716 |
| NCT05057936 | Antibody After COVID-19 Vaccination | https://ClinicalTrials.gov/show/NCT05057936 |
| NCT05057208 | Does the COVID-19 Vaccination Rate Change According to the Education, Income, Culture Level, Prosociality ? | https://ClinicalTrials.gov/show/NCT05057208 |
| NCT05055479 | Nosocomial Outbreak of BHRe in an Intensive Care Unit During SARS-CoV-2 Pandemic | https://ClinicalTrials.gov/show/NCT05055479 |
| NCT05055466 | COVID-19: Infectious Potential of SARS-CoV-2 Intestinal Shedding in Pediatric Patients (INPOSIS) | https://ClinicalTrials.gov/show/NCT05055466 |
| NCT05055440 | Evaluation of Peripheral Muscle With Ultrassonografic of Critical Patients With Covid-19 | https://ClinicalTrials.gov/show/NCT05055440 |
| NCT05054283 | Baseline Blood Indices and Prolonged Length of Hospital Stay | https://ClinicalTrials.gov/show/NCT05054283 |
| NCT05054582 | COVID-19 Antibody Responses In Cystic Fibrosis: CAR-CF | https://ClinicalTrials.gov/show/NCT05054582 |
| NCT05054218 | COVID-19 Immunogenicity of a Third Dose of mRNA-1273 Vaccine Among Cancer Patients | https://ClinicalTrials.gov/show/NCT05054218 |
| NCT05052294 | COVID-19 Antibody Responses in Cystic Fibrosis | https://ClinicalTrials.gov/show/NCT05052294 |
| NCT05051605 | Immune Response to COVID-19 Vaccine in Recipients of Living Donor Liver Transplantation | https://ClinicalTrials.gov/show/NCT05051605 |
| NCT05052034 | Music for Decreasing Dental Anxiety During Oral Surgery in Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT05052034 |
| NCT05052008 | Management of Migraine Using Enerumab and Traditional Therapy at the Time of COVID-19 | https://ClinicalTrials.gov/show/NCT05052008 |
| NCT05049187 | Characterization and Durability of COVID-19 Vaccine Induced Immune Responses in Healthcare/Frontline Workers | https://ClinicalTrials.gov/show/NCT05049187 |
| NCT05047835 | Comparison of Prone Position and Standard Electrocardiogram in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT05047835 |
| NCT05047822 | Oxford/AstraZeneca COVID-19 Vaccine Effectiveness in England | https://ClinicalTrials.gov/show/NCT05047822 |
| NCT05047874 | High-dose, Short-term Steroid and Low-dose Long-term Steroid Use in ARDS Caused by COVID-19 | https://ClinicalTrials.gov/show/NCT05047874 |
| NCT05046652 | Effectiveness of Convalescent Plasma Therapy in 8 Non-Intubated COVID-19 Patients in Indonesia: A Case Series | https://ClinicalTrials.gov/show/NCT05046652 |
| NCT05047653 | RALE Versus CORADS/CT-Severity Score in COVID-19 | https://ClinicalTrials.gov/show/NCT05047653 |
| NCT05042011 | Role of mHealth-based Interventions Including Social Media to Improve Childhood Immunization Coverage During COVID 19 Pandemic in Pakistan: Qualitative Study | https://ClinicalTrials.gov/show/NCT05042011 |
| NCT05046769 | COVID-19: A Scope Research on Epidemiology and Clinical Course | https://ClinicalTrials.gov/show/NCT05046769 |
| NCT05043168 | Kidney Histopathology After COVID-19 and SARS-CoV-2 Vaccination | https://ClinicalTrials.gov/show/NCT05043168 |
| NCT05043155 | Strategies to Continue Gynae-oncology Services in the Era of COVID-19 Outbreak: Concerns and Challenges in a Referral Centre in Malaysia | https://ClinicalTrials.gov/show/NCT05043155 |
| NCT05043142 | Epidemiological Study of the COVID-2019 in Participating Organizations. | https://ClinicalTrials.gov/show/NCT05043142 |
| NCT05043129 | Safety and Immune Response of COVID-19 Vaccination in Patients With HIV Infection | https://ClinicalTrials.gov/show/NCT05043129 |
| NCT05042232 | A Prospective Virtual Study of Patient Reported Behaviors and Health Outcomes in Individuals With COVID-19 | https://ClinicalTrials.gov/show/NCT05042232 |
| NCT05042193 | A Prospective Virtual Study to Evaluate the Longevity of IgG Antibodies in Individuals Exposed to COVID-19 | https://ClinicalTrials.gov/show/NCT05042193 |
| NCT05046509 | The Clinical Manifestations Of SARS-Cov-2 Disease Not Only Pulmonary | https://ClinicalTrials.gov/show/NCT05046509 |
| NCT05046470 | SARS-CoV-2 Transmission in Belgian Primary Schools of the Federation Wallonie - Bruxelles: An Epidemiological Pilot Study | https://ClinicalTrials.gov/show/NCT05046470 |
| NCT05045924 | CirrhoCare in COVID-19: A Pilot, Remote, Home Monitoring Study in Advanced Cirrhosis | https://ClinicalTrials.gov/show/NCT05045924 |
| NCT05045846 | Diagnostic Accuracy of Rapid Antigen Test Based on Anterior Nasal Swab Compared With RT-PCR for SARS-CoV-2 Detection. | https://ClinicalTrials.gov/show/NCT05045846 |
| NCT05043363 | LuCID - Investigating the Use of a Novel Digital Rectoscope for Community Examinations During COVID-19 | https://ClinicalTrials.gov/show/NCT05043363 |
| NCT05043272 | Safety and Immune Response of COVID-19 Vaccination in Overweight People With Excessive BMI | https://ClinicalTrials.gov/show/NCT05043272 |
| NCT05043246 | Safety and Immune Response of COVID-19 Vaccination in Middle-aged and Elderly Patients With Basic Disease | https://ClinicalTrials.gov/show/NCT05043246 |
| NCT05041764 | RNA Sequencing of Individual Versus Wastewater - SARS-CoV2 | https://ClinicalTrials.gov/show/NCT05041764 |
| NCT05040750 | Correlation Between Cardiac Markers and Severity of COVID-19 | https://ClinicalTrials.gov/show/NCT05040750 |
| NCT05038475 | Clinical and Immunological Responses After SARS-CoV-2 Infection Causing COVID-19 | https://ClinicalTrials.gov/show/NCT05038475 |
| NCT05037227 | Safety Profile Following Inactivated COVID-19 Vaccine in Healthy Adults Aged >18 Years in Indonesia | https://ClinicalTrials.gov/show/NCT05037227 |
| NCT05037214 | COVID-19 : Stress Within Hospital Workers | https://ClinicalTrials.gov/show/NCT05037214 |
| NCT05036824 | Intensive Dose Tinzaparin in Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT05036824 |
| NCT05034978 | Novel SARS-CoV-2 Point-of-care Testing | https://ClinicalTrials.gov/show/NCT05034978 |
| NCT05033613 | Home Blood Pressure Monitoring Before and After COVID-19 Vaccination in Patients at High Risk of Cardiovascular Disease | https://ClinicalTrials.gov/show/NCT05033613 |
| NCT05028998 | Covid-related Opioid Treatment Policy Evaluation | https://ClinicalTrials.gov/show/NCT05028998 |
| NCT05031845 | Low-Dose Chest CT (LDCT) COVID-19 Study | https://ClinicalTrials.gov/show/NCT05031845 |
| NCT05031468 | Multisite Observational Maternal and Infant Study for COVID-19 | https://ClinicalTrials.gov/show/NCT05031468 |
| NCT05028881 | COVID-19 Serology in People Living With HIV in Hong Kong | https://ClinicalTrials.gov/show/NCT05028881 |
| NCT05028842 | Effect of Lockdown During COVID 19 Pandemic on Liver Disease and Metabolic Parameters. | https://ClinicalTrials.gov/show/NCT05028842 |
| NCT05027724 | Technology Assisted Solutions for the Recognition of Objective Physiological Indicators of Post-Coronavirus-19 Fatigue | https://ClinicalTrials.gov/show/NCT05027724 |
| NCT05026840 | GDM Screening During COVID Pandemic. IADPSG vs WHO ’99 Criteria | https://ClinicalTrials.gov/show/NCT05026840 |
| NCT05026879 | Adverse Events Report of Inactivated COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT05026879 |
| NCT05025839 | Neurological Outcome After SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT05025839 |
| NCT05012306 | Covid-19 Antibody Responses in Cystic Fibrosis | https://ClinicalTrials.gov/show/NCT05012306 |
| NCT05022446 | The Impact of COVID-19 on Pulmonary Procedures | https://ClinicalTrials.gov/show/NCT05022446 |
| NCT05022407 | Impact of COVID-19 Epidemic on Clinical Outcomes and Service Delivery Among People Living With HIV and Health Care Workers in Mozambique | https://ClinicalTrials.gov/show/NCT05022407 |
| NCT05021575 | Effects of COVID-19 Pandemic on a Health Care System: Case Study of the CirculatORy System in LiThuania | https://ClinicalTrials.gov/show/NCT05021575 |
| NCT05020691 | NIV in Covid-19 Respiratory Failure | https://ClinicalTrials.gov/show/NCT05020691 |
| NCT05020145 | COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States | https://ClinicalTrials.gov/show/NCT05020145 |
| NCT05019313 | Diaphragm Ultrasound Evaluation During Weaning From Mechanical Ventilation in the Positive COVID-19 Patient | https://ClinicalTrials.gov/show/NCT05019313 |
| NCT05019300 | Long-term Neurocognitive and Psychiatric Consequences in Severe COVID-19 Survivors. | https://ClinicalTrials.gov/show/NCT05019300 |
| NCT05017441 | TOcilizumab and Covid-19 : Risk of Severe INfection | https://ClinicalTrials.gov/show/NCT05017441 |
| NCT05014516 | Lung Structure-Function In SurVivors of Mild and SEvere COVID-19 Infection: 129Xe MRI | https://ClinicalTrials.gov/show/NCT05014516 |
| NCT05012839 | Complicated Appendicitis in COVID-19 Era | https://ClinicalTrials.gov/show/NCT05012839 |
| NCT05013047 | Impact of the COVID-19 Pandemic on the Organization of Healthcare in France | https://ClinicalTrials.gov/show/NCT05013047 |
| NCT05009134 | Influences of Allergic Rhinitis and Allergen Immunotherapy on SARS-CoV-2 Vaccination | https://ClinicalTrials.gov/show/NCT05009134 |
| NCT05008627 | PERSONAL PROTECTION EQUIPMENT AND SARS-CoV-2 CONTAMINATION | https://ClinicalTrials.gov/show/NCT05008627 |
| NCT05008562 | HOW SARS COV- 2 EFFECTS TO MUSCLE MASS CHANGE IN ICU? | https://ClinicalTrials.gov/show/NCT05008562 |
| NCT05008016 | Procalcitonin Level and the High Risk of Mortality in 30 Days in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patient , Cases Series. | https://ClinicalTrials.gov/show/NCT05008016 |
| NCT05009043 | COVID-19 Vaccine Hesitancy and Dental Faculty Staff Members in Egypt | https://ClinicalTrials.gov/show/NCT05009043 |
| NCT05009030 | Anti-SARS-COV2 Vaccination Study in Lung Cancer Patients | https://ClinicalTrials.gov/show/NCT05009030 |
| NCT05008406 | E-Learning During COVID-19 Pandemic: Turning a Crisis Into Opportunity | https://ClinicalTrials.gov/show/NCT05008406 |
| NCT05007665 | Safety and Immune Response of COVID-19 Vaccination in Patients With Chronic Liver Diseases | https://ClinicalTrials.gov/show/NCT05007665 |
| NCT05004740 | Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1c | https://ClinicalTrials.gov/show/NCT05004740 |
| NCT05004701 | Impact of the Lockdown Due to the COVID Pandemic in French Wilson’s Disease Patients | https://ClinicalTrials.gov/show/NCT05004701 |
| NCT05004246 | Longitudinal Changes in Characteristics of COVID-19 Survivors and Their Long-term Follow-up Study | https://ClinicalTrials.gov/show/NCT05004246 |
| NCT05000229 | Residual Symptoms After Coronavirus Disease (COVID-19) in Lithuanian Population | https://ClinicalTrials.gov/show/NCT05000229 |
| NCT04998799 | Practice Variation on Antithrombotics in COVID-19 | https://ClinicalTrials.gov/show/NCT04998799 |
| NCT05000099 | the Role of Technology in Elderly Patients | https://ClinicalTrials.gov/show/NCT05000099 |
| NCT04997915 | Acute Kidney Injury in Coronavirus Disease-19 (COVID-19) Patients Admitted to the Intensive Care Unit (ICU) | https://ClinicalTrials.gov/show/NCT04997915 |
| NCT04995289 | Prone Position During ECMO in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Hypoxaemic Patient | https://ClinicalTrials.gov/show/NCT04995289 |
| NCT04797091 | Kidney in Coronavirus Disease 2019 Registry | https://ClinicalTrials.gov/show/NCT04797091 |
| NCT04993573 | Acceptability, Representations and Experiences of the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04993573 |
| NCT04992234 | COVID-19 Antibody Responses in Cystic Fibrosis | https://ClinicalTrials.gov/show/NCT04992234 |
| NCT04992221 | Arterial Line Patency in ICU Bound COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04992221 |
| NCT04992195 | Impact of COVID-19 Vaccines on Cerebrovascular Health | https://ClinicalTrials.gov/show/NCT04992195 |
| NCT04989452 | Cough Sound Recordings to Understand COVID-19-like Symptom Progression to Understand COVID-19-like Symptom Progression | https://ClinicalTrials.gov/show/NCT04989452 |
| NCT04988438 | Gastrointestinal Motor Disorders (Esophageal and Anorectal) After COVID-19 | https://ClinicalTrials.gov/show/NCT04988438 |
| NCT04988269 | Assessment of Diurnal Salivary Cortisol Production in COVID-19 | https://ClinicalTrials.gov/show/NCT04988269 |
| NCT04987736 | Assessment of Long-term Effects (Complications) of COVID-19 in the Southern Part of Bangladesh - a Retrospective Observational Study. | https://ClinicalTrials.gov/show/NCT04987736 |
| NCT04987853 | Clinical, Functional, Immunological and Genetic Factors on the Severity of the Course of Coronavirus Infection | https://ClinicalTrials.gov/show/NCT04987853 |
| NCT04987606 | Post COVID-19 Interstitial Lung Disease: A Study of Genetic and Environmental Interactions | https://ClinicalTrials.gov/show/NCT04987606 |
| NCT04988126 | Pain, Fatigue and Life Quality in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04988126 |
| NCT04987528 | Pulmonary Fibrosis During Severe COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04987528 |
| NCT04984564 | Cardiovascular Fellow-in-training Feedback on Virtual and Simulator-based Learning Experience in A Low to Middle Income Country | https://ClinicalTrials.gov/show/NCT04984564 |
| NCT04982263 | Blood Coagulation Abnormalities in COVID-19 (Corona Virus Disease-19) Patients | https://ClinicalTrials.gov/show/NCT04982263 |
| NCT04982341 | HFNC and Prone Positioning in Awake Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04982341 |
| NCT04982328 | COVID-19 and Nonalcoholic Fatty Liver Disease | https://ClinicalTrials.gov/show/NCT04982328 |
| NCT04981405 | Real-world Evidence of COVID-19 Vaccines Effectiveness | https://ClinicalTrials.gov/show/NCT04981405 |
| NCT04981249 | Chronic Multimorbidity Patterns in Relation to COVID-19 Severe Infection | https://ClinicalTrials.gov/show/NCT04981249 |
| NCT04979897 | Impact on Mental, Physical, And Cognitive Functioning of a Critical Care sTay During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04979897 |
| NCT04980560 | Gut Microbiota Profile and Its Impact on Immunity Status in COVID-19 Vaccinated Cohorts | https://ClinicalTrials.gov/show/NCT04980560 |
| NCT04979208 | Impact of Changes in the Use of Care and Reorganization of the Healthcare System Linked to the Covid-19 Outbreak on the Quality of Care Pathways of Patients Suffering From Acute Myocardial Infarction and Stroke in Aquitaine (AVICOVID) | https://ClinicalTrials.gov/show/NCT04979208 |
| NCT04979091 | Sex Hormone Dysregulations Are Associated With Critical Illness in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04979091 |
| NCT04978246 | Cognitive Functions After COVID-19 | https://ClinicalTrials.gov/show/NCT04978246 |
| NCT04978233 | The Opal - COVID-19 Study | https://ClinicalTrials.gov/show/NCT04978233 |
| NCT04978220 | Mental and Psychological Problems and Insomnia Disorder of Medical Staff in Hospital With Infected COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04978220 |
| NCT04977934 | Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 | https://ClinicalTrials.gov/show/NCT04977934 |
| NCT04974177 | A Study to Determine the Role of Physician Gestalt in Predicting COVID-19 in Patients | https://ClinicalTrials.gov/show/NCT04974177 |
| NCT04972708 | Genetics of COVID-19 Risks & Resilience in Bipolar Disorder | https://ClinicalTrials.gov/show/NCT04972708 |
| NCT04977050 | The Role of Frequent Point-of-care Molecular Workplace Surveillance for Miners | https://ClinicalTrials.gov/show/NCT04977050 |
| NCT04972591 | Follow-up Study of Population Vaccinated With COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04972591 |
| NCT04970849 | Survey Study About Endoscopy During COVID-19 Pandemic for IBD Doctors | https://ClinicalTrials.gov/show/NCT04970849 |
| NCT04970927 | The Effect of Pandemic on Children With Cerebral Palsy | https://ClinicalTrials.gov/show/NCT04970927 |
| NCT04970550 | Vaccination Against SARS-Cov2 (COVID-19) in Chronic Inflammatory Rheumatism and Factors Determining Its Decision. | https://ClinicalTrials.gov/show/NCT04970550 |
| NCT04967781 | Autoimmunity Contributes to the Severe Progression of COVID-19 | https://ClinicalTrials.gov/show/NCT04967781 |
| NCT04967768 | The Influence and Effects of the COVID-19 Pandemic on Orthopaedic Resident Training | https://ClinicalTrials.gov/show/NCT04967768 |
| NCT04967586 | Medical Students and Risk of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04967586 |
| NCT04966845 | Effect of Face Mask on Exhaled Carbon Monoxide of Smokers | https://ClinicalTrials.gov/show/NCT04966845 |
| NCT04961385 | Immunogenicity of the ChAdox1 n CoV-19 Vaccine With 12-dose Vial | https://ClinicalTrials.gov/show/NCT04961385 |
| NCT04961489 | Impact of Measures Taken to Contain COVID-19 on Hospital Surgical Care Services and Clinical Outcomes | https://ClinicalTrials.gov/show/NCT04961489 |
| NCT04961372 | Socio-psychological Status of Healthcare Workers During SARS-CoV2 Pandemic | https://ClinicalTrials.gov/show/NCT04961372 |
| NCT04961242 | Pilot Evaluation of Together for Wellness Website in COVID-19 | https://ClinicalTrials.gov/show/NCT04961242 |
| NCT04959773 | Muscle Weakness in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04959773 |
| NCT04959734 | COVID-19 Impact on RSV Emergency Presentations | https://ClinicalTrials.gov/show/NCT04959734 |
| NCT04958889 | COVID-19 Recovery Study: Symptoms and Biomarkers of Long COVID-19 in People Living With and Without HIV | https://ClinicalTrials.gov/show/NCT04958889 |
| NCT04958681 | Changes in Physical Activity Status: Comparison of Older Adults With Versus Without a History of Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04958681 |
| NCT04957199 | Physiotherapist Awareness in the Community | https://ClinicalTrials.gov/show/NCT04957199 |
| NCT04954651 | Assessment of the Immunization Levels Against Sars-Cov2 Virus in Subjects Who Have Received EU-approved COVID-19 Vaccines | https://ClinicalTrials.gov/show/NCT04954651 |
| NCT04956562 | Effect of Sinovac on Survival in Intensive Care Unit | https://ClinicalTrials.gov/show/NCT04956562 |
| NCT04956445 | Collection of SARS CoV-2 (COVID-19) Virus Secretions and Serum for Countermeasure Development | https://ClinicalTrials.gov/show/NCT04956445 |
| NCT04954612 | Musculoskeletal Problems in School Children During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04954612 |
| NCT04954105 | Influence of the COvid-19 Epidemic on STRESS and Heart-Rate Variability in Health-care Workers | https://ClinicalTrials.gov/show/NCT04954105 |
| NCT04954235 | Effectiveness and Safety Study of Specific Hyperimmune Equine Serum for the Treatment of Severe Hospitalized SARS-CoV-2 in Adults: Retrospective Cohort Study | https://ClinicalTrials.gov/show/NCT04954235 |
| NCT04953091 | Evaluation of the Sofia SARS Antigen FIA Assay for COVID-19 | https://ClinicalTrials.gov/show/NCT04953091 |
| NCT04953247 | Use of Compromised Lung Volume in Monitoring Usage of Steroid Therapy on Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04953247 |
| NCT04953065 | Coronavirus Disease 2019 (COVID-19) Vaccination in Cancer Patients | https://ClinicalTrials.gov/show/NCT04953065 |
| NCT04952337 | Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ) | https://ClinicalTrials.gov/show/NCT04952337 |
| NCT04950673 | Open-label, Post-marketing, Prospective Study to Assess Impact of COVID-19 on Cognitive Function in Patients | https://ClinicalTrials.gov/show/NCT04950673 |
| NCT04947943 | Geriatric Care for Older People Hospitalised for COVID-19 | https://ClinicalTrials.gov/show/NCT04947943 |
| NCT04949230 | A Retrospective Study of COVID-19 Treatments | https://ClinicalTrials.gov/show/NCT04949230 |
| NCT04948255 | Measuring Work-Related Stress in Primary Care in the Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04948255 |
| NCT04948229 | Annexin A1 Levels in SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04948229 |
| NCT04949035 | Mental Status and Quality of Life of Post-COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04949035 |
| NCT04948190 | Canine COVID-19 Detection Phase 2 and 3 | https://ClinicalTrials.gov/show/NCT04948190 |
| NCT04945863 | COVID-19 in Nursing Homes 2020 and 2021 | https://ClinicalTrials.gov/show/NCT04945863 |
| NCT04947046 | Carotid Stenosis Management During COVID-19 Era - Pilot Study | https://ClinicalTrials.gov/show/NCT04947046 |
| NCT04946565 | The Impact of Sinopharm COVID-19 Vaccination on Male Fertility | https://ClinicalTrials.gov/show/NCT04946565 |
| NCT04946175 | National Survey Among Egyptian Pain Practitioners | https://ClinicalTrials.gov/show/NCT04946175 |
| NCT04945577 | The Relationship Between Vitamin D Levels, Inflammatory Parameters and Disease Severity of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04945577 |
| NCT04944329 | Hip Fracture and COVID-19 | https://ClinicalTrials.gov/show/NCT04944329 |
| NCT04944160 | Impact of the Covid-19 on RSV Epidemic | https://ClinicalTrials.gov/show/NCT04944160 |
| NCT04940208 | Chronic Pain in COVID-19 Patients Discharged From Intensive Care Unit | https://ClinicalTrials.gov/show/NCT04940208 |
| NCT04942249 | Long COVID in Military Organisations | https://ClinicalTrials.gov/show/NCT04942249 |
| NCT04941092 | ARDS COVID vs ARDS Influenza | https://ClinicalTrials.gov/show/NCT04941092 |
| NCT04944433 | Safety and Efficacy of the Coronavirus Disease 2019 Vaccine in Hemodialysis Patients | https://ClinicalTrials.gov/show/NCT04944433 |
| NCT04944394 | Psychological and Ethical Support for Hospital Professionals During the COVID-19 Pandemic: Suitability and Post-crisis Implications for the Experience of All Professionals | https://ClinicalTrials.gov/show/NCT04944394 |
| NCT04944134 | COVID-19 Antibody Levels After Vaccines | https://ClinicalTrials.gov/show/NCT04944134 |
| NCT04944095 | Change in Antibody Levels Following SARS-CoV-2 (Covid-19) Vaccinations | https://ClinicalTrials.gov/show/NCT04944095 |
| NCT04941209 | imPulseâ„¢ Una Infrasound-to-ultrasound E-stethoscope | https://ClinicalTrials.gov/show/NCT04941209 |
| NCT04941144 | Long-Term Follow-up Survey of COVID-19 Vaccine After Vaccination | https://ClinicalTrials.gov/show/NCT04941144 |
| NCT04939155 | Methylation Effects of COV-19 Infection and Vaccinations | https://ClinicalTrials.gov/show/NCT04939155 |
| NCT04937712 | Analysis of SARS-CoV2 Urine Viral Particles and Association With Proximal Tubular Dysfunction | https://ClinicalTrials.gov/show/NCT04937712 |
| NCT04937621 | Study of Arrhythmia and ECG Abnormalities in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04937621 |
| NCT04937608 | Impact of the Coronavirus Disease 2019 (COVID-19) on Sperm Parameters | https://ClinicalTrials.gov/show/NCT04937608 |
| NCT04934085 | COVID-19 Versus Neurological Impairment, Physical Activity, Social Contacts and Education | https://ClinicalTrials.gov/show/NCT04934085 |
| NCT04935450 | Pulmonary Inflammation in COVID-19 ARDS | https://ClinicalTrials.gov/show/NCT04935450 |
| NCT04935463 | Mucormycosis in COVID-19 | https://ClinicalTrials.gov/show/NCT04935463 |
| NCT04934215 | Evaluation of Post-vaccination Anti-SARS-CoV-2 Serological Response in Health Care Workers With a History of COVID-19. | https://ClinicalTrials.gov/show/NCT04934215 |
| NCT04934202 | Cohort Follow-up of Survivors of Hospitalization for COVID-19 During the 2nd Wave of the Epidemic in France | https://ClinicalTrials.gov/show/NCT04934202 |
| NCT04934020 | Global Impact of the COVID 19 Pandemic on Stroke Care, Cerebral Venous Thrombosis, and Subarachnoid Hemorrhage | https://ClinicalTrials.gov/show/NCT04934020 |
| NCT04933981 | Benefit of Expanded Surveillance of Nursing Homes During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04933981 |
| NCT04932967 | Use of nMoABs for the Treatment of COVID-19 in Patients With HM. | https://ClinicalTrials.gov/show/NCT04932967 |
| NCT04932876 | The Response of the Immune System of Patients With End Stage Kidney Disease on Dialysis and Kidney Transplant Recipients Vaccinated for COVID-19 | https://ClinicalTrials.gov/show/NCT04932876 |
| NCT04932863 | BNT162b2 Messenger Ribonucleic Acid (mRNA) Covid-19 Vaccine in Cancer Patients on Active Treatment | https://ClinicalTrials.gov/show/NCT04932863 |
| NCT04932954 | Immunohematology in COVID-19 Patients: A Hospital-based Retrospective Cohort Study | https://ClinicalTrials.gov/show/NCT04932954 |
| NCT04932889 | Musculoskeletal Symptoms in Post Acute Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04932889 |
| NCT04930978 | Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis | https://ClinicalTrials.gov/show/NCT04930978 |
| NCT04930016 | Quality of Life and Survival of Patients With Colorectal Cancer 5 Years After Surgery - Follow-up of the RCT DIQOL | https://ClinicalTrials.gov/show/NCT04930016 |
| NCT04930757 | Involvement of Polymorphonuclear Neutrophils and Platelets in Severe Form of COVID-19 | https://ClinicalTrials.gov/show/NCT04930757 |
| NCT04930120 | Assessing the Impact of COVID-19 Patients Long Distance Transfers Between Intensive Care Units | https://ClinicalTrials.gov/show/NCT04930120 |
| NCT04930055 | Immune Responses in Oncology Patients to Novel Coronavirus Vaccines (IROC) | https://ClinicalTrials.gov/show/NCT04930055 |
| NCT04928911 | Expectations About the COVID-19 Vaccines | https://ClinicalTrials.gov/show/NCT04928911 |
| NCT04928469 | Clinical Impact of COVID-19 by P.1 SARS-CoV-2 Lineage | https://ClinicalTrials.gov/show/NCT04928469 |
| NCT04927078 | Analysis of Vital Signs in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04927078 |
| NCT04926571 | Dexamethasone and COVID-19 Inpatient Mortality | https://ClinicalTrials.gov/show/NCT04926571 |
| NCT04925908 | Exclusive Breastfeeding in Infants of Mothers Infected With Novel Coronavirus | https://ClinicalTrials.gov/show/NCT04925908 |
| NCT04925999 | Distance Learning and Neck Problems During Pandemic Period | https://ClinicalTrials.gov/show/NCT04925999 |
| NCT04924842 | COVID-19 - SARS-CoV-2 Community Contamination in Children and Adults - Impact of Variants (Dyn3CEA - Nosocor Phase 2) | https://ClinicalTrials.gov/show/NCT04924842 |
| NCT04924829 | Safety and Effectiveness Study of Tocilizumab in Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04924829 |
| NCT04924816 | Awake Prone Position in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04924816 |
| NCT04924790 | The Effect of the COVID-19 on Patient Preferences and Decision Making for Obstructive Urinary Stone Interventions | https://ClinicalTrials.gov/show/NCT04924790 |
| NCT04923386 | mRNA Based-Covid-19 Vaccine Effects on Blood Glucose Levels | https://ClinicalTrials.gov/show/NCT04923386 |
| NCT04924673 | Impact of the COVID-19 Epidemic on Glycemic Balance and the Level of Stress in Diabetic Patients | https://ClinicalTrials.gov/show/NCT04924673 |
| NCT04924634 | Stress Levels and Mental Well-Being Among Slovak Students During e-Learning | https://ClinicalTrials.gov/show/NCT04924634 |
| NCT04922944 | Post COVID-19 Vaccination Analysis in Healthcare Worker Recipients | https://ClinicalTrials.gov/show/NCT04922944 |
| NCT04921241 | In Utero Exposure to SARS-CoV-2 (COVID-19) and Cardiovascular and Metabolic Endpoints in Early Life | https://ClinicalTrials.gov/show/NCT04921241 |
| NCT04920851 | Cytokine Hemadsorption in Covid 19 Patients With Bacterial Sepsis | https://ClinicalTrials.gov/show/NCT04920851 |
| NCT04918849 | WhatsApp in India During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04918849 |
| NCT04918888 | COVID-19 Vaccination in Oncologic Patients | https://ClinicalTrials.gov/show/NCT04918888 |
| NCT04916847 | Comparative Analysis of Anti-COVID-19 (Severe Acute Respiratory Syndrome) Humoral and Memory T Cell Responses in Children With Various Degrees of Immunosuppression: | https://ClinicalTrials.gov/show/NCT04916847 |
| NCT04916873 | Rehabilitation Status of Children With Cerebral Palsy and Anxiety of Their Caregivers During the Covid19 Pandemic | https://ClinicalTrials.gov/show/NCT04916873 |
| NCT04916834 | Impact of SARS-CoV-2/COVID-19 Related Pneumonia on Lung Function and Structure. | https://ClinicalTrials.gov/show/NCT04916834 |
| NCT04916275 | Post-traumatic Stress, Signs of Depression and Burnout Syndrome Among Nursing Home Staff in Occitanie During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04916275 |
| NCT04915781 | Tobacco Use and COVID-19 Incidence in the Finnish General Population | https://ClinicalTrials.gov/show/NCT04915781 |
| NCT04915001 | An Investigation on the Role of Emergency Departments in Combatting Against COVID-19 in Zhejiang Province | https://ClinicalTrials.gov/show/NCT04915001 |
| NCT04914754 | Mechanisms Underlying Long-term Fatigue and Exercise Intolerance Following CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04914754 |
| NCT04913948 | Assessing the Mother-to-infant Transmission Capabilities of COVID-19 Infection Among Pregnant Women in Ontario, Canada | https://ClinicalTrials.gov/show/NCT04913948 |
| NCT04913701 | COVID-19 Epidemiological Surveillance on Healthcare Workers and Patients in a Rehabilitation Medicine Facility | https://ClinicalTrials.gov/show/NCT04913701 |
| NCT04912934 | The Relationship Between COVID-19 Anxiety Level and Emotional Eating in Individuals With Metabolic Syndrome | https://ClinicalTrials.gov/show/NCT04912934 |
| NCT04913116 | Generic Testing of Antigen Tests for COVID-19 in Denmark | https://ClinicalTrials.gov/show/NCT04913116 |
| NCT04912700 | The Impact of Vaccination on Severity of Illness in COVID-19 | https://ClinicalTrials.gov/show/NCT04912700 |
| NCT04912804 | Perceived Health After Hospitalization for COVID-19 | https://ClinicalTrials.gov/show/NCT04912804 |
| NCT04912778 | Profiling of Post Covid-19 Infection Patients: an Online Survey | https://ClinicalTrials.gov/show/NCT04912778 |
| NCT04912284 | Africa COVID-19 Vaccine Hesitancy | https://ClinicalTrials.gov/show/NCT04912284 |
| NCT04911868 | Surgical Management During the Era of COVID-19 | https://ClinicalTrials.gov/show/NCT04911868 |
| NCT04910971 | Quantification of Binding and Neutralizing Antibody Levels in COVID-19 Vaccinated Health Care Workers Over 1 Year | https://ClinicalTrials.gov/show/NCT04910971 |
| NCT04910880 | Personal Protective Equipment Comfort and User Attitude During COVID-19 | https://ClinicalTrials.gov/show/NCT04910880 |
| NCT04910958 | Impact of COVID-19 Pandemic on Early Spontaneous Abortions and Early Termination of Pregnancy | https://ClinicalTrials.gov/show/NCT04910958 |
| NCT04910633 | Medical Treatment of Solid Tumors at the Lyon University Hospital Cancer Institute During the First Wave of COVID-19 in France: A Conservative Approach | https://ClinicalTrials.gov/show/NCT04910633 |
| NCT04910360 | Embolism in COVID-19 Positive Patients | https://ClinicalTrials.gov/show/NCT04910360 |
| NCT04910334 | Long-term Cognitive and Functional Status After COVID-19 Treatment at Danish ICUs | https://ClinicalTrials.gov/show/NCT04910334 |
| NCT04910295 | Immunogenicity and Safety of COVID-19 Vaccine in Cancer Patients | https://ClinicalTrials.gov/show/NCT04910295 |
| NCT04908007 | COvid Pandemic Institutional maNaGement | https://ClinicalTrials.gov/show/NCT04908007 |
| NCT04909476 | Tracheal Intubation in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04909476 |
| NCT04906850 | Evaluation of the New Variant 501Y.V2 of COVID-19 | https://ClinicalTrials.gov/show/NCT04906850 |
| NCT04905875 | Prone Positioning for Invasively Ventilated Patients With COVID-19 Registry | https://ClinicalTrials.gov/show/NCT04905875 |
| NCT04905862 | Assessment of Immune Response After Vaccination Against COVID-19 in Patients Treated With Renal Replacement Therapy | https://ClinicalTrials.gov/show/NCT04905862 |
| NCT04905823 | Effect of SARSCoV2 (COVID-19) Vaccination in Type 1 Diabetes (CoVaxT1D) | https://ClinicalTrials.gov/show/NCT04905823 |
| NCT04904731 | Effects of Body Position on Diaphragmatic Activity in Patients Requiring Noninvasive Ventilation for Acute Respiratory Failure COVID-19 Related | https://ClinicalTrials.gov/show/NCT04904731 |
| NCT04904692 | Virological and Immunological Monitoring in Patients (Suspected of/Confirmed With) COVID-19 | https://ClinicalTrials.gov/show/NCT04904692 |
| NCT04904523 | Blood Markers for Identifying & Investigating Infection With COVID19 & Sepsis in Children. | https://ClinicalTrials.gov/show/NCT04904523 |
| NCT04903132 | Cellular Senescence and COVID-19 Long-Hauler Syndrome | https://ClinicalTrials.gov/show/NCT04903132 |
| NCT04902157 | Relationship Between CT- Value With Prognosis in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04902157 |
| NCT04903834 | Identification of Novel Factors Leading to Activated Macrophage Expansion in COVID19 - INFLAME Study | https://ClinicalTrials.gov/show/NCT04903834 |
| NCT04902118 | Burnout Determinants Among Pediatric Psychiatry Workers During COVID-19 Crisis | https://ClinicalTrials.gov/show/NCT04902118 |
| NCT04900441 | Tele-assessment in Individuals With COVID-19 | https://ClinicalTrials.gov/show/NCT04900441 |
| NCT04900376 | Evaluation of Covid-19 Vaccination in Elderly Subjects in Retirement Home (EHPAD) and Long-term Care Units (USLD) in Ile-de-France | https://ClinicalTrials.gov/show/NCT04900376 |
| NCT04898179 | Support for COVID19 Patients at Home | https://ClinicalTrials.gov/show/NCT04898179 |
| NCT04900259 | The Effect of the COVID-19 Pandemic on Primary Bladder Cancer Presentations | https://ClinicalTrials.gov/show/NCT04900259 |
| NCT04900233 | Effect of Covid-19 Pandemic in Non Covid-19 Patients at the Emergency Surgical Department | https://ClinicalTrials.gov/show/NCT04900233 |
| NCT04898985 | The Leukemia and Lymphoma Society (LLS) T-cells in Blood Cancer and COVID-19 | https://ClinicalTrials.gov/show/NCT04898985 |
| NCT04898946 | Serological Response to mRNA and Inactivated COVID-19 Vaccine in Health Care Workers in Hong Kong | https://ClinicalTrials.gov/show/NCT04898946 |
| NCT04898140 | The Evaluation of Cellular and Humoral Immunity to COVID-19 in Moscow Residents | https://ClinicalTrials.gov/show/NCT04898140 |
| NCT04898192 | Monitoring of Incidence of Mental Discomfort in Pregnant Women During the Serious COVID-19 Pandemic Conditions | https://ClinicalTrials.gov/show/NCT04898192 |
| NCT04896983 | National Survey of Mental Health After COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04896983 |
| NCT04897152 | Coronavirus Associated Pneumomediastinum and Pneumothorax | https://ClinicalTrials.gov/show/NCT04897152 |
| NCT04896957 | Perceptions and Representations of Vaccination Against COVID-19 | https://ClinicalTrials.gov/show/NCT04896957 |
| NCT04896944 | Is Precariousness a Risk Factor for COVID-19 Mortality in Intensive Care? | https://ClinicalTrials.gov/show/NCT04896944 |
| NCT04896918 | Tobacco Use and the Risk of COVID-19 | https://ClinicalTrials.gov/show/NCT04896918 |
| NCT04896762 | Extrapulmonary Presentations of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04896762 |
| NCT04895189 | Yale COVID-19 Recovery Study | https://ClinicalTrials.gov/show/NCT04895189 |
| NCT04894760 | Evaluation of a COVID-19 Rapid Diagnostic Test in ER Departments in Mexico: a Multi-center Study | https://ClinicalTrials.gov/show/NCT04894760 |
| NCT04894682 | Safety and Long-term Effects of COVID-19 Vaccines in Patients With Pulmonary Tumor | https://ClinicalTrials.gov/show/NCT04894682 |
| NCT04895462 | Acute Revascularization Treatment in Ischemic Stroke Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04895462 |
| NCT04895007 | Comparative Evaluation of Covid-19 Vaccines Response | https://ClinicalTrials.gov/show/NCT04895007 |
| NCT04894448 | Immunogenicity of COVID-19 Vaccination in PLWH | https://ClinicalTrials.gov/show/NCT04894448 |
| NCT04894331 | Telemedicine for SNAS Patients in COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04894331 |
| NCT04894214 | Flow-controlled Ventilation (FCV) in Moderate Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04894214 |
| NCT04893694 | the Prevalence of Oral Manifestation in Patients With SARS-CoV2 Infection | https://ClinicalTrials.gov/show/NCT04893694 |
| NCT04892888 | Survey of the Moderna COVID-19 Vaccine in People at High-Risk of Developing Severe COVID-19 Symptoms | https://ClinicalTrials.gov/show/NCT04892888 |
| NCT04509752 | Dysphagia Management During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04509752 |
| NCT04892797 | Understanding Immunology and Patient Outcomes of COVID-19 in Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04892797 |
| NCT04893122 | Impact of Pandemic of Presentation to Emergency Department and Admissions | https://ClinicalTrials.gov/show/NCT04893122 |
| NCT04893070 | Impact of SARS-CoV-2 (COVID-19) Infection, Treated in Ambulatory Care, on Long-term Quality of Life in a Parisian Military Population | https://ClinicalTrials.gov/show/NCT04893070 |
| NCT04891276 | Impact of COVID-19 Infection and Confinement on Diabetic Ulcer Management and Amputation Risk | https://ClinicalTrials.gov/show/NCT04891276 |
| NCT04890600 | COVID-19 and Psycological Well-being in Healthcare Workers | https://ClinicalTrials.gov/show/NCT04890600 |
| NCT04889326 | Collection of the Thrombo-VaxCov Cohort | https://ClinicalTrials.gov/show/NCT04889326 |
| NCT04889365 | COVID-19 Antigen Rapid Test Kit | https://ClinicalTrials.gov/show/NCT04889365 |
| NCT04889313 | Post COVID-19 Neurologic Symptoms : a Somatic Spectrum Disorder ? (SOMATiC) | https://ClinicalTrials.gov/show/NCT04889313 |
| NCT04889261 | External Validation of the CHOD Risk Scale | https://ClinicalTrials.gov/show/NCT04889261 |
| NCT04888793 | Immune Response to Anti COVID-19 Vaccine in Immunocompromised Patients: a Cohort Study | https://ClinicalTrials.gov/show/NCT04888793 |
| NCT04887623 | Dynamics of Markers of Infection and Inflammation in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients | https://ClinicalTrials.gov/show/NCT04887623 |
| NCT04887220 | Persistent Pain and Its Impact on Quality of Life COVID-19 Patients That Required Critical Care | https://ClinicalTrials.gov/show/NCT04887220 |
| NCT04887142 | Predictors of Disease Severity in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04887142 |
| NCT04887246 | Monitoring the Effectiveness and Safety of COVID-19 Vaccines at National University of Colombia | https://ClinicalTrials.gov/show/NCT04887246 |
| NCT04885543 | COVID-19 STAndard of Care in Sub-Saharan Africa | https://ClinicalTrials.gov/show/NCT04885543 |
| NCT04885478 | Professional’s Health in Epidemiological Crisis Covid-19 | https://ClinicalTrials.gov/show/NCT04885478 |
| NCT04885192 | Implementation and Evaluation of a Stepped-Care Mental Health Treatment Program for Patients With Chronic Pain | https://ClinicalTrials.gov/show/NCT04885192 |
| NCT04884061 | Narrow Band Imaging Bronchoscopy During SARS-CoV2 Infection | https://ClinicalTrials.gov/show/NCT04884061 |
| NCT04884321 | Complementary And Alternative Medicine During The COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04884321 |
| NCT04884477 | COVID-19 Infection in Patients Receiving Anti-CD20 Therapy | https://ClinicalTrials.gov/show/NCT04884477 |
| NCT04883801 | Clinical Outcomes of Newborns Born to Pregnant Women With and Without COVID-19 | https://ClinicalTrials.gov/show/NCT04883801 |
| NCT04883190 | Fatigue a Long COVID-19 Symptom Substudy of FSC19-KN Trial | https://ClinicalTrials.gov/show/NCT04883190 |
| NCT04883177 | Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101) | https://ClinicalTrials.gov/show/NCT04883177 |
| NCT04883164 | Immunity After COVID-19 Vaccination | https://ClinicalTrials.gov/show/NCT04883164 |
| NCT04881305 | Characterizing Long-term Cognitive and Emotional Impairment in Post-COVID-19 Sequelae | https://ClinicalTrials.gov/show/NCT04881305 |
| NCT04882670 | COVID-19 Pandemic on Health Care and Rehabilitation Outcomes | https://ClinicalTrials.gov/show/NCT04882670 |
| NCT04881266 | Long-Term Functional, Quality-of-Life, Neuropsychological and Cognitive Outcomes in COVID-19 Critical Illness Survivors | https://ClinicalTrials.gov/show/NCT04881266 |
| NCT04880720 | Deciphering a Specific Signature of the Immunosenescence Induced in COVID-19+ Patients Versus Rheumatoid Arthritis Patients | https://ClinicalTrials.gov/show/NCT04880720 |
| NCT04878913 | Retrospective Evaluation of Lung Pathology in Subjects With COVID-19 | https://ClinicalTrials.gov/show/NCT04878913 |
| NCT04879251 | The Impact of the COVID-19 Pandemic on Cardiovascular Risk Factors in Patients With Diabetes | https://ClinicalTrials.gov/show/NCT04879251 |
| NCT04878900 | Effects of COVID-19 in Chronic Pain | https://ClinicalTrials.gov/show/NCT04878900 |
| NCT04878822 | Immunogenicity of Covid-19 Vaccination for Patients With Hematological Malignancies | https://ClinicalTrials.gov/show/NCT04878822 |
| NCT04878796 | Effectiveness of mRNA Covid-19 Vaccines on Cancer Patients:Observational Study. (ANTICOV) | https://ClinicalTrials.gov/show/NCT04878796 |
| NCT04876898 | High Body Mass Index and Severity of Coronavirus | https://ClinicalTrials.gov/show/NCT04876898 |
| NCT04877808 | Bacterial Surinfections in COVID-19 ICU Patients | https://ClinicalTrials.gov/show/NCT04877808 |
| NCT04877509 | Micronutrient Status Involved in Immunity in Elderly Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04877509 |
| NCT04876872 | Modified Pediatric Early Warning Score and Modified PRISA II During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04876872 |
| NCT04876443 | Impact of COVID-19 Outbreak on the Alcohol Consumption in Patients With Alcohol-related Liver Disease (ICoLD) | https://ClinicalTrials.gov/show/NCT04876443 |
| NCT04874792 | Clinical Characteristics of Deceased With COVID-19 | https://ClinicalTrials.gov/show/NCT04874792 |
| NCT04874363 | The Effects of Smoking on Mortality in Patients With Acute Respiratory Syndrome Coronavirus 2 Infection | https://ClinicalTrials.gov/show/NCT04874363 |
| NCT04873388 | Early Predictors of Prognostic Course in Patients With COVID-19 in Critical or Semi-intensive Area. | https://ClinicalTrials.gov/show/NCT04873388 |
| NCT04874779 | Acute Kidney Injury Risk in COVID-19 | https://ClinicalTrials.gov/show/NCT04874779 |
| NCT04874753 | The Effect of COVID-19 Pandemia on Follow up of Patients With Chronic Kidney Disease | https://ClinicalTrials.gov/show/NCT04874753 |
| NCT04874740 | Seroprevalence of the Anti-SARS-CoV-2 Antibodies (Causing COVID-19) in Kidney Transplant Recipients in Severely Affected Region | https://ClinicalTrials.gov/show/NCT04874740 |
| NCT04872764 | Acute Kidney Injury in Patients With CoVID-19 | https://ClinicalTrials.gov/show/NCT04872764 |
| NCT04872751 | Immune Response of Haemodialysis Patients Post Covid-19 Vaccination | https://ClinicalTrials.gov/show/NCT04872751 |
| NCT04872738 | Patient Experiences With the COVID-19 Vaccination After Breast Cancer Treatment | https://ClinicalTrials.gov/show/NCT04872738 |
| NCT04872699 | Prevalence of COVID-19 in a French Dependent Care Facility for the Elderly and in a French Long-term Care Unit: Observational Study | https://ClinicalTrials.gov/show/NCT04872699 |
| NCT04872673 | The Professional Values and Ethical Sensitivities During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04872673 |
| NCT04872049 | Assessment of SARS-CoV-2 Effect on Post-traumatic Stress of Patients Hospitalized in Intensive Care Unit | https://ClinicalTrials.gov/show/NCT04872049 |
| NCT04871945 | Protective Antibody Level After COVID-19 Vaccination Among Patients Under Hemodialysis | https://ClinicalTrials.gov/show/NCT04871945 |
| NCT04871932 | COVID-2019 Vaccine Immune Response Base on Single Cell Multi-Omics | https://ClinicalTrials.gov/show/NCT04871932 |
| NCT04870411 | Immunological Response to COVID-19 Vaccine in Patients With Autoimmune and Inflammatory Diseases Treated With Immunosuppressants and/or Biologics | https://ClinicalTrials.gov/show/NCT04870411 |
| NCT04871841 | Study of Sputnik V COVID-19 Vaccination in Adults in Kazakhstan | https://ClinicalTrials.gov/show/NCT04871841 |
| NCT04871789 | Optimization of Patients Long-term Management After the Coronavirus Infection COVID-19 | https://ClinicalTrials.gov/show/NCT04871789 |
| NCT04871685 | The ECOVITA Study - Validation of LUS Score in SARS-CoV-2 Disease, i.e COVID-19 | https://ClinicalTrials.gov/show/NCT04871685 |
| NCT04871165 | Analysis of Immunogenicity, Safety and Efficacy of COVID-19 Vaccines in Immunosuppressed Individuals | https://ClinicalTrials.gov/show/NCT04871165 |
| NCT04869202 | Covid-19 Infection in Pregnancy | https://ClinicalTrials.gov/show/NCT04869202 |
| NCT04867213 | Breath Analysis of Patients Diagnosed With COVID-19 Using Infrared Spectroscopy | https://ClinicalTrials.gov/show/NCT04867213 |
| NCT04868448 | COVID-19 Vaccine Effectiveness Among Health Workers in Georgia | https://ClinicalTrials.gov/show/NCT04868448 |
| NCT04868188 | Pharmacokinetics of Voriconazole in Adult ECMO Patients | https://ClinicalTrials.gov/show/NCT04868188 |
| NCT04867161 | Superinfection and Hyperinflammatory Phenotype in COVID-19 (Coronavirus Disease 2019) Pneumonia Patients | https://ClinicalTrials.gov/show/NCT04867161 |
| NCT04865913 | Venous Thrombosis Virtual Surveillance in COVID | https://ClinicalTrials.gov/show/NCT04865913 |
| NCT04865133 | Efficacy and Safety of COVID-19 Vaccine in Cancer Patients | https://ClinicalTrials.gov/show/NCT04865133 |
| NCT04864938 | Recovery After Critical Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04864938 |
| NCT04854837 | Safety of Remdesivir Treatment in COVID-19 Patients Requiring Hemodialysis | https://ClinicalTrials.gov/show/NCT04854837 |
| NCT04864535 | A Pilot Study for the Collection Of Vocalized, Individual Digital Cough Sound Recordings to Screen for COVID-19 | https://ClinicalTrials.gov/show/NCT04864535 |
| NCT04492371 | COVID-19 Infection and Multiple Myeloma | https://ClinicalTrials.gov/show/NCT04492371 |
| NCT04863586 | COVID-19 and Multiple Sclerosis Disease Modifying Therapies | https://ClinicalTrials.gov/show/NCT04863586 |
| NCT04863534 | Ultrasound Grayscale Analysis in ARDS covid19 | https://ClinicalTrials.gov/show/NCT04863534 |
| NCT04861272 | Risk Perception Associated With Covid-19 Among Anesthetists | https://ClinicalTrials.gov/show/NCT04861272 |
| NCT04860908 | COVID 19 ANTOBODIES IN PREGNANT WOMEN AND THEIR CONNECTION TO BETA CELL FUNCTION IN THE FETUS | https://ClinicalTrials.gov/show/NCT04860908 |
| NCT04861402 | Non-Invasive Intracranial Pressure in COVID-19 Individuals | https://ClinicalTrials.gov/show/NCT04861402 |
| NCT04860869 | Endocrine, Metabolic and Microbiome Influence on the Post COVID-19 Syndrome | https://ClinicalTrials.gov/show/NCT04860869 |
| NCT04860687 | Quality of Life After COVID-19 Related Acute respIratory Distress Syndrome Among ICU Survivors Patients in Italy: the ODISSEA Study. | https://ClinicalTrials.gov/show/NCT04860687 |
| NCT04860245 | Risks and Outcomes Among COVID-19 Patients Admitted to Assiut University Hospitals. | https://ClinicalTrials.gov/show/NCT04860245 |
| NCT04860206 | Post COVID19 Functional and Cognitive Assessments | https://ClinicalTrials.gov/show/NCT04860206 |
| NCT04859894 | Physiological Studies in Post-COVID-19 Syndrome, and the Association With DNA Methylation | https://ClinicalTrials.gov/show/NCT04859894 |
| NCT04859881 | Risk Factors for Barotrauma in COVID-19 | https://ClinicalTrials.gov/show/NCT04859881 |
| NCT04858607 | Humoral and Cellular Immune Response to COVID-19 Vaccines in Immunocompromised and Healthy Individuals | https://ClinicalTrials.gov/show/NCT04858607 |
| NCT04854824 | A Simple Approach to Prevent Hospitalization for COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04854824 |
| NCT04854980 | Serologic Response to the SARS-CoV-2 (COVID-19) mRNA-1273 Vaccine in Select Subsets of Oncology Patients | https://ClinicalTrials.gov/show/NCT04854980 |
| NCT04854863 | Respiratory Muscles After Hospitalisation for COVID-19 | https://ClinicalTrials.gov/show/NCT04854863 |
| NCT04854785 | Neuroinflammation in COVID-19 and Depression | https://ClinicalTrials.gov/show/NCT04854785 |
| NCT04855539 | Coronavirus: Ventilator Outcomes Using Artificial Intelligence Chest Radiographs & Other Evidence-based Co-variates | https://ClinicalTrials.gov/show/NCT04855539 |
| NCT04854408 | Evaluation of the Effect of Coronavac Vaccine (Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2 Vaccine) on Healthcare Workers’ Menstrual Patterns | https://ClinicalTrials.gov/show/NCT04854408 |
| NCT04853940 | Respiratory Muscle Function, Dyspnea, Exercise Capacity and Quality of Life in Severe COVID19 Patients | https://ClinicalTrials.gov/show/NCT04853940 |
| NCT04853316 | Asymptomatic SARS-CoV-2 Detection in Children | https://ClinicalTrials.gov/show/NCT04853316 |
| NCT04853108 | Remote Monitoring of COVID-19 Positive Outpatients | https://ClinicalTrials.gov/show/NCT04853108 |
| NCT04852835 | COVID-19 Vaccine Response | https://ClinicalTrials.gov/show/NCT04852835 |
| NCT04852822 | Immune Response to SARS-CoV-2 (COVID-19) Vaccines in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | https://ClinicalTrials.gov/show/NCT04852822 |
| NCT04852757 | Estimating the Prevalence of Postpartum Anxiety and Depression in the Context of the Coronavirus Disease (COVID-19) Pandemic | https://ClinicalTrials.gov/show/NCT04852757 |
| NCT04852718 | Rehabilitation Program for the Sequelae of COVID 19 Infection | https://ClinicalTrials.gov/show/NCT04852718 |
| NCT04849546 | Staff Physical and Mental Health Assessment in the Aftermath of the First Peak of the Covid-19 Outbreak | https://ClinicalTrials.gov/show/NCT04849546 |
| NCT04851561 | Post-coronavirus Disease-2019 Fatigue | https://ClinicalTrials.gov/show/NCT04851561 |
| NCT04849624 | Body Composition Study in Critically Ill Patients-Extended to COVID-19 | https://ClinicalTrials.gov/show/NCT04849624 |
| NCT04849611 | Covid-19 Fear and Compliance With Protective Measures of Students | https://ClinicalTrials.gov/show/NCT04849611 |
| NCT04849585 | Evaluation of the Impact of Hospitalization in Intensive Care for COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04849585 |
| NCT04848493 | National Project on Vaccines, COVID-19 and Frail Patients | https://ClinicalTrials.gov/show/NCT04848493 |
| NCT04848610 | The Factors That Affect the Infection of COVID-19 | https://ClinicalTrials.gov/show/NCT04848610 |
| NCT04848584 | Pfizer-BioNTech COVID-19 BNT162b2 Vaccine Effectiveness Study - Kaiser Permanente Southern California | https://ClinicalTrials.gov/show/NCT04848584 |
| NCT04847687 | Investigation of Hospitalisation Times and Mortality According to Drug Dose in Patients Given Systemic Methylprednisolone With a Pre-diagnosis of Covid-19 Pneumonia; Retrospective Study | https://ClinicalTrials.gov/show/NCT04847687 |
| NCT04847622 | Study to Evaluate the Clinical Outcomes in Adults With Covid-19 Who Have Been Treated With Remdesivir. | https://ClinicalTrials.gov/show/NCT04847622 |
| NCT04847596 | A Multicenter Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab | https://ClinicalTrials.gov/show/NCT04847596 |
| NCT04847817 | Important Data on COVID-19 Profile in Africa | https://ClinicalTrials.gov/show/NCT04847817 |
| NCT04847804 | Large-scale COVID-19 Population Screening | https://ClinicalTrials.gov/show/NCT04847804 |
| NCT04847336 | Improving MAternal Newborn carE In the in the WHO European Region During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04847336 |
| NCT04846907 | Mental Health of Professionals Working in Pediatric Intensive Care Units During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04846907 |
| NCT04845984 | Evaluation of the Prevalence of SARS-CoV-2 Infection in the Healthcare Workers (HCWs) in Four Hospital of the Alpine Region | https://ClinicalTrials.gov/show/NCT04845984 |
| NCT04844632 | COVID19 Vaccination: Clinical, Laboratory and Cellular Monitoring | https://ClinicalTrials.gov/show/NCT04844632 |
| NCT04844697 | Resilience and Coping in a Rare Skeletal Disease Population to Face Coronavirus (COVID-19) Outbreak Distress: a Longitudinal Study | https://ClinicalTrials.gov/show/NCT04844697 |
| NCT04844242 | MISC COVID-19 Study in Pediatric Population | https://ClinicalTrials.gov/show/NCT04844242 |
| NCT04844541 | Prophylaxis and Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04844541 |
| NCT04843917 | Immunity Against COVID-19 Vaccine in Healthcare Workers in Argentine | https://ClinicalTrials.gov/show/NCT04843917 |
| NCT04843878 | COVID-19 Testing Pilot Study | https://ClinicalTrials.gov/show/NCT04843878 |
| NCT04839913 | Seroprevalence of SARS-CoV-2 in Unselected Surgical Patients: an Unicentric, Regional Study | https://ClinicalTrials.gov/show/NCT04839913 |
| NCT04841785 | Long Term Efficacy and Safety of COVID-19 (SARS-CoV-2) Vaccination in Kidney Disease Patients | https://ClinicalTrials.gov/show/NCT04841785 |
| NCT04840966 | A Simplified Test to Assess Flavor in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04840966 |
| NCT04840940 | Presepsin Biomarker for Ventilator-associated Pneumonia Diagnosis in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04840940 |
| NCT04839094 | Dry Versus Wet Nasopharyngeal Rapid Test for the Detection of COVID-19. | https://ClinicalTrials.gov/show/NCT04839094 |
| NCT04838119 | Preop COVID Testing Patterns | https://ClinicalTrials.gov/show/NCT04838119 |
| NCT04838834 | Monitoring Serologic Response to Severe Acute Respiratory Syndrome-2 (SARS-COV-2)/COVID-19 in Children | https://ClinicalTrials.gov/show/NCT04838834 |
| NCT04838093 | COVID-19 Testing in Patients With Vascular Disorders | https://ClinicalTrials.gov/show/NCT04838093 |
| NCT04837651 | Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or Natalizumab | https://ClinicalTrials.gov/show/NCT04837651 |
| NCT04834882 | Burnout, Stress and Coping Strategies: Impact of the Covid-19 Epidemic | https://ClinicalTrials.gov/show/NCT04834882 |
| NCT04836793 | COVID-19-Study of Immune Responses Following Vaccination Against SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04836793 |
| NCT04836065 | ESICM UNITE COVID-19 Project (UNITE-COVID) | https://ClinicalTrials.gov/show/NCT04836065 |
| NCT04836039 | Rehabilitation Experiences of Physiotherapists in Covid-19 Outbreak | https://ClinicalTrials.gov/show/NCT04836039 |
| NCT04834934 | Artificial Intelligence - SARS-CoV-2 Risk Evaluation | https://ClinicalTrials.gov/show/NCT04834934 |
| NCT04834869 | COVID-19 Vaccines Safety Tracking (CoVaST) | https://ClinicalTrials.gov/show/NCT04834869 |
| NCT04834583 | Corona And Manual Professions | https://ClinicalTrials.gov/show/NCT04834583 |
| NCT04834102 | COVID-19 Induced Telogen Effluvium | https://ClinicalTrials.gov/show/NCT04834102 |
| NCT04834401 | Effect of Disease Modifying Therapy on Antibody Response to COVID19 Vaccination in Multiple Sclerosis | https://ClinicalTrials.gov/show/NCT04834401 |
| NCT04832867 | Pulmonary Rehabilitation in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04832867 |
| NCT04832841 | IgG Antibodies After SARS-CoV-2 mRNA Vaccine in Kidney Transplantation (TASMANIA) | https://ClinicalTrials.gov/show/NCT04832841 |
| NCT04832945 | SARS-CoV-2 Pre-exposure Prophylaxis With Ivermectin Retrospective Cohort Study | https://ClinicalTrials.gov/show/NCT04832945 |
| NCT04832932 | The COVID-19 Back-to-Normal Study | https://ClinicalTrials.gov/show/NCT04832932 |
| NCT04832828 | Sensitivity and Specificity of the Roth Test in Patients With COVID-19 Positive | https://ClinicalTrials.gov/show/NCT04832828 |
| NCT04832061 | Respiratory Supports and COVID-19 Mortality | https://ClinicalTrials.gov/show/NCT04832061 |
| NCT04832022 | Longitudinal Follow-up of Patients With Chronic Inflammatory Rheumatisms (CIRs) Vaccinated Against COVID-19 Compared to Patients Refusing Vaccination | https://ClinicalTrials.gov/show/NCT04832022 |
| NCT04831866 | COVID-19 Surveillance and Exposure Testing in School Communities | https://ClinicalTrials.gov/show/NCT04831866 |
| NCT04830852 | Pediatric COVID-19 and MIS-C Long-term Follow-up | https://ClinicalTrials.gov/show/NCT04830852 |
| NCT04829552 | Prophylactic Versus Therapeutic Dose Anticoagulation In COVID-19 Infection at the Time of Admission To Critical Care Units | https://ClinicalTrials.gov/show/NCT04829552 |
| NCT04828629 | Complications and the Influence of COVID-19 on Myocardial Function and Exercise Capacity | https://ClinicalTrials.gov/show/NCT04828629 |
| NCT04828772 | A Study of Anticoagulation Treatment Patterns and Outcomes of Participants Hospitalized With Coronavirus Disease 2019 (COVID-19) in Japan | https://ClinicalTrials.gov/show/NCT04828772 |
| NCT04828148 | Incidence of Infection and Mortality by COVID-19 in Specialists | https://ClinicalTrials.gov/show/NCT04828148 |
| NCT04828460 | Monitoring of COVID-19 Vaccine Response in Organ Transplant Patients | https://ClinicalTrials.gov/show/NCT04828460 |
| NCT04827160 | Prediction of Thrombosis Using D-dimer Trends in COVID-19 | https://ClinicalTrials.gov/show/NCT04827160 |
| NCT04826770 | Adaptive Immune Response Against Corona Virus Vaccination | https://ClinicalTrials.gov/show/NCT04826770 |
| NCT04826731 | Effect of Respiratory Exerciser on Pulmonary Functions of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04826731 |
| NCT04826640 | Observational Maternal COVID-19 Vaccination Study | https://ClinicalTrials.gov/show/NCT04826640 |
| NCT04825301 | Prognostic Prediction of COVID-19 Clinical Course Through the Development of Machine Learning Based Algorithms | https://ClinicalTrials.gov/show/NCT04825301 |
| NCT04824664 | The ALIGHIERI Survey: an Italian Overview of Global Impact of tHe COVID-19 pandemIc on General surgERy practIce | https://ClinicalTrials.gov/show/NCT04824664 |
| NCT04824651 | Covid-19 Vaccine Cohort in Specific Populations | https://ClinicalTrials.gov/show/NCT04824651 |
| NCT04824495 | Evaluation of Inflammatory Cytokines During COVID-19 | https://ClinicalTrials.gov/show/NCT04824495 |
| NCT04824625 | Incidence of Infection Reported by COVID-19 in Attendees of a Commercial Music Concert | https://ClinicalTrials.gov/show/NCT04824625 |
| NCT04821986 | Oral Manifestation in Patients With SARS-CoV2 Infection. | https://ClinicalTrials.gov/show/NCT04821986 |
| NCT04823234 | Lung Ultrasound Signs and Patterns in COVID-19 Pregnant Women | https://ClinicalTrials.gov/show/NCT04823234 |
| NCT04821921 | The Impact of the COVID-19 Pandemic on Diabetes Management | https://ClinicalTrials.gov/show/NCT04821921 |
| NCT04822012 | Anti COVID-19 Antibodies in Follicular Fluid and Spermatic Fluid | https://ClinicalTrials.gov/show/NCT04822012 |
| NCT04821570 | To Assess Immunogenicity of Coronavirus Disease 2019 (COVID-19) Vaccine in Cancer Patients Receiving Cancer Treatment | https://ClinicalTrials.gov/show/NCT04821570 |
| NCT04806815 | Menstrual Cycle-induced Pain, Fatigue and Anxiety in Women Suffered From COVID-19 | https://ClinicalTrials.gov/show/NCT04806815 |
| NCT04819802 | MIcrovascular Dysfunction in CRitically Ill cOVID-19 Patients | https://ClinicalTrials.gov/show/NCT04819802 |
| NCT04817553 | Impact of COVID-19 on the Clinical Outcomes and Management of IgG4 Related Disease Patients | https://ClinicalTrials.gov/show/NCT04817553 |
| NCT04818892 | Immunogenicity of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease | https://ClinicalTrials.gov/show/NCT04818892 |
| NCT04818866 | International Study of Inflammation in COVID-19 | https://ClinicalTrials.gov/show/NCT04818866 |
| NCT04818853 | COVID-19 Associated Pulmonary Aspergillosis (CAPA) and Other Invasive Fungal Infections (IFI) | https://ClinicalTrials.gov/show/NCT04818853 |
| NCT04818463 | Characterization and Verification of the Intensive Care Standard Operating Procedure (SOP) Adherence of the Treated COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04818463 |
| NCT04819165 | Healthcare-associated Infections in Severe COVID-19 During 2020 | https://ClinicalTrials.gov/show/NCT04819165 |
| NCT04818697 | Effect of Social Isolation on Physical Activity Level, and Kinesophobia in Heart Rhythm Disorders During Pandemic | https://ClinicalTrials.gov/show/NCT04818697 |
| NCT04816630 | Feasibility Study of Hematology Parameters in COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04816630 |
| NCT04817397 | The Lymphocyte/Neutrophil Ratio as a Prognostic Index for Short Term Outcome in the ICU Admitted COVID-19 Adult Patients | https://ClinicalTrials.gov/show/NCT04817397 |
| NCT04817293 | Prolonged Symptoms and Reasons for Consultation in Town Medicine Associated With COVID-19 Infection in the Hauts de France Region | https://ClinicalTrials.gov/show/NCT04817293 |
| NCT04817280 | COVID-19 in Polish Ice Swimmers. | https://ClinicalTrials.gov/show/NCT04817280 |
| NCT04816786 | COVID-19 Patients Admitted to the ICU | https://ClinicalTrials.gov/show/NCT04816786 |
| NCT04816760 | Immune Cells Phenotypes During COVID-19 | https://ClinicalTrials.gov/show/NCT04816760 |
| NCT04815135 | Effect of Covid-19 Pandemic on Emergency Surgery Practice | https://ClinicalTrials.gov/show/NCT04815135 |
| NCT04815850 | Phenotyping Seroconversion Following Vaccination Against COVID-19 in Patients on Haemodialysis Study | https://ClinicalTrials.gov/show/NCT04815850 |
| NCT04815759 | Dental Anxiety Among Children Pre and Post COVID 19 Pandemic | https://ClinicalTrials.gov/show/NCT04815759 |
| NCT04815304 | Clinical Features of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04815304 |
| NCT04815018 | Shifts in the Respiratory Microbiome and Clinical Outcomes of SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04815018 |
| NCT04814914 | An Observational Clinical Study to Evaluate COVID-19 Symptoms in “Long Hauler” Patients Who Participated in K031-120 or K032-120 | https://ClinicalTrials.gov/show/NCT04814914 |
| NCT04815109 | Prospective Electroencephalography Evaluation of Sedation in COVID-19 | https://ClinicalTrials.gov/show/NCT04815109 |
| NCT04813939 | Is Bio-adrenomedullin (Bio-ADM) a Prognostic Factor in Patients With COVID-19 Treated in the ICU? | https://ClinicalTrials.gov/show/NCT04813939 |
| NCT04813731 | COVID-19 And Lingering Symptoms In Primary Care Patients | https://ClinicalTrials.gov/show/NCT04813731 |
| NCT04813692 | Mechanical Complications of Acute Myocardial Infarction During COVID-19 Pandemics | https://ClinicalTrials.gov/show/NCT04813692 |
| NCT04805970 | REsearching Covid-19 Outcomes in Diabetes (RECODE) | https://ClinicalTrials.gov/show/NCT04805970 |
| NCT04812496 | Tenofovir-DF Versus Hydroxychloroquine in the Treatment of Hospitalized Patients With COVID-19 (TEDHICOV) | https://ClinicalTrials.gov/show/NCT04812496 |
| NCT04811885 | The Effects of Covid-19 Pandemic on the Cardiovascular Heath of Children With Autism Spectrum Disorder | https://ClinicalTrials.gov/show/NCT04811885 |
| NCT04811781 | Epidemiological Features and Clinical Course of COVID -19 Infection in Cancer Patients: The Rovid Study | https://ClinicalTrials.gov/show/NCT04811781 |
| NCT04811391 | COVID-19 Vaccine Effectiveness in Albanian Health Workers | https://ClinicalTrials.gov/show/NCT04811391 |
| NCT04811352 | Drug Abuse During the COVID-19 Pandemic. | https://ClinicalTrials.gov/show/NCT04811352 |
| NCT04810117 | Monitoring the IgG/IgM Antibodies in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04810117 |
| NCT04809480 | COVID-19 and Acute Invasive Fungal Rhinosinusitis | https://ClinicalTrials.gov/show/NCT04809480 |
| NCT04806867 | Selection of Patients With Chronic Inflammatory Rheumatism Requiring Management During the COVID-19 Pandemia | https://ClinicalTrials.gov/show/NCT04806867 |
| NCT04805840 | Sensitivity of Frequent SARS-CoV-2 (COVID-19) Rapid Antigen Testing Regimen | https://ClinicalTrials.gov/show/NCT04805840 |
| NCT04805216 | Covid-19 Vaccine Response in Immunocompromised Haematology Patients | https://ClinicalTrials.gov/show/NCT04805216 |
| NCT04805632 | Immune Response in Dialysis Patients Vaccinated Against COVID-19 | https://ClinicalTrials.gov/show/NCT04805632 |
| NCT04802642 | Evaluation of COVID-19 Fear, Anxiety and Their Effects in Physiotherapy Technician Students | https://ClinicalTrials.gov/show/NCT04802642 |
| NCT04802044 | COVID-19, Aging, and Cardiometabolic Risk Factors Study | https://ClinicalTrials.gov/show/NCT04802044 |
| NCT04800731 | Study of Lymphopenia as a Specific Biomarker or Prognostic Risk Factor for Disease Severity in Elderly Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04800731 |
| NCT04799977 | COVID-19: Post-covid Olfactory Disorders Assessment | https://ClinicalTrials.gov/show/NCT04799977 |
| NCT04800146 | A Study on the Immune-response to COVID-19 Vaccination in Cancer Patients - the IOSI-COVID-19-001 Study | https://ClinicalTrials.gov/show/NCT04800146 |
| NCT04799873 | Alpha-1-Antitrypsin-Deficiency in COVID-19 | https://ClinicalTrials.gov/show/NCT04799873 |
| NCT04799834 | Genotype and Susceptibility to COVID-19 | https://ClinicalTrials.gov/show/NCT04799834 |
| NCT04799808 | Saxon SARS-CoV-2 Infection and Vaccination Study in Dialysis Patients, Solid Organ Recipients and Staff | https://ClinicalTrials.gov/show/NCT04799808 |
| NCT04799704 | Tear Film SARS-nCoV-2 Detection in Symptomatic and Pauci-symptomatic Patients. | https://ClinicalTrials.gov/show/NCT04799704 |
| NCT04799691 | Comparison of 2 Ventilatory Support Strategies During Coronavirus Disease 2019 (Covid-19) Pneumonia | https://ClinicalTrials.gov/show/NCT04799691 |
| NCT04799652 | Are Surgeons Ready to Get the COVID-19 Vaccine? | https://ClinicalTrials.gov/show/NCT04799652 |
| NCT04799600 | The Effect of the Severity of COVID-19 Disease on the Incidence of Acute Renal Failure in ICU | https://ClinicalTrials.gov/show/NCT04799600 |
| NCT04799132 | Association Between Body Mass Index and HFNC Therapy Success | https://ClinicalTrials.gov/show/NCT04799132 |
| NCT04797624 | Does Coronavirus Disease 2019 (COVID-19) Pandemic Cause a Delay in the Diagnosis of Gastric Cancer Patients? | https://ClinicalTrials.gov/show/NCT04797624 |
| NCT04796584 | Efficacy of COVID-19 Vaccination in Patients With Multiple Sclerosis Treated With Immune Modulating Medication | https://ClinicalTrials.gov/show/NCT04796584 |
| NCT04794829 | Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination | https://ClinicalTrials.gov/show/NCT04794829 |
| NCT04794361 | Management of Patients Suspected of COVID 19 With Ultra Low Dose Thoracic Scanner | https://ClinicalTrials.gov/show/NCT04794361 |
| NCT04795414 | Safety and Immunogenicity of an Inactivated Vaccine Against COVID-19 in Medical Workers | https://ClinicalTrials.gov/show/NCT04795414 |
| NCT04794998 | A Simple Approach to Treat COVID-19 Patients at Home. | https://ClinicalTrials.gov/show/NCT04794998 |
| NCT04794920 | Post-Covid-19 Emotional Aspects of Hospital Staff | https://ClinicalTrials.gov/show/NCT04794920 |
| NCT04794062 | Myocardial Injury and Quality of Life After COVID-19 | https://ClinicalTrials.gov/show/NCT04794062 |
| NCT04793269 | Characteristics of Long COVID-19 Syndrome | https://ClinicalTrials.gov/show/NCT04793269 |
| NCT04791085 | Investigation of Stress Levels and Lifestyle of a Sample of Greek General Surgeons in Covid-19 | https://ClinicalTrials.gov/show/NCT04791085 |
| NCT04792086 | Disease Containment Measures Among Older Adults During the Covid-19 Pandemia | https://ClinicalTrials.gov/show/NCT04792086 |
| NCT04790994 | COVID-19 Prevalence in UNIVI Geriatric Institutions: Epidemiological Study of Immunological Status With Rapid Serological Tests | https://ClinicalTrials.gov/show/NCT04790994 |
| NCT04789460 | Relationship Between Potential Predictors and Mortality in COVID-19 Patients ın Turkey | https://ClinicalTrials.gov/show/NCT04789460 |
| NCT04789447 | Initial CT Findings and CO-RADS Stage in COVID-19 | https://ClinicalTrials.gov/show/NCT04789447 |
| NCT04789395 | Evaluation of Post-covid 19 Patients Who Receive Ozonetheraphy With Thorax CT | https://ClinicalTrials.gov/show/NCT04789395 |
| NCT04789512 | Respiratory Muscle Strength in Volleyball Players Suffered From COVID-19 | https://ClinicalTrials.gov/show/NCT04789512 |
| NCT04788394 | Renal Involvement in Hospitalized Children With COVID-19 | https://ClinicalTrials.gov/show/NCT04788394 |
| NCT04788433 | Registry of Coronavirus Complications - CORRELATION WITH GLYCOMIC PROFILE | https://ClinicalTrials.gov/show/NCT04788433 |
| NCT04787614 | 2019 NSECE COVID-19 Follow-up | https://ClinicalTrials.gov/show/NCT04787614 |
| NCT04787588 | COVID-19 Infection and Epithelial Cell Markers | https://ClinicalTrials.gov/show/NCT04787588 |
| NCT04786808 | Risk Factors for COVID-19 Mortality | https://ClinicalTrials.gov/show/NCT04786808 |
| NCT04787536 | Perioperative Cognitive Trajectories in Deferred Surgery (CoTELE-SURGE) | https://ClinicalTrials.gov/show/NCT04787536 |
| NCT04786301 | Severe Acute Respiratory Infection - Preparedness (COVID-19 and Influenza) | https://ClinicalTrials.gov/show/NCT04786301 |
| NCT04786249 | Impact of Rapid Screening for COVID-19 in Delocalized Biology in the Emergency Department | https://ClinicalTrials.gov/show/NCT04786249 |
| NCT04786197 | Detection of SARS-CoV-2 (COVID-19) by SERS Spectroscopy Combined With Artificial Intelligence | https://ClinicalTrials.gov/show/NCT04786197 |
| NCT04786041 | the Impact of COVID-19 Pandemic on the Incidence and Outcome of Complicated Appendicitis | https://ClinicalTrials.gov/show/NCT04786041 |
| NCT04784403 | SCREENING AND SEROEPIDEMIOLOGY OF SARS-CoV-2 INFECTION AT THE UNIVERSITY OF BARCELONA: A CROSS-SECTIONAL STUDY | https://ClinicalTrials.gov/show/NCT04784403 |
| NCT04785157 | Neurotropism and Neuroinflammation in COVID-19 Patients With Delirium. | https://ClinicalTrials.gov/show/NCT04785157 |
| NCT04784689 | Host Immune Response to Novel RNA COVID-19 Vaccination | https://ClinicalTrials.gov/show/NCT04784689 |
| NCT04784546 | Evaluation of Muscle Strength, Functional Independence, Myalgia, Fatigue and Dyspnea in COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04784546 |
| NCT04784468 | DNA Damage and Oxidative Stress in Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04784468 |
| NCT04782739 | Evaluation of the Impact of the COVID-19 Pandemic on Provision and Uptake of Services for the Prevention of Mother-to-child Transmission of HIV and Syphilis in Zimbabwe | https://ClinicalTrials.gov/show/NCT04782739 |
| NCT04782427 | COVID-19 Infections and Mortality in Long-term Care Facilities During the First Wave | https://ClinicalTrials.gov/show/NCT04782427 |
| NCT04780555 | Evaluation of Musculoskeletal System Symptoms and Biochemical Parameters in COVID-19 | https://ClinicalTrials.gov/show/NCT04780555 |
| NCT04780594 | Impact of the COVID-19 Pandemic on the Surgical Activity of Bellvitge University Hospital | https://ClinicalTrials.gov/show/NCT04780594 |
| NCT04780295 | COvid-19 REgistry on THROMBOSIS Complications | https://ClinicalTrials.gov/show/NCT04780295 |
| NCT04780113 | Evolution of Perceived Stress in General Practice Residents During COVID-19 Sanitary Crisis | https://ClinicalTrials.gov/show/NCT04780113 |
| NCT04780373 | Prognostic Score in Covid-19 | https://ClinicalTrials.gov/show/NCT04780373 |
| NCT04779996 | Antibodies Production After Covid-19 Vaccination Among Patients With Medical History of Cancer and Anti-CD-20 Treatment | https://ClinicalTrials.gov/show/NCT04779996 |
| NCT04779944 | Impact of SARS-CoV-2 Pandemic on Psychological State of Health Care Workers | https://ClinicalTrials.gov/show/NCT04779944 |
| NCT04779541 | National Survey Concerning Vaccination Against COVID-19 in Nursing Homes and Long-Term Care Units | https://ClinicalTrials.gov/show/NCT04779541 |
| NCT04779424 | Prevalence and Incidence of Antibodies Against SARS-CoV-2 Among Primary Healthcare Providers in Belgium (COVID-19) | https://ClinicalTrials.gov/show/NCT04779424 |
| NCT04779749 | Pregnancy Outcomes According to the Gestational Age of Acquiring COVID-19 | https://ClinicalTrials.gov/show/NCT04779749 |
| NCT04779021 | Caracterisation of COVID-19 Patients Hospitalized in Infectious Disease Department | https://ClinicalTrials.gov/show/NCT04779021 |
| NCT04778033 | Semen Analysis Parameters Following Pfizer’s COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04778033 |
| NCT04775966 | CPAP Observance During the COVID-19 (SARS-CoV-2) Pandemic | https://ClinicalTrials.gov/show/NCT04775966 |
| NCT04775784 | Determination of COVID-19 Related Virus in Central Nervous System | https://ClinicalTrials.gov/show/NCT04775784 |
| NCT04775134 | Residual SARS-CoV-2 Presence in the Respiratory Tract and Lung Parenchyma (After SARS-CoV-2 Infection or COVID-19) | https://ClinicalTrials.gov/show/NCT04775134 |
| NCT04775407 | COVID-19 Serological Testing of Patients With a Mental Disorder From the Catchment Area of the Capital Region of Denmark | https://ClinicalTrials.gov/show/NCT04775407 |
| NCT04775563 | COVID-19 Vaccine Hesitancy Among Rheumatic Diseases Patients | https://ClinicalTrials.gov/show/NCT04775563 |
| NCT04775017 | Delirium in Covid-19: Germany-wide Covid-19 Intensive Register | https://ClinicalTrials.gov/show/NCT04775017 |
| NCT04771117 | Defiances to Face COVID-19 Pandemic in Mexico | https://ClinicalTrials.gov/show/NCT04771117 |
| NCT04772703 | DNA Damage in Critically Ill COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04772703 |
| NCT04772586 | Sarcopenia and Mechanical Ventilation in Older Patients Admitted Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04772586 |
| NCT04771624 | Assessment of Executive Functions After Covid-19 | https://ClinicalTrials.gov/show/NCT04771624 |
| NCT04772833 | Spanish Study to Analyze the Histopathological, Ultrastructural and Microbiological Findings Obtained in Autopsies of Patients Who Died Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04772833 |
| NCT04772404 | Repercussion of the COVID-19 Pandemic on Physical Activity, Psychological State and Sleep | https://ClinicalTrials.gov/show/NCT04772404 |
| NCT04771052 | Minimizing the Effects of COVID-19 Hospitalization With the COVID Rehabilitation Program for the Elderly | https://ClinicalTrials.gov/show/NCT04771052 |
| NCT04769700 | Post-partum Depression, Breastfeeding Adherence and Fear in COVID-19 | https://ClinicalTrials.gov/show/NCT04769700 |
| NCT04769245 | The Effectiveness of ACB-IP 1.0 Convalescent Plasma in COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04769245 |
| NCT04769349 | Effectiveness of Supportive Housing on COVID-19 Related Outcomes for People Experiencing Homelessness | https://ClinicalTrials.gov/show/NCT04769349 |
| NCT04769284 | Psychological State of Students of Health Sciences During COVID-19 | https://ClinicalTrials.gov/show/NCT04769284 |
| NCT04768244 | Impact of Maternal COVID-19 Disease on Breast Milk and Infant Health | https://ClinicalTrials.gov/show/NCT04768244 |
| NCT04768153 | Prioritising Prevention of COVID-19 in Persons With Cancer in the French West Indies | https://ClinicalTrials.gov/show/NCT04768153 |
| NCT04766983 | Incidence of VAP in Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04766983 |
| NCT04766294 | Macrophage Activation Markers in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04766294 |
| NCT04765254 | COVID-19 Infection in Diabetic Patients | https://ClinicalTrials.gov/show/NCT04765254 |
| NCT04764747 | Effectiveness of Convalescent Plasma in Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04764747 |
| NCT04764773 | Persistence of Symptoms After Improvement of Acute COVID-19 | https://ClinicalTrials.gov/show/NCT04764773 |
| NCT04764032 | Right Ventricular Dysfunction in Ventilated Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04764032 |
| NCT04763213 | New Predictors in Determining the Need for Invasive Treatment in Non-STEMI | https://ClinicalTrials.gov/show/NCT04763213 |
| NCT04763395 | Liver Function Test Abnormalities in COVID-19 | https://ClinicalTrials.gov/show/NCT04763395 |
| NCT04762056 | CPAx for Assessing Functional Status of COVID-19 Patients After Intensive Care Unit Discharge | https://ClinicalTrials.gov/show/NCT04762056 |
| NCT04761107 | Impact of COVID-19 on GU Disease | https://ClinicalTrials.gov/show/NCT04761107 |
| NCT04760704 | Covid-19 Vaccine Response in Elderly Subjects | https://ClinicalTrials.gov/show/NCT04760704 |
| NCT04760639 | COVID Breath Test - Ancon | https://ClinicalTrials.gov/show/NCT04760639 |
| NCT04760990 | A Study to Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort. | https://ClinicalTrials.gov/show/NCT04760990 |
| NCT04760795 | Stress, Personality, Attachment and Coping During the Covid Crisis. | https://ClinicalTrials.gov/show/NCT04760795 |
| NCT04760184 | Impact of COVID-19 After Autologous Hematopoietic Stem Cell Transplantation in Sweden | https://ClinicalTrials.gov/show/NCT04760184 |
| NCT04757883 | Immunological Follow-up After SARS CoV2 Vaccination in Kidney Transplant Recipients | https://ClinicalTrials.gov/show/NCT04757883 |
| NCT04757792 | Back to the Traditional: Anti-COX Drugs Can Improve the Outcome of COVID-19 Patients Admitted to ICU | https://ClinicalTrials.gov/show/NCT04757792 |
| NCT04757272 | Does Hepatitis C Management Protect Egyptian Population Against Severe Corona Virus Disease-2019? | https://ClinicalTrials.gov/show/NCT04757272 |
| NCT04756869 | Monitoring Health Care Workers at Risk for COVID-19 Using Wearable Sensors and Smartphone Technology | https://ClinicalTrials.gov/show/NCT04756869 |
| NCT04756817 | Immunogenicity of the BNT162b2 Covid-19 Vaccine in Elderly People Aged 85 and Older in Greece | https://ClinicalTrials.gov/show/NCT04756817 |
| NCT04756674 | The Impact of Covid-19 on Skeletal Muscle | https://ClinicalTrials.gov/show/NCT04756674 |
| NCT04756518 | COVID-19 Infection and Machine Learning Using Artificial Intelligence (AI) | https://ClinicalTrials.gov/show/NCT04756518 |
| NCT04756193 | Evaluate Long Term Cardiovascular and Pulmonary Complications After COVID-19 With Point of Care Ultrasound | https://ClinicalTrials.gov/show/NCT04756193 |
| NCT04756479 | Mortality Due to COVID-19 in the COVID-AGEBRU Study | https://ClinicalTrials.gov/show/NCT04756479 |
| NCT04753346 | Comparison of Cardiopulmonary Fitness Level With Normal Values After COVID-19 | https://ClinicalTrials.gov/show/NCT04753346 |
| NCT04753632 | Status of People With Cerebral Palsy and Their Caregivers During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04753632 |
| NCT04754633 | Comparison of Chest CT Findings Related to COVID-19 With RSNA and BSTI Guidelines | https://ClinicalTrials.gov/show/NCT04754633 |
| NCT04753762 | Multimodal IMAgery Characterization of Cardiac Damage and Severity After COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04753762 |
| NCT04752085 | Prognosis and Course of COVID-19 Infection in Hospitalised Patients | https://ClinicalTrials.gov/show/NCT04752085 |
| NCT04753463 | Assessment of the Impact of COVID-19 Pandemic on Residents Training and Mental Health in Poland | https://ClinicalTrials.gov/show/NCT04753463 |
| NCT04750369 | Enhanced Triage for COVID-19 | https://ClinicalTrials.gov/show/NCT04750369 |
| NCT04751227 | Modafinil for Wakefulness in the Critical Care Units | https://ClinicalTrials.gov/show/NCT04751227 |
| NCT04750330 | Mitochondrial DNA and Nuclear SNPs to Predict Severity of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04750330 |
| NCT04751734 | Impact of Maternal COVID-19 Vaccines on Breast Milk | https://ClinicalTrials.gov/show/NCT04751734 |
| NCT04750629 | Clinical Evaluation of a Point-of-Care (POC), COVID-19 Rapid Antigen Test (CoviDxâ„¢) | https://ClinicalTrials.gov/show/NCT04750629 |
| NCT04750356 | SARS-CoV-2 (COVID-19) Longitudinal Study: Understanding Susceptibility, Transmission and Disease Severity (Legacy Study) | https://ClinicalTrials.gov/show/NCT04750356 |
| NCT04748185 | Immunogenicity and Safety of Commercially Available Vaccines Against SARS-CoV-2 (COVID-19) in Patients With Hematologic Malignancies | https://ClinicalTrials.gov/show/NCT04748185 |
| NCT04748172 | COVID-19 Vaccine and Ovarian Reserve | https://ClinicalTrials.gov/show/NCT04748172 |
| NCT04747782 | COVID-19 Longitudinal Biomarkers in Lung Injury | https://ClinicalTrials.gov/show/NCT04747782 |
| NCT04747522 | Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Immune Kidney Transplant Study (COVID-19) | https://ClinicalTrials.gov/show/NCT04747522 |
| NCT04747769 | COVID-19. CT-Scan Modeling in COVID19 Sequelae | https://ClinicalTrials.gov/show/NCT04747769 |
| NCT04746521 | Cellular-Mediated Immunity in COVID-19 | https://ClinicalTrials.gov/show/NCT04746521 |
| NCT04746443 | Effect of Covid-19 Affliction on Psychological and Mental Health Among College Going Students: Cross-Sectional Survey | https://ClinicalTrials.gov/show/NCT04746443 |
| NCT04746092 | The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19 | https://ClinicalTrials.gov/show/NCT04746092 |
| NCT04746066 | Observational Study for Patients With Hemoglobinopathies and Rare Inherited Anemia and Covid 19 | https://ClinicalTrials.gov/show/NCT04746066 |
| NCT04745923 | Physical Activity Level in Patients With Chronic Kidney Disease During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04745923 |
| NCT04743609 | RSV Burden in Outpatient Settings | https://ClinicalTrials.gov/show/NCT04743609 |
| NCT04743947 | Vaccination Against COVID-19 in Chronic Kidney Disease | https://ClinicalTrials.gov/show/NCT04743947 |
| NCT04745416 | Clinical Characteristics of Patients With Leukemia and COVID-19 | https://ClinicalTrials.gov/show/NCT04745416 |
| NCT04745377 | Responses to COVID-19 Vaccination in Patients With Cancer | https://ClinicalTrials.gov/show/NCT04745377 |
| NCT04742712 | A Feasibility Study Using the CoronaCheck Device to Identify Incident Cases of SARS CoV-2 Covid-19 | https://ClinicalTrials.gov/show/NCT04742712 |
| NCT04741178 | PAtterns and Extension in COVID-19 Related Interstitial Pneumonia: CT Analysis | https://ClinicalTrials.gov/show/NCT04741178 |
| NCT04740658 | Organizational Measures to Prevent and Control COVID-19 Infection in Nursing Homes on the Risk of Death of Residents | https://ClinicalTrials.gov/show/NCT04740658 |
| NCT04742569 | Wearable Diagnostic for Detection of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04742569 |
| NCT04740125 | SURVEY ABOUT STRESS-COVID IN HEALTH CARE WORKERS IN NORTH AFRICA COUNTRY | https://ClinicalTrials.gov/show/NCT04740125 |
| NCT04740372 | Development of an International COVID-19 Specific Quality of Life Questionnaire, Phase III. The OSLO COVID-19 QLQ | https://ClinicalTrials.gov/show/NCT04740372 |
| NCT04739345 | New Immune-inflammation Index for Predicting Prognosis of Coronavirus Disease 2019 (COVID- 19) Infection | https://ClinicalTrials.gov/show/NCT04739345 |
| NCT04738331 | Analysing the French COVID-19 Epidemic Using a National SARS-CoV-2 RT-PCR Database | https://ClinicalTrials.gov/show/NCT04738331 |
| NCT04738760 | Clinical Outcomes of High Dose Vitamin D Versus Standard Dose in COVID-19 Egyptian Patients | https://ClinicalTrials.gov/show/NCT04738760 |
| NCT04738695 | SARS-CoV-2 Seroprevalence Among Nursing Home Staff and Residents (COVID-19) | https://ClinicalTrials.gov/show/NCT04738695 |
| NCT04736901 | Effect of Prophylactic and Therapeutic Anticoagulants in Egyptian Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04736901 |
| NCT04736732 | Institut de Recherche Cliniques de Montreal (IRCM) Post-COVID-19 (IPCO) Research Clinic | https://ClinicalTrials.gov/show/NCT04736732 |
| NCT04736680 | Pediatric Virtual Visits as a Strategy for Access to Care During the COVID-19 Pandemic in a Pediatric Hospital | https://ClinicalTrials.gov/show/NCT04736680 |
| NCT04738032 | Stories for Change: Digital Storytelling Intervention for Diabetes Self-Management in the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04738032 |
| NCT04735744 | Evaluation of Allied Healthcare in Patients Recovering From COVID-19 | https://ClinicalTrials.gov/show/NCT04735744 |
| NCT04736524 | Immune Response Following COVID-19 Vaccination | https://ClinicalTrials.gov/show/NCT04736524 |
| NCT04736004 | Hearts of Athletes | https://ClinicalTrials.gov/show/NCT04736004 |
| NCT04735757 | Effects of COVID-19 Infection and Critical Illness on Diaphragm Tissue Characteristics and Movement, Visualized With MRI | https://ClinicalTrials.gov/show/NCT04735757 |
| NCT04734678 | Comparison of Tocilizumab Versus Tocilizumab/Infliximab in Patients With COVID-19-associated Cytokine Storm Syndrome | https://ClinicalTrials.gov/show/NCT04734678 |
| NCT04734223 | Neuroimaging Findings in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04734223 |
| NCT04733807 | Antibodies Response to mRNA Vaccine Against Covid-19 | https://ClinicalTrials.gov/show/NCT04733807 |
| NCT04733105 | Pronostic Value of Type I ANTi-Interferon Antibodies in Patients With COVID-19 Acute Respiratory Failure | https://ClinicalTrials.gov/show/NCT04733105 |
| NCT04732663 | Understanding Exertional Dyspnea and Exercise Intolerance in COVID-19 | https://ClinicalTrials.gov/show/NCT04732663 |
| NCT04732858 | Educational Interventions for Surgeons During COVID-19 Pandemic: Cross-sectional, E-survey | https://ClinicalTrials.gov/show/NCT04732858 |
| NCT04732702 | Effects of Contact Restrictions During the COVID-19 Pandemic on Newborns and Their Parents | https://ClinicalTrials.gov/show/NCT04732702 |
| NCT04729452 | Characterisation of the Immune Response to SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04729452 |
| NCT04729374 | COVID-19 Vaccine Induced Adaptive Immune Responses | https://ClinicalTrials.gov/show/NCT04729374 |
| NCT04728880 | Remdesivir in Adults With Covid-19: Mansoura University Hospital Experience | https://ClinicalTrials.gov/show/NCT04728880 |
| NCT04728828 | COVADIAL - Immunogenicity of COVID-19 Vaccine in Hemodialysis Patients | https://ClinicalTrials.gov/show/NCT04728828 |
| NCT04727775 | Antiviral Drugs on the Treatment of SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04727775 |
| NCT04727762 | Use of the Mask and Current Pandemic | https://ClinicalTrials.gov/show/NCT04727762 |
| NCT04727294 | MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey | https://ClinicalTrials.gov/show/NCT04727294 |
| NCT04726865 | COVID-19 Pandemic and Medical Students | https://ClinicalTrials.gov/show/NCT04726865 |
| NCT04725097 | A Study to Evaluate Rapid Throughput Screening for Human COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04725097 |
| NCT04725084 | Comparison of Non-invasive Oxygenation Strategies in Patients Admitted for Covid-19 Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04725084 |
| NCT04724642 | COVID-19 Vaccine in Patients After Allogeneic HCT, CAR-T Therapy and With Primary Immune Deficiency | https://ClinicalTrials.gov/show/NCT04724642 |
| NCT04724434 | Follow-up Study of COVID-19 Patients in the District Konstanz | https://ClinicalTrials.gov/show/NCT04724434 |
| NCT04724395 | Disability Following Hospitalization in People of Working-age Surviving SARS-CoV-2 Infection - COVID-19 | https://ClinicalTrials.gov/show/NCT04724395 |
| NCT04723706 | Response to SARS-CoV-2 Vaccine in Stem Cell Transplant and Cellular Therapy Patients | https://ClinicalTrials.gov/show/NCT04723706 |
| NCT04713150 | HEALthy Brain and Child Development Study - COVID-19 Supplement | https://ClinicalTrials.gov/show/NCT04713150 |
| NCT04718519 | Migrant Workers’ Responses to the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04718519 |
| NCT04717089 | Extended Post Anaesthetic Care in PACU During COVID-19: Multi-perspective Value-based Analysis | https://ClinicalTrials.gov/show/NCT04717089 |
| NCT04717024 | The Nanowear Wearable Covid-19 Observational and Analysis Trend | https://ClinicalTrials.gov/show/NCT04717024 |
| NCT04717011 | Case Series Study to Detect SARS-CoV-2 in Semen of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04717011 |
| NCT04716023 | Physiology and Structure of the Small Airways in Patients With Chronic Airflow Obstruction or COVID-19 | https://ClinicalTrials.gov/show/NCT04716023 |
| NCT04715919 | Long Term Outcomes of Coronavirus Disease-19 (COVID-19) | https://ClinicalTrials.gov/show/NCT04715919 |
| NCT04715477 | Intensive Care Anxiety in SARS-CoV-2 Patients | https://ClinicalTrials.gov/show/NCT04715477 |
| NCT04721444 | Optimising Cancer Therapy And Identifying Causes of Pneumonitis USing Artificial Intelligence (COVID-19) | https://ClinicalTrials.gov/show/NCT04721444 |
| NCT04719182 | Practice of Adjunctive Treatments in Intensive Care Unit Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04719182 |
| NCT04716972 | Evaluating the Impact of COVID-19 (Coronavirus) on Research in Care Homes | https://ClinicalTrials.gov/show/NCT04716972 |
| NCT04716907 | Thymic Function in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04716907 |
| NCT04716465 | Dysautonomia in Patients Post COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04716465 |
| NCT04716088 | Rapid Antigen Testing for SARS-CoV-2 Among Healthcare Workers to Prevent Spread of COVID-19 | https://ClinicalTrials.gov/show/NCT04716088 |
| NCT04714333 | Detection of Covid-19 by Volatile Organic Compounds in Exhaled Breath | https://ClinicalTrials.gov/show/NCT04714333 |
| NCT04714515 | Montelukast - a Treatment Choice for COVID-19 | https://ClinicalTrials.gov/show/NCT04714515 |
| NCT04714008 | Covid-19 and ONline GAmbling | https://ClinicalTrials.gov/show/NCT04714008 |
| NCT04714138 | Remote Video Consultation for Quality of Life Assessment in Patients Hospitalised After COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04714138 |
| NCT04714125 | Prognostic Value of Flow-mediated Dilation in Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04714125 |
| NCT04713852 | Predictive Value of SOFA and APACHE Scores for In-hospital Mortality in COVID-19 ICU Patients | https://ClinicalTrials.gov/show/NCT04713852 |
| NCT04712448 | Serum Prevalence of SARS-Cov-2 Antibodies in Pre-pandemic Blood Samples (SPARE) | https://ClinicalTrials.gov/show/NCT04712448 |
| NCT04713540 | Rehabilitation in Intensive Care Unit | https://ClinicalTrials.gov/show/NCT04713540 |
| NCT04712292 | Effects of COVID-19 Pandemic on the Diagnosis and Outcomes of Colorectal Cancer (COVID-CRC) | https://ClinicalTrials.gov/show/NCT04712292 |
| NCT04710836 | NoRCoRP Assessment Clinic | https://ClinicalTrials.gov/show/NCT04710836 |
| NCT04710771 | Effect of Prone Positioning in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04710771 |
| NCT04712175 | Diagnostic Validation of Rapid Detection of the COVID-19 Causative Virus (SARS-CoV-2) in Saliva Samples by Mass Spectrometry | https://ClinicalTrials.gov/show/NCT04712175 |
| NCT04710329 | High-Dose Vitamin C Treatment in Critically Ill COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04710329 |
| NCT04709744 | Impact of Vitamin D Level and Supplement on SLE Patients During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04709744 |
| NCT04709003 | Covid-19 Vaccine Effectiveness in Healthcare Personnel in Clalit Health Services in Israel (CoVEHPI) | https://ClinicalTrials.gov/show/NCT04709003 |
| NCT04708912 | Nasopharynx Microbiota Component and in Vitro Cytokines Production in Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04708912 |
| NCT04709068 | Risk Stratification and Early Alerting Regarding COVID-19 Hospitalization | https://ClinicalTrials.gov/show/NCT04709068 |
| NCT04706533 | Michigan Medicine COVID-19 Cohort: Clinical Characteristics, Inflammatory Markers and Outcomes of Patients Hospitalized for COVID-19 | https://ClinicalTrials.gov/show/NCT04706533 |
| NCT04706260 | Clinical Evolution and Becoming of Adult Patients Infected With Covid-19 Hospitalized at Strasbourg University Hospitals | https://ClinicalTrials.gov/show/NCT04706260 |
| NCT04706390 | Comparison of the Immune Response to Natural COVID-19 Infection and Vaccination | https://ClinicalTrials.gov/show/NCT04706390 |
| NCT04706325 | COVID-19 RELATED KIDNEY DAMAGE | https://ClinicalTrials.gov/show/NCT04706325 |
| NCT04706156 | Oral Side Effects of COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04706156 |
| NCT04704466 | Impact of Covid-19 Pandemic on Management of Head and Neck Cancers | https://ClinicalTrials.gov/show/NCT04704466 |
| NCT04704388 | Study Project Comparing the Sequelae of COVID-19 Infection in Patients Who Have and Have Not Received Ventilatory Support in Critical Care | https://ClinicalTrials.gov/show/NCT04704388 |
| NCT04703790 | Acceptability of a COVID-19 Vaccine Among US Adults Over Two Time Periods | https://ClinicalTrials.gov/show/NCT04703790 |
| NCT04703777 | Relationship Between Social Status and Use of Healthcare Services During the Confinement Period Linked to the COVID-19 Epidemic | https://ClinicalTrials.gov/show/NCT04703777 |
| NCT04703270 | Understanding COVID-19 Infection in Pregnant Women and Their Babies | https://ClinicalTrials.gov/show/NCT04703270 |
| NCT04703452 | poSt Covid-19 Infection centraL sENsitisaTion | https://ClinicalTrials.gov/show/NCT04703452 |
| NCT04701905 | The Offer of Neurosurgery Care in the Grand Est of France During the Health Crisis Linked to Covid-19 | https://ClinicalTrials.gov/show/NCT04701905 |
| NCT04701892 | poSt Covid-19 Infection centraL Sensitisation 2 | https://ClinicalTrials.gov/show/NCT04701892 |
| NCT04701996 | Transmission Dynamics of COVID-19 in a Rural Setting of the Democratic Republic of the Congo | https://ClinicalTrials.gov/show/NCT04701996 |
| NCT04701944 | Clinical Study of Pregnant Women With COVID-19 | https://ClinicalTrials.gov/show/NCT04701944 |
| NCT04701515 | Cardiovascular Manifestations of COVID-19 | https://ClinicalTrials.gov/show/NCT04701515 |
| NCT04699578 | COVID-19 Infection and Fetal-neonatal Outcomes | https://ClinicalTrials.gov/show/NCT04699578 |
| NCT04699903 | Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 (COVID-19) IgG Antibody Test in Fingerstick Whole Blood | https://ClinicalTrials.gov/show/NCT04699903 |
| NCT04700254 | Anxiety, Depression and Eating Attitudes of Diabetes Mellitus Patients During COVID-19 Lockdown in Greece | https://ClinicalTrials.gov/show/NCT04700254 |
| NCT04699097 | The Effect of Azithromycin Use on Conduction System of Heart in COVID-19 Positive Children | https://ClinicalTrials.gov/show/NCT04699097 |
| NCT04699058 | COVID-19 Sero-prevalence Health Care Workers Kinshasa | https://ClinicalTrials.gov/show/NCT04699058 |
| NCT04698083 | Electrocardiographic QRS Axis Shift ,Rotation and COVÄ°D-19 | https://ClinicalTrials.gov/show/NCT04698083 |
| NCT04698837 | Understanding Potential Airborne Transmission and the Protective Value of Type II Surgical Masks in SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04698837 |
| NCT04698382 | Impact of COVID-19 on the Incidence, Characteristics, Management and Outcome of Sepsis | https://ClinicalTrials.gov/show/NCT04698382 |
| NCT04698044 | Anxiety and Depression Perceived by Individuals With and Without Cancer During the COVID-19 Pandemic Period | https://ClinicalTrials.gov/show/NCT04698044 |
| NCT04697927 | A Study of Risk Factors for the COVID-19 Virus Infection | https://ClinicalTrials.gov/show/NCT04697927 |
| NCT04697030 | Burnout Among Adolescent Population During Covid-19 Lockdown in Pakistan | https://ClinicalTrials.gov/show/NCT04697030 |
| NCT04696679 | Quality of Life of Very Preterm Children With Dysexecutive Disorders at Elementary School Age During the Confinement-deconfinement Period of Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04696679 |
| NCT04695756 | Liver Transplantation and Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04695756 |
| NCT04695678 | Epidemiological Multicohort Study of Latent COVID-19 Infections | https://ClinicalTrials.gov/show/NCT04695678 |
| NCT04695457 | Correlation Between the Incidence of COVID-19 in Nursing-homes and the Profile of Nursing Homes in the French Alps | https://ClinicalTrials.gov/show/NCT04695457 |
| NCT04695379 | Follow-up of a Cohort of Patients With Myasthenic Syndrome and COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04695379 |
| NCT04695158 | Blood Sample Measurements and Physical Activity Levels in Type II Diabetes and/or COVID-19 | https://ClinicalTrials.gov/show/NCT04695158 |
| NCT04694664 | COVID-19 Vaccine Confidence Among Pregnant Women and Mothers | https://ClinicalTrials.gov/show/NCT04694664 |
| NCT04694768 | Implementation of Rehabilitation Program for Post COVID-19 | https://ClinicalTrials.gov/show/NCT04694768 |
| NCT04694742 | Ventilatory Efficiency in Critically Ill COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04694742 |
| NCT04694716 | Determination of Serum Trace Element and Physical Activity Levels in COVID-19 | https://ClinicalTrials.gov/show/NCT04694716 |
| NCT04694703 | Changing of Trace Element, Homocysteine, Oxidative Stress Parameters and Physical Activity Levels in Covid-19 | https://ClinicalTrials.gov/show/NCT04694703 |
| NCT04692129 | Prone Positioning Short-term Effects on Tissue Oxygen Saturation in Critical COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04692129 |
| NCT04692779 | A Prospective Clinical Study to Explore Response to Prone Positioning in ARDS Patients | https://ClinicalTrials.gov/show/NCT04692779 |
| NCT04694482 | The Impact of the COVID-19 (SARS-CoV-2 Disease) on Psychopathology | https://ClinicalTrials.gov/show/NCT04694482 |
| NCT04694014 | Emotional Intelligence Skills Health Leaders Need During Covid-19 | https://ClinicalTrials.gov/show/NCT04694014 |
| NCT04693052 | Attitudes Towards Receiving Mental Health Care Using Telehealth During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04693052 |
| NCT04691609 | Assiut University Registry for ACS Patients During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04691609 |
| NCT04691934 | Obstetric Anesthesia Experiences in COVID-19 Positive Patients | https://ClinicalTrials.gov/show/NCT04691934 |
| NCT04691921 | Current Pharmacological Practices in Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04691921 |
| NCT04690816 | Natural History of Coronavirus Disease (COVID-19) in Systemic Autoimmune Diseases | https://ClinicalTrials.gov/show/NCT04690816 |
| NCT04689724 | Covid-19 Airway Management | https://ClinicalTrials.gov/show/NCT04689724 |
| NCT04689711 | Prognostic Models for COVID-19 Care | https://ClinicalTrials.gov/show/NCT04689711 |
| NCT04689672 | Predictivity of Hemogasanalysis and Lung UltraSound in Determining COVID-19 Severity | https://ClinicalTrials.gov/show/NCT04689672 |
| NCT04688840 | Smartphone Application: A Possible Solution for Follow up of Patients With Hip Arthroplasty | https://ClinicalTrials.gov/show/NCT04688840 |
| NCT04688372 | Hospital COVID-19 Surge and Associated Mortality Risk | https://ClinicalTrials.gov/show/NCT04688372 |
| NCT04689464 | COVID 19 and Psychological Health: a Cross Sectional Study to Evaluate Anxiety and Depression in Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04689464 |
| NCT04686747 | COVID - 19 and Advanced Gastro-intestinal Cancer Treatment | https://ClinicalTrials.gov/show/NCT04686747 |
| NCT04686734 | Long-term Effects of COVID-19 in Adolescents | https://ClinicalTrials.gov/show/NCT04686734 |
| NCT04686708 | COVID-19 Pandemic and General Surgery Emergencies | https://ClinicalTrials.gov/show/NCT04686708 |
| NCT04686578 | The Effects of Covid-19 Pandemic on The Patients With Fibromyalgia | https://ClinicalTrials.gov/show/NCT04686578 |
| NCT04686565 | Covid-19 Pandemic and Cerebral Palsy | https://ClinicalTrials.gov/show/NCT04686565 |
| NCT04685629 | Covid-19 Long-term Revalidation Follow-up | https://ClinicalTrials.gov/show/NCT04685629 |
| NCT04684836 | Comparative Effectiveness of Telemedicine in Primary Care | https://ClinicalTrials.gov/show/NCT04684836 |
| NCT04684433 | Surgery in the Time of COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04684433 |
| NCT04682912 | Blood Types in Children With COVID-19 | https://ClinicalTrials.gov/show/NCT04682912 |
| NCT04682548 | Estimating Prevalence of COVID-19 Infection and SARS-CoV-2 Antibodies in MS Patients | https://ClinicalTrials.gov/show/NCT04682548 |
| NCT04682132 | Polk COVID-19 and Flu Response | https://ClinicalTrials.gov/show/NCT04682132 |
| NCT04682093 | Risk Stratification of Patients With Suspected COVID-19 Presenting to the ED | https://ClinicalTrials.gov/show/NCT04682093 |
| NCT04681755 | Rehabilitation Required Due to Clinical Disorders After Severe Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04681755 |
| NCT04681950 | Assessment of Self-Collected Sample Compared to Clinician Collected Sample in COVID-19 and Influenza Program | https://ClinicalTrials.gov/show/NCT04681950 |
| NCT04681157 | Retrospective Study on Anosmias and Ageusias Linked to Infection by Covid-19 | https://ClinicalTrials.gov/show/NCT04681157 |
| NCT04681040 | Risk Stratification of COVID-19 Using Urine Biomarkers | https://ClinicalTrials.gov/show/NCT04681040 |
| NCT04681079 | Comparison of Viral Particle Dispersion Following Administration of an MDI or Nebulizer in Subjects With COVID-19 | https://ClinicalTrials.gov/show/NCT04681079 |
| NCT04679584 | COVIDOM: Longterm Morbidity of SARS-CoV-2 Infection and COVID-19 Disease - Consequences for Health Status and Quality of Life | https://ClinicalTrials.gov/show/NCT04679584 |
| NCT04679428 | Immunological Characteristics of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04679428 |
| NCT04679272 | Prognostic Evaluation of COVID-19 in Rheumatoid Arthritis Patients | https://ClinicalTrials.gov/show/NCT04679272 |
| NCT04677283 | Study of Symptoms Linked to Covid-19 in Residents and Professionals in EHPAD, Associated With a Dual Diagnostic Approach by PCR and Serology: a Cohort in ÃŽle-de-France. | https://ClinicalTrials.gov/show/NCT04677283 |
| NCT04678024 | Sensitivity Evaluation of Serological Tests for Covid-19 | https://ClinicalTrials.gov/show/NCT04678024 |
| NCT04675281 | Pathological Findings of Fatal COVID-19 | https://ClinicalTrials.gov/show/NCT04675281 |
| NCT04673331 | Physical Activity, Exercise Capacity and Coronavirus Phobia of Adult Cystic Fibrosis Patients During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04673331 |
| NCT04674553 | Effect of Obesity Among COVID-19 Patients in Critical Care Settings | https://ClinicalTrials.gov/show/NCT04674553 |
| NCT04674410 | Utility of Empiric Antibiotics for Non-intubated Novel Coronavirus Diseases 2019 Patients | https://ClinicalTrials.gov/show/NCT04674410 |
| NCT04672343 | Prognostic Impact of the Nutritional Status of Individuals Aged 70 Years and Older With SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04672343 |
| NCT04670094 | Comorbidities and Risk Score in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04670094 |
| NCT04669990 | Remdesivir and Convalescent Plasma Therapy for Treatment of COVID-19 Infection in Nepal : A Registry Study | https://ClinicalTrials.gov/show/NCT04669990 |
| NCT04669509 | Effect of Liver Injury on Mortality in Coronavirus Disease-2019 Patients Admitted to Intensive Care Unit | https://ClinicalTrials.gov/show/NCT04669509 |
| NCT04670328 | Role of Hematological Parameters in the Stratification of COVID-19 Disease Severity | https://ClinicalTrials.gov/show/NCT04670328 |
| NCT04669938 | Role of the Microbiota in the Evolution of the SARS-CoV-2 Disease,COVID-19, in Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04669938 |
| NCT04669925 | COVID-19 Impact on the Lombardy Region’s Emergency System | https://ClinicalTrials.gov/show/NCT04669925 |
| NCT04669912 | COVID-19 Pandemic Lockdown Effect in Adolescents and Young Adults With Type 1 Diabetes: Positive Results of an Unpreceded Challenge for Telemedicine and Patient Self-management | https://ClinicalTrials.gov/show/NCT04669912 |
| NCT04668937 | Conséquences of the COVID-19 Lockdown Measures on the CHRU Nancy Pediatric Emergency Services | https://ClinicalTrials.gov/show/NCT04668937 |
| NCT04668911 | Oral Health, Microbial Burden and COVID-19 | https://ClinicalTrials.gov/show/NCT04668911 |
| NCT04668196 | Noninvasive Respiratory Support in COVID-19 (CATCOVID-AIR) | https://ClinicalTrials.gov/show/NCT04668196 |
| NCT04668170 | Predictive Immune Biomarkers of COVID-19 Pathogenesis to Influence Therapeutic Management | https://ClinicalTrials.gov/show/NCT04668170 |
| NCT04667936 | Evaluation of Sedation in COVID-19 ARDS | https://ClinicalTrials.gov/show/NCT04667936 |
| NCT04667923 | Noninvasive Ventilation in Moderate-to-severe COVID-19-associated Acute Respiratory Distress-syndrome | https://ClinicalTrials.gov/show/NCT04667923 |
| NCT04667442 | Investigational Performance Evaluation of the Nanomix eLab® COVID-19 Rapid Antigen Panel With Samples From COVID-19 Positive and Negative Human Subjects | https://ClinicalTrials.gov/show/NCT04667442 |
| NCT04667962 | Impact of the Change in Hospital Service of Caregivers During COVID-19 Health Crisis on Operational Strain | https://ClinicalTrials.gov/show/NCT04667962 |
| NCT04666753 | Retrospective Study of ImmunoFormulation for COVID-19 | https://ClinicalTrials.gov/show/NCT04666753 |
| NCT04666285 | Southampton Women’s Survey COVID-19 Study | https://ClinicalTrials.gov/show/NCT04666285 |
| NCT04666207 | Viral Shedding, Symptoms and Exposure of SARS-CoV-2 in Non-hospitalized Children With COVID-19 | https://ClinicalTrials.gov/show/NCT04666207 |
| NCT04666064 | Validation of COVILUS Score in Patients Suspected of COVID-19 Infection in the Emergency Room | https://ClinicalTrials.gov/show/NCT04666064 |
| NCT04665258 | COVID-19 Vaccine and Impact on Fertility Study | https://ClinicalTrials.gov/show/NCT04665258 |
| NCT04666025 | SARS-CoV-2 Donor-Recipient Immunity Transfer | https://ClinicalTrials.gov/show/NCT04666025 |
| NCT04665960 | Infection Control for Severe Acute Respiratory Syndrome Coronavirus 2 | https://ClinicalTrials.gov/show/NCT04665960 |
| NCT04665752 | Ocular Findings and Viral Persistence in Ocular Fluids in COVID-19 Survivors | https://ClinicalTrials.gov/show/NCT04665752 |
| NCT04665245 | Symptom-Based Markers for COVID-19 Transmission | https://ClinicalTrials.gov/show/NCT04665245 |
| NCT04664296 | COVID-19 - SARS-CoV-2 Community Contamination in Children and Adults (Dyn3CEA_Nosocor) | https://ClinicalTrials.gov/show/NCT04664296 |
| NCT04664075 | Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19) | https://ClinicalTrials.gov/show/NCT04664075 |
| NCT04664049 | The Outcomes of NRICM101 on SARS-COV-2 (COVID-19) Infection | https://ClinicalTrials.gov/show/NCT04664049 |
| NCT04663659 | The Effect of Diabetes Mellitus on Mortality of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04663659 |
| NCT04664023 | Description of Immunologic, Enzymatic and Metabolic Biomarkers Associated to the Severity of COVID-19 (SARS-CoV-2) and Its Resolution | https://ClinicalTrials.gov/show/NCT04664023 |
| NCT04662437 | The Status of Parathyroid Hormone Secretion in Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04662437 |
| NCT04659889 | Clinical and Haematological Phenotypes in Long COVID | https://ClinicalTrials.gov/show/NCT04659889 |
| NCT04661462 | Health After Covid-19 in Tyrol | https://ClinicalTrials.gov/show/NCT04661462 |
| NCT04659876 | Factors Affecting Mortality in Critical Patients Admitted to Intensive Care Unit Due to COVID 19 | https://ClinicalTrials.gov/show/NCT04659876 |
| NCT04659759 | COVID-19 Pregnancy Related Immunological, Clinical and Epidemiological Factors and Perinatal Outcomes | https://ClinicalTrials.gov/show/NCT04659759 |
| NCT04659356 | NOSOcomial COVID-19 in ICU (NOSOCOVID) | https://ClinicalTrials.gov/show/NCT04659356 |
| NCT04659252 | CORONADO (Circulating tumOur pROtein quaNtification cApillary blooD cOvid-19) | https://ClinicalTrials.gov/show/NCT04659252 |
| NCT04659200 | Thyroid Function Tests and Status of Thyroid Autoantibodies in Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04659200 |
| NCT04659187 | CORONA Germany- Clinical Outcome and Risk in Hospitalized COVID-19 Patients - An Epidemiological Study From Germany | https://ClinicalTrials.gov/show/NCT04659187 |
| NCT04658121 | SARS-CoV-2/COVID-19 Prevalence Study | https://ClinicalTrials.gov/show/NCT04658121 |
| NCT04657419 | Fatigue and Sleep in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04657419 |
| NCT04657510 | Femoral frACturEs and COVID-19. | https://ClinicalTrials.gov/show/NCT04657510 |
| NCT04657445 | EFFECT OF COVID-19 DISEASE IN SMELL AND TASTE OF PATIENTS WITH MILD, MODERATE OR SEVERE SYMPTOMATOLOGY | https://ClinicalTrials.gov/show/NCT04657445 |
| NCT04655612 | Seroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic Diseases | https://ClinicalTrials.gov/show/NCT04655612 |
| NCT04655521 | Dynamics of the Immune Response to COVID-19 / Infection by SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04655521 |
| NCT04653857 | Cardiac Assessment After Covid-19 Disease in Elite Altheltic Population | https://ClinicalTrials.gov/show/NCT04653857 |
| NCT04654442 | Feasibility and Analytic Performance of TestNPass (IVDMD) for CoViD-19 Diagnosis on Saliva Sample | https://ClinicalTrials.gov/show/NCT04654442 |
| NCT04654416 | Clinical Outcome of Patients With COVID-19 Pneumonia Treated With Corticosteroids and Colchicine | https://ClinicalTrials.gov/show/NCT04654416 |
| NCT04653844 | RT-PCR Database Analysis for COVID-19 Infections and Re-infection | https://ClinicalTrials.gov/show/NCT04653844 |
| NCT04653727 | Effects of Integrative Medicine on Infectious Respiratory Diseases Including COVID-19 | https://ClinicalTrials.gov/show/NCT04653727 |
| NCT04652505 | Effect of the COVID-19 Public Health Crisis on the Mental Health and Physical Well-Being of Cancer Patients, the Coping With COVID Study | https://ClinicalTrials.gov/show/NCT04652505 |
| NCT04651400 | Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04651400 |
| NCT04650178 | Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials | https://ClinicalTrials.gov/show/NCT04650178 |
| NCT04651413 | PCR Cycle Threshold Values and COVID-19 Outcomes | https://ClinicalTrials.gov/show/NCT04651413 |
| NCT04650035 | The Impact of COVID-19 on Surgical Practice in Jordan During the Second Outbreak | https://ClinicalTrials.gov/show/NCT04650035 |
| NCT04649996 | Variation in Acute Appendicitis During COVID-19 Pandemic in Italy | https://ClinicalTrials.gov/show/NCT04649996 |
| NCT04649931 | Differences in Exhaled Breath by Using Ion Mobility Spectrometry (IMS) in Subjects Tested for SARS-CoV-2 Infection (COVID-19 Disease) | https://ClinicalTrials.gov/show/NCT04649931 |
| NCT04649918 | Short and Medium-term Effects of Pulmonary Rehabilitation in Mild to Critical Post-acute COVID-19 | https://ClinicalTrials.gov/show/NCT04649918 |
| NCT04649840 | Estimation of Dynamics of Humoral and Cellular Immunity in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04649840 |
| NCT04649827 | A Clinical Trial for Hospitalized Patients With COVID-19 in Ceará: ResCOVID Study | https://ClinicalTrials.gov/show/NCT04649827 |
| NCT04649658 | Pronation in COVID-19 Patients Undergoing Non Invasive Respiratory Support | https://ClinicalTrials.gov/show/NCT04649658 |
| NCT04649333 | COVID-19 and Sports - an Online Survey on the Impact of the Pandemic and Possible Preventive Measures | https://ClinicalTrials.gov/show/NCT04649333 |
| NCT04649320 | Perception of the COVID-19 Pandemic in Patients With Haematological or Solid Neoplasias | https://ClinicalTrials.gov/show/NCT04649320 |
| NCT04648709 | Evaluation and Longitudinal Follow-up of Biomarkers Predictive of Severe Forms of COVID-19 | https://ClinicalTrials.gov/show/NCT04648709 |
| NCT04648410 | Corticosteroids in Severe COVID-19(ASAP-C Study) | https://ClinicalTrials.gov/show/NCT04648410 |
| NCT04647994 | Exploratory Study: COVID-19 and Pregnancy | https://ClinicalTrials.gov/show/NCT04647994 |
| NCT04647682 | Physical Activity Program Implementation in Hospitalized Positive Covid-19 Older Adults | https://ClinicalTrials.gov/show/NCT04647682 |
| NCT04645433 | Effect of Favipiravir on Mortality in Patients With COVID-19 at a Tertiary Center Intensive Care Unit | https://ClinicalTrials.gov/show/NCT04645433 |
| NCT04646642 | Psychological Health, Coping Strategies and Preferences of Military COVID-19 Deployers | https://ClinicalTrials.gov/show/NCT04646642 |
| NCT04645563 | Using Whatsapp for the Consultation | https://ClinicalTrials.gov/show/NCT04645563 |
| NCT04646525 | The Relationship Between Covid-19 Infection in Pediatric Patients and Secondary Lymphoid Organs | https://ClinicalTrials.gov/show/NCT04646525 |
| NCT04645368 | Study of Longidaze in the Prevention & Treatment of Pulmonary Fibrosis, Interstitial Lung Diseases Caused by COVID-19 | https://ClinicalTrials.gov/show/NCT04645368 |
| NCT04644159 | Longitudinal Follow-up of a Population Cohort in a French City With High SARS-CoV-2 Circulation, in Early 2020 [COVID-19] | https://ClinicalTrials.gov/show/NCT04644159 |
| NCT04644146 | Genetic Predisposition to Severe Forms of COVID-19 (SARS-CoV2 Infection) | https://ClinicalTrials.gov/show/NCT04644146 |
| NCT04644341 | Tele-monitoring of COVID-19 Survivors for Long-Term Impacts | https://ClinicalTrials.gov/show/NCT04644341 |
| NCT04644302 | Circulatory Coherence in COVID-19 and Non-COVID-19 Patients With Sepsis | https://ClinicalTrials.gov/show/NCT04644302 |
| NCT04643860 | Differential Leucocyte Count and Covid-19 Diagnosis | https://ClinicalTrials.gov/show/NCT04643860 |
| NCT04643548 | WHO Covid 19 - Neurological Abnormalities in SARS-CoV-2 ICU Patients | https://ClinicalTrials.gov/show/NCT04643548 |
| NCT04643522 | Semen Parameters and COVID-19 in Infertile Men | https://ClinicalTrials.gov/show/NCT04643522 |
| NCT04642196 | COVID-19 in Home Healthcare | https://ClinicalTrials.gov/show/NCT04642196 |
| NCT04642703 | Mortality in Patients With Severe COVID-19 Pneumonia Who Underwent Tracheostomy | https://ClinicalTrials.gov/show/NCT04642703 |
| NCT04643444 | Police COVID-19 Serosurvey | https://ClinicalTrials.gov/show/NCT04643444 |
| NCT04641988 | Cardiac Biomarkers and Mortality in Critically Ill Patients With SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04641988 |
| NCT04640428 | COVID-19 Stroke Apical Lung Examination Study | https://ClinicalTrials.gov/show/NCT04640428 |
| NCT04639427 | Benefits of Using a Transparent Visor to Replace the Face Mask in Speech Therapy Rehabilitation of Oral-Linguo-Facial Praxies in the Context of COVID-19: a Series of Cases | https://ClinicalTrials.gov/show/NCT04639427 |
| NCT04637295 | Perceptions, Experiences, and Activity in CancEr Survivors During COVID-19 | https://ClinicalTrials.gov/show/NCT04637295 |
| NCT04636203 | Burden of COVID-19 Infection in Populations With High or Low Risk of Infection | https://ClinicalTrials.gov/show/NCT04636203 |
| NCT04636294 | Borderline COVID-19 PCR Test Result | https://ClinicalTrials.gov/show/NCT04636294 |
| NCT04635813 | The Impact of COVID-19 Pandemic on Thyroid Surgery in Italy: Results From a Nation-wide Multicentric Study | https://ClinicalTrials.gov/show/NCT04635813 |
| NCT04635787 | Vital Sensor Monitors for CV19 Detection | https://ClinicalTrials.gov/show/NCT04635787 |
| NCT04633941 | Impact of Social Distancing on Bariatric Versus Non-Surgical Obese Patients During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04633941 |
| NCT04633915 | Antibody Response in Hemodialysis and Non-dialysis Patients Diagnosed With COVID-19. | https://ClinicalTrials.gov/show/NCT04633915 |
| NCT04632615 | Sleep Behaviour in Athletes During Home Confinement Due to the Covid-19 Outbreak | https://ClinicalTrials.gov/show/NCT04632615 |
| NCT04632173 | Head and Neck cancERs International cOviD-19 collabOraTion | https://ClinicalTrials.gov/show/NCT04632173 |
| NCT04631861 | Physical Activity and the Risk of COVID-19 Infection and Mortality | https://ClinicalTrials.gov/show/NCT04631861 |
| NCT04631497 | Assessment of Stress, Depression and Anxiety in Healthcare Caring for Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04631497 |
| NCT04629222 | Tracheobronchitis in Respiratory Involvement on the Lung SPECT/CT Images of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04629222 |
| NCT04630015 | Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth | https://ClinicalTrials.gov/show/NCT04630015 |
| NCT04629183 | Risk Stratification of COVID-19 Patients Discharged From the Emergency Department | https://ClinicalTrials.gov/show/NCT04629183 |
| NCT04629638 | Maternal Attachment and Depression Anxiety Score Evaluation in COVID-19 Positive Pregnant Women | https://ClinicalTrials.gov/show/NCT04629638 |
| NCT04628637 | High GRP78 Levels in Covid-19 Infection: A Case-Control Study | https://ClinicalTrials.gov/show/NCT04628637 |
| NCT04628208 | Clinical Study Spartan COVID-19 V2 System (Canada Alternate) | https://ClinicalTrials.gov/show/NCT04628208 |
| NCT04628195 | Cardiac Performance in Mechanically Ventilated COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04628195 |
| NCT04628000 | Baseline Vitamin D Deficiency and COVID-19 Disease Severity | https://ClinicalTrials.gov/show/NCT04628000 |
| NCT04627623 | Prevalence and Risk Factors of COVID-19 in the Upper Silesian Agglomeration | https://ClinicalTrials.gov/show/NCT04627623 |
| NCT04625296 | Behaviour and Experience of Communities Healthcare Professionals Facing the SARS CoV-2 (COVID-19) Epidemic | https://ClinicalTrials.gov/show/NCT04625296 |
| NCT04625257 | COVID-19 in Baselland: Validation of Simple and Accurate Tests for COVID-19 Detection, Monitoring and Tracing (ACCURATE-BL-COVID-19) | https://ClinicalTrials.gov/show/NCT04625257 |
| NCT04625075 | Manganese-Enhanced Magnetic Resonance Imaging of MyOcardial injuRY in COVID 19 (COVID-19) | https://ClinicalTrials.gov/show/NCT04625075 |
| NCT04627194 | Characteristics of COVID-19 Patients in Kazakhstan in Early 2020 | https://ClinicalTrials.gov/show/NCT04627194 |
| NCT04624997 | Coagulopathy and Vasculopathy Assessment as a Predictor of the Severity of SARS-CoV-2 / COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04624997 |
| NCT04624503 | Prognostic and Clinical Impact of Cardiovascular Involvement in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04624503 |
| NCT04623346 | Orthopaedic Conservative Treatment in the Time of Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04623346 |
| NCT04623177 | Thromboprophylaxis for Patients in ICU With COVID-19 | https://ClinicalTrials.gov/show/NCT04623177 |
| NCT04622748 | Neurocognitive Functions of Recovered COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04622748 |
| NCT04621084 | Influence of the COVId-19 Pandemic on STRESS and Eating Habits | https://ClinicalTrials.gov/show/NCT04621084 |
| NCT04621214 | Innovation of Audio-Visual Triage System in Combating the Spread of COVID-19 Infection and Its Efficacy: A Novel Strategy | https://ClinicalTrials.gov/show/NCT04621214 |
| NCT04619693 | Biomarkers for Dexamethasone Response in Sars-Cov-2 / COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04619693 |
| NCT04619576 | Influence of the COVId-19 Pandemic on STRESS of Occupational Health Workers | https://ClinicalTrials.gov/show/NCT04619576 |
| NCT04619407 | Screening for COVID-19 in Teachers, Childcare Educators, Pupils and Preschoolers | https://ClinicalTrials.gov/show/NCT04619407 |
| NCT04618861 | Surfactant Protein D Levels in Covid-19 Infection: Case-Control Study | https://ClinicalTrials.gov/show/NCT04618861 |
| NCT04618835 | Physical Activity a Vital Sign? 40 Steps to Safety Test for Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04618835 |
| NCT04618341 | A Clinical Study of Online Active Play Program With Adolescents | https://ClinicalTrials.gov/show/NCT04618341 |
| NCT04616976 | COVID-19 With Convalescent Plasma | https://ClinicalTrials.gov/show/NCT04616976 |
| NCT04616950 | Impact of the COVID-19 Epidemic on the Hospital Journey of Patients With Cancer of the Digestive System | https://ClinicalTrials.gov/show/NCT04616950 |
| NCT04615728 | MANAGEMENT OF APPENDICITIS DURING THE COVID-19 PANDEMIC | https://ClinicalTrials.gov/show/NCT04615728 |
| NCT04615390 | Recovery Profiles in Patients With SARS-CoV-2 Outcomes Undergoing Rehabilitation | https://ClinicalTrials.gov/show/NCT04615390 |
| NCT04615195 | Effect of COVID-9 Related COntainment in ChildreN | https://ClinicalTrials.gov/show/NCT04615195 |
| NCT04611243 | Lung Function, Exercise Capacity, and Serology Responses in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04611243 |
| NCT04611230 | A Study to Assess Infection Rate of Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2) and It’s Affect on Quality of Life in Adult Volunteers in Lake County, Illinois | https://ClinicalTrials.gov/show/NCT04611230 |
| NCT04611841 | Medical-biological Research of the Pathogenesis of COVID-19 Disease Caused by SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04611841 |
| NCT04610554 | Lung Diffusing Capacity for Nitric Oxide and Carbon Monoxide Early After Mild-to-severe COVID-19 | https://ClinicalTrials.gov/show/NCT04610554 |
| NCT04609774 | Aerosol Transmission of Severe Acute Respiratory Syndrome Coronavirus of Coronavirus Disease 2019 | https://ClinicalTrials.gov/show/NCT04609774 |
| NCT04609839 | FOLLOW-UP OF PATIENTS WITH COVID-19. | https://ClinicalTrials.gov/show/NCT04609839 |
| NCT04608383 | Laparoscopy and COVID-19 Contamination | https://ClinicalTrials.gov/show/NCT04608383 |
| NCT04607941 | Study of Socio-demographic Factors, Behaviors and Practices Associated With Infection With SARS-CoV-2 Responsible for COVID-19 | https://ClinicalTrials.gov/show/NCT04607941 |
| NCT04606498 | Blood Purification With Seraph 100 Microbind Affinity Blood Filter for Treatment of Severe COVID19 Observational Study | https://ClinicalTrials.gov/show/NCT04606498 |
| NCT04605757 | Long-term Evolution of Pulmonary Involvement of Novel SARS-COV-2 Infection (COVID-19): Follow the Covid Study | https://ClinicalTrials.gov/show/NCT04605757 |
| NCT04605952 | Study to Find the Percentage of Cases Retaining COVID-19 IgG Antibodies 45-65 After They Have Tested Positive | https://ClinicalTrials.gov/show/NCT04605952 |
| NCT04605692 | Evaluation of Occupational Burnout and Stress Among Dentists in Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04605692 |
| NCT04605172 | Lockdown Impact on Spontaneous Premature Birth in a Level III NICU | https://ClinicalTrials.gov/show/NCT04605172 |
| NCT04604769 | Perceived Stress Among ICU Medical Staff During COVID-19 Crisis | https://ClinicalTrials.gov/show/NCT04604769 |
| NCT04604080 | Post-COVID-19 Epidemic Depression Assessment in Adults in South Punjab Pakistan | https://ClinicalTrials.gov/show/NCT04604080 |
| NCT04604249 | Prevalence of COVID-19 in High Altitude : Insights From the Highest City of the World | https://ClinicalTrials.gov/show/NCT04604249 |
| NCT04603755 | Electrical Impedance Tomography: Collapse in Dependent Areas as a Predictor of Response to Prone Position Ventilation in COVID-19 Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04603755 |
| NCT04603677 | Northern Colorado COVID-19 Biobank | https://ClinicalTrials.gov/show/NCT04603677 |
| NCT04603664 | Role of NGAL and Cystatin C in Prediction of Acute Kidney Injury Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04603664 |
| NCT04602351 | Communication in ICU During COVID-19 | https://ClinicalTrials.gov/show/NCT04602351 |
| NCT04602481 | COVID-19 in People With Primary Ciliary Dyskinesia | https://ClinicalTrials.gov/show/NCT04602481 |
| NCT04602637 | Training Load Management in Three Professional Tennis Players During COVID-19 Lockdown: a Case Series Study | https://ClinicalTrials.gov/show/NCT04602637 |
| NCT04602260 | Functional Recovery of Hospitalised Patients With COVID-19: The COREG Extension Study | https://ClinicalTrials.gov/show/NCT04602260 |
| NCT04601415 | Point of Care Artificial Intelligence Tool for Heart Failure Diagnosis | https://ClinicalTrials.gov/show/NCT04601415 |
| NCT04601012 | OCTA Study: Retinal Vascular Changes in Patients With SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04601012 |
| NCT04599998 | Long-term Follow-up Findings of Inpatients for COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04599998 |
| NCT04598620 | Non-invasive Prognostication of COVID-19 Patients by Use of Biomarkers in Exhaled Breath Condensate | https://ClinicalTrials.gov/show/NCT04598620 |
| NCT04597853 | Assessment of Lung Mechanics in COVID-19 Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04597853 |
| NCT04596098 | Immune Responses to COVID-19; Isolation of Neutralizing Antibodies for Therapeutics and Vaccine. | https://ClinicalTrials.gov/show/NCT04596098 |
| NCT04596943 | RGD PET/CT Imaging in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04596943 |
| NCT04595240 | Semen Analysis Changes in Covid-19 Positivepatients | https://ClinicalTrials.gov/show/NCT04595240 |
| NCT04595123 | Impact of COVID-19 Pandemic in Perinatal Mental Health (RISEUP-PPD-COVID-19) | https://ClinicalTrials.gov/show/NCT04595123 |
| NCT04595110 | Hemostatic Profile in Patients Affected by COVID-19 | https://ClinicalTrials.gov/show/NCT04595110 |
| NCT04594356 | Assessment of Netosis During COVID-19, Under Treatment With Anakinra, an Interleukin-1 Receptor Antagonist | https://ClinicalTrials.gov/show/NCT04594356 |
| NCT04594291 | MRI Changes of Acute Kidney Injury in COVID-19 | https://ClinicalTrials.gov/show/NCT04594291 |
| NCT04593654 | Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04593654 |
| NCT04592510 | Impact of COVID-19 on Pediatric Dental Practice During First, Second And Third Wave. | https://ClinicalTrials.gov/show/NCT04592510 |
| NCT04592055 | The Effect of COVID-19 on Diabetes Mellitus | https://ClinicalTrials.gov/show/NCT04592055 |
| NCT04591704 | The Effect of Diabetes Mellitus on the Prognosis of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04591704 |
| NCT04590378 | Pulmonary Embolism and COVID-19 | https://ClinicalTrials.gov/show/NCT04590378 |
| NCT04590352 | Mucosal Immunity Against SARS-CoV-2 Infection in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04590352 |
| NCT04590170 | French Cohort of COVID-19 Patients With Post-intensive Care Syndrome | https://ClinicalTrials.gov/show/NCT04590170 |
| NCT04588909 | Outcomes of Elective Colorectal Cancer Surgery During COVID 19 Pandemic: Implications for Cancer Care Policy | https://ClinicalTrials.gov/show/NCT04588909 |
| NCT04588363 | COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C | https://ClinicalTrials.gov/show/NCT04588363 |
| NCT04586413 | Post Acute COVID-19 Quality of Life (PAC-19QoL) Tool Development and Patient Registry (PAC-19QoLReg) | https://ClinicalTrials.gov/show/NCT04586413 |
| NCT04587375 | Diagnosis of Endocrine Dysfunctions in Covid-19 | https://ClinicalTrials.gov/show/NCT04587375 |
| NCT04587323 | VEGF and sFlt-1 Levels in the Pathogenesis and Severity of COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04587323 |
| NCT04587258 | Improving Cancer Screening and Prevention During the COVID-19 Pandemic in Underserved Populations of Rhode Island | https://ClinicalTrials.gov/show/NCT04587258 |
| NCT04586140 | Operation of the GHPSJ Clinical Ethical Reflection Assistance Group During the COVID-19 Period | https://ClinicalTrials.gov/show/NCT04586140 |
| NCT04586114 | Effect of Corticosteroid Treatment on Prognosis in ARDS Secondary to Covid-19 | https://ClinicalTrials.gov/show/NCT04586114 |
| NCT04585945 | COVID-19 on Placental Gene Expression and Pathology | https://ClinicalTrials.gov/show/NCT04585945 |
| NCT04584606 | Ain Shams University Experience: Clinical Determinants of Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04584606 |
| NCT04584450 | Investigation of Validity and Reliability of Post-COVID-19 Functional Status Scale | https://ClinicalTrials.gov/show/NCT04584450 |
| NCT04584658 | Dysphagia and Dysphonia Outcomes in SARS CoV-2 (COVID-19) Infection (DYADS Study) | https://ClinicalTrials.gov/show/NCT04584658 |
| NCT04583982 | ImmuneSenseâ„¢ COVID-19 Study | https://ClinicalTrials.gov/show/NCT04583982 |
| NCT04583865 | Feasibility and Quality of TeleConsultation in Pediatric Anesthesia | https://ClinicalTrials.gov/show/NCT04583865 |
| NCT04583761 | Tobacco and Nicotine Consumption and the Risk of Acquisition of Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04583761 |
| NCT04583319 | Validation of a Rapid, Non-invasive Point-of-care IVD Test for Diagnosis of SARS-COV-2 (COVID-19) Infection | https://ClinicalTrials.gov/show/NCT04583319 |
| NCT04583345 | Physical Activity Levels of Hypertensive and Healthy Individuals Under Social Isolation During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04583345 |
| NCT04583293 | Acute kIDnEy Injury in coviD-19 | https://ClinicalTrials.gov/show/NCT04583293 |
| NCT04582903 | Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence | https://ClinicalTrials.gov/show/NCT04582903 |
| NCT04582331 | Improving Real-time COVID-19 Monitoring Through Smartphone Voice Analysis | https://ClinicalTrials.gov/show/NCT04582331 |
| NCT04581928 | Patients Reactions Towards Their Diagnosis as Having COVID-19 | https://ClinicalTrials.gov/show/NCT04581928 |
| NCT04581889 | Prevalence of Antibodies Against SARS-CoV-2 Virus That Causes COVID-19 in Tübingen Children | https://ClinicalTrials.gov/show/NCT04581889 |
| NCT04581577 | Perceptions of the Clinical and Psychosocial Impact of Covid-19 in Patients With Neuromuscular and Neurological Disorders | https://ClinicalTrials.gov/show/NCT04581577 |
| NCT04581083 | Validation of Laboratory Techniques, Strategies, and Types of Samples for Epidemiological Control in the Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04581083 |
| NCT04581070 | The COVID-IYON Study - Study Examining Data Pertaining to Clinical Outcomes and Organisational Responses to the 2020 SARS-CoV-2 Pandemic" | https://ClinicalTrials.gov/show/NCT04581070 |
| NCT04581044 | Impact of COVID-19 on Psoriasis Practice | https://ClinicalTrials.gov/show/NCT04581044 |
| NCT04579627 | Facial Hair, PPE and COVID-19 | https://ClinicalTrials.gov/show/NCT04579627 |
| NCT04579588 | Understanding Immunity to the Flu Vaccine in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04579588 |
| NCT04579289 | Managerial and Environmental Risk for COVID 19 in French Long Term Care Institutions | https://ClinicalTrials.gov/show/NCT04579289 |
| NCT04579471 | Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study | https://ClinicalTrials.gov/show/NCT04579471 |
| NCT04578509 | Evaluation of a Screening Program for SARS-CoV-2 Infection in the General Population Based on the Use of New Detection Approaches or for Diagnostic Orientation on Saliva | https://ClinicalTrials.gov/show/NCT04578509 |
| NCT04578132 | Description of the Population With Genitourinary Tumors and COVID-19 | https://ClinicalTrials.gov/show/NCT04578132 |
| NCT04578197 | NeuroCovid - a Study of Intensive Care-requiring Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04578197 |
| NCT04577105 | Risk Factors and Computed Tomography Findings in COVID-19. | https://ClinicalTrials.gov/show/NCT04577105 |
| NCT04576351 | The Norwegian Study of Nervous System Manifestations and Sequelae After COVID-19 | https://ClinicalTrials.gov/show/NCT04576351 |
| NCT04576299 | Health Care Workers’ Perception of Patient Safety During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04576299 |
| NCT04575571 | MAVIPAN: My Life and the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04575571 |
| NCT04575532 | Detection of COVID-19 Decompensation | https://ClinicalTrials.gov/show/NCT04575532 |
| NCT04575168 | Clinical Study Spartan COVID-19 V2 System | https://ClinicalTrials.gov/show/NCT04575168 |
| NCT04573634 | A Registry Study of COVID-19 Serologic and Virologic Testing to Accelerate Recovery and Transition | https://ClinicalTrials.gov/show/NCT04573634 |
| NCT04573335 | Diabetes Outcomes in COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04573335 |
| NCT04573062 | Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health | https://ClinicalTrials.gov/show/NCT04573062 |
| NCT04569292 | COVID-19 Infection in Cancer Pantients | https://ClinicalTrials.gov/show/NCT04569292 |
| NCT04572438 | A Cohort Study of Mechanically Ventilated COVID-19 Patients Undergoing Tracheostomy | https://ClinicalTrials.gov/show/NCT04572438 |
| NCT04570982 | Clinical Protocol for Convalescent Plasma and Remdesivir Therapy in Nepal | https://ClinicalTrials.gov/show/NCT04570982 |
| NCT04570189 | Evaluating Auscul-X, a Touch Free Digital Stethoscope | https://ClinicalTrials.gov/show/NCT04570189 |
| NCT04569851 | Clinical Characteristics and Prognostic Factors of Patients With COVID-19 (Coronavirus Disease 2019) | https://ClinicalTrials.gov/show/NCT04569851 |
| NCT04569344 | COVID-19 and Venous Thromboembolism Risk | https://ClinicalTrials.gov/show/NCT04569344 |
| NCT04568499 | Presenting Nutrition Characteristics, Comorbidities and Outcomes of COVID-19 in African Humanitarian Settings | https://ClinicalTrials.gov/show/NCT04568499 |
| NCT04568018 | Surfactant-BL in Adult Acute Respiratory Distress Syndrome Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04568018 |
| NCT04567979 | Prospective Determination of COVID-19 Infection Rate in a Chemotherapy Unit in Mexico. | https://ClinicalTrials.gov/show/NCT04567979 |
| NCT04567927 | Prevalence and Risk Factors for Venous Thromboembolic Events in Critically Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04567927 |
| NCT04568850 | Waxing and Waning of Serum SARS CoV-2-IgG Level in COVID-19 Exposed Population | https://ClinicalTrials.gov/show/NCT04568850 |
| NCT04568655 | The Noninvasive Ventilation to COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04568655 |
| NCT04568551 | COVID-19-associated Anxiety of Pregnant Women for Anomalies, Stillbirth and Preterm Labor | https://ClinicalTrials.gov/show/NCT04568551 |
| NCT04568148 | COVID-19 Biorepository | https://ClinicalTrials.gov/show/NCT04568148 |
| NCT04568044 | Evaluation of Humoral Immunity Following COVID-19 in Pregnancy | https://ClinicalTrials.gov/show/NCT04568044 |
| NCT04567836 | Screening of Health-care Workers in an University Hospital for SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04567836 |
| NCT04566965 | Serology to Covid for Recording Exposures and Evaluating Needs | https://ClinicalTrials.gov/show/NCT04566965 |
| NCT04565522 | Transmission of COVID-19 Virus Among Patients and Staff in Dialysis Centers | https://ClinicalTrials.gov/show/NCT04565522 |
| NCT04565782 | Corona Virus Infection Among Liver Transplant Recipients | https://ClinicalTrials.gov/show/NCT04565782 |
| NCT04565106 | Automatic Oxygen Titration With O2matic® to Patients Admitted With COVID-19 and Hypoxemic Respiratory Failure | https://ClinicalTrials.gov/show/NCT04565106 |
| NCT04565080 | Clinical Correlates of COVID-19 Pandemic in Patients With Functional Movement Disorder (FMD) and Parkinson’s Disease (PD) | https://ClinicalTrials.gov/show/NCT04565080 |
| NCT04565067 | Identification and Characterization of SARS-CoV-2 Specific CD8 T Cells in Humans | https://ClinicalTrials.gov/show/NCT04565067 |
| NCT04564287 | An Observational Study of Neurologic Function After COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04564287 |
| NCT04564274 | COV2Base-A Rare Disease by COVID Study | https://ClinicalTrials.gov/show/NCT04564274 |
| NCT04563247 | Seroprevalence of SARS-CoV-2 in Asymptomatic Frontline COVID-19 HCWs | https://ClinicalTrials.gov/show/NCT04563247 |
| NCT04563156 | Follow-up and Rehabilitation of Survivors of Severe Coronavirus Disease 2019 (COVID-19) Infection | https://ClinicalTrials.gov/show/NCT04563156 |
| NCT04561102 | Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From a COVID-19 Asymptomatic Population | https://ClinicalTrials.gov/show/NCT04561102 |
| NCT04561089 | Evaluation of the COVIDSeq Test in Saliva Specimens From COVID-19 Asymptomatic Illumina Personnel | https://ClinicalTrials.gov/show/NCT04561089 |
| NCT04562285 | Sustained Immunity to COVID-19 as Measured by SARS-CoV-2 Serology Assays | https://ClinicalTrials.gov/show/NCT04562285 |
| NCT04562246 | SARS-CoV-2 IgG and IgM Serologic Assays | https://ClinicalTrials.gov/show/NCT04562246 |
| NCT04561193 | Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04561193 |
| NCT04561024 | Evaluation of a COVID-19 Pneumonia CXR AI Detection Algorithm | https://ClinicalTrials.gov/show/NCT04561024 |
| NCT04560530 | The Role of CT Chest Scan in the Pre-anesthetic Assessment of Suspected or Confirmed COVID -19 Patients | https://ClinicalTrials.gov/show/NCT04560530 |
| NCT04560855 | Secure Self-monitoring Through a Combination of Connected Objects: Implementation in COVID-19 Patients Monitored at Home | https://ClinicalTrials.gov/show/NCT04560855 |
| NCT04559542 | Body Weight Regulation, Disordered Eating Behaviour, and Experiences of Sexual Harassment in Female Martial Art Athletes | https://ClinicalTrials.gov/show/NCT04559542 |
| NCT04560413 | Depression, Anxiety and SARS-CoV-2 (Covid-19) Phobia in Post-stroke Patients | https://ClinicalTrials.gov/show/NCT04560413 |
| NCT04558749 | Anxiety and Depression Among Pregnant Women During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04558749 |
| NCT04559100 | Long-term Characterization of Patients With Severe/Critical Infection by COVID-19 Virus | https://ClinicalTrials.gov/show/NCT04559100 |
| NCT04558645 | Evaluation of Quality of Life in Patients With Type 1 Diabetes Mellitus During the Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04558645 |
| NCT04558320 | COVID-19 and Lactating Mothers | https://ClinicalTrials.gov/show/NCT04558320 |
| NCT04558307 | Feasibility of Rapid COVID-19 Testing in Disadvantaged Populations | https://ClinicalTrials.gov/show/NCT04558307 |
| NCT04558437 | COVID-Impact “Psychological IMPACT of Covid-19 on AP-HP Staff” | https://ClinicalTrials.gov/show/NCT04558437 |
| NCT04558385 | Seroconversion in COVID-19 Recovered Population | https://ClinicalTrials.gov/show/NCT04558385 |
| NCT04557358 | Impact in the Medical Care Among the Rheumatic Diseases Patients in a Tertiary Hospital in México During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04557358 |
| NCT04556604 | Surgical Consent During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04556604 |
| NCT04556565 | MIND/COVID-19: Mental Health Impact and NeeDs Associated With COVID-19: a Comprehensive National Evaluation in Spain | https://ClinicalTrials.gov/show/NCT04556565 |
| NCT04556513 | Functional Recovery From Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: Influence of Socio-Economic Status | https://ClinicalTrials.gov/show/NCT04556513 |
| NCT04556149 | imPulseâ„¢ Una Full-spectrum, Over Clothing E-stethoscope | https://ClinicalTrials.gov/show/NCT04556149 |
| NCT04555954 | Determining the Physical Activity Level of Healthy Adults During Pandemic | https://ClinicalTrials.gov/show/NCT04555954 |
| NCT04556318 | Identification of Differences in Breath Components Detected With IMS in Patients Tested on SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04556318 |
| NCT04555109 | Convalescent Plasma for COVID-19 Research Donor Study | https://ClinicalTrials.gov/show/NCT04555109 |
| NCT04555187 | Cardiovascular Risk Stratification in Covid-19 | https://ClinicalTrials.gov/show/NCT04555187 |
| NCT04554979 | COVID-19 Disease Duration and GIT Manifestations. A New Disease Severity Classification. An Egyptian Experience | https://ClinicalTrials.gov/show/NCT04554979 |
| NCT04554251 | Global Impact of COVID-19 on Pulmonology Special Units | https://ClinicalTrials.gov/show/NCT04554251 |
| NCT04552340 | Epidemiologic, Clinical and Molecular Characteristics of Patients With Acute Respiratory Failure Affected by 2019-NCOV. | https://ClinicalTrials.gov/show/NCT04552340 |
| NCT04551690 | Prevalence of COVID-19 (Coronavirus Disease 19) in Pregnant Women on Labor in a Public Hospital in Chile (COroNavirus diSease Covid-19 pandEmic iN ChilE) | https://ClinicalTrials.gov/show/NCT04551690 |
| NCT04551378 | The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors | https://ClinicalTrials.gov/show/NCT04551378 |
| NCT04550312 | The Impact of Lifestyle Changes on Non-COVID Deaths | https://ClinicalTrials.gov/show/NCT04550312 |
| NCT04550403 | Clinical Phenotype and Outcomes of Inpatients With COVID-19 and Diabetes | https://ClinicalTrials.gov/show/NCT04550403 |
| NCT04550390 | Study of the Analytical Performance of Different Salivary Self-collection Methods for the Detection of COVID-19 | https://ClinicalTrials.gov/show/NCT04550390 |
| NCT04549831 | Genetic Bases of COVID-19 Clinical Variability | https://ClinicalTrials.gov/show/NCT04549831 |
| NCT04549636 | COVID-19 Related Lung Ventilation and Perfusion Injury | https://ClinicalTrials.gov/show/NCT04549636 |
| NCT04549350 | Sleep Quality Among HCWs | https://ClinicalTrials.gov/show/NCT04549350 |
| NCT04548908 | Prevalence Of COVID-19 Among Health-workers in a French General Hospital | https://ClinicalTrials.gov/show/NCT04548908 |
| NCT04548895 | Non-invasive Biometric Monitoring in Nursing Homes to Fight COVID-19 | https://ClinicalTrials.gov/show/NCT04548895 |
| NCT04548505 | Recovery of Exertion Ability Following COVID-19 Infection in Military Staff | https://ClinicalTrials.gov/show/NCT04548505 |
| NCT04547218 | Study on Incidence of Elective Surgery Postponed During COVID-19 Pandemic in Geriatric Population | https://ClinicalTrials.gov/show/NCT04547218 |
| NCT04547114 | Breath Analysis for SARS-CoV-2 in Infected and Healthy Subjects | https://ClinicalTrials.gov/show/NCT04547114 |
| NCT04546776 | COVID-19 Persistence in Stool | https://ClinicalTrials.gov/show/NCT04546776 |
| NCT04545047 | Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19 | https://ClinicalTrials.gov/show/NCT04545047 |
| NCT04544033 | IL- 6 Gene (174G/C) Single Nucleotide Polymorphism as an Indicator of COVID-19 Severity in Egyptian Patients | https://ClinicalTrials.gov/show/NCT04544033 |
| NCT04544605 | Special Chinese Medicine Out-patient Programme for Discharged COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04544605 |
| NCT04544072 | Analysis of the Quality and Quantity of Antibiotic Prescriptions for Bacterial Respiratory Tract Superinfection in Patients Hospitalized in COVID-19 Wards | https://ClinicalTrials.gov/show/NCT04544072 |
| NCT04544176 | COVID-19 Risk From Attending Outpatient Radiology Appointments | https://ClinicalTrials.gov/show/NCT04544176 |
| NCT04544150 | Gastrointestinal Manifestations Among Patients With COVID19 | https://ClinicalTrials.gov/show/NCT04544150 |
| NCT04542915 | COVID-19-Related Health and Practices Among Dental Hygienists | https://ClinicalTrials.gov/show/NCT04542915 |
| NCT04542044 | Evaluation of the Safety and Outcomes of Outpatient Management With Mild to Moderate COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04542044 |
| NCT04542226 | Observational Open Study of Polyoxidonium in Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04542226 |
| NCT04542200 | Workforce Serosurveillance to Track Long-term Modifications to COVID-19 Exposure Due to Factors in the Built Environment | https://ClinicalTrials.gov/show/NCT04542200 |
| NCT04541472 | Influence of the COVId-19 Pandemic on the STRESS of Dental Surgeons (COVISTRESS - Dental Surgery) | https://ClinicalTrials.gov/show/NCT04541472 |
| NCT04540484 | COVID-19 IgG Formation in Physicians at ALGH and Their Household Members | https://ClinicalTrials.gov/show/NCT04540484 |
| NCT04539834 | Electrolyte State in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04539834 |
| NCT04540029 | Measuring Outcomes of Maternal COVID-19-related Prenatal Exposure | https://ClinicalTrials.gov/show/NCT04540029 |
| NCT04538586 | Influence of the COVId-19 Pandemic on STRESS, and Screening Procedures (COVISTRESS Screening) | https://ClinicalTrials.gov/show/NCT04538586 |
| NCT04538456 | Impact of COVID-19 on Lung Cancer Patients | https://ClinicalTrials.gov/show/NCT04538456 |
| NCT04537650 | Swallowing Impairment After COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04537650 |
| NCT04537559 | Impact of COVID-19 Outbreak on Non-COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04537559 |
| NCT04537117 | Knowledge, Attitudes and Clinical Practices of Pediatric Dentists Regarding Covid-19 | https://ClinicalTrials.gov/show/NCT04537117 |
| NCT04536285 | Hospitalized Children and Adolescent Patients With Type 1 Diabetes During the COVID-19 Pandemic in Egypt | https://ClinicalTrials.gov/show/NCT04536285 |
| NCT04535297 | Consequences of the COVID-19 Lockdown on Health and Well-being of Patients With Parkinson Disease and Post-stroke | https://ClinicalTrials.gov/show/NCT04535297 |
| NCT04535154 | Patient-reported Outcomes and Lung Function After Hospitalization for COVID-19 | https://ClinicalTrials.gov/show/NCT04535154 |
| NCT04534608 | COVID-19 Child Health Investigation of Latent Disease in Hamburg | https://ClinicalTrials.gov/show/NCT04534608 |
| NCT04534595 | Data Collection on the Model Schools Pediatric Health Initiative at 5 SBHC Sites: COVID-19 Questionnaire | https://ClinicalTrials.gov/show/NCT04534595 |
| NCT04534569 | Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF) | https://ClinicalTrials.gov/show/NCT04534569 |
| NCT04534400 | Automated Quantification of Radiologic Pulmonary Alteration During Acute Respiratory Failure | https://ClinicalTrials.gov/show/NCT04534400 |
| NCT04532411 | COVID-19 Testing Sample Acquisition Throughput and Efficiency | https://ClinicalTrials.gov/show/NCT04532411 |
| NCT04531111 | Glycemic Control Among Children and Adolescents With Type 1 Diabetes During COVID-19 Pandemic in Egypt | https://ClinicalTrials.gov/show/NCT04531111 |
| NCT04531735 | Respiratory Syncytial Virus Infection May be More Dangerous in Neonate | https://ClinicalTrials.gov/show/NCT04531735 |
| NCT04531345 | Cytokine Status of Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04531345 |
| NCT04531319 | Immune Cell Subgroups in Covid 19 Patients | https://ClinicalTrials.gov/show/NCT04531319 |
| NCT04531254 | Back to School COVID-19 Simulation Study | https://ClinicalTrials.gov/show/NCT04531254 |
| NCT04531501 | COVID-19 Saliva Test Research Study | https://ClinicalTrials.gov/show/NCT04531501 |
| NCT04530682 | COVID-19 in Rheumatic Inflammatory Diseases Under Immuno-suppressive Drugs | https://ClinicalTrials.gov/show/NCT04530682 |
| NCT04530500 | COVID-19 In-vitro Diagnostic Test and Androgen Receptor Gene Expression | https://ClinicalTrials.gov/show/NCT04530500 |
| NCT04530461 | Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases | https://ClinicalTrials.gov/show/NCT04530461 |
| NCT04529447 | Response of Korean Medicine Hospital to COVID-19 | https://ClinicalTrials.gov/show/NCT04529447 |
| NCT04529421 | Assocation Between In-person Instruction and COVID-19 Risk | https://ClinicalTrials.gov/show/NCT04529421 |
| NCT04529408 | EARSATS-19: In-ear Measurement of Blood Oxygen Saturation in COVID-19 Follow up | https://ClinicalTrials.gov/show/NCT04529408 |
| NCT04528901 | Study of seroPREvalence Vis-Ã -vis SARS-CoV2 and Correlation With Clinical Forms of COVID-19 in Patients Followed in Pneumology in the Cluster Area of the Grand-Est Region (Strasbourg University Hospital) | https://ClinicalTrials.gov/show/NCT04528901 |
| NCT04527601 | Extremely Premature Births During the Peak of the COVID-19 Pandemic: an International Study of the Active SafeBoosC III Departments | https://ClinicalTrials.gov/show/NCT04527601 |
| NCT04527497 | Clinical Course and Treatment of COVID-19 Inpatients in Hospital | https://ClinicalTrials.gov/show/NCT04527497 |
| NCT04527458 | Case Fatalities in Hospitalised COVID-19 Patients in the UK | https://ClinicalTrials.gov/show/NCT04527458 |
| NCT04526405 | Frequency of COVID-19 Antibodies in Patients With Hereditary Hematological Diseases | https://ClinicalTrials.gov/show/NCT04526405 |
| NCT04525911 | Assessment of Long-term Impact Post COVID-19 for Patients and Health Care Professionals of the European Hospital | https://ClinicalTrials.gov/show/NCT04525911 |
| NCT04525716 | The Effect of Covid-19 on Patient Outcomes Among Operated Patients | https://ClinicalTrials.gov/show/NCT04525716 |
| NCT04525287 | Prediction Models for Diagnosis and Prognosis of Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04525287 |
| NCT04525443 | Endothelial Function and COVID-19 | https://ClinicalTrials.gov/show/NCT04525443 |
| NCT04525404 | MOIST Study: Multi-Organ Imaging With Serial Testing in COVID-19 Infected Patients | https://ClinicalTrials.gov/show/NCT04525404 |
| NCT04524754 | Prevalence and Outcomes of Olfactory and Gustatory Dysfunctions in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04524754 |
| NCT04524234 | Cardiac Dysfunction in Critically Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04524234 |
| NCT04524520 | COVID19-OR (SARS-CoV-2): Observation,Risk & Recovery | https://ClinicalTrials.gov/show/NCT04524520 |
| NCT04523051 | Rehabilitation After Admission in Intensive Care Unit for COVID-19 | https://ClinicalTrials.gov/show/NCT04523051 |
| NCT04523012 | COVID-19 and HIV Patients | https://ClinicalTrials.gov/show/NCT04523012 |
| NCT04522310 | ProAdrenomedullin Assessment of Multi-Organ Failure in COvid-19 Sepsis | https://ClinicalTrials.gov/show/NCT04522310 |
| NCT04522076 | Prospective Hospital Registry of Patients With Suspected or Confirmed Coronavirus Infection (COVID-19) and Community-acquired Pneumonia | https://ClinicalTrials.gov/show/NCT04522076 |
| NCT04522037 | Measurement of the Efficacy of MORPHINE in the Early Management of Dyspnea in COVID-19 Positive Patients | https://ClinicalTrials.gov/show/NCT04522037 |
| NCT04521010 | Staff Absenteeism and Delivery of Healthcare Services During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04521010 |
| NCT04519502 | Maternal Morbidity and Mortality During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04519502 |
| NCT04519398 | Investigating the Involvement of ACE and Angiotensinogen Genes’ Polymorphism Along With Other Thrombophilic Genotypes in Severe Forms of COVID-19 With/Without Thrombotic Events | https://ClinicalTrials.gov/show/NCT04519398 |
| NCT04519372 | SARS-CoV-2 /COVID-19 Admission Screening in a University Hospital Setting | https://ClinicalTrials.gov/show/NCT04519372 |
| NCT04519307 | Evaluation of Newborns Presenting With Suspected COVID 19 | https://ClinicalTrials.gov/show/NCT04519307 |
| NCT04519255 | Study for Quantitative Analysis of the Recovered COVID-19 Patients by 18F-FDG-PET/CT | https://ClinicalTrials.gov/show/NCT04519255 |
| NCT04520191 | Home-based Kidney Care in Native Americans of New Mexico (HBKC) - Enhancement: COVID-19 Study | https://ClinicalTrials.gov/show/NCT04520191 |
| NCT04518735 | Evolution of COVID-19 in Anticoagulated or Antiaggregated Patients (CORONA Study) | https://ClinicalTrials.gov/show/NCT04518735 |
| NCT04519034 | Vitamin D Status and Immune-inflammatory Status in Different UK Populations With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04519034 |
| NCT04517682 | COVID-19 and SARS-CoV-2 Detection in Saliva | https://ClinicalTrials.gov/show/NCT04517682 |
| NCT04517695 | Blood Volume Assessment in COVID-19 ICU Patients - BVAC19 | https://ClinicalTrials.gov/show/NCT04517695 |
| NCT04517136 | Impact of Perceived Control on Operational Strain: a Study of COVID-19 Pandemic Caregivers and Military Personnel on Operational Missions | https://ClinicalTrials.gov/show/NCT04517136 |
| NCT04517097 | Study of the Specific Seroprevalence of SARS-CoV-2 in a Sample of Patients and Salaried Staff From a French Anti-cancer Center at the End of the Containment Period of the SARS-CoV-2 Pandemic | https://ClinicalTrials.gov/show/NCT04517097 |
| NCT04516928 | Study of SARS-CoV2 Virus (COVID-19) Seroprevalence Among Lyon-Bron Military Health Schools Personnel | https://ClinicalTrials.gov/show/NCT04516928 |
| NCT04516824 | Experience of Orthopaedic and Spine Center Pakistan During COVID-19 | https://ClinicalTrials.gov/show/NCT04516824 |
| NCT04515225 | COVID-19 Prevalence in HIV-infected Patients | https://ClinicalTrials.gov/show/NCT04515225 |
| NCT04516486 | Coronavirus Studied by Metagenomics in ARDS COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04516486 |
| NCT04515108 | Perinatal Outcomes and Hematologic Parameters in COVID-19 Pregnancies | https://ClinicalTrials.gov/show/NCT04515108 |
| NCT04514874 | Assessment of the Prevalence and the Impact of the COVID-19 Epidemic in the French Flight Crew in 2020 | https://ClinicalTrials.gov/show/NCT04514874 |
| NCT04513561 | Evaluation of the Impact of Lock Down and End of Lock Down on the Management of Patients With Inflammatory and Dysimmune Diseases Followed in the Context of IMMINeNT FHU and COVID-19 | https://ClinicalTrials.gov/show/NCT04513561 |
| NCT04513847 | PsoVac: Educational Needs re Vaccines for Biologic Patients With Psoriasis | https://ClinicalTrials.gov/show/NCT04513847 |
| NCT04514016 | Cross Sectional CFAR HIV/COVID-19 Study | https://ClinicalTrials.gov/show/NCT04514016 |
| NCT04514003 | The Corona and COVID-19 Study in Telemark and Agder | https://ClinicalTrials.gov/show/NCT04514003 |
| NCT04513964 | Impact of COVID-19 on the Benefit of Cardiac Rehabilitation | https://ClinicalTrials.gov/show/NCT04513964 |
| NCT04513210 | Reliability of Standardized Protocol of Ultrasound of the Lungs in Prediction of Severity of Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04513210 |
| NCT04512300 | Parental Attitude Toward Children Dental Treatment During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04512300 |
| NCT04511962 | Feasibility, of Tele-rehabilitation Following COVID-19 | https://ClinicalTrials.gov/show/NCT04511962 |
| NCT04512118 | CT Abnormalities Evocative of Lung Infection Are Associated With Lower 18F-FDG Uptake in Confirmed COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04512118 |
| NCT04510623 | Host Response Mediators in Coronavirus (COVID-19) Infection | https://ClinicalTrials.gov/show/NCT04510623 |
| NCT04510441 | Artificial Intelligence-assisted Diagnosis and Prognostication in COVID-19 Using Electrocardiograms | https://ClinicalTrials.gov/show/NCT04510441 |
| NCT04509713 | Canine COVID-19 Detection | https://ClinicalTrials.gov/show/NCT04509713 |
| NCT04510025 | Capturing MultiORgan Effects of COVID-19 | https://ClinicalTrials.gov/show/NCT04510025 |
| NCT04510012 | Characterizing the Immune Response and Neuronal Damage in COVID-19 | https://ClinicalTrials.gov/show/NCT04510012 |
| NCT04508777 | COVID SAFE: COVID-19 Screening Assessment for Exposure | https://ClinicalTrials.gov/show/NCT04508777 |
| NCT04508972 | The VOICE-COVID-19 | https://ClinicalTrials.gov/show/NCT04508972 |
| NCT04508556 | Performance Assessment of SARS-CoV-2 Detection Breath Biopsy - SARS-CoV-2 Study | https://ClinicalTrials.gov/show/NCT04508556 |
| NCT04507893 | Comparison Between Positive and Negative COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04507893 |
| NCT04507230 | COVID-19 Associated Coagulopathy in Egypt | https://ClinicalTrials.gov/show/NCT04507230 |
| NCT04507282 | Eosinophil and Anticoagulation in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04507282 |
| NCT04506632 | Burden for STaff Working in the NHS | https://ClinicalTrials.gov/show/NCT04506632 |
| NCT04506229 | Genetic Mechanisms Underlying SARS-CoV-2 Infection and the Impact of COVID-19 on Cognitive Function | https://ClinicalTrials.gov/show/NCT04506229 |
| NCT04506515 | Psychological Impact of COVID-19 Pandemic in Healthcare Workers | https://ClinicalTrials.gov/show/NCT04506515 |
| NCT04505631 | Follow-up of Respiratory Sequelae of Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04505631 |
| NCT04505605 | Study of a Possible Respiratory Degradation Prognosis Caused by Biomarkers in Severe Forms of COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04505605 |
| NCT04503525 | Nutritional Assessment of Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04503525 |
| NCT04503447 | COVID-19 Seroprevalence Study in ITM Staff | https://ClinicalTrials.gov/show/NCT04503447 |
| NCT04501822 | One-year Cardiac Follow-up of Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04501822 |
| NCT04502108 | Behavior During and After COVID-19 Crisis | https://ClinicalTrials.gov/show/NCT04502108 |
| NCT04501991 | Short-term Impact of COVID-19 Lockdown on Metabolic Control of Type 2 Diabetes | https://ClinicalTrials.gov/show/NCT04501991 |
| NCT04501432 | Cardiac Rehabilitation and Ongoing Physical Activity During COVID-19 | https://ClinicalTrials.gov/show/NCT04501432 |
| NCT04500652 | Mental Health Status and Related Factors Among Physical Medicine & Rehabilitation Physicians in the Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04500652 |
| NCT04500639 | Over-the-counter Medications & COVID-19 | https://ClinicalTrials.gov/show/NCT04500639 |
| NCT04500600 | Well-Being and Health-Related Quality of Life in Cancer Patients and Survivors During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04500600 |
| NCT04498091 | EPIdemiological Approaches to the Cardiovascular Consequences of COVID-19 | https://ClinicalTrials.gov/show/NCT04498091 |
| NCT04499378 | Tomographic Findings in COVID-19 and Influenza H1N1 | https://ClinicalTrials.gov/show/NCT04499378 |
| NCT04499300 | Elderly Patients and COVID-19 Infection: a Cohort of Fifty Patients Over Ninety Years of Age | https://ClinicalTrials.gov/show/NCT04499300 |
| NCT04498507 | Psychosocial Outcomes in Families of COVID-19 ICU Patients | https://ClinicalTrials.gov/show/NCT04498507 |
| NCT04498286 | COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients | https://ClinicalTrials.gov/show/NCT04498286 |
| NCT04498416 | CoCo-20: a Longitudinal Follow-up Study of the French Paediatric Population During and After the Coronavirus Pandemic COVID-19 | https://ClinicalTrials.gov/show/NCT04498416 |
| NCT04498299 | Stress Echocardiography in Patients Recovery From Mild COVID-19 Illness | https://ClinicalTrials.gov/show/NCT04498299 |
| NCT04498065 | MYocardial DOmmages Related to COVID-19 | https://ClinicalTrials.gov/show/NCT04498065 |
| NCT04497818 | Correlation Fear of COVID-19 & Dental Treatment Anxiety | https://ClinicalTrials.gov/show/NCT04497818 |
| NCT04497467 | Changes in Out-patient Visits in Taiwan During the Time of Global COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04497467 |
| NCT04497441 | Netizens’ Perception of COVID-19 Information & Information Sources. | https://ClinicalTrials.gov/show/NCT04497441 |
| NCT04497779 | Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma | https://ClinicalTrials.gov/show/NCT04497779 |
| NCT04497636 | Mental Health Impact of the COVID-19 Pandemic Among Migrants in Chile | https://ClinicalTrials.gov/show/NCT04497636 |
| NCT04497311 | Tomographic Findings in COVID-19 and Influenza | https://ClinicalTrials.gov/show/NCT04497311 |
| NCT04497246 | Psychological Impact, Mental Health and Sleep Disorder Among Patients Hospitalized and Health Care Workers During the 2019 Coronavirus Outbreak (COVID-19) | https://ClinicalTrials.gov/show/NCT04497246 |
| NCT04496141 | Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19 | https://ClinicalTrials.gov/show/NCT04496141 |
| NCT04496128 | COVID19 Neurological Manifestation | https://ClinicalTrials.gov/show/NCT04496128 |
| NCT04496869 | Psychological Impact of COVID19 Among Women Undergoing Infertility Treatment | https://ClinicalTrials.gov/show/NCT04496869 |
| NCT04496076 | COVID-19 Brain Injury | https://ClinicalTrials.gov/show/NCT04496076 |
| NCT04495907 | COVID-19 Progression in End-Stage Kidney Disease | https://ClinicalTrials.gov/show/NCT04495907 |
| NCT04495764 | Registry of Sustained Immunity to COVID-19 Among ESKD Patients | https://ClinicalTrials.gov/show/NCT04495764 |
| NCT04494893 | ImmuneRACE - Immune Response Action to COVID-19 Events | https://ClinicalTrials.gov/show/NCT04494893 |
| NCT04494776 | SARS-COV-2 Infection in Kidney Transplant Recipients: a Brazilian Multicenter Study | https://ClinicalTrials.gov/show/NCT04494776 |
| NCT04493307 | The Evaluation of Hemostasis in Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04493307 |
| NCT04493268 | HYPONATREMIA IN COVID-19 PATIENTS | https://ClinicalTrials.gov/show/NCT04493268 |
| NCT04492943 | To Observe Whether Isoflurane Can Treat COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04492943 |
| NCT04492904 | Singapore COVID-19 Chemosensory Tracking (SCCT) Study | https://ClinicalTrials.gov/show/NCT04492904 |
| NCT04492267 | Inflammatory Bowel Disease (IBD) and Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04492267 |
| NCT04491318 | COVID-19 Quarantine on Musculoskeletal Status in Hemophilia | https://ClinicalTrials.gov/show/NCT04491318 |
| NCT04491227 | Global Assessment of Acute and Chronic Kidney Disease Incidence and Outcomes in Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04491227 |
| NCT04491214 | Post ICU Follow up in Patients With Severe SARS-CoV-2 Infection (Covid-19) | https://ClinicalTrials.gov/show/NCT04491214 |
| NCT04491201 | National Survey of the Impact of COVID-19 Pandemics | https://ClinicalTrials.gov/show/NCT04491201 |
| NCT04491071 | Stress Induced by the COVID-19 Pandemic and Nonconfinement: Study of Anxiety Factors and Potential Effects on Immunity. | https://ClinicalTrials.gov/show/NCT04491071 |
| NCT04491292 | Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce | https://ClinicalTrials.gov/show/NCT04491292 |
| NCT04490811 | Seroprevalence and Immunoprotection Against COVID-19 in Parisian Children | https://ClinicalTrials.gov/show/NCT04490811 |
| NCT04490174 | Serological Surveillance for COVID-19 in Central North Carolina | https://ClinicalTrials.gov/show/NCT04490174 |
| NCT04488588 | Survival and 30-days Hospital Outcome in COVID-19 Patients in Upper Egypt | https://ClinicalTrials.gov/show/NCT04488588 |
| NCT04488549 | Delayed Colorectal Cancer Care During Coronavirus Disease (COVID-19) Pandemic (DECOR-19) | https://ClinicalTrials.gov/show/NCT04488549 |
| NCT04488510 | Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia: | https://ClinicalTrials.gov/show/NCT04488510 |
| NCT04488471 | Impact of Isolation in Patients With IBD During the COVID-19 Crisis | https://ClinicalTrials.gov/show/NCT04488471 |
| NCT04487769 | Lung Ultrasound in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04487769 |
| NCT04487951 | N-terminal Pro B-type Natriuretic Peptide and Vitamin D Levels as Prognostic Markers in COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04487951 |
| NCT04487873 | COVID-19 Phobia in Patients With Bronchiectasis During Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04487873 |
| NCT04487977 | Survey on COVID-19 Airway Management | https://ClinicalTrials.gov/show/NCT04487977 |
| NCT04487197 | SARS-CoV2 (COVID-19) Seroepidemiological Transplanted Subjects (Kidney, Kidney-pancreas, Pancreas, Langerhans Islets) | https://ClinicalTrials.gov/show/NCT04487197 |
| NCT04487119 | Hematology and Clinical Picture in Pediatric COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04487119 |
| NCT04486729 | Respiratory Mechanics and Gas Exchange Characteristics in Patient With SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04486729 |
| NCT04486417 | Feasibility of a Telematics Pre-operative Assessment in a Bariatric Surgery During Covid-19 | https://ClinicalTrials.gov/show/NCT04486417 |
| NCT04486404 | Needs, Perceptions and Acute Stress of Healtcare Workers Caring for COVID-19 Patients in South America | https://ClinicalTrials.gov/show/NCT04486404 |
| NCT04486521 | Anti-IL6 and Corticosteroid Monotherapy vs Combination in COVID-19 | https://ClinicalTrials.gov/show/NCT04486521 |
| NCT04485364 | Place of Circulating Biomarkers and Respiratory Eicosanoids in the Prognosis of Severe Forms of Covid-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04485364 |
| NCT04485351 | Assessing the Impact of the COVID-19 Lockdown on Metabolic Control and Access to Health Care in Patients With Diabetes | https://ClinicalTrials.gov/show/NCT04485351 |
| NCT04485338 | Chest Radiography in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04485338 |
| NCT04484597 | Predictors of COVID-19 Infection and Disease Progression | https://ClinicalTrials.gov/show/NCT04484597 |
| NCT04484545 | Prognostic Factors in Patients Admitted to an Urban Teaching Hospital With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04484545 |
| NCT04483908 | COVID-19 in Baselland: Investigation and Validation of Serological Diagnostic Assays and Epidemiological Study of Sars-CoV-2 Specific Antibody Responses | https://ClinicalTrials.gov/show/NCT04483908 |
| NCT04483622 | Immunoglobulin G Antibody Immune Response Profile Following Infection With SARS-CoV-2 in COVID-19 Egyptian Patients | https://ClinicalTrials.gov/show/NCT04483622 |
| NCT04482023 | Emotional Support and Stress Management in Patients Diagnosed With COVID-19 | https://ClinicalTrials.gov/show/NCT04482023 |
| NCT04482205 | Covid -19 Pandemic: Economic Burden on Patients Operated for Traumatic Close Fractures | https://ClinicalTrials.gov/show/NCT04482205 |
| NCT04481529 | COVID-19 Serological Status of Hospital Staff Working or Not in the COVID-19 Sector | https://ClinicalTrials.gov/show/NCT04481529 |
| NCT04481516 | Yoga in NHS Health Care Workers With COVID-19 Related Stress | https://ClinicalTrials.gov/show/NCT04481516 |
| NCT04481477 | Results of Emotional Support Activities During Hospital Admission With a Diagnosis of COVID19 | https://ClinicalTrials.gov/show/NCT04481477 |
| NCT04481620 | Development and Validation of a Prediction Model for the Transition From Mild to Moderate Form of COVID-19, Using Data From Chest CT | https://ClinicalTrials.gov/show/NCT04481620 |
| NCT04480580 | Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for Surgery | https://ClinicalTrials.gov/show/NCT04480580 |
| NCT04480515 | Does COVID-19 Pandemic Reduce In-hospital Mortality? | https://ClinicalTrials.gov/show/NCT04480515 |
| NCT04480398 | Efficacy and Safety of Guduchi Ghan Vati for Covid-19 Asymptomatic Patients | https://ClinicalTrials.gov/show/NCT04480398 |
| NCT04480060 | Experience of an Emergency Intensive Care Unit During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04480060 |
| NCT04480034 | Obesity Surgery During 2020 Italian Pandemic | https://ClinicalTrials.gov/show/NCT04480034 |
| NCT04479982 | Microbial Infection and AMR in Hospitalized Patients With Covid 19 | https://ClinicalTrials.gov/show/NCT04479982 |
| NCT04479319 | Decision Support System Algorithm for COVID-19 Diagnosis | https://ClinicalTrials.gov/show/NCT04479319 |
| NCT04479137 | Possible Predictors of Mortality Based on COVID-19 for Patients Under 50 Years Old: A Multi-Center Experience of Istanbul | https://ClinicalTrials.gov/show/NCT04479137 |
| NCT04479124 | The Impact of COVID-19 Pandemic to Trauma Patients in Emergency Department: A Multicenter Experience of Istanbul | https://ClinicalTrials.gov/show/NCT04479124 |
| NCT04479293 | Post COVID-19 Functional Status in Egypt | https://ClinicalTrials.gov/show/NCT04479293 |
| NCT04479280 | Evaluation of Coagulopathy in Critically Ill COVID-19 Patients. | https://ClinicalTrials.gov/show/NCT04479280 |
| NCT04477902 | Long-Term Experience and Health Effects of COVID-19 | https://ClinicalTrials.gov/show/NCT04477902 |
| NCT04477889 | Methodist Health System COVID-19 Patient Registry | https://ClinicalTrials.gov/show/NCT04477889 |
| NCT04477473 | Perceived Impact of the COVID-19 Pandemic on Medical Management and Symptoms in a High Risk Group | https://ClinicalTrials.gov/show/NCT04477473 |
| NCT04477213 | Risk Profiling of the Occupational Exposure of COVID-19 to Healthcare Workers. | https://ClinicalTrials.gov/show/NCT04477213 |
| NCT04476914 | Stress Related Disorders in Family Members of COVID-19 Patients Admitted to the ICU | https://ClinicalTrials.gov/show/NCT04476914 |
| NCT04476823 | European Pathology Laboratories and COVID-19 | https://ClinicalTrials.gov/show/NCT04476823 |
| NCT04476602 | Ambulatory Management of Moderate to High Risk COVID-19 (SARS-CoV-2) Patients - The Coronavirus Related Outpatient Work Navigators (CROWN) Protocol | https://ClinicalTrials.gov/show/NCT04476602 |
| NCT04475484 | Online Survey on Psychological Impact of COVID-19 Epidemic on School-age Children | https://ClinicalTrials.gov/show/NCT04475484 |
| NCT04475471 | WORLD HEART FEDERATION (WHF) COVID-19 and Cardiovascular Disease Survey | https://ClinicalTrials.gov/show/NCT04475471 |
| NCT04475211 | LILLE COVID RESEARCH NETWORK (Covid-19) | https://ClinicalTrials.gov/show/NCT04475211 |
| NCT04475068 | Postural Recruitment Maneuver in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04475068 |
| NCT04474496 | Impact of COVID-19 on Marshallese Communities in the U.S. | https://ClinicalTrials.gov/show/NCT04474496 |
| NCT04474457 | Efficacy and Safety of Favipiravir in the Treatment of COVID-19 Patients Over 15 Years of Age | https://ClinicalTrials.gov/show/NCT04474457 |
| NCT04474444 | Ambulance Calls for Substance Use and Alcohol in a Pandemic (ASAP) | https://ClinicalTrials.gov/show/NCT04474444 |
| NCT04474301 | Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04474301 |
| NCT04474288 | The COVID-19 PUI Reality Check (CPRC) Study | https://ClinicalTrials.gov/show/NCT04474288 |
| NCT04474236 | Lung Ultrasound for COVID-19 Initial Triage and Monitoring | https://ClinicalTrials.gov/show/NCT04474236 |
| NCT04473547 | COVID 19 Preventive Measures Among Mansoura Nursing Students | https://ClinicalTrials.gov/show/NCT04473547 |
| NCT04474067 | COVID-19 - Cytokine Storm | https://ClinicalTrials.gov/show/NCT04474067 |
| NCT04473365 | Rapid Diagnostic Profiling of SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04473365 |
| NCT04473157 | COVID-19 in Patients With Anosmia in Egypt | https://ClinicalTrials.gov/show/NCT04473157 |
| NCT04473300 | Assessment of Lung Recruitablity of Acute Respiratory Distress Syndrome With SARS-CoV-2 Pneumonia by Electrical Impedance Tomography | https://ClinicalTrials.gov/show/NCT04473300 |
| NCT04473131 | Immune Profiling of COVID19-patients Admitted to ICU | https://ClinicalTrials.gov/show/NCT04473131 |
| NCT04473118 | Assessment of Mental Health in Healthcare Workers Exposed to COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04473118 |
| NCT04473105 | Optimising Resource Allocation Via Prediction of Outcomes for Covid-19 | https://ClinicalTrials.gov/show/NCT04473105 |
| NCT04473183 | Epidemiologic Assessment of SARS-CoV-2 (COVID-19) Prevalence in Minnesota | https://ClinicalTrials.gov/show/NCT04473183 |
| NCT04472052 | Frequency of Perforated Appendicitis in Times of COVID-19 | https://ClinicalTrials.gov/show/NCT04472052 |
| NCT04472013 | Systematic Assessment of SARS-CoV-2 Neurotropic Capacity in Modestly and Critically Ill Patients, and Patients Who Died From COVID-19 | https://ClinicalTrials.gov/show/NCT04472013 |
| NCT04471701 | Italian Web-based Cross-sectional Survey on COVID-19 | https://ClinicalTrials.gov/show/NCT04471701 |
| NCT04471649 | Hydroxy Chloroquine and Covid in RA Patients | https://ClinicalTrials.gov/show/NCT04471649 |
| NCT04471051 | An Observational Cohort Trial of Outcomes and Antibody Responses Following Treatment With COVID19 Convalescent Plasma in Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04471051 |
| NCT04470648 | COVID-19 Infection at Samusocial in Paris: Descriptive and Serological Survey | https://ClinicalTrials.gov/show/NCT04470648 |
| NCT04470583 | Evaluating Clinical Parameters of COVID-19 in Pregnancy | https://ClinicalTrials.gov/show/NCT04470583 |
| NCT04470323 | Functional Exhaustion of T Cells in COVID19 Patients | https://ClinicalTrials.gov/show/NCT04470323 |
| NCT04469660 | Impact of COVID-19 Pandemic on the Psychological Wellbeing of Healthcare Professionals in India | https://ClinicalTrials.gov/show/NCT04469660 |
| NCT04469647 | COVID 19 Seroprevalence Amongst Healthcare Workers in JHAH | https://ClinicalTrials.gov/show/NCT04469647 |
| NCT04467931 | ACEI or ARB and COVID-19 Severity and Mortality in US Veterans | https://ClinicalTrials.gov/show/NCT04467931 |
| NCT04468802 | Do Childhood Measles and DTaP Vaccination Decrease the Mortality Rate Caused by COVID-19 in OECD Countries? | https://ClinicalTrials.gov/show/NCT04468802 |
| NCT04469153 | Interest of the Dosage of Ferritin / Glycosylated Ferritin in COVID-19 | https://ClinicalTrials.gov/show/NCT04469153 |
| NCT04468386 | Specimen Collection Study Protocol | https://ClinicalTrials.gov/show/NCT04468386 |
| NCT04468308 | VRQOL in Cataract Patients During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04468308 |
| NCT04468412 | Influence of COVID-19 on Vascular Endothelial Function | https://ClinicalTrials.gov/show/NCT04468412 |
| NCT04468035 | Early Cognitive Assessment and Evolutionary Monitoring of Patients With Severe ARDS on COVID-19 Pneumonia Requiring Mechanical Ventilation | https://ClinicalTrials.gov/show/NCT04468035 |
| NCT04468256 | The Heart Hive COVID-19 Study | https://ClinicalTrials.gov/show/NCT04468256 |
| NCT04468217 | Evaluation of an Alternative Method of Obtaining Viral RNA for the Detection of SARS-CoV-2 Virus Using PCR | https://ClinicalTrials.gov/show/NCT04468217 |
| NCT04467008 | Covid-19 Rapid Diagnostic Tests on Blood Drop | https://ClinicalTrials.gov/show/NCT04467008 |
| NCT04467112 | Non Inferiority Trial for Detection of nCOVID-19 Through Analysis of Exhaled Breath Aerosols | https://ClinicalTrials.gov/show/NCT04467112 |
| NCT04466982 | Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection | https://ClinicalTrials.gov/show/NCT04466982 |
| NCT04466462 | Cross-sectional Study of COVID-19 Infection in Hospital Health Personnel | https://ClinicalTrials.gov/show/NCT04466462 |
| NCT04466644 | COVID-19: A Prevalence Study of Two ART Centres After the Pandemic Lockdown in the USA (COVID-19 Free Clinics) | https://ClinicalTrials.gov/show/NCT04466644 |
| NCT04466839 | Evaluation of the Containment Impact Linked to the Covid-19 Pandemic in a Population of Parkinson Patients | https://ClinicalTrials.gov/show/NCT04466839 |
| NCT04465981 | Investigation of Antibody and Immune Responses to SARS-CoV-2 Proteins in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04465981 |
| NCT04465656 | Registry of the Evolution of Diagnosed and/or Hospitalized Patients for Pulmonary Embolism During the Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04465656 |
| NCT04465552 | Arrhythmic Manifestations and Management in Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04465552 |
| NCT04463706 | COVID19 Severity Prediction and Health Services Research Evaluation | https://ClinicalTrials.gov/show/NCT04463706 |
| NCT04465058 | Characteristics of Critically Ill COVID 19 Patients | https://ClinicalTrials.gov/show/NCT04465058 |
| NCT04463823 | “NORPLASMA” Covid-19 Convalescent Plasma Treatment Monitoring Study | https://ClinicalTrials.gov/show/NCT04463823 |
| NCT04463758 | Covid-19 in Pregnancy: a French Population-based Cohort of Women and Newborns | https://ClinicalTrials.gov/show/NCT04463758 |
| NCT04463628 | Impacts of the Covid-19 Epidemic and Associated Lockdown Measures on the Management, Health and Behaviors of Cystic Fibrosis Patients During the 2020 Epidemic | https://ClinicalTrials.gov/show/NCT04463628 |
| NCT04462367 | Northeast COVID-19 and Pregnancy Study Group | https://ClinicalTrials.gov/show/NCT04462367 |
| NCT04462120 | IL-12RB and TNF-alpha Gene Polymorphism and Susceptibility and Progress of Covid-19 SARS-CoV-2: A Case Control Study | https://ClinicalTrials.gov/show/NCT04462120 |
| NCT04460599 | Neurological Features During COVID19 | https://ClinicalTrials.gov/show/NCT04460599 |
| NCT04460469 | Anxiety Level and Oral Hygiene Practice in Dental Students During Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04460469 |
| NCT04459975 | Acute Kidney Injury and Renal Outcomes for COVID-19 Patients in Intensive Care Units | https://ClinicalTrials.gov/show/NCT04459975 |
| NCT04460664 | Coagulation Changes Associated With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04460664 |
| NCT04460638 | SARS-CoV2 (COVID-19) Diagnosis in Human Saliva by MALDI-TOF MS Profiling | https://ClinicalTrials.gov/show/NCT04460638 |
| NCT04460274 | Forecast Number of Covid-19 Cases Worldwide | https://ClinicalTrials.gov/show/NCT04460274 |
| NCT04459533 | Sparing in Neuromuscular Blockade in COVID 19 ICU | https://ClinicalTrials.gov/show/NCT04459533 |
| NCT04459403 | Psychiatric Disturbances and COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04459403 |
| NCT04459819 | Respiratory Physiotherapy in Severe COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04459819 |
| NCT04459390 | Association of Comorbidities With COVID19 | https://ClinicalTrials.gov/show/NCT04459390 |
| NCT04459351 | PHenotyping patiENts Admitted to Hospital With cOvid-19 Infection and idenTifYing Prognostic markErs | https://ClinicalTrials.gov/show/NCT04459351 |
| NCT04459312 | National Covid-19 Surveillance Physicians | https://ClinicalTrials.gov/show/NCT04459312 |
| NCT04458337 | SURgical Outcomes in COvid Patients - the SUROCO Multicenter Cohort Study (COVID-19) | https://ClinicalTrials.gov/show/NCT04458337 |
| NCT04456933 | Intracorporeal Anastomosis in Laparoscopic Left Colectomy. Cohort Comparative Study | https://ClinicalTrials.gov/show/NCT04456933 |
| NCT04456556 | Combined Endophthalmitis and Orbital Cellulitis in Patients With Novel Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04456556 |
| NCT04452630 | Cardiovascular Consequences After COVID-19 | https://ClinicalTrials.gov/show/NCT04452630 |
| NCT04457570 | Excess Risk of Morbi-mortality Due to COVID-19 in Patients With Cancer | https://ClinicalTrials.gov/show/NCT04457570 |
| NCT04456010 | COVID-19 in ART: Perception and Experience | https://ClinicalTrials.gov/show/NCT04456010 |
| NCT04456101 | Study on the Recovery of Pulmonary Function, Chest CT, Hematologic, and Immune & Inflammatory Conditions in COVID-19 Rehabilitation Patients | https://ClinicalTrials.gov/show/NCT04456101 |
| NCT04456075 | Risk Prediction and Therapy Monitoring in Patients With SARS-Cov-2 Infection / COVID 19 | https://ClinicalTrials.gov/show/NCT04456075 |
| NCT04455451 | Intensive Care Therapy of Covid-19 Disease in Germany | https://ClinicalTrials.gov/show/NCT04455451 |
| NCT04454333 | COVID-19 in Pain Perspective | https://ClinicalTrials.gov/show/NCT04454333 |
| NCT04453982 | Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1b | https://ClinicalTrials.gov/show/NCT04453982 |
| NCT04453969 | Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1a | https://ClinicalTrials.gov/show/NCT04453969 |
| NCT04453670 | Neuropathology in Adults Intensive Care Unit Patients With COVID 19 | https://ClinicalTrials.gov/show/NCT04453670 |
| NCT04453566 | Effect of COVID-19 Pandemic on Perceived Stress, Anxiety, Mood, and Training Quality in Elite Athletes. | https://ClinicalTrials.gov/show/NCT04453566 |
| NCT04453527 | The CASCADE Study - Measures of Complement Activation and Inflammation in Patients With Covid-19 | https://ClinicalTrials.gov/show/NCT04453527 |
| NCT04453501 | Anti Infective Agents Impact in COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04453501 |
| NCT04453280 | Antibody Detection in COVID-19 Cured Patients (SARS-CoV-2-CZ-Immunity) | https://ClinicalTrials.gov/show/NCT04453280 |
| NCT04452487 | Study of the Consequences of Infection on Compliance of Modalities of Decisions of Limitations and Stops of Treatments (COVID-19-LAT) | https://ClinicalTrials.gov/show/NCT04452487 |
| NCT04452708 | HFNC and NIV for COVID-19 Complicated by Respiratory Failure | https://ClinicalTrials.gov/show/NCT04452708 |
| NCT04452695 | Acceptability of Telehealth Triage Using Robotic Systems in COVID-19 | https://ClinicalTrials.gov/show/NCT04452695 |
| NCT04452682 | The Impact of COVID-19 Pandemic on Critical Limb Threatening Ischemia and Emergency Vascular Practice | https://ClinicalTrials.gov/show/NCT04452682 |
| NCT04452617 | Safety of Short-term Hydroxychloroquine Plus Azithromycin Treatment in Critically Ill Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04452617 |
| NCT04452604 | Multicentric Registry of Patients With Acute Leukemia Infected by COVID-19 | https://ClinicalTrials.gov/show/NCT04452604 |
| NCT04452422 | Deep Venous Thrombosis in Non-severe COVID-19 Patients Hospitalized for a Neurovascular Pathology | https://ClinicalTrials.gov/show/NCT04452422 |
| NCT04451993 | Physical Activity Level in Patients With OSAS During Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04451993 |
| NCT04451577 | Epidemiologic, Clinical, Molecular Characteristics of Hospital Employees With or Without Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04451577 |
| NCT04451694 | Nutritional Follow up After Hospital Discharge for Coronavirus Disease-19 | https://ClinicalTrials.gov/show/NCT04451694 |
| NCT04451317 | Physical Activity Following the Containment Period Imposed by the COVID-19 Pandemic in Patients | https://ClinicalTrials.gov/show/NCT04451317 |
| NCT04449783 | Preoperative Shielding and N/T RT-PCR Swabbing for Elective Cancer Surgery | https://ClinicalTrials.gov/show/NCT04449783 |
| NCT04450017 | Clinical Features of Severe Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04450017 |
| NCT04449978 | TARGet Kids! COVID-19 Study of Children and Families | https://ClinicalTrials.gov/show/NCT04449978 |
| NCT04449731 | Changes in Dietary Behaviours During the COVID-19 Outbreak Confinement in the Adult Population (COVIDiet_Int) | https://ClinicalTrials.gov/show/NCT04449731 |
| NCT04320862 | COVID-19 Pandemic Response Network | https://ClinicalTrials.gov/show/NCT04320862 |
| NCT04449094 | Emergence of the COVID 19 Epidemic in the City of Nice | https://ClinicalTrials.gov/show/NCT04449094 |
| NCT04449081 | Knowledge, Attitude and Practice of Dental Students About COVID-19 | https://ClinicalTrials.gov/show/NCT04449081 |
| NCT04448782 | Characterization of Reverse Triggering and Other Asynchronies in COVID-19 Patients Under Invasive Mechanical Ventilation | https://ClinicalTrials.gov/show/NCT04448782 |
| NCT04448717 | Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children | https://ClinicalTrials.gov/show/NCT04448717 |
| NCT04448704 | Understanding the Mental Health of Migrant Workers During the COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04448704 |
| NCT04448418 | The Impact of COVID-19 Outbreak on Trans-population’s Health in Italy | https://ClinicalTrials.gov/show/NCT04448418 |
| NCT04448405 | Covid-19 Lockdown and Deviant Sexual Fantasies | https://ClinicalTrials.gov/show/NCT04448405 |
| NCT04448054 | Imaging SARS-CoV-2 Involvement of Leptomeninges, Olfactory and Limbic Areas | https://ClinicalTrials.gov/show/NCT04448054 |
| NCT04448145 | Determinants of SARS-COV2 (COVID-19) Persistence After Convalescence | https://ClinicalTrials.gov/show/NCT04448145 |
| NCT04447638 | Percutaneous Tracheostomy With COVID-19 | https://ClinicalTrials.gov/show/NCT04447638 |
| NCT04447222 | Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors | https://ClinicalTrials.gov/show/NCT04447222 |
| NCT04447209 | Dietary Diversity of Young Children During CoVID-19 Outbreak: A Longitudinal Study | https://ClinicalTrials.gov/show/NCT04447209 |
| NCT04447131 | Effect of COVID-19 on Platelet Aggregation | https://ClinicalTrials.gov/show/NCT04447131 |
| NCT04446338 | Immune Status SARS-CoV-2 in a Sample of a Tertiary Eye Health Centre | https://ClinicalTrials.gov/show/NCT04446338 |
| NCT04446286 | Bicentric Study on the Use of ECMO-VV or VA for Severe ARDS Associated With Covid-19 | https://ClinicalTrials.gov/show/NCT04446286 |
| NCT04445961 | Respiratory Mechanics and Gas Exchange in Patients With COVID-19 and Hypoxemic Acute Respiratory Failure | https://ClinicalTrials.gov/show/NCT04445961 |
| NCT04447144 | Nutritional Habits, and Coronavirus Disease 2019 (COVID-19) Outcome | https://ClinicalTrials.gov/show/NCT04447144 |
| NCT04446169 | COVID-19 (SARS-CoV-2) in Urine and Semen | https://ClinicalTrials.gov/show/NCT04446169 |
| NCT04423770 | COVID-19 Related Health and Infection Control Practices Among Dentists | https://ClinicalTrials.gov/show/NCT04423770 |
| NCT04445870 | Oncology Care Pathway’s Modifications Impact During COVID-19 Pandemic : the ONCOCARE-COV Study | https://ClinicalTrials.gov/show/NCT04445870 |
| NCT04445506 | Short Term Corticosteroids in SARS-CoV2 Patients | https://ClinicalTrials.gov/show/NCT04445506 |
| NCT04445493 | EPISODE-PS-COVID: hEad Pulse for Ischemic StrOke DEtection Prehospital Study During the COVID-19 Pandemic ( EPISODEPSCOVID ) | https://ClinicalTrials.gov/show/NCT04445493 |
| NCT04445441 | An Observational Study to Assess the Protocol for the COVID-19 Treatment in Burkina Faso | https://ClinicalTrials.gov/show/NCT04445441 |
| NCT04445259 | Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 and High Risk of Acute Kidney Injury | https://ClinicalTrials.gov/show/NCT04445259 |
| NCT04444401 | Registry on NEN Patients and COVID-19 | https://ClinicalTrials.gov/show/NCT04444401 |
| NCT04445233 | COVID-19 Household Transmission Study | https://ClinicalTrials.gov/show/NCT04445233 |
| NCT04444661 | Effects of COVID-19 Induced Deconditioning After Long-term High Intensity Resistance Exercise | https://ClinicalTrials.gov/show/NCT04444661 |
| NCT04444531 | Ozone Therapy and Coronavirus Disease of 2019 (COVID-19) Pneumonia | https://ClinicalTrials.gov/show/NCT04444531 |
| NCT04444609 | PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort | https://ClinicalTrials.gov/show/NCT04444609 |
| NCT04444557 | Effect of COvid-19 on Mental Health in Syrian and Turkish Maintenance HemoDialysis Patients: COST-HD Study | https://ClinicalTrials.gov/show/NCT04444557 |
| NCT04443075 | Alterations of Gut Microbiome in the Frontline Medical Staff Under the Stress | https://ClinicalTrials.gov/show/NCT04443075 |
| NCT04443803 | Characterizing the Perioperative Epidemiology of SARS-CoV-2 (COVID-19) Spread for Quality Improvement of Perioperative Infection Control Program | https://ClinicalTrials.gov/show/NCT04443803 |
| NCT04443712 | Screening for Patients Admitted to Ain-Shams University Hospitals for SARS-COV-2 (COVID19) | https://ClinicalTrials.gov/show/NCT04443712 |
| NCT04443257 | REassessement After Hospitalization for Sars-COV-2 disordER | https://ClinicalTrials.gov/show/NCT04443257 |
| NCT04442789 | Sequelae of Sars-CoV-2 Infections | https://ClinicalTrials.gov/show/NCT04442789 |
| NCT04442165 | Characterising Transmission of SARS-CoV-2 in a Peri-urban Population in Mozambique | https://ClinicalTrials.gov/show/NCT04442165 |
| NCT04441814 | FOUND - Ancillary Study to Smile Protocol NCT03654105 | https://ClinicalTrials.gov/show/NCT04441814 |
| NCT04441502 | Identification of Predictors for the Evolution of COVID-19 Related Pneumonia by Transcriptomic and Seroproteomic | https://ClinicalTrials.gov/show/NCT04441502 |
| NCT04441489 | Assessment of Lung Inflammation With FDG PET/CT in COVID-19 | https://ClinicalTrials.gov/show/NCT04441489 |
| NCT04441476 | Ethical and Psychological Support for Health Care Professions in Intensive Care Units in the COVID19 Pandemic Context: Adequacy With Needs and Psychological Impact Crisis and Post-crisis | https://ClinicalTrials.gov/show/NCT04441476 |
| NCT04440098 | Isolated During COVID-19: Effects of COVID-19’s Social Restrictions on Loneliness and Psychosocial Symptomatology | https://ClinicalTrials.gov/show/NCT04440098 |
| NCT04438993 | The COVID-19 Disease and CARdiac Events Study | https://ClinicalTrials.gov/show/NCT04438993 |
| NCT04438967 | Brain Health in the Time of COVID-19 | https://ClinicalTrials.gov/show/NCT04438967 |
| NCT04438954 | Investigation of Fatigue, Physical Activity, Sleep Quality and Anxiety Levels | https://ClinicalTrials.gov/show/NCT04438954 |
| NCT04438941 | Contribution of a Prone Team in Intensive Care During the Covid-19 Epidemic | https://ClinicalTrials.gov/show/NCT04438941 |
| NCT04438863 | Daily Home Spirometry for Early Detection of Pulmonary Complications in Patients With COVID19 | https://ClinicalTrials.gov/show/NCT04438863 |
| NCT04439084 | COVID-19 in Patients With Chronic Liver Diseases | https://ClinicalTrials.gov/show/NCT04439084 |
| NCT04438629 | Evaluation of Immune Response in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04438629 |
| NCT04438239 | Rehabilitation Needs After COVID-19 Hospital Treatment | https://ClinicalTrials.gov/show/NCT04438239 |
| NCT04437940 | Evaluation of Vaginal Fluid for Covid-19 Positivity in Women With Positive Nasofarengeal Covid-19 Test | https://ClinicalTrials.gov/show/NCT04437940 |
| NCT04437121 | Dietary and Lifestyle Habits During the Pandemic of COVID-19 in Greece | https://ClinicalTrials.gov/show/NCT04437121 |
| NCT04437706 | Network-Targeted Strategies for Efficient Community SARS-CoV-2 (COVID-19) Sampling | https://ClinicalTrials.gov/show/NCT04437706 |
| NCT04437342 | Postpartum Depression in the Covid-19 Pandemic and the Impact of Anaesthesia | https://ClinicalTrials.gov/show/NCT04437342 |
| NCT04427280 | Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04427280 |
| NCT04436484 | Immune Biomarkers of Outcome From COVID-19 | https://ClinicalTrials.gov/show/NCT04436484 |
| NCT04435327 | Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19) | https://ClinicalTrials.gov/show/NCT04435327 |
| NCT04434261 | Oncological Surgery in Times of COVID-19: Effectiveness of Preoperative Screening for Sars-Cov-2 | https://ClinicalTrials.gov/show/NCT04434261 |
| NCT04435223 | Lipid Metabolism in COVID-19 Severe Pneumonia Compared With Severe Pneumonia Caused by Other Pathogen | https://ClinicalTrials.gov/show/NCT04435223 |
| NCT04435119 | Covid-19 and Vitamin D in Nursing-home | https://ClinicalTrials.gov/show/NCT04435119 |
| NCT04435106 | Compassionate Use of Opaganib in Patients With Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04435106 |
| NCT04435080 | Physical Rehabilitation in ICU in ARDS Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04435080 |
| NCT04435028 | Ketotifen: as a Cardioprotective Agent in Breast Cancer Patients Receiving Anthracycline-containing Chemotherapy | https://ClinicalTrials.gov/show/NCT04435028 |
| NCT04434157 | Association of the Neutrophil/Lymphocyte Ratio With Clinical Complications and Mortality in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04434157 |
| NCT04434118 | Anti-rheumatic Drug Use and Risk of COVID-19 Infection in Rheumatoid Arthritis Patients | https://ClinicalTrials.gov/show/NCT04434118 |
| NCT04433754 | The Development of Pancreatic Injury in the Course of Severe Acute Respiratory Syndrome Coronavirus 2 Infection | https://ClinicalTrials.gov/show/NCT04433754 |
| NCT04434014 | Proper Nutrition And Its Relation To Oral Diseases In Covid -19 Era | https://ClinicalTrials.gov/show/NCT04434014 |
| NCT04433260 | COVID19 and Physical and Emotional Wellbeing of HCP | https://ClinicalTrials.gov/show/NCT04433260 |
| NCT04431908 | Validation of a Rapid Quantitative Test for Loss of Smell in COVID-19 Subjects | https://ClinicalTrials.gov/show/NCT04431908 |
| NCT04432870 | Patients’ Preferences About Rescheduling Colonoscopies Delayed Due to COVID-19: Cross Sectional Study | https://ClinicalTrials.gov/show/NCT04432870 |
| NCT04432779 | Impact of COVID-19 Infection During Pregnancy on Newborns and Young Children | https://ClinicalTrials.gov/show/NCT04432779 |
| NCT04432350 | Assessment of Mortality Rates in COVID-19 Infected Populations Treated With Repurposed Medications | https://ClinicalTrials.gov/show/NCT04432350 |
| NCT04433039 | COVID19 Versus H1N1: Radiological Challenge During Next Influenza Season Rising | https://ClinicalTrials.gov/show/NCT04433039 |
| NCT04433000 | Reliability of a Pocket Sized Ultrasound Scanner in the Evaluation Covid-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04433000 |
| NCT04432961 | Natural Language Processing (NLP) Analysis of Free Text Notes to Investigate Coronavirus (COVID-19) | https://ClinicalTrials.gov/show/NCT04432961 |
| NCT04432948 | Maternal Psychological Implications of Covid-19 Pandemic and Possible Effect on Anaesthetic Management. | https://ClinicalTrials.gov/show/NCT04432948 |
| NCT04432922 | Perceptions, Representations and Experiences of Septic Isolation of Hospitalized Patients for COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04432922 |
| NCT04431414 | A Study of Immune Responses to the Virus That Causes COVID-19 | https://ClinicalTrials.gov/show/NCT04431414 |
| NCT04431310 | Seroconversion Among Staff at a Large Acute Care Hospital in Denmark During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04431310 |
| NCT04431284 | Impact of COVID-19 Lockdown on Obesity and Eating Behaviors | https://ClinicalTrials.gov/show/NCT04431284 |
| NCT04430322 | Covid-19 at the Regional Medical Center Metz-Thionville: a Descriptive Study | https://ClinicalTrials.gov/show/NCT04430322 |
| NCT04430062 | Short-term Outcome of Covid-19 Surgical Patients: Case-series of a High-risk Area Community Hospital | https://ClinicalTrials.gov/show/NCT04430062 |
| NCT04430049 | Impact of Covid-19 Restrictive Measure on Anxiety, Depression and PTSD for Relatives of ICU Patients | https://ClinicalTrials.gov/show/NCT04430049 |
| NCT04430023 | Epidemiological and Demographic Data From 150 Patients Diagnosed With Coronavirus Disease 2019 Pneumonia | https://ClinicalTrials.gov/show/NCT04430023 |
| NCT04429815 | Impact of Smoking and Nicotine on the Risk of Being Infected With COVID-19 | https://ClinicalTrials.gov/show/NCT04429815 |
| NCT04429620 | Prospective Assay for SARS-CoV-2 (COVID-19) Antibody Detection Indirectly by Immunofluorescence: SARS-CoV2 IIF Method | https://ClinicalTrials.gov/show/NCT04429620 |
| NCT04427969 | Early Prone Position on Coronavirus Disease 2019 Pneumonia | https://ClinicalTrials.gov/show/NCT04427969 |
| NCT04427735 | Effect of Covid-19 Epidemic on Primary PCI in Patients With STEMI | https://ClinicalTrials.gov/show/NCT04427735 |
| NCT04427358 | RT-PCR SARS-CoV-2 at 1 Month of COVID-19 Infection in the Geriatric Population | https://ClinicalTrials.gov/show/NCT04427358 |
| NCT04427176 | Evaluation of ARFC Masks Equipped With CF5 Filter in the Care Unit to Allow a Wider Distribution of FFP2 Masks (Covid-19). | https://ClinicalTrials.gov/show/NCT04427176 |
| NCT04427345 | Predictive Factors COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04427345 |
| NCT04427332 | Smell and Taste Disorders in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04427332 |
| NCT04427267 | Assessment of Thermal Condition of Health Workers Who Use Personal Protective Equipment From Biological Hazards During Their Work With COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04427267 |
| NCT04426279 | Morbimortality of Covid-19 in Patients With Chronic Inflammatory Rheumatism Treated With Immunosuppressants | https://ClinicalTrials.gov/show/NCT04426279 |
| NCT04426266 | Psychological Effects of the COVID-19 Pandemic on the Hungarian Adult Population | https://ClinicalTrials.gov/show/NCT04426266 |
| NCT04426253 | Identification of Genetic Factors Determining Disease Course in the New Type of Coronavirus Infection, COVID-19 | https://ClinicalTrials.gov/show/NCT04426253 |
| NCT04426071 | The Impact of a Societal Lockdown on Those With Spinal Cord and Brain Injuries | https://ClinicalTrials.gov/show/NCT04426071 |
| NCT04425863 | Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19 | https://ClinicalTrials.gov/show/NCT04425863 |
| NCT04425850 | USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19 | https://ClinicalTrials.gov/show/NCT04425850 |
| NCT04425889 | COVID-19 Antibodies Among Healthcare Workers | https://ClinicalTrials.gov/show/NCT04425889 |
| NCT04425382 | Darunavir/Cobicistat vs. Lopinavir/Ritonavir in COVID-19 Pneumonia in Qatar | https://ClinicalTrials.gov/show/NCT04425382 |
| NCT04425044 | AiM Covid Self Monitoring | https://ClinicalTrials.gov/show/NCT04425044 |
| NCT04424992 | The Natural History of Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04424992 |
| NCT04425213 | Obesity and Mortality of Critically Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04425213 |
| NCT04424355 | Magnetic Resonance Imaging to Detect Signs of Viral Pneumonia in Patients With Coronavirus Infection. | https://ClinicalTrials.gov/show/NCT04424355 |
| NCT04423692 | Knowledge About Covid-19 Infection in Pregnant Women | https://ClinicalTrials.gov/show/NCT04423692 |
| NCT04423640 | Analysis of the Inflammatory Response and the Development of Humoral and Cellular Immunity in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04423640 |
| NCT04423315 | Thrombosis Risk Assessment and Clinical Presentation of Covid-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04423315 |
| NCT04422769 | Needs of Persons With Spinal Cord Injury (SCI) | https://ClinicalTrials.gov/show/NCT04422769 |
| NCT04422691 | Ultrasonography in Norwegian Emergency Department Patients With Suspected Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04422691 |
| NCT04422574 | COVID 19 Serology in Pulmonologists | https://ClinicalTrials.gov/show/NCT04422574 |
| NCT04422535 | Effects on the Qt Interval of COVID-19 Coronavirus Infection | https://ClinicalTrials.gov/show/NCT04422535 |
| NCT04422522 | Fibromyalgia During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04422522 |
| NCT04422262 | Analysis of Long Term Risk of Coronavirus Disease-19 Emergency | https://ClinicalTrials.gov/show/NCT04422262 |
| NCT04420637 | Impact of the Covid-19 Pandemic on Gastrointestinal and Liver Diseases | https://ClinicalTrials.gov/show/NCT04420637 |
| NCT04420312 | Prevalence and Characteristics of Pulmonary Embolism on COVID-19 Patients Presenting Respiratory Symptoms | https://ClinicalTrials.gov/show/NCT04420312 |
| NCT04420286 | Study of the Increase in ICU Beds Capacity During COVID-19 Pandemic in France | https://ClinicalTrials.gov/show/NCT04420286 |
| NCT04424849 | Thorax Computed Tomography Severity Score and Outcome in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04424849 |
| NCT04424836 | HFNC Treatment in COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04424836 |
| NCT04424771 | Post-traumatic Stress Disease in Health Workers During COVID-19 Pandemia | https://ClinicalTrials.gov/show/NCT04424771 |
| NCT04424446 | Saliva as Source of Detection for SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04424446 |
| NCT04424017 | Sero-prevalence of Coronavirus Disease 2019 (COVID-19) in Healthcare Workers | https://ClinicalTrials.gov/show/NCT04424017 |
| NCT04424004 | MURDOCK Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study | https://ClinicalTrials.gov/show/NCT04424004 |
| NCT04423978 | Implications of Covid-19 on the Lifestyle Changes | https://ClinicalTrials.gov/show/NCT04423978 |
| NCT04422873 | The Impact of COVID-19 on Dialysis Users | https://ClinicalTrials.gov/show/NCT04422873 |
| NCT04422418 | Impact of Burnout on Cardiovascular and Immune Biomarkers in Healthcare Professionals - Covid-19 Pandemic in Abu Dhabi | https://ClinicalTrials.gov/show/NCT04422418 |
| NCT04422340 | Senior-COVID-Rea Multicentric Survey | https://ClinicalTrials.gov/show/NCT04422340 |
| NCT04419545 | Covid Radiographic Images Data-set for A.I | https://ClinicalTrials.gov/show/NCT04419545 |
| NCT04420468 | Descriptive and Retrospective Analysis of Acute Myocarditis Associated With Pandemic COVID-19 in Children | https://ClinicalTrials.gov/show/NCT04420468 |
| NCT04420416 | Mental Health and Academic Performance in COVID-19 | https://ClinicalTrials.gov/show/NCT04420416 |
| NCT04419870 | Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity During the COVID19 Pandemic | https://ClinicalTrials.gov/show/NCT04419870 |
| NCT04419571 | Outcomes in Emergency Laparotomies During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04419571 |
| NCT04418284 | Online Learning of Veterinary Anatomy During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04418284 |
| NCT04418375 | Establishment of a Biological Collection During COVID-19 Serological Screening in APHP Professionals (COVID-HOP) | https://ClinicalTrials.gov/show/NCT04418375 |
| NCT04418609 | Neuro-COVID-19: Neurological Complications of COVID-19 | https://ClinicalTrials.gov/show/NCT04418609 |
| NCT04418544 | Vocal Feature Analysis Algorithm for COVID-19 Detection | https://ClinicalTrials.gov/show/NCT04418544 |
| NCT04418245 | CT Biomarkers Identification by Artificial Intelligence for COVID-19 Prognosis | https://ClinicalTrials.gov/show/NCT04418245 |
| NCT04416464 | Quality of Life and Patient-centered Outcomes After ICU Admission for COVID-19 | https://ClinicalTrials.gov/show/NCT04416464 |
| NCT04416438 | COVID-19 Epidemic and Patients With Myeloproliferative Neoplasias | https://ClinicalTrials.gov/show/NCT04416438 |
| NCT04416373 | COVID-19 and Pregnancy Outcomes | https://ClinicalTrials.gov/show/NCT04416373 |
| NCT04416347 | COVID19 Clinical Predictors and Outcome | https://ClinicalTrials.gov/show/NCT04416347 |
| NCT04416256 | COVID-19 Pandemic and Worldwide Organ Procurement | https://ClinicalTrials.gov/show/NCT04416256 |
| NCT04417374 | Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in the Context COVID-19 | https://ClinicalTrials.gov/show/NCT04417374 |
| NCT04416100 | Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04416100 |
| NCT04416061 | The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04416061 |
| NCT04414657 | USZ BioResource COVID | https://ClinicalTrials.gov/show/NCT04414657 |
| NCT04414410 | Echocardiography in Critically-ill Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04414410 |
| NCT04414059 | Protein Electrophoresis as a Tool for Complications Prediction in COVID-19 Hospitalised Patients | https://ClinicalTrials.gov/show/NCT04414059 |
| NCT04414319 | Severe Acute Respiratory Syndrome-Coronavirus-2 and Loss of Autonomy in the Elderly | https://ClinicalTrials.gov/show/NCT04414319 |
| NCT04413071 | Cardiac COVID-19 Health Care Workers | https://ClinicalTrials.gov/show/NCT04413071 |
| NCT04413435 | Clinical Characteristics of Critically Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04413435 |
| NCT04413058 | Menstrual Cycle Characteristics of Healthcare Professionals | https://ClinicalTrials.gov/show/NCT04413058 |
| NCT04413045 | Novel COVID-19, A National Analysis | https://ClinicalTrials.gov/show/NCT04413045 |
| NCT04412746 | Covid-19 and Diabetes in West of Algeria | https://ClinicalTrials.gov/show/NCT04412746 |
| NCT04412304 | Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04412304 |
| NCT04412278 | Impact of COVID-19 Pandemic on Perceived Exercise Benefits and Barriers | https://ClinicalTrials.gov/show/NCT04412278 |
| NCT04412265 | Frailty in Elderly Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04412265 |
| NCT04412226 | Effect of Using Barrier Devices for Intubation in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04412226 |
| NCT04412473 | COVID-19 Respiratory Distress and Antithrombotic Drugs in Subject’s Habits | https://ClinicalTrials.gov/show/NCT04412473 |
| NCT04412655 | Primary Angioplasty for STEMI During COVID-19 Pandemic (ISACS-STEMI COVID-19) Registry | https://ClinicalTrials.gov/show/NCT04412655 |
| NCT04412369 | Multi-modality Imaging & Immunophenotyping of COVID-19 Related Myocardial Injury | https://ClinicalTrials.gov/show/NCT04412369 |
| NCT04412031 | Prediction of Unfavourable Outcome in Newly Covid-19 Hospitalized Patient | https://ClinicalTrials.gov/show/NCT04412031 |
| NCT04411784 | PROTECT-ASUC: Covid-19 Pandemic Response Of assessmenT, EndosCopy and Treatment in Acute Severe Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT04411784 |
| NCT04411576 | Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare | https://ClinicalTrials.gov/show/NCT04411576 |
| NCT04411511 | COVID-19, Obesity and Lifestyle in Children | https://ClinicalTrials.gov/show/NCT04411511 |
| NCT04410939 | COVID-19 PCR Test Results in Asymptomatic Pregnants | https://ClinicalTrials.gov/show/NCT04410939 |
| NCT04411459 | Risk Factors for Prolonged Invasive Mechanical Ventilation in COVID-19 Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04411459 |
| NCT04411147 | A Longitudinal Study of COVID-19 Sequelae and Immunity | https://ClinicalTrials.gov/show/NCT04411147 |
| NCT04410835 | Psychological Impact of the Corona Virus (SARS-CoV-2) and COVID-19 Pandemic in Individuals With Psychiatric Disorders | https://ClinicalTrials.gov/show/NCT04410835 |
| NCT04410718 | Glycaemia and Cardiac Function in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04410718 |
| NCT04410484 | PREPARE-IBD: Physician Responses to Disease Flares and Patient Adaptation in Relation to Events in Inflammatory Bowel Disease During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04410484 |
| NCT04410432 | Immune Response and Risk of Serious Infection to SARS-Cov2 | https://ClinicalTrials.gov/show/NCT04410432 |
| NCT04410263 | Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches | https://ClinicalTrials.gov/show/NCT04410263 |
| NCT04409899 | The Utility of Enhanced Pre and Post-surgical Work-out to Prevent the Spread of COVID-19 in a Large Urology Department | https://ClinicalTrials.gov/show/NCT04409899 |
| NCT04409847 | COVID-19 Blood Pressure Endothelium Interaction Study (OBELIX) | https://ClinicalTrials.gov/show/NCT04409847 |
| NCT04410107 | Lung Function, Exercise Capacity and Health-Related Quality of Life After Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04410107 |
| NCT04389320 | Antimalarial and Covid 19 in Rheumatoid Arthritis | https://ClinicalTrials.gov/show/NCT04389320 |
| NCT04409535 | Effects of the COVID-19 Health Emergency on Biopsychosocial Health | https://ClinicalTrials.gov/show/NCT04409535 |
| NCT04409275 | LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION | https://ClinicalTrials.gov/show/NCT04409275 |
| NCT04409249 | Prognosis in Pregnant With COVID-19 | https://ClinicalTrials.gov/show/NCT04409249 |
| NCT04409197 | Evaluation of Changes in Weight, Sleep, and Other Psycho-behavioural Parameters During Covid-19 Confinement in Subjects Monitored by the RNPC Network | https://ClinicalTrials.gov/show/NCT04409197 |
| NCT04408378 | Change in the Ratio of Mean Platelet Volume (MPV) to Platellet(PLT) in Covid-19 Pneumonia Patients | https://ClinicalTrials.gov/show/NCT04408378 |
| NCT04408365 | Endothelial Function, Inflammation and Organ Dysfunction in COVID-19 | https://ClinicalTrials.gov/show/NCT04408365 |
| NCT04408326 | Efficacy and Safety of Angiotensin II Use in Coronavirus Disease(COVID)-19 Patients With Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04408326 |
| NCT04408001 | Study of Kinetics and Efficacy of the Immune Response Against COVID-19 Among Hospital Staff | https://ClinicalTrials.gov/show/NCT04408001 |
| NCT04408248 | AKI Biomarkers in Coronavirus(COVID)-19 | https://ClinicalTrials.gov/show/NCT04408248 |
| NCT04408222 | Awake Proning in COVID-19 Patients With Hypoxemic Respiratory Failure | https://ClinicalTrials.gov/show/NCT04408222 |
| NCT04408196 | QoL and the Emotional-affective Sphere o in Rehabilitation Setting During COVID-19 Quarantine | https://ClinicalTrials.gov/show/NCT04408196 |
| NCT04407923 | Drug Management of Juvenile Idiopathic Arthritis in Covid-19 Context : Impact on Therapeutical Managment | https://ClinicalTrials.gov/show/NCT04407923 |
| NCT04408170 | Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 (FALCON-C19) | https://ClinicalTrials.gov/show/NCT04408170 |
| NCT04407663 | Outpatient Clinic in Obesity Care During COVID-19 Outbreak: Physically Far, Virtually Near | https://ClinicalTrials.gov/show/NCT04407663 |
| NCT04407598 | COPD in the Time of COVID-19 | https://ClinicalTrials.gov/show/NCT04407598 |
| NCT04407533 | Dietary Intake and Eating Habits During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04407533 |
| NCT04407494 | Diagnostic Value of Patient - Reported and Clinically Verified Olfactory Disorders (COVID-19) | https://ClinicalTrials.gov/show/NCT04407494 |
| NCT04407468 | Awake Prone Positioning and Oxygen Therapy in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04407468 |
| NCT04407585 | Testing the Accuracy of a Digital Test to Diagnose Covid-19 | https://ClinicalTrials.gov/show/NCT04407585 |
| NCT04407572 | Evaluation of the Relationship Between Zinc Vitamin D and b12 Levels in the Covid-19 Positive Pregnant Women | https://ClinicalTrials.gov/show/NCT04407572 |
| NCT04407559 | COVID-SErology in Rheumatoid Arthritis (COVID-19) | https://ClinicalTrials.gov/show/NCT04407559 |
| NCT04407546 | Role of Children in Transmission of COVID-19 to Immunocompromised Patients | https://ClinicalTrials.gov/show/NCT04407546 |
| NCT04407429 | Vienna Versus SARS-CoV-2 Virus Study | https://ClinicalTrials.gov/show/NCT04407429 |
| NCT04407299 | COVID-19 Impact on Rheumatic Patients | https://ClinicalTrials.gov/show/NCT04407299 |
| NCT04407195 | COVID-19 and Mental Health | https://ClinicalTrials.gov/show/NCT04407195 |
| NCT04407169 | Prevalence of Critical Forms of CoVid-19 in Patients With Chronic Respiratory Disease | https://ClinicalTrials.gov/show/NCT04407169 |
| NCT04407156 | Epidemiology of Acute Kidney Injury in COVID19 Disease in United Kingdom | https://ClinicalTrials.gov/show/NCT04407156 |
| NCT04407143 | Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04407143 |
| NCT04407117 | Appendicitis During the National Lockdown During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04407117 |
| NCT04406844 | Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04406844 |
| NCT04407273 | Statin Therapy and COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04407273 |
| NCT04407260 | Use of Oxygen Hoods in Patients Failing on Conventional High-flow Oxygen Delivery Systems, Effects on Oxygenation, Mechanical Ventilation and Mortality Rates in Hypoxic COVID-19 Patients. Prospective Cohort Study. | https://ClinicalTrials.gov/show/NCT04407260 |
| NCT04407221 | COVID-19 Research in Organ Transplant Recipients | https://ClinicalTrials.gov/show/NCT04407221 |
| NCT04406688 | Prediction of Acute Kidney Injury in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04406688 |
| NCT04406571 | Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer | https://ClinicalTrials.gov/show/NCT04406571 |
| NCT04406324 | COVID-19: Respiratory and Sleep Follow-up | https://ClinicalTrials.gov/show/NCT04406324 |
| NCT04406558 | Psychological Impact of the Health Measures Generated by the COVID19 in Adolescents | https://ClinicalTrials.gov/show/NCT04406558 |
| NCT04406545 | Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of COVID-19. | https://ClinicalTrials.gov/show/NCT04406545 |
| NCT04406233 | Muscle Mass and Strength as Predictors of Time to Discharge in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04406233 |
| NCT04406090 | Endovascular Thrombectomy in COVID-19 Infected Patients | https://ClinicalTrials.gov/show/NCT04406090 |
| NCT04405973 | Clinical Scores for Outcome Prediction in Patients With Severe COVID-19 Pneumonia Requiring ECMO | https://ClinicalTrials.gov/show/NCT04405973 |
| NCT04405869 | Thromboembolic Events in Severe COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04405869 |
| NCT04405726 | Prognostic Factors of COVID19 | https://ClinicalTrials.gov/show/NCT04405726 |
| NCT04406038 | Study of the Spread of COVID-19 in Saint Petersburg, Russia | https://ClinicalTrials.gov/show/NCT04406038 |
| NCT04405466 | A Study to Assess the Feasibility of Screening for SARS-CoV-2 Among Healthy Workers | https://ClinicalTrials.gov/show/NCT04405466 |
| NCT04405284 | The Use of Disinfectants Among Women in Egypt and the Toxicity by Bleach During the Coronavirus Lock-down. | https://ClinicalTrials.gov/show/NCT04405284 |
| NCT04405232 | Coagulopathy in COVID19 - A Multi-Centre Observational Study in UK | https://ClinicalTrials.gov/show/NCT04405232 |
| NCT04404179 | Setting up a COVID-19 Care Facility at a Prison in Pakistan | https://ClinicalTrials.gov/show/NCT04404179 |
| NCT04404270 | Study of SARS-CoV2 Virus (COVID-19) Seroprevalence in the Population of Creil Air Force Base (BA110) | https://ClinicalTrials.gov/show/NCT04404270 |
| NCT04404244 | Extraordinary Measures for Egyptian Children With Hemato-Oncological Disorders During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04404244 |
| NCT04403932 | Increased Risk of Severe Coronavirus Disease 2019 in Patients With Vitamin D Deficiency | https://ClinicalTrials.gov/show/NCT04403932 |
| NCT04404062 | Serological and PCR Testing for COVID-19 | https://ClinicalTrials.gov/show/NCT04404062 |
| NCT04403880 | Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19 | https://ClinicalTrials.gov/show/NCT04403880 |
| NCT04403828 | Impact of COVID-19 on Personal Protection Among Dentist in Egypt | https://ClinicalTrials.gov/show/NCT04403828 |
| NCT04403607 | Cardiac Imaging in SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04403607 |
| NCT04403438 | Familial Mediterranean Fever and Behçet: Analysis Before and After Covid19 Pandemic | https://ClinicalTrials.gov/show/NCT04403438 |
| NCT04403386 | Prospective Natural History Study of Smoking, Immune Cell Profiles, Epigenetics and COVID-19 | https://ClinicalTrials.gov/show/NCT04403386 |
| NCT04403061 | Th1/Th2/Th17/TREG and TLRs Activation/KIR for COVID 19 Prediction of Outcome | https://ClinicalTrials.gov/show/NCT04403061 |
| NCT04403009 | The Clinical Difference Between the Nonfatal Patients and the Fatal Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04403009 |
| NCT04402229 | Psychological Impact of the Covid-19 Pandemic on Student Nurses | https://ClinicalTrials.gov/show/NCT04402229 |
| NCT04402905 | Observational Study in Diagnosed Patients COVID-19, Supported on an Outpatient Basis. (COVID-PSL) | https://ClinicalTrials.gov/show/NCT04402905 |
| NCT04402853 | SARS Cov-2 in Conjunctival Secretion in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04402853 |
| NCT04402814 | IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With the Standard Method of COVID19 Testing. | https://ClinicalTrials.gov/show/NCT04402814 |
| NCT04401436 | COVID-19 Associated Lymphopenia Pathogenesis Study in Blood | https://ClinicalTrials.gov/show/NCT04401436 |
| NCT04401449 | Cardiopulmonary Inflammation and Multi-System Imaging During the Clinical Course of COVID-19 Infection in Asymptomatic and Symptomatic Persons | https://ClinicalTrials.gov/show/NCT04401449 |
| NCT04401254 | Recovery of Patients From COVID-19 After Critical Illness | https://ClinicalTrials.gov/show/NCT04401254 |
| NCT04401241 | How Routine Biomarkers and Blood Leucocytes Count Can Assist Diagnosis of COVID-19 in Emergency Department | https://ClinicalTrials.gov/show/NCT04401241 |
| NCT04401228 | Predictive Models for Intensive Care Admission and Death of COVID-19 | https://ClinicalTrials.gov/show/NCT04401228 |
| NCT04401111 | One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU) | https://ClinicalTrials.gov/show/NCT04401111 |
| NCT04401098 | Changing Of Egyptian Population Behaviour Towards COVID 19 Outbreak | https://ClinicalTrials.gov/show/NCT04401098 |
| NCT04401085 | COVID-19: Herd Immunity Study in the Czech Republic | https://ClinicalTrials.gov/show/NCT04401085 |
| NCT04401072 | Attitude of Egyptian Population Toward COVID 19 in Ramadan | https://ClinicalTrials.gov/show/NCT04401072 |
| NCT04401371 | Distance Learning for Dental Student During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04401371 |
| NCT04400812 | Attitude and Perception Towards COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04400812 |
| NCT04400877 | Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04400877 |
| NCT04400461 | Short-term Physical Function Outcomes in Severe COVID-19 Patients Admitted to ICU for Invasive Mechanical Ventilation | https://ClinicalTrials.gov/show/NCT04400461 |
| NCT04400006 | Ozone Therapy in the Prevention of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04400006 |
| NCT04399603 | Mechanisms of Multi-organ Failure in COVID-19 | https://ClinicalTrials.gov/show/NCT04399603 |
| NCT04355702 | Covid-19 in Lupus Patients | https://ClinicalTrials.gov/show/NCT04355702 |
| NCT04397848 | Mental Health Outcomes in Healthcare Workers During COVID-19 | https://ClinicalTrials.gov/show/NCT04397848 |
| NCT04397835 | Psychological Impact of COVID-19 Quarantine and Worsening of Cardiovascular Risk in the French General Population | https://ClinicalTrials.gov/show/NCT04397835 |
| NCT04397822 | COVID-19 : Study of INFLAmmasome and PLAtelets Functions | https://ClinicalTrials.gov/show/NCT04397822 |
| NCT04397939 | Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04397939 |
| NCT04353401 | WGS Analysis of COVID-19 Positive Patients | https://ClinicalTrials.gov/show/NCT04353401 |
| NCT04397900 | Blood Collection Study From COVID-19 Convalescents Previously Hospitalized to Identify Immunogenic Viral Epitopes | https://ClinicalTrials.gov/show/NCT04397900 |
| NCT04397588 | Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19 | https://ClinicalTrials.gov/show/NCT04397588 |
| NCT04397172 | Intensive Care Associated Complications and Outcome of Acute Respiratory Distress Syndrome Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04397172 |
| NCT04397237 | Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in Europe | https://ClinicalTrials.gov/show/NCT04397237 |
| NCT04396197 | Physical Activity Levels in COVID-19 Patients Admitted to Intensive Care | https://ClinicalTrials.gov/show/NCT04396197 |
| NCT04396600 | The Professional Peer Resilience Initiative | https://ClinicalTrials.gov/show/NCT04396600 |
| NCT04396210 | Patients Perspectives on Discontinuation of Their Fertility Treatment Due to the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04396210 |
| NCT04396353 | EXercise TRAining and Sedentary Lifestyle on Clinical Outcomes in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04396353 |
| NCT04395885 | Sexual Function During COVID 19 Pandemic | https://ClinicalTrials.gov/show/NCT04395885 |
| NCT04395859 | Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents | https://ClinicalTrials.gov/show/NCT04395859 |
| NCT04395833 | National Survey on the Lockdown of Children With Disabilities | https://ClinicalTrials.gov/show/NCT04395833 |
| NCT04395755 | Impact of COVID-19 on Psychological Status in Case of IVF Interrupted or Postponed | https://ClinicalTrials.gov/show/NCT04395755 |
| NCT04395924 | Maternal-foetal Transmission of SARS-Cov-2 | https://ClinicalTrials.gov/show/NCT04395924 |
| NCT04395664 | Arrhythmias in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04395664 |
| NCT04395391 | Home Usability Study of the SARS-CoV-2 (COVID-19) Test | https://ClinicalTrials.gov/show/NCT04395391 |
| NCT04395482 | Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury | https://ClinicalTrials.gov/show/NCT04395482 |
| NCT04395300 | Sleep Quality in Healthcare Personnel During COVID-19 | https://ClinicalTrials.gov/show/NCT04395300 |
| NCT04394104 | COVID-19 Wellness Survey | https://ClinicalTrials.gov/show/NCT04394104 |
| NCT04394429 | Endotracheal Tube Obstruction in Covid-19 Patients Requiring Mechanical Ventilation | https://ClinicalTrials.gov/show/NCT04394429 |
| NCT04371692 | Prevalence of COVID-19 Infection Among HCW in a French University Hospital | https://ClinicalTrials.gov/show/NCT04371692 |
| NCT04394026 | Imaging Feature of SARS-CoV2 Infection | https://ClinicalTrials.gov/show/NCT04394026 |
| NCT04393974 | COVID-19 and Cancer Patients | https://ClinicalTrials.gov/show/NCT04393974 |
| NCT04394195 | sFlt1: a Biomarker of Organ Dysfunction in Critically-ill Patients With COVID-19? | https://ClinicalTrials.gov/show/NCT04394195 |
| NCT04393805 | Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO Study in Veneto | https://ClinicalTrials.gov/show/NCT04393805 |
| NCT04394078 | Impact of COVID-19 Pandemic on Depression and Quality of Life | https://ClinicalTrials.gov/show/NCT04394078 |
| NCT04393402 | Lung Ultrasound Score in Covid 19 Infectious Disease in Critical Care (LUS-COVID19) | https://ClinicalTrials.gov/show/NCT04393402 |
| NCT04393558 | Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms | https://ClinicalTrials.gov/show/NCT04393558 |
| NCT04393233 | Drug Management of Rheumatoid Arthritis in Covid-19 Context : Impact on Therapeutic De-escalation | https://ClinicalTrials.gov/show/NCT04393233 |
| NCT04393155 | COVID Cohort Study | https://ClinicalTrials.gov/show/NCT04393155 |
| NCT04393428 | Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04393428 |
| NCT04392245 | Proctologic Practice and Covid-19 | https://ClinicalTrials.gov/show/NCT04392245 |
| NCT04392401 | COVID-19 - Study of the Kinetics of the Immune Response During the Intensive Care Unit Stay in Adult Patients Infected With SARS-CoV-2: Multicentric Non Interventional Study | https://ClinicalTrials.gov/show/NCT04392401 |
| NCT04392388 | Health, Perception, Practices, Relations and Social Inequalities in the General Population During the Covid-19 Crisis | https://ClinicalTrials.gov/show/NCT04392388 |
| NCT04392089 | Effects of Cardiovascular and Pulmonary Optimization on Cerebral Oxygenation in COVID-19 Patients With Severe ARDS | https://ClinicalTrials.gov/show/NCT04392089 |
| NCT04391881 | Oral Manifestation of COVID 19 Patient: A Cross Sectional Study on Egyptian Population | https://ClinicalTrials.gov/show/NCT04391881 |
| NCT04391816 | COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study | https://ClinicalTrials.gov/show/NCT04391816 |
| NCT04391738 | Association Between BMI and COVID-19 | https://ClinicalTrials.gov/show/NCT04391738 |
| NCT04391166 | Validity of at Home Visual Acuity Measurements for Telemedicine During Corona Virus (COVID-19) Pandemic | https://ClinicalTrials.gov/show/NCT04391166 |
| NCT04390269 | Immunogenetics Predictors With COVID-19 | https://ClinicalTrials.gov/show/NCT04390269 |
| NCT04390165 | Malaysian COVID-19 Anosmia Study (Phase 1) - A Nationwide Multicentre Cross-Sectional Study | https://ClinicalTrials.gov/show/NCT04390165 |
| NCT04390126 | COVID-19 Related Lockdown Effects On Chronic Diseases | https://ClinicalTrials.gov/show/NCT04390126 |
| NCT04390074 | COVID-19 in the Swedish ICU-cohort: Risk Factors of Critical Care Admission and Intensive Care Mortality | https://ClinicalTrials.gov/show/NCT04390074 |
| NCT04389684 | Clinical and Psycho-social Impact of COVID-19 Related Confinement on Patients With Digestive Tumors | https://ClinicalTrials.gov/show/NCT04389684 |
| NCT04389567 | Famotidine Outpatient COVID-19 Treatment Study | https://ClinicalTrials.gov/show/NCT04389567 |
| NCT04389658 | Contagiousness and Immunogenicity Status of COVID-19 in Asymptomatic Population (COVID-19 CONDITION) | https://ClinicalTrials.gov/show/NCT04389658 |
| NCT04389645 | Interferon Gamma Induced Protein 10 (IP-10) in a Clinical Decision Support Protocol in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04389645 |
| NCT04388813 | Predictors of Severe COVID-19 Outcomes | https://ClinicalTrials.gov/show/NCT04388813 |
| NCT04388644 | Survey of Satisfaction on Traditional Chinese Medicine Jing-Guan-Fang (JGF) for COVID-19 Prevention | https://ClinicalTrials.gov/show/NCT04388644 |
| NCT04388618 | Investigating Anosmia and Ageusia in COVID-19 Adult Patients in Saudi Arabia | https://ClinicalTrials.gov/show/NCT04388618 |
| NCT04388579 | Screening Patients for a Strategic Shift to Pulmonary Telerehabilitation Because of COVID-19 | https://ClinicalTrials.gov/show/NCT04388579 |
| NCT04389515 | Postoperative Recovery Index, Patient Expectations and Satisfaction With Prenatal Care Instrument in Pregnant Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04389515 |
| NCT04389489 | Postpartum Sexual Function in Pregnant Women With COVID-19 | https://ClinicalTrials.gov/show/NCT04389489 |
| NCT04389463 | Patient Outcome of Cardiac Surgery During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04389463 |
| NCT04388670 | Epidemiological and Clinical Characteristics of Critically Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04388670 |
| NCT04388657 | COVID-19, bLOod Coagulation and Thrombosis | https://ClinicalTrials.gov/show/NCT04388657 |
| NCT04387968 | Epidemiological Study of the Covid-19 Presto Test - The “COVIDOR” Study | https://ClinicalTrials.gov/show/NCT04387968 |
| NCT04387838 | Study of the SARS-COV-2 (COVID-19) Serological Profile of an Army Training Hospital Staff | https://ClinicalTrials.gov/show/NCT04387838 |
| NCT04387799 | Determinants of COVID-19 Pneumonia (MC-19) | https://ClinicalTrials.gov/show/NCT04387799 |
| NCT04387786 | Dornase Alfa Administered to Patients With COVID-19 (DACOVID) | https://ClinicalTrials.gov/show/NCT04387786 |
| NCT04385069 | COVID-19 Hyperinflammation Syndrome (COV-HI): Protocol for a Rapidly Executed Cohort Study | https://ClinicalTrials.gov/show/NCT04385069 |
| NCT04387708 | Care in Patients Hospitalized for Anorexia Nervosa at the Time of the Coronavirus-19 Epidemic (QUALICOVID) | https://ClinicalTrials.gov/show/NCT04387708 |
| NCT04387279 | The Impact of COVID-19 on the Health Care Utilization of Inflammatory Bowel Disease | https://ClinicalTrials.gov/show/NCT04387279 |
| NCT04387643 | Protecting Health Care Workers During the COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04387643 |
| NCT04387214 | COVID-19 Pandemic and Academic Performance of Veterinary Students | https://ClinicalTrials.gov/show/NCT04387214 |
| NCT04386720 | Measurement of Airway Opening Pressure (AOP) in Patients With Acute Respiratory Distress Syndrom and With or Without Covid 19. | https://ClinicalTrials.gov/show/NCT04386720 |
| NCT04386460 | Covid-19 and Prevention of Malnutrition After Confinement by Dentists | https://ClinicalTrials.gov/show/NCT04386460 |
| NCT04386395 | Immune Changes in Severe COVID-19 Pulmonary Infections | https://ClinicalTrials.gov/show/NCT04386395 |
| NCT04386369 | Evaluation of Airway Pressure Release Ventilation in COVID-19 ARDS | https://ClinicalTrials.gov/show/NCT04386369 |
| NCT04386564 | Kidney Injury Severity and COVID-19 | https://ClinicalTrials.gov/show/NCT04386564 |
| NCT04386551 | Detection of COVID-19 in Saliva Collection | https://ClinicalTrials.gov/show/NCT04386551 |
| NCT04386512 | Clinical Epidemiology and Characteristics Of Covid-19 Cases Occurred In A Lymphoma Setting In The First Epidemic Phase (LymphoCov1) | https://ClinicalTrials.gov/show/NCT04386512 |
| NCT04386109 | Neonatal Complications of Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04386109 |
| NCT04386083 | Neurologic Manifestations of COVID-19 | https://ClinicalTrials.gov/show/NCT04386083 |
| NCT04386044 | Investigating the Role of Vitamin D in the Morbidity of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04386044 |
| NCT04385251 | International SARS-CoV-2 (COVID-19) Infection Observational Study | https://ClinicalTrials.gov/show/NCT04385251 |
| NCT04385238 | Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04385238 |
| NCT04385823 | Use of High Flow Nasal Cannula Oxygen and Covid-19 Acute Hypoxemic Respiratory Failure | https://ClinicalTrials.gov/show/NCT04385823 |
| NCT04385160 | Myeloproliferative Neoplasms (MPN) and COVID-19 | https://ClinicalTrials.gov/show/NCT04385160 |
| NCT04385147 | Advanced Endoscopy During COVID-19 | https://ClinicalTrials.gov/show/NCT04385147 |
| NCT04385121 | Psychological Impact of the Hospitalization of a Family Member in Intensive Care for Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04385121 |
| NCT04385004 | Clinical, Biological and Histological Pulmonary and Renal Damage Associated With the SARS-CoV-2 Syndrome in Patients Admitted in ICU | https://ClinicalTrials.gov/show/NCT04385004 |
| NCT04385212 | Outcomes in Hospitalized Older Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04385212 |
| NCT04384926 | Outcomes of Elective Cancer Surgery During the COVID-19 Pandemic Crisis | https://ClinicalTrials.gov/show/NCT04384926 |
| NCT04384887 | “Investigation of the Relationship Between New Coronary Virus Disease (COVID-19) and Anxiety and Depressive Symptoms in Pregnant Women” | https://ClinicalTrials.gov/show/NCT04384887 |
| NCT04384250 | Genetic Basis of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04384250 |
| NCT04384471 | Covid-19 Pandemic: Patients’ Experience in T1D | https://ClinicalTrials.gov/show/NCT04384471 |
| NCT04384419 | Death Number Perception in Depression, Anxiety, and Schizoypal Personnality in General Population (Covid-19 Pandemic) | https://ClinicalTrials.gov/show/NCT04384419 |
| NCT04384406 | COVID-19 Outbreak Consequences for Outpatients Followed in PRM | https://ClinicalTrials.gov/show/NCT04384406 |
| NCT04384705 | HDL Target of CoViD19 ? Analysis on the Caregivers of the Reunion University Hospital | https://ClinicalTrials.gov/show/NCT04384705 |
| NCT04384055 | Predicting Outcomes for Covid-19 Using Sonography | https://ClinicalTrials.gov/show/NCT04384055 |
| NCT04384042 | Malaysian COVID-19 Anosmia Study (Phase 2) - A Nationwide Multicentre Case-Control Study | https://ClinicalTrials.gov/show/NCT04384042 |
| NCT04383730 | Inhaled Sedation in COVID-19-related Acute Respiratory Distress Syndrome (ISCA): an International Research Data Study in the Recent Context of Widespread Disease Resulting From the 2019 (SARS-CoV2) Coronavirus Pandemics (COVID-19) | https://ClinicalTrials.gov/show/NCT04383730 |
| NCT04383886 | Evaluation of Emergency Department (ED) Staff Stress Level During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04383886 |
| NCT04383678 | Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04383678 |
| NCT04383652 | Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales | https://ClinicalTrials.gov/show/NCT04383652 |
| NCT04383483 | CoV-ICU Score, Intensive Care Unit, SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04383483 |
| NCT04383626 | Fear Among Dentists During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04383626 |
| NCT04383470 | Collaborative Outcomes Study on Health and Functioning During Infection Times During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04383470 |
| NCT04383444 | Surveillance of Individuals Following SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04383444 |
| NCT04382469 | Egyptian Initial Experience About 2019 Novel Corona Virus: Study of 48 Patients in Alexandria-Egypt Using Chest CT | https://ClinicalTrials.gov/show/NCT04382469 |
| NCT04382794 | Sitagliptin Treatment in Diabetic COVID-19 Positive Patients | https://ClinicalTrials.gov/show/NCT04382794 |
| NCT04382781 | Immunosupressive Treatment in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04382781 |
| NCT04382495 | The Impact of COVID-19 Pandemic on Cancer Care | https://ClinicalTrials.gov/show/NCT04382495 |
| NCT04382534 | A Cross-sectional and Cohort Study of COVID-19 Patients With Post - Discharge Dysfunction | https://ClinicalTrials.gov/show/NCT04382534 |
| NCT04382508 | Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults. | https://ClinicalTrials.gov/show/NCT04382508 |
| NCT04381273 | Oral Health and Psychosocial Factors During the Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04381273 |
| NCT04382417 | Prospective Observational Cohort Study of Critically Ill Patients With Covid-19 in Sweden | https://ClinicalTrials.gov/show/NCT04382417 |
| NCT04382235 | Non-invasive Ventilatory Support of Patients Affected by COVID-19 | https://ClinicalTrials.gov/show/NCT04382235 |
| NCT04382196 | Impact of COVID-19 on Mental Health of Health Care Workers | https://ClinicalTrials.gov/show/NCT04382196 |
| nct_id | brief_title | link |
|---|---|---|
| NCT04380766 | Covid-19 Pandemic and Pancreatic Surgery in Italy | https://ClinicalTrials.gov/show/NCT04380766 |
| NCT04380727 | Almitrine and COVID-19 Related Hypoxemia | https://ClinicalTrials.gov/show/NCT04380727 |
| NCT04379544 | Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19 | https://ClinicalTrials.gov/show/NCT04379544 |
| NCT04379440 | Geriatric Population COVID-19 Observational Study (GEROCOVIDobs) | https://ClinicalTrials.gov/show/NCT04379440 |
| NCT04379258 | Analysis of Mortality of Critically Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04379258 |
| NCT04378452 | Assessment of the Psycho-social Impact of COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04378452 |
| NCT04376398 | Survey: COVID-19 Patients Managed in the Operating Theatre of Belgian Hospitals | https://ClinicalTrials.gov/show/NCT04376398 |
| NCT04374045 | Testing for Dysautonomia in Patients Hospitalized for SARS-CoV-2 Infection (COVID-19) : COVIDANS Study | https://ClinicalTrials.gov/show/NCT04374045 |
| NCT04374110 | Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04374110 |
| NCT04373759 | Cardiac Arrest Incidence and Outcome Among Patients With COVID-19 in French ICUs | https://ClinicalTrials.gov/show/NCT04373759 |
| NCT04371744 | QT-Logs : Artificial Intelligence for QT Interval Analysis of ECG From Smartwatches in Patient Receiving Treatment for Covid-19 | https://ClinicalTrials.gov/show/NCT04371744 |
| NCT04371328 | Emergency Management in a Dedicated Respiratory Unit of Patients With a Possible COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04371328 |
| NCT04369300 | Anxiety And Depression During COVID-19 IN INDIA | https://ClinicalTrials.gov/show/NCT04369300 |
| NCT04368975 | ARDS Caused by COVID-19 | https://ClinicalTrials.gov/show/NCT04368975 |
| NCT04368143 | COVID-19 Immune Repertoire Sequencing | https://ClinicalTrials.gov/show/NCT04368143 |
| NCT04368065 | COVID-19 Active Research Experience (CARE) | https://ClinicalTrials.gov/show/NCT04368065 |
| NCT04367714 | Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19 | https://ClinicalTrials.gov/show/NCT04367714 |
| NCT04367350 | Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement | https://ClinicalTrials.gov/show/NCT04367350 |
| NCT04367207 | African Covid-19 Critical Care Outcomes Study | https://ClinicalTrials.gov/show/NCT04367207 |
| NCT04366986 | International Registry of Coronavirus (COVID-19) Exposure in Pregnancy | https://ClinicalTrials.gov/show/NCT04366986 |
| NCT04366206 | Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est | https://ClinicalTrials.gov/show/NCT04366206 |
| NCT04365322 | Study of Specific Viral Immune Responses Induced by SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04365322 |
| NCT04372199 | SEVERITY SCORE FOR COVID-19 PNEUMONIA | https://ClinicalTrials.gov/show/NCT04372199 |
| NCT04370821 | COVID-19 CHAMPS Study of Healthcare, First Responder and Service Workers | https://ClinicalTrials.gov/show/NCT04370821 |
| NCT04370067 | HUNgarian COronaVirus Disease-19 Epidemiological Research | https://ClinicalTrials.gov/show/NCT04370067 |
| NCT04368234 | Duke COVID-19 Shared Data and Specimen Repository | https://ClinicalTrials.gov/show/NCT04368234 |
| NCT04367857 | ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers | https://ClinicalTrials.gov/show/NCT04367857 |
| NCT04364984 | ARB, ACEi, DRi in COVID-19 | https://ClinicalTrials.gov/show/NCT04364984 |
| NCT04363632 | Prospective Analysis of Morbi-mortality of Patients With Cancers in Active Phase of Treatment Suspected or Diagnosed of a SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04363632 |
| NCT04361500 | Registry of COVID-19 Patients Treated With the Seraph 100 Microbind Affinity Blood Filter | https://ClinicalTrials.gov/show/NCT04361500 |
| NCT04361591 | COVID-19 in Liver Transplant Recipients | https://ClinicalTrials.gov/show/NCT04361591 |
| NCT04359927 | Long-term Effects of Coronavirus Disease 2019 on the Cardiovascular System: CV COVID-19 Registry | https://ClinicalTrials.gov/show/NCT04359927 |
| NCT04357639 | Impact of Long-term Protease Inhibitors in Patients Living With HIV on the Incidence of COVID-19 ( COVIP ) | https://ClinicalTrials.gov/show/NCT04357639 |
| NCT04357275 | The RIsk Stratification in COVID-19 Patients in the ICU Registry | https://ClinicalTrials.gov/show/NCT04357275 |
| NCT04354818 | Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA) | https://ClinicalTrials.gov/show/NCT04354818 |
| NCT04354701 | COVID-19 and Cancer Consortium Registry | https://ClinicalTrials.gov/show/NCT04354701 |
| NCT04352764 | ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings | https://ClinicalTrials.gov/show/NCT04352764 |
| NCT04351529 | Austrian COVID-19 Registry | https://ClinicalTrials.gov/show/NCT04351529 |
| NCT04358042 | PSYCHIATRIC Disorders and Covid-19 | https://ClinicalTrials.gov/show/NCT04358042 |
| NCT04356586 | Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms | https://ClinicalTrials.gov/show/NCT04356586 |
| NCT04354519 | The United Kingdom Multiple Sclerosis Register Covid-19 Substudy | https://ClinicalTrials.gov/show/NCT04354519 |
| NCT04353583 | Renal Outcome in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04353583 |
| NCT04349982 | ICU Trial in Critical Ill COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04349982 |
| NCT04348942 | A COVID-19 Symptom, Exposure and Immune Response Registry | https://ClinicalTrials.gov/show/NCT04348942 |
| NCT04347993 | A Prospective “Universal” Observational Database for COVID-19 | https://ClinicalTrials.gov/show/NCT04347993 |
| NCT04348227 | How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country’s ICU? | https://ClinicalTrials.gov/show/NCT04348227 |
| NCT04347798 | IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT | https://ClinicalTrials.gov/show/NCT04347798 |
| NCT04341766 | Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid (Coronavirus Disease) 19 | https://ClinicalTrials.gov/show/NCT04341766 |
| NCT04339881 | NOsocomial Dissemination Risk of SARS-Cov2 | https://ClinicalTrials.gov/show/NCT04339881 |
| NCT04337346 | Evaluation of Covid 19 Anxiety in Endometriosis Patients | https://ClinicalTrials.gov/show/NCT04337346 |
| NCT04336956 | Covid-19 Pediatric Observatory | https://ClinicalTrials.gov/show/NCT04336956 |
| NCT04347278 | Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 Registry | https://ClinicalTrials.gov/show/NCT04347278 |
| NCT04345536 | Prospective Quality Register of Patients With Confirmed Covid-19 at Oslo University Hospital | https://ClinicalTrials.gov/show/NCT04345536 |
| NCT04344912 | Impact of COVID19 Outbreak in Cardiac Acute Care | https://ClinicalTrials.gov/show/NCT04344912 |
| NCT04344249 | Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04344249 |
| NCT04344002 | LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID) | https://ClinicalTrials.gov/show/NCT04344002 |
| NCT04340479 | The Use of Ultrasound in Establishing COVID-19 Infection as Part of a Trauma Evaluation | https://ClinicalTrials.gov/show/NCT04340479 |
| NCT04340466 | French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study | https://ClinicalTrials.gov/show/NCT04340466 |
| NCT04336345 | Outcomes of Patients With COVID-19 in the Intensive Care Unit | https://ClinicalTrials.gov/show/NCT04336345 |
| NCT04335773 | COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology | https://ClinicalTrials.gov/show/NCT04335773 |
| NCT04334291 | International COVID19 Clinical Evaluation Registry, | https://ClinicalTrials.gov/show/NCT04334291 |
| NCT04333953 | COVID-19 in Patients With HIV | https://ClinicalTrials.gov/show/NCT04333953 |
| NCT04333875 | Morbidity and Mortality Due to Deferral of Aortic Valve Replacement in Patients With Severe Aortic Stenosis | https://ClinicalTrials.gov/show/NCT04333875 |
| NCT04331171 | Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients’ Triage | https://ClinicalTrials.gov/show/NCT04331171 |
| NCT04331574 | Renin-Angiotensin System Inhibitors and COVID-19 | https://ClinicalTrials.gov/show/NCT04331574 |
| NCT04329559 | COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study | https://ClinicalTrials.gov/show/NCT04329559 |
| NCT04327674 | The Use of Focused Lung Ultrasound in Patients Suspected of COVID-19 | https://ClinicalTrials.gov/show/NCT04327674 |
| NCT04327479 | Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04327479 |
| NCT04327570 | In-depth Immunological Investigation of COVID-19. | https://ClinicalTrials.gov/show/NCT04327570 |
| NCT04325412 | Cardiac complicAtions in Patients With SARS Corona vIrus 2 (COVID-19) regisTrY | https://ClinicalTrials.gov/show/NCT04325412 |
| NCT04325048 | Clinical Evaluation of Cordio Application in Adult COVID-19 Virus Positive Patients | https://ClinicalTrials.gov/show/NCT04325048 |
| NCT04323839 | COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY) | https://ClinicalTrials.gov/show/NCT04323839 |
| NCT04323592 | Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome | https://ClinicalTrials.gov/show/NCT04323592 |
| NCT04321811 | Behavior, Environment And Treatments for Covid-19 | https://ClinicalTrials.gov/show/NCT04321811 |
| NCT04320472 | Acute Encephalopathy in Critically Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04320472 |
| NCT04319016 | Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy | https://ClinicalTrials.gov/show/NCT04319016 |
| NCT04318314 | COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04318314 |
| NCT04315870 | Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy. | https://ClinicalTrials.gov/show/NCT04315870 |
| NCT04314271 | The Observational Study of Cardiac and Pulmonary Ultrasound and Evaluation of Treatment of Severe Patients With Novel Coronavirus Pneumonia | https://ClinicalTrials.gov/show/NCT04314271 |
| NCT04359602 | COVID-19 Recovered Volunteer Research Participant Pool Registry | https://ClinicalTrials.gov/show/NCT04359602 |
| NCT04953039 | Use of Saliva for COVID-19 Diagnosis | https://ClinicalTrials.gov/show/NCT04953039 |
| NCT04709120 | Analysis of Health Status of Сomorbid Adult COVID-19 Patients Hospitalised in Second Wave of SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04709120 |
| NCT05087394 | COVID19 Hospitilized in Clinica Pasteur of Neuquen (Argentina) | https://ClinicalTrials.gov/show/NCT05087394 |
| NCT05087160 | Socioeconomic Inequalities Exacerbated by Mitigation Measures to COVID-19 and Differences in Prematurity Prevalence | https://ClinicalTrials.gov/show/NCT05087160 |
| NCT05077189 | Temporomandibular Joint and COVID-19 | https://ClinicalTrials.gov/show/NCT05077189 |
| NCT04422470 | Registry of Patients With Hematologic Disease and COVID-19 in Russia | https://ClinicalTrials.gov/show/NCT04422470 |
| NCT04449042 | The PAWS-COVID-19 (Pediatric AirWay complicationS COVID-19) Registry | https://ClinicalTrials.gov/show/NCT04449042 |
| NCT05092568 | Comparison of General Characteristics of Patients Diagnosed of Pcr Positive Covid 19 Followed Ä°n Service | https://ClinicalTrials.gov/show/NCT05092568 |
| NCT04342806 | Healthcare Worker Exposure Response and Outcomes (HERO) Registry Study, COVID-19 | https://ClinicalTrials.gov/show/NCT04342806 |
| NCT04479488 | Brazilian Registry for Clinical Presentation of Individuals With COVID-19 (SARS-Brazil) | https://ClinicalTrials.gov/show/NCT04479488 |
| NCT05094687 | Cutaneous Manifestations of Coronavirus Disease 2019(COVID-19). | https://ClinicalTrials.gov/show/NCT05094687 |
| NCT04898166 | Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019 (COVID-19). | https://ClinicalTrials.gov/show/NCT04898166 |
| NCT04610515 | Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE) | https://ClinicalTrials.gov/show/NCT04610515 |
| NCT05097677 | Follow-up of Covid-19 Long Term Sequelae | https://ClinicalTrials.gov/show/NCT05097677 |
| NCT05075785 | Covid-19 Respiratory Sequelae French Cohort | https://ClinicalTrials.gov/show/NCT05075785 |
| NCT04345887 | Spironolactone in Covid-19 Induced ARDS | https://ClinicalTrials.gov/show/NCT04345887 |
| NCT05077202 | A New Scoring Model to Diagnose COVID-19 Using Lung Ultrasound in the Emergency Department | https://ClinicalTrials.gov/show/NCT05077202 |
| NCT05074407 | Neck Pain in Office Workers During Covid 19 Pandemic | https://ClinicalTrials.gov/show/NCT05074407 |
| NCT05067920 | Correlation Between Cycle Threshold (Ct) Values in COVID-19, Health Status and Laboratory Biomarkers in the Population of Medellin- Colombia Evaluated in a Specialized Laboratory. | https://ClinicalTrials.gov/show/NCT05067920 |
| NCT05064501 | Impact of COVID19 on Asthma | https://ClinicalTrials.gov/show/NCT05064501 |
| NCT05063214 | Muscle Evaluation of Patients Infected by the Coronavirus | https://ClinicalTrials.gov/show/NCT05063214 |
| NCT05052346 | Association of the Neutrophil/Lymphocyte Ratio With Pulmonary Complications and Mortality in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT05052346 |
| NCT05049200 | Characteristics of Weaning From Mechanical Ventilation in COVID-19 | https://ClinicalTrials.gov/show/NCT05049200 |
| NCT05048745 | Recurrent Appendicitis Following Successful Drainage of Appendicular Abscess in Adult | https://ClinicalTrials.gov/show/NCT05048745 |
| NCT05046002 | COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry | https://ClinicalTrials.gov/show/NCT05046002 |
| NCT05045885 | Safety and Feasibility of Percutaneous Dilatational Tracheostomy in Patients With Severe COVID-19 Supported by ECMO | https://ClinicalTrials.gov/show/NCT05045885 |
| NCT05026151 | Comparing Metabolic Characteristics of Persistent Critically Ill Non-COVID and COVID-19 Patients | https://ClinicalTrials.gov/show/NCT05026151 |
| NCT05018052 | Early and Late Complications of COVID-19 | https://ClinicalTrials.gov/show/NCT05018052 |
| NCT05012280 | Malaria as a Protection Factor Against Severe COVID-19 (Known as SARS-COV-2) in the Democratic Republic of Congo (Palu-COVID) | https://ClinicalTrials.gov/show/NCT05012280 |
| NCT05008991 | Lung Functions in Menopausal Obese Women After COVID 19 Recovery | https://ClinicalTrials.gov/show/NCT05008991 |
| NCT04997928 | PAI-1 Levels and Predicting Covid-19 Patients’ Prognosis | https://ClinicalTrials.gov/show/NCT04997928 |
| NCT04996784 | Pharmacokinetics of Dexamethasone in COVID-19 Obese Patients | https://ClinicalTrials.gov/show/NCT04996784 |
| NCT04990570 | Telemedicine (Virtual Clinic) for Pediatric Surgery During Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04990570 |
| NCT04979871 | SARS-CoV-2 Antibodies and Virus Neutralisation in a Cohort Vaccinted Against COVID-19 | https://ClinicalTrials.gov/show/NCT04979871 |
| NCT04979195 | Acute Kidney Injury Among COVID-19 Positive Patients | https://ClinicalTrials.gov/show/NCT04979195 |
| NCT04964115 | Post Acute Sequelae of COVID-19 | https://ClinicalTrials.gov/show/NCT04964115 |
| NCT04961476 | Use of 1-MNA to Improve Exercise Tolerance and Fatigue in Patients After COVID-19 | https://ClinicalTrials.gov/show/NCT04961476 |
| NCT04958304 | Moderna COVID-19 Vaccine mRNA-1273 Observational Pregnancy Outcome Study | https://ClinicalTrials.gov/show/NCT04958304 |
| NCT04949412 | Assessment of Vitamin D Level in COVID-19 | https://ClinicalTrials.gov/show/NCT04949412 |
| NCT04948242 | Characteristics of Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04948242 |
| NCT04948216 | Management and Healthcare Utilization of Patients With Chronic Airway Disease During the COVID-19 Epidemic | https://ClinicalTrials.gov/show/NCT04948216 |
| NCT04948515 | Gene Polymorphism of IL17 and IL 23 | https://ClinicalTrials.gov/show/NCT04948515 |
| NCT04945850 | Can COVID-19 Persist in Intraocular Fluid? | https://ClinicalTrials.gov/show/NCT04945850 |
| NCT04941053 | Seroprevalence of COVID-19 | https://ClinicalTrials.gov/show/NCT04941053 |
| NCT04933994 | Comparison of COVID-19 and H1N1 Influenza Pneumonia | https://ClinicalTrials.gov/show/NCT04933994 |
| NCT04929964 | COVID-19 Pandemic: Effect on Management of Patients With Breast Cancer | https://ClinicalTrials.gov/show/NCT04929964 |
| NCT04924855 | Immunity After COVID-19 Vaccination | https://ClinicalTrials.gov/show/NCT04924855 |
| NCT04922931 | Post-COVID 19 Patients Undergoing Surgery | https://ClinicalTrials.gov/show/NCT04922931 |
| NCT04920357 | Immune Response to Vaccination Against Covid-19, a Follow up Study | https://ClinicalTrials.gov/show/NCT04920357 |
| NCT04918901 | Comparative Analysis of Clinical Parameters and Radiographic Changes of Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04918901 |
| NCT04917549 | Prevalence of Oral Lesions in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04917549 |
| NCT04916561 | Detection of Covid-19 in Tissue Samples of Orthopedic Origin | https://ClinicalTrials.gov/show/NCT04916561 |
| NCT04907981 | Eye Detection to Identify Novel Coronavirus Infection | https://ClinicalTrials.gov/show/NCT04907981 |
| NCT04896905 | Rehabilitation After Covid19-Clinical Results and Predictive Factors | https://ClinicalTrials.gov/show/NCT04896905 |
| NCT04894253 | Immune Response to SARS-CoV-2 Vaccination in Systemic Lupus | https://ClinicalTrials.gov/show/NCT04894253 |
| NCT04893031 | Effect of Tocilizumab on Intensive Care Patients With COVID-19 Pneumonia, a Retrospective Cohort Study | https://ClinicalTrials.gov/show/NCT04893031 |
| NCT04508712 | Long-term Outcomes in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04508712 |
| NCT04885504 | Post COVID-19 Biorepository | https://ClinicalTrials.gov/show/NCT04885504 |
| NCT04883216 | Investigation of the Characteristics of Chronic Pain Developing After COVID-19 | https://ClinicalTrials.gov/show/NCT04883216 |
| NCT04877496 | Responses to COVID19 Vaccination in Patients With a Treatment History of Rituximab. | https://ClinicalTrials.gov/show/NCT04877496 |
| NCT04873141 | Tocilizumab and Cytokine Release Syndrome (CRS) In Covid-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04873141 |
| NCT04873336 | Closed Loop Ventilation in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04873336 |
| NCT04872725 | The Effect of Covid-19 Process | https://ClinicalTrials.gov/show/NCT04872725 |
| NCT04871867 | Cardiac and Lung Assessment of Professional Soccer Players Following COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04871867 |
| NCT04868864 | The Ontario Multi-Regional Hospital COVID-19 Registry (COREG)- Recovery Trajectory Sub-study | https://ClinicalTrials.gov/show/NCT04868864 |
| NCT04865900 | Prevalence of Perimyocarditis After Covid-19 Vaccine | https://ClinicalTrials.gov/show/NCT04865900 |
| NCT04864132 | The Investigation Of Exercise Capacity And Exercise-Induced Fatigue in Young Adults Who Survived From Coronavirus | https://ClinicalTrials.gov/show/NCT04864132 |
| NCT04863547 | Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04863547 |
| NCT04852796 | Efficacy and Safety of the Anti- COVID-19 Vaccin in Clinical Hematology Patients | https://ClinicalTrials.gov/show/NCT04852796 |
| NCT04845997 | COVID-19 Vaccination in Patients With Rheumatic Diseases | https://ClinicalTrials.gov/show/NCT04845997 |
| NCT04844515 | The ESPERES Prospective Cohort of Healthcare Workers in France: Study on COVID-19 Vaccine and the COVID-19 Pandemic (ESPERES_COVID19) | https://ClinicalTrials.gov/show/NCT04844515 |
| NCT04840953 | Negative Pressure Therapy, Minimally Invasive and Accessible Technique in the Treatment of Massive Subcutaneous Emphysema in COVID-19 or Non Infected Critical Patients | https://ClinicalTrials.gov/show/NCT04840953 |
| NCT04839107 | Institutional Registry on Outpatient and Hospitalized COVID-19 Infected Patients | https://ClinicalTrials.gov/show/NCT04839107 |
| NCT04836767 | Evaluation of Physical and Functional Status in Patients With COVID-19 in Long Term | https://ClinicalTrials.gov/show/NCT04836767 |
| NCT04830683 | Endothelial Dysfunction in Covid-19 | https://ClinicalTrials.gov/show/NCT04830683 |
| NCT04828915 | Early Detection of Clinical Deterioration in Patients With COVID-19 Using Machine Learning | https://ClinicalTrials.gov/show/NCT04828915 |
| NCT04826718 | SARS-CoV-2/COVID-19 Infection Among Health Care Workers | https://ClinicalTrials.gov/show/NCT04826718 |
| NCT04824313 | Vascular Abnormalities Detected With Chest CT in COVID-19 | https://ClinicalTrials.gov/show/NCT04824313 |
| NCT04824677 | Risk Factors and Prognoses in Patients Hospitalized for COVID-19 | https://ClinicalTrials.gov/show/NCT04824677 |
| NCT04823182 | Study of HEarT DiseAse and ImmuNiTy After COVID-19 in Ireland | https://ClinicalTrials.gov/show/NCT04823182 |
| NCT04819282 | Mask Usage and Physical Performance During COVID-19 Pandemic in Geriatrics | https://ClinicalTrials.gov/show/NCT04819282 |
| NCT04812041 | Relationship Between Delirium Severity by CAM-ICU 7 and 4C Mortality Score of the COVID-19 Patients in ICU | https://ClinicalTrials.gov/show/NCT04812041 |
| NCT04811456 | MultiOrgan Inflammatory Syndromes COVID-19 Related Study | https://ClinicalTrials.gov/show/NCT04811456 |
| NCT04806880 | Study Evaluating the Olfactory Recovery of Anosmia Post COVID-19 by Olfactory Rehabilitation Assisted by Web-application | https://ClinicalTrials.gov/show/NCT04806880 |
| NCT04807699 | Collaborative Network for Generating Scientific Evidence in COVID-19 For the Unified Health System in Brazil - RECOVER SUS-BRASIL | https://ClinicalTrials.gov/show/NCT04807699 |
| NCT04806620 | Comparison of ME/CFS and Long COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04806620 |
| NCT04800770 | The Effect of COVID-19 Patients’ Serum Phosphate Level on Mortality in ICU | https://ClinicalTrials.gov/show/NCT04800770 |
| NCT04799444 | LATE-COVID/LATE-COVID-Kids - Observational Study in Children and Adults | https://ClinicalTrials.gov/show/NCT04799444 |
| NCT04794387 | The Lymphoma and Leukemia Society Amended COVID-19 Registry | https://ClinicalTrials.gov/show/NCT04794387 |
| NCT04787510 | COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04787510 |
| NCT04780126 | Sarco-COVID Study: Measuring the Loss of Skeletal Muscle Mass in the Hospitalized Patient With the Diagnosis of COVID-19 | https://ClinicalTrials.gov/show/NCT04780126 |
| NCT04779268 | Large Scale ICU Data Sharing for 1000 Critically Ill Patients With Severe Acute Respiratory Distress Syndrome coronavirus2(SARS.COV2) in Three Distinct Isoltion Centers | https://ClinicalTrials.gov/show/NCT04779268 |
| NCT04779346 | Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Disease (COVID-19) in the Oncology Outpatient Setting | https://ClinicalTrials.gov/show/NCT04779346 |
| NCT04769154 | Airway Management in the Intensive Care and Regular Hospital Units During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04769154 |
| NCT04768413 | Evaluation of a Non-face to Face Multidisciplinary Health Care Model in a Population With Rheumatoid Arthritis | https://ClinicalTrials.gov/show/NCT04768413 |
| NCT04758039 | Clinical Characteristics and In-hospital Death of a Chilean COVID-19 Prospective Cohort | https://ClinicalTrials.gov/show/NCT04758039 |
| NCT04757285 | Copeptin and Psychological Stress of Medic During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04757285 |
| NCT04747678 | Adverse Effects of Ivermectin Used in Egypt During COVID-19 | https://ClinicalTrials.gov/show/NCT04747678 |
| NCT04747366 | Analysis of the Pathophysiology and Pathology of Coronavirus Disease 2019 (COVID-19), Including Chronic Morbidity | https://ClinicalTrials.gov/show/NCT04747366 |
| NCT04745611 | Neurological and Neuropsychological Sequelae of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04745611 |
| NCT04744415 | Hospitalizations During Pandemia in the Italian Coronary Care Unit Network | https://ClinicalTrials.gov/show/NCT04744415 |
| NCT04743388 | Study of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune System | https://ClinicalTrials.gov/show/NCT04743388 |
| NCT04741412 | Pediatric SARS-CoV-2 Infections: Course of COVID-19, Immune Responses, Complications and Long-term Consequences | https://ClinicalTrials.gov/show/NCT04741412 |
| NCT04741386 | The REnal Patients COVID-19 VACcination Immune Response (RECOVAC IR) Study | https://ClinicalTrials.gov/show/NCT04741386 |
| NCT04740320 | COVID-19 SARS-CoV-2 Screening Protocol | https://ClinicalTrials.gov/show/NCT04740320 |
| NCT04738721 | Physical Activity and Physical Fitness Parameters in COVID-19 Lockdown | https://ClinicalTrials.gov/show/NCT04738721 |
| NCT04733729 | Covid-19 in Hematological Malignancies | https://ClinicalTrials.gov/show/NCT04733729 |
| NCT04730934 | Effects of the COVID-19 Pandemic on Fibromyalgia Patients | https://ClinicalTrials.gov/show/NCT04730934 |
| NCT04729075 | Associations Between COVID-19 ARDS Treatment, Clinical Trajectories and Liberation From Mechanical Ventilator - an Analysis of the NorthCARDS Dataset | https://ClinicalTrials.gov/show/NCT04729075 |
| NCT04727372 | Social Acceptability of COVID-19 Vaccines in Pakistan | https://ClinicalTrials.gov/show/NCT04727372 |
| NCT04724707 | Russian Cardiovascular Registry of COVID-19 | https://ClinicalTrials.gov/show/NCT04724707 |
| NCT04720118 | Parkinson’s Disease and Experiences Throughout the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04720118 |
| NCT04711954 | HIV/COV in Ukraine-NL | https://ClinicalTrials.gov/show/NCT04711954 |
| NCT04709302 | Effects of COVID-19 on Endothelium in HIV-Positive Patients in Sub-Saharan Africa | https://ClinicalTrials.gov/show/NCT04709302 |
| NCT04705766 | KIDney Injury in Times of COVID-19 (KIDCOV) | https://ClinicalTrials.gov/show/NCT04705766 |
| NCT04705116 | COVID-19 Vaccines International Pregnancy Exposure Registry | https://ClinicalTrials.gov/show/NCT04705116 |
| NCT04702945 | Canadian COVID-19 Emergency Department Registry | https://ClinicalTrials.gov/show/NCT04702945 |
| NCT04694651 | Potential Acceptance of COVID-19 Vaccines in Healthcare Workers in Egypt | https://ClinicalTrials.gov/show/NCT04694651 |
| NCT04694573 | Multicenter CTS Pre-and Post-Transplantation Covid-19 Serum Studies | https://ClinicalTrials.gov/show/NCT04694573 |
| NCT04693975 | Social Distancing During the COVID-19 Pandemic and People Living With Chronic Respiratory Diseases | https://ClinicalTrials.gov/show/NCT04693975 |
| NCT04691895 | Gastrointestinal Symptoms in COVID-19 | https://ClinicalTrials.gov/show/NCT04691895 |
| NCT04690114 | COVID-10 in the Pediatric Population: SARS-CoV-2 Seropositivity | https://ClinicalTrials.gov/show/NCT04690114 |
| NCT04689477 | Non-invasive Characterization of Systemic Microvascular Reactivity by Near-infrared Diffuse Optical Spectroscopy in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04689477 |
| NCT04686721 | Observational Study for the Evaluation of Tracheal Stenosis in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04686721 |
| NCT04679168 | Study on Kidney Disease and EnviromenTal Chemical | https://ClinicalTrials.gov/show/NCT04679168 |
| NCT04678193 | COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy | https://ClinicalTrials.gov/show/NCT04678193 |
| NCT04673279 | Long-term COVID-19 Immune Response in a Vulnerable Neighbourhood in Argentina | https://ClinicalTrials.gov/show/NCT04673279 |
| NCT04668404 | Study of Coagulation Profile and Role of Heparin Like Effect in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04668404 |
| NCT04670003 | Spread Analysis of COVID-19 Outbreak in France by Self-assessment Web-application | https://ClinicalTrials.gov/show/NCT04670003 |
| NCT04668313 | COVID-19 Advanced Respiratory Physiology (CARP) Study | https://ClinicalTrials.gov/show/NCT04668313 |
| NCT04666779 | Access to Chiropractic Care During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04666779 |
| NCT04661657 | COvid-19 LongitUdinal Multiethnic BioImaging Assessment of CARDiovascular Sequelae Registry | https://ClinicalTrials.gov/show/NCT04661657 |
| NCT04661631 | Surgery and Lung Ultrasound in COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04661631 |
| NCT04659135 | ASCO Survey on COVID-19 in Oncology (ASCO) Registry | https://ClinicalTrials.gov/show/NCT04659135 |
| NCT04650191 | Surfactant Protein Genetic Variants in COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04650191 |
| NCT04641182 | Prone Position for Nonintubated Patients With COVID-19 and Hypoxemic Respiratory Failure | https://ClinicalTrials.gov/show/NCT04641182 |
| NCT04636021 | Restoring Non-Emergent Cardiovascular Care in the Peri- COVID-19 Era | https://ClinicalTrials.gov/show/NCT04636021 |
| NCT04632732 | Apelin; ACE2 and Biomarkers of Alveolar-capillary Permeability in SARS-cov-2 (COVID-19). | https://ClinicalTrials.gov/show/NCT04632732 |
| NCT04631172 | Covid-19 Anxiety and Phobia Levels of the Parents | https://ClinicalTrials.gov/show/NCT04631172 |
| NCT04629001 | Effect of Covid-19 on Outcomes of Pregnancy | https://ClinicalTrials.gov/show/NCT04629001 |
| NCT04626076 | International Registry of Healthcare Workers Exposed to COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04626076 |
| NCT04625036 | NO-mediated Vascular Function in Covid-19 Patient | https://ClinicalTrials.gov/show/NCT04625036 |
| NCT04623697 | Covid-19 Infection and New Onset Type 1 Diabetes | https://ClinicalTrials.gov/show/NCT04623697 |
| NCT04619368 | Post-intensive Care Follow-up of Patients Hospitalized for an Acute Respiratory Distress Syndrome Caused by COVID-19 | https://ClinicalTrials.gov/show/NCT04619368 |
| NCT04615676 | Prospective Evaluation of the Predictive Criteria of Severity for Respiratory Infection Due to COVID-19 Virus | https://ClinicalTrials.gov/show/NCT04615676 |
| NCT04615000 | SeroCovid<19: A Prospective Covid-19 Seroconversion Study in a Tertiary Pediatric Patient Cohort | https://ClinicalTrials.gov/show/NCT04615000 |
| NCT04613817 | Sero-prevalence COVID-19 Among Belgian Children | https://ClinicalTrials.gov/show/NCT04613817 |
| NCT04615026 | Prevalence of Thrombosis in COVID-Patients | https://ClinicalTrials.gov/show/NCT04615026 |
| NCT04613245 | Health-Related Quality of Life of Patients With Asthma During the Pandemic of COVID-19 | https://ClinicalTrials.gov/show/NCT04613245 |
| NCT04611269 | Clinical Characteristics and Outcomes of Patients With COVID-19 on Mechanical Ventilation in Argentina | https://ClinicalTrials.gov/show/NCT04611269 |
| NCT04609501 | Delivery During Covid-19 Pandemic: Implications for Obstetrics, Maternal Psychopathology, and Mother-Infant Relationship | https://ClinicalTrials.gov/show/NCT04609501 |
| NCT04609332 | Endothelial Damage and Angiogenesis Biomarkers During COVID-19 | https://ClinicalTrials.gov/show/NCT04609332 |
| NCT04606732 | CardioVascular Disease Progression and Prognosis in COVID-19 | https://ClinicalTrials.gov/show/NCT04606732 |
| NCT04605965 | WEAICOR: Wearables to Investigate the Long Term Cardiovascular and Behavioral Impacts of COVID-19 | https://ClinicalTrials.gov/show/NCT04605965 |
| NCT04604119 | Anxiety and Burnout in Anesthetists and Intensive Care Unit Nurses During Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04604119 |
| NCT04601090 | Survival Rates and Longterm Outcomes After COVID-19 | https://ClinicalTrials.gov/show/NCT04601090 |
| NCT04598347 | Evaluation of the Possible Vertical Transmission of SARS-CoV-2 Through Study of Amniotic Fluid and Chorionic Villi of Affected Pregnant Women for the COVID-19 | https://ClinicalTrials.gov/show/NCT04598347 |
| NCT04598256 | Endoscopic Procedures of Children in the Normalization Process of Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04598256 |
| NCT04583566 | Differential Expression of Cytokines, Transcriptome and miRNA in Coronavirus Disease 2019 (COVID-19) Egyptian’s Patients | https://ClinicalTrials.gov/show/NCT04583566 |
| NCT04583306 | The Salivary Raman COVID-19 Fingerprint | https://ClinicalTrials.gov/show/NCT04583306 |
| NCT04581187 | An Online-platform to Improve Patient-centered Care During the COVID-19 Pandemic: a GIMEMA Surveillance Program in Hematologic Malignancies | https://ClinicalTrials.gov/show/NCT04581187 |
| NCT04581135 | Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19 | https://ClinicalTrials.gov/show/NCT04581135 |
| NCT04581096 | Mapping COVID-19 Spread in a Tertiary Hospital | https://ClinicalTrials.gov/show/NCT04581096 |
| NCT04573868 | National Study “AEC COVID-19” | https://ClinicalTrials.gov/show/NCT04573868 |
| NCT04568421 | Argentinian Registry of Patients With Rheumatic Diseases and COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04568421 |
| NCT04568005 | Evaluation of Lymphedema Patients Status During Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04568005 |
| NCT04560608 | Elucidating the Symptomatic, Explanatory and Prognostic Characteristics of GERIAtric Patients Hospitalized for COVID-19 | https://ClinicalTrials.gov/show/NCT04560608 |
| NCT04559009 | COVID-19 Amyotrophic Lateral Sclerosis (ALS) Registry | https://ClinicalTrials.gov/show/NCT04559009 |
| NCT04558996 | Spanish Registry of Pregnant Women With COVID-19 | https://ClinicalTrials.gov/show/NCT04558996 |
| NCT04558203 | The Relationship Between COVID-19 and Autoimmune Diseases, Lessons From Practice | https://ClinicalTrials.gov/show/NCT04558203 |
| NCT04553575 | CoViD-19 Patient in Reims University Hospital in March to April 2020 | https://ClinicalTrials.gov/show/NCT04553575 |
| NCT04553055 | Antibiotic Misuse During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04553055 |
| NCT04546191 | Symptoms and Wellbeing of People Infected With Covid-19 Virus in Iceland | https://ClinicalTrials.gov/show/NCT04546191 |
| NCT04544878 | Pediatric Intensive Care and COVID-19 | https://ClinicalTrials.gov/show/NCT04544878 |
| NCT04542954 | Optimized Management of Covid-19 Positive Kidney Transplant Recipients: Single Center Experience From the Middle East | https://ClinicalTrials.gov/show/NCT04542954 |
| NCT04542512 | Risk Factors for Necrotic Cholecystitis During COVID-19 Pandemic. | https://ClinicalTrials.gov/show/NCT04542512 |
| NCT04535128 | COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications | https://ClinicalTrials.gov/show/NCT04535128 |
| NCT04533360 | Prevalence of COVID-19 Antibodies Kingman AZ | https://ClinicalTrials.gov/show/NCT04533360 |
| NCT04532632 | Taste and Smell Impairment in Critically Ill COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04532632 |
| NCT04531202 | CORE Study COVID-19 | https://ClinicalTrials.gov/show/NCT04531202 |
| NCT04527315 | COVID-19 Survivorship Registry | https://ClinicalTrials.gov/show/NCT04527315 |
| NCT04521088 | Epidemiological Analysis of Ambulant Patients in a COVID-19 Outpatient Clinic | https://ClinicalTrials.gov/show/NCT04521088 |
| NCT04517630 | Renal Biomarkers in AKI and COVID-19 | https://ClinicalTrials.gov/show/NCT04517630 |
| NCT04515199 | Home Management of Adult Egyptian Mild COVID-19 Cases | https://ClinicalTrials.gov/show/NCT04515199 |
| NCT04511429 | COVID-19 in Immunosuppressed Children | https://ClinicalTrials.gov/show/NCT04511429 |
| NCT04508920 | A Survey to Assess Effects of Covid-19 on Cardiovascular Patients | https://ClinicalTrials.gov/show/NCT04508920 |
| NCT04508959 | The McMaster Multi-Regional COVID-19 Hospital Case Registry | https://ClinicalTrials.gov/show/NCT04508959 |
| NCT04505709 | Clinical, Immunological, Genomic, Virological and Bioethical Actors of COVID-19 | https://ClinicalTrials.gov/show/NCT04505709 |
| NCT04506528 | The C3I COVID-19 Project | https://ClinicalTrials.gov/show/NCT04506528 |
| NCT04503434 | Patients’ Experiences in a Medicalized Hotel for COVID-19 Acute Care Support | https://ClinicalTrials.gov/show/NCT04503434 |
| NCT04503057 | Exhaled Breath Particles as a Clinical Indicator for Lung Injury and Acute Respiratory Distress Syndrome (ARDS) | https://ClinicalTrials.gov/show/NCT04503057 |
| NCT04498546 | Mask Usage and Exercise During the COVÄ°D-19 Pandemic | https://ClinicalTrials.gov/show/NCT04498546 |
| NCT04497402 | Sex-Informed Data in the COVID-19 Pandemic. | https://ClinicalTrials.gov/show/NCT04497402 |
| NCT04497194 | Registry of COVID-19 Patients at AOUI Verona | https://ClinicalTrials.gov/show/NCT04497194 |
| NCT04490837 | Rapid Diagnostic Test for COVID-19 Based on Antibody Detection (YCOVID) | https://ClinicalTrials.gov/show/NCT04490837 |
| NCT04488562 | Home Monitoring and Evaluation After Admission for COVID-19 in the Netherlands | https://ClinicalTrials.gov/show/NCT04488562 |
| NCT04482361 | SERO-EPIDEMIOLOGY OF SARS-COV2 INFECTION IN THE AUTONOMOUS CITY OF BUENOS AIRES | https://ClinicalTrials.gov/show/NCT04482361 |
| NCT04481646 | Novel Face Mask Sampling for COVID-19: A Diagnostic and Public Health Tool | https://ClinicalTrials.gov/show/NCT04481646 |
| NCT04479150 | Complications and Mortality Following Emergency Digestive Surgery During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04479150 |
| NCT04472078 | Seroprevalence of Coronavirus Disease 2019 (COVID-19) Antibodies in a Vulnerable Neighbourhood, Buenos Aries Argentina | https://ClinicalTrials.gov/show/NCT04472078 |
| NCT04466306 | Pediatric Acute Kidney Injury in COVID-19 | https://ClinicalTrials.gov/show/NCT04466306 |
| NCT04465474 | Coronavirus Disease 2019 (COVID-19) During Pregnancy: Prevalence of Seroconversion, Effect on Maternal and Perinatal Outcomes and Risk of Vertical Transmission (COVID-MAP) | https://ClinicalTrials.gov/show/NCT04465474 |
| NCT04463862 | COVID - AirPollution | https://ClinicalTrials.gov/show/NCT04463862 |
| NCT04460196 | Healthcare Renunciation During the Confinement Period in Connection With the COVID-19 Epidemic in Adult Emergency Departments | https://ClinicalTrials.gov/show/NCT04460196 |
| NCT04460170 | COVID-19 Follow up Intensive Care Studies | https://ClinicalTrials.gov/show/NCT04460170 |
| NCT04459689 | COVID-19 in PID Survey | https://ClinicalTrials.gov/show/NCT04459689 |
| NCT04459364 | The Prevalence of Pulmonary Hypertension in Patients With COVID-19. | https://ClinicalTrials.gov/show/NCT04459364 |
| NCT04457505 | One Year Follow-ups of Patients Admitted to Spanish Intensive Care Units Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04457505 |
| NCT04456036 | Rehabilitation Needs and Functional Recovery in Covid-19 Acute and Post-acute Care | https://ClinicalTrials.gov/show/NCT04456036 |
| NCT04455347 | Cardiac and Thoracic Imaging in Pediatric Patients With Evidence of Systemic Inflammation COVID19 Linked | https://ClinicalTrials.gov/show/NCT04455347 |
| NCT04453579 | Bariatric Surgery During Lockdown, Impact of COVID-19 on Physical and Mental Health | https://ClinicalTrials.gov/show/NCT04453579 |
| NCT04453748 | The Assessment of the Prevalence, Clinical Course and Treatment of COVID-19 Complications | https://ClinicalTrials.gov/show/NCT04453748 |
| NCT04451902 | COVID-19 and Rare Skin Diseases European Observational Study During an Epidemic | https://ClinicalTrials.gov/show/NCT04451902 |
| NCT04450277 | Delivery of Protocolised Emergency Surgical Care During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04450277 |
| NCT04445402 | Pediatrics HOT COVID-19 Database in NY Tristate | https://ClinicalTrials.gov/show/NCT04445402 |
| NCT04444310 | Antibody Responses in Contacts of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04444310 |
| NCT04443140 | Preeclampsia-like Syndrome Induced by COVID-19: Is it a Real Public Health Issue in Pregnancy During the Pandemic? | https://ClinicalTrials.gov/show/NCT04443140 |
| NCT04441710 | Caregiver Serological Monitoring Extended Secondarily to Patients With the SARS-CoV-2 Coronavirus | https://ClinicalTrials.gov/show/NCT04441710 |
| NCT04441372 | Prognostication of Oxygen Requirement in Non-severe SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04441372 |
| NCT04435457 | Cardiovascular Implications of COVID-19 | https://ClinicalTrials.gov/show/NCT04435457 |
| NCT04435041 | Remote-by-Default Care in the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04435041 |
| NCT04433871 | COVID-19 in Pediatric Oncology and Hematology Centers in France | https://ClinicalTrials.gov/show/NCT04433871 |
| NCT04434144 | A Comparative Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh | https://ClinicalTrials.gov/show/NCT04434144 |
| NCT04433364 | COPE - COVID-19 in Pregnancy and Early Childhood | https://ClinicalTrials.gov/show/NCT04433364 |
| NCT04431869 | In-Utero Vascular Accidents in Neonates From COVID-19 Infected Mothers | https://ClinicalTrials.gov/show/NCT04431869 |
| NCT04430374 | Registry for a Cardiovascular Patient Who COVID-19 Infection in Qatar and Gulf | https://ClinicalTrials.gov/show/NCT04430374 |
| NCT04429477 | Cerebral Compliance Impairment in COVID-19 | https://ClinicalTrials.gov/show/NCT04429477 |
| NCT04426084 | Cardiovascular Risk Factors and Severe COVID-19. A Nationwide Registry-based Case-Control Study | https://ClinicalTrials.gov/show/NCT04426084 |
| NCT04425759 | Prevalence and Risk Factors of SARS-CoV-2 Antibody Responses (COVID-19) | https://ClinicalTrials.gov/show/NCT04425759 |
| NCT04423003 | Endoscopic Interventions in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04423003 |
| NCT04422587 | Evaluation of the COVID-19 Infection Response in Patients Admitted to the Emergency Department for Dyspnea | https://ClinicalTrials.gov/show/NCT04422587 |
| NCT04422444 | Post Intensive Care Syndrome in COVID19 Patients | https://ClinicalTrials.gov/show/NCT04422444 |
| NCT04418557 | COVID-19 and Obstetric Transmission | https://ClinicalTrials.gov/show/NCT04418557 |
| NCT04416009 | Extracellular Water in Covid 19 Pneumonia | https://ClinicalTrials.gov/show/NCT04416009 |
| NCT04413955 | Registry of Seraph®-100 Microbind® Affinity Blood Filter for COVID-19 Under EUA | https://ClinicalTrials.gov/show/NCT04413955 |
| NCT04412317 | Use of PCR-Sars-CoV-2 in Children | https://ClinicalTrials.gov/show/NCT04412317 |
| NCT04412551 | Lung Ultrasound for Assessment of Patients With Moderate to Severe Covid-19 | https://ClinicalTrials.gov/show/NCT04412551 |
| NCT04412382 | Covid-19: Possible Role of Neutrophil Extracellular Traps | https://ClinicalTrials.gov/show/NCT04412382 |
| NCT04411563 | Epigenetic Tools as Prognostic Predictors in Covid19 | https://ClinicalTrials.gov/show/NCT04411563 |
| NCT04410471 | Humoral Immunity Against SARS-CoV-2 in Liver Transplanted Patients After COVID-19 in Comparison With Immunocompetent Patients | https://ClinicalTrials.gov/show/NCT04410471 |
| NCT04408339 | COVID-19 in Cancer Patients: Evaluation of Clinical Course and Impact on Oncological Care Including Biobanking | https://ClinicalTrials.gov/show/NCT04408339 |
| NCT04403672 | Performance Evaluation of RealDetectâ„¢ COVID-19 RT-PCR Kit for the Detection of SARS-CoV-2 Virus | https://ClinicalTrials.gov/show/NCT04403672 |
| NCT04401540 | Characteristics of Neonatal Covid-19 in Turkey | https://ClinicalTrials.gov/show/NCT04401540 |
| NCT04401033 | Increased Risk of SARS-CoronaVirus-2 (SARS-CoV-2) Infection Associated With Endoscopy (DECORE Study) | https://ClinicalTrials.gov/show/NCT04401033 |
| NCT04398264 | Characteristics of COVID-19 Infection Among PREGnant Women | https://ClinicalTrials.gov/show/NCT04398264 |
| NCT04397575 | The GCO-002 CACOVID-19 Cohort: a French Nationwide Multicenter Study of COVID-19 Infected Cancer Patients | https://ClinicalTrials.gov/show/NCT04397575 |
| NCT04395794 | SARS-CoV-2 Disguise Study | https://ClinicalTrials.gov/show/NCT04395794 |
| NCT04395781 | Pediatric Acute and Critical Care COVID-19 Registry of Asia | https://ClinicalTrials.gov/show/NCT04395781 |
| NCT04394390 | Do Vitamin D Levels Really Correlated With Disease Severity in COVID-19 Patients? | https://ClinicalTrials.gov/show/NCT04394390 |
| NCT04394000 | Impact of an Intensified Thromboprofylaxis Protocol in COVID-19 | https://ClinicalTrials.gov/show/NCT04394000 |
| NCT04393324 | The Critical Care Response to the COVID-19 Pandemic in Madrid | https://ClinicalTrials.gov/show/NCT04393324 |
| NCT04393142 | Serologic Testing of Household Contacts of Confirmed Cases of COVID-19 | https://ClinicalTrials.gov/show/NCT04393142 |
| NCT04391946 | Observatory of Patients With Chronic Lymphocytic Leukemia / Lymphocytic Lymphoma or Waldenstrom Disease Infected With COVID-19 | https://ClinicalTrials.gov/show/NCT04391946 |
| NCT04391920 | Registry of CytoSorb Therapy in COVID-19 ICU Patients | https://ClinicalTrials.gov/show/NCT04391920 |
| NCT04391686 | Resting Energy Expenditure of the COronaVirus (COVID19) Patient in Reanimation Context | https://ClinicalTrials.gov/show/NCT04391686 |
| NCT04390555 | The Global PCHF-COVICAV Registry | https://ClinicalTrials.gov/show/NCT04390555 |
| NCT04389996 | COVID-19 Pandemic Impact on Patients With Cancer - a Danish Survey | https://ClinicalTrials.gov/show/NCT04389996 |
| NCT04389554 | D-dimer Levels in Pregnant With COVID-19 | https://ClinicalTrials.gov/show/NCT04389554 |
| NCT04388631 | Detection Rate of SARS-CoV-2 in Male Genitourinary System and Its Impact on Male Reproductive Health. | https://ClinicalTrials.gov/show/NCT04388631 |
| NCT04388605 | Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic | https://ClinicalTrials.gov/show/NCT04388605 |
| NCT04388436 | Post Covid-19 Cardiopulmonary and Immunological Changes | https://ClinicalTrials.gov/show/NCT04388436 |
| NCT04387929 | Detection of Anti-COVID-19 Antibody Levels in an Hospital Population | https://ClinicalTrials.gov/show/NCT04387929 |
| NCT04386265 | Compassionate Use of Hyperbaric Oxygen Therapy | https://ClinicalTrials.gov/show/NCT04386265 |
| NCT04385797 | Cognitive Outcomes During COVID-19 confiNemeNt in Elderly and Their Caregivers Using Technologies for DEMentia | https://ClinicalTrials.gov/show/NCT04385797 |
| NCT04383457 | Covid-19 Triage Using Camera-based AI | https://ClinicalTrials.gov/show/NCT04383457 |